,go_term,negative_log_p_value,fold_enrichment
0,anterior/posterior pattern specification (GO:0009952),18.931229083906324,8.769888597640891
1,regionalization (GO:0003002),17.715747560557034,6.450187969924813
2,pattern specification process (GO:0007389),15.826335999987434,5.148859018443264
3,cellular metabolic process (GO:0044237),15.29415296232424,0.40072012456208644
4,primary metabolic process (GO:0044238),14.618241888195515,0.44762234168708986
5,metabolic process (GO:0008152),14.48915954914379,0.48834530983713126
6,nitrogen compound metabolic process (GO:0006807),13.683316216320478,0.4383436235895253
7,organic substance metabolic process (GO:0071704),13.27855193128732,0.49677425341969966
8,macromolecule metabolic process (GO:0043170),12.591388106197636,0.42082020823815136
9,regulation of transcription by RNA polymerase II (GO:0006357),12.252631619118384,2.1444523626795307
10,cell population proliferation (GO:0008283),11.534345492255891,3.482023477914843
11,neuron fate commitment (GO:0048663),11.433467346448486,12.97626050420168
12,animal organ development (GO:0048513),11.337688394994638,1.9433817718851523
13,"phagocytosis, recognition (GO:0006910)",11.295464077599126,9.621028037383176
14,anatomical structure development (GO:0048856),11.276833268394178,1.686779326816263
15,defense response to bacterium (GO:0042742),11.233680481920269,4.69354103343465
16,multicellular organism development (GO:0007275),11.17931029638173,1.773954250574402
17,anatomical structure morphogenesis (GO:0009653),10.986327950442103,2.1694776167060477
18,cellular response to stress (GO:0033554),10.79354707521486,0.0
19,"complement activation, classical pathway (GO:0006958)",10.542109887967754,8.50785123966942
20,central nervous system development (GO:0007417),10.49282498031138,2.844570323293728
21,regulation of ossification (GO:0030278),10.491913925737284,8.438114754098361
22,regulation of B cell activation (GO:0050864),10.447776929369615,5.935329916720051
23,humoral immune response mediated by circulating immunoglobulin (GO:0002455),10.343944033379461,8.235600000000002
24,neuroblast proliferation (GO:0007405),10.269145433967159,14.706428571428571
25,positive regulation of B cell activation (GO:0050871),10.258285861864243,6.722938775510205
26,embryo development (GO:0009790),10.162347525105577,2.7774180493727236
27,positive regulation of lymphocyte activation (GO:0051251),10.156665916185222,4.191856124872753
28,B cell receptor signaling pathway (GO:0050853),10.152511162387224,7.980232558139535
29,"phagocytosis, engulfment (GO:0006911)",10.013113234485951,7.798863636363636
30,nucleosome assembly (GO:0006334),9.771680002170582,9.488018433179723
31,developmental process (GO:0032502),9.760187914114542,1.5802221998540475
32,embryonic morphogenesis (GO:0048598),9.684252302046403,3.4837563451776647
33,complement activation (GO:0006956),9.657645654547576,7.3532142857142855
34,plasma membrane invagination (GO:0099024),9.614782078835713,7.301063829787234
35,cell fate commitment (GO:0045165),9.593684304850939,5.294314285714286
36,system development (GO:0048731),9.544087990502607,1.7626256234646018
37,neural precursor cell proliferation (GO:0061351),9.389987717030802,8.823857142857143
38,membrane invagination (GO:0010324),9.323806403060685,6.9557432432432424
39,regulation of DNA-templated transcription (GO:0006355),9.200556307480985,1.7882744643891142
40,regulation of nucleic acid-templated transcription (GO:1903506),9.191883541605241,1.7872395833333332
41,nucleobase-containing compound metabolic process (GO:0006139),9.173955663880646,0.2602907711757269
42,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),9.164311150347281,4.9946361185983825
43,positive regulation of leukocyte activation (GO:0002696),9.154553823222304,3.7628388668900397
44,multicellular organismal process (GO:0032501),9.049702623925118,1.49723554822324
45,cellular macromolecule metabolic process (GO:0044260),8.868937619329182,0.23362078747305118
46,positive regulation of cell activation (GO:0050867),8.830345796636406,3.6312169312169313
47,fear response (GO:0042596),8.79950244685612,16.340476190476192
48,regulation of RNA biosynthetic process (GO:2001141),8.794206793701198,1.7825974025974027
49,heterocycle metabolic process (GO:0046483),8.776477695980818,0.2942266469775639
50,nervous system development (GO:0007399),8.63869742118115,2.0136597770098454
51,animal organ morphogenesis (GO:0009887),8.612371283493758,2.639239424583393
52,antigen receptor-mediated signaling pathway (GO:0050851),8.544930099069852,5.205815423514538
53,pancreas development (GO:0031016),8.530304927812761,9.936776061776062
54,regulation of lymphocyte activation (GO:0051249),8.360135217989754,3.234916606236403
55,skeletal system development (GO:0001501),8.309762889405516,3.426740638002774
56,nucleosome organization (GO:0034728),8.229221674392267,7.0590857142857155
57,adrenal chromaffin cell differentiation (GO:0061104),8.21954860846738,147.06428571428572
58,muscle organ development (GO:0007517),8.171007294142877,4.353876879699249
59,regulation of bone mineralization (GO:0030500),8.132855924713024,9.07804232804233
60,embryonic skeletal system development (GO:0048706),8.067264394250781,6.8401993355481725
61,macromolecule modification (GO:0043412),8.051445846058717,0.306065110747733
62,leukocyte mediated immunity (GO:0002443),8.031896752408342,4.269608294930876
63,tissue development (GO:0009888),8.028125419363713,2.130131600728356
64,endocrine system development (GO:0035270),8.027641829086644,6.787582417582417
65,ventral spinal cord development (GO:0021517),7.927494352826677,12.788198757763974
66,cell fate specification (GO:0001708),7.921744339871076,8.650840336134454
67,regulation of RNA metabolic process (GO:0051252),7.862315950086956,1.6854382424611636
68,immunoglobulin mediated immune response (GO:0016064),7.789358707514616,5.36171875
69,autonomic nervous system development (GO:0048483),7.776209168834168,12.255357142857143
70,lymphocyte mediated immunity (GO:0002449),7.7097914675937,4.577876598110061
71,B cell mediated immunity (GO:0019724),7.670200869181871,5.252295918367347
72,organonitrogen compound metabolic process (GO:1901564),7.637785174802684,0.49872189450286397
73,cell differentiation in spinal cord (GO:0021515),7.631207978899434,11.765142857142857
74,regulation of multicellular organismal development (GO:2000026),7.532587299964716,2.2330802603036877
75,neuromuscular process (GO:0050905),7.506107739356343,6.1276785714285715
76,regulation of neural precursor cell proliferation (GO:2000177),7.483207697973113,7.822568389057751
77,regulation of cell activation (GO:0050865),7.413752052930121,2.7785425101214574
78,humoral immune response (GO:0006959),7.403373880172488,3.9043615676359034
79,nucleic acid metabolic process (GO:0090304),7.393885194268494,0.2584609590760733
80,sympathetic nervous system development (GO:0048485),7.382683672249982,20.05422077922078
81,adaptive immune response (GO:0002250),7.349776494548777,2.901116410145242
82,cellular nitrogen compound metabolic process (GO:0034641),7.274298478778376,0.4115988964855464
83,muscle structure development (GO:0061061),7.261326841983202,3.241898081878042
84,response to bacterium (GO:0009617),7.247269380606097,2.730636604774536
85,sensory organ development (GO:0007423),7.242686540834104,3.0322533136966126
86,regulation of biomineral tissue development (GO:0070167),7.17238010770139,7.28041018387553
87,tumor necrosis factor-mediated signaling pathway (GO:0033209),7.166832164535604,10.3203007518797
88,immune response-activating cell surface receptor signaling pathway (GO:0002429),7.097500122524854,4.157294295810197
89,immune response-activating signal transduction (GO:0002757),7.097500122524854,4.157294295810197
90,regulation of biomineralization (GO:0110149),7.087869813575585,7.139042995839112
91,anterior/posterior axis specification (GO:0009948),7.044956419470204,9.970460048426151
92,regulation of leukocyte activation (GO:0002694),7.013968938570637,2.7950814536340856
93,noradrenergic neuron development (GO:0003358),6.980110305025168,58.82571428571429
94,protein metabolic process (GO:0019538),6.857681000310129,0.4501967930029155
95,generation of neurons (GO:0048699),6.820645046492444,2.334353741496599
96,skeletal system morphogenesis (GO:0048705),6.809144805378344,4.5151315789473685
97,regulation of macromolecule biosynthetic process (GO:0010556),6.798488389205184,1.6058314590437495
98,cellular aromatic compound metabolic process (GO:0006725),6.764022518003678,0.3857423887587822
99,cell recognition (GO:0008037),6.76016360871625,4.475869565217391
100,embryonic hindlimb morphogenesis (GO:0035116),6.742227605497611,15.756887755102042
101,regulation of nervous system development (GO:0051960),6.728971590104501,3.2536346396965867
102,embryonic organ morphogenesis (GO:0048562),6.712660477084477,3.9086853345989563
103,embryonic organ development (GO:0048568),6.696706562471223,3.239301447451227
104,protein modification process (GO:0036211),6.632178757915072,0.33197355691712355
105,regulation of cellular biosynthetic process (GO:0031326),6.611269889474965,1.5774813679738109
106,neurogenesis (GO:0022008),6.565752565418709,2.1660631229235885
107,eye development (GO:0001654),6.551217681252666,3.4468191964285713
108,cell differentiation (GO:0030154),6.5008510375666555,1.629868469126781
109,visual system development (GO:0150063),6.481725834433526,3.4112849779086893
110,spinal cord motor neuron differentiation (GO:0021522),6.470883772743447,14.232027649769586
111,neuroepithelial cell differentiation (GO:0060563),6.470883772743447,14.232027649769586
112,neuron differentiation (GO:0030182),6.467027562918977,2.3475050301810865
113,positive regulation of gastrulation (GO:2000543),6.449985247795642,42.01836734693878
114,T-helper 2 cell differentiation (GO:0045064),6.449985247795642,42.01836734693878
115,immune effector process (GO:0002252),6.445246264343685,3.1290273556231005
116,cellular developmental process (GO:0048869),6.440779711790319,1.6192849076389448
117,immune response-regulating cell surface receptor signaling pathway (GO:0002768),6.432669430937237,3.7349659863945575
118,head development (GO:0060322),6.428758712216292,2.5017010935601456
119,phosphate-containing compound metabolic process (GO:0006796),6.396395975983427,0.23783981517135153
120,phosphorus metabolic process (GO:0006793),6.395259135797454,0.2345522898154477
121,regulation of developmental process (GO:0050793),6.393996831571919,1.772570739826666
122,sensory system development (GO:0048880),6.379223253405725,3.3593364757070336
123,cell communication (GO:0007154),6.252299475754098,1.4590803337433813
124,regulation of nucleobase-containing compound metabolic process (GO:0019219),6.242957854015738,1.5548965541466158
125,norepinephrine biosynthetic process (GO:0042421),6.231273910465392,36.76607142857143
126,phagocytosis (GO:0006909),6.20982974660815,4.052952755905512
127,negative regulation of neuron differentiation (GO:0045665),6.202901017060321,7.843428571428572
128,multicellular organismal response to stress (GO:0033555),6.202901017060321,7.843428571428572
129,regulation of biosynthetic process (GO:0009889),6.192226390250054,1.5543666998387151
130,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),6.156795765715203,7.7402255639097755
131,cell surface receptor signaling pathway (GO:0007166),6.15130608793645,1.8264653699566302
132,dopaminergic neuron differentiation (GO:0071542),6.147149681958349,12.605510204081632
133,hindlimb morphogenesis (GO:0035137),6.147149681958349,12.605510204081632
134,camera-type eye development (GO:0043010),6.076929296383098,3.5224978614200175
135,sympathetic ganglion development (GO:0061549),6.035033086862812,32.680952380952384
136,signaling (GO:0023052),6.03030069834759,1.4619275200043695
137,regulation of neuron differentiation (GO:0045664),6.003444963244156,4.525054945054944
138,negative regulation of cell differentiation (GO:0045596),6.001707899004692,2.610608622147084
139,organic cyclic compound metabolic process (GO:1901360),5.991088291593549,0.4467323381357403
140,regulation of gene expression (GO:0010468),5.958754184893178,1.48427394438723
141,brain development (GO:0007420),5.92681665809939,2.466884792626728
142,signal transduction (GO:0007165),5.914273477308009,1.4745549416820136
143,regulation of cellular process (GO:0050794),5.893367021509993,1.2357238631574916
144,acute inflammatory response (GO:0002526),5.893234332580822,7.173867595818816
145,protein-DNA complex assembly (GO:0065004),5.881473681290171,4.411928571428572
146,regulation of cell population proliferation (GO:0042127),5.869351918675404,1.9327444956477215
147,DNA replication-dependent chromatin assembly (GO:0006335),5.857139057448041,29.412857142857145
148,regulation of uterine smooth muscle contraction (GO:0070472),5.857139057448041,29.412857142857145
149,primitive streak formation (GO:0090009),5.857139057448041,29.412857142857145
150,pancreatic A cell differentiation (GO:0003310),5.857139057448041,29.412857142857145
151,endocrine pancreas development (GO:0031018),5.725594608918477,10.760801393728224
152,activation of immune response (GO:0002253),5.696230882763327,3.3048154093097915
153,noradrenergic neuron differentiation (GO:0003357),5.694510152949605,26.73896103896104
154,catabolic process (GO:0009056),5.636534794071358,0.29800260529743816
155,oligodendrocyte development (GO:0014003),5.598975185776248,10.26029900332226
156,negative regulation of transcription by RNA polymerase II (GO:0000122),5.551147785638979,2.2648503960105604
157,lymphoid progenitor cell differentiation (GO:0002320),5.544782303618584,24.510714285714286
158,type 2 immune response (GO:0042092),5.544782303618584,24.510714285714286
159,regulation of cerebellar granule cell precursor proliferation (GO:0021936),5.544782303618584,24.510714285714286
160,cell fate determination (GO:0001709),5.53792225423582,10.02711038961039
161,phenol-containing compound metabolic process (GO:0018958),5.534916425640598,6.464364207221349
162,regulation of multicellular organismal process (GO:0051239),5.516800617879897,1.6578155844155842
163,anatomical structure maturation (GO:0071695),5.4927643656473295,4.066293614219881
164,negative regulation of alpha-beta T cell activation (GO:0046636),5.478287214274153,9.804285714285713
165,catecholamine metabolic process (GO:0006584),5.420010236695422,9.591149068322979
166,catechol-containing compound metabolic process (GO:0009712),5.420010236695422,9.591149068322979
167,acute inflammatory response to antigenic stimulus (GO:0002438),5.406101938011528,22.625274725274725
168,norepinephrine metabolic process (GO:0042415),5.406101938011528,22.625274725274725
169,regulation of biological process (GO:0050789),5.398181101935038,1.2083038890636721
170,RNA processing (GO:0006396),5.3573116179733855,0.0
171,axis specification (GO:0009798),5.352350583890623,6.1276785714285715
172,organic substance catabolic process (GO:1901575),5.336212356182934,0.2627712073513146
173,sexual reproduction (GO:0019953),5.319619367835527,0.0
174,regulation of amine transport (GO:0051952),5.282265185261741,6.002623906705539
175,regulation of norepinephrine secretion (GO:0014061),5.276988668554309,21.00918367346939
176,spinal cord development (GO:0021510),5.247819130073256,5.941991341991342
177,bone morphogenesis (GO:0060349),5.21376039487839,5.882571428571429
178,bicellular tight junction assembly (GO:0070830),5.199409963657549,8.823857142857143
179,chordate embryonic development (GO:0043009),5.1884311921815,2.4697818974918215
180,protein-DNA complex subunit organization (GO:0071824),5.159536188283773,3.787063151440834
181,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),5.147145655475671,8.650840336134454
182,response to external stimulus (GO:0009605),5.117917511009523,1.6678007290400974
183,immune response-regulating signaling pathway (GO:0002764),5.063362878983753,2.963512054695934
184,columnar/cuboidal epithelial cell differentiation (GO:0002065),5.049019831104972,5.602448979591837
185,neuroendocrine cell differentiation (GO:0061101),5.042871661047707,18.383035714285715
186,hematopoietic progenitor cell differentiation (GO:0002244),5.017133872473456,5.549595687331536
187,skeletal muscle cell differentiation (GO:0035914),4.996602077955484,8.170238095238094
188,cellular catabolic process (GO:0044248),4.98974238015628,0.2715032967032967
189,RNA metabolic process (GO:0016070),4.9860317315551805,0.26984272608125814
190,positive regulation of cell population proliferation (GO:0008284),4.9738533748457145,2.1695468914646994
191,positive regulation of transcription by RNA polymerase II (GO:0045944),4.965111362449338,1.9857766935209349
192,embryo development ending in birth or egg hatching (GO:0009792),4.953239513396624,2.389523106140536
193,positive regulation of ossification (GO:0045778),4.948380064826934,8.021688311688312
194,spinal cord dorsal/ventral patterning (GO:0021513),4.936057068843384,17.30168067226891
195,embryonic digestive tract morphogenesis (GO:0048557),4.936057068843384,17.30168067226891
196,ganglion development (GO:0061548),4.936057068843384,17.30168067226891
197,regulation of gastrulation (GO:0010470),4.936057068843384,17.30168067226891
198,dorsal/ventral neural tube patterning (GO:0021904),4.936057068843384,17.30168067226891
199,chromatin remodeling (GO:0006338),4.932198111945613,3.1871517027863776
200,epithelium development (GO:0060429),4.924913721502743,2.0578025053304905
201,regulation of postsynaptic membrane potential (GO:0060078),4.923484157780111,5.396854521625165
202,organonitrogen compound catabolic process (GO:1901565),4.911481347731649,0.13225205549845837
203,tight junction assembly (GO:0120192),4.901080545036802,7.878443877551021
204,central nervous system neuron differentiation (GO:0021953),4.880728924855381,4.201836734693878
205,defense response (GO:0006952),4.870349214253677,1.8905422385462982
206,innate immune response (GO:0045087),4.867366079130137,2.2978794642857143
207,positive regulation of neural precursor cell proliferation (GO:2000179),4.854671903116253,7.740225563909775
208,regulation of catecholamine secretion (GO:0050433),4.854671903116253,7.740225563909775
209,cellular response to tumor necrosis factor (GO:0071356),4.813101964905387,4.131019261637239
210,glial cell development (GO:0021782),4.803083311892954,5.205815423514538
211,cellular biosynthetic process (GO:0044249),4.784498418590701,0.41779626623376626
212,tight junction organization (GO:0120193),4.764408661737312,7.4778450363196125
213,apical junction assembly (GO:0043297),4.764408661737312,7.4778450363196125
214,spinal cord patterning (GO:0021511),4.739428082259209,15.480451127819551
215,thymic T cell selection (GO:0045061),4.739428082259209,15.480451127819551
216,regulation of alpha-beta T cell activation (GO:0046634),4.715939827734722,5.071182266009853
217,developmental maturation (GO:0021700),4.674882413986467,3.4068946497517922
218,catechol-containing compound biosynthetic process (GO:0009713),4.648521841961354,14.706428571428573
219,middle ear morphogenesis (GO:0042474),4.648521841961354,14.706428571428573
220,catecholamine biosynthetic process (GO:0042423),4.648521841961354,14.706428571428573
221,regulation of catecholamine metabolic process (GO:0042069),4.648521841961354,14.706428571428573
222,regulation of dopamine metabolic process (GO:0042053),4.648521841961354,14.706428571428573
223,positive regulation of synapse assembly (GO:0051965),4.634991312484252,7.116013824884793
224,Notch signaling pathway (GO:0007219),4.631351342515844,4.9433373349339735
225,defense response to Gram-positive bacterium (GO:0050830),4.631351342515844,4.9433373349339735
226,glial cell differentiation (GO:0010001),4.618244126791174,3.9322001527883876
227,biosynthetic process (GO:0009058),4.577758649149009,0.4519839745348773
228,embryonic limb morphogenesis (GO:0030326),4.576316244424016,4.8616292798110985
229,embryonic appendage morphogenesis (GO:0035113),4.576316244424016,4.8616292798110985
230,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),4.561951630415826,14.006122448979593
231,positive regulation of icosanoid secretion (GO:0032305),4.561951630415826,14.006122448979593
232,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),4.561951630415826,14.006122448979593
233,cellular response to DNA damage stimulus (GO:0006974),4.541354748912212,0.0
234,gamete generation (GO:0007276),4.541354748912212,0.0
235,endocytosis (GO:0006897),4.526949359705542,2.506777597402597
236,glandular epithelial cell differentiation (GO:0002067),4.5121618994026855,6.787582417582417
237,regulation of morphogenesis of an epithelium (GO:1905330),4.5121618994026855,6.787582417582417
238,biological regulation (GO:0065007),4.464517243226906,1.1723874817784257
239,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",4.43364656503761,6.584968017057569
240,positive regulation of embryonic development (GO:0040019),4.400354648906352,12.788198757763974
241,regulation of icosanoid secretion (GO:0032303),4.400354648906352,12.788198757763974
242,alpha-beta T cell differentiation (GO:0046632),4.395341512647394,6.48813025210084
243,negative regulation of developmental process (GO:0051093),4.389313145988611,2.071327967806841
244,positive regulation of nervous system development (GO:0051962),4.3426121432698634,3.162672811059908
245,sensory organ morphogenesis (GO:0090596),4.3426121432698634,3.162672811059908
246,ear morphogenesis (GO:0042471),4.341122687204164,4.525054945054945
247,regulation of cellular metabolic process (GO:0031323),4.325315978546288,1.354231070859369
248,response to lithium ion (GO:0010226),4.32470637388382,12.255357142857143
249,adrenergic receptor signaling pathway (GO:0071875),4.32470637388382,12.255357142857143
250,negative regulation of neural precursor cell proliferation (GO:2000178),4.32470637388382,12.255357142857143
251,response to tumor necrosis factor (GO:0034612),4.317794018718418,3.640205091937765
252,negative regulation of detection of glucose (GO:2000971),4.307857948025121,147.06428571428572
253,regulation of detection of glucose (GO:2000970),4.307857948025121,147.06428571428572
254,neuroblast fate determination (GO:0007400),4.307857948025121,147.06428571428572
255,positive regulation of hindgut contraction (GO:0060450),4.307857948025121,147.06428571428572
256,cerebellar granular layer maturation (GO:0021686),4.307857948025121,147.06428571428572
257,phospholipase C-activating adrenergic receptor signaling pathway (GO:0071882),4.307857948025121,147.06428571428572
258,adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071881),4.307857948025121,147.06428571428572
259,NLRP6 inflammasome complex assembly (GO:0140739),4.307857948025121,147.06428571428572
260,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000734),4.307857948025121,147.06428571428572
261,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000733),4.307857948025121,147.06428571428572
262,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000703),4.307857948025121,147.06428571428572
263,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000702),4.307857948025121,147.06428571428572
264,regulation of cellular response to X-ray (GO:2000683),4.307857948025121,147.06428571428572
265,regulation of timing of subpallium neuron differentiation (GO:0060165),4.307857948025121,147.06428571428572
266,negative regulation of cell proliferation involved in mesonephros development (GO:2000607),4.307857948025121,147.06428571428572
267,regulation of cell proliferation involved in mesonephros development (GO:2000606),4.307857948025121,147.06428571428572
268,FasL biosynthetic process (GO:0045210),4.307857948025121,147.06428571428572
269,neuroblast fate commitment (GO:0014017),4.307857948025121,147.06428571428572
270,positive regulation of kidney smooth muscle cell differentiation (GO:2000358),4.307857948025121,147.06428571428572
271,negative regulation of kidney smooth muscle cell differentiation (GO:2000357),4.307857948025121,147.06428571428572
272,regulation of kidney smooth muscle cell differentiation (GO:2000356),4.307857948025121,147.06428571428572
273,cellular response to magnetism (GO:0071259),4.307857948025121,147.06428571428572
274,positive regulation of ureter smooth muscle cell differentiation (GO:2000063),4.307857948025121,147.06428571428572
275,negative regulation of ureter smooth muscle cell differentiation (GO:2000062),4.307857948025121,147.06428571428572
276,regulation of ureter smooth muscle cell differentiation (GO:2000061),4.307857948025121,147.06428571428572
277,negative regulation of uterine smooth muscle contraction (GO:0070473),4.307857948025121,147.06428571428572
278,negative regulation of glutamatergic neuron differentiation (GO:0120007),4.307857948025121,147.06428571428572
279,regulation of glutamatergic neuron differentiation (GO:0120006),4.307857948025121,147.06428571428572
280,tracheoesophageal septum formation (GO:1905327),4.307857948025121,147.06428571428572
281,negative regulation of transcription from RNA polymerase II promoter by glucose (GO:0061987),4.307857948025121,147.06428571428572
282,negative regulation of transcription by glucose (GO:0061986),4.307857948025121,147.06428571428572
283,mesenchymal smoothened signaling pathway involved in prostate gland development (GO:0060783),4.307857948025121,147.06428571428572
284,regulation of mesenchymal cell proliferation involved in prostate gland development (GO:0060782),4.307857948025121,147.06428571428572
285,noradrenergic neuron fate commitment (GO:0003359),4.307857948025121,147.06428571428572
286,regulation of sclerotome development (GO:0061190),4.307857948025121,147.06428571428572
287,positive regulation of sclerotome development (GO:0061189),4.307857948025121,147.06428571428572
288,carotid body glomus cell differentiation (GO:0061103),4.307857948025121,147.06428571428572
289,lung neuroendocrine cell differentiation (GO:0061100),4.307857948025121,147.06428571428572
290,radial glia guided migration of cerebellar granule cell (GO:0021933),4.307857948025121,147.06428571428572
291,cardiac muscle tissue growth involved in heart morphogenesis (GO:0003245),4.307857948025121,147.06428571428572
292,positive regulation of synaptic assembly at neuromuscular junction (GO:0045887),4.307857948025121,147.06428571428572
293,organic substance biosynthetic process (GO:1901576),4.28479942351452,0.464291351899876
294,negative regulation of DNA-templated transcription (GO:0045892),4.281896250891732,1.8897149335924848
295,negative regulation of nucleic acid-templated transcription (GO:1903507),4.276796979876711,1.8868625336927225
296,negative regulation of RNA biosynthetic process (GO:1902679),4.271576239707359,1.884018731833351
297,regulation of activin receptor signaling pathway (GO:0032925),4.252137382298633,11.765142857142857
298,positive regulation of fatty acid transport (GO:2000193),4.252137382298633,11.765142857142857
299,regulation of alpha-beta T cell differentiation (GO:0046637),4.248062875682386,6.1276785714285715
300,skeletal muscle tissue development (GO:0007519),4.24264720796798,4.389978678038379
301,positive regulation of developmental process (GO:0051094),4.237796806220842,1.8671343219886911
302,regulation of neurogenesis (GO:0050767),4.211129915432771,2.759919571045576
303,negative regulation of cellular process (GO:0048523),4.188432128795591,1.3985403332930804
304,positive regulation of oligodendrocyte differentiation (GO:0048714),4.1824190741554546,11.312637362637362
305,positive regulation of positive chemotaxis (GO:0050927),4.1824190741554546,11.312637362637362
306,retina layer formation (GO:0010842),4.1824190741554546,11.312637362637362
307,negative regulation of alpha-beta T cell differentiation (GO:0046639),4.1824190741554546,11.312637362637362
308,macromolecule catabolic process (GO:0009057),4.166513250988022,0.14869998555539504
309,carbohydrate derivative metabolic process (GO:1901135),4.151000476660271,0.1463326226012793
310,regulation of cellular response to stress (GO:0080135),4.118197900430165,0.0
311,blastoderm segmentation (GO:0007350),4.1153473860290015,10.893650793650792
312,animal organ maturation (GO:0048799),4.1153473860290015,10.893650793650792
313,regulation of positive chemotaxis (GO:0050926),4.1153473860290015,10.893650793650792
314,adrenal gland development (GO:0030325),4.1153473860290015,10.893650793650792
315,negative regulation of cellular biosynthetic process (GO:0031327),4.112492307519957,1.7529620003584871
316,negative regulation of cell activation (GO:0050866),4.0614930177362565,3.4042658730158726
317,gastrulation with mouth forming second (GO:0001702),4.050739399576393,10.504591836734695
318,mesenchymal cell proliferation (GO:0010463),4.050739399576393,10.504591836734695
319,stem cell proliferation (GO:0072089),4.04328195310442,5.656318681318682
320,regulation of nitrogen compound metabolic process (GO:0051171),4.0429864074451,1.3395240597552736
321,negative regulation of multicellular organismal process (GO:0051241),4.042667090003181,1.9816169393647738
322,digestive system development (GO:0055123),4.033283391701933,4.113686313686314
323,forebrain development (GO:0030900),4.020236578718551,2.653221649484536
324,immune response (GO:0006955),4.019733062128193,1.7237639904820656
325,oligodendrocyte differentiation (GO:0048709),4.010859883055576,5.584719710669078
326,lymphocyte migration (GO:0072676),4.010859883055576,5.584719710669078
327,negative regulation of biosynthetic process (GO:0009890),4.008708033770995,1.7205796973962
328,cell cycle (GO:0007049),3.9914306317992443,0.23549125014297148
329,limb morphogenesis (GO:0035108),3.988894075541359,4.056945812807882
330,appendage morphogenesis (GO:0035107),3.988894075541359,4.056945812807882
331,small molecule metabolic process (GO:0044281),3.9883651000938194,0.3556572810502677
332,regulation of primary metabolic process (GO:0080090),3.9843238891157156,1.3273854126119113
333,skeletal muscle organ development (GO:0060538),3.966974741265221,4.029158512720157
334,defense response to other organism (GO:0098542),3.9374745341394504,1.9278089887640448
335,response to amphetamine (GO:0001975),3.9282720920922127,9.804285714285715
336,protein localization to chromatin (GO:0071168),3.9282720920922127,9.804285714285715
337,enteroendocrine cell differentiation (GO:0035883),3.9282720920922127,9.804285714285715
338,regulation of stem cell proliferation (GO:0072091),3.9162844379514548,5.380400696864112
339,vestibular nucleus development (GO:0021750),3.905747761451022,73.53214285714286
340,left lung development (GO:0060459),3.905747761451022,73.53214285714286
341,right lung development (GO:0060458),3.905747761451022,73.53214285714286
342,bud outgrowth involved in lung branching (GO:0060447),3.905747761451022,73.53214285714286
343,pro-T cell differentiation (GO:0002572),3.905747761451022,73.53214285714286
344,positive regulation of the force of heart contraction by epinephrine-norepinephrine (GO:0001997),3.905747761451022,73.53214285714286
345,positive regulation of mesenchymal cell proliferation involved in ureter development (GO:2000729),3.905747761451022,73.53214285714286
346,cell-cell signaling involved in metanephros development (GO:0072204),3.905747761451022,73.53214285714286
347,type IV hypersensitivity (GO:0001806),3.905747761451022,73.53214285714286
348,subpallium neuron fate commitment (GO:0060163),3.905747761451022,73.53214285714286
349,beta-alanine transport (GO:0001762),3.905747761451022,73.53214285714286
350,neural crest cell fate specification (GO:0014036),3.905747761451022,73.53214285714286
351,neutrophil-mediated killing of gram-positive bacterium (GO:0070946),3.905747761451022,73.53214285714286
352,polarity specification of anterior/posterior axis (GO:0009949),3.905747761451022,73.53214285714286
353,detection of mechanical stimulus involved in sensory perception of touch (GO:0050976),3.905747761451022,73.53214285714286
354,negative regulation of adaptive immune memory response (GO:1905675),3.905747761451022,73.53214285714286
355,"musculoskeletal movement, spinal reflex action (GO:0050883)",3.905747761451022,73.53214285714286
356,parathyroid hormone secretion (GO:0035898),3.905747761451022,73.53214285714286
357,protein splicing (GO:0030908),3.905747761451022,73.53214285714286
358,intein-mediated protein splicing (GO:0016539),3.905747761451022,73.53214285714286
359,regulation of hindgut contraction (GO:0043134),3.905747761451022,73.53214285714286
360,positive regulation of neuromuscular junction development (GO:1904398),3.905747761451022,73.53214285714286
361,cell-cell signaling involved in kidney development (GO:0060995),3.905747761451022,73.53214285714286
362,positive regulation of convergent extension involved in gastrulation (GO:1904105),3.905747761451022,73.53214285714286
363,regulation of convergent extension involved in gastrulation (GO:1904103),3.905747761451022,73.53214285714286
364,establishment of glial blood-brain barrier (GO:0060857),3.905747761451022,73.53214285714286
365,canonical Wnt signaling pathway involved in metanephric kidney development (GO:0061290),3.905747761451022,73.53214285714286
366,Wnt signaling pathway involved in kidney development (GO:0061289),3.905747761451022,73.53214285714286
367,epithelial-mesenchymal signaling involved in prostate gland development (GO:0060738),3.905747761451022,73.53214285714286
368,positive regulation of female receptivity (GO:0045925),3.905747761451022,73.53214285714286
369,stomach neuroendocrine cell differentiation (GO:0061102),3.905747761451022,73.53214285714286
370,negative regulation of cerebellar granule cell precursor proliferation (GO:0021941),3.905747761451022,73.53214285714286
371,primary prostatic bud elongation (GO:0060516),3.905747761451022,73.53214285714286
372,negative regulation of inflammatory response (GO:0050728),3.90228853175418,3.9480345158197507
373,peripheral nervous system development (GO:0007422),3.8856205385123523,5.315576592082617
374,nephron tubule development (GO:0072080),3.8856205385123523,5.315576592082617
375,dorsal/ventral pattern formation (GO:0009953),3.8856205385123523,5.315576592082617
376,positive regulation of immune response (GO:0050778),3.8834584950571296,2.2433535108958838
377,behavioral fear response (GO:0001662),3.8701294331199163,9.488018433179723
378,neuron fate specification (GO:0048665),3.8701294331199163,9.488018433179723
379,hair follicle morphogenesis (GO:0031069),3.8701294331199163,9.488018433179723
380,regulation of immune system process (GO:0002682),3.826810290919412,1.7415507518796993
381,metanephros development (GO:0001656),3.825524318460066,5.190504201680673
382,adult locomotory behavior (GO:0008344),3.825524318460066,5.190504201680673
383,behavioral defense response (GO:0002209),3.8138801084936733,9.191517857142857
384,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),3.8138801084936733,9.191517857142857
385,embryonic forelimb morphogenesis (GO:0035115),3.8138801084936733,9.191517857142857
386,aortic valve morphogenesis (GO:0003180),3.8138801084936733,9.191517857142857
387,phosphorylation (GO:0016310),3.801001121960205,0.16020074696545283
388,ear development (GO:0043583),3.7932939454018757,3.169488916256158
389,negative regulation of macromolecule biosynthetic process (GO:0010558),3.7888636996204865,1.72678221973721
390,renal tubule development (GO:0061326),3.7670077765075165,5.071182266009853
391,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),3.7614509574244592,3.1423992673992673
392,neural tube patterning (GO:0021532),3.7594125023022444,8.912987012987013
393,embryonic digestive tract development (GO:0048566),3.7594125023022444,8.912987012987013
394,regulation of type 2 immune response (GO:0002828),3.7594125023022444,8.912987012987013
395,hindbrain development (GO:0030902),3.7573103212206576,3.7708791208791212
396,mitotic cell cycle (GO:0000278),3.7469364464011266,0.0
397,axon guidance (GO:0007411),3.745662013185685,3.1290273556231005
398,negative regulation of defense response (GO:0031348),3.729960435001721,3.115768765133172
399,neuron projection guidance (GO:0097485),3.729960435001721,3.115768765133172
400,positive regulation of immune system process (GO:0002684),3.716133491589706,1.9770793322499631
401,cellular biogenic amine metabolic process (GO:0006576),3.7100003683814475,4.957223113964687
402,cellular amine metabolic process (GO:0044106),3.7100003683814475,4.957223113964687
403,regulation of fatty acid transport (GO:2000191),3.7066245766507007,8.650840336134454
404,positive regulation of cell-cell adhesion (GO:0022409),3.698433722350791,2.7234126984126985
405,nitrogen compound transport (GO:0071705),3.673243189275454,0.37020587970871166
406,cellular nitrogen compound biosynthetic process (GO:0044271),3.673099721641357,0.37043900683699177
407,negative regulation of biological process (GO:0048519),3.6579625383109793,1.328393999677402
408,"CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294)",3.6554228052549607,8.403673469387755
409,regulation of cellular amine metabolic process (GO:0033238),3.6554228052549607,8.403673469387755
410,epidermis morphogenesis (GO:0048730),3.6554228052549607,8.403673469387755
411,G protein-coupled serotonin receptor signaling pathway (GO:0098664),3.6554228052549607,8.403673469387755
412,negative regulation of epithelial to mesenchymal transition (GO:0010719),3.6554228052549607,8.403673469387755
413,T-helper cell differentiation (GO:0042093),3.6554228052549607,8.403673469387755
414,regulation of organelle organization (GO:0033043),3.645855650551889,0.24737474468340745
415,roof of mouth development (GO:0060021),3.627175794220265,4.7955745341614895
416,positive regulation of the force of heart contraction by chemical signal (GO:0003099),3.621416945024709,49.02142857142857
417,cerebellar cortex maturation (GO:0021699),3.621416945024709,49.02142857142857
418,mast cell differentiation (GO:0060374),3.621416945024709,49.02142857142857
419,cerebellum maturation (GO:0021590),3.621416945024709,49.02142857142857
420,spinal cord oligodendrocyte cell fate specification (GO:0021530),3.621416945024709,49.02142857142857
421,positive regulation of hh target transcription factor activity (GO:0007228),3.621416945024709,49.02142857142857
422,signal transduction downstream of smoothened (GO:0007227),3.621416945024709,49.02142857142857
423,regulation of mesenchymal cell proliferation involved in ureter development (GO:0072199),3.621416945024709,49.02142857142857
424,metanephric mesenchymal cell proliferation involved in metanephros development (GO:0072136),3.621416945024709,49.02142857142857
425,kidney mesenchymal cell proliferation (GO:0072135),3.621416945024709,49.02142857142857
426,olfactory pit development (GO:0060166),3.621416945024709,49.02142857142857
427,regulation of timing of neuron differentiation (GO:0060164),3.621416945024709,49.02142857142857
428,positive regulation of catecholamine uptake involved in synaptic transmission (GO:0051944),3.621416945024709,49.02142857142857
429,maternal aggressive behavior (GO:0002125),3.621416945024709,49.02142857142857
430,positive regulation of interleukin-18-mediated signaling pathway (GO:2000494),3.621416945024709,49.02142857142857
431,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002025),3.621416945024709,49.02142857142857
432,negative regulation of DNA demethylation (GO:1901536),3.621416945024709,49.02142857142857
433,positive regulation of dopamine uptake involved in synaptic transmission (GO:0051586),3.621416945024709,49.02142857142857
434,protein polyglycylation (GO:0018094),3.621416945024709,49.02142857142857
435,response to magnetism (GO:0071000),3.621416945024709,49.02142857142857
436,regulation of adaptive immune memory response (GO:1905674),3.621416945024709,49.02142857142857
437,positive regulation of transcription from RNA polymerase II promoter by glucose (GO:0000432),3.621416945024709,49.02142857142857
438,regulation of transcription from RNA polymerase II promoter by glucose (GO:0000430),3.621416945024709,49.02142857142857
439,skeletal muscle fiber differentiation (GO:0098528),3.621416945024709,49.02142857142857
440,embryonic skeletal limb joint morphogenesis (GO:0036023),3.621416945024709,49.02142857142857
441,siderophore transport (GO:0015891),3.621416945024709,49.02142857142857
442,negative regulation of dopaminergic neuron differentiation (GO:1904339),3.621416945024709,49.02142857142857
443,positive regulation of epithelial cell proliferation involved in prostate gland development (GO:0060769),3.621416945024709,49.02142857142857
444,positive regulation of skeletal muscle cell proliferation (GO:0014858),3.621416945024709,49.02142857142857
445,Peyer's patch morphogenesis (GO:0061146),3.621416945024709,49.02142857142857
446,regulation of neural retina development (GO:0061074),3.621416945024709,49.02142857142857
447,prostate epithelial cord elongation (GO:0060523),3.621416945024709,49.02142857142857
448,positive regulation of blood pressure (GO:0045777),3.605721253137017,8.170238095238096
449,phenol-containing compound biosynthetic process (GO:0046189),3.605721253137017,8.170238095238096
450,alpha-beta T cell differentiation involved in immune response (GO:0002293),3.605721253137017,8.170238095238096
451,alpha-beta T cell activation involved in immune response (GO:0002287),3.605721253137017,8.170238095238096
452,negative regulation of lymphocyte activation (GO:0051250),3.6010741008825637,3.586933797909408
453,mesonephros development (GO:0001823),3.6002533941711343,4.744009216589862
454,gliogenesis (GO:0042063),3.5775917137011612,2.9891114982578397
455,neural crest cell differentiation (GO:0014033),3.5736618351850544,4.69354103343465
456,embryonic skeletal system morphogenesis (GO:0048704),3.5736618351850544,4.69354103343465
457,negative regulation of RNA metabolic process (GO:0051253),3.5636066702304925,1.742224987555998
458,lung epithelium development (GO:0060428),3.5574407755002553,7.949420849420849
459,positive regulation of morphogenesis of an epithelium (GO:1905332),3.5574407755002553,7.949420849420849
460,cellular biogenic amine biosynthetic process (GO:0042401),3.5574407755002553,7.949420849420849
461,aortic valve development (GO:0003176),3.5574407755002553,7.949420849420849
462,heart morphogenesis (GO:0003007),3.533466247921849,2.953098106712565
463,organic substance transport (GO:0071702),3.511171557419203,0.449279895257492
464,amine biosynthetic process (GO:0009309),3.5105083211910126,7.7402255639097755
465,negative regulation of immune system process (GO:0002683),3.4949059703649072,2.372004608294931
466,nervous system process (GO:0050877),3.4898050990871,1.7065480253534862
467,mesenchymal cell differentiation (GO:0048762),3.4719180381473755,3.4401002506265668
468,amine metabolic process (GO:0009308),3.470469239884709,4.501967930029155
469,alpha-beta T cell activation (GO:0046631),3.470469239884709,4.501967930029155
470,inflammatory response to antigenic stimulus (GO:0002437),3.4648563224537874,7.5417582417582425
471,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),3.4648563224537874,7.5417582417582425
472,forelimb morphogenesis (GO:0035136),3.4648563224537874,7.5417582417582425
473,response to alcohol (GO:0097305),3.46147185943084,2.8949662542182226
474,regulation of neuroblast proliferation (GO:1902692),3.420422159354979,7.353214285714286
475,serotonin receptor signaling pathway (GO:0007210),3.420422159354979,7.353214285714286
476,T cell differentiation involved in immune response (GO:0002292),3.420422159354979,7.353214285714286
477,female pregnancy (GO:0007565),3.418572429585007,3.380788177339902
478,oligodendrocyte cell fate commitment (GO:0021779),3.401620984018041,36.76607142857143
479,oligodendrocyte cell fate specification (GO:0021778),3.401620984018041,36.76607142857143
480,regulation of vascular permeability involved in acute inflammatory response (GO:0002528),3.401620984018041,36.76607142857143
481,negative regulation of T-helper 2 cell differentiation (GO:0045629),3.401620984018041,36.76607142857143
482,negative regulation of mammary gland epithelial cell proliferation (GO:0033600),3.401620984018041,36.76607142857143
483,positive regulation of transcription by glucose (GO:0046016),3.401620984018041,36.76607142857143
484,medulla oblongata development (GO:0021550),3.401620984018041,36.76607142857143
485,positive regulation of ureteric bud formation (GO:0072107),3.401620984018041,36.76607142857143
486,regulation of ureteric bud formation (GO:0072106),3.401620984018041,36.76607142857143
487,positive regulation of thyroid hormone generation (GO:2000611),3.401620984018041,36.76607142857143
488,regulation of interleukin-18-mediated signaling pathway (GO:2000492),3.401620984018041,36.76607142857143
489,positive regulation of histone H3-K14 acetylation (GO:0071442),3.401620984018041,36.76607142857143
490,glutamatergic neuron differentiation (GO:1905962),3.401620984018041,36.76607142857143
491,positive regulation of protein oligomerization (GO:0032461),3.401620984018041,36.76607142857143
492,sensory perception of touch (GO:0050975),3.401620984018041,36.76607142857143
493,sensory perception of salty taste (GO:0050914),3.401620984018041,36.76607142857143
494,carbon catabolite activation of transcription from RNA polymerase II promoter (GO:0000436),3.401620984018041,36.76607142857143
495,carbon catabolite regulation of transcription from RNA polymerase II promoter (GO:0000429),3.401620984018041,36.76607142857143
496,cellular response to amiloride (GO:0036254),3.401620984018041,36.76607142857143
497,response to amiloride (GO:0036253),3.401620984018041,36.76607142857143
498,ureter maturation (GO:0035799),3.401620984018041,36.76607142857143
499,protein localization to CENP-A containing chromatin (GO:0061644),3.401620984018041,36.76607142857143
500,positive regulation of norepinephrine secretion (GO:0010701),3.401620984018041,36.76607142857143
501,prostate gland morphogenetic growth (GO:0060737),3.401620984018041,36.76607142857143
502,growth involved in heart morphogenesis (GO:0003241),3.401620984018041,36.76607142857143
503,establishment of blood-nerve barrier (GO:0008065),3.401620984018041,36.76607142857143
504,organ growth (GO:0035265),3.396230968145038,4.368246110325318
505,positive regulation of biological process (GO:0048518),3.382780370333331,1.283079903915881
506,semi-lunar valve development (GO:1905314),3.377147688257282,7.173867595818816
507,regulation of calcium ion-dependent exocytosis (GO:0017158),3.377147688257282,7.173867595818816
508,exocrine system development (GO:0035272),3.377147688257282,7.173867595818816
509,canonical Wnt signaling pathway (GO:0060070),3.372054702901005,4.325420168067227
510,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),3.363804334946028,2.8173234811165844
511,immune system process (GO:0002376),3.3612310587632876,1.5136299476562962
512,regulation of synapse assembly (GO:0051963),3.3481541882662804,4.283425797503467
513,ubiquitin-dependent protein catabolic process (GO:0006511),3.33916156179266,0.0
514,heterocycle biosynthetic process (GO:0018130),3.337285453322649,0.2725936713888521
515,regulation of T-helper cell differentiation (GO:0045622),3.334978824869962,7.003061224489796
516,negative regulation of cellular response to growth factor stimulus (GO:0090288),3.32452416157308,4.242239010989011
517,spermatogenesis (GO:0007283),3.3156719418381044,0.0
518,regulation of cell differentiation (GO:0045595),3.3142298994060013,1.6743561940905394
519,positive regulation of cellular process (GO:0048522),3.310166111967858,1.2968631897203327
520,cellular response to BMP stimulus (GO:0071773),3.3011595084805196,4.201836734693877
521,response to BMP (GO:0071772),3.3011595084805196,4.201836734693877
522,positive regulation of cell junction assembly (GO:1901890),3.3011595084805196,4.201836734693877
523,limb development (GO:0060173),3.298485416369962,3.2500394632991316
524,appendage development (GO:0048736),3.298485416369962,3.2500394632991316
525,positive regulation of glial cell differentiation (GO:0045687),3.293865174928597,6.840199335548173
526,positive regulation of amine transport (GO:0051954),3.293865174928597,6.840199335548173
527,negative regulation of interferon-gamma production (GO:0032689),3.293865174928597,6.840199335548173
528,T cell selection (GO:0045058),3.293865174928597,6.840199335548173
529,musculoskeletal movement (GO:0050881),3.293865174928597,6.840199335548173
530,multicellular organismal movement (GO:0050879),3.293865174928597,6.840199335548173
531,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),3.2828582981083083,2.7540128410914924
532,mRNA metabolic process (GO:0016071),3.2815664513458795,0.0
533,nephron epithelium development (GO:0072009),3.278055257273202,4.162196765498652
534,regulation of potassium ion transport (GO:0043266),3.278055257273202,4.162196765498652
535,regulation of immune response (GO:0050776),3.276195738244728,1.8874560733384265
536,male gamete generation (GO:0048232),3.2705190689608523,0.0
537,negative regulation of leukocyte differentiation (GO:1902106),3.2552065737693687,4.123297730307076
538,response to amine (GO:0014075),3.2537597058459666,6.68474025974026
539,regulation of oligodendrocyte differentiation (GO:0048713),3.2537597058459666,6.68474025974026
540,negative regulation of response to stimulus (GO:0048585),3.2406023389799383,1.6340476190476192
541,synaptic signaling (GO:0099536),3.223141889319323,2.2330802603036877
542,glial cell fate specification (GO:0021780),3.2226433512530392,29.412857142857145
543,positive regulation of penile erection (GO:0060406),3.2226433512530392,29.412857142857145
544,"blood coagulation, common pathway (GO:0072377)",3.2226433512530392,29.412857142857145
545,hindbrain maturation (GO:0021578),3.2226433512530392,29.412857142857145
546,spinal cord oligodendrocyte cell differentiation (GO:0021529),3.2226433512530392,29.412857142857145
547,specification of axis polarity (GO:0065001),3.2226433512530392,29.412857142857145
548,adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:0007195),3.2226433512530392,29.412857142857145
549,nephric duct formation (GO:0072179),3.2226433512530392,29.412857142857145
550,somatostatin signaling pathway (GO:0038170),3.2226433512530392,29.412857142857145
551,somatostatin receptor signaling pathway (GO:0038169),3.2226433512530392,29.412857142857145
552,negative regulation of epinephrine secretion (GO:0032811),3.2226433512530392,29.412857142857145
553,gamma-aminobutyric acid import (GO:0051939),3.2226433512530392,29.412857142857145
554,negative regulation of cell proliferation involved in kidney development (GO:1901723),3.2226433512530392,29.412857142857145
555,negative regulation of glucokinase activity (GO:0033132),3.2226433512530392,29.412857142857145
556,positive regulation of sodium:proton antiporter activity (GO:0032417),3.2226433512530392,29.412857142857145
557,trunk neural crest cell migration (GO:0036484),3.2226433512530392,29.412857142857145
558,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation (GO:0098535),3.2226433512530392,29.412857142857145
559,negative regulation of urine volume (GO:0035811),3.2226433512530392,29.412857142857145
560,receptor transactivation (GO:0035624),3.2226433512530392,29.412857142857145
561,limb joint morphogenesis (GO:0036022),3.2226433512530392,29.412857142857145
562,de novo centriole assembly (GO:0097742),3.2226433512530392,29.412857142857145
563,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900175),3.2226433512530392,29.412857142857145
564,regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900145),3.2226433512530392,29.412857142857145
565,stomach development (GO:0062094),3.2226433512530392,29.412857142857145
566,diterpenoid catabolic process (GO:0016103),3.2226433512530392,29.412857142857145
567,trunk segmentation (GO:0035290),3.2226433512530392,29.412857142857145
568,negative regulation of norepinephrine secretion (GO:0010700),3.2226433512530392,29.412857142857145
569,mesenchymal cell proliferation involved in lung development (GO:0060916),3.2226433512530392,29.412857142857145
570,retinoic acid catabolic process (GO:0034653),3.2226433512530392,29.412857142857145
571,regulation of mesonephros development (GO:0061217),3.2226433512530392,29.412857142857145
572,carbon catabolite activation of transcription (GO:0045991),3.2226433512530392,29.412857142857145
573,carbon catabolite regulation of transcription (GO:0045990),3.2226433512530392,29.412857142857145
574,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation (GO:0021938),3.2226433512530392,29.412857142857145
575,ureteric bud formation (GO:0060676),3.2226433512530392,29.412857142857145
576,epithelial cell proliferation involved in salivary gland morphogenesis (GO:0060664),3.2226433512530392,29.412857142857145
577,salivary gland cavitation (GO:0060662),3.2226433512530392,29.412857142857145
578,tube lumen cavitation (GO:0060605),3.2226433512530392,29.412857142857145
579,negative regulation of hexokinase activity (GO:1903300),3.2226433512530392,29.412857142857145
580,chondroblast differentiation (GO:0060591),3.2226433512530392,29.412857142857145
581,phosphatidylinositol 3-kinase signaling (GO:0014065),3.214618454301087,6.536190476190475
582,positive regulation of bone mineralization (GO:0030501),3.214618454301087,6.536190476190475
583,epithelial cell differentiation (GO:0030855),3.2116949957633514,2.134804147465438
584,regulation of secretion (GO:0051046),3.2005643925481704,2.1245241916991513
585,organelle organization (GO:0006996),3.193567979256616,0.5832027192899633
586,negative regulation of immune response (GO:0050777),3.1841631392084895,3.1290273556231
587,negative regulation of hemopoiesis (GO:1903707),3.166275368052744,3.974710424710425
588,gene expression (GO:0010467),3.1634192539220565,0.5084331398938141
589,negative regulation of T cell differentiation (GO:0045581),3.1390665552967754,6.2580547112462
590,response to retinoic acid (GO:0032526),3.123226776876962,3.9043615676359043
591,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),3.105798682159121,3.047964470762398
592,response to other organism (GO:0051707),3.1047501672816598,1.646626012196341
593,regulation of body fluid levels (GO:0050878),3.103342517548333,2.3530285714285717
594,positive regulation of organic acid transport (GO:0032892),3.102581107423142,6.1276785714285715
595,digestive tract morphogenesis (GO:0048546),3.102581107423142,6.1276785714285715
596,"CD4-positive, alpha-beta T cell differentiation (GO:0043367)",3.102581107423142,6.1276785714285715
597,vasodilation (GO:0042311),3.102581107423142,6.1276785714285715
598,response to cocaine (GO:0042220),3.102581107423142,6.1276785714285715
599,mononuclear cell migration (GO:0071674),3.10204225432182,3.8701127819548873
600,response to external biotic stimulus (GO:0043207),3.0957109916950425,1.64317637669593
601,negative regulation of leukocyte activation (GO:0002695),3.0904403743340603,3.0322533136966126
602,metencephalon development (GO:0022037),3.081079015837332,3.8364596273291927
603,multi-organism reproductive process (GO:0044703),3.0751844051010506,3.0167032967032963
604,DNA metabolic process (GO:0006259),3.0721316126712006,0.18521950341849588
605,ventral midline development (GO:0007418),3.0718329286193438,24.510714285714286
606,regulation of the force of heart contraction by chemical signal (GO:0003057),3.0718329286193438,24.510714285714286
607,negative regulation of gastric acid secretion (GO:0060455),3.0718329286193438,24.510714285714286
608,embryonic body morphogenesis (GO:0010172),3.0718329286193438,24.510714285714286
609,hypersensitivity (GO:0002524),3.0718329286193438,24.510714285714286
610,negative regulation of megakaryocyte differentiation (GO:0045653),3.0718329286193438,24.510714285714286
611,positive regulation of T-helper 1 cell differentiation (GO:0045627),3.0718329286193438,24.510714285714286
612,positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),3.0718329286193438,24.510714285714286
613,transdifferentiation (GO:0060290),3.0718329286193438,24.510714285714286
614,male mating behavior (GO:0060179),3.0718329286193438,24.510714285714286
615,regulation of thyroid hormone generation (GO:2000609),3.0718329286193438,24.510714285714286
616,neural crest cell fate commitment (GO:0014034),3.0718329286193438,24.510714285714286
617,mesenchymal cell development (GO:0014031),3.0718329286193438,24.510714285714286
618,regulation of histone H3-K14 acetylation (GO:0071440),3.0718329286193438,24.510714285714286
619,clustering of voltage-gated sodium channels (GO:0045162),3.0718329286193438,24.510714285714286
620,NADPH oxidation (GO:0070995),3.0718329286193438,24.510714285714286
621,positive regulation of immature T cell proliferation in thymus (GO:0033092),3.0718329286193438,24.510714285714286
622,positive regulation of immature T cell proliferation (GO:0033091),3.0718329286193438,24.510714285714286
623,negative regulation of cholesterol efflux (GO:0090370),3.0718329286193438,24.510714285714286
624,stem cell fate specification (GO:0048866),3.0718329286193438,24.510714285714286
625,regulation of protein oligomerization (GO:0032459),3.0718329286193438,24.510714285714286
626,positive regulation of neurotransmitter uptake (GO:0051582),3.0718329286193438,24.510714285714286
627,G1 to G0 transition involved in cell differentiation (GO:0070315),3.0718329286193438,24.510714285714286
628,ISG15-protein conjugation (GO:0032020),3.0718329286193438,24.510714285714286
629,sperm ejaculation (GO:0042713),3.0718329286193438,24.510714285714286
630,regulation of synaptic assembly at neuromuscular junction (GO:0008582),3.0718329286193438,24.510714285714286
631,commitment of neuronal cell to specific neuron type in forebrain (GO:0021902),3.0718329286193438,24.510714285714286
632,regulation of prostatic bud formation (GO:0060685),3.0718329286193438,24.510714285714286
633,epithelial-mesenchymal cell signaling (GO:0060684),3.0718329286193438,24.510714285714286
634,determination of left/right asymmetry in lateral mesoderm (GO:0003140),3.0718329286193438,24.510714285714286
635,negative regulation of blood pressure (GO:0045776),3.066909876408171,6.002623906705539
636,positive regulation of stem cell proliferation (GO:2000648),3.066909876408171,6.002623906705539
637,thymus development (GO:0048538),3.066909876408171,6.002623906705539
638,macromolecule biosynthetic process (GO:0009059),3.0552352158166824,0.3955999615717168
639,positive regulation of T cell differentiation (GO:0045582),3.039801293274565,3.770879120879121
640,cell cycle process (GO:0022402),3.0321996849736874,0.17486835400033973
641,cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114),3.020535493503785,2.3038791495710558
642,G protein-coupled receptor signaling pathway (GO:0007186),3.0165215322134826,1.683483237939493
643,regulation of interferon-gamma production (GO:0032649),2.9993643567338735,3.70750300120048
644,negative regulation of calcium ion transmembrane transport (GO:1903170),2.9978837514481813,5.7672268907563025
645,positive regulation of potassium ion transport (GO:0043268),2.9978837514481813,5.7672268907563025
646,positive regulation of anion transport (GO:1903793),2.9978837514481813,5.7672268907563025
647,ossification (GO:0001503),2.9942208925464735,2.5355911330049263
648,positive regulation of ion transport (GO:0043270),2.9942208925464735,2.5355911330049263
649,positive regulation of cell adhesion (GO:0045785),2.9745674293600652,2.1095286885245903
650,protein processing (GO:0016485),2.9711719869524504,2.912164073550212
651,positive regulation of alpha-beta T cell differentiation (GO:0046638),2.9644701840185124,5.656318681318681
652,negative regulation of cellular carbohydrate metabolic process (GO:0010677),2.9644701840185124,5.656318681318681
653,regulation of macromolecule metabolic process (GO:0060255),2.946120564498318,1.2543300841417995
654,hindgut morphogenesis (GO:0007442),2.941638126199621,21.00918367346939
655,lung lobe morphogenesis (GO:0060463),2.941638126199621,21.00918367346939
656,lung lobe development (GO:0060462),2.941638126199621,21.00918367346939
657,regulation of penile erection (GO:0060405),2.941638126199621,21.00918367346939
658,central nervous system maturation (GO:0021626),2.941638126199621,21.00918367346939
659,regulation of transcription by glucose (GO:0046015),2.941638126199621,21.00918367346939
660,cell proliferation involved in metanephros development (GO:0072203),2.941638126199621,21.00918367346939
661,adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),2.941638126199621,21.00918367346939
662,ureter morphogenesis (GO:0072197),2.941638126199621,21.00918367346939
663,inflammasome complex assembly (GO:0140632),2.941638126199621,21.00918367346939
664,female mating behavior (GO:0060180),2.941638126199621,21.00918367346939
665,regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),2.941638126199621,21.00918367346939
666,proximal tubule development (GO:0072014),2.941638126199621,21.00918367346939
667,parathyroid gland development (GO:0060017),2.941638126199621,21.00918367346939
668,regulation of serotonin secretion (GO:0014062),2.941638126199621,21.00918367346939
669,regulation of epinephrine secretion (GO:0014060),2.941638126199621,21.00918367346939
670,cellular response to magnesium ion (GO:0071286),2.941638126199621,21.00918367346939
671,host-mediated regulation of intestinal microbiota composition (GO:0048874),2.941638126199621,21.00918367346939
672,formation of anatomical boundary (GO:0048859),2.941638126199621,21.00918367346939
673,regulation of presynaptic membrane potential (GO:0099505),2.941638126199621,21.00918367346939
674,regulation of sodium:proton antiporter activity (GO:0032415),2.941638126199621,21.00918367346939
675,positive regulation of arachidonic acid secretion (GO:0090238),2.941638126199621,21.00918367346939
676,heat generation (GO:0031649),2.941638126199621,21.00918367346939
677,response to sucrose (GO:0009744),2.941638126199621,21.00918367346939
678,regulation of cell chemotaxis to fibroblast growth factor (GO:1904847),2.941638126199621,21.00918367346939
679,bone mineralization involved in bone maturation (GO:0035630),2.941638126199621,21.00918367346939
680,exocrine pancreas development (GO:0031017),2.941638126199621,21.00918367346939
681,regulation of neuromuscular junction development (GO:1904396),2.941638126199621,21.00918367346939
682,neuronal signal transduction (GO:0023041),2.941638126199621,21.00918367346939
683,establishment of blood-brain barrier (GO:0060856),2.941638126199621,21.00918367346939
684,positive regulation of blood pressure by epinephrine-norepinephrine (GO:0003321),2.941638126199621,21.00918367346939
685,skeletal muscle cell proliferation (GO:0014856),2.941638126199621,21.00918367346939
686,negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179),2.941638126199621,21.00918367346939
687,regulation of female receptivity (GO:0045924),2.941638126199621,21.00918367346939
688,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation (GO:0021937),2.941638126199621,21.00918367346939
689,forebrain neuron fate commitment (GO:0021877),2.941638126199621,21.00918367346939
690,response to disaccharide (GO:0034285),2.941638126199621,21.00918367346939
691,DNA repair (GO:0006281),2.9408838631578513,0.0
692,positive regulation of organelle organization (GO:0010638),2.9408838631578513,0.0
693,negative regulation of response to external stimulus (GO:0032102),2.9402493035127533,2.2567409572524664
694,organelle localization (GO:0051640),2.938610812758236,0.0
695,cell division (GO:0051301),2.937979468874185,0.0
696,negative regulation of nucleobase-containing compound metabolic process (GO:0045934),2.934735161026689,1.6005716114871045
697,biological process involved in intraspecies interaction between organisms (GO:0051703),2.93175322026004,5.549595687331536
698,social behavior (GO:0035176),2.93175322026004,5.549595687331536
699,multi-multicellular organism process (GO:0044706),2.9280302616925016,2.8695470383275263
700,cell-cell signaling (GO:0007267),2.9247965594991903,1.7653146022952115
701,mitotic cell cycle process (GO:1903047),2.9151323788834196,0.0
702,ncRNA metabolic process (GO:0034660),2.909709643728936,0.0
703,neuromuscular process controlling balance (GO:0050885),2.8997074290397475,5.446825396825396
704,regulation of hemopoiesis (GO:1903706),2.871984960671748,2.2170495333811915
705,positive regulation of biomineral tissue development (GO:0070169),2.8683087418502637,5.347792207792208
706,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",2.8683087418502637,5.347792207792208
707,heart valve morphogenesis (GO:0003179),2.8683087418502637,5.347792207792208
708,endomembrane system organization (GO:0010256),2.867651327060273,0.0
709,cell-cell junction assembly (GO:0007043),2.86406660940862,3.501530612244898
710,odontogenesis (GO:0042476),2.86406660940862,3.501530612244898
711,regulation of metabolic process (GO:0019222),2.856212643840928,1.2411406996911882
712,negative regulation of apoptotic process (GO:0043066),2.848701080539241,1.8014556156538337
713,negative regulation of T cell activation (GO:0050868),2.84548785880074,3.4739595050618672
714,positive regulation of biomineralization (GO:0110151),2.8375343578051657,5.252295918367348
715,lung-associated mesenchyme development (GO:0060484),2.8271880132158533,18.383035714285715
716,blood vessel maturation (GO:0001955),2.8271880132158533,18.383035714285715
717,positive regulation of histone H3-K9 acetylation (GO:2000617),2.8271880132158533,18.383035714285715
718,regulation of catecholamine uptake involved in synaptic transmission (GO:0051940),2.8271880132158533,18.383035714285715
719,aggressive behavior (GO:0002118),2.8271880132158533,18.383035714285715
720,neuroblast differentiation (GO:0014016),2.8271880132158533,18.383035714285715
721,regulation of dopamine uptake involved in synaptic transmission (GO:0051584),2.8271880132158533,18.383035714285715
722,regulation of arachidonic acid secretion (GO:0090237),2.8271880132158533,18.383035714285715
723,thermoception (GO:0050955),2.8271880132158533,18.383035714285715
724,positive regulation of uterine smooth muscle contraction (GO:0070474),2.8271880132158533,18.383035714285715
725,neurotransmitter loading into synaptic vesicle (GO:0098700),2.8271880132158533,18.383035714285715
726,regulation of mucus secretion (GO:0070255),2.8271880132158533,18.383035714285715
727,regulation of nodal signaling pathway (GO:1900107),2.8271880132158533,18.383035714285715
728,hindgut development (GO:0061525),2.8271880132158533,18.383035714285715
729,cellular response to vasopressin (GO:1904117),2.8271880132158533,18.383035714285715
730,response to vasopressin (GO:1904116),2.8271880132158533,18.383035714285715
731,cellular response to aldosterone (GO:1904045),2.8271880132158533,18.383035714285715
732,positive regulation of cell fate commitment (GO:0010455),2.8271880132158533,18.383035714285715
733,negative regulation of calcium ion-dependent exocytosis (GO:0045955),2.8271880132158533,18.383035714285715
734,hindbrain radial glia guided cell migration (GO:0021932),2.8271880132158533,18.383035714285715
735,negative regulation of lymphocyte differentiation (GO:0045620),2.8073626551744675,5.16015037593985
736,ureteric bud morphogenesis (GO:0060675),2.8073626551744675,5.16015037593985
737,tissue morphogenesis (GO:0048729),2.7967584464097994,2.071327967806841
738,response to ethanol (GO:0045471),2.790812028940001,3.3937912087912085
739,regulation of wound healing (GO:0061041),2.790812028940001,3.3937912087912085
740,regulation of ion transport (GO:0043269),2.788357299837325,1.8694612590799033
741,mesonephric tubule morphogenesis (GO:0072171),2.7777731123272598,5.071182266009853
742,zymogen activation (GO:0031638),2.7777731123272598,5.071182266009853
743,negative regulation of BMP signaling pathway (GO:0030514),2.7777731123272598,5.071182266009853
744,bone mineralization (GO:0030282),2.7777731123272598,5.071182266009853
745,negative regulation of carbohydrate metabolic process (GO:0045912),2.7777731123272598,5.071182266009853
746,blood circulation (GO:0008015),2.777544760501523,2.1627100840336135
747,bone development (GO:0060348),2.7767224489464697,2.723412698412698
748,negative regulation of programmed cell death (GO:0043069),2.7743005838011054,1.7622082166199813
749,positive regulation of locomotion (GO:0040017),2.774293174321831,2.049676455948233
750,positive regulation of lymphocyte differentiation (GO:0045621),2.7729312153239687,3.367884405670665
751,negative regulation of cell population proliferation (GO:0008285),2.7610244960189703,1.8563514325786417
752,digestive tract development (GO:0048565),2.7552182796387643,3.3423701298701296
753,embryonic digit morphogenesis (GO:0042733),2.7487462338379176,4.985230024213076
754,positive regulation of nucleic acid-templated transcription (GO:1903508),2.7461163859145445,1.5435318617242815
755,positive regulation of DNA-templated transcription (GO:0045893),2.7461163859145445,1.5435318617242815
756,positive regulation of RNA biosynthetic process (GO:1902680),2.7350214071696786,1.5381505769071138
757,chromatin organization (GO:0006325),2.7301922425340885,2.011135531135531
758,regulation of cellular response to growth factor stimulus (GO:0090287),2.7253561711883223,2.3417879890809825
759,multi-ciliated epithelial cell differentiation (GO:1903251),2.7251567521698767,16.340476190476192
760,negative regulation of neuroblast proliferation (GO:0007406),2.7251567521698767,16.340476190476192
761,cranial suture morphogenesis (GO:0060363),2.7251567521698767,16.340476190476192
762,regulation of systemic arterial blood pressure by norepinephrine-epinephrine (GO:0001993),2.7251567521698767,16.340476190476192
763,cell proliferation in hindbrain (GO:0021534),2.7251567521698767,16.340476190476192
764,mesonephric tubule formation (GO:0072172),2.7251567521698767,16.340476190476192
765,positive regulation of T-helper 2 cell cytokine production (GO:2000553),2.7251567521698767,16.340476190476192
766,neutrophil-mediated killing of bacterium (GO:0070944),2.7251567521698767,16.340476190476192
767,neutrophil-mediated killing of symbiont cell (GO:0070943),2.7251567521698767,16.340476190476192
768,neutrophil mediated cytotoxicity (GO:0070942),2.7251567521698767,16.340476190476192
769,establishment of protein localization to chromatin (GO:0071169),2.7251567521698767,16.340476190476192
770,embryonic foregut morphogenesis (GO:0048617),2.7251567521698767,16.340476190476192
771,sensory perception of sour taste (GO:0050915),2.7251567521698767,16.340476190476192
772,Peyer's patch development (GO:0048541),2.7251567521698767,16.340476190476192
773,mucosa-associated lymphoid tissue development (GO:0048537),2.7251567521698767,16.340476190476192
774,negative regulation of retinoic acid receptor signaling pathway (GO:0048387),2.7251567521698767,16.340476190476192
775,amacrine cell differentiation (GO:0035881),2.7251567521698767,16.340476190476192
776,positive regulation of epithelial tube formation (GO:1905278),2.7251567521698767,16.340476190476192
777,regulation of epithelial tube formation (GO:1905276),2.7251567521698767,16.340476190476192
778,behavioral response to ethanol (GO:0048149),2.7251567521698767,16.340476190476192
779,terpenoid catabolic process (GO:0016115),2.7251567521698767,16.340476190476192
780,epithelial cell proliferation involved in prostate gland development (GO:0060767),2.7251567521698767,16.340476190476192
781,cerebellar granule cell precursor proliferation (GO:0021930),2.7251567521698767,16.340476190476192
782,cell proliferation in external granule layer (GO:0021924),2.7251567521698767,16.340476190476192
783,lymphocyte migration into lymphoid organs (GO:0097021),2.7251567521698767,16.340476190476192
784,chemical synaptic transmission (GO:0007268),2.722553751134104,2.1313664596273294
785,anterograde trans-synaptic signaling (GO:0098916),2.722553751134104,2.1313664596273294
786,positive regulation of wound healing (GO:0090303),2.7202634833966357,4.902142857142858
787,astrocyte differentiation (GO:0048708),2.7202634833966357,4.902142857142858
788,positive regulation of protein tyrosine kinase activity (GO:0061098),2.7202634833966357,4.902142857142858
789,system process (GO:0003008),2.716372630998275,1.4854978354978354
790,protein catabolic process (GO:0030163),2.7050584022419843,0.19452947845804988
791,nephron development (GO:0072006),2.703061770854943,3.268095238095238
792,positive regulation of production of molecular mediator of immune response (GO:0002702),2.703061770854943,3.268095238095238
793,protein transport (GO:0015031),2.697998124231662,0.3742093784078517
794,regulation of smooth muscle contraction (GO:0006940),2.6923072217574493,4.821779859484778
795,regulation of neurotransmitter levels (GO:0001505),2.6857020431929146,2.6379244074311337
796,response to biotic stimulus (GO:0009607),2.6847071143672747,1.592035569302146
797,organic cyclic compound biosynthetic process (GO:1901362),2.6844255733791673,0.36282307330827074
798,anatomical structure formation involved in morphogenesis (GO:0048646),2.682027948838395,1.7191361773189615
799,kidney epithelium development (GO:0072073),2.669085326905992,3.220385818561001
800,cellular macromolecule catabolic process (GO:0044265),2.6679152859394324,0.18734303912647862
801,transmission of nerve impulse (GO:0019226),2.6648606498001723,4.744009216589862
802,negative regulation of protein secretion (GO:0050709),2.6648606498001723,4.744009216589862
803,"CD4-positive, alpha-beta T cell activation (GO:0035710)",2.6648606498001723,4.744009216589862
804,negative regulation of leukocyte cell-cell adhesion (GO:1903038),2.6523285390633,3.1970496894409934
805,gland development (GO:0048732),2.651108019275944,2.0909614082599863
806,regulation of cell adhesion (GO:0030155),2.6423212579440802,1.8639326453014666
807,nucleobase-containing compound biosynthetic process (GO:0034654),2.6392822798302684,0.2920839835437651
808,regulation of vasoconstriction (GO:0019229),2.6379077560911113,4.668707482993197
809,heart looping (GO:0001947),2.6379077560911113,4.668707482993197
810,T cell differentiation in thymus (GO:0033077),2.6379077560911113,4.668707482993197
811,neuron migration (GO:0001764),2.6357230741652495,3.1740493319630008
812,regulation of lipid transport (GO:0032368),2.6357230741652495,3.1740493319630008
813,foregut morphogenesis (GO:0007440),2.633172158693478,14.706428571428573
814,regulation of T-helper 1 cell differentiation (GO:0045625),2.633172158693478,14.706428571428573
815,spinal cord motor neuron cell fate specification (GO:0021520),2.633172158693478,14.706428571428573
816,metanephric collecting duct development (GO:0072205),2.633172158693478,14.706428571428573
817,negative regulation of mesenchymal cell apoptotic process (GO:2001054),2.633172158693478,14.706428571428573
818,inhibitory postsynaptic potential (GO:0060080),2.633172158693478,14.706428571428573
819,regulation of glucokinase activity (GO:0033131),2.633172158693478,14.706428571428573
820,cellular response to parathyroid hormone stimulus (GO:0071374),2.633172158693478,14.706428571428573
821,stem cell fate commitment (GO:0048865),2.633172158693478,14.706428571428573
822,response to folic acid (GO:0051593),2.633172158693478,14.706428571428573
823,neuron fate determination (GO:0048664),2.633172158693478,14.706428571428573
824,hyperosmotic salinity response (GO:0042538),2.633172158693478,14.706428571428573
825,serotonin metabolic process (GO:0042428),2.633172158693478,14.706428571428573
826,regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768),2.633172158693478,14.706428571428573
827,lung secretory cell differentiation (GO:0061140),2.633172158693478,14.706428571428573
828,positive regulation of cerebellar granule cell precursor proliferation (GO:0021940),2.633172158693478,14.706428571428573
829,regulation of histone H3-K27 methylation (GO:0061085),2.633172158693478,14.706428571428573
830,positive regulation of RNA metabolic process (GO:0051254),2.615424621810628,1.5120245825602967
831,positive regulation of multicellular organismal process (GO:0051240),2.611886915212332,1.553154172560113
832,retina morphogenesis in camera-type eye (GO:0060042),2.611433268346482,4.595758928571429
833,muscle tissue development (GO:0060537),2.60174717997559,2.255587204206836
834,positive regulation of response to stimulus (GO:0048584),2.598595441435442,1.4554270291112397
835,cellular response to corticosteroid stimulus (GO:0071384),2.5854226084641105,4.525054945054945
836,heart valve development (GO:0003170),2.5854226084641105,4.525054945054945
837,trans-synaptic signaling (GO:0099537),2.5731995467213733,2.0472986410341396
838,positive regulation of gliogenesis (GO:0014015),2.5598618512012417,4.456493506493507
839,blood vessel diameter maintenance (GO:0097746),2.5548913469243364,3.0638392857142858
840,regulation of tube diameter (GO:0035296),2.5548913469243364,3.0638392857142858
841,regulation of hexokinase activity (GO:1903299),2.549482699395307,13.36948051948052
842,regulation of gastric acid secretion (GO:0060453),2.549482699395307,13.36948051948052
843,branching involved in prostate gland morphogenesis (GO:0060442),2.549482699395307,13.36948051948052
844,trachea morphogenesis (GO:0060439),2.549482699395307,13.36948051948052
845,regulation of T-helper 2 cell differentiation (GO:0045628),2.549482699395307,13.36948051948052
846,pons development (GO:0021548),2.549482699395307,13.36948051948052
847,spinal cord association neuron differentiation (GO:0021527),2.549482699395307,13.36948051948052
848,embryonic skeletal joint morphogenesis (GO:0060272),2.549482699395307,13.36948051948052
849,limb bud formation (GO:0060174),2.549482699395307,13.36948051948052
850,cell proliferation involved in kidney development (GO:0072111),2.549482699395307,13.36948051948052
851,negative regulation of activin receptor signaling pathway (GO:0032926),2.549482699395307,13.36948051948052
852,Bergmann glial cell differentiation (GO:0060020),2.549482699395307,13.36948051948052
853,actin filament reorganization (GO:0090527),2.549482699395307,13.36948051948052
854,negative thymic T cell selection (GO:0045060),2.549482699395307,13.36948051948052
855,positive thymic T cell selection (GO:0045059),2.549482699395307,13.36948051948052
856,positive regulation of T cell differentiation in thymus (GO:0033089),2.549482699395307,13.36948051948052
857,negative regulation of T cell differentiation in thymus (GO:0033085),2.549482699395307,13.36948051948052
858,positive regulation of histone H3-K9 methylation (GO:0051574),2.549482699395307,13.36948051948052
859,positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),2.549482699395307,13.36948051948052
860,negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106072),2.549482699395307,13.36948051948052
861,regulation of timing of cell differentiation (GO:0048505),2.549482699395307,13.36948051948052
862,positive regulation of smooth muscle cell differentiation (GO:0051152),2.549482699395307,13.36948051948052
863,response to histamine (GO:0034776),2.549482699395307,13.36948051948052
864,isoprenoid catabolic process (GO:0008300),2.549482699395307,13.36948051948052
865,Notch signaling involved in heart development (GO:0061314),2.549482699395307,13.36948051948052
866,cerebral cortex GABAergic interneuron differentiation (GO:0021892),2.549482699395307,13.36948051948052
867,cell fate commitment involved in pattern specification (GO:0060581),2.549482699395307,13.36948051948052
868,ventral spinal cord interneuron fate commitment (GO:0060579),2.549482699395307,13.36948051948052
869,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),2.5391498824303778,3.0427093596059116
870,regulation of tube size (GO:0035150),2.5391498824303778,3.0427093596059116
871,biological process involved in interspecies interaction between organisms (GO:0044419),2.5373944236009276,1.5606072766185124
872,mitochondrion organization (GO:0007005),2.5373310287904554,0.0
873,ribonucleoprotein complex biogenesis (GO:0022613),2.536856568347163,0.0
874,mRNA processing (GO:0006397),2.5362762043502274,0.0
875,negative regulation of calcium ion transport (GO:0051926),2.534737685838583,4.389978678038379
876,nephron tubule morphogenesis (GO:0072078),2.510037380580144,4.325420168067227
877,regulation of cellular response to insulin stimulus (GO:1900076),2.510037380580144,4.325420168067227
878,regulation of insulin receptor signaling pathway (GO:0046626),2.510037380580144,4.325420168067227
879,regulation of cold-induced thermogenesis (GO:0120161),2.508076303417412,3.00131195335277
880,adult behavior (GO:0030534),2.492740481898135,2.9810328185328183
881,mesenchyme development (GO:0060485),2.491527916203414,2.4613269575612673
882,determination of heart left/right asymmetry (GO:0061371),2.4857487488934344,4.262732919254658
883,embryonic heart tube morphogenesis (GO:0003143),2.4857487488934344,4.262732919254658
884,response to stimulus (GO:0050896),2.4813189991647238,1.182390407740633
885,thalamus development (GO:0021794),2.4727582403193655,12.255357142857143
886,glial cell fate commitment (GO:0021781),2.4727582403193655,12.255357142857143
887,cerebellar Purkinje cell differentiation (GO:0021702),2.4727582403193655,12.255357142857143
888,osteoblast proliferation (GO:0033687),2.4727582403193655,12.255357142857143
889,nephric duct morphogenesis (GO:0072178),2.4727582403193655,12.255357142857143
890,positive regulation of interleukin-5 production (GO:0032754),2.4727582403193655,12.255357142857143
891,neuronal ion channel clustering (GO:0045161),2.4727582403193655,12.255357142857143
892,T-helper 1 cell differentiation (GO:0045063),2.4727582403193655,12.255357142857143
893,regulation of DNA demethylation (GO:1901535),2.4727582403193655,12.255357142857143
894,"regulation of development, heterochronic (GO:0040034)",2.4727582403193655,12.255357142857143
895,positive regulation of renal sodium excretion (GO:0035815),2.4727582403193655,12.255357142857143
896,negative T cell selection (GO:0043383),2.4727582403193655,12.255357142857143
897,drinking behavior (GO:0042756),2.4727582403193655,12.255357142857143
898,cellular response to interferon-alpha (GO:0035457),2.4727582403193655,12.255357142857143
899,glycine transport (GO:0015816),2.4727582403193655,12.255357142857143
900,gamma-aminobutyric acid transport (GO:0015812),2.4727582403193655,12.255357142857143
901,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),2.4727582403193655,12.255357142857143
902,regulation of dopaminergic neuron differentiation (GO:1904338),2.4727582403193655,12.255357142857143
903,self proteolysis (GO:0097264),2.4727582403193655,12.255357142857143
904,prostate gland growth (GO:0060736),2.4727582403193655,12.255357142857143
905,mesenchymal cell apoptotic process (GO:0097152),2.4727582403193655,12.255357142857143
906,epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),2.4727582403193655,12.255357142857143
907,organonitrogen compound biosynthetic process (GO:1901566),2.4691710568389413,0.4413031829385918
908,intracellular transport (GO:0046907),2.465092205015326,0.4325420168067227
909,nephron epithelium morphogenesis (GO:0072088),2.4618601196412455,4.201836734693877
910,intermediate filament organization (GO:0045109),2.4618601196412455,4.201836734693877
911,actin cytoskeleton reorganization (GO:0031532),2.4618601196412455,4.201836734693877
912,regulation of blood coagulation (GO:0030193),2.4618601196412455,4.201836734693877
913,response to activity (GO:0014823),2.4618601196412455,4.201836734693877
914,cardiac ventricle morphogenesis (GO:0003208),2.4618601196412455,4.201836734693877
915,regulation of hormone secretion (GO:0046883),2.4571109059746763,2.4308146399055492
916,positive regulation of response to wounding (GO:1903036),2.415238588212125,4.085119047619048
917,response to estrogen (GO:0043627),2.415238588212125,4.085119047619048
918,negative regulation of ERK1 and ERK2 cascade (GO:0070373),2.415238588212125,4.085119047619048
919,regulation of hemostasis (GO:1900046),2.415238588212125,4.085119047619048
920,renal tubule morphogenesis (GO:0061333),2.415238588212125,4.085119047619048
921,T cell proliferation (GO:0042098),2.415238588212125,4.085119047619048
922,regulation of insulin secretion (GO:0050796),2.4034279976248416,2.8648886827458258
923,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),2.4019648475676165,11.312637362637362
924,positive regulation of catecholamine secretion (GO:0033605),2.4019648475676165,11.312637362637362
925,negative regulation of catecholamine secretion (GO:0033604),2.4019648475676165,11.312637362637362
926,insemination (GO:0007320),2.4019648475676165,11.312637362637362
927,ventral spinal cord interneuron differentiation (GO:0021514),2.4019648475676165,11.312637362637362
928,response to ether (GO:0045472),2.4019648475676165,11.312637362637362
929,regulation of nephron tubule epithelial cell differentiation (GO:0072182),2.4019648475676165,11.312637362637362
930,regulation of histone H3-K9 acetylation (GO:2000615),2.4019648475676165,11.312637362637362
931,regulation of mesenchymal cell apoptotic process (GO:2001053),2.4019648475676165,11.312637362637362
932,regulation of T-helper 2 cell cytokine production (GO:2000551),2.4019648475676165,11.312637362637362
933,negative regulation of fibrinolysis (GO:0051918),2.4019648475676165,11.312637362637362
934,diet induced thermogenesis (GO:0002024),2.4019648475676165,11.312637362637362
935,cellular response to mineralocorticoid stimulus (GO:0071389),2.4019648475676165,11.312637362637362
936,chromatin organization (GO:0006336),2.4019648475676165,11.312637362637362
937,regulation of immature T cell proliferation in thymus (GO:0033084),2.4019648475676165,11.312637362637362
938,regulation of immature T cell proliferation (GO:0033083),2.4019648475676165,11.312637362637362
939,cellular response to lithium ion (GO:0071285),2.4019648475676165,11.312637362637362
940,negative regulation of multicellular organism growth (GO:0040015),2.4019648475676165,11.312637362637362
941,positive regulation of astrocyte differentiation (GO:0048711),2.4019648475676165,11.312637362637362
942,primary amino compound metabolic process (GO:1901160),2.4019648475676165,11.312637362637362
943,regulation of postsynaptic neurotransmitter receptor internalization (GO:0099149),2.4019648475676165,11.312637362637362
944,lateral mesoderm development (GO:0048368),2.4019648475676165,11.312637362637362
945,maternal behavior (GO:0042711),2.4019648475676165,11.312637362637362
946,magnesium ion homeostasis (GO:0010960),2.4019648475676165,11.312637362637362
947,sleep (GO:0030431),2.4019648475676165,11.312637362637362
948,fat-soluble vitamin catabolic process (GO:0042363),2.4019648475676165,11.312637362637362
949,cellular response to interleukin-17 (GO:0097398),2.4019648475676165,11.312637362637362
950,negative regulation of cell fate commitment (GO:0010454),2.4019648475676165,11.312637362637362
951,telencephalon regionalization (GO:0021978),2.4019648475676165,11.312637362637362
952,branching involved in labyrinthine layer morphogenesis (GO:0060670),2.4019648475676165,11.312637362637362
953,eyelid development in camera-type eye (GO:0061029),2.4019648475676165,11.312637362637362
954,regulation of cell development (GO:0060284),2.3936356893978514,2.0067251461988302
955,T cell activation involved in immune response (GO:0002286),2.3924846704300786,4.029158512720157
956,nephron morphogenesis (GO:0072028),2.3924846704300786,4.029158512720157
957,positive regulation of alpha-beta T cell activation (GO:0046635),2.3924846704300786,4.029158512720157
958,negative regulation of T cell proliferation (GO:0042130),2.3924846704300786,4.029158512720157
959,ventricular septum development (GO:0003281),2.3924846704300786,4.029158512720157
960,chemotaxis (GO:0006935),2.3758617795267805,1.9873552123552123
961,regulation of glial cell differentiation (GO:0045685),2.3700886754327866,3.9747104247104246
962,taxis (GO:0042330),2.368548885586077,1.9797115384615385
963,regulation of protein secretion (GO:0050708),2.3681779675585757,2.3530285714285717
964,regulation of blood circulation (GO:1903522),2.3573429148804905,2.343653955606147
965,regulation of coagulation (GO:0050818),2.3480411144200932,3.921714285714286
966,protein localization to chromosome (GO:0034502),2.3480411144200932,3.921714285714286
967,multicellular organism reproduction (GO:0032504),2.3430649524041325,0.3239301447451227
968,regulation of hormone levels (GO:0010817),2.338224119186644,1.949715909090909
969,cerebellar Purkinje cell layer formation (GO:0021694),2.336282885752143,10.504591836734695
970,cerebellar granular layer development (GO:0021681),2.336282885752143,10.504591836734695
971,metanephric mesenchyme development (GO:0072075),2.336282885752143,10.504591836734695
972,otic vesicle development (GO:0071599),2.336282885752143,10.504591836734695
973,neural crest formation (GO:0014029),2.336282885752143,10.504591836734695
974,regulation of cell proliferation involved in kidney development (GO:1901722),2.336282885752143,10.504591836734695
975,iron coordination entity transport (GO:1901678),2.336282885752143,10.504591836734695
976,response to parathyroid hormone (GO:0071107),2.336282885752143,10.504591836734695
977,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),2.336282885752143,10.504591836734695
978,negative regulation of oligodendrocyte differentiation (GO:0048715),2.336282885752143,10.504591836734695
979,negative regulation of cholesterol transport (GO:0032375),2.336282885752143,10.504591836734695
980,negative regulation of sterol transport (GO:0032372),2.336282885752143,10.504591836734695
981,positive regulation of prostaglandin secretion (GO:0032308),2.336282885752143,10.504591836734695
982,detection of mechanical stimulus involved in sensory perception of pain (GO:0050966),2.336282885752143,10.504591836734695
983,regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070),2.336282885752143,10.504591836734695
984,nose development (GO:0043584),2.336282885752143,10.504591836734695
985,behavioral response to cocaine (GO:0048148),2.336282885752143,10.504591836734695
986,motor neuron migration (GO:0097475),2.336282885752143,10.504591836734695
987,response to interleukin-17 (GO:0097396),2.336282885752143,10.504591836734695
988,positive regulation of cardiac muscle cell apoptotic process (GO:0010666),2.336282885752143,10.504591836734695
989,positive regulation of striated muscle cell apoptotic process (GO:0010663),2.336282885752143,10.504591836734695
990,response to aldosterone (GO:1904044),2.336282885752143,10.504591836734695
991,parental behavior (GO:0060746),2.336282885752143,10.504591836734695
992,negative regulation of type 2 immune response (GO:0002829),2.336282885752143,10.504591836734695
993,positive regulation of T cell activation (GO:0050870),2.3358549654184055,2.3251270468661773
994,organophosphate metabolic process (GO:0019637),2.3299222207439088,0.3159275740371336
995,regulation of organic acid transport (GO:0032890),2.3263328684352333,3.8701127819548877
996,regulation of behavior (GO:0050795),2.3263328684352333,3.8701127819548877
997,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),2.3263328684352333,3.8701127819548877
998,neural retina development (GO:0003407),2.3263328684352333,3.8701127819548877
999,protein phosphorylation (GO:0006468),2.3238511202083854,0.20454003576395788
1000,muscle organ morphogenesis (GO:0048644),2.3049551689003547,3.819851576994435
1001,locomotion (GO:0040011),2.2940387012051473,1.909925788497217
1002,regulation of response to wounding (GO:1903034),2.2910963966157114,2.7234126984126985
1003,"regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",2.283899580300596,3.7708791208791212
1004,embryonic pattern specification (GO:0009880),2.283899580300596,3.7708791208791212
1005,embryonic skeletal joint development (GO:0072498),2.2750516044152085,9.804285714285715
1006,branching involved in salivary gland morphogenesis (GO:0060445),2.2750516044152085,9.804285714285715
1007,collecting duct development (GO:0072044),2.2750516044152085,9.804285714285715
1008,positive regulation of interleukin-13 production (GO:0032736),2.2750516044152085,9.804285714285715
1009,calcineurin-NFAT signaling cascade (GO:0033173),2.2750516044152085,9.804285714285715
1010,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),2.2750516044152085,9.804285714285715
1011,peripheral nervous system neuron development (GO:0048935),2.2750516044152085,9.804285714285715
1012,peripheral nervous system neuron differentiation (GO:0048934),2.2750516044152085,9.804285714285715
1013,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),2.2750516044152085,9.804285714285715
1014,positive regulation of hormone metabolic process (GO:0032352),2.2750516044152085,9.804285714285715
1015,regulation of prostaglandin secretion (GO:0032306),2.2750516044152085,9.804285714285715
1016,induction of positive chemotaxis (GO:0050930),2.2750516044152085,9.804285714285715
1017,negative regulation of calcineurin-mediated signaling (GO:0106057),2.2750516044152085,9.804285714285715
1018,enteric nervous system development (GO:0048484),2.2750516044152085,9.804285714285715
1019,establishment of protein localization to chromosome (GO:0070199),2.2750516044152085,9.804285714285715
1020,vitamin catabolic process (GO:0009111),2.2750516044152085,9.804285714285715
1021,sphingosine-1-phosphate receptor signaling pathway (GO:0003376),2.2750516044152085,9.804285714285715
1022,negative regulation of androgen receptor signaling pathway (GO:0060766),2.2750516044152085,9.804285714285715
1023,regulation of skeletal muscle cell proliferation (GO:0014857),2.2750516044152085,9.804285714285715
1024,negative regulation of smooth muscle contraction (GO:0045986),2.2750516044152085,9.804285714285715
1025,grooming behavior (GO:0007625),2.2750516044152085,9.804285714285715
1026,telencephalon development (GO:0021537),2.2728137927078977,2.271263099834528
1027,potassium ion transmembrane transport (GO:0071805),2.2641392685810975,2.690200348432056
1028,negative regulation of ion transmembrane transporter activity (GO:0032413),2.2631579836347244,3.7231464737793853
1029,regulation of response to external stimulus (GO:0032101),2.2558365285238313,1.6625972691234767
1030,epithelial to mesenchymal transition (GO:0001837),2.2427225603660426,3.676607142857143
1031,axonogenesis (GO:0007409),2.2426284867065083,2.0145792563600784
1032,response to corticosteroid (GO:0031960),2.2376104270583808,2.6577882960413084
1033,heart development (GO:0007507),2.22564913435646,1.8548648648648651
1034,regulation of lipid localization (GO:1905952),2.224503372262403,2.641873396065013
1035,negative regulation of secretion (GO:0051048),2.224503372262403,2.641873396065013
1036,hair follicle development (GO:0001942),2.2225857780209597,3.6312169312169313
1037,neural crest cell development (GO:0014032),2.2225857780209597,3.6312169312169313
1038,phosphatidylinositol-mediated signaling (GO:0048015),2.2225857780209597,3.6312169312169313
1039,positive regulation of cytokine production involved in immune response (GO:0002720),2.2225857780209597,3.6312169312169313
1040,positive regulation of digestive system process (GO:0060456),2.217730552110415,9.191517857142857
1041,"synaptic transmission, dopaminergic (GO:0001963)",2.217730552110415,9.191517857142857
1042,cell migration in hindbrain (GO:0021535),2.217730552110415,9.191517857142857
1043,mesenchymal to epithelial transition (GO:0060231),2.217730552110415,9.191517857142857
1044,nephric duct development (GO:0072176),2.217730552110415,9.191517857142857
1045,"regulation of circadian sleep/wake cycle, sleep (GO:0045187)",2.217730552110415,9.191517857142857
1046,sphingolipid mediated signaling pathway (GO:0090520),2.217730552110415,9.191517857142857
1047,negative regulation of smooth muscle cell differentiation (GO:0051151),2.217730552110415,9.191517857142857
1048,regulation of retinoic acid receptor signaling pathway (GO:0048385),2.217730552110415,9.191517857142857
1049,endocrine hormone secretion (GO:0060986),2.217730552110415,9.191517857142857
1050,negative regulation of alpha-beta T cell proliferation (GO:0046642),2.217730552110415,9.191517857142857
1051,GABAergic neuron differentiation (GO:0097154),2.217730552110415,9.191517857142857
1052,branch elongation of an epithelium (GO:0060602),2.217730552110415,9.191517857142857
1053,positive regulation of cell motility (GO:2000147),2.212390323739797,1.8448924731182796
1054,cartilage development (GO:0051216),2.2114995453632167,2.626147959183674
1055,cell maturation (GO:0048469),2.2114995453632167,2.626147959183674
1056,cellular response to dopamine (GO:1903351),2.2027403765224243,3.586933797909408
1057,regulation of muscle contraction (GO:0006937),2.1985977117677504,2.610608622147084
1058,gastrulation (GO:0007369),2.1985977117677504,2.610608622147084
1059,T cell differentiation (GO:0030217),2.1985977117677504,2.610608622147084
1060,regulation of catalytic activity (GO:0050790),2.195167455173018,0.6197399313707784
1061,vascular process in circulatory system (GO:0003018),2.191941892475027,2.203210272873194
1062,positive regulation of immune effector process (GO:0002699),2.191941892475027,2.203210272873194
1063,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),2.185796658672751,2.5952521008403364
1064,regulation of inflammatory response (GO:0050727),2.1843169563717724,1.9766705069124424
1065,establishment of protein localization (GO:0045184),2.1833719640778675,0.464291351899876
1066,endothelial cell differentiation (GO:0045446),2.183179354718284,3.5437177280550776
1067,odontogenesis of dentin-containing tooth (GO:0042475),2.183179354718284,3.5437177280550776
1068,embryonic heart tube development (GO:0035050),2.183179354718284,3.5437177280550776
1069,response to dopamine (GO:1903350),2.183179354718284,3.5437177280550776
1070,regulation of secretion by cell (GO:1903530),2.17649825681433,1.818816254416961
1071,hippocampus development (GO:0021766),2.163895958940699,3.501530612244898
1072,negative regulation of myeloid cell differentiation (GO:0045638),2.163895958940699,3.501530612244898
1073,regulation of histone methylation (GO:0031060),2.163895958940699,3.501530612244898
1074,negative regulation of digestive system process (GO:0060457),2.163872037480115,8.650840336134454
1075,regulation of mammary gland epithelial cell proliferation (GO:0033599),2.163872037480115,8.650840336134454
1076,cellular response to aldehyde (GO:0110096),2.163872037480115,8.650840336134454
1077,ureter development (GO:0072189),2.163872037480115,8.650840336134454
1078,regulation of epithelial cell differentiation involved in kidney development (GO:2000696),2.163872037480115,8.650840336134454
1079,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),2.163872037480115,8.650840336134454
1080,cellular response to acidic pH (GO:0071468),2.163872037480115,8.650840336134454
1081,G1 to G0 transition (GO:0070314),2.163872037480115,8.650840336134454
1082,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),2.163872037480115,8.650840336134454
1083,inner dynein arm assembly (GO:0036159),2.163872037480115,8.650840336134454
1084,type B pancreatic cell development (GO:0003323),2.163872037480115,8.650840336134454
1085,3'-UTR-mediated mRNA destabilization (GO:0061158),2.163872037480115,8.650840336134454
1086,pulmonary valve morphogenesis (GO:0003184),2.163872037480115,8.650840336134454
1087,negative regulation of Wnt signaling pathway (GO:0030178),2.147986366566389,2.5502477291494636
1088,blood coagulation (GO:0007596),2.147986366566389,2.5502477291494636
1089,neurotransmitter secretion (GO:0007269),2.144883670776147,3.4603361344537817
1090,signal release from synapse (GO:0099643),2.144883670776147,3.4603361344537817
1091,skin epidermis development (GO:0098773),2.144883670776147,3.4603361344537817
1092,inositol lipid-mediated signaling (GO:0048017),2.144883670776147,3.4603361344537817
1093,hair cycle process (GO:0022405),2.144883670776147,3.4603361344537817
1094,molting cycle process (GO:0022404),2.144883670776147,3.4603361344537817
1095,negative regulation of cell death (GO:0060548),2.1393213393277657,1.5828837014257757
1096,negative regulation of DNA-binding transcription factor activity (GO:0043433),2.1355767205852034,2.5355911330049263
1097,purine nucleotide metabolic process (GO:0006163),2.1294979202142477,0.0
1098,embryonic placenta development (GO:0001892),2.1261361967506636,3.4200996677740867
1099,regulation of smoothened signaling pathway (GO:0008589),2.1261361967506636,3.4200996677740867
1100,ribonucleotide metabolic process (GO:0009259),2.1238398572795028,0.0
1101,potassium ion transport (GO:0006813),2.1232620970902993,2.5211020408163267
1102,coagulation (GO:0050817),2.1232620970902993,2.5211020408163267
1103,generation of precursor metabolites and energy (GO:0006091),2.1219122837307416,0.0
1104,ncRNA processing (GO:0034470),2.1136035333339653,0.0
1105,ribose phosphate metabolic process (GO:0019693),2.1136035333339653,0.0
1106,negative regulation of gluconeogenesis (GO:0045721),2.1131010446136367,8.170238095238096
1107,cerebellar Purkinje cell layer morphogenesis (GO:0021692),2.1131010446136367,8.170238095238096
1108,negative regulation of T-helper cell differentiation (GO:0045623),2.1131010446136367,8.170238095238096
1109,kidney mesenchyme development (GO:0072074),2.1131010446136367,8.170238095238096
1110,regulation of fibrinolysis (GO:0051917),2.1131010446136367,8.170238095238096
1111,peptidyl-tyrosine autophosphorylation (GO:0038083),2.1131010446136367,8.170238095238096
1112,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),2.1131010446136367,8.170238095238096
1113,regulation of neurotransmitter uptake (GO:0051580),2.1131010446136367,8.170238095238096
1114,retinoic acid receptor signaling pathway (GO:0048384),2.1131010446136367,8.170238095238096
1115,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369)",2.1131010446136367,8.170238095238096
1116,regulation of odontogenesis (GO:0042481),2.1131010446136367,8.170238095238096
1117,positive regulation of type 2 immune response (GO:0002830),2.1131010446136367,8.170238095238096
1118,copulation (GO:0007620),2.1131010446136367,8.170238095238096
1119,glucose import (GO:0046323),2.1131010446136367,8.170238095238096
1120,negative regulation of transcription elongation by RNA polymerase II (GO:0034244),2.1131010446136367,8.170238095238096
1121,cell-cell junction organization (GO:0045216),2.1110414025404314,2.5067775974025976
1122,stem cell development (GO:0048864),2.1076474577650126,3.380788177339902
1123,negative regulation of transporter activity (GO:0032410),2.1076474577650126,3.380788177339902
1124,positive regulation of leukocyte cell-cell adhesion (GO:1903039),2.1050592337772382,2.131366459627329
1125,cellular process involved in reproduction in multicellular organism (GO:0022412),2.1012475962821244,0.0
1126,pallium development (GO:0021543),2.098913561860422,2.492615012106538
1127,ureteric bud development (GO:0001657),2.089411579590627,3.34237012987013
1128,hemostasis (GO:0007599),2.0868775175817857,2.4786115569823437
1129,purine-containing compound metabolic process (GO:0072521),2.0860228188978867,0.0
1130,regulation of cell cycle phase transition (GO:1901987),2.081792194532599,0.0
1131,aromatic compound biosynthetic process (GO:0019438),2.0805315601603316,0.40513577331759154
1132,regulation of T cell differentiation (GO:0045580),2.074932230213218,2.464764565043895
1133,mesonephric tubule development (GO:0072164),2.0714228839407958,3.3048154093097915
1134,mesonephric epithelium development (GO:0072163),2.0714228839407958,3.3048154093097915
1135,positive regulation of lipid transport (GO:0032370),2.0714228839407958,3.3048154093097915
1136,negative regulation of lymphocyte proliferation (GO:0050672),2.0714228839407958,3.3048154093097915
1137,midbrain development (GO:0030901),2.0714228839407958,3.3048154093097915
1138,response to cytokine (GO:0034097),2.0710913333073653,1.6380922913719942
1139,trachea development (GO:0060438),2.0651003079633177,7.7402255639097755
1140,ectoderm development (GO:0007398),2.0651003079633177,7.7402255639097755
1141,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),2.0651003079633177,7.7402255639097755
1142,dorsal spinal cord development (GO:0021516),2.0651003079633177,7.7402255639097755
1143,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),2.0651003079633177,7.7402255639097755
1144,nephron tubule formation (GO:0072079),2.0651003079633177,7.7402255639097755
1145,osteoblast development (GO:0002076),2.0651003079633177,7.7402255639097755
1146,response to magnesium ion (GO:0032026),2.0651003079633177,7.7402255639097755
1147,regulation of renal sodium excretion (GO:0035813),2.0651003079633177,7.7402255639097755
1148,calcineurin-mediated signaling (GO:0097720),2.0651003079633177,7.7402255639097755
1149,positive regulation of voltage-gated potassium channel activity (GO:1903818),2.0651003079633177,7.7402255639097755
1150,negative regulation of platelet activation (GO:0010544),2.0651003079633177,7.7402255639097755
1151,cardiac right ventricle morphogenesis (GO:0003215),2.0651003079633177,7.7402255639097755
1152,craniofacial suture morphogenesis (GO:0097094),2.0651003079633177,7.7402255639097755
1153,negative regulation of mononuclear cell proliferation (GO:0032945),2.0536758795337784,3.2680952380952375
1154,positive regulation of reproductive process (GO:2000243),2.0536758795337784,3.2680952380952375
1155,kidney morphogenesis (GO:0060993),2.0536758795337784,3.2680952380952375
1156,regulation of embryonic development (GO:0045995),2.0536758795337784,3.2680952380952375
1157,protein maturation (GO:0051604),2.0403080963999183,2.0786471479050985
1158,regulation of potassium ion transmembrane transport (GO:1901379),2.036165254089654,3.2321821036106746
1159,positive regulation of leukocyte differentiation (GO:1902107),2.0280384468779538,2.4108899297423885
1160,stem cell differentiation (GO:0048863),2.0280384468779538,2.4108899297423885
1161,positive regulation of hemopoiesis (GO:1903708),2.0280384468779538,2.4108899297423885
1162,signal release (GO:0023061),2.0280384468779538,2.4108899297423885
1163,cell-cell signaling by wnt (GO:0198738),2.0222419316225153,2.0640601503759397
1164,Wnt signaling pathway (GO:0016055),2.0222419316225153,2.0640601503759397
1165,oxoacid metabolic process (GO:0043436),2.02211986855727,0.346849730458221
1166,cartilage condensation (GO:0001502),2.019599030209299,7.353214285714286
1167,ossification involved in bone maturation (GO:0043931),2.019599030209299,7.353214285714286
1168,negative regulation of voltage-gated calcium channel activity (GO:1901386),2.019599030209299,7.353214285714286
1169,negative regulation of calcium-mediated signaling (GO:0050849),2.019599030209299,7.353214285714286
1170,necroptotic process (GO:0070266),2.019599030209299,7.353214285714286
1171,regulation of circadian sleep/wake cycle (GO:0042749),2.019599030209299,7.353214285714286
1172,cell communication by electrical coupling (GO:0010644),2.019599030209299,7.353214285714286
1173,activation of cysteine-type endopeptidase activity (GO:0097202),2.019599030209299,7.353214285714286
1174,apoptotic process involved in morphogenesis (GO:0060561),2.019599030209299,7.353214285714286
1175,positive regulation of neuron differentiation (GO:0045666),2.018885866782827,3.1970496894409934
1176,intermediate filament cytoskeleton organization (GO:0045104),2.018885866782827,3.1970496894409934
1177,organic acid metabolic process (GO:0006082),2.0183411408389675,0.34320720120020004
1178,positive regulation of GTPase activity (GO:0043547),2.0132794720002334,2.056843156843157
1179,multicellular organismal reproductive process (GO:0048609),2.009550055610098,0.3380788177339901
1180,response to chemical (GO:0042221),2.002361178230181,1.2677955665024632
1181,cellular response to leukemia inhibitory factor (GO:1990830),2.001832740812955,3.162672811059908
1182,intermediate filament-based process (GO:0045103),2.001832740812955,3.162672811059908
1183,positive regulation of cell division (GO:0051781),2.001832740812955,3.162672811059908
1184,response to cAMP (GO:0051591),2.001832740812955,3.162672811059908
1185,peptidyl-amino acid modification (GO:0018193),1.9980816812111295,0.3334791059280855
1186,negative regulation of cellular metabolic process (GO:0031324),1.9970443872650356,1.364112190812721
1187,proteolysis involved in protein catabolic process (GO:0051603),1.9881207898449096,0.22730183263413556
1188,response to leukemia inhibitory factor (GO:1990823),1.9850010562812566,3.1290273556231
1189,"chemical synaptic transmission, postsynaptic (GO:0099565)",1.9850010562812566,3.1290273556231
1190,regulation of peptide hormone secretion (GO:0090276),1.9825179025243047,2.3593200916730326
1191,negative regulation of cell adhesion (GO:0007162),1.9778926349328914,2.028472906403941
1192,regulation of endothelial cell chemotaxis (GO:2001026),1.976364229830552,7.003061224489796
1193,reflex (GO:0060004),1.976364229830552,7.003061224489796
1194,positive regulation of sodium ion transmembrane transport (GO:1902307),1.976364229830552,7.003061224489796
1195,adaptive thermogenesis (GO:1990845),1.976364229830552,7.003061224489796
1196,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",1.976364229830552,7.003061224489796
1197,prostaglandin biosynthetic process (GO:0001516),1.976364229830552,7.003061224489796
1198,regulation of interleukin-5 production (GO:0032674),1.976364229830552,7.003061224489796
1199,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),1.976364229830552,7.003061224489796
1200,positive regulation of skeletal muscle tissue development (GO:0048643),1.976364229830552,7.003061224489796
1201,cell aggregation (GO:0098743),1.976364229830552,7.003061224489796
1202,prostanoid biosynthetic process (GO:0046457),1.976364229830552,7.003061224489796
1203,T-helper 1 type immune response (GO:0042088),1.976364229830552,7.003061224489796
1204,pulmonary valve development (GO:0003177),1.976364229830552,7.003061224489796
1205,regulation of anion transport (GO:0044070),1.968386144025364,3.0960902255639096
1206,regulation of protein tyrosine kinase activity (GO:0061097),1.968386144025364,3.0960902255639096
1207,macromolecule localization (GO:0033036),1.9659804769772915,0.6271398111483399
1208,regulation of production of molecular mediator of immune response (GO:0002700),1.9602540425977133,2.3343537414965985
1209,cell migration (GO:0016477),1.9581860233165864,1.6286188894162315
1210,regulation of peptide secretion (GO:0002791),1.949243109077351,2.3220676691729323
1211,cellular response to catecholamine stimulus (GO:0071870),1.935788676039824,3.0322533136966126
1212,cellular response to monoamine stimulus (GO:0071868),1.935788676039824,3.0322533136966126
1213,regulation of calcium ion transmembrane transporter activity (GO:1901019),1.935788676039824,3.0322533136966126
1214,regulation of epithelial to mesenchymal transition (GO:0010717),1.935788676039824,3.0322533136966126
1215,negative regulation of systemic arterial blood pressure (GO:0003085),1.9351940110500052,6.68474025974026
1216,positive regulation of T-helper cell differentiation (GO:0045624),1.9351940110500052,6.68474025974026
1217,tripartite regional subdivision (GO:0007351),1.9351940110500052,6.68474025974026
1218,cellular sodium ion homeostasis (GO:0006883),1.9351940110500052,6.68474025974026
1219,antiviral innate immune response (GO:0140374),1.9351940110500052,6.68474025974026
1220,regulation of interleukin-13 production (GO:0032656),1.9351940110500052,6.68474025974026
1221,smooth muscle tissue development (GO:0048745),1.9351940110500052,6.68474025974026
1222,regulation of muscle organ development (GO:0048634),1.9351940110500052,6.68474025974026
1223,regulation of excretion (GO:0044062),1.9351940110500052,6.68474025974026
1224,regulation of urine volume (GO:0035809),1.9351940110500052,6.68474025974026
1225,"negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)",1.9351940110500052,6.68474025974026
1226,"anterior/posterior axis specification, embryo (GO:0008595)",1.9351940110500052,6.68474025974026
1227,positive regulation of insulin receptor signaling pathway (GO:0046628),1.9351940110500052,6.68474025974026
1228,labyrinthine layer morphogenesis (GO:0060713),1.9351940110500052,6.68474025974026
1229,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),1.9351940110500052,6.68474025974026
1230,ammonium ion metabolic process (GO:0097164),1.9351940110500052,6.68474025974026
1231,cellular response to stimulus (GO:0051716),1.9282240563081996,1.1865439401517952
1232,regulation of peptide transport (GO:0090087),1.927458951817035,2.2978794642857143
1233,regulation of blood pressure (GO:0008217),1.927458951817035,2.2978794642857143
1234,negative regulation of leukocyte proliferation (GO:0070664),1.9197974804287612,3.0013119533527695
1235,positive regulation of cold-induced thermogenesis (GO:0120162),1.9197974804287612,3.0013119533527695
1236,hair cycle (GO:0042633),1.9197974804287612,3.0013119533527695
1237,molting cycle (GO:0042303),1.9197974804287612,3.0013119533527695
1238,negative regulation of cation transmembrane transport (GO:1904063),1.9197974804287612,3.0013119533527695
1239,endothelium development (GO:0003158),1.9040057667200831,2.970995670995671
1240,kidney development (GO:0001822),1.900893009783431,1.96741519350215
1241,regulation of cell-cell adhesion (GO:0022407),1.8983651851340133,1.8231109799291618
1242,regulation of proton transport (GO:0010155),1.895912268849481,6.394099378881987
1243,central nervous system myelination (GO:0022010),1.895912268849481,6.394099378881987
1244,cell differentiation in hindbrain (GO:0021533),1.895912268849481,6.394099378881987
1245,innate immune response in mucosa (GO:0002227),1.895912268849481,6.394099378881987
1246,uterus development (GO:0060065),1.895912268849481,6.394099378881987
1247,bone maturation (GO:0070977),1.895912268849481,6.394099378881987
1248,axon ensheathment in central nervous system (GO:0032291),1.895912268849481,6.394099378881987
1249,sodium ion import across plasma membrane (GO:0098719),1.895912268849481,6.394099378881987
1250,response to interferon-alpha (GO:0035455),1.895912268849481,6.394099378881987
1251,indole-containing compound metabolic process (GO:0042430),1.895912268849481,6.394099378881987
1252,embryonic hemopoiesis (GO:0035162),1.895912268849481,6.394099378881987
1253,signal transduction involved in regulation of gene expression (GO:0023019),1.895912268849481,6.394099378881987
1254,endocardial cushion formation (GO:0003272),1.895912268849481,6.394099378881987
1255,protein homooligomerization (GO:0051260),1.8953645331242306,2.262527472527472
1256,negative regulation of cell-cell adhesion (GO:0022408),1.8953645331242306,2.262527472527472
1257,T cell activation (GO:0042110),1.8925542674003193,1.960857142857143
1258,response to catecholamine (GO:0071869),1.8884095315808138,2.9412857142857143
1259,response to monoamine (GO:0071867),1.8884095315808138,2.9412857142857143
1260,response to alkaloid (GO:0043279),1.8884095315808138,2.9412857142857143
1261,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),1.8730048891829605,2.912164073550212
1262,regulation of gliogenesis (GO:0014013),1.8730048891829605,2.912164073550212
1263,regulation of ERK1 and ERK2 cascade (GO:0070372),1.8677904518305415,1.9414427157001413
1264,regulation of adaptive immune response (GO:0002819),1.8639490399576748,2.2282467532467534
1265,hyperosmotic response (GO:0006972),1.858364474832167,6.1276785714285715
1266,regulation of megakaryocyte differentiation (GO:0045652),1.858364474832167,6.1276785714285715
1267,"blood coagulation, fibrin clot formation (GO:0072378)",1.858364474832167,6.1276785714285715
1268,T cell lineage commitment (GO:0002360),1.858364474832167,6.1276785714285715
1269,positive regulation of mesenchymal cell proliferation (GO:0002053),1.858364474832167,6.1276785714285715
1270,positive regulation of neurotransmitter transport (GO:0051590),1.858364474832167,6.1276785714285715
1271,response to food (GO:0032094),1.858364474832167,6.1276785714285715
1272,male genitalia development (GO:0030539),1.858364474832167,6.1276785714285715
1273,cell surface receptor signaling pathway involved in heart development (GO:0061311),1.858364474832167,6.1276785714285715
1274,axis elongation (GO:0003401),1.858364474832167,6.1276785714285715
1275,prostate gland epithelium morphogenesis (GO:0060740),1.858364474832167,6.1276785714285715
1276,type B pancreatic cell differentiation (GO:0003309),1.858364474832167,6.1276785714285715
1277,cell differentiation involved in embryonic placenta development (GO:0060706),1.858364474832167,6.1276785714285715
1278,response to muscle activity (GO:0014850),1.858364474832167,6.1276785714285715
1279,negative regulation of muscle contraction (GO:0045932),1.858364474832167,6.1276785714285715
1280,forebrain regionalization (GO:0021871),1.858364474832167,6.1276785714285715
1281,atrioventricular valve morphogenesis (GO:0003181),1.858364474832167,6.1276785714285715
1282,positive regulation of nucleobase-containing compound metabolic process (GO:0045935),1.845622751962127,1.3577363598500625
1283,circulatory system process (GO:0003013),1.8435237056072917,1.7718588640275388
1284,regulation of myeloid cell differentiation (GO:0045637),1.843372259925538,2.205964285714286
1285,cellular response to metal ion (GO:0071248),1.843372259925538,2.205964285714286
1286,telomere organization (GO:0032200),1.84275540156212,2.855617198335645
1287,biomineral tissue development (GO:0031214),1.84275540156212,2.855617198335645
1288,regulation of cell junction assembly (GO:1901888),1.833191694433507,2.1949893390191897
1289,locomotory behavior (GO:0007626),1.833191694433507,2.1949893390191897
1290,regulation of heart rate (GO:0002027),1.8279033334100476,2.8281593406593406
1291,regulation of glucose metabolic process (GO:0010906),1.8279033334100476,2.8281593406593406
1292,segmentation (GO:0035282),1.8279033334100476,2.8281593406593406
1293,renal system development (GO:0072001),1.827341769374505,1.9099257884972174
1294,lung epithelial cell differentiation (GO:0060487),1.8224142904365503,5.882571428571429
1295,lung cell differentiation (GO:0060479),1.8224142904365503,5.882571428571429
1296,negative regulation of glial cell differentiation (GO:0045686),1.8224142904365503,5.882571428571429
1297,neutrophil mediated immunity (GO:0002446),1.8224142904365503,5.882571428571429
1298,positive regulation of muscle tissue development (GO:1901863),1.8224142904365503,5.882571428571429
1299,"protein localization to chromosome, centromeric region (GO:0071459)",1.8224142904365503,5.882571428571429
1300,regulation of establishment of cell polarity (GO:2000114),1.8224142904365503,5.882571428571429
1301,regulation of membrane protein ectodomain proteolysis (GO:0051043),1.8224142904365503,5.882571428571429
1302,negative regulation of receptor signaling pathway via STAT (GO:1904893),1.8224142904365503,5.882571428571429
1303,arachidonic acid secretion (GO:0050482),1.8224142904365503,5.882571428571429
1304,positive regulation of cellular response to insulin stimulus (GO:1900078),1.8224142904365503,5.882571428571429
1305,arachidonate transport (GO:1903963),1.8224142904365503,5.882571428571429
1306,response to prostaglandin E (GO:0034695),1.8224142904365503,5.882571428571429
1307,programmed necrotic cell death (GO:0097300),1.8224142904365503,5.882571428571429
1308,cerebellum development (GO:0021549),1.8132284041835276,2.8012244897959184
1309,regulation of BMP signaling pathway (GO:0030510),1.8132284041835276,2.8012244897959184
1310,negative regulation of ion transmembrane transport (GO:0034766),1.8132284041835276,2.8012244897959184
1311,inner ear development (GO:0048839),1.8030726310554914,2.1627100840336135
1312,epithelial tube branching involved in lung morphogenesis (GO:0060441),1.7879408192300275,5.656318681318681
1313,cerebellar cortex formation (GO:0021697),1.7879408192300275,5.656318681318681
1314,protein activation cascade (GO:0072376),1.7879408192300275,5.656318681318681
1315,positive regulation of transcription regulatory region DNA binding (GO:2000679),1.7879408192300275,5.656318681318681
1316,killing by host of symbiont cells (GO:0051873),1.7879408192300275,5.656318681318681
1317,regulation of the force of heart contraction (GO:0002026),1.7879408192300275,5.656318681318681
1318,regulation of non-canonical Wnt signaling pathway (GO:2000050),1.7879408192300275,5.656318681318681
1319,negative regulation of lipid catabolic process (GO:0050995),1.7879408192300275,5.656318681318681
1320,response to salt stress (GO:0009651),1.7879408192300275,5.656318681318681
1321,positive regulation of muscle cell apoptotic process (GO:0010661),1.7879408192300275,5.656318681318681
1322,positive regulation of heart rate (GO:0010460),1.7879408192300275,5.656318681318681
1323,embryonic placenta morphogenesis (GO:0060669),1.7879408192300275,5.656318681318681
1324,positive regulation of T cell cytokine production (GO:0002726),1.7879408192300275,5.656318681318681
1325,negative regulation of regulated secretory pathway (GO:1903306),1.7879408192300275,5.656318681318681
1326,prostate gland morphogenesis (GO:0060512),1.7879408192300275,5.656318681318681
1327,positive regulation of histone modification (GO:0031058),1.7843966097640225,2.7488651535380506
1328,cardiac septum development (GO:0003279),1.7843966097640225,2.7488651535380506
1329,establishment of localization in cell (GO:0051649),1.7766777414904513,0.5875856164383562
1330,biomineralization (GO:0110148),1.7702332981450173,2.723412698412698
1331,regulation of neurotransmitter transport (GO:0051588),1.7702332981450173,2.723412698412698
1332,viral entry into host cell (GO:0046718),1.7702332981450173,2.723412698412698
1333,regulation of leukocyte differentiation (GO:1902105),1.7646916217980722,1.8615732368896927
1334,inner ear morphogenesis (GO:0042472),1.7562342258873818,2.6984272608125823
1335,positive regulation of acute inflammatory response (GO:0002675),1.7548363598788197,5.446825396825396
1336,salivary gland morphogenesis (GO:0007435),1.7548363598788197,5.446825396825396
1337,cardiac epithelial to mesenchymal transition (GO:0060317),1.7548363598788197,5.446825396825396
1338,subpallium development (GO:0021544),1.7548363598788197,5.446825396825396
1339,startle response (GO:0001964),1.7548363598788197,5.446825396825396
1340,negative regulation of amine transport (GO:0051953),1.7548363598788197,5.446825396825396
1341,positive regulation of interleukin-4 production (GO:0032753),1.7548363598788197,5.446825396825396
1342,negative regulation of interleukin-2 production (GO:0032703),1.7548363598788197,5.446825396825396
1343,cellular response to pH (GO:0071467),1.7548363598788197,5.446825396825396
1344,regulation of histone H3-K9 methylation (GO:0051570),1.7548363598788197,5.446825396825396
1345,pyroptosis (GO:0070269),1.7548363598788197,5.446825396825396
1346,protein autoprocessing (GO:0016540),1.7548363598788197,5.446825396825396
1347,inositol phosphate-mediated signaling (GO:0048016),1.7548363598788197,5.446825396825396
1348,detection of stimulus involved in sensory perception of pain (GO:0062149),1.7548363598788197,5.446825396825396
1349,cerebral cortex neuron differentiation (GO:0021895),1.7548363598788197,5.446825396825396
1350,atrioventricular valve development (GO:0003171),1.7548363598788197,5.446825396825396
1351,regulation of animal organ formation (GO:0003156),1.7548363598788197,5.446825396825396
1352,positive regulation of epithelial cell proliferation (GO:0050679),1.7542413434742705,2.1109706083390294
1353,cell motility (GO:0048870),1.7464038229379935,1.5247004173959877
1354,regulation of lymphocyte differentiation (GO:0045619),1.7446741366380234,2.1009183673469387
1355,regulation of synapse organization (GO:0050807),1.7446741366380234,2.1009183673469387
1356,entry into host (GO:0044409),1.7423963847971466,2.673896103896104
1357,positive regulation of lipid localization (GO:1905954),1.7287168473568113,2.64980694980695
1358,methylation (GO:0032259),1.7240867467548653,0.0
1359,vesicle organization (GO:0016050),1.724065937944021,0.0
1360,sulfur compound metabolic process (GO:0006790),1.7240206265252525,0.0
1361,cellular nitrogen compound catabolic process (GO:0044270),1.7240206265252525,0.0
1362,alcohol metabolic process (GO:0006066),1.7239785795322533,0.0
1363,regulation of mitotic cell cycle phase transition (GO:1901990),1.7237364661270553,0.0
1364,negative regulation of myoblast differentiation (GO:0045662),1.7230045529320166,5.252295918367348
1365,cerebellar Purkinje cell layer development (GO:0021680),1.7230045529320166,5.252295918367348
1366,endochondral ossification (GO:0001958),1.7230045529320166,5.252295918367348
1367,gamma-aminobutyric acid signaling pathway (GO:0007214),1.7230045529320166,5.252295918367348
1368,positive regulation of neuroblast proliferation (GO:0002052),1.7230045529320166,5.252295918367348
1369,regulation of T cell differentiation in thymus (GO:0033081),1.7230045529320166,5.252295918367348
1370,regulation of skeletal muscle tissue development (GO:0048641),1.7230045529320166,5.252295918367348
1371,necrotic cell death (GO:0070265),1.7230045529320166,5.252295918367348
1372,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),1.7230045529320166,5.252295918367348
1373,thyroid gland development (GO:0030878),1.7230045529320166,5.252295918367348
1374,replacement ossification (GO:0036075),1.7230045529320166,5.252295918367348
1375,positive regulation of hemostasis (GO:1900048),1.7230045529320166,5.252295918367348
1376,positive regulation of blood coagulation (GO:0030194),1.7230045529320166,5.252295918367348
1377,regulation of androgen receptor signaling pathway (GO:0060765),1.7230045529320166,5.252295918367348
1378,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1.7230045529320166,5.252295918367348
1379,aromatic compound catabolic process (GO:0019439),1.7162400120361305,0.0
1380,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1.715347998014691,0.0
1381,organelle fission (GO:0048285),1.7134267236275817,0.0
1382,cellular macromolecule biosynthetic process (GO:0034645),1.7099576698840915,0.3805026797264831
1383,negative regulation of catalytic activity (GO:0043086),1.7090627682241453,0.3766050850557893
1384,positive regulation of cell migration (GO:0030335),1.7025710441860549,1.6586197636949516
1385,limbic system development (GO:0021761),1.7018213585313116,2.602907711757269
1386,cellular amide metabolic process (GO:0043603),1.7002321141676737,0.3667438546490916
1387,microtubule-based process (GO:0007017),1.695280592686457,0.36357054564718344
1388,negative regulation of hydrolase activity (GO:0051346),1.6950790361528982,0.0
1389,regulation of apoptotic signaling pathway (GO:2001233),1.6934562849527979,0.0
1390,salivary gland development (GO:0007431),1.6923588419570537,5.071182266009853
1391,activation of adenylate cyclase activity (GO:0007190),1.6923588419570537,5.071182266009853
1392,regulation of establishment or maintenance of cell polarity (GO:0032878),1.6923588419570537,5.071182266009853
1393,pharyngeal system development (GO:0060037),1.6923588419570537,5.071182266009853
1394,glandular epithelial cell development (GO:0002068),1.6923588419570537,5.071182266009853
1395,peptidyl-glutamic acid modification (GO:0018200),1.6923588419570537,5.071182266009853
1396,regulation of astrocyte differentiation (GO:0048710),1.6923588419570537,5.071182266009853
1397,negative regulation of stress fiber assembly (GO:0051497),1.6923588419570537,5.071182266009853
1398,sensory perception of temperature stimulus (GO:0050951),1.6923588419570537,5.071182266009853
1399,activation of protein kinase B activity (GO:0032148),1.6923588419570537,5.071182266009853
1400,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),1.6923588419570537,5.071182266009853
1401,centriole assembly (GO:0098534),1.6923588419570537,5.071182266009853
1402,exploration behavior (GO:0035640),1.6923588419570537,5.071182266009853
1403,androgen metabolic process (GO:0008209),1.6923588419570537,5.071182266009853
1404,histone modification (GO:0016570),1.6917939770768307,0.0
1405,regulation of synapse structure or activity (GO:0050803),1.6886109636538444,2.0425595238095235
1406,response to oxidative stress (GO:0006979),1.68835229482269,0.0
1407,RNA splicing (GO:0008380),1.6865737277456083,0.0
1408,carboxylic acid metabolic process (GO:0019752),1.6835661097570664,0.3578206465067779
1409,regulation of apoptotic process (GO:0042981),1.6785830206716374,1.4025204359673025
1410,protein import into nucleus (GO:0006606),1.6755258440304546,2.557639751552795
1411,positive regulation of ion transmembrane transporter activity (GO:0032414),1.6755258440304546,2.557639751552795
1412,organic cyclic compound catabolic process (GO:1901361),1.675119905574714,0.0
1413,regulation of neuron apoptotic process (GO:0043523),1.670419246821716,2.0238204456094366
1414,proteasomal protein catabolic process (GO:0010498),1.6667691951940793,0.0
1415,establishment of organelle localization (GO:0051656),1.6645959876472387,0.0
1416,positive regulation of macromolecule biosynthetic process (GO:0010557),1.6631074753861224,1.3624071759429452
1417,skeletal muscle contraction (GO:0003009),1.6628211877349397,4.902142857142858
1418,dopamine receptor signaling pathway (GO:0007212),1.6628211877349397,4.902142857142858
1419,regulation of epidermal growth factor-activated receptor activity (GO:0007176),1.6628211877349397,4.902142857142858
1420,branching involved in blood vessel morphogenesis (GO:0001569),1.6628211877349397,4.902142857142858
1421,negative regulation of endothelial cell apoptotic process (GO:2000352),1.6628211877349397,4.902142857142858
1422,cellular response to interleukin-4 (GO:0071353),1.6628211877349397,4.902142857142858
1423,negative regulation of lipid transport (GO:0032369),1.6628211877349397,4.902142857142858
1424,icosanoid secretion (GO:0032309),1.6628211877349397,4.902142857142858
1425,positive regulation of coagulation (GO:0050820),1.6628211877349397,4.902142857142858
1426,regulation of smooth muscle cell differentiation (GO:0051150),1.6628211877349397,4.902142857142858
1427,positive T cell selection (GO:0043368),1.6628211877349397,4.902142857142858
1428,dopamine metabolic process (GO:0042417),1.6628211877349397,4.902142857142858
1429,positive regulation of smooth muscle contraction (GO:0045987),1.6628211877349397,4.902142857142858
1430,response to acidic pH (GO:0010447),1.6628211877349397,4.902142857142858
1431,positive regulation of protein kinase B signaling (GO:0051897),1.6625965366143738,2.5355911330049263
1432,regulation of molecular function (GO:0065009),1.659306550451335,0.7129813463847077
1433,organophosphate biosynthetic process (GO:0090407),1.6583341952719397,0.2678766588602654
1434,purine ribonucleotide metabolic process (GO:0009150),1.655573635066935,0.0
1435,positive regulation of MAP kinase activity (GO:0043406),1.649809507083465,2.513919413919414
1436,neuron development (GO:0048666),1.6481165321912543,1.570081342145399
1437,modification-dependent protein catabolic process (GO:0019941),1.641979149913539,0.25096294490492443
1438,negative regulation of protein transport (GO:0051224),1.6371623185049509,2.492615012106538
1439,response to X-ray (GO:0010165),1.6343209859427161,4.744009216589862
1440,positive regulation of erythrocyte differentiation (GO:0045648),1.6343209859427161,4.744009216589862
1441,positive regulation of filopodium assembly (GO:0051491),1.6343209859427161,4.744009216589862
1442,regulation of mesenchymal cell proliferation (GO:0010464),1.6343209859427161,4.744009216589862
1443,regulation of T-helper 1 type immune response (GO:0002825),1.6343209859427161,4.744009216589862
1444,placenta blood vessel development (GO:0060674),1.6343209859427161,4.744009216589862
1445,nucleobase-containing small molecule metabolic process (GO:0055086),1.6324809442525965,0.2471668667466987
1446,modification-dependent macromolecule catabolic process (GO:0043632),1.6288765806366743,0.24592689918776875
1447,carbohydrate derivative biosynthetic process (GO:1901137),1.6276278332136322,0.24551633675172907
1448,connective tissue development (GO:0061448),1.6259813212599177,1.9784433055733504
1449,import into nucleus (GO:0051170),1.6246525944999934,2.4716686674669868
1450,regulation of circadian rhythm (GO:0042752),1.6122780177789595,2.451071428571429
1451,regulation of cytokine production involved in immune response (GO:0002718),1.6122780177789595,2.451071428571429
1452,in utero embryonic development (GO:0001701),1.6118959967179087,1.8615732368896927
1453,positive regulation of animal organ morphogenesis (GO:0110110),1.606794151744133,4.595758928571429
1454,mucosal immune response (GO:0002385),1.606794151744133,4.595758928571429
1455,temperature homeostasis (GO:0001659),1.606794151744133,4.595758928571429
1456,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),1.606794151744133,4.595758928571429
1457,negative regulation of actin filament bundle assembly (GO:0032232),1.606794151744133,4.595758928571429
1458,intestinal absorption (GO:0050892),1.606794151744133,4.595758928571429
1459,striated muscle cell proliferation (GO:0014855),1.606794151744133,4.595758928571429
1460,negative regulation of establishment of protein localization (GO:1904950),1.5879253195190894,2.410889929742389
1461,memory (GO:0007613),1.5879253195190894,2.410889929742389
1462,axon development (GO:0061564),1.5857610724395959,1.8201025459688824
1463,regulation of chemotaxis (GO:0050920),1.5829769035688785,1.9350563909774436
1464,negative regulation of osteoclast differentiation (GO:0045671),1.580182340972601,4.456493506493507
1465,acetylcholine receptor signaling pathway (GO:0095500),1.580182340972601,4.456493506493507
1466,response to interleukin-6 (GO:0070741),1.580182340972601,4.456493506493507
1467,response to interleukin-4 (GO:0070670),1.580182340972601,4.456493506493507
1468,regulation of renal system process (GO:0098801),1.580182340972601,4.456493506493507
1469,eating behavior (GO:0042755),1.580182340972601,4.456493506493507
1470,retinoic acid metabolic process (GO:0042573),1.580182340972601,4.456493506493507
1471,response to prostaglandin (GO:0034694),1.580182340972601,4.456493506493507
1472,heart trabecula morphogenesis (GO:0061384),1.580182340972601,4.456493506493507
1473,adult walking behavior (GO:0007628),1.580182340972601,4.456493506493507
1474,mating behavior (GO:0007617),1.580182340972601,4.456493506493507
1475,lymphocyte proliferation (GO:0046651),1.5759428407311546,2.391289198606272
1476,positive regulation of cell differentiation (GO:0045597),1.5753237652150447,1.4972608274078862
1477,cellular response to inorganic substance (GO:0071241),1.566162043466396,1.9182298136645963
1478,cardiac chamber morphogenesis (GO:0003206),1.564086791213533,2.372004608294931
1479,regulation of protein-containing complex assembly (GO:0043254),1.5610875829910411,1.784760748959778
1480,positive regulation of neurogenesis (GO:0050769),1.557835540928667,1.909925788497217
1481,neuronal action potential (GO:0019228),1.5544322844339107,4.325420168067227
1482,walking behavior (GO:0090659),1.5544322844339107,4.325420168067227
1483,response to dietary excess (GO:0002021),1.5544322844339107,4.325420168067227
1484,regulation of interleukin-4 production (GO:0032673),1.5544322844339107,4.325420168067227
1485,regulation of kidney development (GO:0090183),1.5544322844339107,4.325420168067227
1486,establishment of epithelial cell polarity (GO:0090162),1.5544322844339107,4.325420168067227
1487,cellular response to nutrient (GO:0031670),1.5544322844339107,4.325420168067227
1488,"positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",1.5544322844339107,4.325420168067227
1489,cardiac muscle tissue growth (GO:0055017),1.5544322844339107,4.325420168067227
1490,positive regulation of sodium ion transport (GO:0010765),1.5544322844339107,4.325420168067227
1491,T cell migration (GO:0072678),1.5544322844339107,4.325420168067227
1492,multicellular organismal signaling (GO:0035637),1.5523551201924488,2.3530285714285717
1493,synaptic vesicle cycle (GO:0099504),1.54074582595759,2.3343537414965985
1494,positive regulation of transporter activity (GO:0032411),1.54074582595759,2.3343537414965985
1495,cardiac ventricle development (GO:0003231),1.54074582595759,2.3343537414965985
1496,negative regulation of signal transduction (GO:0009968),1.5389520857221641,1.4039549948857823
1497,apoptotic process involved in development (GO:1902742),1.5294952158641526,4.201836734693877
1498,cerebellar cortex morphogenesis (GO:0021696),1.5294952158641526,4.201836734693877
1499,T cell mediated immunity (GO:0002456),1.5294952158641526,4.201836734693877
1500,regulation of glial cell proliferation (GO:0060251),1.5294952158641526,4.201836734693877
1501,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",1.5294952158641526,4.201836734693877
1502,positive regulation of T cell migration (GO:2000406),1.5294952158641526,4.201836734693877
1503,proximal/distal pattern formation (GO:0009954),1.5294952158641526,4.201836734693877
1504,brown fat cell differentiation (GO:0050873),1.5294952158641526,4.201836734693877
1505,maintenance of blood-brain barrier (GO:0035633),1.5294952158641526,4.201836734693877
1506,cellular response to acetylcholine (GO:1905145),1.5294952158641526,4.201836734693877
1507,extracellular matrix assembly (GO:0085029),1.5294952158641526,4.201836734693877
1508,mononuclear cell proliferation (GO:0032943),1.5292569532822353,2.315973003374578
1509,lymphocyte activation involved in immune response (GO:0002285),1.5178865924694103,2.2978794642857143
1510,regulation of muscle system process (GO:0090257),1.51699330480791,1.8694612590799031
1511,positive regulation of transmembrane transport (GO:0034764),1.51699330480791,1.8694612590799031
1512,cellular lipid metabolic process (GO:0044255),1.5130801824430296,0.4754233374384237
1513,developmental process involved in reproduction (GO:0003006),1.5096311006204493,0.46588474883089454
1514,regulation of animal organ morphogenesis (GO:2000027),1.5066328778147013,2.280066445182724
1515,heart growth (GO:0060419),1.5053263781381017,4.085119047619048
1516,organ or tissue specific immune response (GO:0002251),1.5053263781381017,4.085119047619048
1517,detection of mechanical stimulus involved in sensory perception (GO:0050974),1.5053263781381017,4.085119047619048
1518,negative regulation of B cell activation (GO:0050869),1.5053263781381017,4.085119047619048
1519,negative regulation of insulin secretion (GO:0046676),1.5053263781381017,4.085119047619048
1520,negative regulation of insulin receptor signaling pathway (GO:0046627),1.5053263781381017,4.085119047619048
1521,positive regulation of glucose import (GO:0046326),1.5053263781381017,4.085119047619048
1522,regulation of membrane potential (GO:0042391),1.5016187977074258,1.7100498338870431
1523,camera-type eye morphogenesis (GO:0048593),1.4954939863928587,2.2625274725274727
1524,negative regulation of transmembrane transport (GO:0034763),1.4954939863928587,2.2625274725274727
1525,determination of left/right symmetry (GO:0007368),1.4844681365938701,2.24525627044711
1526,developmental growth involved in morphogenesis (GO:0060560),1.4844681365938701,2.24525627044711
1527,positive regulation of adenylate cyclase activity (GO:0045762),1.4818845959324656,3.9747104247104246
1528,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),1.4818845959324656,3.9747104247104246
1529,negative regulation of toll-like receptor signaling pathway (GO:0034122),1.4818845959324656,3.9747104247104246
1530,NADP metabolic process (GO:0006739),1.4818845959324656,3.9747104247104246
1531,regulation of dopamine secretion (GO:0014059),1.4818845959324656,3.9747104247104246
1532,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),1.4818845959324656,3.9747104247104246
1533,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),1.4818845959324656,3.9747104247104246
1534,TOR signaling (GO:0031929),1.4818845959324656,3.9747104247104246
1535,response to mineralocorticoid (GO:0051385),1.4818845959324656,3.9747104247104246
1536,regulation of cholesterol efflux (GO:0010874),1.4818845959324656,3.9747104247104246
1537,positive regulation of dendritic spine development (GO:0060999),1.4818845959324656,3.9747104247104246
1538,regulation of cardiac muscle cell apoptotic process (GO:0010665),1.4818845959324656,3.9747104247104246
1539,positive regulation of histone acetylation (GO:0035066),1.4818845959324656,3.9747104247104246
1540,lamellipodium assembly (GO:0030032),1.4818845959324656,3.9747104247104246
1541,endocardial cushion morphogenesis (GO:0003203),1.4818845959324656,3.9747104247104246
1542,negative regulation of cell communication (GO:0010648),1.478942928619879,1.4088693546689126
1543,negative regulation of signaling (GO:0023057),1.4742565954166067,1.402667435279321
1544,cellular hormone metabolic process (GO:0034754),1.4735535869938894,2.2282467532467534
1545,response to organophosphorus (GO:0046683),1.4735535869938894,2.2282467532467534
1546,regulation of lymphocyte proliferation (GO:0050670),1.4696612493495667,1.8231109799291618
1547,cell morphogenesis involved in neuron differentiation (GO:0048667),1.4667838336334307,1.671185064935065
1548,icosanoid transport (GO:0071715),1.4591319026938685,3.8701127819548877
1549,regulation of sensory perception (GO:0051931),1.4591319026938685,3.8701127819548877
1550,regulation of sensory perception of pain (GO:0051930),1.4591319026938685,3.8701127819548877
1551,sarcomere organization (GO:0045214),1.4591319026938685,3.8701127819548877
1552,response to acetylcholine (GO:1905144),1.4591319026938685,3.8701127819548877
1553,glucose transmembrane transport (GO:1904659),1.4591319026938685,3.8701127819548877
1554,sodium ion homeostasis (GO:0055078),1.4591319026938685,3.8701127819548877
1555,negative regulation of cellular response to insulin stimulus (GO:1900077),1.4591319026938685,3.8701127819548877
1556,positive regulation of smoothened signaling pathway (GO:0045880),1.4591319026938685,3.8701127819548877
1557,regulation of T cell cytokine production (GO:0002724),1.4591319026938685,3.8701127819548877
1558,vesicle-mediated transport in synapse (GO:0099003),1.4414609021284965,2.1787301587301586
1559,regulation of mononuclear cell proliferation (GO:0032944),1.4390806661247502,1.7934668989547038
1560,prostaglandin metabolic process (GO:0006693),1.4370332163057826,3.7708791208791212
1561,prostanoid metabolic process (GO:0006692),1.4370332163057826,3.7708791208791212
1562,unsaturated fatty acid biosynthetic process (GO:0006636),1.4370332163057826,3.7708791208791212
1563,response to progesterone (GO:0032570),1.4370332163057826,3.7708791208791212
1564,regulation of histone H3-K4 methylation (GO:0051569),1.4370332163057826,3.7708791208791212
1565,regulation of protein localization to cell surface (GO:2000008),1.4370332163057826,3.7708791208791212
1566,positive regulation of ERBB signaling pathway (GO:1901186),1.4370332163057826,3.7708791208791212
1567,neuron maturation (GO:0042551),1.4370332163057826,3.7708791208791212
1568,negative regulation of ossification (GO:0030279),1.4370332163057826,3.7708791208791212
1569,negative regulation of exocytosis (GO:0045920),1.4370332163057826,3.7708791208791212
1570,positive regulation of heart contraction (GO:0045823),1.4370332163057826,3.7708791208791212
1571,regulation of response to stimulus (GO:0048583),1.425880452444456,1.2030543947871661
1572,determination of bilateral symmetry (GO:0009855),1.4205920543273507,2.146923879040667
1573,regulation of locomotion (GO:0040012),1.4186103600611,1.422285161646864
1574,regulation of type I interferon-mediated signaling pathway (GO:0060338),1.415556053978545,3.676607142857143
1575,fat-soluble vitamin metabolic process (GO:0006775),1.415556053978545,3.676607142857143
1576,myoblast differentiation (GO:0045445),1.415556053978545,3.676607142857143
1577,positive regulation of interleukin-10 production (GO:0032733),1.415556053978545,3.676607142857143
1578,regulation of hormone metabolic process (GO:0032350),1.415556053978545,3.676607142857143
1579,animal organ formation (GO:0048645),1.415556053978545,3.676607142857143
1580,axonemal dynein complex assembly (GO:0070286),1.415556053978545,3.676607142857143
1581,regulation of striated muscle cell apoptotic process (GO:0010662),1.415556053978545,3.676607142857143
1582,positive regulation of blood circulation (GO:1903524),1.415556053978545,3.676607142857143
1583,regulation of cell fate commitment (GO:0010453),1.415556053978545,3.676607142857143
1584,positive regulation of response to external stimulus (GO:0032103),1.4129294299639916,1.6160910518053375
1585,neurotransmitter transport (GO:0006836),1.410310838454354,2.131366459627329
1586,specification of symmetry (GO:0009799),1.410310838454354,2.131366459627329
1587,leukocyte migration (GO:0050900),1.4092489354050894,1.7647714285714289
1588,regulation of cell cycle process (GO:0010564),1.4020542007121886,0.41136863136863133
1589,movement in host (GO:0044000),1.4001297615552604,2.116032887975334
1590,morphogenesis of an epithelium (GO:0002009),1.3983400263987267,1.6020074696545283
1591,ventricular septum morphogenesis (GO:0060412),1.3946702814538745,3.586933797909408
1592,reproductive behavior (GO:0019098),1.3946702814538745,3.586933797909408
1593,positive regulation of interferon-beta production (GO:0032728),1.3946702814538745,3.586933797909408
1594,negative regulation of gliogenesis (GO:0014014),1.3946702814538745,3.586933797909408
1595,muscle cell proliferation (GO:0033002),1.3946702814538745,3.586933797909408
1596,T cell costimulation (GO:0031295),1.3946702814538745,3.586933797909408
1597,hexose transmembrane transport (GO:0008645),1.3946702814538745,3.586933797909408
1598,forebrain neuron differentiation (GO:0021879),1.3946702814538745,3.586933797909408
1599,negative regulation of canonical Wnt signaling pathway (GO:0090090),1.390047363941266,2.1009183673469387
1600,regulation of programmed cell death (GO:0043067),1.3865879886344492,1.3744325767690253
1601,protein complex oligomerization (GO:0051259),1.3801413439867714,1.7369797525309336
1602,lymphocyte activation (GO:0046649),1.376334652146677,1.581336405529954
1603,cerebellum morphogenesis (GO:0021587),1.3743478921032581,3.501530612244898
1604,columnar/cuboidal epithelial cell development (GO:0002066),1.3743478921032581,3.501530612244898
1605,regulation of calcineurin-NFAT signaling cascade (GO:0070884),1.3743478921032581,3.501530612244898
1606,negative regulation of peptide hormone secretion (GO:0090278),1.3743478921032581,3.501530612244898
1607,gluconeogenesis (GO:0006094),1.3743478921032581,3.501530612244898
1608,positive regulation of protein import into nucleus (GO:0042307),1.3743478921032581,3.501530612244898
1609,embryo implantation (GO:0007566),1.3743478921032581,3.501530612244898
1610,cellular localization (GO:0051641),1.3732816652981785,0.720088781275222
1611,positive regulation of Wnt signaling pathway (GO:0030177),1.370172919678964,2.071327967806841
1612,positive regulation of cellular biosynthetic process (GO:0031328),1.362879246414445,1.2925571986607143
1613,response to glucocorticoid (GO:0051384),1.3603781039785023,2.056843156843157
1614,negative regulation of protein-containing complex assembly (GO:0031333),1.3603781039785023,2.056843156843157
1615,regulation of cell cycle (GO:0051726),1.3584229022446876,0.5242933537051184
1616,response to organic substance (GO:0010033),1.3554060037718003,1.2509166314454778
1617,positive regulation of peptidyl-lysine acetylation (GO:2000758),1.3545628112132888,3.4200996677740867
1618,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",1.3545628112132888,3.4200996677740867
1619,positive regulation of lymphocyte migration (GO:2000403),1.3545628112132888,3.4200996677740867
1620,regulation of bone resorption (GO:0045124),1.3545628112132888,3.4200996677740867
1621,regulation of actin cytoskeleton reorganization (GO:2000249),1.3545628112132888,3.4200996677740867
1622,postsynaptic signal transduction (GO:0098926),1.3545628112132888,3.4200996677740867
1623,regulation of calcineurin-mediated signaling (GO:0106056),1.3545628112132888,3.4200996677740867
1624,positive regulation of striated muscle cell differentiation (GO:0051155),1.3545628112132888,3.4200996677740867
1625,lymphocyte costimulation (GO:0031294),1.3545628112132888,3.4200996677740867
1626,acidic amino acid transport (GO:0015800),1.3545628112132888,3.4200996677740867
1627,positive regulation of glucose transmembrane transport (GO:0010828),1.3545628112132888,3.4200996677740867
1628,positive regulation of organ growth (GO:0046622),1.3545628112132888,3.4200996677740867
1629,chromosome condensation (GO:0030261),1.3545628112132888,3.4200996677740867
1630,regulation of inflammatory response to antigenic stimulus (GO:0002861),1.3545628112132888,3.4200996677740867
1631,negative regulation of peptide secretion (GO:0002792),1.3545628112132888,3.4200996677740867
1632,neuromuscular junction development (GO:0007528),1.3545628112132888,3.4200996677740867
1633,response to ionizing radiation (GO:0010212),1.3506764276297294,2.042559523809524
1634,negative regulation of neurogenesis (GO:0050768),1.3506764276297294,2.042559523809524
1635,positive regulation of inflammatory response (GO:0050729),1.3506764276297294,2.042559523809524
1636,negative regulation of secretion by cell (GO:1903531),1.3506764276297294,2.042559523809524
1637,leukocyte proliferation (GO:0070661),1.3410665763481875,2.028472906403941
1638,positive regulation of growth (GO:0045927),1.3377864569560074,1.6968956043956043
1639,body morphogenesis (GO:0010171),1.335290722099726,3.34237012987013
1640,response to electrical stimulus (GO:0051602),1.335290722099726,3.34237012987013
1641,positive regulation of potassium ion transmembrane transport (GO:1901381),1.335290722099726,3.34237012987013
1642,regulation of digestive system process (GO:0044058),1.335290722099726,3.34237012987013
1643,monosaccharide transmembrane transport (GO:0015749),1.335290722099726,3.34237012987013
1644,positive regulation of biosynthetic process (GO:0009891),1.3338038833989398,1.2684030392223973
1645,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),1.3315472628788907,2.0145792563600784
1646,biological process involved in symbiotic interaction (GO:0044403),1.3308752365499148,1.6903940886699507
1647,neuron projection morphogenesis (GO:0048812),1.3246547734133374,1.5351178049507903
1648,response to purine-containing compound (GO:0014074),1.322117225859665,2.000874635568513
1649,lung morphogenesis (GO:0060425),1.316508911750919,3.2680952380952375
1650,regulation of erythrocyte differentiation (GO:0045646),1.316508911750919,3.2680952380952375
1651,hexose biosynthetic process (GO:0019319),1.316508911750919,3.2680952380952375
1652,hindbrain morphogenesis (GO:0021575),1.316508911750919,3.2680952380952375
1653,regulation of voltage-gated calcium channel activity (GO:1901385),1.316508911750919,3.2680952380952375
1654,embryonic axis specification (GO:0000578),1.316508911750919,3.2680952380952375
1655,calcium-ion regulated exocytosis (GO:0017156),1.316508911750919,3.2680952380952375
1656,negative regulation of DNA recombination (GO:0045910),1.316508911750919,3.2680952380952375
1657,regulation of mitotic cell cycle (GO:0007346),1.3154935419434233,0.29830483917705014
1658,regulation of cellular macromolecule biosynthetic process (GO:2000112),1.3154935419434233,0.29830483917705014
1659,post-transcriptional regulation of gene expression (GO:0010608),1.314730458981811,0.2953098106712565
1660,positive regulation of chemotaxis (GO:0050921),1.3127752293607284,1.9873552123552123
1661,positive regulation of lymphocyte proliferation (GO:0050671),1.3127752293607284,1.9873552123552123
1662,negative regulation of DNA metabolic process (GO:0051053),1.3127752293607284,1.9873552123552123
1663,nucleoside phosphate biosynthetic process (GO:1901293),1.3125253871692233,0.0
1664,nucleotide biosynthetic process (GO:0009165),1.3125158921920015,0.0
1665,negative regulation of cell cycle process (GO:0010948),1.3123509899588954,0.0
1666,cellular response to chemical stress (GO:0062197),1.3121955444038946,0.0
1667,macromolecule methylation (GO:0043414),1.3098615896577308,0.0
1668,cellular amino acid metabolic process (GO:0006520),1.3082113594935822,0.0
1669,nucleobase-containing compound catabolic process (GO:0034655),1.307577047833259,0.0
1670,nucleotide metabolic process (GO:0009117),1.3063090321102577,0.28445703232937275
1671,regulation of angiogenesis (GO:0045765),1.3046278607731594,0.0
1672,negative regulation of nervous system development (GO:0051961),1.3035200622048695,1.9740172579098754
1673,response to nutrient (GO:0007584),1.3035200622048695,1.9740172579098754
1674,regulation of regulated secretory pathway (GO:1903305),1.3035200622048695,1.9740172579098754
1675,Golgi vesicle transport (GO:0048193),1.302911078471134,0.0
1676,chromosome segregation (GO:0007059),1.301993407064652,0.0
1677,regulation of vasculature development (GO:1901342),1.3010367061570727,0.0
1678,nucleoside phosphate metabolic process (GO:0006753),1.300282316516804,0.2801224489795919
1679,amide biosynthetic process (GO:0043604),1.2985584785613493,0.2790593656817566
1680,positive regulation of Notch signaling pathway (GO:0045747),1.298196132843634,3.1970496894409934
1681,branching involved in ureteric bud morphogenesis (GO:0001658),1.298196132843634,3.1970496894409934
1682,positive regulation of B cell proliferation (GO:0030890),1.298196132843634,3.1970496894409934
1683,response to pH (GO:0009268),1.298196132843634,3.1970496894409934
1684,lamellipodium organization (GO:0097581),1.298196132843634,3.1970496894409934
1685,trabecula morphogenesis (GO:0061383),1.298196132843634,3.1970496894409934
1686,negative regulation of blood coagulation (GO:0030195),1.298196132843634,3.1970496894409934
1687,ribosome biogenesis (GO:0042254),1.2880450070738423,0.0
1688,placenta development (GO:0001890),1.2852654904987288,1.9478713339640492
1689,positive regulation of mononuclear cell proliferation (GO:0032946),1.2852654904987288,1.9478713339640492
1690,positive regulation of DNA metabolic process (GO:0051054),1.2852201242211094,0.0
1691,localization within membrane (GO:0051668),1.2841874204043935,0.27183786638500135
1692,negative regulation of metabolic process (GO:0009892),1.2809764148011586,1.2304575444635686
1693,regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044),1.2803324801289995,3.1290273556231
1694,regulation of muscle tissue development (GO:1901861),1.2803324801289995,3.1290273556231
1695,response to epidermal growth factor (GO:0070849),1.2803324801289995,3.1290273556231
1696,positive regulation of signaling receptor activity (GO:2000273),1.2803324801289995,3.1290273556231
1697,negative regulation of lipid localization (GO:1905953),1.2803324801289995,3.1290273556231
1698,genitalia development (GO:0048806),1.2803324801289995,3.1290273556231
1699,negative regulation of cold-induced thermogenesis (GO:0120163),1.2803324801289995,3.1290273556231
1700,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1.2803324801289995,3.1290273556231
1701,receptor clustering (GO:0043113),1.2803324801289995,3.1290273556231
1702,negative regulation of hemostasis (GO:1900047),1.2803324801289995,3.1290273556231
1703,labyrinthine layer development (GO:0060711),1.2803324801289995,3.1290273556231
1704,endocardial cushion development (GO:0003197),1.2803324801289995,3.1290273556231
1705,positive regulation of miRNA transcription (GO:1902895),1.2803324801289995,3.1290273556231
1706,regulation of cytokine-mediated signaling pathway (GO:0001959),1.276263781075664,1.9350563909774439
1707,cellular response to steroid hormone stimulus (GO:0071383),1.276263781075664,1.9350563909774439
1708,regulation of epithelial cell differentiation (GO:0030856),1.276263781075664,1.9350563909774439
1709,tube formation (GO:0035148),1.276263781075664,1.9350563909774439
1710,positive regulation of leukocyte migration (GO:0002687),1.276263781075664,1.9350563909774439
1711,germ cell development (GO:0007281),1.2759508168874363,0.0
1712,peptidyl-lysine modification (GO:0018205),1.2759508168874363,0.0
1713,regulation of small GTPase mediated signal transduction (GO:0051056),1.2742942150275058,0.0
1714,regulation of response to DNA damage stimulus (GO:2001020),1.2708888379903511,0.0
1715,regulation of cell morphogenesis (GO:0022604),1.2708888379903511,0.0
1716,response to light stimulus (GO:0009416),1.265556317016507,0.0
1717,cellular component disassembly (GO:0022411),1.2637205478740987,0.0
1718,regulation of myelination (GO:0031641),1.2628992799653942,3.0638392857142858
1719,regulation of alpha-beta T cell proliferation (GO:0046640),1.2628992799653942,3.0638392857142858
1720,positive regulation of muscle contraction (GO:0045933),1.2628992799653942,3.0638392857142858
1721,nuclear division (GO:0000280),1.254122596059622,0.0
1722,proteolysis (GO:0006508),1.2535724687822853,0.5808226134055519
1723,heterocycle catabolic process (GO:0046700),1.2521219506006154,0.0
1724,negative regulation of ion transport (GO:0043271),1.2497475960733953,1.8976036866359447
1725,cell development (GO:0048468),1.2484879106017732,1.2788198757763976
1726,regulation of acute inflammatory response (GO:0002673),1.2458789905493097,3.0013119533527695
1727,regulation of T cell migration (GO:2000404),1.2458789905493097,3.0013119533527695
1728,negative regulation of proteasomal protein catabolic process (GO:1901799),1.2458789905493097,3.0013119533527695
1729,prostate gland development (GO:0030850),1.2458789905493097,3.0013119533527695
1730,regulation of vascular permeability (GO:0043114),1.2458789905493097,3.0013119533527695
1731,neutral amino acid transport (GO:0015804),1.2458789905493097,3.0013119533527695
1732,monosaccharide biosynthetic process (GO:0046364),1.2458789905493097,3.0013119533527695
1733,biological process involved in interaction with host (GO:0051701),1.2410682613046378,1.8854395604395606
1734,positive regulation of nitrogen compound metabolic process (GO:0051173),1.231996626042385,1.2046853902241426
1735,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),1.2292551121951412,2.9412857142857143
1736,negative regulation of cation channel activity (GO:2001258),1.2292551121951412,2.9412857142857143
1737,regulation of endothelial cell apoptotic process (GO:2000351),1.2292551121951412,2.9412857142857143
1738,negative regulation of coagulation (GO:0050819),1.2292551121951412,2.9412857142857143
1739,positive regulation of cyclase activity (GO:0031281),1.2292551121951412,2.9412857142857143
1740,regulation of bone remodeling (GO:0046850),1.2292551121951412,2.9412857142857143
1741,icosanoid biosynthetic process (GO:0046456),1.2292551121951412,2.9412857142857143
1742,regulation of Wnt signaling pathway (GO:0030111),1.2261892808005612,1.7718588640275388
1743,retina development in camera-type eye (GO:0060041),1.2239424378413681,1.8615732368896927
1744,regulation of cellular carbohydrate metabolic process (GO:0010675),1.2239424378413681,1.8615732368896927
1745,endothelial cell development (GO:0001885),1.2130121067773,2.8836134453781512
1746,regulation of gluconeogenesis (GO:0006111),1.2130121067773,2.8836134453781512
1747,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),1.2130121067773,2.8836134453781512
1748,positive regulation of lyase activity (GO:0051349),1.2130121067773,2.8836134453781512
1749,wound healing (GO:0042060),1.2120206151940163,1.7404057480980561
1750,eye morphogenesis (GO:0048592),1.2071203971384532,1.8383035714285716
1751,cerebellar cortex development (GO:0021695),1.197135324119866,2.8281593406593406
1752,receptor signaling pathway via JAK-STAT (GO:0007259),1.197135324119866,2.8281593406593406
1753,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1.197135324119866,2.8281593406593406
1754,regulation of filopodium assembly (GO:0051489),1.197135324119866,2.8281593406593406
1755,cochlea development (GO:0090102),1.197135324119866,2.8281593406593406
1756,positive regulation of histone methylation (GO:0031062),1.197135324119866,2.8281593406593406
1757,epithelial cell apoptotic process (GO:1904019),1.197135324119866,2.8281593406593406
1758,regulation of morphogenesis of a branching structure (GO:0060688),1.197135324119866,2.8281593406593406
1759,response to type I interferon (GO:0034340),1.197135324119866,2.8281593406593406
1760,forebrain generation of neurons (GO:0021872),1.197135324119866,2.8281593406593406
1761,regulation of transmembrane transport (GO:0034762),1.1916691980302307,1.4880028908696699
1762,protein localization (GO:0008104),1.1860416185738247,0.689723070051366
1763,cellular macromolecule localization (GO:0070727),1.1850342689288478,0.6875732838589982
1764,regulation of response to cytokine stimulus (GO:0060759),1.1824400391442356,1.804469763365469
1765,urogenital system development (GO:0001655),1.1816736181615768,1.6807346938775511
1766,positive regulation of immunoglobulin production (GO:0002639),1.1816109356437328,2.774797843665768
1767,negative regulation of fat cell differentiation (GO:0045599),1.1816109356437328,2.774797843665768
1768,positive regulation of miRNA metabolic process (GO:2000630),1.1816109356437328,2.774797843665768
1769,positive regulation of protein acetylation (GO:1901985),1.1816109356437328,2.774797843665768
1770,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),1.1816109356437328,2.774797843665768
1771,response to cold (GO:0009409),1.1816109356437328,2.774797843665768
1772,receptor signaling pathway via STAT (GO:0097696),1.1816109356437328,2.774797843665768
1773,regulation of platelet activation (GO:0010543),1.1816109356437328,2.774797843665768
1774,negative regulation of myeloid leukocyte differentiation (GO:0002762),1.1816109356437328,2.774797843665768
1775,cellular response to chemical stimulus (GO:0070887),1.180380668916959,1.2367791612057666
1776,regulation of cellular component biogenesis (GO:0044087),1.1774614450126948,1.3917755745831457
1777,positive regulation of developmental growth (GO:0048639),1.174356920936541,1.793466898954704
1778,cellular component morphogenesis (GO:0032989),1.169131162298118,1.4609035004730369
1779,iron ion transport (GO:0006826),1.1664258741222269,2.723412698412698
1780,mesenchyme morphogenesis (GO:0072132),1.1664258741222269,2.723412698412698
1781,detection of mechanical stimulus (GO:0050982),1.1664258741222269,2.723412698412698
1782,endocrine process (GO:0050886),1.1664258741222269,2.723412698412698
1783,protein kinase B signaling (GO:0043491),1.1664258741222269,2.723412698412698
1784,long-chain fatty acid transport (GO:0015909),1.1664258741222269,2.723412698412698
1785,morphogenesis of a branching epithelium (GO:0061138),1.1663441356286954,1.7825974025974025
1786,neural tube development (GO:0021915),1.1663441356286954,1.7825974025974025
1787,behavior (GO:0007610),1.164916199164523,1.456082036775106
1788,cell adhesion (GO:0007155),1.1559121501289138,1.365922158337019
1789,regulation of transcription regulatory region DNA binding (GO:2000677),1.1515677787995142,2.673896103896104
1790,ERK1 and ERK2 cascade (GO:0070371),1.1515677787995142,2.673896103896104
1791,positive regulation of neuron apoptotic process (GO:0043525),1.1515677787995142,2.673896103896104
1792,regulation of glucose import (GO:0046324),1.1515677787995142,2.673896103896104
1793,male sex differentiation (GO:0046661),1.150526074388778,1.7612489307100088
1794,response to metal ion (GO:0010038),1.1463445180402572,1.6205430932703662
1795,positive regulation of leukocyte proliferation (GO:0070665),1.142719092296093,1.750765306122449
1796,cardiac chamber development (GO:0003205),1.142719092296093,1.750765306122449
1797,cytokine-mediated signaling pathway (GO:0019221),1.1379002492105421,1.6072599531615923
1798,glomerulus development (GO:0032835),1.1370249453064738,2.626147959183674
1799,cellular response to glucocorticoid stimulus (GO:0071385),1.1370249453064738,2.626147959183674
1800,regulation of dendritic spine development (GO:0060998),1.1370249453064738,2.626147959183674
1801,somatic stem cell population maintenance (GO:0035019),1.1370249453064738,2.626147959183674
1802,response to gamma radiation (GO:0010332),1.1370249453064738,2.626147959183674
1803,regulation of endothelial cell migration (GO:0010594),1.1349790304485716,1.7404057480980561
1804,regulation of leukocyte cell-cell adhesion (GO:1903037),1.1293634753848034,1.5941927990708478
1805,regulation of epithelial cell proliferation (GO:0050678),1.1293634753848034,1.5941927990708478
1806,regulation of cell motility (GO:2000145),1.1290259295408673,1.3382998699985555
1807,regulation of protein kinase B signaling (GO:0051896),1.1273050726046585,1.7301680672268909
1808,epithelial cell proliferation (GO:0050673),1.1273050726046585,1.7301680672268909
1809,negative regulation of MAPK cascade (GO:0043409),1.1273050726046585,1.7301680672268909
1810,carbohydrate transmembrane transport (GO:0034219),1.1227862802350543,2.580075187969925
1811,endochondral bone morphogenesis (GO:0060350),1.1227862802350543,2.580075187969925
1812,positive regulation of cytokine-mediated signaling pathway (GO:0001961),1.1227862802350543,2.580075187969925
1813,neural crest cell migration (GO:0001755),1.1227862802350543,2.580075187969925
1814,negative regulation of viral genome replication (GO:0045071),1.1227862802350543,2.580075187969925
1815,presynaptic endocytosis (GO:0140238),1.1227862802350543,2.580075187969925
1816,regulation of action potential (GO:0098900),1.1227862802350543,2.580075187969925
1817,synaptic vesicle endocytosis (GO:0048488),1.1227862802350543,2.580075187969925
1818,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1.1227862802350543,2.580075187969925
1819,positive regulation of cation transmembrane transport (GO:1904064),1.1196964171568644,1.7200501253132834
1820,regulation of adenylate cyclase activity (GO:0045761),1.1088412587860077,2.5355911330049263
1821,regulation of sodium ion transmembrane transporter activity (GO:2000649),1.1088412587860077,2.5355911330049263
1822,regulation of interferon-beta production (GO:0032648),1.1088412587860077,2.5355911330049263
1823,positive regulation of DNA binding (GO:0043388),1.1088412587860077,2.5355911330049263
1824,synaptic vesicle exocytosis (GO:0016079),1.1088412587860077,2.5355911330049263
1825,negative regulation of epithelial cell apoptotic process (GO:1904036),1.1088412587860077,2.5355911330049263
1826,regulation of T cell activation (GO:0050863),1.106202794455573,1.5603637741568774
1827,regulation of GTPase activity (GO:0043087),1.1032719482580502,1.556235827664399
1828,organic hydroxy compound biosynthetic process (GO:1901617),1.0972544537987448,1.690394088669951
1829,myeloid leukocyte mediated immunity (GO:0002444),1.0951798873158938,2.492615012106538
1830,leukocyte mediated cytotoxicity (GO:0001909),1.0951798873158938,2.492615012106538
1831,mesenchymal cell migration (GO:0090497),1.0951798873158938,2.492615012106538
1832,negative regulation of muscle cell differentiation (GO:0051148),1.0951798873158938,2.492615012106538
1833,cardiac muscle tissue morphogenesis (GO:0055008),1.0951798873158938,2.492615012106538
1834,fibroblast growth factor receptor signaling pathway (GO:0008543),1.0951798873158938,2.492615012106538
1835,morphogenesis of a branching structure (GO:0001763),1.089899263209782,1.6807346938775511
1836,regulation of cation transmembrane transport (GO:1904062),1.0855461992271478,1.5319196428571429
1837,maternal process involved in female pregnancy (GO:0060135),1.0817926674745562,2.451071428571429
1838,regulation of interleukin-10 production (GO:0032653),1.0817926674745562,2.451071428571429
1839,antibacterial humoral response (GO:0019731),1.0817926674745562,2.451071428571429
1840,positive regulation of T cell mediated immunity (GO:0002711),1.0817926674745562,2.451071428571429
1841,regulation of immune effector process (GO:0002697),1.0795897191915838,1.523982235381199
1842,regulation of receptor internalization (GO:0002090),1.0686705647625132,2.410889929742389
1843,viral life cycle (GO:0019058),1.0681997845505342,1.6524077046548957
1844,cellular response to cytokine stimulus (GO:0071345),1.060819215687978,1.4418067226890756
1845,regulation of protein import into nucleus (GO:0042306),1.055804977876563,2.372004608294931
1846,myofibril assembly (GO:0030239),1.055804977876563,2.372004608294931
1847,negative regulation of adaptive immune response (GO:0002820),1.055804977876563,2.372004608294931
1848,regulation of histone modification (GO:0031056),1.047034636774191,1.6250197316495658
1849,regulation of cell death (GO:0010941),1.0447421595431,1.244800483675937
1850,regulation of synaptic vesicle exocytosis (GO:2000300),1.0431877124042916,2.3343537414965985
1851,positive regulation of type I interferon production (GO:0032481),1.0431877124042916,2.3343537414965985
1852,regulation of lipid catabolic process (GO:0050994),1.0431877124042916,2.3343537414965985
1853,striated muscle cell development (GO:0055002),1.0431877124042916,2.3343537414965985
1854,regulation of miRNA transcription (GO:1902893),1.0431877124042916,2.3343537414965985
1855,lung development (GO:0030324),1.0400951448165638,1.6160910518053373
1856,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002822),1.0400951448165638,1.6160910518053373
1857,negative regulation of nitrogen compound metabolic process (GO:0051172),1.0367361783189262,1.2209571250667142
1858,regulation of intracellular signal transduction (GO:1902531),1.0357028113837,0.683622478625384
1859,negative regulation of cell development (GO:0010721),1.0332123319127884,1.6072599531615923
1860,cellular iron ion homeostasis (GO:0006879),1.0308109549312339,2.2978794642857143
1861,Rho protein signal transduction (GO:0007266),1.0308109549312339,2.2978794642857143
1862,regulation of interleukin-2 production (GO:0032663),1.0308109549312339,2.2978794642857143
1863,regulation of cholesterol transport (GO:0032374),1.0308109549312339,2.2978794642857143
1864,regulation of sterol transport (GO:0032371),1.0308109549312339,2.2978794642857143
1865,positive regulation of muscle cell differentiation (GO:0051149),1.0308109549312339,2.2978794642857143
1866,regulation of potassium ion transmembrane transporter activity (GO:1901016),1.0308109549312339,2.2978794642857143
1867,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),1.0308109549312339,2.2978794642857143
1868,negative regulation of hormone secretion (GO:0046888),1.0308109549312339,2.2978794642857143
1869,positive regulation of nucleocytoplasmic transport (GO:0046824),1.0308109549312339,2.2978794642857143
1870,positive regulation of response to cytokine stimulus (GO:0060760),1.0308109549312339,2.2978794642857143
1871,regulation of MAP kinase activity (GO:0043405),1.0263855541597908,1.5985248447204967
1872,regulation of calcium ion transmembrane transport (GO:1903169),1.0196141783543349,1.5898841698841697
1873,regulation of cation channel activity (GO:2001257),1.0196141783543349,1.5898841698841697
1874,negative regulation of proteolysis involved in protein catabolic process (GO:1903051),1.0186672499389184,2.2625274725274727
1875,positive regulation of ion transmembrane transport (GO:0034767),1.0128975809510627,1.581336405529954
1876,respiratory tube development (GO:0030323),1.0128975809510627,1.581336405529954
1877,regulation of T cell proliferation (GO:0042129),1.0128975809510627,1.581336405529954
1878,regulation of metal ion transport (GO:0010959),1.0069554260163827,1.4347735191637632
1879,pyridine nucleotide metabolic process (GO:0019362),1.0067494785617508,2.2282467532467534
1880,synaptic vesicle recycling (GO:0036465),1.0067494785617508,2.2282467532467534
1881,natural killer cell activation (GO:0030101),1.0067494785617508,2.2282467532467534
1882,nicotinamide nucleotide metabolic process (GO:0046496),1.0067494785617508,2.2282467532467534
1883,secretion by cell (GO:0032940),1.000852449223106,1.4278085991678224
1884,leukocyte activation involved in immune response (GO:0002366),0.9996262784549328,1.56451367781155
1885,striated muscle tissue development (GO:0014706),0.9996262784549328,1.56451367781155
1886,growth (GO:0040007),0.997800388818348,1.4243514354894502
1887,developmental growth (GO:0048589),0.997800388818348,1.4243514354894502
1888,regulation of sodium ion transmembrane transport (GO:1902305),0.9950508380068559,2.1949893390191897
1889,positive regulation of macromolecule metabolic process (GO:0010604),0.9949075860203384,1.1625635234330887
1890,regulation of carbohydrate metabolic process (GO:0006109),0.9930703754877667,1.556235827664399
1891,regulation of cell division (GO:0051302),0.9930703754877667,1.556235827664399
1892,response to hormone (GO:0009725),0.9926430017057849,1.3421773142112126
1893,cellular response to retinoic acid (GO:0071300),0.9835648239003909,2.1627100840336135
1894,neural nucleus development (GO:0048857),0.9835648239003909,2.1627100840336135
1895,regulation of multicellular organism growth (GO:0040014),0.9835648239003909,2.1627100840336135
1896,regulation of B cell proliferation (GO:0030888),0.9835648239003909,2.1627100840336135
1897,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.9835648239003909,2.1627100840336135
1898,regulation of muscle cell apoptotic process (GO:0010660),0.9835648239003909,2.1627100840336135
1899,regulation of histone acetylation (GO:0035065),0.9835648239003909,2.1627100840336135
1900,epithelial cell development (GO:0002064),0.9801151421055443,1.5399401645474942
1901,regulation of cell growth (GO:0001558),0.977785992671792,0.34280719280719285
1902,response to xenobiotic stimulus (GO:0009410),0.9777744564094574,0.34766970618034454
1903,protein-containing complex assembly (GO:0065003),0.9738399219546532,1.273785151856018
1904,cell activation involved in immune response (GO:0002263),0.9737146692713887,1.5319196428571429
1905,regulation of lymphocyte migration (GO:2000401),0.972285212435801,2.131366459627329
1906,regulation of lipid kinase activity (GO:0043550),0.972285212435801,2.131366459627329
1907,negative regulation of wound healing (GO:0061045),0.972285212435801,2.131366459627329
1908,protein localization to membrane (GO:0072657),0.9716114687008228,0.32608489071903707
1909,regulation of peptidase activity (GO:0052547),0.9711100077714956,0.32536346396965865
1910,organelle assembly (GO:0070925),0.9655869892871309,0.5494307062800213
1911,muscle tissue morphogenesis (GO:0060415),0.9612060446744555,2.1009183673469387
1912,cardiac septum morphogenesis (GO:0060411),0.9612060446744555,2.1009183673469387
1913,regulation of osteoclast differentiation (GO:0045670),0.9612060446744555,2.1009183673469387
1914,sensory perception of taste (GO:0050909),0.9612060446744555,2.1009183673469387
1915,protein localization to nucleus (GO:0034504),0.9610652212392843,1.5161266568483063
1916,regulation of cellular amide metabolic process (GO:0034248),0.959880471112236,0.31356990557416997
1917,carbohydrate metabolic process (GO:0005975),0.9547654942671904,0.30960902255639094
1918,vasculogenesis (GO:0001570),0.9503216120318376,2.071327967806841
1919,positive regulation of insulin secretion (GO:0032024),0.9503216120318376,2.071327967806841
1920,negative regulation of protein localization (GO:1903828),0.9486141491318301,1.5006559766763847
1921,membrane organization (GO:0061024),0.9459959691823738,1.3825079738123214
1922,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.9418118926339694,1.5192591499409682
1923,organic hydroxy compound metabolic process (GO:1901615),0.940715535459725,1.5161266568483063
1924,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.939626441928714,2.042559523809524
1925,response to endogenous stimulus (GO:0009719),0.9368571956675473,1.287214754610816
1926,cell projection morphogenesis (GO:0048858),0.9361952935092753,1.5037248028045573
1927,vesicle-mediated transport (GO:0016192),0.9318407217950513,1.2769691957825098
1928,regulation of toll-like receptor signaling pathway (GO:0034121),0.9291152853867062,2.0145792563600784
1929,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.9291152853867062,2.0145792563600784
1930,regulation of glucose transmembrane transport (GO:0010827),0.9291152853867062,2.0145792563600784
1931,pyridine-containing compound metabolic process (GO:0072524),0.9291152853867062,2.0145792563600784
1932,regulation of protein transport (GO:0051223),0.9201025847739512,1.4647837222538418
1933,tube development (GO:0035295),0.9198520073372006,1.329394673123487
1934,regulation of miRNA metabolic process (GO:2000628),0.9187831048239774,1.9873552123552123
1935,cranial skeletal system development (GO:1904888),0.9187831048239774,1.9873552123552123
1936,digestive system process (GO:0022600),0.9187831048239774,1.9873552123552123
1937,mRNA destabilization (GO:0061157),0.9187831048239774,1.9873552123552123
1938,response to growth factor (GO:0070848),0.9133856079672156,1.4503381234150465
1939,regulation of heart contraction (GO:0008016),0.9124095105103779,1.456082036775106
1940,cell part morphogenesis (GO:0032990),0.9120095267276134,1.4474831271091113
1941,regulation of ion transmembrane transport (GO:0034765),0.9092257101007539,1.4418067226890756
1942,regulation of tissue remodeling (GO:0034103),0.908625062726719,1.960857142857143
1943,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.908625062726719,1.960857142857143
1944,fatty acid transport (GO:0015908),0.908625062726719,1.960857142857143
1945,outflow tract morphogenesis (GO:0003151),0.908625062726719,1.960857142857143
1946,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.9007108764756087,1.4418067226890756
1947,striated muscle cell differentiation (GO:0051146),0.9007108764756087,1.4418067226890756
1948,positive regulation of cellular metabolic process (GO:0031325),0.8986729658106071,1.177644824746042
1949,regulation of immunoglobulin production (GO:0002637),0.8986365115003488,1.9350563909774439
1950,sensory perception of pain (GO:0019233),0.8986365115003488,1.9350563909774439
1951,positive regulation of mononuclear cell migration (GO:0071677),0.8986365115003488,1.9350563909774439
1952,regulation of lyase activity (GO:0051339),0.8986365115003488,1.9350563909774439
1953,myotube differentiation (GO:0014902),0.8986365115003488,1.9350563909774439
1954,negative regulation of innate immune response (GO:0045824),0.8986365115003488,1.9350563909774439
1955,circulatory system development (GO:0072359),0.8962357420557395,1.2942951438000945
1956,ribonucleoprotein complex subunit organization (GO:0071826),0.8941823990613201,0.0
1957,regulation of organelle assembly (GO:1902115),0.8941823990613201,0.0
1958,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.8941580895436224,0.0
1959,regulation of DNA repair (GO:0006282),0.8940217702847,0.0
1960,ribonucleotide biosynthetic process (GO:0009260),0.8940217702847,0.0
1961,response to insulin (GO:0032868),0.8938915152914513,0.0
1962,negative regulation of mitotic cell cycle (GO:0045930),0.8938915152914513,0.0
1963,establishment of protein localization to membrane (GO:0090150),0.8937234813733141,0.0
1964,response to starvation (GO:0042594),0.8935180188526105,0.0
1965,purine-containing compound biosynthetic process (GO:0072522),0.893275480437942,0.0
1966,regulation of cell-substrate adhesion (GO:0010810),0.8923289711643093,0.0
1967,ribose phosphate biosynthetic process (GO:0046390),0.8923289711643093,0.0
1968,protein glycosylation (GO:0006486),0.8919417008166851,0.0
1969,macromolecule glycosylation (GO:0043413),0.8919417008166851,0.0
1970,protein folding (GO:0006457),0.8915191501191784,0.0
1971,response to endoplasmic reticulum stress (GO:0034976),0.8910616839309976,0.0
1972,cellular response to oxidative stress (GO:0034599),0.8910616839309976,0.0
1973,rRNA processing (GO:0006364),0.8905696681891706,0.0
1974,negative regulation of cell cycle phase transition (GO:1901988),0.8900434706553485,0.0
1975,nucleobase-containing compound transport (GO:0015931),0.8894834602089303,0.0
1976,regulation of myoblast differentiation (GO:0045661),0.8888129836182472,1.9099257884972174
1977,diencephalon development (GO:0021536),0.8888129836182472,1.9099257884972174
1978,regulation of peptidyl-lysine acetylation (GO:2000756),0.8888129836182472,1.9099257884972174
1979,protein autoubiquitination (GO:0051865),0.8888129836182472,1.9099257884972174
1980,regulation of cyclase activity (GO:0031279),0.8888129836182472,1.9099257884972174
1981,negative regulation of apoptotic signaling pathway (GO:2001234),0.8869127040582198,0.0
1982,protein polyubiquitination (GO:0000209),0.8861891983702057,0.0
1983,cellular response to biotic stimulus (GO:0071216),0.8854341132491078,0.0
1984,regulation of establishment of protein localization (GO:0070201),0.8839955059182025,1.3952968284087828
1985,secretion (GO:0046903),0.8839955059182025,1.3952968284087828
1986,nuclear chromosome segregation (GO:0098813),0.882983128864643,0.0
1987,protein localization to cell periphery (GO:1990778),0.8792957890915998,0.0
1988,response to osmotic stress (GO:0006970),0.8791501820907931,1.8854395604395606
1989,positive regulation of interferon-gamma production (GO:0032729),0.8791501820907931,1.8854395604395606
1990,regulation of ERBB signaling pathway (GO:1901184),0.8791501820907931,1.8854395604395606
1991,RNA destabilization (GO:0050779),0.8791501820907931,1.8854395604395606
1992,glycosylation (GO:0070085),0.8783015696702926,0.0
1993,protein targeting (GO:0006605),0.8740463858559826,0.0
1994,"mRNA splicing, via spliceosome (GO:0000398)",0.8740463858559826,0.0
1995,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.8740463858559826,0.0
1996,regulation of cell migration (GO:0030334),0.8738758849444148,1.2664308780562819
1997,DNA recombination (GO:0006310),0.8717570314636051,0.0
1998,calcium ion transport (GO:0006816),0.870573213645853,0.0
1999,dephosphorylation (GO:0016311),0.870573213645853,0.0
2000,negative regulation of response to cytokine stimulus (GO:0060761),0.8696439723152957,1.8615732368896927
2001,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.8696439723152957,1.8615732368896927
2002,"RNA splicing, via transesterification reactions (GO:0000375)",0.8693637950398052,0.0
2003,negative regulation of endopeptidase activity (GO:0010951),0.8681291437636307,0.0
2004,meiotic cell cycle (GO:0051321),0.8642774600645341,0.0
2005,positive regulation of cell cycle process (GO:0090068),0.8642774600645341,0.0
2006,inflammatory response (GO:0006954),0.8630640235871964,1.3617063492063493
2007,regulation of chromosome organization (GO:0033044),0.8629455375156253,0.0
2008,regulation of catabolic process (GO:0009894),0.8618404719717039,0.5960052105948763
2009,positive regulation of cation channel activity (GO:2001259),0.8602903737970875,1.8383035714285716
2010,response to vitamin (GO:0033273),0.8602903737970875,1.8383035714285716
2011,lens development in camera-type eye (GO:0002088),0.8602903737970875,1.8383035714285716
2012,rRNA metabolic process (GO:0016072),0.8602118235664941,0.0
2013,cell-cell adhesion (GO:0098609),0.8580632438338152,1.3541831097079715
2014,negative regulation of peptidase activity (GO:0010466),0.8559419608389878,0.0
2015,regulation of microtubule-based process (GO:0032886),0.8514774654050328,0.0
2016,energy derivation by oxidation of organic compounds (GO:0015980),0.8499476856897207,0.0
2017,somite development (GO:0061053),0.8420258141103469,1.793466898954704
2018,cell morphogenesis involved in differentiation (GO:0000904),0.8357661193956258,1.3225205549845838
2019,skin development (GO:0043588),0.8335933315314281,1.6462420042643922
2020,muscle cell differentiation (GO:0042692),0.8335933315314281,1.6462420042643922
2021,modulation by host of symbiont process (GO:0051851),0.8331075968173529,1.7718588640275388
2022,protein localization to mitochondrion (GO:0070585),0.8331075968173529,1.7718588640275388
2023,regulation of striated muscle cell differentiation (GO:0051153),0.8331075968173529,1.7718588640275388
2024,negative regulation of protein ubiquitination (GO:0031397),0.8331075968173529,1.7718588640275388
2025,regulation of leukocyte proliferation (GO:0070663),0.8283427214844521,1.6280179230363732
2026,regulation of ion transmembrane transporter activity (GO:0032412),0.8265602298944021,1.62203256302521
2027,regulation of calcium-mediated signaling (GO:0050848),0.8243274653726516,1.750765306122449
2028,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.8211202810869904,1.6043376623376624
2029,cell junction assembly (GO:0034329),0.8192771684685124,1.5985248447204967
2030,regulation of protein metabolic process (GO:0051246),0.8166220868505865,0.7958639350599149
2031,negative regulation of response to wounding (GO:1903035),0.8156821054392661,1.7301680672268909
2032,chondrocyte differentiation (GO:0002062),0.8156821054392661,1.7301680672268909
2033,cellular response to fibroblast growth factor stimulus (GO:0044344),0.8156821054392661,1.7301680672268909
2034,positive regulation of smooth muscle cell proliferation (GO:0048661),0.8156821054392661,1.7301680672268909
2035,carbohydrate transport (GO:0008643),0.8156821054392661,1.7301680672268909
2036,regulation of system process (GO:0044057),0.8144252920749041,1.2945799798792756
2037,lymphocyte differentiation (GO:0030098),0.8117638045118079,1.575688775510204
2038,regulation of transmembrane transporter activity (GO:0022898),0.807926717429164,1.56451367781155
2039,regulation of receptor signaling pathway via STAT (GO:1904892),0.8071683171963002,1.7100498338870433
2040,iron ion homeostasis (GO:0055072),0.8071683171963002,1.7100498338870433
2041,central nervous system neuron development (GO:0021954),0.8071683171963002,1.7100498338870433
2042,regulation of transcription elongation by RNA polymerase II (GO:0034243),0.8071683171963002,1.7100498338870433
2043,lipid biosynthetic process (GO:0008610),0.8066428710695648,0.4869678334910123
2044,positive regulation of metabolic process (GO:0009893),0.8064834727823681,1.1435792046211952
2045,response to steroid hormone (GO:0048545),0.8040391184021695,1.5534959758551308
2046,DNA-templated transcription (GO:0006351),0.8033508230140636,0.47981822419016545
2047,nucleic acid-templated transcription (GO:0097659),0.8029301424684993,0.47903676128431827
2048,retinoid metabolic process (GO:0001523),0.7987830109631855,1.690394088669951
2049,regulation of viral genome replication (GO:0045069),0.7987830109631855,1.690394088669951
2050,RNA biosynthetic process (GO:0032774),0.7981403035808997,0.47135989010989016
2051,biological_process (GO:0008150),0.7928970593743039,1.029054842940311
2052,regulation of defense response (GO:0031347),0.7841038890732778,1.3744325767690255
2053,regulation of protein acetylation (GO:1901983),0.782386004468713,1.6524077046548957
2054,cellular response to calcium ion (GO:0071277),0.782386004468713,1.6524077046548957
2055,positive regulation of protein localization to nucleus (GO:1900182),0.782386004468713,1.6524077046548957
2056,regulation of organ growth (GO:0046620),0.782386004468713,1.6524077046548957
2057,regulation of T cell mediated immunity (GO:0002709),0.782386004468713,1.6524077046548957
2058,positive regulation of mRNA catabolic process (GO:0061014),0.782386004468713,1.6524077046548957
2059,smoothened signaling pathway (GO:0007224),0.7743686300111156,1.6340476190476187
2060,excitatory postsynaptic potential (GO:0060079),0.7743686300111156,1.6340476190476187
2061,diterpenoid metabolic process (GO:0016101),0.7743686300111156,1.6340476190476187
2062,regulation of transporter activity (GO:0032409),0.7734932924446531,1.4755613951266124
2063,response to fibroblast growth factor (GO:0071774),0.7664683806455798,1.6160910518053373
2064,regulation of sodium ion transport (GO:0002028),0.7664683806455798,1.6160910518053373
2065,BMP signaling pathway (GO:0030509),0.7664683806455798,1.6160910518053373
2066,"retrograde transport, endosome to Golgi (GO:0042147)",0.7664683806455798,1.6160910518053373
2067,feeding behavior (GO:0007631),0.7664683806455798,1.6160910518053373
2068,regulation of stress fiber assembly (GO:0051492),0.7586826461307317,1.5985248447204967
2069,defense response to Gram-negative bacterium (GO:0050829),0.7586826461307317,1.5985248447204967
2070,regulation of MAPK cascade (GO:0043408),0.7582286106964549,1.313073979591837
2071,positive regulation of cell development (GO:0010720),0.7542275785338095,1.4324443413729129
2072,neuron projection development (GO:0031175),0.7532682410601873,1.3033762397130195
2073,cellular oxidant detoxification (GO:0098869),0.7510089001305085,1.581336405529954
2074,positive regulation of neuron death (GO:1901216),0.7510089001305085,1.581336405529954
2075,hormone secretion (GO:0046879),0.7510089001305085,1.581336405529954
2076,positive regulation of secretion (GO:0051047),0.7476872737888302,1.418626550298576
2077,post-embryonic development (GO:0009791),0.7434446965843817,1.56451367781155
2078,regulation of neurotransmitter secretion (GO:0046928),0.7434446965843817,1.56451367781155
2079,amino acid transmembrane transport (GO:0003333),0.7434446965843817,1.56451367781155
2080,lipid metabolic process (GO:0006629),0.7389266087181994,0.7150613567955544
2081,negative regulation of viral process (GO:0048525),0.7359876661071155,1.5480451127819548
2082,regulation of Notch signaling pathway (GO:0008593),0.7359876661071155,1.5480451127819548
2083,erythrocyte differentiation (GO:0030218),0.7359876661071155,1.5480451127819548
2084,axoneme assembly (GO:0035082),0.7359876661071155,1.5480451127819548
2085,artery development (GO:0060840),0.7359876661071155,1.5480451127819548
2086,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.7359876661071155,1.5480451127819548
2087,epithelial tube morphogenesis (GO:0060562),0.7322431581162158,1.3873989218328842
2088,cell activation (GO:0001775),0.7284670969703376,1.2605510204081634
2089,positive regulation of peptide hormone secretion (GO:0090277),0.7213860132200365,1.5161266568483063
2090,platelet activation (GO:0030168),0.7213860132200365,1.5161266568483063
2091,regulation of developmental growth (GO:0048638),0.7188414863094931,1.3617063492063493
2092,hematopoietic or lymphoid organ development (GO:0048534),0.7167979131279533,1.2427967806841047
2093,regulation of neuron death (GO:1901214),0.7165961724187544,1.3575164835164835
2094,mononuclear cell differentiation (GO:1903131),0.7143479803261473,1.3533523225241015
2095,cellular response to alcohol (GO:0097306),0.7142370090207667,1.5006559766763847
2096,regulation of epithelial cell apoptotic process (GO:1904035),0.7142370090207667,1.5006559766763847
2097,inorganic ion import across plasma membrane (GO:0099587),0.7071864086585405,1.4854978354978354
2098,inorganic cation import across plasma membrane (GO:0098659),0.7071864086585405,1.4854978354978354
2099,regulation of carbohydrate biosynthetic process (GO:0043255),0.7071864086585405,1.4854978354978354
2100,positive regulation of peptide secretion (GO:0002793),0.7071864086585405,1.4854978354978354
2101,regulation of proteolysis (GO:0030162),0.7054545420530705,0.5937992693712748
2102,cellular metal ion homeostasis (GO:0006875),0.7053297760809943,1.3369480519480519
2103,regulation of systemic arterial blood pressure (GO:0003073),0.7002321827192265,1.4706428571428571
2104,positive regulation of myeloid cell differentiation (GO:0045639),0.7002321827192265,1.4706428571428571
2105,vitamin metabolic process (GO:0006766),0.7002321827192265,1.4706428571428571
2106,action potential (GO:0001508),0.7002321827192265,1.4706428571428571
2107,establishment of protein localization to organelle (GO:0072594),0.6962786162109262,1.3209366980325066
2108,integrin-mediated signaling pathway (GO:0007229),0.6933723618600927,1.456082036775106
2109,regulation of actomyosin structure organization (GO:0110020),0.6933723618600927,1.456082036775106
2110,terpenoid metabolic process (GO:0006721),0.6933723618600927,1.456082036775106
2111,transition metal ion transport (GO:0000041),0.6933723618600927,1.456082036775106
2112,monocarboxylic acid transport (GO:0015718),0.6933723618600927,1.456082036775106
2113,chloride transmembrane transport (GO:1902476),0.6866050342547529,1.4418067226890756
2114,hormone transport (GO:0009914),0.6866050342547529,1.4418067226890756
2115,regulation of cellular component organization (GO:0051128),0.6821533628354352,0.8087291515591007
2116,unsaturated fatty acid metabolic process (GO:0033559),0.6799283437598922,1.4278085991678224
2117,regulation of DNA-templated transcription elongation (GO:0032784),0.6799283437598922,1.4278085991678224
2118,regulation of type I interferon production (GO:0032479),0.6799283437598922,1.4278085991678224
2119,cellular component organization or biogenesis (GO:0071840),0.6771089633148847,0.8987689889994763
2120,erythrocyte homeostasis (GO:0034101),0.6733404874566805,1.4140796703296703
2121,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.6733404874566805,1.4140796703296703
2122,regulation of pattern recognition receptor signaling pathway (GO:0062207),0.6733404874566805,1.4140796703296703
2123,regulation of actin filament bundle assembly (GO:0032231),0.6668397138344601,1.4006122448979592
2124,negative regulation of small molecule metabolic process (GO:0062014),0.6668397138344601,1.4006122448979592
2125,cellular response to ketone (GO:1901655),0.6604243206131084,1.387398921832884
2126,microtubule organizing center organization (GO:0031023),0.6604243206131084,1.387398921832884
2127,gland morphogenesis (GO:0022612),0.6604243206131084,1.387398921832884
2128,positive regulation of endothelial cell migration (GO:0010595),0.6540926531670337,1.3744325767690253
2129,cellular detoxification (GO:1990748),0.6478431027182356,1.361706349206349
2130,cellular component assembly involved in morphogenesis (GO:0010927),0.6478431027182356,1.361706349206349
2131,positive regulation of T cell proliferation (GO:0042102),0.6478431027182356,1.361706349206349
2132,negative regulation of lipid metabolic process (GO:0045833),0.6478431027182356,1.361706349206349
2133,digestion (GO:0007586),0.6478431027182356,1.361706349206349
2134,regulation of protein localization (GO:0032880),0.64772204283067,1.2111176470588236
2135,glycerolipid metabolic process (GO:0046486),0.645651640080017,0.40625493291239145
2136,negative regulation of cell cycle (GO:0045786),0.6456103898929214,0.409649820931158
2137,small molecule catabolic process (GO:0044282),0.6456016907666883,0.4040227629513343
2138,regulation of response to biotic stimulus (GO:0002831),0.6456016907666883,0.4040227629513343
2139,phospholipid metabolic process (GO:0006644),0.6454122174305028,0.40072012456208644
2140,lipid localization (GO:0010876),0.6450872879028091,0.3974710424710424
2141,regulation of cellular component size (GO:0032535),0.6447965531020683,0.3953341013824885
2142,regulation of binding (GO:0051098),0.644447339829674,0.39322001527883876
2143,translation (GO:0006412),0.6433231443165421,0.38803241613268
2144,striated muscle contraction (GO:0006941),0.6416741045728642,1.3492136304062912
2145,negative regulation of developmental growth (GO:0048640),0.6416741045728642,1.3492136304062912
2146,microtubule-based movement (GO:0007018),0.6415135583182385,0.38198515769944347
2147,monocarboxylic acid catabolic process (GO:0072329),0.6355841366556055,1.336948051948052
2148,T cell receptor signaling pathway (GO:0050852),0.6355841366556055,1.336948051948052
2149,regulation of receptor-mediated endocytosis (GO:0048259),0.6355841366556055,1.336948051948052
2150,negative regulation of protein catabolic process (GO:0042177),0.6355841366556055,1.336948051948052
2151,protein modification by small protein conjugation or removal (GO:0070647),0.6321884576755668,0.6550747693286668
2152,peptide biosynthetic process (GO:0043043),0.630283481909548,0.3604516806722689
2153,chloride transport (GO:0006821),0.6295717176275558,1.324903474903475
2154,regulation of translation (GO:0006417),0.6290105503823065,0.3586933797909408
2155,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.6236354061704351,1.313073979591837
2156,cellular transition metal ion homeostasis (GO:0046916),0.6236354061704351,1.313073979591837
2157,regulation of nucleocytoplasmic transport (GO:0046822),0.6236354061704351,1.313073979591837
2158,negative regulation of macromolecule metabolic process (GO:0010605),0.6232053880976438,1.117348046309696
2159,regulation of endopeptidase activity (GO:0052548),0.6204809634594939,0.3484935680433311
2160,metal ion homeostasis (GO:0055065),0.6197044134577552,1.4006122448979592
2161,neuropeptide signaling pathway (GO:0007218),0.6177737985511305,1.3014538558786346
2162,biological process involved in interaction with symbiont (GO:0051702),0.6177737985511305,1.3014538558786346
2163,glucose metabolic process (GO:0006006),0.6119855283248494,1.2900375939849624
2164,actomyosin structure organization (GO:0031032),0.6119855283248494,1.2900375939849624
2165,stem cell population maintenance (GO:0019827),0.6119855283248494,1.2900375939849624
2166,negative regulation of response to biotic stimulus (GO:0002832),0.6119855283248494,1.2900375939849624
2167,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.6119855283248494,1.2900375939849624
2168,negative regulation of transport (GO:0051051),0.6069542412420559,1.3523152709359605
2169,myelination (GO:0042552),0.6062692643928367,1.2788198757763976
2170,cellular monovalent inorganic cation homeostasis (GO:0030004),0.6062692643928367,1.2788198757763976
2171,regulation of DNA-binding transcription factor activity (GO:0051090),0.6041731345305662,1.3430528375733854
2172,renal system process (GO:0003014),0.6006237098888673,1.2677955665024632
2173,icosanoid metabolic process (GO:0006690),0.6006237098888673,1.2677955665024632
2174,sperm motility (GO:0097722),0.6006237098888673,1.2677955665024632
2175,flagellated sperm motility (GO:0030317),0.6006237098888673,1.2677955665024632
2176,cellular response to toxic substance (GO:0097237),0.6006237098888673,1.2677955665024632
2177,response to wounding (GO:0009611),0.5954147186911866,1.3160115052732502
2178,ensheathment of neurons (GO:0007272),0.5950476014900741,1.256959706959707
2179,axon ensheathment (GO:0008366),0.5950476014900741,1.256959706959707
2180,amino acid transport (GO:0006865),0.5895397074609992,1.246307506053269
2181,epigenetic regulation of gene expression (GO:0040029),0.5895397074609992,1.246307506053269
2182,maintenance of cell number (GO:0098727),0.5895397074609992,1.246307506053269
2183,positive regulation of lymphocyte mediated immunity (GO:0002708),0.5895397074609992,1.246307506053269
2184,regulation of hydrolase activity (GO:0051336),0.5793437895496848,0.7209033613445378
2185,apoptotic process (GO:0006915),0.5792054224725695,0.7118310053934449
2186,fat cell differentiation (GO:0045444),0.5787237904939507,1.2255357142857144
2187,positive regulation of adaptive immune response (GO:0002821),0.5787237904939507,1.2255357142857144
2188,cerebral cortex development (GO:0021987),0.5787237904939507,1.2255357142857144
2189,negative regulation of protein metabolic process (GO:0051248),0.5786298631887287,0.7056827529476283
2190,positive regulation of cellular component organization (GO:0051130),0.5772665880916836,0.6976484142043914
2191,cellular response to oxygen-containing compound (GO:1901701),0.5765018201278647,0.6943545123431809
2192,export from cell (GO:0140352),0.5740096321594222,1.2596512695013764
2193,isoprenoid metabolic process (GO:0006720),0.5734134552270821,1.2154073199527746
2194,fatty acid biosynthetic process (GO:0006633),0.5734134552270821,1.2154073199527746
2195,response to nutrient levels (GO:0031667),0.5706007233124216,1.2516109422492403
2196,regulation of myeloid leukocyte differentiation (GO:0002761),0.568166707812193,1.2054449648711945
2197,positive regulation of mRNA metabolic process (GO:1903313),0.568166707812193,1.2054449648711945
2198,cilium movement involved in cell motility (GO:0060294),0.5629824619676607,1.195644599303136
2199,response to estradiol (GO:0032355),0.5629824619676607,1.195644599303136
2200,negative regulation of immune effector process (GO:0002698),0.5629824619676607,1.195644599303136
2201,cellular response to growth factor stimulus (GO:0071363),0.5624753301401774,1.2332434860736747
2202,cellular response to endogenous stimulus (GO:0071495),0.5621508535934822,1.1956445993031357
2203,activation of GTPase activity (GO:0090630),0.5578596571133605,1.1860023041474654
2204,inorganic anion transmembrane transport (GO:0098661),0.5578596571133605,1.1860023041474654
2205,regulation of DNA binding (GO:0051101),0.5578596571133605,1.1860023041474654
2206,positive regulation of cytokine production (GO:0001819),0.5577328962441607,1.222987822987823
2207,response to abiotic stimulus (GO:0009628),0.5564606251453452,1.1807123741557284
2208,positive regulation of MAPK cascade (GO:0043410),0.5541325115367897,1.2154073199527746
2209,regulation of mononuclear cell migration (GO:0071675),0.5527972586161608,1.1765142857142858
2210,organelle fusion (GO:0048284),0.5527972586161608,1.1765142857142858
2211,cellular response to hormone stimulus (GO:0032870),0.548055005867726,1.202979842243646
2212,microtubule bundle formation (GO:0001578),0.5477942557727636,1.1671768707482992
2213,establishment of cell polarity (GO:0030010),0.5428496624640649,1.157986501687289
2214,positive regulation of hormone secretion (GO:0046887),0.5379625151276731,1.1489397321428572
2215,cell junction organization (GO:0034330),0.5368996421210664,1.181239242685026
2216,transport (GO:0006810),0.5343975144513449,0.8808537946428572
2217,response to extracellular stimulus (GO:0009991),0.5343871543022183,1.1765142857142858
2218,mesoderm development (GO:0007498),0.5331318727537828,1.140033222591362
2219,cell killing (GO:0001906),0.5331318727537828,1.140033222591362
2220,embryonic epithelial tube formation (GO:0001838),0.5331318727537828,1.140033222591362
2221,phosphatidylinositol biosynthetic process (GO:0006661),0.5331318727537828,1.140033222591362
2222,positive regulation of cellular component biogenesis (GO:0044089),0.5331267528489165,1.1741659538066724
2223,positive regulation of apoptotic process (GO:0043065),0.5305979698504492,1.1694973019028685
2224,positive regulation of catabolic process (GO:0009896),0.5287576049432289,0.5733500417710944
2225,monocarboxylic acid metabolic process (GO:0032787),0.5287528572194562,0.5789932508436445
2226,negative regulation of intracellular signal transduction (GO:1902532),0.5285451325626012,0.567815774958632
2227,peptide metabolic process (GO:0006518),0.5258339787202942,0.5477254588986433
2228,regulation of cytoskeleton organization (GO:0051493),0.5251415018671746,0.5446825396825397
2229,establishment of localization (GO:0051234),0.5249529637251162,0.8830480002859287
2230,regulation of DNA metabolic process (GO:0051052),0.5248952564191163,0.5436757327700027
2231,liver development (GO:0001889),0.5236364465910394,1.122628135223555
2232,hormone-mediated signaling pathway (GO:0009755),0.5236364465910394,1.122628135223555
2233,sodium ion transmembrane transport (GO:0035725),0.5236364465910394,1.122628135223555
2234,carbohydrate biosynthetic process (GO:0016051),0.5236364465910394,1.122628135223555
2235,microtubule cytoskeleton organization (GO:0000226),0.5232587525691703,0.5377121963959258
2236,myeloid cell homeostasis (GO:0002262),0.5189698865485897,1.1141233766233767
2237,positive regulation of protein secretion (GO:0050714),0.5189698865485897,1.1141233766233767
2238,regulation of DNA recombination (GO:0000018),0.5143562778185553,1.1057465091299676
2239,cellular component assembly (GO:0022607),0.5137176044447912,1.1057465091299676
2240,myeloid leukocyte differentiation (GO:0002573),0.5097947813746082,1.0974946695095948
2241,hepaticobiliary system development (GO:0061008),0.5097947813746082,1.0974946695095948
2242,leukocyte activation (GO:0045321),0.5076448670153675,1.2656134743053846
2243,regulation of fat cell differentiation (GO:0045598),0.5052845768537416,1.0893650793650793
2244,positive regulation of synaptic transmission (GO:0050806),0.5052845768537416,1.0893650793650793
2245,positive regulation of hydrolase activity (GO:0051345),0.5031554479128946,1.2484234780499637
2246,cilium-dependent cell motility (GO:0060285),0.5008248621003067,1.0813550420168068
2247,cilium or flagellum-dependent cell motility (GO:0001539),0.5008248621003067,1.0813550420168068
2248,detoxification (GO:0098754),0.5008248621003067,1.0813550420168068
2249,regulation of muscle cell differentiation (GO:0051147),0.5008248621003067,1.0813550420168068
2250,sterol metabolic process (GO:0016125),0.5008248621003067,1.0813550420168068
2251,epithelial tube formation (GO:0072175),0.4964148524859546,1.0734619395203335
2252,branching morphogenesis of an epithelial tube (GO:0048754),0.4964148524859546,1.0734619395203335
2253,detection of external stimulus (GO:0009581),0.4964148524859546,1.0734619395203335
2254,regulated exocytosis (GO:0045055),0.492053780303553,1.0656832298136645
2255,detection of abiotic stimulus (GO:0009582),0.4877408945081381,1.058016443987667
2256,regulation of actin filament polymerization (GO:0030833),0.4877408945081381,1.058016443987667
2257,carboxylic acid transmembrane transport (GO:1905039),0.4877408945081381,1.058016443987667
2258,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4877408945081381,1.058016443987667
2259,protein-containing complex organization (GO:0043933),0.4852802134126682,1.1368286316634877
2260,negative regulation of epithelial cell proliferation (GO:0050680),0.4834754600413984,1.0504591836734694
2261,transition metal ion homeostasis (GO:0055076),0.4834754600413984,1.0504591836734694
2262,organic acid transmembrane transport (GO:1903825),0.4834754600413984,1.0504591836734694
2263,positive regulation of leukocyte mediated immunity (GO:0002705),0.4834754600413984,1.0504591836734694
2264,activation of protein kinase activity (GO:0032147),0.47925675774369614,1.0430091185410333
2265,regulation of protein localization to nucleus (GO:1900180),0.47925675774369614,1.0430091185410333
2266,osteoblast differentiation (GO:0001649),0.47508408334363017,1.0356639839034205
2267,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.47508408334363017,1.0356639839034205
2268,regulation of smooth muscle cell proliferation (GO:0048660),0.47508408334363017,1.0356639839034205
2269,regulation of viral life cycle (GO:1903900),0.47508408334363017,1.0356639839034205
2270,metal ion transport (GO:0030001),0.473692293767815,1.163483273056058
2271,male gonad development (GO:0008584),0.4668740751861123,1.021279761904762
2272,antimicrobial humoral response (GO:0019730),0.4668740751861123,1.021279761904762
2273,development of primary male sexual characteristics (GO:0046546),0.4628354054820216,1.0142364532019705
2274,mitochondrial transport (GO:0006839),0.4627515688960039,0.0
2275,myeloid leukocyte activation (GO:0002274),0.4627515688960039,0.0
2276,sister chromatid segregation (GO:0000819),0.4627515688960039,0.0
2277,olefinic compound metabolic process (GO:0120254),0.4627515688960039,0.0
2278,plasma membrane organization (GO:0007009),0.4627496240235295,0.0
2279,cellular response to insulin stimulus (GO:0032869),0.4627496240235295,0.0
2280,positive regulation of small molecule metabolic process (GO:0062013),0.4627496240235295,0.0
2281,protein methylation (GO:0006479),0.4627264551615862,0.0
2282,protein alkylation (GO:0008213),0.4627264551615862,0.0
2283,Golgi organization (GO:0007030),0.4626746476456737,0.0
2284,single fertilization (GO:0007338),0.4625965096269601,0.0
2285,protein-containing complex localization (GO:0031503),0.4625965096269601,0.0
2286,response to UV (GO:0009411),0.4625965096269601,0.0
2287,protein deubiquitination (GO:0016579),0.4625965096269601,0.0
2288,female gamete generation (GO:0007292),0.4624924028089775,0.0
2289,regulation of interleukin-6 production (GO:0032675),0.4624924028089775,0.0
2290,regulation of mitochondrion organization (GO:0010821),0.4624924028089775,0.0
2291,cellular response to oxygen levels (GO:0071453),0.4623626871061236,0.0
2292,learning (GO:0007612),0.4623626871061236,0.0
2293,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4622077208189226,0.0
2294,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4622077208189226,0.0
2295,regeneration (GO:0031099),0.4622077208189226,0.0
2296,positive regulation of lipid metabolic process (GO:0045834),0.4622077208189226,0.0
2297,response to monosaccharide (GO:0034284),0.4622077208189226,0.0
2298,protein acetylation (GO:0006473),0.46202786044300503,0.0
2299,regulation of cell shape (GO:0008360),0.46202786044300503,0.0
2300,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.46182346069125396,0.0
2301,organophosphate catabolic process (GO:0046434),0.46182346069125396,0.0
2302,ATP metabolic process (GO:0046034),0.46159487424418594,0.0
2303,regulation of microtubule cytoskeleton organization (GO:0070507),0.46159487424418594,0.0
2304,cell cycle checkpoint signaling (GO:0000075),0.46159487424418594,0.0
2305,regulation of axonogenesis (GO:0050770),0.46134245201142193,0.0
2306,membrane fusion (GO:0061025),0.46134245201142193,0.0
2307,aerobic respiration (GO:0009060),0.4610665427413274,0.0
2308,sphingolipid metabolic process (GO:0006665),0.46076749323288435,0.0
2309,spindle organization (GO:0007051),0.46076749323288435,0.0
2310,regulation of macroautophagy (GO:0016241),0.46076749323288435,0.0
2311,sensory perception of sound (GO:0007605),0.46076749323288435,0.0
2312,response to transforming growth factor beta (GO:0071559),0.4604456482631182,0.0
2313,transport along microtubule (GO:0010970),0.4604456482631182,0.0
2314,vacuolar transport (GO:0007034),0.46010135027607413,0.0
2315,RNA catabolic process (GO:0006401),0.46010135027607413,0.0
2316,lipid homeostasis (GO:0055088),0.46010135027607413,0.0
2317,regulation of tumor necrosis factor production (GO:0032680),0.4597349397568468,0.0
2318,negative regulation of binding (GO:0051100),0.4597349397568468,0.0
2319,intrinsic apoptotic signaling pathway (GO:0097193),0.4597349397568468,0.0
2320,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.45934675477411796,0.0
2321,organic hydroxy compound transport (GO:0015850),0.45934675477411796,0.0
2322,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.45850640293120587,0.0
2323,positive regulation of angiogenesis (GO:0045766),0.4580549009875705,0.0
2324,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.4580549009875705,0.0
2325,response to reactive oxygen species (GO:0000302),0.4580549009875705,0.0
2326,electron transport chain (GO:0022900),0.4580549009875705,0.0
2327,positive regulation of vasculature development (GO:1904018),0.4580549009875705,0.0
2328,regulation of cell projection organization (GO:0031344),0.4578854648789147,0.672550087108014
2329,regulation of protein kinase activity (GO:0045859),0.4576689840793374,0.6604683490162533
2330,positive regulation of response to DNA damage stimulus (GO:2001022),0.4575829543621377,0.0
2331,establishment of vesicle localization (GO:0051650),0.4575829543621377,0.0
2332,RNA transport (GO:0050658),0.4575829543621377,0.0
2333,nucleic acid transport (GO:0050657),0.4575829543621377,0.0
2334,regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.4575829543621377,0.0
2335,protein modification by small protein removal (GO:0070646),0.45709088958755983,0.0
2336,establishment of RNA localization (GO:0051236),0.4565790306813752,0.0
2337,intracellular protein transport (GO:0006886),0.4563920861162871,0.6469103477167993
2338,protein ubiquitination (GO:0016567),0.4561224588501458,0.6450187969924813
2339,receptor-mediated endocytosis (GO:0006898),0.45604769955988156,0.0
2340,cellular modified amino acid metabolic process (GO:0006575),0.45549721505063023,0.0
2341,cellular carbohydrate metabolic process (GO:0044262),0.45549721505063023,0.0
2342,negative regulation of cellular component organization (GO:0051129),0.4551863461685871,0.6394099378881988
2343,mitotic cell cycle phase transition (GO:0044772),0.45492789394388994,0.0
2344,mitotic nuclear division (GO:0140014),0.45492789394388994,0.0
2345,meiotic nuclear division (GO:0140013),0.45492789394388994,0.0
2346,regulation of lipid biosynthetic process (GO:0046890),0.45492789394388994,0.0
2347,positive regulation of cellular amide metabolic process (GO:0034250),0.45492789394388994,0.0
2348,carbohydrate derivative catabolic process (GO:1901136),0.4537339958812939,0.0
2349,maintenance of location (GO:0051235),0.4531100393513805,0.0
2350,regulation of protein localization to membrane (GO:1905475),0.4531100393513805,0.0
2351,positive regulation of supramolecular fiber organization (GO:1902905),0.4531100393513805,0.0
2352,cellular response to starvation (GO:0009267),0.4518096432462131,0.0
2353,vacuole organization (GO:0007033),0.4511338085066807,0.0
2354,vesicle localization (GO:0051648),0.4511338085066807,0.0
2355,RNA modification (GO:0009451),0.4511338085066807,0.0
2356,lipid modification (GO:0030258),0.4504412815091341,0.0
2357,regulation of RNA splicing (GO:0043484),0.44973235796214595,0.0
2358,cellular response to radiation (GO:0071478),0.44900733100321333,0.0
2359,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.44900733100321333,0.0
2360,cell cycle phase transition (GO:0044770),0.4482664910021917,0.0
2361,protein dephosphorylation (GO:0006470),0.4482664910021917,0.0
2362,cellular response to xenobiotic stimulus (GO:0071466),0.4482664910021917,0.0
2363,DNA-templated transcription elongation (GO:0006354),0.446738520192993,0.0
2364,peptidyl-serine phosphorylation (GO:0018105),0.4459519565023986,0.0
2365,purine nucleoside triphosphate metabolic process (GO:0009144),0.44515071441112697,0.0
2366,negative regulation of cell growth (GO:0030308),0.4443350704602188,0.0
2367,ribonucleoside triphosphate metabolic process (GO:0009199),0.443505298917078,0.0
2368,macroautophagy (GO:0016236),0.443505298917078,0.0
2369,positive regulation of response to biotic stimulus (GO:0002833),0.443505298917078,0.0
2370,meiotic cell cycle process (GO:1903046),0.4426616710235065,0.0
2371,cellular respiration (GO:0045333),0.4426616710235065,0.0
2372,regulation of stress-activated MAPK cascade (GO:0032872),0.4426616710235065,0.0
2373,RNA localization (GO:0006403),0.4426616710235065,0.0
2374,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.4426616710235065,0.0
2375,regulation of cell size (GO:0008361),0.4426616710235065,0.0
2376,spermatid development (GO:0007286),0.44180445524177187,0.0
2377,negative regulation of cell projection organization (GO:0031345),0.44180445524177187,0.0
2378,regulation of cell cycle G1/S phase transition (GO:1902806),0.44093391743152904,0.0
2379,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.4400503206413508,0.0
2380,fertilization (GO:0009566),0.4400503206413508,0.0
2381,cellular response to lipopolysaccharide (GO:0071222),0.439153925106439,0.0
2382,cell-substrate adhesion (GO:0031589),0.439153925106439,0.0
2383,regulation of synaptic plasticity (GO:0048167),0.439153925106439,0.0
2384,positive regulation of cytoskeleton organization (GO:0051495),0.43824498846231397,0.0
2385,protein acylation (GO:0043543),0.43824498846231397,0.0
2386,tRNA metabolic process (GO:0006399),0.43732376528415373,0.0
2387,calcium ion transmembrane transport (GO:0070588),0.43732376528415373,0.0
2388,purine ribonucleotide biosynthetic process (GO:0009152),0.4363905078332352,0.0
2389,positive regulation of protein phosphorylation (GO:0001934),0.4359118907099368,1.1796600458365163
2390,alpha-amino acid metabolic process (GO:1901605),0.43544546527526096,0.0
2391,spermatid differentiation (GO:0048515),0.43544546527526096,0.0
2392,cytoskeleton-dependent intracellular transport (GO:0030705),0.43448888414434167,0.0
2393,regulation of Ras protein signal transduction (GO:0046578),0.43352100828268775,0.0
2394,epidermal cell differentiation (GO:0009913),0.4325420786517459,0.0
2395,regulation of protein binding (GO:0043393),0.4325420786517459,0.0
2396,ribonucleoprotein complex assembly (GO:0022618),0.4325420786517459,0.0
2397,protein localization to plasma membrane (GO:0072659),0.4325420786517459,0.0
2398,immune system development (GO:0002520),0.4317593082158838,1.165635025476505
2399,double-strand break repair (GO:0006302),0.4305520091181152,0.0
2400,microtubule-based transport (GO:0099111),0.4305520091181152,0.0
2401,cellular response to molecule of bacterial origin (GO:0071219),0.4295413375704748,0.0
2402,purine nucleotide biosynthetic process (GO:0006164),0.42852054947474766,0.0
2403,membrane lipid metabolic process (GO:0006643),0.4274898722357567,0.0
2404,peptidyl-serine modification (GO:0018209),0.4274898722357567,0.0
2405,negative regulation of protein kinase activity (GO:0006469),0.42644953069907376,0.0
2406,nucleoside triphosphate metabolic process (GO:0009141),0.42644953069907376,0.0
2407,response to ketone (GO:1901654),0.42539974705007805,1.4278085991678224
2408,respiratory system development (GO:0060541),0.42539974705007805,1.4278085991678224
2409,regulation of reproductive process (GO:2000241),0.4221959249155863,1.4073137388926864
2410,hormone metabolic process (GO:0042445),0.4221959249155863,1.4073137388926864
2411,regulation of biological quality (GO:0065008),0.4186287614147657,1.0798846109017446
2412,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4132898408606676,1.3554312047399606
2413,regulation of exocytosis (GO:0017157),0.4132898408606676,1.3554312047399606
2414,response to mechanical stimulus (GO:0009612),0.41214312289415,1.3492136304062912
2415,cellular response to organic substance (GO:0071310),0.39998767249494954,1.088827386828374
2416,regulation of epithelial cell migration (GO:0010632),0.3991207050366089,1.2844042420461634
2417,response to organic cyclic compound (GO:0014070),0.398266968341109,1.171160409556314
2418,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.395457303302056,1.2677955665024632
2419,regulation of leukocyte migration (GO:0002685),0.395457303302056,1.2677955665024632
2420,exocytosis (GO:0006887),0.3892655505114004,1.2410488245931286
2421,positive regulation of transport (GO:0051050),0.3846106919183363,1.1201849836779108
2422,carboxylic acid transport (GO:0046942),0.37917550352603935,1.200524781341108
2423,nucleocytoplasmic transport (GO:0006913),0.37534559010399426,1.1860023041474654
2424,nuclear transport (GO:0051169),0.37534559010399426,1.1860023041474654
2425,viral process (GO:0016032),0.37149583250154106,1.1718269778030734
2426,defense response to virus (GO:0051607),0.36891989129519037,1.1625635234330887
2427,defense response to symbiont (GO:0140546),0.36762943474636356,1.157986501687289
2428,positive regulation of protein modification process (GO:0031401),0.36655010547681355,1.1545773166970419
2429,regulation of canonical Wnt signaling pathway (GO:0060828),0.3663374698079696,1.1534453781512604
2430,homeostasis of number of cells (GO:0048872),0.3637494517373659,1.1444691495275152
2431,steroid metabolic process (GO:0008202),0.35856002007423404,1.1269293924466337
2432,regulation of calcium ion transport (GO:0051924),0.35465941968708536,1.1141233766233767
2433,cellular component organization (GO:0016043),0.35389682802786193,0.9319663226507333
2434,small GTPase mediated signal transduction (GO:0007264),0.3468474414213356,1.0893650793650793
2435,divalent inorganic cation homeostasis (GO:0072507),0.3468474414213356,1.0893650793650793
2436,cell death (GO:0008219),0.34581468916514146,0.7963769984528107
2437,organic acid transport (GO:0015849),0.34424287796573677,1.0813550420168068
2438,negative regulation of molecular function (GO:0044092),0.3429479768078999,0.7672919254658385
2439,cell projection organization (GO:0030030),0.3410625806245106,1.140033222591362
2440,learning or memory (GO:0007611),0.34033781186006445,1.0695584415584416
2441,regulation of actin filament organization (GO:0110053),0.339036916875692,1.0656832298136645
2442,sex differentiation (GO:0007548),0.33124517807541143,1.0430091185410333
2443,positive regulation of secretion by cell (GO:1903532),0.32865484484582064,1.0356639839034205
2444,negative regulation of cytokine production (GO:0001818),0.3260688766203319,1.0284215784215784
2445,glycerophospholipid metabolic process (GO:0006650),0.3195824188802201,0.4985230024213075
2446,synapse organization (GO:0050808),0.3194082566016552,0.48858566682486954
2447,regulation of mRNA metabolic process (GO:1903311),0.3194082566016552,0.48858566682486954
2448,autophagy (GO:0006914),0.31928241482110287,0.4853606789250353
2449,anatomical structure homeostasis (GO:0060249),0.31928241482110287,0.4853606789250353
2450,cellular response to peptide (GO:1901653),0.31928241482110287,0.4853606789250353
2451,process utilizing autophagic mechanism (GO:0061919),0.31928241482110287,0.4853606789250353
2452,response to lipopolysaccharide (GO:0032496),0.3181664864759625,0.46985394796896396
2453,response to oxygen levels (GO:0070482),0.3171251320734791,0.46101656963725934
2454,cilium assembly (GO:0060271),0.3165051426245525,0.45672138420585623
2455,cellular response to external stimulus (GO:0071496),0.31582116608252747,0.45250549450549454
2456,fatty acid metabolic process (GO:0006631),0.3150748683329159,0.448366724738676
2457,response to molecule of bacterial origin (GO:0002237),0.3142679131643581,0.44430297798877855
2458,lipid transport (GO:0006869),0.3136970643749385,0.44163449163449164
2459,regulation of protein stability (GO:0031647),0.3136970643749385,0.44163449163449164
2460,regulation of intracellular transport (GO:0032386),0.3108168781809264,0.43001253132832085
2461,negative regulation of organelle organization (GO:0010639),0.3097486955631131,0.4262732919254658
2462,regulation of autophagy (GO:0010506),0.3097486955631131,0.4262732919254658
2463,negative regulation of proteolysis (GO:0045861),0.3097486955631131,0.4262732919254658
2464,regulation of lipid metabolic process (GO:0019216),0.30938114391763555,0.42504128819157727
2465,glycoprotein metabolic process (GO:0009100),0.30938114391763555,0.42504128819157727
2466,positive regulation of cell cycle (GO:0045787),0.306653529540498,0.41661270740590856
2467,cilium organization (GO:0044782),0.30582624022399485,0.4142655935613682
2468,response to virus (GO:0009615),0.3041107371976435,1.2358343337334934
2469,reproductive process (GO:0022414),0.30393238708144477,0.8187294959737548
2470,reproduction (GO:0000003),0.3031399929622526,0.813071379208214
2471,negative regulation of phosphorylation (GO:0042326),0.3004488778413657,1.208747553816047
2472,leukocyte differentiation (GO:0002521),0.28145059475425477,1.102982142857143
2473,localization (GO:0051179),0.2750079551919054,0.9340482447906889
2474,cellular cation homeostasis (GO:0030003),0.27470863978933124,1.0734619395203338
2475,regulation of transport (GO:0051049),0.2729260140042144,1.0825796796634848
2476,negative regulation of phosphate metabolic process (GO:0045936),0.26770320714570006,1.0454807041299932
2477,positive regulation of protein kinase activity (GO:0045860),0.26770320714570006,1.0454807041299932
2478,negative regulation of phosphorus metabolic process (GO:0010563),0.26705519029064184,1.0430091185410335
2479,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.2664054850780718,1.040549191374663
2480,cellular ion homeostasis (GO:0006873),0.26379054753675807,1.030824432576769
2481,regulation of trans-synaptic signaling (GO:0099177),0.2577793179041772,0.6699967458509599
2482,response to peptide (GO:1901652),0.2577716157119834,0.6609630818619582
2483,regulation of neuron projection development (GO:0010975),0.2577716157119834,0.6609630818619582
2484,small molecule biosynthetic process (GO:0044283),0.25767556349684806,0.6550747693286668
2485,response to radiation (GO:0009314),0.25767556349684806,0.6550747693286668
2486,positive regulation of protein localization (GO:1903829),0.25687906211928707,0.6366419294990724
2487,cation homeostasis (GO:0055080),0.24876232921509533,1.1625635234330887
2488,regulation of anatomical structure size (GO:0090066),0.2474467603471146,1.1511881464914733
2489,cellular response to organic cyclic compound (GO:0071407),0.24662184098976725,1.1444691495275152
2490,positive regulation of programmed cell death (GO:0043068),0.24605747103764944,1.140033222591362
2491,inorganic ion homeostasis (GO:0098771),0.2445974593043339,1.1290924047162052
2492,response to inorganic substance (GO:0010035),0.2408226657937519,1.1036719378182793
2493,ion homeostasis (GO:0050801),0.24049176328712116,1.101605136436597
2494,actin cytoskeleton organization (GO:0030036),0.23525254716002647,1.0715066354410616
2495,sensory perception of chemical stimulus (GO:0007606),0.23451724682147454,1.067617319159969
2496,detection of stimulus involved in sensory perception (GO:0050906),0.231110974786969,1.0504591836734694
2497,positive regulation of cell death (GO:0010942),0.22177088988709998,1.009017397696643
2498,positive regulation of transferase activity (GO:0051347),0.22175285854653953,0.7477845036319613
2499,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.21814333498597258,0.6893638392857143
2500,cellular homeostasis (GO:0019725),0.2180060549406469,0.6882883886784044
2501,hemopoiesis (GO:0030097),0.2146007783689248,1.1141233766233767
2502,tube morphogenesis (GO:0035239),0.21202574479858152,1.092602419868393
2503,protein localization to organelle (GO:0033365),0.20719574940021723,1.059540963359407
2504,inorganic ion transmembrane transport (GO:0098660),0.2054189446489535,1.048960668432851
2505,cell morphogenesis (GO:0000902),0.2021982813790036,1.0313063514325786
2506,protein modification by small protein conjugation (GO:0032446),0.19728422720830074,0.7812179852020489
2507,regulation of cellular catabolic process (GO:0031329),0.195095585974966,0.7484187568157035
2508,positive regulation of phosphorylation (GO:0042327),0.18958392327682164,1.0682635766170876
2509,response to lipid (GO:0033993),0.18660219972679462,1.0467208947635993
2510,cation transport (GO:0006812),0.1844708881412477,1.0332385413181668
2511,ion transmembrane transport (GO:0034220),0.17995240885772595,0.8252765752765753
2512,regulation of transferase activity (GO:0051338),0.17921256369369737,0.8036299765807963
2513,chemical homeostasis (GO:0048878),0.17916318549815682,0.8027526512788521
2514,regulation of anatomical structure morphogenesis (GO:0022603),0.17871641459545462,0.7958024118738404
2515,regulation of cellular localization (GO:0060341),0.17517587974858617,1.0701143451143451
2516,sensory perception (GO:0007600),0.17047396082064148,1.0325476429287863
2517,programmed cell death (GO:0012501),0.16533748241290874,0.8215881883479649
2518,regulation of protein phosphorylation (GO:0001932),0.16300954320835465,1.0647188106011636
2519,plasma membrane bounded cell projection organization (GO:0120036),0.16207983347263938,1.0551697629724535
2520,positive regulation of gene expression (GO:0010628),0.1579496783860317,1.02216705969964
2521,regulation of phosphorylation (GO:0042325),0.1531577124260307,1.0605597527472528
2522,intracellular signal transduction (GO:0035556),0.13899420838472695,0.8759619930036872
2523,positive regulation of protein metabolic process (GO:0051247),0.13887414424736833,0.8736492220650636
2524,regulation of protein modification process (GO:0031399),0.13647114674159938,1.0350013709898545
2525,positive regulation of molecular function (GO:0044093),0.13452313340830052,1.0174258760107815
2526,regulation of signal transduction (GO:0009966),0.10091094294887651,0.9348348707164363
2527,regulation of signaling (GO:0023051),0.09536887355846663,0.9569400430979844
2528,regulation of cell communication (GO:0010646),0.09534546428634663,0.9603485561633379
2529,response to stress (GO:0006950),0.09452399220407487,1.018333195944275
2530,cellular process (GO:0009987),0.07886283739862587,0.9971122801686482
2531,regulation of response to stress (GO:0080134),3.658342518478561e-10,0.9640047861824991
2532,positive regulation of cell communication (GO:0010647),3.0298974445102577e-10,0.9538367587601078
2533,regulation of phosphorus metabolic process (GO:0051174),2.974039903678549e-10,0.9420488052872393
2534,positive regulation of signaling (GO:0023056),2.721048942093075e-10,0.9510330057949106
2535,homeostatic process (GO:0042592),2.548757871748199e-10,0.9294793338683789
2536,regulation of phosphate metabolic process (GO:0019220),2.428398593618633e-10,0.9427197802197801
2537,transmembrane transport (GO:0055085),2.1875778968455602e-10,0.9604198250728863
2538,ion transport (GO:0006811),2.135945864851181e-10,0.9787972426907534
2539,regulation of cysteine-type endopeptidase activity (GO:2000116),1.6822299110679754e-10,0.6153317393903168
2540,anion transmembrane transport (GO:0098656),1.654721915182248e-10,0.597822299651568
2541,phospholipid biosynthetic process (GO:0008654),1.654721915182248e-10,0.597822299651568
2542,negative regulation of growth (GO:0045926),1.6149948046855914e-10,0.5954019664545981
2543,tissue homeostasis (GO:0001894),1.5916479246970057e-10,0.600262390670554
2544,organic acid biosynthetic process (GO:0016053),1.587112663640691e-10,0.5367309697601668
2545,negative regulation of cellular catabolic process (GO:0031330),1.5516565811206977e-10,0.6077036599763873
2546,actin filament organization (GO:0007015),1.5494405759632024e-10,0.5347792207792208
2547,negative regulation of transferase activity (GO:0051348),1.5494405759632024e-10,0.5347792207792208
2548,cytoskeleton organization (GO:0007010),1.5334300497226149e-10,0.9488018433179723
2549,positive regulation of catalytic activity (GO:0043085),1.5272294541291347e-10,0.9853553481694185
2550,nucleic acid phosphodiester bond hydrolysis (GO:0090305),1.491685663990395e-10,0.570016611295681
2551,regulation of innate immune response (GO:0045088),1.3964540635933708e-10,0.6127678571428572
2552,visual perception (GO:0007601),1.270945571088807e-10,0.6654492566257272
2553,endosomal transport (GO:0016197),1.2435552588448362e-10,0.6231537530266344
2554,response to hypoxia (GO:0001666),1.2346768053158087e-10,0.5309179989685405
2555,glycoprotein biosynthetic process (GO:0009101),1.2346768053158087e-10,0.5309179989685405
2556,myeloid cell differentiation (GO:0030099),1.22231003104299e-10,0.5570616883116883
2557,extracellular structure organization (GO:0043062),1.1967982161570425e-10,0.5233604473817997
2558,regulation of protein modification by small protein conjugation or removal (GO:1903320),1.1772605113673698e-10,0.5812817617165443
2559,external encapsulating structure organization (GO:0045229),1.165485485966816e-10,0.5196617869762746
2560,cellular divalent inorganic cation homeostasis (GO:0072503),1.1540746137183953e-10,0.6311771919068057
2561,sensory perception of light stimulus (GO:0050953),1.1325029803474624e-10,0.6565369897959185
2562,calcium ion homeostasis (GO:0055074),1.1325029803474624e-10,0.6565369897959185
2563,carboxylic acid catabolic process (GO:0046395),1.1325029803474624e-10,0.6565369897959185
2564,cellular response to peptide hormone stimulus (GO:0071375),1.1252598853339901e-10,0.6102252519264968
2565,regulation of leukocyte mediated immunity (GO:0002703),1.1252598853339901e-10,0.6102252519264968
2566,establishment or maintenance of cell polarity (GO:0007163),1.1246803489150707e-10,0.7003061224489796
2567,cellular response to extracellular stimulus (GO:0031668),1.060976861978142e-10,0.5744698660714286
2568,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),1.059781151780494e-10,0.5835884353741496
2569,glycerolipid biosynthetic process (GO:0045017),1.0355161173517445e-10,0.6536190476190477
2570,extracellular matrix organization (GO:0030198),1.032414154220621e-10,0.5252295918367347
2571,chromosome organization (GO:0051276),1.011499772880595e-10,0.9936776061776063
2572,blood vessel development (GO:0001568),9.962797254344807e-11,0.8650840336134453
2573,sensory perception of mechanical stimulus (GO:0050954),9.893297292996373e-11,0.8125098658247829
2574,response to carbohydrate (GO:0009743),9.893297292996373e-11,0.8125098658247829
2575,positive regulation of binding (GO:0051099),9.893297292996373e-11,0.8125098658247829
2576,regulation of mRNA catabolic process (GO:0061013),9.893297292996373e-11,0.8125098658247829
2577,response to organonitrogen compound (GO:0010243),9.672074253087922e-11,0.9115554899645809
2578,negative regulation of neuron death (GO:1901215),9.658740474560886e-11,0.668474025974026
2579,MAPK cascade (GO:0000165),9.658740474560886e-11,0.668474025974026
2580,Ras protein signal transduction (GO:0007265),9.221834407638902e-11,0.7580633284241531
2581,positive regulation of protein-containing complex assembly (GO:0031334),9.221834407638902e-11,0.7580633284241531
2582,regulation of proteasomal protein catabolic process (GO:0061136),9.221834407638902e-11,0.7580633284241531
2583,regulation of endocytosis (GO:0030100),9.173684035056481e-11,0.7070398351648352
2584,sodium ion transport (GO:0006814),9.0153107205793e-11,0.790668202764977
2585,protein autophosphorylation (GO:0046777),8.886369418487792e-11,0.7781179138321995
2586,positive regulation of DNA-binding transcription factor activity (GO:0051091),8.498834969478448e-11,0.5487473347547974
2587,DNA replication (GO:0006260),8.400835583086505e-11,0.7173867595818816
2588,glycerophospholipid biosynthetic process (GO:0046474),8.400835583086505e-11,0.7173867595818816
2589,rhythmic process (GO:0048511),8.383083116921258e-11,0.5406775210084034
2590,carboxylic acid biosynthetic process (GO:0046394),8.383083116921258e-11,0.5406775210084034
2591,regulation of proteolysis involved in protein catabolic process (GO:1903050),8.211686886365405e-11,0.6450187969924812
2592,organic acid catabolic process (GO:0016054),8.211686886365405e-11,0.6450187969924812
2593,regulation of mRNA stability (GO:0043488),8.160927489675388e-11,0.9022348816827345
2594,protein stabilization (GO:0050821),8.152578612529526e-11,0.6746068152031456
2595,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),8.097167381365982e-11,0.7139042995839112
2596,detection of chemical stimulus involved in sensory perception of smell (GO:0050911),7.859646267458726e-11,0.9959206707513705
2597,import into cell (GO:0098657),7.823464099083355e-11,0.7659598214285714
2598,negative regulation of cellular amide metabolic process (GO:0034249),7.823464099083355e-11,0.7659598214285714
2599,RNA phosphodiester bond hydrolysis (GO:0090501),7.708977900775117e-11,0.9078042328042328
2600,negative regulation of supramolecular fiber organization (GO:1902904),7.708977900775117e-11,0.9078042328042328
2601,positive regulation of intracellular signal transduction (GO:1902533),7.635325705315834e-11,0.8832689832689833
2602,actin filament-based process (GO:0030029),7.608491614808599e-11,0.9627776478840309
2603,carbohydrate homeostasis (GO:0033500),7.562439563743654e-11,0.728041018387553
2604,cellular component biogenesis (GO:0044085),7.494860288229633e-11,1.005376810807878
2605,cardiac muscle tissue development (GO:0048738),7.2769901218611e-11,0.8080455259026686
2606,peptidyl-tyrosine modification (GO:0018212),7.033906790602028e-11,0.8650840336134454
2607,negative regulation of translation (GO:0017148),7.033906790602028e-11,0.8650840336134454
2608,cilium movement (GO:0003341),7.033906790602028e-11,0.8650840336134454
2609,monosaccharide metabolic process (GO:0005996),6.971379029850762e-11,0.8355925324675325
2610,regulation of signaling receptor activity (GO:0010469),6.971379029850762e-11,0.8355925324675325
2611,negative regulation of kinase activity (GO:0033673),6.895617410645087e-11,0.6366419294990724
2612,development of primary sexual characteristics (GO:0045137),6.895617410645087e-11,0.6366419294990724
2613,regulation of intracellular protein transport (GO:0033157),6.895617410645087e-11,0.6366419294990724
2614,second-messenger-mediated signaling (GO:0019932),6.895617410645087e-11,0.6366419294990724
2615,positive regulation of signal transduction (GO:0009967),6.782707729032987e-11,0.9624626028421839
2616,modulation of chemical synaptic transmission (GO:0050804),6.77261580173846e-11,0.6715264187866927
2617,cellular lipid catabolic process (GO:0044242),6.756650794643271e-11,0.7699700822737471
2618,B cell activation (GO:0042113),6.756650794643271e-11,0.7699700822737471
2619,cell chemotaxis (GO:0060326),6.642564276625146e-11,0.6969871360866622
2620,regulation of protein ubiquitination (GO:0031396),6.642564276625146e-11,0.6969871360866622
2621,response to decreased oxygen levels (GO:0036293),6.399858421196013e-11,0.5071182266009853
2622,monocarboxylic acid biosynthetic process (GO:0072330),6.216327452983652e-11,0.8859294320137694
2623,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),6.104428074324788e-11,0.7740225563909774
2624,muscle contraction (GO:0006936),6.093370252998847e-11,0.6394099378881988
2625,positive regulation of protein catabolic process (GO:0045732),6.041411815443237e-11,0.6840199335548173
2626,peptidyl-tyrosine phosphorylation (GO:0018108),5.936218183853704e-11,0.8753826530612245
2627,positive regulation of cell growth (GO:0030307),5.936218183853704e-11,0.8753826530612245
2628,muscle system process (GO:0003012),5.725475649307069e-11,0.5215045592705166
2629,inorganic cation transmembrane transport (GO:0098662),5.7179594394299267e-11,0.9707213578500706
2630,positive regulation of intracellular protein transport (GO:0090316),5.5699889146995345e-11,0.9191517857142858
2631,muscle cell development (GO:0055001),5.5699889146995345e-11,0.9191517857142858
2632,reproductive structure development (GO:0048608),5.338329778368614e-11,0.9804285714285715
2633,response to oxygen-containing compound (GO:1901700),5.240508027663717e-11,0.9481901077645758
2634,positive regulation of endopeptidase activity (GO:0010950),5.1088799858573473e-11,0.8451970443349754
2635,aging (GO:0007568),5.1088799858573473e-11,0.8451970443349754
2636,regulation of actin filament length (GO:0030832),4.9407811176904055e-11,0.9134427684117125
2637,cellular response to nutrient levels (GO:0031669),4.394107300339463e-11,0.6507269279393173
2638,gonad development (GO:0008406),4.394107300339463e-11,0.6507269279393173
2639,detection of chemical stimulus (GO:0009593),4.365130479395477e-11,0.8387696903856598
2640,positive regulation of intracellular transport (GO:0032388),4.311040413633393e-11,0.724454609429979
2641,cell projection assembly (GO:0030031),4.003697373713634e-11,0.6840199335548173
2642,cellular response to abiotic stimulus (GO:0071214),3.958822159056498e-11,0.9022348816827345
2643,negative regulation of catabolic process (GO:0009895),3.958822159056498e-11,0.9022348816827345
2644,cellular response to environmental stimulus (GO:0104004),3.958822159056498e-11,0.9022348816827345
2645,negative regulation of protein modification process (GO:0031400),3.9250158679553295e-11,0.8771229764271514
2646,response to toxic substance (GO:0009636),3.6662339831356297e-11,0.6338977832512316
2647,negative regulation of locomotion (GO:0040013),3.290401284826449e-11,0.8676359039190897
2648,immunoglobulin production (GO:0002377),3.116307212329401e-11,0.896733449477352
2649,regulation of viral process (GO:0050792),3.116307212329401e-11,0.896733449477352
2650,vesicle fusion (GO:0006906),3.097311296377475e-11,0.0
2651,nuclear-transcribed mRNA catabolic process (GO:0000956),3.097311296377475e-11,0.0
2652,tissue remodeling (GO:0048771),3.097311296377475e-11,0.0
2653,negative regulation of angiogenesis (GO:0016525),3.097311296377475e-11,0.0
2654,ribonucleoside triphosphate biosynthetic process (GO:0009201),3.097311296377475e-11,0.0
2655,granulocyte migration (GO:0097530),3.097311296377475e-11,0.0
2656,epithelial cell migration (GO:0010631),3.097311296377475e-11,0.0
2657,positive regulation of kinase activity (GO:0033674),3.016231708886621e-11,0.8841540223303751
2658,non-membrane-bounded organelle assembly (GO:0140694),2.9814595237543183e-11,0.9307866184448463
2659,apoptotic signaling pathway (GO:0097190),2.9814595237543183e-11,0.9307866184448463
2660,regulation of RNA stability (GO:0043487),2.9574453997309634e-11,0.8403673469387756
2661,inorganic anion transport (GO:0015698),2.9574453997309634e-11,0.8403673469387756
2662,positive regulation of peptidase activity (GO:0010952),2.8498647886416618e-11,0.7619911176905995
2663,cellular response to interferon-gamma (GO:0071346),2.6133206710085646e-11,0.0
2664,regulation of sister chromatid segregation (GO:0033045),2.6133206710085646e-11,0.0
2665,DNA conformation change (GO:0071103),2.6133206710085646e-11,0.0
2666,pigmentation (GO:0043473),2.6133206710085646e-11,0.0
2667,anion transport (GO:0006820),2.41904274392452e-11,0.9892216527866752
2668,positive regulation of chromosome organization (GO:2001252),2.3951174377432718e-11,0.0
2669,regulation of TOR signaling (GO:0032006),2.3951174377432718e-11,0.0
2670,cellular chemical homeostasis (GO:0055082),2.3531510074114447e-11,0.8262038523274478
2671,regulation of growth (GO:0040008),2.2739254923723605e-11,0.9382091592617908
2672,ameboidal-type cell migration (GO:0001667),2.1285972984457286e-11,0.7316631130063966
2673,regulation of protein polymerization (GO:0032271),2.1285972984457286e-11,0.7316631130063966
2674,glucose homeostasis (GO:0042593),2.1285972984457286e-11,0.7316631130063966
2675,response to temperature stimulus (GO:0009266),2.0543122758665055e-11,0.8262038523274479
2676,regulation of lymphocyte mediated immunity (GO:0002706),2.0543122758665055e-11,0.8262038523274479
2677,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),1.972366714417273e-11,0.8550249169435217
2678,vasculature development (GO:0001944),1.887301426268852e-11,0.8293098818474758
2679,calcium-mediated signaling (GO:0019722),1.8346435482099008e-11,0.936715195632393
2680,quinolinate catabolic process (GO:0034213),1.7408852137786303e-11,0.0
2681,response to silver ion (GO:0010272),1.7408852137786303e-11,0.0
2682,glycolipid translocation (GO:0034203),1.7408852137786303e-11,0.0
2683,positive regulation of tolerance induction to self antigen (GO:0002651),1.7408852137786303e-11,0.0
2684,positive regulation of cell volume (GO:0045795),1.7408852137786303e-11,0.0
2685,regulation of tolerance induction to self antigen (GO:0002649),1.7408852137786303e-11,0.0
2686,positive regulation of central tolerance induction (GO:0002648),1.7408852137786303e-11,0.0
2687,regulation of central tolerance induction (GO:0002646),1.7408852137786303e-11,0.0
2688,negative regulation of tolerance induction (GO:0002644),1.7408852137786303e-11,0.0
2689,negative regulation of T cell antigen processing and presentation (GO:0002626),1.7408852137786303e-11,0.0
2690,regulation of B cell antigen processing and presentation (GO:0002622),1.7408852137786303e-11,0.0
2691,negative regulation of asymmetric cell division (GO:0045769),1.7408852137786303e-11,0.0
2692,negative regulation of macrophage antigen processing and presentation (GO:0002617),1.7408852137786303e-11,0.0
2693,regulation of macrophage antigen processing and presentation (GO:0002616),1.7408852137786303e-11,0.0
2694,negative regulation of Toll signaling pathway (GO:0045751),1.7408852137786303e-11,0.0
2695,arginine catabolic process to proline (GO:0019493),1.7408852137786303e-11,0.0
2696,positive regulation of hydrogen peroxide catabolic process (GO:1903285),1.7408852137786303e-11,0.0
2697,positive regulation of glutathione peroxidase activity (GO:1903284),1.7408852137786303e-11,0.0
2698,negative regulation of calcium:sodium antiporter activity (GO:1903280),1.7408852137786303e-11,0.0
2699,chemorepulsion of branchiomotor axon (GO:0021793),1.7408852137786303e-11,0.0
2700,"L-alanine catabolic process, by transamination (GO:0019481)",1.7408852137786303e-11,0.0
2701,lateral geniculate nucleus development (GO:0021771),1.7408852137786303e-11,0.0
2702,exon-exon junction complex disassembly (GO:1903259),1.7408852137786303e-11,0.0
2703,ectoderm and mesoderm interaction (GO:0007499),1.7408852137786303e-11,0.0
2704,visceral mesoderm-endoderm interaction involved in midgut development (GO:0007495),1.7408852137786303e-11,0.0
2705,nucleus accumbens development (GO:0021768),1.7408852137786303e-11,0.0
2706,mammillary body development (GO:0021767),1.7408852137786303e-11,0.0
2707,negative regulation of citrulline biosynthetic process (GO:1903249),1.7408852137786303e-11,0.0
2708,regulation of citrulline biosynthetic process (GO:1903248),1.7408852137786303e-11,0.0
2709,L-cysteine catabolic process to taurine (GO:0019452),1.7408852137786303e-11,0.0
2710,putamen development (GO:0021758),1.7408852137786303e-11,0.0
2711,caudate nucleus development (GO:0021757),1.7408852137786303e-11,0.0
2712,pronephric duct morphogenesis (GO:0039023),1.7408852137786303e-11,0.0
2713,pronephric duct development (GO:0039022),1.7408852137786303e-11,0.0
2714,L-cysteine catabolic process to hypotaurine (GO:0019449),1.7408852137786303e-11,0.0
2715,tryptophan catabolic process to acetyl-CoA (GO:0019442),1.7408852137786303e-11,0.0
2716,positive regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903235),1.7408852137786303e-11,0.0
2717,tryptophan catabolic process to indole-3-acetate (GO:0019440),1.7408852137786303e-11,0.0
2718,hypoglossal nucleus development (GO:0021743),1.7408852137786303e-11,0.0
2719,abducens nucleus development (GO:0021742),1.7408852137786303e-11,0.0
2720,pronephric nephron tubule morphogenesis (GO:0039008),1.7408852137786303e-11,0.0
2721,pronephric nephron morphogenesis (GO:0039007),1.7408852137786303e-11,0.0
2722,midbrain-hindbrain boundary maturation (GO:0021732),1.7408852137786303e-11,0.0
2723,renal water retention (GO:0003092),1.7408852137786303e-11,0.0
2724,medullary reticular formation development (GO:0021723),1.7408852137786303e-11,0.0
2725,acetate biosynthetic process (GO:0019413),1.7408852137786303e-11,0.0
2726,positive regulation of L-dopa decarboxylase activity (GO:1903200),1.7408852137786303e-11,0.0
2727,negative regulation of renal output by angiotensin (GO:0003083),1.7408852137786303e-11,0.0
2728,hexitol catabolic process (GO:0019407),1.7408852137786303e-11,0.0
2729,negative regulation of ATP citrate synthase activity (GO:2000984),1.7408852137786303e-11,0.0
2730,galactitol metabolic process (GO:0019402),1.7408852137786303e-11,0.0
2731,mesenchymal-epithelial cell signaling involved in lung development (GO:0060496),1.7408852137786303e-11,0.0
2732,lateral sprouting involved in lung morphogenesis (GO:0060490),1.7408852137786303e-11,0.0
2733,regulation of systemic arterial blood pressure by neurotransmitter (GO:0003070),1.7408852137786303e-11,0.0
2734,positive regulation of forebrain neuron differentiation (GO:2000979),1.7408852137786303e-11,0.0
2735,locus ceruleus development (GO:0021703),1.7408852137786303e-11,0.0
2736,positive regulation of pro-B cell differentiation (GO:2000975),1.7408852137786303e-11,0.0
2737,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060489),1.7408852137786303e-11,0.0
2738,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060488),1.7408852137786303e-11,0.0
2739,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0003069),1.7408852137786303e-11,0.0
2740,regulation of systemic arterial blood pressure by acetylcholine (GO:0003068),1.7408852137786303e-11,0.0
2741,positive regulation of heart rate by epinephrine (GO:0003065),1.7408852137786303e-11,0.0
2742,protein deglutathionylation (GO:0080058),1.7408852137786303e-11,0.0
2743,positive regulation of cytosolic calcium ion concentration involved in egg activation (GO:0060470),1.7408852137786303e-11,0.0
2744,hormonal regulation of the force of heart contraction (GO:0003058),1.7408852137786303e-11,0.0
2745,response to G1 DNA damage checkpoint signaling (GO:0072432),1.7408852137786303e-11,0.0
2746,activation of meiosis involved in egg activation (GO:0060466),1.7408852137786303e-11,0.0
2747,glial cell fate determination (GO:0007403),1.7408852137786303e-11,0.0
2748,right lung morphogenesis (GO:0060461),1.7408852137786303e-11,0.0
2749,left lung morphogenesis (GO:0060460),1.7408852137786303e-11,0.0
2750,response to mitotic cell cycle checkpoint signaling (GO:0072414),1.7408852137786303e-11,0.0
2751,response to benzoic acid (GO:0080021),1.7408852137786303e-11,0.0
2752,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling (GO:0003029),1.7408852137786303e-11,0.0
2753,positive regulation of choline O-acetyltransferase activity (GO:1902771),1.7408852137786303e-11,0.0
2754,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling (GO:0003027),1.7408852137786303e-11,0.0
2755,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback (GO:0003026),1.7408852137786303e-11,0.0
2756,regulation of choline O-acetyltransferase activity (GO:1902769),1.7408852137786303e-11,0.0
2757,bronchiole morphogenesis (GO:0060436),1.7408852137786303e-11,0.0
2758,lung pattern specification process (GO:0060432),1.7408852137786303e-11,0.0
2759,primary lung bud formation (GO:0060431),1.7408852137786303e-11,0.0
2760,thiocyanate metabolic process (GO:0018969),1.7408852137786303e-11,0.0
2761,lung connective tissue development (GO:0060427),1.7408852137786303e-11,0.0
2762,propylene metabolic process (GO:0018964),1.7408852137786303e-11,0.0
2763,4-nitrophenol metabolic process (GO:0018960),1.7408852137786303e-11,0.0
2764,D-alanine family amino acid metabolic process (GO:0046144),1.7408852137786303e-11,0.0
2765,positive regulation of lens fiber cell differentiation (GO:1902748),1.7408852137786303e-11,0.0
2766,imidazole-containing compound catabolic process (GO:0052805),1.7408852137786303e-11,0.0
2767,toll-like receptor 10 signaling pathway (GO:0034166),1.7408852137786303e-11,0.0
2768,regulation of acetylcholine metabolic process (GO:0060408),1.7408852137786303e-11,0.0
2769,negative regulation of penile erection (GO:0060407),1.7408852137786303e-11,0.0
2770,axonemal microtubule depolymerization (GO:0060404),1.7408852137786303e-11,0.0
2771,pyrimidine deoxyribonucleoside catabolic process (GO:0046127),1.7408852137786303e-11,0.0
2772,negative regulation of toll-like receptor 7 signaling pathway (GO:0034156),1.7408852137786303e-11,0.0
2773,negative regulation of proteoglycan biosynthetic process (GO:1902729),1.7408852137786303e-11,0.0
2774,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation (GO:1902728),1.7408852137786303e-11,0.0
2775,regulation of toll-like receptor 6 signaling pathway (GO:0034151),1.7408852137786303e-11,0.0
2776,toll-like receptor 6 signaling pathway (GO:0034150),1.7408852137786303e-11,0.0
2777,positive regulation of skeletal muscle satellite cell proliferation (GO:1902724),1.7408852137786303e-11,0.0
2778,positive regulation of prolactin secretion (GO:1902722),1.7408852137786303e-11,0.0
2779,positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria (GO:0006965),1.7408852137786303e-11,0.0
2780,positive regulation of antibacterial peptide biosynthetic process (GO:0006963),1.7408852137786303e-11,0.0
2781,xanthine biosynthetic process (GO:0046111),1.7408852137786303e-11,0.0
2782,negative regulation of toll-like receptor 5 signaling pathway (GO:0034148),1.7408852137786303e-11,0.0
2783,regulation of toll-like receptor 5 signaling pathway (GO:0034147),1.7408852137786303e-11,0.0
2784,toll-like receptor 5 signaling pathway (GO:0034146),1.7408852137786303e-11,0.0
2785,protein localization to spindle pole body (GO:0071988),1.7408852137786303e-11,0.0
2786,cell gliding (GO:0071976),1.7408852137786303e-11,0.0
2787,toll-like receptor 1 signaling pathway (GO:0034130),1.7408852137786303e-11,0.0
2788,extracellular exosome assembly (GO:0071971),1.7408852137786303e-11,0.0
2789,benzene metabolic process (GO:0018910),1.7408852137786303e-11,0.0
2790,negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),1.7408852137786303e-11,0.0
2791,"substrate-dependent cell migration, cell attachment to substrate (GO:0006931)",1.7408852137786303e-11,0.0
2792,vitamin E biosynthetic process (GO:0010189),1.7408852137786303e-11,0.0
2793,positive regulation of cellular defense response (GO:0010186),1.7408852137786303e-11,0.0
2794,regulation of cellular defense response (GO:0010185),1.7408852137786303e-11,0.0
2795,basophil chemotaxis (GO:0002575),1.7408852137786303e-11,0.0
2796,thrombocyte differentiation (GO:0002574),1.7408852137786303e-11,0.0
2797,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA (GO:0071951),1.7408852137786303e-11,0.0
2798,formation of animal organ boundary (GO:0010160),1.7408852137786303e-11,0.0
2799,vitamin A import into cell (GO:0071939),1.7408852137786303e-11,0.0
2800,vitamin A transport (GO:0071938),1.7408852137786303e-11,0.0
2801,activation of plasma proteins involved in acute inflammatory response (GO:0002541),1.7408852137786303e-11,0.0
2802,nitric oxide production involved in inflammatory response (GO:0002537),1.7408852137786303e-11,0.0
2803,respiratory burst involved in inflammatory response (GO:0002536),1.7408852137786303e-11,0.0
2804,G-quadruplex DNA formation (GO:0071919),1.7408852137786303e-11,0.0
2805,synchronous neurotransmitter secretion (GO:0071911),1.7408852137786303e-11,0.0
2806,determination of stomach left/right asymmetry (GO:0071909),1.7408852137786303e-11,0.0
2807,determination of intestine left/right asymmetry (GO:0071908),1.7408852137786303e-11,0.0
2808,positive regulation of neutrophil differentiation (GO:0045660),1.7408852137786303e-11,0.0
2809,lymphocyte chemotaxis across high endothelial venule (GO:0002518),1.7408852137786303e-11,0.0
2810,B cell tolerance induction (GO:0002514),1.7408852137786303e-11,0.0
2811,arginine catabolic process to proline via ornithine (GO:0010121),1.7408852137786303e-11,0.0
2812,central tolerance induction to self antigen (GO:0002509),1.7408852137786303e-11,0.0
2813,antigen processing and presentation of polysaccharide antigen via MHC class II (GO:0002505),1.7408852137786303e-11,0.0
2814,regulation of L-dopa decarboxylase activity (GO:1903198),1.7408852137786303e-11,0.0
2815,positive regulation of L-dopa biosynthetic process (GO:1903197),1.7408852137786303e-11,0.0
2816,regulation of L-dopa biosynthetic process (GO:1903195),1.7408852137786303e-11,0.0
2817,glyoxal catabolic process (GO:1903190),1.7408852137786303e-11,0.0
2818,glyoxal metabolic process (GO:1903189),1.7408852137786303e-11,0.0
2819,regulation of SUMO transferase activity (GO:1903182),1.7408852137786303e-11,0.0
2820,negative regulation by symbiont of host apoptotic process (GO:0033668),1.7408852137786303e-11,0.0
2821,positive regulation of tyrosine 3-monooxygenase activity (GO:1903178),1.7408852137786303e-11,0.0
2822,regulation of tyrosine 3-monooxygenase activity (GO:1903176),1.7408852137786303e-11,0.0
2823,cerebellar molecular layer formation (GO:0021688),1.7408852137786303e-11,0.0
2824,cerebellar granular layer structural organization (GO:0021685),1.7408852137786303e-11,0.0
2825,positive regulation of pyrroline-5-carboxylate reductase activity (GO:1903168),1.7408852137786303e-11,0.0
2826,regulation of pyrroline-5-carboxylate reductase activity (GO:1903167),1.7408852137786303e-11,0.0
2827,negative regulation of hemocyte differentiation (GO:0045611),1.7408852137786303e-11,0.0
2828,regulation of hemocyte differentiation (GO:0045610),1.7408852137786303e-11,0.0
2829,pyridine nucleotide salvage (GO:0019365),1.7408852137786303e-11,0.0
2830,lipoxin B4 biosynthetic process (GO:2001306),1.7408852137786303e-11,0.0
2831,rhombomere 5 formation (GO:0021666),1.7408852137786303e-11,0.0
2832,rhombomere 5 structural organization (GO:0021665),1.7408852137786303e-11,0.0
2833,rhombomere 5 morphogenesis (GO:0021664),1.7408852137786303e-11,0.0
2834,rhombomere 3 formation (GO:0021660),1.7408852137786303e-11,0.0
2835,posterior compartment specification (GO:0007388),1.7408852137786303e-11,0.0
2836,anterior compartment pattern formation (GO:0007387),1.7408852137786303e-11,0.0
2837,rhombomere 3 structural organization (GO:0021659),1.7408852137786303e-11,0.0
2838,dibenzo-p-dioxin catabolic process (GO:0019341),1.7408852137786303e-11,0.0
2839,ventral midline determination (GO:0007371),1.7408852137786303e-11,0.0
2840,trochlear nerve formation (GO:0021642),1.7408852137786303e-11,0.0
2841,negative regulation of centriole-centriole cohesion (GO:1903126),1.7408852137786303e-11,0.0
2842,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation (GO:1903125),1.7408852137786303e-11,0.0
2843,negative regulation of TRAIL-activated apoptotic signaling pathway (GO:1903122),1.7408852137786303e-11,0.0
2844,oxalate metabolic process (GO:0033609),1.7408852137786303e-11,0.0
2845,chemokine receptor transport within lipid bilayer (GO:0033606),1.7408852137786303e-11,0.0
2846,trochlear nerve morphogenesis (GO:0021639),1.7408852137786303e-11,0.0
2847,flavin adenine dinucleotide catabolic process (GO:0072389),1.7408852137786303e-11,0.0
2848,flavin adenine dinucleotide biosynthetic process (GO:0072388),1.7408852137786303e-11,0.0
2849,protein localization to actin cytoskeleton (GO:1903119),1.7408852137786303e-11,0.0
2850,urate homeostasis (GO:1903118),1.7408852137786303e-11,0.0
2851,minus-end-directed vesicle transport along microtubule (GO:0072382),1.7408852137786303e-11,0.0
2852,olfactory nerve structural organization (GO:0021629),1.7408852137786303e-11,0.0
2853,amylopectin metabolic process (GO:2000896),1.7408852137786303e-11,0.0
2854,cellobiose catabolic process (GO:2000892),1.7408852137786303e-11,0.0
2855,cellobiose metabolic process (GO:2000891),1.7408852137786303e-11,0.0
2856,inositol catabolic process (GO:0019310),1.7408852137786303e-11,0.0
2857,cellularization (GO:0007349),1.7408852137786303e-11,0.0
2858,"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process (GO:1903100)",1.7408852137786303e-11,0.0
2859,pronuclear fusion (GO:0007344),1.7408852137786303e-11,0.0
2860,hypoglossal nerve morphogenesis (GO:0021618),1.7408852137786303e-11,0.0
2861,chromosome passenger complex localization to kinetochore (GO:0072356),1.7408852137786303e-11,0.0
2862,positive regulation of progesterone secretion (GO:2000872),1.7408852137786303e-11,0.0
2863,synapse assembly involved in innervation (GO:0060386),1.7408852137786303e-11,0.0
2864,positive regulation of DNA strand elongation (GO:0060383),1.7408852137786303e-11,0.0
2865,sperm displacement (GO:0007321),1.7408852137786303e-11,0.0
2866,positive regulation of single-stranded telomeric DNA binding (GO:0060381),1.7408852137786303e-11,0.0
2867,regulation of single-stranded telomeric DNA binding (GO:0060380),1.7408852137786303e-11,0.0
2868,response to anesthetic (GO:0072347),1.7408852137786303e-11,0.0
2869,cellular lactam catabolic process (GO:0072340),1.7408852137786303e-11,0.0
2870,regulation of brood size (GO:0060378),1.7408852137786303e-11,0.0
2871,negative regulation of mast cell differentiation (GO:0060377),1.7408852137786303e-11,0.0
2872,positive regulation of mast cell differentiation (GO:0060376),1.7408852137786303e-11,0.0
2873,guanine biosynthetic process (GO:0046099),1.7408852137786303e-11,0.0
2874,deoxycytidine metabolic process (GO:0046092),1.7408852137786303e-11,0.0
2875,positive regulation of corticosterone secretion (GO:2000854),1.7408852137786303e-11,0.0
2876,negative regulation of corticosterone secretion (GO:2000853),1.7408852137786303e-11,0.0
2877,sagittal suture morphogenesis (GO:0060367),1.7408852137786303e-11,0.0
2878,lambdoid suture morphogenesis (GO:0060366),1.7408852137786303e-11,0.0
2879,respiratory basal cell differentiation (GO:1902691),1.7408852137786303e-11,0.0
2880,adenosine biosynthetic process (GO:0046086),1.7408852137786303e-11,0.0
2881,regulation of NAD metabolic process (GO:1902688),1.7408852137786303e-11,0.0
2882,negative regulation of receptor localization to synapse (GO:1902684),1.7408852137786303e-11,0.0
2883,protein localization to pericentric heterochromatin (GO:1902682),1.7408852137786303e-11,0.0
2884,positive regulation of androgen secretion (GO:2000836),1.7408852137786303e-11,0.0
2885,regulation of androgen secretion (GO:2000834),1.7408852137786303e-11,0.0
2886,carbon tetrachloride metabolic process (GO:0018885),1.7408852137786303e-11,0.0
2887,spleen trabecula formation (GO:0060345),1.7408852137786303e-11,0.0
2888,dGDP catabolic process (GO:0046067),1.7408852137786303e-11,0.0
2889,dCTP metabolic process (GO:0046065),1.7408852137786303e-11,0.0
2890,mitochondrial RNA surveillance (GO:2000827),1.7408852137786303e-11,0.0
2891,negative regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072308),1.7408852137786303e-11,0.0
2892,positive regulation of glomerular metanephric mesangial cell proliferation (GO:0072303),1.7408852137786303e-11,0.0
2893,negative regulation of metanephric glomerular mesangial cell proliferation (GO:0072302),1.7408852137786303e-11,0.0
2894,benzoate metabolic process (GO:0018874),1.7408852137786303e-11,0.0
2895,dADP catabolic process (GO:0046057),1.7408852137786303e-11,0.0
2896,UTP catabolic process (GO:0046052),1.7408852137786303e-11,0.0
2897,negative regulation of synaptic vesicle clustering (GO:2000808),1.7408852137786303e-11,0.0
2898,"positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000806)",1.7408852137786303e-11,0.0
2899,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000802),1.7408852137786303e-11,0.0
2900,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000800),1.7408852137786303e-11,0.0
2901,negative regulation of elastin catabolic process (GO:0060311),1.7408852137786303e-11,0.0
2902,regulation of elastin catabolic process (GO:0060310),1.7408852137786303e-11,0.0
2903,regulation of cell diameter (GO:0060305),1.7408852137786303e-11,0.0
2904,positive regulation of cytokine activity (GO:0060301),1.7408852137786303e-11,0.0
2905,positive regulation of membrane hyperpolarization (GO:1902632),1.7408852137786303e-11,0.0
2906,regulation of mRNA stability involved in cellular response to UV (GO:1902629),1.7408852137786303e-11,0.0
2907,BMP signaling pathway involved in nephric duct formation (GO:0071893),1.7408852137786303e-11,0.0
2908,assembly of large subunit precursor of preribosome (GO:1902626),1.7408852137786303e-11,0.0
2909,programmed cell death induced by symbiont (GO:0034050),1.7408852137786303e-11,0.0
2910,acyl carnitine transmembrane transport (GO:1902616),1.7408852137786303e-11,0.0
2911,negative regulation of anti-Mullerian hormone signaling pathway (GO:1902613),1.7408852137786303e-11,0.0
2912,regulation of anti-Mullerian hormone signaling pathway (GO:1902612),1.7408852137786303e-11,0.0
2913,"positive regulation of circadian sleep/wake cycle, REM sleep (GO:0046005)",1.7408852137786303e-11,0.0
2914,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071879),1.7408852137786303e-11,0.0
2915,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071877),1.7408852137786303e-11,0.0
2916,negative regulation of large conductance calcium-activated potassium channel activity (GO:1902607),1.7408852137786303e-11,0.0
2917,heterotrimeric G-protein complex assembly (GO:1902605),1.7408852137786303e-11,0.0
2918,acyl carnitine transport (GO:0006844),1.7408852137786303e-11,0.0
2919,mitochondrial citrate transmembrane transport (GO:0006843),1.7408852137786303e-11,0.0
2920,"antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent (GO:0002489)",1.7408852137786303e-11,0.0
2921,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway (GO:0002488),1.7408852137786303e-11,0.0
2922,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",1.7408852137786303e-11,0.0
2923,negative regulation of lipid transporter activity (GO:0110114),1.7408852137786303e-11,0.0
2924,plasmacytoid dendritic cell antigen processing and presentation (GO:0002470),1.7408852137786303e-11,0.0
2925,zygote asymmetric cell division (GO:0010070),1.7408852137786303e-11,0.0
2926,peripheral T cell tolerance induction (GO:0002458),1.7408852137786303e-11,0.0
2927,peripheral B cell tolerance induction (GO:0002451),1.7408852137786303e-11,0.0
2928,apoptotic process in bone marrow cell (GO:0071839),1.7408852137786303e-11,0.0
2929,cell proliferation in bone marrow (GO:0071838),1.7408852137786303e-11,0.0
2930,intermediate-density lipoprotein particle clearance (GO:0071831),1.7408852137786303e-11,0.0
2931,negative regulation of cytotoxic T cell differentiation (GO:0045584),1.7408852137786303e-11,0.0
2932,lateral ganglionic eminence cell proliferation (GO:0022018),1.7408852137786303e-11,0.0
2933,pallium cell proliferation in forebrain (GO:0022013),1.7408852137786303e-11,0.0
2934,subpallium cell proliferation in forebrain (GO:0022012),1.7408852137786303e-11,0.0
2935,immune complex clearance by monocytes and macrophages (GO:0002436),1.7408852137786303e-11,0.0
2936,response to nickel cation (GO:0010045),1.7408852137786303e-11,0.0
2937,immune complex clearance by erythrocytes (GO:0002435),1.7408852137786303e-11,0.0
2938,midbrain-hindbrain boundary maturation during brain development (GO:0022004),1.7408852137786303e-11,0.0
2939,natural killer cell mediated immune response to tumor cell (GO:0002423),1.7408852137786303e-11,0.0
2940,natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002420),1.7408852137786303e-11,0.0
2941,negative regulation of C-C chemokine binding (GO:2001264),1.7408852137786303e-11,0.0
2942,regulation of C-C chemokine binding (GO:2001263),1.7408852137786303e-11,0.0
2943,positive regulation of semaphorin-plexin signaling pathway (GO:2001262),1.7408852137786303e-11,0.0
2944,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor (GO:0002416),1.7408852137786303e-11,0.0
2945,antigen transcytosis by M cells in mucosal-associated lymphoid tissue (GO:0002412),1.7408852137786303e-11,0.0
2946,amylopectin biosynthetic process (GO:0010021),1.7408852137786303e-11,0.0
2947,positive regulation of ammonia assimilation cycle (GO:2001250),1.7408852137786303e-11,0.0
2948,antigen sampling by M cells in mucosal-associated lymphoid tissue (GO:0002406),1.7408852137786303e-11,0.0
2949,antigen sampling in mucosal-associated lymphoid tissue (GO:0002404),1.7408852137786303e-11,0.0
2950,protein localization to meiotic spindle midzone (GO:1903096),1.7408852137786303e-11,0.0
2951,regulation of ammonia assimilation cycle (GO:2001248),1.7408852137786303e-11,0.0
2952,negative regulation of phosphatidylcholine biosynthetic process (GO:2001246),1.7408852137786303e-11,0.0
2953,siderophore biosynthetic process (GO:0019290),1.7408852137786303e-11,0.0
2954,positive regulation of C-C chemokine receptor CCR7 signaling pathway (GO:1903082),1.7408852137786303e-11,0.0
2955,regulation of C-C chemokine receptor CCR7 signaling pathway (GO:1903080),1.7408852137786303e-11,0.0
2956,rhombomere structural organization (GO:0021595),1.7408852137786303e-11,0.0
2957,rhombomere formation (GO:0021594),1.7408852137786303e-11,0.0
2958,fourth ventricle development (GO:0021592),1.7408852137786303e-11,0.0
2959,negative regulation of death-inducing signaling complex assembly (GO:1903073),1.7408852137786303e-11,0.0
2960,regulation of death-inducing signaling complex assembly (GO:1903072),1.7408852137786303e-11,0.0
2961,regulation of response to gamma radiation (GO:2001228),1.7408852137786303e-11,0.0
2962,cerebellum formation (GO:0021588),1.7408852137786303e-11,0.0
2963,positive regulation of reverse cholesterol transport (GO:1903064),1.7408852137786303e-11,0.0
2964,regulation of reverse cholesterol transport (GO:1903062),1.7408852137786303e-11,0.0
2965,hindbrain formation (GO:0021576),1.7408852137786303e-11,0.0
2966,rhombomere 6 development (GO:0021572),1.7408852137786303e-11,0.0
2967,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001998),1.7408852137786303e-11,0.0
2968,sperm individualization (GO:0007291),1.7408852137786303e-11,0.0
2969,hypoglossal nerve development (GO:0021566),1.7408852137786303e-11,0.0
2970,negative regulation of acetylcholine-gated cation channel activity (GO:1903049),1.7408852137786303e-11,0.0
2971,glucose 1-phosphate metabolic process (GO:0019255),1.7408852137786303e-11,0.0
2972,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001985),1.7408852137786303e-11,0.0
2973,positive regulation of chondrocyte hypertrophy (GO:1903043),1.7408852137786303e-11,0.0
2974,artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001984),1.7408852137786303e-11,0.0
2975,regulation of chondrocyte hypertrophy (GO:1903041),1.7408852137786303e-11,0.0
2976,regulation of systemic arterial blood pressure by ischemic conditions (GO:0001980),1.7408852137786303e-11,0.0
2977,central nervous system formation (GO:0021556),1.7408852137786303e-11,0.0
2978,regulation of systemic arterial blood pressure by chemoreceptor signaling (GO:0001979),1.7408852137786303e-11,0.0
2979,lactate biosynthetic process from pyruvate (GO:0019244),1.7408852137786303e-11,0.0
2980,methylglyoxal biosynthetic process (GO:0019242),1.7408852137786303e-11,0.0
2981,L-lysine catabolic process to acetyl-CoA via L-pipecolate (GO:0033514),1.7408852137786303e-11,0.0
2982,midbrain-hindbrain boundary initiation (GO:0021547),1.7408852137786303e-11,0.0
2983,ammon gyrus development (GO:0021541),1.7408852137786303e-11,0.0
2984,subthalamus development (GO:0021539),1.7408852137786303e-11,0.0
2985,metanephric distal tubule morphogenesis (GO:0072287),1.7408852137786303e-11,0.0
2986,metanephric connecting tubule development (GO:0072286),1.7408852137786303e-11,0.0
2987,siRNA-mediated gene silencing (GO:0140766),1.7408852137786303e-11,0.0
2988,mesenchymal to epithelial transition involved in metanephric renal vesicle formation (GO:0072285),1.7408852137786303e-11,0.0
2989,positive regulation of exo-alpha-sialidase activity (GO:1903017),1.7408852137786303e-11,0.0
2990,negative regulation of bone development (GO:1903011),1.7408852137786303e-11,0.0
2991,commissural neuron differentiation in spinal cord (GO:0021528),1.7408852137786303e-11,0.0
2992,negative regulation of amniotic stem cell differentiation (GO:2000798),1.7408852137786303e-11,0.0
2993,regulation of amniotic stem cell differentiation (GO:2000797),1.7408852137786303e-11,0.0
2994,negative regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000795),1.7408852137786303e-11,0.0
2995,cell proliferation involved in heart valve development (GO:2000793),1.7408852137786303e-11,0.0
2996,positive regulation of Lys63-specific deubiquitinase activity (GO:1903007),1.7408852137786303e-11,0.0
2997,metanephric glomerular basement membrane development (GO:0072274),1.7408852137786303e-11,0.0
2998,reorganization of cellular membranes to establish viral sites of replication (GO:0140754),1.7408852137786303e-11,0.0
2999,positive regulation of lipid transport across blood-brain barrier (GO:1903002),1.7408852137786303e-11,0.0
3000,negative regulation of lipid transport across blood-brain barrier (GO:1903001),1.7408852137786303e-11,0.0
3001,regulation of lipid transport across blood-brain barrier (GO:1903000),1.7408852137786303e-11,0.0
3002,spinal cord anterior/posterior patterning (GO:0021512),1.7408852137786303e-11,0.0
3003,metanephric capsule specification (GO:0072267),1.7408852137786303e-11,0.0
3004,metanephric capsule formation (GO:0072266),1.7408852137786303e-11,0.0
3005,metanephric capsule morphogenesis (GO:0072265),1.7408852137786303e-11,0.0
3006,siRNA transcription (GO:0140745),1.7408852137786303e-11,0.0
3007,metanephric glomerular mesangial cell proliferation involved in metanephros development (GO:0072262),1.7408852137786303e-11,0.0
3008,negative regulation of sarcomere organization (GO:0060299),1.7408852137786303e-11,0.0
3009,roof plate formation (GO:0021509),1.7408852137786303e-11,0.0
3010,neural fold bending (GO:0021503),1.7408852137786303e-11,0.0
3011,metanephric interstitial fibroblast development (GO:0072259),1.7408852137786303e-11,0.0
3012,prechordal plate formation (GO:0021501),1.7408852137786303e-11,0.0
3013,metanephric interstitial fibroblast differentiation (GO:0072258),1.7408852137786303e-11,0.0
3014,metanephric glomerular mesangial cell development (GO:0072255),1.7408852137786303e-11,0.0
3015,regulation of exocyst assembly (GO:0001928),1.7408852137786303e-11,0.0
3016,positive regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000771),1.7408852137786303e-11,0.0
3017,patched ligand maturation (GO:0007225),1.7408852137786303e-11,0.0
3018,negative regulation of oocyte development (GO:0060283),1.7408852137786303e-11,0.0
3019,negative regulation of ovulation (GO:0060280),1.7408852137786303e-11,0.0
3020,regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000769),1.7408852137786303e-11,0.0
3021,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis (GO:2000764),1.7408852137786303e-11,0.0
3022,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process (GO:2000763),1.7408852137786303e-11,0.0
3023,positive regulation of N-terminal peptidyl-lysine acetylation (GO:2000761),1.7408852137786303e-11,0.0
3024,metanephric DCT cell differentiation (GO:0072240),1.7408852137786303e-11,0.0
3025,regulation of N-terminal peptidyl-lysine acetylation (GO:2000759),1.7408852137786303e-11,0.0
3026,positive regulation of glucosylceramide catabolic process (GO:2000753),1.7408852137786303e-11,0.0
3027,regulation of glucosylceramide catabolic process (GO:2000752),1.7408852137786303e-11,0.0
3028,metanephric proximal convoluted tubule segment 2 development (GO:0072232),1.7408852137786303e-11,0.0
3029,metanephric proximal straight tubule development (GO:0072230),1.7408852137786303e-11,0.0
3030,negative regulation of N-terminal protein palmitoylation (GO:0060262),1.7408852137786303e-11,0.0
3031,CAT tailing (GO:0140708),1.7408852137786303e-11,0.0
3032,metanephric macula densa development (GO:0072227),1.7408852137786303e-11,0.0
3033,protein-containing complex localization to centriolar satellite (GO:0140706),1.7408852137786303e-11,0.0
3034,metanephric descending thin limb development (GO:0072220),1.7408852137786303e-11,0.0
3035,regulation of N-terminal protein palmitoylation (GO:0060254),1.7408852137786303e-11,0.0
3036,metanephric cortical collecting duct development (GO:0072219),1.7408852137786303e-11,0.0
3037,negative regulation of metanephros development (GO:0072217),1.7408852137786303e-11,0.0
3038,metanephric cortex development (GO:0072214),1.7408852137786303e-11,0.0
3039,negative regulation of calcium import into the mitochondrion (GO:0110099),1.7408852137786303e-11,0.0
3040,metanephric capsule development (GO:0072213),1.7408852137786303e-11,0.0
3041,regulation of termination of RNA polymerase I transcription (GO:2000730),1.7408852137786303e-11,0.0
3042,negative regulation of nuclear cell cycle DNA replication (GO:1902576),1.7408852137786303e-11,0.0
3043,negative regulation of cell growth involved in contact inhibition (GO:0060243),1.7408852137786303e-11,0.0
3044,positive regulation of cardiac vascular smooth muscle cell differentiation (GO:2000724),1.7408852137786303e-11,0.0
3045,metanephric juxtaglomerular apparatus development (GO:0072206),1.7408852137786303e-11,0.0
3046,negative regulation of cardiac vascular smooth muscle cell differentiation (GO:2000723),1.7408852137786303e-11,0.0
3047,negative regulation of mesenchymal cell proliferation involved in ureter development (GO:0072200),1.7408852137786303e-11,0.0
3048,negative regulation of activation of Janus kinase activity (GO:1902569),1.7408852137786303e-11,0.0
3049,neuroblast delamination (GO:0060234),1.7408852137786303e-11,0.0
3050,"negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric (GO:2000719)",1.7408852137786303e-11,0.0
3051,"regulation of maintenance of mitotic sister chromatid cohesion, centromeric (GO:2000718)",1.7408852137786303e-11,0.0
3052,positive regulation of catalase activity (GO:1902553),1.7408852137786303e-11,0.0
3053,camera-type eye photoreceptor cell fate commitment (GO:0060220),1.7408852137786303e-11,0.0
3054,polyphosphate metabolic process (GO:0006797),1.7408852137786303e-11,0.0
3055,negative regulation of dense core granule biogenesis (GO:2000706),1.7408852137786303e-11,0.0
3056,positive regulation of DNA N-glycosylase activity (GO:1902546),1.7408852137786303e-11,0.0
3057,succinyl-CoA pathway (GO:0006781),1.7408852137786303e-11,0.0
3058,negative regulation of blood vessel endothelial cell differentiation (GO:0110059),1.7408852137786303e-11,0.0
3059,regulation of blood vessel endothelial cell differentiation (GO:0110057),1.7408852137786303e-11,0.0
3060,metabolite repair (GO:0110051),1.7408852137786303e-11,0.0
3061,nicotinamide metabolic process (GO:0006769),1.7408852137786303e-11,0.0
3062,endoplasmic reticulum tubular network maintenance (GO:0071788),1.7408852137786303e-11,0.0
3063,AMP phosphorylation (GO:0006756),1.7408852137786303e-11,0.0
3064,MHC class Ib protein complex assembly (GO:0002398),1.7408852137786303e-11,0.0
3065,regulation of DNA strand resection involved in replication fork processing (GO:0110026),1.7408852137786303e-11,0.0
3066,FAD biosynthetic process (GO:0006747),1.7408852137786303e-11,0.0
3067,immune response in brain or nervous system (GO:0002383),1.7408852137786303e-11,0.0
3068,cap-independent translational initiation of linear mRNA (GO:0110017),1.7408852137786303e-11,0.0
3069,nuclear inner membrane organization (GO:0071765),1.7408852137786303e-11,0.0
3070,protein localization to P-body (GO:0110012),1.7408852137786303e-11,0.0
3071,nicotinamide riboside catabolic process (GO:0006738),1.7408852137786303e-11,0.0
3072,plasmacytoid dendritic cell cytokine production (GO:0002373),1.7408852137786303e-11,0.0
3073,dendritic cell cytokine production (GO:0002371),1.7408852137786303e-11,0.0
3074,ncRNA deadenylation (GO:0110008),1.7408852137786303e-11,0.0
3075,NK T cell lineage commitment (GO:0002364),1.7408852137786303e-11,0.0
3076,glucocorticoid catabolic process (GO:0006713),1.7408852137786303e-11,0.0
3077,estrogen catabolic process (GO:0006711),1.7408852137786303e-11,0.0
3078,positive regulation of gamma-delta T cell activation involved in immune response (GO:2001193),1.7408852137786303e-11,0.0
3079,regulation of gamma-delta T cell activation involved in immune response (GO:2001191),1.7408852137786303e-11,0.0
3080,B-1 B cell lineage commitment (GO:0002336),1.7408852137786303e-11,0.0
3081,transitional two stage B cell differentiation (GO:0002334),1.7408852137786303e-11,0.0
3082,transitional one stage B cell differentiation (GO:0002333),1.7408852137786303e-11,0.0
3083,positive regulation of mediator complex assembly (GO:2001178),1.7408852137786303e-11,0.0
3084,regulation of mediator complex assembly (GO:2001176),1.7408852137786303e-11,0.0
3085,regulation of MAPK export from nucleus (GO:0071701),1.7408852137786303e-11,0.0
3086,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:2001165),1.7408852137786303e-11,0.0
3087,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:2001163),1.7408852137786303e-11,0.0
3088,memory B cell differentiation (GO:0002319),1.7408852137786303e-11,0.0
3089,negative regulation of histone H3-K79 methylation (GO:2001161),1.7408852137786303e-11,0.0
3090,positive regulation of renal water transport (GO:2001153),1.7408852137786303e-11,0.0
3091,regulation of renal water transport (GO:2001151),1.7408852137786303e-11,0.0
3092,"CD8-positive, alpha-beta T cell differentiation involved in immune response (GO:0002302)",1.7408852137786303e-11,0.0
3093,"CD8-positive, alpha-beta intraepithelial T cell differentiation (GO:0002300)",1.7408852137786303e-11,0.0
3094,S-methylmethionine metabolic process (GO:0033477),1.7408852137786303e-11,0.0
3095,nicotinate transport (GO:2001142),1.7408852137786303e-11,0.0
3096,negative regulation of phospholipid transport (GO:2001139),1.7408852137786303e-11,0.0
3097,negative regulation of translational frameshifting (GO:2001125),1.7408852137786303e-11,0.0
3098,regulation of translational frameshifting (GO:2001124),1.7408852137786303e-11,0.0
3099,positive regulation of cellular response to hepatocyte growth factor stimulus (GO:2001114),1.7408852137786303e-11,0.0
3100,negative regulation of cellular response to hepatocyte growth factor stimulus (GO:2001113),1.7408852137786303e-11,0.0
3101,negative regulation of cytolysis by symbiont of host cells (GO:0001899),1.7408852137786303e-11,0.0
3102,regulation of cytolysis by symbiont of host cells (GO:0001898),1.7408852137786303e-11,0.0
3103,epidermal growth factor catabolic process (GO:0007174),1.7408852137786303e-11,0.0
3104,ureter epithelial cell differentiation (GO:0072192),1.7408852137786303e-11,0.0
3105,positive regulation of oxytocin production (GO:0140668),1.7408852137786303e-11,0.0
3106,metanephric cap morphogenesis (GO:0072186),1.7408852137786303e-11,0.0
3107,regulation of oxytocin production (GO:0140667),1.7408852137786303e-11,0.0
3108,metanephric cap development (GO:0072185),1.7408852137786303e-11,0.0
3109,renal vesicle progenitor cell differentiation (GO:0072184),1.7408852137786303e-11,0.0
3110,negative regulation of cardiac muscle cell myoblast differentiation (GO:2000691),1.7408852137786303e-11,0.0
3111,regulation of cardiac muscle cell myoblast differentiation (GO:2000690),1.7408852137786303e-11,0.0
3112,female meiosis II (GO:0007147),1.7408852137786303e-11,0.0
3113,actomyosin contractile ring assembly actin filament organization (GO:2000689),1.7408852137786303e-11,0.0
3114,specification of posterior mesonephric tubule identity (GO:0072169),1.7408852137786303e-11,0.0
3115,specification of anterior mesonephric tubule identity (GO:0072168),1.7408852137786303e-11,0.0
3116,specification of mesonephric tubule identity (GO:0072167),1.7408852137786303e-11,0.0
3117,anterior mesonephric tubule development (GO:0072165),1.7408852137786303e-11,0.0
3118,male somatic sex determination (GO:0019102),1.7408852137786303e-11,0.0
3119,female somatic sex determination (GO:0019101),1.7408852137786303e-11,0.0
3120,trophectodermal cell fate commitment (GO:0001830),1.7408852137786303e-11,0.0
3121,CARD8 inflammasome complex assembly (GO:0140633),1.7408852137786303e-11,0.0
3122,positive regulation of interleukin-1-mediated signaling pathway (GO:2000661),1.7408852137786303e-11,0.0
3123,positive regulation of antibody-dependent cellular cytotoxicity (GO:0001815),1.7408852137786303e-11,0.0
3124,negative regulation of antibody-dependent cellular cytotoxicity (GO:0001814),1.7408852137786303e-11,0.0
3125,positive regulation of type I hypersensitivity (GO:0001812),1.7408852137786303e-11,0.0
3126,regulation of exocyst localization (GO:0060178),1.7408852137786303e-11,0.0
3127,negative regulation of type I hypersensitivity (GO:0001811),1.7408852137786303e-11,0.0
3128,male meiosis cytokinesis (GO:0007112),1.7408852137786303e-11,0.0
3129,negative regulation of apolipoprotein binding (GO:2000657),1.7408852137786303e-11,0.0
3130,keratinocyte activation (GO:0032980),1.7408852137786303e-11,0.0
3131,regulation of apolipoprotein binding (GO:2000656),1.7408852137786303e-11,0.0
3132,negative regulation of cellular response to testosterone stimulus (GO:2000655),1.7408852137786303e-11,0.0
3133,regulation of cellular response to testosterone stimulus (GO:2000654),1.7408852137786303e-11,0.0
3134,positive regulation of type IV hypersensitivity (GO:0001809),1.7408852137786303e-11,0.0
3135,negative regulation of type IV hypersensitivity (GO:0001808),1.7408852137786303e-11,0.0
3136,renal capsule specification (GO:0072130),1.7408852137786303e-11,0.0
3137,negative regulation of adenosine receptor signaling pathway (GO:0060169),1.7408852137786303e-11,0.0
3138,iron-sulfur cluster transmembrane transport (GO:1902497),1.7408852137786303e-11,0.0
3139,negative regulation of sperm capacitation (GO:1902491),1.7408852137786303e-11,0.0
3140,release of matrix enzymes from mitochondria (GO:0032976),1.7408852137786303e-11,0.0
3141,amino acid transmembrane export from vacuole (GO:0032974),1.7408852137786303e-11,0.0
3142,renal capsule formation (GO:0072129),1.7408852137786303e-11,0.0
3143,renal capsule morphogenesis (GO:0072128),1.7408852137786303e-11,0.0
3144,renal capsule development (GO:0072127),1.7408852137786303e-11,0.0
3145,regulatory T cell apoptotic process (GO:1902482),1.7408852137786303e-11,0.0
3146,protein localization to mitotic spindle (GO:1902480),1.7408852137786303e-11,0.0
3147,positive regulation of pre-miRNA processing (GO:2000633),1.7408852137786303e-11,0.0
3148,negative regulation of miRNA catabolic process (GO:2000626),1.7408852137786303e-11,0.0
3149,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway (GO:0072101),1.7408852137786303e-11,0.0
3150,specification of ureteric bud anterior/posterior symmetry (GO:0072100),1.7408852137786303e-11,0.0
3151,negative regulation of histone H3-K27 trimethylation (GO:1902465),1.7408852137786303e-11,0.0
3152,somatotropin secreting cell development (GO:0060133),1.7408852137786303e-11,0.0
3153,regulation of thyroid-stimulating hormone secretion (GO:2000612),1.7408852137786303e-11,0.0
3154,vestibular receptor cell stereocilium organization (GO:0060121),1.7408852137786303e-11,0.0
3155,negative regulation of translation in response to oxidative stress (GO:0032938),1.7408852137786303e-11,0.0
3156,negative regulation of ripoptosome assembly involved in necroptotic process (GO:1902443),1.7408852137786303e-11,0.0
3157,regulation of ripoptosome assembly involved in necroptotic process (GO:1902442),1.7408852137786303e-11,0.0
3158,protein localization to mitotic spindle pole body (GO:1902440),1.7408852137786303e-11,0.0
3159,putrescine acetylation (GO:0032920),1.7408852137786303e-11,0.0
3160,"negative regulation of phagocytosis, engulfment (GO:0060101)",1.7408852137786303e-11,0.0
3161,spermine acetylation (GO:0032919),1.7408852137786303e-11,0.0
3162,positive regulation of transforming growth factor beta3 production (GO:0032916),1.7408852137786303e-11,0.0
3163,phytosphingosine metabolic process (GO:0006671),1.7408852137786303e-11,0.0
3164,negative regulation of transforming growth factor beta3 production (GO:0032913),1.7408852137786303e-11,0.0
3165,protein transport within extracellular region (GO:0071693),1.7408852137786303e-11,0.0
3166,sphinganine-1-phosphate biosynthetic process (GO:0006669),1.7408852137786303e-11,0.0
3167,3-keto-sphinganine metabolic process (GO:0006666),1.7408852137786303e-11,0.0
3168,regulation of nerve growth factor production (GO:0032903),1.7408852137786303e-11,0.0
3169,positive regulation of neurotrophin production (GO:0032901),1.7408852137786303e-11,0.0
3170,negative regulation of neurotrophin production (GO:0032900),1.7408852137786303e-11,0.0
3171,alpha-beta intraepithelial T cell differentiation (GO:0002299),1.7408852137786303e-11,0.0
3172,olfactory bulb axon guidance (GO:0071678),1.7408852137786303e-11,0.0
3173,positive regulation of IP-10 production (GO:0071660),1.7408852137786303e-11,0.0
3174,tRNA demethylation (GO:1990983),1.7408852137786303e-11,0.0
3175,negative regulation of granulocyte colony-stimulating factor production (GO:0071656),1.7408852137786303e-11,0.0
3176,positive regulation of chemokine (C-C motif) ligand 1 production (GO:0071654),1.7408852137786303e-11,0.0
3177,regulation of chemokine (C-C motif) ligand 1 production (GO:0071652),1.7408852137786303e-11,0.0
3178,endothelial cell activation involved in immune response (GO:0002264),1.7408852137786303e-11,0.0
3179,negative regulation of chemokine (C-C motif) ligand 4 production (GO:0071644),1.7408852137786303e-11,0.0
3180,regulation of chemokine (C-C motif) ligand 4 production (GO:0071643),1.7408852137786303e-11,0.0
3181,modulation by host of viral RNA-binding transcription factor activity (GO:1990969),1.7408852137786303e-11,0.0
3182,modulation by host of RNA binding by virus (GO:1990968),1.7408852137786303e-11,0.0
3183,establishment of blood-retinal barrier (GO:1990963),1.7408852137786303e-11,0.0
3184,basophil homeostasis (GO:1990960),1.7408852137786303e-11,0.0
3185,homogentisate metabolic process (GO:1901999),1.7408852137786303e-11,0.0
3186,cytoplasm protein quality control by the ubiquitin-proteasome system (GO:0071629),1.7408852137786303e-11,0.0
3187,response to ketamine (GO:1901986),1.7408852137786303e-11,0.0
3188,peptidyl-aspartic acid autophosphorylation (GO:1990938),1.7408852137786303e-11,0.0
3189,phytosphingosine biosynthetic process (GO:0071602),1.7408852137786303e-11,0.0
3190,beta-alanine biosynthetic process via 3-ureidopropionate (GO:0033396),1.7408852137786303e-11,0.0
3191,positive regulation of cell proliferation involved in outflow tract morphogenesis (GO:1901964),1.7408852137786303e-11,0.0
3192,S-adenosyl-L-methionine transmembrane transport (GO:1901962),1.7408852137786303e-11,0.0
3193,"putrescine biosynthetic process from arginine, using agmatinase (GO:0033389)",1.7408852137786303e-11,0.0
3194,putrescine biosynthetic process from arginine (GO:0033388),1.7408852137786303e-11,0.0
3195,geranylgeranyl diphosphate biosynthetic process (GO:0033386),1.7408852137786303e-11,0.0
3196,maintenance of granzyme B location in T cell secretory granule (GO:0033382),1.7408852137786303e-11,0.0
3197,granzyme B localization to T cell secretory granule (GO:0033380),1.7408852137786303e-11,0.0
3198,positive regulation of tendon cell differentiation (GO:2001051),1.7408852137786303e-11,0.0
3199,negative regulation of MHC class I biosynthetic process (GO:0045344),1.7408852137786303e-11,0.0
3200,maintenance of protease location in T cell secretory granule (GO:0033379),1.7408852137786303e-11,0.0
3201,maintenance of protein location in T cell secretory granule (GO:0033377),1.7408852137786303e-11,0.0
3202,protease localization to T cell secretory granule (GO:0033375),1.7408852137786303e-11,0.0
3203,protein localization to T cell secretory granule (GO:0033374),1.7408852137786303e-11,0.0
3204,maintenance of protease location in mast cell secretory granule (GO:0033373),1.7408852137786303e-11,0.0
3205,regulation of tendon cell differentiation (GO:2001049),1.7408852137786303e-11,0.0
3206,T cell secretory granule organization (GO:0033371),1.7408852137786303e-11,0.0
3207,maintenance of protein location in mast cell secretory granule (GO:0033370),1.7408852137786303e-11,0.0
3208,farnesyl diphosphate catabolic process (GO:0045339),1.7408852137786303e-11,0.0
3209,protease localization to mast cell secretory granule (GO:0033368),1.7408852137786303e-11,0.0
3210,protein localization to mast cell secretory granule (GO:0033367),1.7408852137786303e-11,0.0
3211,positive regulation of cellular glucuronidation (GO:2001031),1.7408852137786303e-11,0.0
3212,regulation of response to drug (GO:2001023),1.7408852137786303e-11,0.0
3213,asparagine catabolic process via L-aspartate (GO:0033345),1.7408852137786303e-11,0.0
3214,positive regulation of collagen binding (GO:0033343),1.7408852137786303e-11,0.0
3215,positive regulation of retrograde axon cargo transport (GO:2001019),1.7408852137786303e-11,0.0
3216,negative regulation of collagen binding (GO:0033342),1.7408852137786303e-11,0.0
3217,regulation of retrograde axon cargo transport (GO:2001017),1.7408852137786303e-11,0.0
3218,negative regulation of type IIa hypersensitivity (GO:0001797),1.7408852137786303e-11,0.0
3219,modulation by virus of host cellular process (GO:0019054),1.7408852137786303e-11,0.0
3220,suppression by virus of host apoptotic process (GO:0019050),1.7408852137786303e-11,0.0
3221,nuclear envelope budding (GO:0140591),1.7408852137786303e-11,0.0
3222,UDP-D-xylose biosynthetic process (GO:0033320),1.7408852137786303e-11,0.0
3223,modulation by virus of host process (GO:0019048),1.7408852137786303e-11,0.0
3224,chromatin looping (GO:0140588),1.7408852137786303e-11,0.0
3225,T cell homeostatic proliferation (GO:0001777),1.7408852137786303e-11,0.0
3226,establishment of natural killer cell polarity (GO:0001770),1.7408852137786303e-11,0.0
3227,UDP-D-xylose metabolic process (GO:0033319),1.7408852137786303e-11,0.0
3228,positive regulation of transcription involved in exit from mitosis (GO:0007072),1.7408852137786303e-11,0.0
3229,meiotic spindle assembly checkpoint signaling (GO:0033316),1.7408852137786303e-11,0.0
3230,anterior/posterior pattern specification involved in ureteric bud development (GO:0072099),1.7408852137786303e-11,0.0
3231,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway (GO:0072097),1.7408852137786303e-11,0.0
3232,negative regulation of branch elongation involved in ureteric bud branching (GO:0072096),1.7408852137786303e-11,0.0
3233,extraction of mislocalized protein from mitochondrial outer membrane (GO:0140570),1.7408852137786303e-11,0.0
3234,female meiosis sister chromatid cohesion (GO:0007066),1.7408852137786303e-11,0.0
3235,primary adaptive immune response involving T cells and B cells (GO:0090721),1.7408852137786303e-11,0.0
3236,primary adaptive immune response (GO:0090720),1.7408852137786303e-11,0.0
3237,cell cycle comprising mitosis without cytokinesis (GO:0033301),1.7408852137786303e-11,0.0
3238,extraction of mislocalized protein from ER membrane (GO:0140569),1.7408852137786303e-11,0.0
3239,positive regulation of optic nerve formation (GO:2000597),1.7408852137786303e-11,0.0
3240,regulation of optic nerve formation (GO:2000595),1.7408852137786303e-11,0.0
3241,negative regulation of metanephric mesenchymal cell migration (GO:2000590),1.7408852137786303e-11,0.0
3242,DCT cell differentiation (GO:0072069),1.7408852137786303e-11,0.0
3243,outer medullary collecting duct development (GO:0072060),1.7408852137786303e-11,0.0
3244,"cytoskeletal rearrangement involved in phagocytosis, engulfment (GO:0060097)",1.7408852137786303e-11,0.0
3245,"regulation of synaptic transmission, glycinergic (GO:0060092)",1.7408852137786303e-11,0.0
3246,lipoprotein localization to membrane (GO:0044873),1.7408852137786303e-11,0.0
3247,cortical collecting duct development (GO:0072059),1.7408852137786303e-11,0.0
3248,renal cortex development (GO:0072055),1.7408852137786303e-11,0.0
3249,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes (GO:2000572),1.7408852137786303e-11,0.0
3250,regulation of interleukin-4-dependent isotype switching to IgE isotypes (GO:2000571),1.7408852137786303e-11,0.0
3251,positive regulation of T-helper 2 cell activation (GO:2000570),1.7408852137786303e-11,0.0
3252,eye blink reflex (GO:0060082),1.7408852137786303e-11,0.0
3253,regulation of T-helper 2 cell activation (GO:2000569),1.7408852137786303e-11,0.0
3254,"negative regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000565)",1.7408852137786303e-11,0.0
3255,thromboxane A2 signaling pathway (GO:0038193),1.7408852137786303e-11,0.0
3256,positive regulation of CD24 production (GO:2000560),1.7408852137786303e-11,0.0
3257,ectodermal cell fate commitment (GO:0001712),1.7408852137786303e-11,0.0
3258,actin ubiquitination (GO:0007014),1.7408852137786303e-11,0.0
3259,plasma membrane raft localization (GO:0044856),1.7408852137786303e-11,0.0
3260,plasma membrane raft distribution (GO:0044855),1.7408852137786303e-11,0.0
3261,regulation of mitotic spindle elongation (GO:0032888),1.7408852137786303e-11,0.0
3262,regulation of spindle elongation (GO:0032887),1.7408852137786303e-11,0.0
3263,regulation of CD24 production (GO:2000559),1.7408852137786303e-11,0.0
3264,intracellular bile acid receptor signaling pathway (GO:0038185),1.7408852137786303e-11,0.0
3265,cell surface bile acid receptor signaling pathway (GO:0038184),1.7408852137786303e-11,0.0
3266,mesenchymal to epithelial transition involved in renal vesicle formation (GO:0072036),1.7408852137786303e-11,0.0
3267,proximal convoluted tubule segment 2 development (GO:0072032),1.7408852137786303e-11,0.0
3268,Spemann organizer formation at the anterior end of the primitive streak (GO:0060064),1.7408852137786303e-11,0.0
3269,negative regulation of DNA endoreduplication (GO:0032876),1.7408852137786303e-11,0.0
3270,positive regulation of dendritic cell dendrite assembly (GO:2000549),1.7408852137786303e-11,0.0
3271,negative regulation of dendritic cell dendrite assembly (GO:2000548),1.7408852137786303e-11,0.0
3272,negative regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000545),1.7408852137786303e-11,0.0
3273,connecting tubule development (GO:0072027),1.7408852137786303e-11,0.0
3274,interleukin-17A-mediated signaling pathway (GO:0038173),1.7408852137786303e-11,0.0
3275,macula densa development (GO:0072024),1.7408852137786303e-11,0.0
3276,positive regulation of protein geranylgeranylation (GO:2000541),1.7408852137786303e-11,0.0
3277,descending thin limb development (GO:0072022),1.7408852137786303e-11,0.0
3278,proximal straight tubule development (GO:0072020),1.7408852137786303e-11,0.0
3279,negative regulation of protein glycosylation (GO:0060051),1.7408852137786303e-11,0.0
3280,positive regulation of endoribonuclease activity (GO:1902380),1.7408852137786303e-11,0.0
3281,regulation of protein geranylgeranylation (GO:2000539),1.7408852137786303e-11,0.0
3282,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade (GO:0038168),1.7408852137786303e-11,0.0
3283,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity (GO:0038167),1.7408852137786303e-11,0.0
3284,positive regulation of renal albumin absorption (GO:2000534),1.7408852137786303e-11,0.0
3285,glomerular parietal epithelial cell development (GO:0072016),1.7408852137786303e-11,0.0
3286,negative regulation of renal albumin absorption (GO:2000533),1.7408852137786303e-11,0.0
3287,prolactin signaling pathway (GO:0038161),1.7408852137786303e-11,0.0
3288,VEGF-activated neuropilin signaling pathway involved in axon guidance (GO:1902378),1.7408852137786303e-11,0.0
3289,regulation of rRNA catabolic process (GO:1902374),1.7408852137786303e-11,0.0
3290,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation (GO:2000526),1.7408852137786303e-11,0.0
3291,notochord cell development (GO:0060035),1.7408852137786303e-11,0.0
3292,positive regulation of protein localization to spindle pole body (GO:1902365),1.7408852137786303e-11,0.0
3293,notochord cell differentiation (GO:0060034),1.7408852137786303e-11,0.0
3294,regulation of protein localization to spindle pole body (GO:1902363),1.7408852137786303e-11,0.0
3295,negative regulation of cellular pH reduction (GO:0032848),1.7408852137786303e-11,0.0
3296,negative regulation of T-helper 1 cell activation (GO:2000518),1.7408852137786303e-11,0.0
3297,regulation of T-helper 1 cell activation (GO:2000517),1.7408852137786303e-11,0.0
3298,positive regulation of granzyme A production (GO:2000513),1.7408852137786303e-11,0.0
3299,regulation of granzyme A production (GO:2000511),1.7408852137786303e-11,0.0
3300,cellular response to chloroquine (GO:1902350),1.7408852137786303e-11,0.0
3301,ornithine catabolic process (GO:0006593),1.7408852137786303e-11,0.0
3302,ornithine biosynthetic process (GO:0006592),1.7408852137786303e-11,0.0
3303,negative regulation of dendritic cell chemotaxis (GO:2000509),1.7408852137786303e-11,0.0
3304,granulosa cell development (GO:0060016),1.7408852137786303e-11,0.0
3305,Sertoli cell fate commitment (GO:0060010),1.7408852137786303e-11,0.0
3306,dopamine biosynthetic process from tyrosine (GO:0006585),1.7408852137786303e-11,0.0
3307,ethanolamine metabolic process (GO:0006580),1.7408852137786303e-11,0.0
3308,toll-like receptor TLR1:TLR2 signaling pathway (GO:0038123),1.7408852137786303e-11,0.0
3309,linear vestibuloocular reflex (GO:0060007),1.7408852137786303e-11,0.0
3310,chemokine (C-C motif) ligand 19 signaling pathway (GO:0038115),1.7408852137786303e-11,0.0
3311,interleukin-21-mediated signaling pathway (GO:0038114),1.7408852137786303e-11,0.0
3312,interleukin-9-mediated signaling pathway (GO:0038113),1.7408852137786303e-11,0.0
3313,low-density lipoprotein particle receptor catabolic process (GO:0032802),1.7408852137786303e-11,0.0
3314,sequestering of nodal from receptor via nodal binding (GO:0038101),1.7408852137786303e-11,0.0
3315,DNA strand elongation involved in nuclear cell cycle DNA replication (GO:1902319),1.7408852137786303e-11,0.0
3316,nuclear DNA replication termination (GO:1902317),1.7408852137786303e-11,0.0
3317,negative regulation of zinc ion transmembrane import (GO:0071584),1.7408852137786303e-11,0.0
3318,negative regulation of zinc ion transmembrane transport (GO:0071583),1.7408852137786303e-11,0.0
3319,negative regulation of zinc ion transport (GO:0071582),1.7408852137786303e-11,0.0
3320,regulation of zinc ion transmembrane import (GO:0071581),1.7408852137786303e-11,0.0
3321,regulation of zinc ion transmembrane transport (GO:0071580),1.7408852137786303e-11,0.0
3322,regulation of copper ion transmembrane transport (GO:1902311),1.7408852137786303e-11,0.0
3323,positive regulation of peptidyl-serine dephosphorylation (GO:1902310),1.7408852137786303e-11,0.0
3324,hepatocyte cell migration (GO:0002194),1.7408852137786303e-11,0.0
3325,IRES-dependent translational initiation of linear mRNA (GO:0002192),1.7408852137786303e-11,0.0
3326,cap-independent translational initiation (GO:0002190),1.7408852137786303e-11,0.0
3327,cytoplasmic translational termination (GO:0002184),1.7408852137786303e-11,0.0
3328,glutamate catabolic process via 2-oxoglutarate (GO:0006539),1.7408852137786303e-11,0.0
3329,cysteine biosynthetic process from serine (GO:0006535),1.7408852137786303e-11,0.0
3330,RNA acetylation (GO:1990884),1.7408852137786303e-11,0.0
3331,rRNA acetylation (GO:1990882),1.7408852137786303e-11,0.0
3332,asparagine catabolic process (GO:0006530),1.7408852137786303e-11,0.0
3333,diphosphoinositol polyphosphate catabolic process (GO:0071544),1.7408852137786303e-11,0.0
3334,bile acid conjugation (GO:0002152),1.7408852137786303e-11,0.0
3335,cellular response to endothelin (GO:1990859),1.7408852137786303e-11,0.0
3336,GPI anchor release (GO:0006507),1.7408852137786303e-11,0.0
3337,hypochlorous acid biosynthetic process (GO:0002149),1.7408852137786303e-11,0.0
3338,hypochlorous acid metabolic process (GO:0002148),1.7408852137786303e-11,0.0
3339,tRNA re-export from nucleus (GO:0071528),1.7408852137786303e-11,0.0
3340,negative regulation of catecholamine uptake involved in synaptic transmission (GO:0051945),1.7408852137786303e-11,0.0
3341,positive regulation of post-translational protein modification (GO:1901875),1.7408852137786303e-11,0.0
3342,slow axonal transport (GO:1990832),1.7408852137786303e-11,0.0
3343,tRNA nucleoside ribose methylation (GO:0002128),1.7408852137786303e-11,0.0
3344,tRNA wobble base cytosine methylation (GO:0002127),1.7408852137786303e-11,0.0
3345,hepatocyte dedifferentiation (GO:1990828),1.7408852137786303e-11,0.0
3346,induction of synaptic plasticity by chemical substance (GO:0051915),1.7408852137786303e-11,0.0
3347,positive regulation of synaptic plasticity by chemical substance (GO:0051914),1.7408852137786303e-11,0.0
3348,regulation of synaptic plasticity by chemical substance (GO:0051913),1.7408852137786303e-11,0.0
3349,tRNA wobble adenosine to inosine editing (GO:0002100),1.7408852137786303e-11,0.0
3350,response to vitamin B2 (GO:0033274),1.7408852137786303e-11,0.0
3351,protein palmitoleylation (GO:0045234),1.7408852137786303e-11,0.0
3352,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901835),1.7408852137786303e-11,0.0
3353,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901834),1.7408852137786303e-11,0.0
3354,negative regulation of CD4 production (GO:0045225),1.7408852137786303e-11,0.0
3355,calcium ion transmembrane transport via low voltage-gated calcium channel (GO:0090676),1.7408852137786303e-11,0.0
3356,regulation of CD4 production (GO:0045223),1.7408852137786303e-11,0.0
3357,endothelial cell-matrix adhesion (GO:0090673),1.7408852137786303e-11,0.0
3358,negative regulation of FasL production (GO:0045221),1.7408852137786303e-11,0.0
3359,telomerase RNA localization (GO:0090672),1.7408852137786303e-11,0.0
3360,telomerase RNA localization to Cajal body (GO:0090671),1.7408852137786303e-11,0.0
3361,zeaxanthin biosynthetic process (GO:1901827),1.7408852137786303e-11,0.0
3362,zeaxanthin catabolic process (GO:1901826),1.7408852137786303e-11,0.0
3363,regulation of FasL production (GO:0045219),1.7408852137786303e-11,0.0
3364,endothelial cell chemotaxis to vascular endothelial growth factor (GO:0090668),1.7408852137786303e-11,0.0
3365,cell chemotaxis to vascular endothelial growth factor (GO:0090667),1.7408852137786303e-11,0.0
3366,negative regulation of cellular amine catabolic process (GO:0033242),1.7408852137786303e-11,0.0
3367,regulation of cellular amine catabolic process (GO:0033241),1.7408852137786303e-11,0.0
3368,beta-carotene metabolic process (GO:1901810),1.7408852137786303e-11,0.0
3369,gastrin-induced gastric acid secretion (GO:0001698),1.7408852137786303e-11,0.0
3370,histamine catabolic process (GO:0001695),1.7408852137786303e-11,0.0
3371,response to environmental enrichment (GO:0090648),1.7408852137786303e-11,0.0
3372,very long-chain fatty acid beta-oxidation (GO:0140493),1.7408852137786303e-11,0.0
3373,tRNA 3'-terminal CCA addition (GO:0001680),1.7408852137786303e-11,0.0
3374,5-aminolevulinic acid import across plasma membrane (GO:0140484),1.7408852137786303e-11,0.0
3375,reductive iron assimilation (GO:0033215),1.7408852137786303e-11,0.0
3376,siRNA-mediated gene silencing by mRNA destabilization (GO:0090625),1.7408852137786303e-11,0.0
3377,iron-sulfur cluster export from the mitochondrion (GO:0140466),1.7408852137786303e-11,0.0
3378,mitochondrial mRNA 3'-end processing (GO:0090616),1.7408852137786303e-11,0.0
3379,response to Gram-negative bacterium (GO:0140460),1.7408852137786303e-11,0.0
3380,trans-Golgi network to recycling endosome transport (GO:0044795),1.7408852137786303e-11,0.0
3381,negative regulation of interleukin-18-mediated signaling pathway (GO:2000493),1.7408852137786303e-11,0.0
3382,cytoplasm protein quality control (GO:0140455),1.7408852137786303e-11,0.0
3383,protein aggregate center assembly (GO:0140454),1.7408852137786303e-11,0.0
3384,protein targeting to Golgi apparatus (GO:0140450),1.7408852137786303e-11,0.0
3385,sensory perception of itch (GO:0160025),1.7408852137786303e-11,0.0
3386,negative regulation of glutamine transport (GO:2000486),1.7408852137786303e-11,0.0
3387,positive regulation of metanephric podocyte development (GO:2000478),1.7408852137786303e-11,0.0
3388,regulation of metanephric podocyte development (GO:2000477),1.7408852137786303e-11,0.0
3389,positive regulation of opioid receptor signaling pathway (GO:2000476),1.7408852137786303e-11,0.0
3390,protein stearoylation (GO:0140438),1.7408852137786303e-11,0.0
3391,suppression of symbiont entry into host (GO:0052373),1.7408852137786303e-11,0.0
3392,low-density lipoprotein receptor particle metabolic process (GO:0032799),1.7408852137786303e-11,0.0
3393,glutathione import into mitochondrion (GO:0160007),1.7408852137786303e-11,0.0
3394,negative regulation of peroxidase activity (GO:2000469),1.7408852137786303e-11,0.0
3395,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway (GO:0038097),1.7408852137786303e-11,0.0
3396,positive regulation of astrocyte chemotaxis (GO:2000464),1.7408852137786303e-11,0.0
3397,unsaturated monocarboxylic acid metabolic process (GO:0032789),1.7408852137786303e-11,0.0
3398,saturated monocarboxylic acid metabolic process (GO:0032788),1.7408852137786303e-11,0.0
3399,"positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation (GO:2000454)",1.7408852137786303e-11,0.0
3400,DNA strand elongation involved in cell cycle DNA replication (GO:1902296),1.7408852137786303e-11,0.0
3401,cell cycle DNA replication termination (GO:1902294),1.7408852137786303e-11,0.0
3402,negative regulation of monocyte extravasation (GO:2000438),1.7408852137786303e-11,0.0
3403,"regulation of cytokinesis, actomyosin contractile ring assembly (GO:2000431)",1.7408852137786303e-11,0.0
3404,modification by host of symbiont membrane (GO:0052337),1.7408852137786303e-11,0.0
3405,protection of DNA demethylation of female pronucleus (GO:0044726),1.7408852137786303e-11,0.0
3406,"protein import into peroxisome matrix, substrate release (GO:0044721)",1.7408852137786303e-11,0.0
3407,positive regulation of interleukin-3 production (GO:0032752),1.7408852137786303e-11,0.0
3408,negative regulation of eosinophil extravasation (GO:2000420),1.7408852137786303e-11,0.0
3409,regulation of eosinophil extravasation (GO:2000419),1.7408852137786303e-11,0.0
3410,positive regulation of fibronectin-dependent thymocyte migration (GO:2000415),1.7408852137786303e-11,0.0
3411,regulation of fibronectin-dependent thymocyte migration (GO:2000413),1.7408852137786303e-11,0.0
3412,negative regulation of erythrocyte apoptotic process (GO:1902251),1.7408852137786303e-11,0.0
3413,regulation of erythrocyte apoptotic process (GO:1902250),1.7408852137786303e-11,0.0
3414,positive regulation of interleukin-16 production (GO:0032739),1.7408852137786303e-11,0.0
3415,positive regulation of interleukin-15 production (GO:0032738),1.7408852137786303e-11,0.0
3416,negative regulation of T cell extravasation (GO:2000408),1.7408852137786303e-11,0.0
3417,geranylgeranyl diphosphate catabolic process (GO:1902247),1.7408852137786303e-11,0.0
3418,epidermal growth factor receptor signaling pathway via MAPK cascade (GO:0038029),1.7408852137786303e-11,0.0
3419,insulin receptor recycling (GO:0038020),1.7408852137786303e-11,0.0
3420,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902239),1.7408852137786303e-11,0.0
3421,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902238),1.7408852137786303e-11,0.0
3422,negative regulation of positive thymic T cell selection (GO:1902233),1.7408852137786303e-11,0.0
3423,negative regulation of interleukin-3 production (GO:0032712),1.7408852137786303e-11,0.0
3424,positive regulation of macrophage colony-stimulating factor signaling pathway (GO:1902228),1.7408852137786303e-11,0.0
3425,negative regulation of acrosome reaction (GO:1902225),1.7408852137786303e-11,0.0
3426,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902220),1.7408852137786303e-11,0.0
3427,steroid hormone receptor complex assembly (GO:0006463),1.7408852137786303e-11,0.0
3428,regulation of signal transduction by receptor internalization (GO:0038009),1.7408852137786303e-11,0.0
3429,TRAF-mediated signal transduction (GO:0038008),1.7408852137786303e-11,0.0
3430,endocrine signaling (GO:0038002),1.7408852137786303e-11,0.0
3431,erythrocyte apoptotic process (GO:1902217),1.7408852137786303e-11,0.0
3432,negative regulation of interleukin-4-mediated signaling pathway (GO:1902215),1.7408852137786303e-11,0.0
3433,positive regulation of serotonin secretion (GO:0014064),1.7408852137786303e-11,0.0
3434,negative regulation of interleukin-2-mediated signaling pathway (GO:1902206),1.7408852137786303e-11,0.0
3435,regulation of interleukin-2-mediated signaling pathway (GO:1902205),1.7408852137786303e-11,0.0
3436,positive regulation of hepatocyte growth factor receptor signaling pathway (GO:1902204),1.7408852137786303e-11,0.0
3437,cellular response to non-ionic osmotic stress (GO:0071471),1.7408852137786303e-11,0.0
3438,negative regulation of hepatocyte growth factor receptor signaling pathway (GO:1902203),1.7408852137786303e-11,0.0
3439,peptidyl-proline hydroxylation to 3-hydroxy-L-proline (GO:0018400),1.7408852137786303e-11,0.0
3440,dopamine secretion (GO:0014046),1.7408852137786303e-11,0.0
3441,negative regulation of timing of anagen (GO:0051886),1.7408852137786303e-11,0.0
3442,lysyl-tRNA aminoacylation (GO:0006430),1.7408852137786303e-11,0.0
3443,acrosome matrix dispersal (GO:0002077),1.7408852137786303e-11,0.0
3444,cellular response to anoxia (GO:0071454),1.7408852137786303e-11,0.0
3445,lateral element assembly (GO:0051878),1.7408852137786303e-11,0.0
3446,glycyl-tRNA aminoacylation (GO:0006426),1.7408852137786303e-11,0.0
3447,clathrin-dependent extracellular exosome endocytosis (GO:1990771),1.7408852137786303e-11,0.0
3448,cellular response to lipid hydroperoxide (GO:0071449),1.7408852137786303e-11,0.0
3449,negative regulation of histone H3-K14 acetylation (GO:0071441),1.7408852137786303e-11,0.0
3450,myofibroblast contraction (GO:1990764),1.7408852137786303e-11,0.0
3451,mitotic sister chromatid biorientation (GO:1990758),1.7408852137786303e-11,0.0
3452,mitotic spindle microtubule depolymerization (GO:1990755),1.7408852137786303e-11,0.0
3453,intussusceptive angiogenesis (GO:0002041),1.7408852137786303e-11,0.0
3454,positive regulation of microglia differentiation (GO:0014008),1.7408852137786303e-11,0.0
3455,regulation of microglia differentiation (GO:0014006),1.7408852137786303e-11,0.0
3456,benzoyl-CoA metabolic process (GO:1901787),1.7408852137786303e-11,0.0
3457,angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002033),1.7408852137786303e-11,0.0
3458,basal protein localization (GO:0045175),1.7408852137786303e-11,0.0
3459,cellular response to hydroxyisoflavone (GO:0071413),1.7408852137786303e-11,0.0
3460,cellular response to genistein (GO:0071412),1.7408852137786303e-11,0.0
3461,granulosa cell proliferation (GO:1990739),1.7408852137786303e-11,0.0
3462,asymmetric protein localization involved in cell fate determination (GO:0045167),1.7408852137786303e-11,0.0
3463,cellular response to triglyceride (GO:0071401),1.7408852137786303e-11,0.0
3464,positive regulation of histone ubiquitination (GO:0033184),1.7408852137786303e-11,0.0
3465,leukotriene A4 biosynthetic process (GO:1901753),1.7408852137786303e-11,0.0
3466,xylulose catabolic process (GO:0005998),1.7408852137786303e-11,0.0
3467,detection of hypoxic conditions in blood by chemoreceptor signaling (GO:0002007),1.7408852137786303e-11,0.0
3468,trehalose catabolic process (GO:0005993),1.7408852137786303e-11,0.0
3469,lactose catabolic process (GO:0005990),1.7408852137786303e-11,0.0
3470,sucrose catabolic process (GO:0005987),1.7408852137786303e-11,0.0
3471,starch catabolic process (GO:0005983),1.7408852137786303e-11,0.0
3472,starch metabolic process (GO:0005982),1.7408852137786303e-11,0.0
3473,quercetin catabolic process (GO:1901733),1.7408852137786303e-11,0.0
3474,quercetin metabolic process (GO:1901732),1.7408852137786303e-11,0.0
3475,integrin biosynthetic process (GO:0045112),1.7408852137786303e-11,0.0
3476,L-asparagine biosynthetic process (GO:0070981),1.7408852137786303e-11,0.0
3477,biphenyl catabolic process (GO:0070980),1.7408852137786303e-11,0.0
3478,regulation of intermediate filament polymerization or depolymerization (GO:0045108),1.7408852137786303e-11,0.0
3479,intermediate filament polymerization (GO:0045107),1.7408852137786303e-11,0.0
3480,positive regulation of neutrophil mediated killing of gram-negative bacterium (GO:0070963),1.7408852137786303e-11,0.0
3481,positive regulation of neutrophil mediated killing of bacterium (GO:0070962),1.7408852137786303e-11,0.0
3482,cell septum assembly (GO:0090529),1.7408852137786303e-11,0.0
3483,neutrophil-mediated killing of fungus (GO:0070947),1.7408852137786303e-11,0.0
3484,ovarian follicle rupture (GO:0001543),1.7408852137786303e-11,0.0
3485,regulation of ATP:ADP antiporter activity (GO:0070926),1.7408852137786303e-11,0.0
3486,positive regulation of antral ovarian follicle growth (GO:2000388),1.7408852137786303e-11,0.0
3487,regulation of antral ovarian follicle growth (GO:2000387),1.7408852137786303e-11,0.0
3488,negative regulation of ectoderm development (GO:2000384),1.7408852137786303e-11,0.0
3489,regulation of ectoderm development (GO:2000383),1.7408852137786303e-11,0.0
3490,lysophospholipid translocation (GO:0140329),1.7408852137786303e-11,0.0
3491,negative regulation of hepatocyte growth factor production (GO:0032686),1.7408852137786303e-11,0.0
3492,negative regulation of granulocyte macrophage colony-stimulating factor production (GO:0032685),1.7408852137786303e-11,0.0
3493,negative regulation of connective tissue growth factor production (GO:0032683),1.7408852137786303e-11,0.0
3494,positive regulation of CD40 signaling pathway (GO:2000350),1.7408852137786303e-11,0.0
3495,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine (GO:0018395),1.7408852137786303e-11,0.0
3496,regulation of terminal button organization (GO:2000331),1.7408852137786303e-11,0.0
3497,fibroblast growth factor receptor apoptotic signaling pathway (GO:1902178),1.7408852137786303e-11,0.0
3498,negative regulation of keratinocyte apoptotic process (GO:1902173),1.7408852137786303e-11,0.0
3499,regulation of interleukin-16 production (GO:0032659),1.7408852137786303e-11,0.0
3500,regulation of interleukin-15 production (GO:0032658),1.7408852137786303e-11,0.0
3501,positive regulation of glucocorticoid receptor signaling pathway (GO:2000324),1.7408852137786303e-11,0.0
3502,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902167),1.7408852137786303e-11,0.0
3503,positive regulation of cyclic nucleotide-gated ion channel activity (GO:1902161),1.7408852137786303e-11,0.0
3504,regulation of hepatocyte growth factor production (GO:0032646),1.7408852137786303e-11,0.0
3505,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000314),1.7408852137786303e-11,0.0
3506,regulation of response to DNA damage checkpoint signaling (GO:1902153),1.7408852137786303e-11,0.0
3507,regulation of response to DNA integrity checkpoint signaling (GO:1902151),1.7408852137786303e-11,0.0
3508,protein deadenylylation (GO:0044602),1.7408852137786303e-11,0.0
3509,protein denucleotidylation (GO:0044601),1.7408852137786303e-11,0.0
3510,interleukin-8 production (GO:0032637),1.7408852137786303e-11,0.0
3511,transcription elongation by mitochondrial RNA polymerase (GO:0006392),1.7408852137786303e-11,0.0
3512,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000308),1.7408852137786303e-11,0.0
3513,regulation of response to cell cycle checkpoint signaling (GO:1902145),1.7408852137786303e-11,0.0
3514,termination of RNA polymerase III transcription (GO:0006386),1.7408852137786303e-11,0.0
3515,chemokine production (GO:0032602),1.7408852137786303e-11,0.0
3516,chemokine receptor transport out of membrane raft (GO:0032600),1.7408852137786303e-11,0.0
3517,molybdenum incorporation into molybdenum-molybdopterin complex (GO:0018315),1.7408852137786303e-11,0.0
3518,positive regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902104),1.7408852137786303e-11,0.0
3519,cellular response to gibberellin stimulus (GO:0071370),1.7408852137786303e-11,0.0
3520,protein depalmitoleylation (GO:1990697),1.7408852137786303e-11,0.0
3521,negative regulation of timing of catagen (GO:0051796),1.7408852137786303e-11,0.0
3522,behavioral response to nutrient (GO:0051780),1.7408852137786303e-11,0.0
3523,establishment of integrated proviral latency (GO:0075713),1.7408852137786303e-11,0.0
3524,cellular response to interleukin-9 (GO:0071355),1.7408852137786303e-11,0.0
3525,histone H4-K16 deacetylation (GO:1990678),1.7408852137786303e-11,0.0
3526,cellular response to interleukin-11 (GO:0071348),1.7408852137786303e-11,0.0
3527,positive regulation of hair follicle cell proliferation (GO:0071338),1.7408852137786303e-11,0.0
3528,regulation of hair follicle cell proliferation (GO:0071336),1.7408852137786303e-11,0.0
3529,hair follicle cell proliferation (GO:0071335),1.7408852137786303e-11,0.0
3530,homologous chromosome movement towards spindle pole in meiosis I anaphase (GO:0051758),1.7408852137786303e-11,0.0
3531,cannabinoid biosynthetic process (GO:1901696),1.7408852137786303e-11,0.0
3532,sebum secreting cell proliferation (GO:1990654),1.7408852137786303e-11,0.0
3533,cellular response to sucrose stimulus (GO:0071329),1.7408852137786303e-11,0.0
3534,cellular response to disaccharide stimulus (GO:0071324),1.7408852137786303e-11,0.0
3535,arsenate ion transmembrane transport (GO:1901684),1.7408852137786303e-11,0.0
3536,positive regulation of histone H3-K27 acetylation (GO:1901676),1.7408852137786303e-11,0.0
3537,cytotoxic T cell differentiation (GO:0045065),1.7408852137786303e-11,0.0
3538,extrathymic T cell selection (GO:0045062),1.7408852137786303e-11,0.0
3539,cytolysis in another organism (GO:0051715),1.7408852137786303e-11,0.0
3540,extrathymic T cell differentiation (GO:0033078),1.7408852137786303e-11,0.0
3541,purine nucleotide-sugar transmembrane transport (GO:0090480),1.7408852137786303e-11,0.0
3542,dibasic protein processing (GO:0090472),1.7408852137786303e-11,0.0
3543,mitochondrial tRNA wobble uridine modification (GO:0070899),1.7408852137786303e-11,0.0
3544,RNA polymerase III preinitiation complex assembly (GO:0070898),1.7408852137786303e-11,0.0
3545,negative regulation of postsynaptic membrane organization (GO:1901627),1.7408852137786303e-11,0.0
3546,cellular response to ergosterol (GO:1901625),1.7408852137786303e-11,0.0
3547,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901622),1.7408852137786303e-11,0.0
3548,negative regulation of vesicle transport along microtubule (GO:1901609),1.7408852137786303e-11,0.0
3549,endocytic iron import into cell (GO:0140298),1.7408852137786303e-11,0.0
3550,peptidyl-serine ADP-deribosylation (GO:0140290),1.7408852137786303e-11,0.0
3551,positive regulation of mast cell apoptotic process (GO:0033027),1.7408852137786303e-11,0.0
3552,negative regulation of mast cell apoptotic process (GO:0033026),1.7408852137786303e-11,0.0
3553,Hsp90 deacetylation (GO:0070846),1.7408852137786303e-11,0.0
3554,polyubiquitinated misfolded protein transport (GO:0070845),1.7408852137786303e-11,0.0
3555,polyubiquitinated protein transport (GO:0070844),1.7408852137786303e-11,0.0
3556,misfolded protein transport (GO:0070843),1.7408852137786303e-11,0.0
3557,malonate catabolic process (GO:0090410),1.7408852137786303e-11,0.0
3558,negative regulation of defecation (GO:2000293),1.7408852137786303e-11,0.0
3559,regulation of defecation (GO:2000292),1.7408852137786303e-11,0.0
3560,regulation of myotome development (GO:2000290),1.7408852137786303e-11,0.0
3561,positive regulation of myotome development (GO:2000287),1.7408852137786303e-11,0.0
3562,positive regulation of cellular amino acid biosynthetic process (GO:2000284),1.7408852137786303e-11,0.0
3563,negative regulation of cellular amino acid biosynthetic process (GO:2000283),1.7408852137786303e-11,0.0
3564,regulation of translation at presynapse (GO:0140244),1.7408852137786303e-11,0.0
3565,modification by host of symbiont cellular component (GO:0052187),1.7408852137786303e-11,0.0
3566,modification by host of symbiont structure (GO:0052183),1.7408852137786303e-11,0.0
3567,[4Fe-4S] cluster assembly (GO:0044572),1.7408852137786303e-11,0.0
3568,positive regulation of oxidative phosphorylation uncoupler activity (GO:2000277),1.7408852137786303e-11,0.0
3569,posterior lateral line neuromast hair cell differentiation (GO:0048923),1.7408852137786303e-11,0.0
3570,protein transport out of membrane raft (GO:0032599),1.7408852137786303e-11,0.0
3571,B cell receptor transport into membrane raft (GO:0032597),1.7408852137786303e-11,0.0
3572,B cell receptor transport within lipid bilayer (GO:0032595),1.7408852137786303e-11,0.0
3573,"regulation of blood coagulation, intrinsic pathway (GO:2000266)",1.7408852137786303e-11,0.0
3574,posterior lateral line neuromast development (GO:0048919),1.7408852137786303e-11,0.0
3575,"negative regulation of blood coagulation, common pathway (GO:2000261)",1.7408852137786303e-11,0.0
3576,posterior lateral line development (GO:0048916),1.7408852137786303e-11,0.0
3577,"regulation of blood coagulation, common pathway (GO:2000260)",1.7408852137786303e-11,0.0
3578,posterior lateral line system development (GO:0048915),1.7408852137786303e-11,0.0
3579,negative regulation of protein activation cascade (GO:2000258),1.7408852137786303e-11,0.0
3580,ER-dependent peroxisome organization (GO:0032581),1.7408852137786303e-11,0.0
3581,negative regulation of actin cytoskeleton reorganization (GO:2000250),1.7408852137786303e-11,0.0
3582,modulation by symbiont of host apoptotic process (GO:0052150),1.7408852137786303e-11,0.0
3583,tripeptide import across plasma membrane (GO:0140207),1.7408852137786303e-11,0.0
3584,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate (GO:0140200),1.7408852137786303e-11,0.0
3585,protein-FAD linkage (GO:0018293),1.7408852137786303e-11,0.0
3586,positive regulation of apoptotic process in another organism (GO:0044533),1.7408852137786303e-11,0.0
3587,modulation of apoptotic process in another organism (GO:0044532),1.7408852137786303e-11,0.0
3588,snRNA methylation (GO:0106349),1.7408852137786303e-11,0.0
3589,omega-hydroxyceramide biosynthetic process (GO:0106342),1.7408852137786303e-11,0.0
3590,positive regulation of pancreatic stellate cell proliferation (GO:2000231),1.7408852137786303e-11,0.0
3591,negative regulation of pancreatic stellate cell proliferation (GO:2000230),1.7408852137786303e-11,0.0
3592,positive regulation of lateral motor column neuron migration (GO:1902078),1.7408852137786303e-11,0.0
3593,regulation of lateral motor column neuron migration (GO:1902076),1.7408852137786303e-11,0.0
3594,positive regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902073),1.7408852137786303e-11,0.0
3595,protein sulfhydration (GO:0044524),1.7408852137786303e-11,0.0
3596,regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902071),1.7408852137786303e-11,0.0
3597,postsynaptic neurotransmitter receptor cycle (GO:0099630),1.7408852137786303e-11,0.0
3598,positive regulation of sphingolipid mediated signaling pathway (GO:1902070),1.7408852137786303e-11,0.0
3599,negative regulation of pancreatic A cell differentiation (GO:2000227),1.7408852137786303e-11,0.0
3600,regulation of pancreatic A cell differentiation (GO:2000226),1.7408852137786303e-11,0.0
3601,isopeptide cross-linking via N6-glycyl-L-lysine (GO:0018276),1.7408852137786303e-11,0.0
3602,neurotransmitter receptor cycle (GO:0099627),1.7408852137786303e-11,0.0
3603,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine (GO:0018272),1.7408852137786303e-11,0.0
3604,positive regulation of glutamate metabolic process (GO:2000213),1.7408852137786303e-11,0.0
3605,negative regulation of glutamate metabolic process (GO:2000212),1.7408852137786303e-11,0.0
3606,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",1.7408852137786303e-11,0.0
3607,positive regulation of ribosomal small subunit export from nucleus (GO:2000208),1.7408852137786303e-11,0.0
3608,regulation of ribosomal small subunit export from nucleus (GO:2000206),1.7408852137786303e-11,0.0
3609,positive regulation of ribosomal subunit export from nucleus (GO:2000202),1.7408852137786303e-11,0.0
3610,regulation of action potential firing pattern (GO:0099608),1.7408852137786303e-11,0.0
3611,lateral attachment of mitotic spindle microtubules to kinetochore (GO:0099607),1.7408852137786303e-11,0.0
3612,microtubule plus-end directed mitotic chromosome migration (GO:0099606),1.7408852137786303e-11,0.0
3613,negative regulation of Fas signaling pathway (GO:1902045),1.7408852137786303e-11,0.0
3614,"base-excision repair, DNA ligation (GO:0006288)",1.7408852137786303e-11,0.0
3615,positive regulation of hematopoietic stem cell differentiation (GO:1902038),1.7408852137786303e-11,0.0
3616,"tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate (GO:0000971)",1.7408852137786303e-11,0.0
3617,DNA replication termination (GO:0006274),1.7408852137786303e-11,0.0
3618,cellular response to L-ascorbic acid (GO:0071298),1.7408852137786303e-11,0.0
3619,tRNA exon ligation (GO:0000968),1.7408852137786303e-11,0.0
3620,nitrate import (GO:1902025),1.7408852137786303e-11,0.0
3621,cellular response to iron(III) ion (GO:0071283),1.7408852137786303e-11,0.0
3622,UDP-glucose catabolic process (GO:0006258),1.7408852137786303e-11,0.0
3623,negative regulation of translation in response to endoplasmic reticulum stress (GO:1902010),1.7408852137786303e-11,0.0
3624,CTP catabolic process (GO:0006254),1.7408852137786303e-11,0.0
3625,dCTP catabolic process (GO:0006253),1.7408852137786303e-11,0.0
3626,peptidyl-aspartic acid phosphorylation (GO:0018217),1.7408852137786303e-11,0.0
3627,protein phosphopantetheinylation (GO:0018215),1.7408852137786303e-11,0.0
3628,cellular response to aluminum ion (GO:0071275),1.7408852137786303e-11,0.0
3629,homogentisate catabolic process (GO:1902000),1.7408852137786303e-11,0.0
3630,'de novo' L-methionine biosynthetic process (GO:0071266),1.7408852137786303e-11,0.0
3631,maintenance of ER location (GO:0051685),1.7408852137786303e-11,0.0
3632,cellular response to gravity (GO:0071258),1.7408852137786303e-11,0.0
3633,peptidyl-serine trans-autophosphorylation (GO:1990579),1.7408852137786303e-11,0.0
3634,septin ring assembly (GO:0000921),1.7408852137786303e-11,0.0
3635,transport of viral material towards nucleus (GO:0075606),1.7408852137786303e-11,0.0
3636,cellular response to chromate (GO:0071247),1.7408852137786303e-11,0.0
3637,cellular response to carbon monoxide (GO:0071245),1.7408852137786303e-11,0.0
3638,cellular response to carbon dioxide (GO:0071244),1.7408852137786303e-11,0.0
3639,division septum assembly (GO:0000917),1.7408852137786303e-11,0.0
3640,actomyosin contractile ring contraction (GO:0000916),1.7408852137786303e-11,0.0
3641,actin cortical patch localization (GO:0051666),1.7408852137786303e-11,0.0
3642,thymidine catabolic process (GO:0006214),1.7408852137786303e-11,0.0
3643,regulation of cellular response to alcohol (GO:1905957),1.7408852137786303e-11,0.0
3644,positive regulation of endothelial tube morphogenesis (GO:1905956),1.7408852137786303e-11,0.0
3645,response to capsazepine (GO:1901594),1.7408852137786303e-11,0.0
3646,mitochondrial alpha-ketoglutarate transmembrane transport (GO:1990550),1.7408852137786303e-11,0.0
3647,regulation of response to calcium ion (GO:1905945),1.7408852137786303e-11,0.0
3648,mitochondrial FAD transmembrane transport (GO:1990548),1.7408852137786303e-11,0.0
3649,mitochondrial phosphate ion transmembrane transport (GO:1990547),1.7408852137786303e-11,0.0
3650,regulation of acid-sensing ion channel activity (GO:1901585),1.7408852137786303e-11,0.0
3651,mitochondrial tricarboxylic acid transmembrane transport (GO:1990546),1.7408852137786303e-11,0.0
3652,positive regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901582),1.7408852137786303e-11,0.0
3653,negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581),1.7408852137786303e-11,0.0
3654,regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901580),1.7408852137786303e-11,0.0
3655,mitochondrial manganese ion transmembrane transport (GO:1990540),1.7408852137786303e-11,0.0
3656,cellular response to external biotic stimulus (GO:0071217),1.7408852137786303e-11,0.0
3657,positive regulation of cell fate determination (GO:1905935),1.7408852137786303e-11,0.0
3658,negative regulation of cell fate determination (GO:1905934),1.7408852137786303e-11,0.0
3659,positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905932),1.7408852137786303e-11,0.0
3660,fructose import across plasma membrane (GO:1990539),1.7408852137786303e-11,0.0
3661,barbed-end actin filament uncapping (GO:0051638),1.7408852137786303e-11,0.0
3662,regulation of acetylcholine uptake (GO:0051631),1.7408852137786303e-11,0.0
3663,establishment of protein localization to juxtaparanode region of axon (GO:0071206),1.7408852137786303e-11,0.0
3664,positive regulation of norepinephrine uptake (GO:0051623),1.7408852137786303e-11,0.0
3665,negative regulation of norepinephrine uptake (GO:0051622),1.7408852137786303e-11,0.0
3666,response to benomyl (GO:1901561),1.7408852137786303e-11,0.0
3667,positive regulation of cell differentiation involved in phenotypic switching (GO:1905917),1.7408852137786303e-11,0.0
3668,response to metformin (GO:1901558),1.7408852137786303e-11,0.0
3669,response to fenofibrate (GO:1901557),1.7408852137786303e-11,0.0
3670,response to paracetamol (GO:1901554),1.7408852137786303e-11,0.0
3671,phagosome-lysosome fusion involved in apoptotic cell clearance (GO:0090389),1.7408852137786303e-11,0.0
3672,phagosome-lysosome docking (GO:0090384),1.7408852137786303e-11,0.0
3673,regulation of tryptophan metabolic process (GO:0090357),1.7408852137786303e-11,0.0
3674,efferent axon development in a lateral line nerve (GO:0048894),1.7408852137786303e-11,0.0
3675,lateral line nerve development (GO:0048892),1.7408852137786303e-11,0.0
3676,negative regulation of cellular organofluorine metabolic process (GO:0090350),1.7408852137786303e-11,0.0
3677,negative regulation of cellular organohalogen metabolic process (GO:0090349),1.7408852137786303e-11,0.0
3678,regulation of cellular organofluorine metabolic process (GO:0090348),1.7408852137786303e-11,0.0
3679,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process (GO:0140194),1.7408852137786303e-11,0.0
3680,regulation of cellular organohalogen metabolic process (GO:0090347),1.7408852137786303e-11,0.0
3681,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process (GO:0140193),1.7408852137786303e-11,0.0
3682,cellular organofluorine metabolic process (GO:0090346),1.7408852137786303e-11,0.0
3683,cellular organohalogen metabolic process (GO:0090345),1.7408852137786303e-11,0.0
3684,mechanosensory lateral line system development (GO:0048881),1.7408852137786303e-11,0.0
3685,negative regulation of secretion of lysosomal enzymes (GO:0090341),1.7408852137786303e-11,0.0
3686,positive regulation of secretion of lysosomal enzymes (GO:0090340),1.7408852137786303e-11,0.0
3687,interleukin-35-mediated signaling pathway (GO:0070757),1.7408852137786303e-11,0.0
3688,positive regulation of locomotion involved in locomotory behavior (GO:0090326),1.7408852137786303e-11,0.0
3689,positive regulation of chylomicron remnant clearance (GO:0090321),1.7408852137786303e-11,0.0
3690,regulation of chylomicron remnant clearance (GO:0090320),1.7408852137786303e-11,0.0
3691,adenohypophysis morphogenesis (GO:0048855),1.7408852137786303e-11,0.0
3692,cGMP transport (GO:0070731),1.7408852137786303e-11,0.0
3693,positive regulation of ribonucleoprotein complex localization (GO:2000199),1.7408852137786303e-11,0.0
3694,positive regulation of female gonad development (GO:2000196),1.7408852137786303e-11,0.0
3695,negative regulation of neural crest formation (GO:0090301),1.7408852137786303e-11,0.0
3696,positive regulation of phosphate transmembrane transport (GO:2000187),1.7408852137786303e-11,0.0
3697,regulation of phosphate transmembrane transport (GO:2000185),1.7408852137786303e-11,0.0
3698,positive regulation of progesterone biosynthetic process (GO:2000184),1.7408852137786303e-11,0.0
3699,negative regulation of androgen biosynthetic process (GO:2000180),1.7408852137786303e-11,0.0
3700,sodium-dependent organic cation transport (GO:0070715),1.7408852137786303e-11,0.0
3701,negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0106289),1.7408852137786303e-11,0.0
3702,regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0106288),1.7408852137786303e-11,0.0
3703,positive regulation of pro-T cell differentiation (GO:2000176),1.7408852137786303e-11,0.0
3704,regulation of pro-T cell differentiation (GO:2000174),1.7408852137786303e-11,0.0
3705,negative regulation of branching morphogenesis of a nerve (GO:2000173),1.7408852137786303e-11,0.0
3706,"regulation of translation at presynapse, modulating synaptic transmission (GO:0099577)",1.7408852137786303e-11,0.0
3707,detection of muramyl dipeptide (GO:0032498),1.7408852137786303e-11,0.0
3708,detection of molecule of fungal origin (GO:0032491),1.7408852137786303e-11,0.0
3709,regulation of planar cell polarity pathway involved in neural tube closure (GO:2000167),1.7408852137786303e-11,0.0
3710,cytosol to ERGIC protein transport (GO:0106273),1.7408852137786303e-11,0.0
3711,protein localization to ERGIC (GO:0106272),1.7408852137786303e-11,0.0
3712,"modification of synaptic structure, modulating synaptic transmission (GO:0099564)",1.7408852137786303e-11,0.0
3713,"trans-synaptic signaling by neuropeptide, modulating synaptic transmission (GO:0099551)",1.7408852137786303e-11,0.0
3714,otolith formation (GO:0032475),1.7408852137786303e-11,0.0
3715,peptidyl-alanine modification (GO:0018194),1.7408852137786303e-11,0.0
3716,peptidyl-serine octanoylation (GO:0018191),1.7408852137786303e-11,0.0
3717,protein octanoylation (GO:0018190),1.7408852137786303e-11,0.0
3718,negative regulation by symbiont of host programmed cell death (GO:0052041),1.7408852137786303e-11,0.0
3719,trans-synaptic signaling by neuropeptide (GO:0099540),1.7408852137786303e-11,0.0
3720,modulation by symbiont of host programmed cell death (GO:0052040),1.7408852137786303e-11,0.0
3721,negative regulation of sodium-dependent phosphate transport (GO:2000119),1.7408852137786303e-11,0.0
3722,peptidyl-lysine glutarylation (GO:0106227),1.7408852137786303e-11,0.0
3723,peptidyl-pyrromethane cofactor linkage (GO:0018160),1.7408852137786303e-11,0.0
3724,ITP catabolic process (GO:0006193),1.7408852137786303e-11,0.0
3725,thermosensory behavior (GO:0040040),1.7408852137786303e-11,0.0
3726,positive regulation of mammary stem cell proliferation (GO:2000103),1.7408852137786303e-11,0.0
3727,regulation of mammary stem cell proliferation (GO:2000101),1.7408852137786303e-11,0.0
3728,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine (GO:0018153),1.7408852137786303e-11,0.0
3729,dGDP phosphorylation (GO:0006186),1.7408852137786303e-11,0.0
3730,dGDP biosynthetic process (GO:0006185),1.7408852137786303e-11,0.0
3731,nucleic acid-protein covalent cross-linking (GO:0018143),1.7408852137786303e-11,0.0
3732,protein-DNA covalent cross-linking (GO:0018142),1.7408852137786303e-11,0.0
3733,guanine salvage (GO:0006178),1.7408852137786303e-11,0.0
3734,dATP biosynthetic process (GO:0006175),1.7408852137786303e-11,0.0
3735,dADP phosphorylation (GO:0006174),1.7408852137786303e-11,0.0
3736,dADP biosynthetic process (GO:0006173),1.7408852137786303e-11,0.0
3737,adenine salvage (GO:0006168),1.7408852137786303e-11,0.0
3738,regulation of smooth muscle tissue development (GO:1905899),1.7408852137786303e-11,0.0
3739,regulation of cellular response to very-low-density lipoprotein particle stimulus (GO:1905890),1.7408852137786303e-11,0.0
3740,histone H2B-K12 acetylation (GO:0043980),1.7408852137786303e-11,0.0
3741,viral translational frameshifting (GO:0075523),1.7408852137786303e-11,0.0
3742,microtubule-dependent intracellular transport of viral material towards nucleus (GO:0075521),1.7408852137786303e-11,0.0
3743,peptidyl-histidine phosphorylation (GO:0018106),1.7408852137786303e-11,0.0
3744,ribonucleoprotein complex localization (GO:0071166),1.7408852137786303e-11,0.0
3745,histone H2B-K5 acetylation (GO:0043979),1.7408852137786303e-11,0.0
3746,negative regulation of dopamine uptake involved in synaptic transmission (GO:0051585),1.7408852137786303e-11,0.0
3747,histone H3-K4 acetylation (GO:0043973),1.7408852137786303e-11,0.0
3748,histone H3-K23 acetylation (GO:0043972),1.7408852137786303e-11,0.0
3749,microtubule-dependent intracellular transport of viral material (GO:0075519),1.7408852137786303e-11,0.0
3750,clathrin-dependent endocytosis of virus by host cell (GO:0075512),1.7408852137786303e-11,0.0
3751,negative regulation of postsynaptic density organization (GO:1905875),1.7408852137786303e-11,0.0
3752,negative regulation of protein localization to cell leading edge (GO:1905872),1.7408852137786303e-11,0.0
3753,negative regulation of 3'-UTR-mediated mRNA stabilization (GO:1905869),1.7408852137786303e-11,0.0
3754,positive regulation of heparan sulfate proteoglycan binding (GO:1905860),1.7408852137786303e-11,0.0
3755,protein autosumoylation (GO:1990466),1.7408852137786303e-11,0.0
3756,regulation of heparan sulfate proteoglycan binding (GO:1905858),1.7408852137786303e-11,0.0
3757,negative regulation of pentose-phosphate shunt (GO:1905856),1.7408852137786303e-11,0.0
3758,positive regulation of heparan sulfate binding (GO:1905855),1.7408852137786303e-11,0.0
3759,regulation of heparan sulfate binding (GO:1905853),1.7408852137786303e-11,0.0
3760,regulation of cysteine metabolic process (GO:1901494),1.7408852137786303e-11,0.0
3761,cellular stress response to acidic pH (GO:1990451),1.7408852137786303e-11,0.0
3762,regulation of cellular response to gamma radiation (GO:1905843),1.7408852137786303e-11,0.0
3763,negative regulation of elastin biosynthetic process (GO:0051545),1.7408852137786303e-11,0.0
3764,regulation of elastin biosynthetic process (GO:0051543),1.7408852137786303e-11,0.0
3765,elastin biosynthetic process (GO:0051542),1.7408852137786303e-11,0.0
3766,intrinsic apoptotic signaling pathway in response to nitrosative stress (GO:1990442),1.7408852137786303e-11,0.0
3767,cellular response to pyrimidine ribonucleotide (GO:1905835),1.7408852137786303e-11,0.0
3768,response to pyrimidine ribonucleotide (GO:1905834),1.7408852137786303e-11,0.0
3769,negative regulation of microtubule nucleation (GO:1905833),1.7408852137786303e-11,0.0
3770,U6 2'-O-snRNA methylation (GO:1990438),1.7408852137786303e-11,0.0
3771,snRNA 2'-O-methylation (GO:1990437),1.7408852137786303e-11,0.0
3772,mineralocorticoid receptor signaling pathway (GO:0031959),1.7408852137786303e-11,0.0
3773,regulation of prostaglandin catabolic process (GO:1905828),1.7408852137786303e-11,0.0
3774,positive regulation of glucocorticoid biosynthetic process (GO:0031948),1.7408852137786303e-11,0.0
3775,positive regulation of glucocorticoid metabolic process (GO:0031945),1.7408852137786303e-11,0.0
3776,regulation of neural crest formation (GO:0090299),1.7408852137786303e-11,0.0
3777,negative regulation of mitochondrial DNA replication (GO:0090298),1.7408852137786303e-11,0.0
3778,nitrogen catabolite activation of transcription (GO:0090294),1.7408852137786303e-11,0.0
3779,positive regulation of synapse pruning (GO:1905808),1.7408852137786303e-11,0.0
3780,nitrogen catabolite regulation of transcription (GO:0090293),1.7408852137786303e-11,0.0
3781,regulation of synapse pruning (GO:1905806),1.7408852137786303e-11,0.0
3782,excitatory synapse pruning (GO:1905805),1.7408852137786303e-11,0.0
3783,regulation of cellular response to manganese ion (GO:1905802),1.7408852137786303e-11,0.0
3784,positive regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090282),1.7408852137786303e-11,0.0
3785,negative regulation of somatostatin secretion (GO:0090275),1.7408852137786303e-11,0.0
3786,positive regulation of somatostatin secretion (GO:0090274),1.7408852137786303e-11,0.0
3787,response to benzene (GO:1901423),1.7408852137786303e-11,0.0
3788,regulation of transcription-coupled nucleotide-excision repair (GO:0090262),1.7408852137786303e-11,0.0
3789,regulation of response to alcohol (GO:1901419),1.7408852137786303e-11,0.0
3790,seminal clot liquefaction (GO:0070684),1.7408852137786303e-11,0.0
3791,spontaneous exocytosis of neurotransmitter (GO:0048792),1.7408852137786303e-11,0.0
3792,cytoskeletal matrix organization at active zone (GO:0048789),1.7408852137786303e-11,0.0
3793,convergent extension involved in somitogenesis (GO:0090246),1.7408852137786303e-11,0.0
3794,retinoic acid receptor signaling pathway involved in somitogenesis (GO:0090242),1.7408852137786303e-11,0.0
3795,erythrophore differentiation (GO:0048773),1.7408852137786303e-11,0.0
3796,nonfunctional rRNA decay (GO:0070651),1.7408852137786303e-11,0.0
3797,actin filament bundle distribution (GO:0070650),1.7408852137786303e-11,0.0
3798,cardiac endothelial to mesenchymal transition (GO:0140074),1.7408852137786303e-11,0.0
3799,regulation of microtubule nucleation by Ran protein signal transduction (GO:0090226),1.7408852137786303e-11,0.0
3800,peptidyl-lysine butyrylation (GO:0140067),1.7408852137786303e-11,0.0
3801,peptidyl-lysine crotonylation (GO:0140066),1.7408852137786303e-11,0.0
3802,positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090216),1.7408852137786303e-11,0.0
3803,axon arborization (GO:0140060),1.7408852137786303e-11,0.0
3804,pyridine nucleoside catabolic process (GO:0070638),1.7408852137786303e-11,0.0
3805,pyridine nucleoside metabolic process (GO:0070637),1.7408852137786303e-11,0.0
3806,positive regulation of endocardial cushion to mesenchymal transition (GO:0140051),1.7408852137786303e-11,0.0
3807,zymogen granule exocytosis (GO:0070625),1.7408852137786303e-11,0.0
3808,regulation of endocardial cushion to mesenchymal transition (GO:0140049),1.7408852137786303e-11,0.0
3809,positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000081),1.7408852137786303e-11,0.0
3810,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000080),1.7408852137786303e-11,0.0
3811,cellular detoxification of methylglyoxal (GO:0140041),1.7408852137786303e-11,0.0
3812,positive regulation of cortisol biosynthetic process (GO:2000066),1.7408852137786303e-11,0.0
3813,regulation of rRNA stability (GO:0044357),1.7408852137786303e-11,0.0
3814,clearance of foreign intracellular DNA (GO:0044355),1.7408852137786303e-11,0.0
3815,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis (GO:2000057),1.7408852137786303e-11,0.0
3816,regulation of Wnt signaling pathway involved in digestive tract morphogenesis (GO:2000056),1.7408852137786303e-11,0.0
3817,regulation of cytoplasmic translational fidelity (GO:0140018),1.7408852137786303e-11,0.0
3818,DNA excision (GO:0044349),1.7408852137786303e-11,0.0
3819,stromal-epithelial cell signaling involved in prostate gland development (GO:0044345),1.7408852137786303e-11,0.0
3820,negative regulation of cardiac cell fate specification (GO:2000044),1.7408852137786303e-11,0.0
3821,canonical Wnt signaling pathway involved in negative regulation of apoptotic process (GO:0044336),1.7408852137786303e-11,0.0
3822,pyridoxal phosphate catabolic process (GO:0032361),1.7408852137786303e-11,0.0
3823,negative regulation of cardiac muscle cell contraction (GO:0106135),1.7408852137786303e-11,0.0
3824,positive regulation of cardiac muscle cell contraction (GO:0106134),1.7408852137786303e-11,0.0
3825,negative regulation of male gonad development (GO:2000019),1.7408852137786303e-11,0.0
3826,regulation of adaxial/abaxial pattern formation (GO:2000011),1.7408852137786303e-11,0.0
3827,positive regulation of cobalamin metabolic process (GO:0106121),1.7408852137786303e-11,0.0
3828,cytochrome c-heme linkage (GO:0018063),1.7408852137786303e-11,0.0
3829,negative regulation of metanephric comma-shaped body morphogenesis (GO:2000007),1.7408852137786303e-11,0.0
3830,regulation of metanephric comma-shaped body morphogenesis (GO:2000006),1.7408852137786303e-11,0.0
3831,negative regulation of metanephric S-shaped body morphogenesis (GO:2000005),1.7408852137786303e-11,0.0
3832,regulation of metanephric S-shaped body morphogenesis (GO:2000004),1.7408852137786303e-11,0.0
3833,ER-dependent peroxisome localization (GO:0106101),1.7408852137786303e-11,0.0
3834,protein amidation (GO:0018032),1.7408852137786303e-11,0.0
3835,UDP-glucuronate biosynthetic process (GO:0006065),1.7408852137786303e-11,0.0
3836,negative regulation of prostaglandin secretion (GO:0032307),1.7408852137786303e-11,0.0
3837,sorbitol catabolic process (GO:0006062),1.7408852137786303e-11,0.0
3838,sorbitol metabolic process (GO:0006060),1.7408852137786303e-11,0.0
3839,CMP-N-acetylneuraminate biosynthetic process (GO:0006055),1.7408852137786303e-11,0.0
3840,N-terminal peptidyl-proline dimethylation (GO:0018016),1.7408852137786303e-11,0.0
3841,cellular response to puromycin (GO:1905795),1.7408852137786303e-11,0.0
3842,N-terminal peptidyl-glycine methylation (GO:0018013),1.7408852137786303e-11,0.0
3843,response to puromycin (GO:1905794),1.7408852137786303e-11,0.0
3844,N-terminal peptidyl-alanine trimethylation (GO:0018012),1.7408852137786303e-11,0.0
3845,N-terminal peptidyl-alanine methylation (GO:0018011),1.7408852137786303e-11,0.0
3846,UDP-N-acetylglucosamine catabolic process (GO:0006049),1.7408852137786303e-11,0.0
3847,karyogamy (GO:0000741),1.7408852137786303e-11,0.0
3848,AMPA selective glutamate receptor signaling pathway (GO:0098990),1.7408852137786303e-11,0.0
3849,NMDA selective glutamate receptor signaling pathway (GO:0098989),1.7408852137786303e-11,0.0
3850,strand displacement (GO:0000732),1.7408852137786303e-11,0.0
3851,mitotic cleavage furrow ingression (GO:1990386),1.7408852137786303e-11,0.0
3852,sno(s)RNA polyadenylation (GO:0071050),1.7408852137786303e-11,0.0
3853,anterograde dendritic transport of mitochondrion (GO:0098972),1.7408852137786303e-11,0.0
3854,negative regulation of double-stranded telomeric DNA binding (GO:1905768),1.7408852137786303e-11,0.0
3855,regulation of double-stranded telomeric DNA binding (GO:1905767),1.7408852137786303e-11,0.0
3856,nuclear histone mRNA catabolic process (GO:0071045),1.7408852137786303e-11,0.0
3857,"nucleotide-excision repair, DNA damage removal (GO:0000718)",1.7408852137786303e-11,0.0
3858,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",1.7408852137786303e-11,0.0
3859,antisense RNA transcript catabolic process (GO:0071041),1.7408852137786303e-11,0.0
3860,nuclear polyadenylation-dependent antisense transcript catabolic process (GO:0071040),1.7408852137786303e-11,0.0
3861,neurotransmitter receptor transport postsynaptic membrane to endosome (GO:0098968),1.7408852137786303e-11,0.0
3862,negative regulation of cortisol secretion (GO:0051463),1.7408852137786303e-11,0.0
3863,negative regulation of corticotropin secretion (GO:0051460),1.7408852137786303e-11,0.0
3864,meiotic joint molecule formation (GO:0000709),1.7408852137786303e-11,0.0
3865,meiotic strand invasion (GO:0000708),1.7408852137786303e-11,0.0
3866,meiotic DNA recombinase assembly (GO:0000707),1.7408852137786303e-11,0.0
3867,nuclear mRNA surveillance of mRNA 3'-end processing (GO:0071031),1.7408852137786303e-11,0.0
3868,negative regulation of cardioblast cell fate specification (GO:0009997),1.7408852137786303e-11,0.0
3869,regulation of transforming growth factor beta3 activation (GO:1901398),1.7408852137786303e-11,0.0
3870,monopolar spindle attachment to meiosis I kinetochore (GO:0051455),1.7408852137786303e-11,0.0
3871,positive regulation of transforming growth factor beta1 activation (GO:1901394),1.7408852137786303e-11,0.0
3872,regulation of transforming growth factor beta1 activation (GO:1901392),1.7408852137786303e-11,0.0
3873,cytoplasmic RNA surveillance (GO:0071026),1.7408852137786303e-11,0.0
3874,negative regulation of transforming growth factor beta activation (GO:1901389),1.7408852137786303e-11,0.0
3875,positive regulation of chorionic trophoblast cell proliferation (GO:1901384),1.7408852137786303e-11,0.0
3876,lipid hydroperoxide transport (GO:1901373),1.7408852137786303e-11,0.0
3877,"retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0098925)",1.7408852137786303e-11,0.0
3878,negative regulation of cornification (GO:1905716),1.7408852137786303e-11,0.0
3879,regulation of cornification (GO:1905715),1.7408852137786303e-11,0.0
3880,response to phosphatidylethanolamine (GO:1905711),1.7408852137786303e-11,0.0
3881,radial pattern formation (GO:0009956),1.7408852137786303e-11,0.0
3882,microtubule nucleation by interphase microtubule organizing center (GO:0051415),1.7408852137786303e-11,0.0
3883,response to cortisone (GO:0051413),1.7408852137786303e-11,0.0
3884,negative regulation of glomerulus development (GO:0090194),1.7408852137786303e-11,0.0
3885,negative regulation of inhibitory synapse assembly (GO:1905703),1.7408852137786303e-11,0.0
3886,regulation of Purkinje myocyte action potential (GO:0098906),1.7408852137786303e-11,0.0
3887,negative regulation of vasculature development involved in avascular cornea development in camera-type eye (GO:1901346),1.7408852137786303e-11,0.0
3888,response to leptomycin B (GO:1901344),1.7408852137786303e-11,0.0
3889,negative regulation of store-operated calcium channel activity (GO:1901340),1.7408852137786303e-11,0.0
3890,cell tip growth (GO:0009932),1.7408852137786303e-11,0.0
3891,positive regulation of odontoblast differentiation (GO:1901331),1.7408852137786303e-11,0.0
3892,establishment of planar polarity involved in neural tube closure (GO:0090177),1.7408852137786303e-11,0.0
3893,microtubule cytoskeleton organization involved in homologous chromosome segregation (GO:0090172),1.7408852137786303e-11,0.0
3894,chondrocyte morphogenesis (GO:0090171),1.7408852137786303e-11,0.0
3895,response to cytochalasin B (GO:1901328),1.7408852137786303e-11,0.0
3896,response to tacrolimus (GO:1901327),1.7408852137786303e-11,0.0
3897,negative regulation of heart induction (GO:1901320),1.7408852137786303e-11,0.0
3898,cell-cell adhesion involved in gastrulation (GO:0070586),1.7408852137786303e-11,0.0
3899,positive regulation of sterol regulatory element binding protein cleavage (GO:1901310),1.7408852137786303e-11,0.0
3900,negative regulation of collateral sprouting in absence of injury (GO:0048698),1.7408852137786303e-11,0.0
3901,maintenance of transcriptional fidelity during transcription elongation by RNA polymerase II (GO:0001193),1.7408852137786303e-11,0.0
3902,maintenance of transcriptional fidelity during transcription elongation (GO:0001192),1.7408852137786303e-11,0.0
3903,establishment of protein localization to mitochondrial membrane involved in mitochondrial fission (GO:0090152),1.7408852137786303e-11,0.0
3904,regulation of sterol regulatory element binding protein cleavage (GO:1901308),1.7408852137786303e-11,0.0
3905,positive regulation of spermidine biosynthetic process (GO:1901307),1.7408852137786303e-11,0.0
3906,regulation of spermidine biosynthetic process (GO:1901304),1.7408852137786303e-11,0.0
3907,negative regulation of cargo loading into COPII-coated vesicle (GO:1901303),1.7408852137786303e-11,0.0
3908,negative regulation of collateral sprouting of intact axon in response to injury (GO:0048685),1.7408852137786303e-11,0.0
3909,regulation of collateral sprouting of intact axon in response to injury (GO:0048683),1.7408852137786303e-11,0.0
3910,mitochondrial nucleoid organization (GO:0090144),1.7408852137786303e-11,0.0
3911,nucleoid organization (GO:0090143),1.7408852137786303e-11,0.0
3912,regulation of actin cytoskeleton organization by cell-cell adhesion (GO:0090138),1.7408852137786303e-11,0.0
3913,transcriptional start site selection at RNA polymerase II promoter (GO:0001174),1.7408852137786303e-11,0.0
3914,actin filament branching (GO:0090135),1.7408852137786303e-11,0.0
3915,DNA-templated transcriptional start site selection (GO:0001173),1.7408852137786303e-11,0.0
3916,reverse transcription (GO:0001171),1.7408852137786303e-11,0.0
3917,detection of mechanical stimulus involved in equilibrioception (GO:0050973),1.7408852137786303e-11,0.0
3918,protein-containing complex assembly involved in synapse maturation (GO:0090126),1.7408852137786303e-11,0.0
3919,cholesterol ester hydrolysis involved in cholesterol transport (GO:0090122),1.7408852137786303e-11,0.0
3920,pancreatic epsilon cell differentiation (GO:0090104),1.7408852137786303e-11,0.0
3921,positive regulation of histone H4-K20 methylation (GO:0070512),1.7408852137786303e-11,0.0
3922,regulation of histone H4-K20 methylation (GO:0070510),1.7408852137786303e-11,0.0
3923,negative regulation of cell adhesion involved in sprouting angiogenesis (GO:0106089),1.7408852137786303e-11,0.0
3924,regulation of cell adhesion involved in sprouting angiogenesis (GO:0106088),1.7408852137786303e-11,0.0
3925,myoblast fate specification (GO:0048626),1.7408852137786303e-11,0.0
3926,post-embryonic digestive tract morphogenesis (GO:0048621),1.7408852137786303e-11,0.0
3927,induction of negative chemotaxis (GO:0050929),1.7408852137786303e-11,0.0
3928,negative regulation of positive chemotaxis (GO:0050928),1.7408852137786303e-11,0.0
3929,positive regulation of negative chemotaxis (GO:0050924),1.7408852137786303e-11,0.0
3930,embryonic ectodermal digestive tract morphogenesis (GO:0048613),1.7408852137786303e-11,0.0
3931,transcription open complex formation at RNA polymerase II promoter (GO:0001113),1.7408852137786303e-11,0.0
3932,RNA polymerase II promoter clearance (GO:0001111),1.7408852137786303e-11,0.0
3933,regulation of cobalamin metabolic process (GO:0106064),1.7408852137786303e-11,0.0
3934,promoter clearance during DNA-templated transcription (GO:0001109),1.7408852137786303e-11,0.0
3935,negative regulation of exit from mitosis (GO:0001100),1.7408852137786303e-11,0.0
3936,lipid ubiquitination (GO:0120323),1.7408852137786303e-11,0.0
3937,lipid modification by small protein conjugation (GO:0120322),1.7408852137786303e-11,0.0
3938,spermidine deacetylation (GO:0106048),1.7408852137786303e-11,0.0
3939,polyamine deacetylation (GO:0106047),1.7408852137786303e-11,0.0
3940,"guanine deglycation, glyoxal removal (GO:0106046)",1.7408852137786303e-11,0.0
3941,"guanine deglycation, methylglyoxal removal (GO:0106045)",1.7408852137786303e-11,0.0
3942,guanine deglycation (GO:0106044),1.7408852137786303e-11,0.0
3943,regulation of GABA-A receptor activity (GO:0106040),1.7408852137786303e-11,0.0
3944,positive regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900827),1.7408852137786303e-11,0.0
3945,negative regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900826),1.7408852137786303e-11,0.0
3946,positive regulation of nucleoside transport (GO:0032244),1.7408852137786303e-11,0.0
3947,negative regulation of nucleoside transport (GO:0032243),1.7408852137786303e-11,0.0
3948,neuron projection retraction (GO:0106028),1.7408852137786303e-11,0.0
3949,positive regulation of vesicle docking (GO:0106022),1.7408852137786303e-11,0.0
3950,"negative regulation of synaptic transmission, cholinergic (GO:0032223)",1.7408852137786303e-11,0.0
3951,negative regulation of telomere maintenance via recombination (GO:0032208),1.7408852137786303e-11,0.0
3952,regulation of telomere maintenance via recombination (GO:0032207),1.7408852137786303e-11,0.0
3953,telomere formation via telomerase (GO:0032203),1.7408852137786303e-11,0.0
3954,positive regulation of polysome binding (GO:1905698),1.7408852137786303e-11,0.0
3955,positive regulation of phosphatidic acid biosynthetic process (GO:1905695),1.7408852137786303e-11,0.0
3956,regulation of phosphatidic acid biosynthetic process (GO:1905693),1.7408852137786303e-11,0.0
3957,regulation of nerve growth factor receptor activity (GO:0051394),1.7408852137786303e-11,0.0
3958,tRNA acetylation (GO:0051391),1.7408852137786303e-11,0.0
3959,positive regulation of diacylglycerol kinase activity (GO:1905689),1.7408852137786303e-11,0.0
3960,regulation of diacylglycerol kinase activity (GO:1905687),1.7408852137786303e-11,0.0
3961,RNA localization to chromatin (GO:1990280),1.7408852137786303e-11,0.0
3962,positive regulation of adaptive immune memory response (GO:1905676),1.7408852137786303e-11,0.0
3963,positive regulation of lysosome organization (GO:1905673),1.7408852137786303e-11,0.0
3964,negative regulation of lysosome organization (GO:1905672),1.7408852137786303e-11,0.0
3965,TORC1 complex assembly (GO:1905669),1.7408852137786303e-11,0.0
3966,negative regulation of protein localization to endosome (GO:1905667),1.7408852137786303e-11,0.0
3967,negative regulation of telomerase RNA reverse transcriptase activity (GO:1905662),1.7408852137786303e-11,0.0
3968,protein decanoylation (GO:0051366),1.7408852137786303e-11,0.0
3969,anti-Mullerian hormone signaling pathway (GO:1990262),1.7408852137786303e-11,0.0
3970,pre-mRNA catabolic process (GO:1990261),1.7408852137786303e-11,0.0
3971,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901297),1.7408852137786303e-11,0.0
3972,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901296),1.7408852137786303e-11,0.0
3973,proprioception involved in equilibrioception (GO:0051355),1.7408852137786303e-11,0.0
3974,signal clustering (GO:1990256),1.7408852137786303e-11,0.0
3975,negative regulation of double-strand break repair via single-strand annealing (GO:1901291),1.7408852137786303e-11,0.0
3976,cellular detoxification of cadmium ion (GO:0098849),1.7408852137786303e-11,0.0
3977,regulation of transcription from RNA polymerase II promoter in response to DNA damage (GO:1990248),1.7408852137786303e-11,0.0
3978,cellular response to glyceraldehyde (GO:1905631),1.7408852137786303e-11,0.0
3979,response to glyceraldehyde (GO:1905630),1.7408852137786303e-11,0.0
3980,regulation of serotonin biosynthetic process (GO:1905627),1.7408852137786303e-11,0.0
3981,intestinal folate absorption (GO:0098829),1.7408852137786303e-11,0.0
3982,prophase (GO:0051324),1.7408852137786303e-11,0.0
3983,anaphase (GO:0051322),1.7408852137786303e-11,0.0
3984,positive regulation of mRNA cap binding (GO:1905612),1.7408852137786303e-11,0.0
3985,G2 phase (GO:0051319),1.7408852137786303e-11,0.0
3986,regulation of mRNA cap binding (GO:1905610),1.7408852137786303e-11,0.0
3987,negative regulation of macrophage colony-stimulating factor production (GO:1901257),1.7408852137786303e-11,0.0
3988,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation (GO:0051316),1.7408852137786303e-11,0.0
3989,positive regulation of intracellular transport of viral material (GO:1901254),1.7408852137786303e-11,0.0
3990,auxin metabolic process (GO:0009850),1.7408852137786303e-11,0.0
3991,positive regulation of lung goblet cell differentiation (GO:1901251),1.7408852137786303e-11,0.0
3992,positive regulation of metanephric cap mesenchymal cell proliferation (GO:0090096),1.7408852137786303e-11,0.0
3993,regulation of metanephric cap mesenchymal cell proliferation (GO:0090095),1.7408852137786303e-11,0.0
3994,metanephric cap mesenchymal cell proliferation involved in metanephros development (GO:0090094),1.7408852137786303e-11,0.0
3995,positive regulation of smooth muscle cell-matrix adhesion (GO:1905609),1.7408852137786303e-11,0.0
3996,positive regulation of presynapse assembly (GO:1905608),1.7408852137786303e-11,0.0
3997,negative regulation of presynapse assembly (GO:1905607),1.7408852137786303e-11,0.0
3998,regulation of lung goblet cell differentiation (GO:1901249),1.7408852137786303e-11,0.0
3999,male meiosis chromosome separation (GO:0051308),1.7408852137786303e-11,0.0
4000,negative regulation of lung ciliated cell differentiation (GO:1901247),1.7408852137786303e-11,0.0
4001,negative regulation of convergent extension involved in axis elongation (GO:1901233),1.7408852137786303e-11,0.0
4002,regulation of convergent extension involved in axis elongation (GO:1901232),1.7408852137786303e-11,0.0
4003,positive regulation of non-canonical Wnt signaling pathway via JNK cascade (GO:1901231),1.7408852137786303e-11,0.0
4004,negative regulation of protein homodimerization activity (GO:0090074),1.7408852137786303e-11,0.0
4005,positive regulation of protein homodimerization activity (GO:0090073),1.7408852137786303e-11,0.0
4006,regulation of non-canonical Wnt signaling pathway via JNK cascade (GO:1901229),1.7408852137786303e-11,0.0
4007,regulation of thalamus size (GO:0090067),1.7408852137786303e-11,0.0
4008,"nuclear-transcribed mRNA catabolic process, non-stop decay (GO:0070481)",1.7408852137786303e-11,0.0
4009,stilbene metabolic process (GO:0009810),1.7408852137786303e-11,0.0
4010,negative regulation of cardiac chamber formation (GO:1901211),1.7408852137786303e-11,0.0
4011,regulation of cardiac chamber formation (GO:1901210),1.7408852137786303e-11,0.0
4012,"nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay (GO:0070478)",1.7408852137786303e-11,0.0
4013,negative regulation of heart looping (GO:1901208),1.7408852137786303e-11,0.0
4014,uterine smooth muscle contraction (GO:0070471),1.7408852137786303e-11,0.0
4015,negative regulation of extracellular matrix assembly (GO:1901202),1.7408852137786303e-11,0.0
4016,determination of affect (GO:0050894),1.7408852137786303e-11,0.0
4017,positive regulation of tubulin deacetylation (GO:0090044),1.7408852137786303e-11,0.0
4018,nitrogen catabolite activation of transcription from RNA polymerase II promoter (GO:0001080),1.7408852137786303e-11,0.0
4019,plus-end specific microtubule depolymerization (GO:0070462),1.7408852137786303e-11,0.0
4020,nitrogen catabolite regulation of transcription from RNA polymerase II promoter (GO:0001079),1.7408852137786303e-11,0.0
4021,positive regulation of chaperone-mediated protein complex assembly (GO:0090035),1.7408852137786303e-11,0.0
4022,short-day photoperiodism (GO:0048572),1.7408852137786303e-11,0.0
4023,regulation of chaperone-mediated protein complex assembly (GO:0090034),1.7408852137786303e-11,0.0
4024,long-day photoperiodism (GO:0048571),1.7408852137786303e-11,0.0
4025,ectodermal digestive tract morphogenesis (GO:0048567),1.7408852137786303e-11,0.0
4026,negative regulation of oligodendrocyte progenitor proliferation (GO:0070446),1.7408852137786303e-11,0.0
4027,transforming growth factor beta receptor signaling pathway involved in primitive streak formation (GO:0090010),1.7408852137786303e-11,0.0
4028,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070429),1.7408852137786303e-11,0.0
4029,antibiotic metabolic process (GO:0016999),1.7408852137786303e-11,0.0
4030,trehalose metabolism in response to stress (GO:0070413),1.7408852137786303e-11,0.0
4031,olefinic compound catabolic process (GO:0120256),1.7408852137786303e-11,0.0
4032,carbamoyl phosphate biosynthetic process (GO:0070409),1.7408852137786303e-11,0.0
4033,carbamoyl phosphate metabolic process (GO:0070408),1.7408852137786303e-11,0.0
4034,oxidation-dependent protein catabolic process (GO:0070407),1.7408852137786303e-11,0.0
4035,reverse transcription involved in RNA-mediated transposition (GO:0032199),1.7408852137786303e-11,0.0
4036,"ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate (GO:0032194)",1.7408852137786303e-11,0.0
4037,peptide antigen stabilization (GO:0050823),1.7408852137786303e-11,0.0
4038,peptide stabilization (GO:0050822),1.7408852137786303e-11,0.0
4039,negative regulation of D-amino-acid oxidase activity (GO:1900758),1.7408852137786303e-11,0.0
4040,regulation of D-amino-acid oxidase activity (GO:1900757),1.7408852137786303e-11,0.0
4041,doxorubicin transport (GO:1900753),1.7408852137786303e-11,0.0
4042,glutathione deglycation (GO:0036531),1.7408852137786303e-11,0.0
4043,"protein deglycation, methylglyoxal removal (GO:0036530)",1.7408852137786303e-11,0.0
4044,"protein deglycation, glyoxal removal (GO:0036529)",1.7408852137786303e-11,0.0
4045,peptidyl-lysine deglycation (GO:0036528),1.7408852137786303e-11,0.0
4046,peptidyl-arginine deglycation (GO:0036527),1.7408852137786303e-11,0.0
4047,peptidyl-cysteine deglycation (GO:0036526),1.7408852137786303e-11,0.0
4048,maintenance of ciliary planar beating movement pattern (GO:0120221),1.7408852137786303e-11,0.0
4049,negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900737),1.7408852137786303e-11,0.0
4050,positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:1900731),1.7408852137786303e-11,0.0
4051,chemoattraction of serotonergic neuron axon (GO:0036517),1.7408852137786303e-11,0.0
4052,proacrosomal vesicle fusion (GO:0120211),1.7408852137786303e-11,0.0
4053,regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:1900729),1.7408852137786303e-11,0.0
4054,positive regulation of uterine smooth muscle relaxation (GO:1900721),1.7408852137786303e-11,0.0
4055,formation of structure involved in a symbiotic process (GO:0044111),1.7408852137786303e-11,0.0
4056,regulation of uterine smooth muscle relaxation (GO:1900719),1.7408852137786303e-11,0.0
4057,regulation of carbohydrate phosphatase activity (GO:0032113),1.7408852137786303e-11,0.0
4058,positive regulation of low-density lipoprotein particle receptor binding (GO:1905597),1.7408852137786303e-11,0.0
4059,negative regulation of low-density lipoprotein particle receptor binding (GO:1905596),1.7408852137786303e-11,0.0
4060,establishment of meiotic spindle orientation (GO:0051296),1.7408852137786303e-11,0.0
4061,induction of programmed cell death (GO:0012502),1.7408852137786303e-11,0.0
4062,positive regulation of L-arginine import across plasma membrane (GO:1905589),1.7408852137786303e-11,0.0
4063,negative regulation of outer hair cell apoptotic process (GO:1905586),1.7408852137786303e-11,0.0
4064,regulation of outer hair cell apoptotic process (GO:1905585),1.7408852137786303e-11,0.0
4065,positive regulation of ERBB3 signaling pathway (GO:1905580),1.7408852137786303e-11,0.0
4066,biofilm matrix disassembly (GO:0098786),1.7408852137786303e-11,0.0
4067,biofilm matrix organization (GO:0098784),1.7408852137786303e-11,0.0
4068,regulation of ERBB3 signaling pathway (GO:1905578),1.7408852137786303e-11,0.0
4069,ganglioside GM1 transport to membrane (GO:1905572),1.7408852137786303e-11,0.0
4070,cellular response to interleukin-21 (GO:0098757),1.7408852137786303e-11,0.0
4071,response to interleukin-21 (GO:0098756),1.7408852137786303e-11,0.0
4072,negative regulation of formation of translation preinitiation complex (GO:1901194),1.7408852137786303e-11,0.0
4073,regulation of formation of translation preinitiation complex (GO:1901193),1.7408852137786303e-11,0.0
4074,cellular response to phenylpropanoid (GO:1905546),1.7408852137786303e-11,0.0
4075,positive regulation of abscisic acid-activated signaling pathway (GO:0009789),1.7408852137786303e-11,0.0
4076,regulation of abscisic acid-activated signaling pathway (GO:0009787),1.7408852137786303e-11,0.0
4077,positive regulation of ephrin receptor signaling pathway (GO:1901189),1.7408852137786303e-11,0.0
4078,"fast, calcium ion-dependent exocytosis of neurotransmitter (GO:0098746)",1.7408852137786303e-11,0.0
4079,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process (GO:0043630),1.7408852137786303e-11,0.0
4080,positive regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905537),1.7408852137786303e-11,0.0
4081,regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905535),1.7408852137786303e-11,0.0
4082,positive regulation of leucine import across plasma membrane (GO:1905534),1.7408852137786303e-11,0.0
4083,protein insertion into plasma membrane (GO:0098737),1.7408852137786303e-11,0.0
4084,negative regulation of the force of heart contraction (GO:0098736),1.7408852137786303e-11,0.0
4085,lycopene catabolic process (GO:1901176),1.7408852137786303e-11,0.0
4086,lycopene metabolic process (GO:1901175),1.7408852137786303e-11,0.0
4087,epithelial cell apoptotic process involved in palatal shelf morphogenesis (GO:1990134),1.7408852137786303e-11,0.0
4088,meiotic spindle elongation (GO:0051232),1.7408852137786303e-11,0.0
4089,naphthalene catabolic process (GO:1901170),1.7408852137786303e-11,0.0
4090,negative regulation of heat generation (GO:0031651),1.7408852137786303e-11,0.0
4091,positive regulation of Golgi lumen acidification (GO:1905528),1.7408852137786303e-11,0.0
4092,positive regulation of presynaptic active zone assembly (GO:1905520),1.7408852137786303e-11,0.0
4093,symmetric cell division (GO:0098725),1.7408852137786303e-11,0.0
4094,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1990127),1.7408852137786303e-11,0.0
4095,regulation of carbohydrate utilization (GO:0043610),1.7408852137786303e-11,0.0
4096,regulation of presynaptic active zone assembly (GO:1905518),1.7408852137786303e-11,0.0
4097,negative regulation of short-term synaptic potentiation (GO:1905513),1.7408852137786303e-11,0.0
4098,regulation of short-term synaptic potentiation (GO:1905512),1.7408852137786303e-11,0.0
4099,B cell receptor apoptotic signaling pathway (GO:1990117),1.7408852137786303e-11,0.0
4100,response to salicylic acid (GO:0009751),1.7408852137786303e-11,0.0
4101,RNA polymerase II core complex assembly (GO:1990114),1.7408852137786303e-11,0.0
4102,nitrate catabolic process (GO:0043602),1.7408852137786303e-11,0.0
4103,positive regulation of motile cilium assembly (GO:1905505),1.7408852137786303e-11,0.0
4104,regulation of motile cilium assembly (GO:1905503),1.7408852137786303e-11,0.0
4105,gene expression involved in extracellular matrix organization (GO:1901148),1.7408852137786303e-11,0.0
4106,copper ion import across plasma membrane (GO:0098705),1.7408852137786303e-11,0.0
4107,mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:1901145),1.7408852137786303e-11,0.0
4108,gibberellic acid mediated signaling pathway (GO:0009740),1.7408852137786303e-11,0.0
4109,response to gibberellin (GO:0009739),1.7408852137786303e-11,0.0
4110,gentamycin metabolic process (GO:1901128),1.7408852137786303e-11,0.0
4111,detection of lipoteichoic acid (GO:0070392),1.7408852137786303e-11,0.0
4112,positive regulation of hepatocyte differentiation (GO:0070368),1.7408852137786303e-11,0.0
4113,negative regulation of hepatocyte differentiation (GO:0070367),1.7408852137786303e-11,0.0
4114,detoxification of mercury ion (GO:0050787),1.7408852137786303e-11,0.0
4115,cocaine metabolic process (GO:0050783),1.7408852137786303e-11,0.0
4116,positive regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036494),1.7408852137786303e-11,0.0
4117,negative regulation of bile acid secretion (GO:0120190),1.7408852137786303e-11,0.0
4118,white fat cell proliferation (GO:0070343),1.7408852137786303e-11,0.0
4119,positive regulation of bile acid secretion (GO:0120189),1.7408852137786303e-11,0.0
4120,negative regulation of protein localization to chromatin (GO:0120186),1.7408852137786303e-11,0.0
4121,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0036483),1.7408852137786303e-11,0.0
4122,focal adhesion disassembly (GO:0120181),1.7408852137786303e-11,0.0
4123,cell-substrate junction disassembly (GO:0120180),1.7408852137786303e-11,0.0
4124,adherens junction disassembly (GO:0120179),1.7408852137786303e-11,0.0
4125,cellular response to glyoxal (GO:0036471),1.7408852137786303e-11,0.0
4126,modulation by symbiont of host cellular process (GO:0044068),1.7408852137786303e-11,0.0
4127,positive regulation of collagen catabolic process (GO:0120158),1.7408852137786303e-11,0.0
4128,negative regulation of ERBB4 signaling pathway (GO:0120154),1.7408852137786303e-11,0.0
4129,myofibroblast differentiation (GO:0036446),1.7408852137786303e-11,0.0
4130,neuronal stem cell division (GO:0036445),1.7408852137786303e-11,0.0
4131,translocation of peptides or proteins into host cell cytoplasm (GO:0044053),1.7408852137786303e-11,0.0
4132,regulation of presynaptic dense core granule exocytosis (GO:0099161),1.7408852137786303e-11,0.0
4133,regulation of recycling endosome localization within postsynapse (GO:0099158),1.7408852137786303e-11,0.0
4134,cell-cell signaling via exosome (GO:0099156),1.7408852137786303e-11,0.0
4135,negative regulation of endodeoxyribonuclease activity (GO:0032078),1.7408852137786303e-11,0.0
4136,regulation of restriction endodeoxyribonuclease activity (GO:0032072),1.7408852137786303e-11,0.0
4137,response to copper ion starvation (GO:0120126),1.7408852137786303e-11,0.0
4138,T cell meandering migration (GO:0120117),1.7408852137786303e-11,0.0
4139,glucagon processing (GO:0120116),1.7408852137786303e-11,0.0
4140,mitochondrial DNA catabolic process (GO:0032043),1.7408852137786303e-11,0.0
4141,modulation by symbiont of host process (GO:0044003),1.7408852137786303e-11,0.0
4142,"ion channel modulating, G protein-coupled receptor signaling pathway (GO:0099105)",1.7408852137786303e-11,0.0
4143,maturation of 5S rRNA (GO:0000481),1.7408852137786303e-11,0.0
4144,trypsinogen activation (GO:0032023),1.7408852137786303e-11,0.0
4145,"endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000461)",1.7408852137786303e-11,0.0
4146,"7,8-dihydroneopterin 3'-triphosphate biosynthetic process (GO:0035998)",1.7408852137786303e-11,0.0
4147,enzyme-directed rRNA 2'-O-methylation (GO:0000453),1.7408852137786303e-11,0.0
4148,positive regulation of branching morphogenesis of a nerve (GO:1905492),1.7408852137786303e-11,0.0
4149,regulation of synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0098694),1.7408852137786303e-11,0.0
4150,calcium-dependent self proteolysis (GO:1990092),1.7408852137786303e-11,0.0
4151,peptidyl-histidine dephosphorylation (GO:0035971),1.7408852137786303e-11,0.0
4152,positive regulation of motor neuron migration (GO:1905485),1.7408852137786303e-11,0.0
4153,positive regulation of transcription from RNA polymerase II promoter by galactose (GO:0000435),1.7408852137786303e-11,0.0
4154,regulation of motor neuron migration (GO:1905483),1.7408852137786303e-11,0.0
4155,regulation of transcription from RNA polymerase II promoter by galactose (GO:0000431),1.7408852137786303e-11,0.0
4156,canonical Wnt signaling pathway involved in stem cell proliferation (GO:1905474),1.7408852137786303e-11,0.0
4157,positive regulation of transcription by galactose (GO:0000411),1.7408852137786303e-11,0.0
4158,regulation of translation in response to oxidative stress (GO:0043556),1.7408852137786303e-11,0.0
4159,mitochondrial mRNA surveillance (GO:0035946),1.7408852137786303e-11,0.0
4160,L-xylitol metabolic process (GO:0051164),1.7408852137786303e-11,0.0
4161,mitochondrial ncRNA surveillance (GO:0035945),1.7408852137786303e-11,0.0
4162,L-xylitol catabolic process (GO:0051160),1.7408852137786303e-11,0.0
4163,phospholipase D-activating G protein-coupled receptor signaling pathway (GO:0031583),1.7408852137786303e-11,0.0
4164,regulation of transcription by galactose (GO:0000409),1.7408852137786303e-11,0.0
4165,negative regulation of myeloid progenitor cell differentiation (GO:1905454),1.7408852137786303e-11,0.0
4166,ethylene metabolic process (GO:0009692),1.7408852137786303e-11,0.0
4167,aldosterone secretion (GO:0035932),1.7408852137786303e-11,0.0
4168,mineralocorticoid secretion (GO:0035931),1.7408852137786303e-11,0.0
4169,regulation of actin phosphorylation (GO:0043538),1.7408852137786303e-11,0.0
4170,indoleacetic acid metabolic process (GO:0009683),1.7408852137786303e-11,0.0
4171,induced systemic resistance (GO:0009682),1.7408852137786303e-11,0.0
4172,positive regulation of relaxation of smooth muscle (GO:1901082),1.7408852137786303e-11,0.0
4173,negative regulation of NK T cell proliferation (GO:0051141),1.7408852137786303e-11,0.0
4174,negative regulation of relaxation of smooth muscle (GO:1901081),1.7408852137786303e-11,0.0
4175,foramen ovale closure (GO:0035922),1.7408852137786303e-11,0.0
4176,desmosome disassembly (GO:0035921),1.7408852137786303e-11,0.0
4177,negative regulation of retrograde trans-synaptic signaling by neuropeptide (GO:1905433),1.7408852137786303e-11,0.0
4178,regulation of retrograde trans-synaptic signaling by neuropeptide (GO:1905432),1.7408852137786303e-11,0.0
4179,regulation of myosin II filament organization (GO:0043519),1.7408852137786303e-11,0.0
4180,guanosine-containing compound metabolic process (GO:1901068),1.7408852137786303e-11,0.0
4181,vasomotion (GO:1990029),1.7408852137786303e-11,0.0
4182,descending aorta development (GO:0035906),1.7408852137786303e-11,0.0
4183,negative regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031549),1.7408852137786303e-11,0.0
4184,positive regulation of dense core granule exocytosis (GO:1905415),1.7408852137786303e-11,0.0
4185,sarcosine catabolic process (GO:1901053),1.7408852137786303e-11,0.0
4186,"positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905404)",1.7408852137786303e-11,0.0
4187,response to low light intensity stimulus (GO:0009645),1.7408852137786303e-11,0.0
4188,negative regulation of DNA ligation (GO:0051107),1.7408852137786303e-11,0.0
4189,DNA ligation involved in DNA recombination (GO:0051102),1.7408852137786303e-11,0.0
4190,positive regulation of L-glutamine import across plasma membrane (GO:1901036),1.7408852137786303e-11,0.0
4191,regulation of L-glutamine import across plasma membrane (GO:1901034),1.7408852137786303e-11,0.0
4192,dextrin catabolic process (GO:1901027),1.7408852137786303e-11,0.0
4193,ripoptosome assembly involved in necroptotic process (GO:1901026),1.7408852137786303e-11,0.0
4194,pigment cell development (GO:0070285),1.7408852137786303e-11,0.0
4195,intermediate mesodermal cell differentiation (GO:0048392),1.7408852137786303e-11,0.0
4196,intermediate mesoderm formation (GO:0048391),1.7408852137786303e-11,0.0
4197,intermediate mesoderm morphogenesis (GO:0048390),1.7408852137786303e-11,0.0
4198,negative regulation of leukocyte adhesion to arterial endothelial cell (GO:1904998),1.7408852137786303e-11,0.0
4199,ubiquinone-6 biosynthetic process (GO:1901006),1.7408852137786303e-11,0.0
4200,ubiquinone-6 metabolic process (GO:1901004),1.7408852137786303e-11,0.0
4201,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904992),1.7408852137786303e-11,0.0
4202,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904990),1.7408852137786303e-11,0.0
4203,oncosis (GO:0070267),1.7408852137786303e-11,0.0
4204,negative regulation of quinolinate biosynthetic process (GO:1904985),1.7408852137786303e-11,0.0
4205,regulation of quinolinate biosynthetic process (GO:1904984),1.7408852137786303e-11,0.0
4206,glycine import into mitochondrion (GO:1904983),1.7408852137786303e-11,0.0
4207,positive regulation of endosome organization (GO:1904980),1.7408852137786303e-11,0.0
4208,regulation of lateral mesodermal cell fate specification (GO:0048378),1.7408852137786303e-11,0.0
4209,somatostatin secretion (GO:0070253),1.7408852137786303e-11,0.0
4210,positive regulation of urothelial cell proliferation (GO:0050677),1.7408852137786303e-11,0.0
4211,regulation of urothelial cell proliferation (GO:0050675),1.7408852137786303e-11,0.0
4212,urothelial cell proliferation (GO:0050674),1.7408852137786303e-11,0.0
4213,TCR signalosome assembly (GO:0036399),1.7408852137786303e-11,0.0
4214,negative regulation of peptidyl-lysine crotonylation (GO:0120094),1.7408852137786303e-11,0.0
4215,regulation of natural killer cell apoptotic process (GO:0070247),1.7408852137786303e-11,0.0
4216,regulation of peptidyl-lysine crotonylation (GO:0120093),1.7408852137786303e-11,0.0
4217,positive regulation of activated T cell autonomous cell death (GO:0070241),1.7408852137786303e-11,0.0
4218,regulation of homocysteine metabolic process (GO:0050666),1.7408852137786303e-11,0.0
4219,paraxial mesoderm structural organization (GO:0048352),1.7408852137786303e-11,0.0
4220,regulation of activated T cell autonomous cell death (GO:0070239),1.7408852137786303e-11,0.0
4221,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation (GO:1904955),1.7408852137786303e-11,0.0
4222,"dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0050652)",1.7408852137786303e-11,0.0
4223,cell adhesion involved in sprouting angiogenesis (GO:0120078),1.7408852137786303e-11,0.0
4224,angiogenic sprout fusion (GO:0120077),1.7408852137786303e-11,0.0
4225,positive regulation of pyloric antrum smooth muscle contraction (GO:0120072),1.7408852137786303e-11,0.0
4226,regulation of pyloric antrum smooth muscle contraction (GO:0120071),1.7408852137786303e-11,0.0
4227,folate import into mitochondrion (GO:1904947),1.7408852137786303e-11,0.0
4228,mesoderm structural organization (GO:0048338),1.7408852137786303e-11,0.0
4229,positive regulation of mesodermal cell fate specification (GO:0048337),1.7408852137786303e-11,0.0
4230,axonal transport of messenger ribonucleoprotein complex (GO:0099088),1.7408852137786303e-11,0.0
4231,anterograde axonal transport of messenger ribonucleoprotein complex (GO:0099087),1.7408852137786303e-11,0.0
4232,cone photoresponse recovery (GO:0036368),1.7408852137786303e-11,0.0
4233,positive regulation of cell proliferation in midbrain (GO:1904935),1.7408852137786303e-11,0.0
4234,negative regulation of cell proliferation in midbrain (GO:1904934),1.7408852137786303e-11,0.0
4235,axial mesodermal cell fate specification (GO:0048327),1.7408852137786303e-11,0.0
4236,axial mesodermal cell fate commitment (GO:0048322),1.7408852137786303e-11,0.0
4237,axial mesodermal cell differentiation (GO:0048321),1.7408852137786303e-11,0.0
4238,protein heterotrimerization (GO:0070208),1.7408852137786303e-11,0.0
4239,histone H2A-K15 ubiquitination (GO:0036352),1.7408852137786303e-11,0.0
4240,histone H2A-K13 ubiquitination (GO:0036351),1.7408852137786303e-11,0.0
4241,negative regulation of mitophagy in response to mitochondrial depolarization (GO:1904924),1.7408852137786303e-11,0.0
4242,negative regulation of macrophage proliferation (GO:0120042),1.7408852137786303e-11,0.0
4243,negative regulation of establishment of protein-containing complex localization to telomere (GO:1904914),1.7408852137786303e-11,0.0
4244,regulation of establishment of protein-containing complex localization to telomere (GO:1904913),1.7408852137786303e-11,0.0
4245,negative regulation of establishment of RNA localization to telomere (GO:1904911),1.7408852137786303e-11,0.0
4246,regulation of establishment of RNA localization to telomere (GO:1904910),1.7408852137786303e-11,0.0
4247,lymphocyte adhesion to endothelial cell of high endothelial venule (GO:0036339),1.7408852137786303e-11,0.0
4248,hepatocyte homeostasis (GO:0036333),1.7408852137786303e-11,0.0
4249,avascular cornea development in camera-type eye (GO:0036331),1.7408852137786303e-11,0.0
4250,negative regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904905),1.7408852137786303e-11,0.0
4251,ESCRT III complex assembly (GO:1904902),1.7408852137786303e-11,0.0
4252,clearance of foreign intracellular nucleic acids (GO:0099046),1.7408852137786303e-11,0.0
4253,vascular endothelial growth factor receptor-3 signaling pathway (GO:0036325),1.7408852137786303e-11,0.0
4254,vascular endothelial growth factor receptor-1 signaling pathway (GO:0036323),1.7408852137786303e-11,0.0
4255,intermembrane sphingolipid transfer (GO:0120012),1.7408852137786303e-11,0.0
4256,embryonic heart tube elongation (GO:0036306),1.7408852137786303e-11,0.0
4257,spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) (GO:0000388),1.7408852137786303e-11,0.0
4258,RNA exon ligation (GO:0000378),1.7408852137786303e-11,0.0
4259,regulation of protein heterodimerization activity (GO:0043497),1.7408852137786303e-11,0.0
4260,cellular response to flavonoid (GO:1905396),1.7408852137786303e-11,0.0
4261,cellular response to copper ion starvation (GO:0035874),1.7408852137786303e-11,0.0
4262,negative regulation of snRNA transcription by RNA polymerase II (GO:1905381),1.7408852137786303e-11,0.0
4263,constitutive protein ectodomain proteolysis (GO:0051089),1.7408852137786303e-11,0.0
4264,chaperone mediated protein folding independent of cofactor (GO:0051086),1.7408852137786303e-11,0.0
4265,dITP catabolic process (GO:0035863),1.7408852137786303e-11,0.0
4266,dITP metabolic process (GO:0035862),1.7408852137786303e-11,0.0
4267,ceramide phosphoethanolamine biosynthetic process (GO:1905373),1.7408852137786303e-11,0.0
4268,ceramide phosphoethanolamine metabolic process (GO:1905371),1.7408852137786303e-11,0.0
4269,chromosome passenger complex localization to spindle midzone (GO:0035853),1.7408852137786303e-11,0.0
4270,regulation of endosomal vesicle fusion (GO:1905364),1.7408852137786303e-11,0.0
4271,nephric duct elongation (GO:0035849),1.7408852137786303e-11,0.0
4272,uterine epithelium development (GO:0035847),1.7408852137786303e-11,0.0
4273,protein localization to meiotic spindle (GO:1905359),1.7408852137786303e-11,0.0
4274,spine apparatus assembly (GO:1905355),1.7408852137786303e-11,0.0
4275,response to singlet oxygen (GO:0000304),1.7408852137786303e-11,0.0
4276,detection of UV (GO:0009589),1.7408852137786303e-11,0.0
4277,negative regulation of protein localization to kinetochore (GO:1905341),1.7408852137786303e-11,0.0
4278,acetoacetic acid metabolic process (GO:0043438),1.7408852137786303e-11,0.0
4279,N-terminal peptidyl-glutamine acetylation (GO:0017192),1.7408852137786303e-11,0.0
4280,negative regulation of calcium-independent cell-cell adhesion (GO:0051042),1.7408852137786303e-11,0.0
4281,positive regulation of calcium-independent cell-cell adhesion (GO:0051041),1.7408852137786303e-11,0.0
4282,positive regulation of transcription involved in meiotic cell cycle (GO:0051039),1.7408852137786303e-11,0.0
4283,regulation of transcription involved in meiotic cell cycle (GO:0051037),1.7408852137786303e-11,0.0
4284,positive regulation of strand invasion (GO:0098530),1.7408852137786303e-11,0.0
4285,"neuromuscular junction development, skeletal muscle fiber (GO:0098529)",1.7408852137786303e-11,0.0
4286,negative regulation of skeletal muscle tissue regeneration (GO:0043417),1.7408852137786303e-11,0.0
4287,slow-twitch skeletal muscle fiber contraction (GO:0031444),1.7408852137786303e-11,0.0
4288,fast-twitch skeletal muscle fiber contraction (GO:0031443),1.7408852137786303e-11,0.0
4289,mesenchymal stem cell migration (GO:1905319),1.7408852137786303e-11,0.0
4290,inferior endocardial cushion morphogenesis (GO:1905317),1.7408852137786303e-11,0.0
4291,transforming growth factor beta receptor signaling pathway involved in heart development (GO:1905313),1.7408852137786303e-11,0.0
4292,glucocorticoid mediated signaling pathway (GO:0043402),1.7408852137786303e-11,0.0
4293,cortisol secretion (GO:0043400),1.7408852137786303e-11,0.0
4294,positive regulation of mRNA cleavage (GO:0031439),1.7408852137786303e-11,0.0
4295,regulation of mRNA cleavage (GO:0031437),1.7408852137786303e-11,0.0
4296,negative regulation of cardiac myofibril assembly (GO:1905305),1.7408852137786303e-11,0.0
4297,regulation of cardiac myofibril assembly (GO:1905304),1.7408852137786303e-11,0.0
4298,negative regulation of macropinocytosis (GO:1905302),1.7408852137786303e-11,0.0
4299,response to methotrexate (GO:0031427),1.7408852137786303e-11,0.0
4300,insecticide metabolic process (GO:0017143),1.7408852137786303e-11,0.0
4301,mitochondrial tyrosyl-tRNA aminoacylation (GO:0070184),1.7408852137786303e-11,0.0
4302,mitochondrial tryptophanyl-tRNA aminoacylation (GO:0070183),1.7408852137786303e-11,0.0
4303,regulation of Golgi to plasma membrane CFTR protein transport (GO:0042999),1.7408852137786303e-11,0.0
4304,negative regulation of isotype switching to IgA isotypes (GO:0048297),1.7408852137786303e-11,0.0
4305,isotype switching to IgG isotypes (GO:0048291),1.7408852137786303e-11,0.0
4306,isotype switching to IgA isotypes (GO:0048290),1.7408852137786303e-11,0.0
4307,D-serine biosynthetic process (GO:0070179),1.7408852137786303e-11,0.0
4308,positive regulation of hepatic stellate cell proliferation (GO:1904899),1.7408852137786303e-11,0.0
4309,regulation of hepatic stellate cell proliferation (GO:1904897),1.7408852137786303e-11,0.0
4310,ESCRT complex assembly (GO:1904895),1.7408852137786303e-11,0.0
4311,amyloid precursor protein biosynthetic process (GO:0042983),1.7408852137786303e-11,0.0
4312,Wnt signalosome assembly (GO:1904887),1.7408852137786303e-11,0.0
4313,mitochondrial threonyl-tRNA aminoacylation (GO:0070159),1.7408852137786303e-11,0.0
4314,mitochondrial seryl-tRNA aminoacylation (GO:0070158),1.7408852137786303e-11,0.0
4315,positive regulation of DNA ligase activity (GO:1904877),1.7408852137786303e-11,0.0
4316,negative regulation of DNA ligase activity (GO:1904876),1.7408852137786303e-11,0.0
4317,mitochondrial glycyl-tRNA aminoacylation (GO:0070150),1.7408852137786303e-11,0.0
4318,determination of ventral identity (GO:0048264),1.7408852137786303e-11,0.0
4319,DNA rewinding (GO:0036292),1.7408852137786303e-11,0.0
4320,protein localization to Cajal body (GO:1904867),1.7408852137786303e-11,0.0
4321,mitochondrial asparaginyl-tRNA aminoacylation (GO:0070145),1.7408852137786303e-11,0.0
4322,mitochondrial alanyl-tRNA aminoacylation (GO:0070143),1.7408852137786303e-11,0.0
4323,protein trans-autophosphorylation (GO:0036290),1.7408852137786303e-11,0.0
4324,SAGA complex assembly (GO:0036285),1.7408852137786303e-11,0.0
4325,negative regulation of mitochondrial translation (GO:0070130),1.7408852137786303e-11,0.0
4326,negative regulation of establishment of protein localization to telomere (GO:1904850),1.7408852137786303e-11,0.0
4327,D-alanine transport (GO:0042941),1.7408852137786303e-11,0.0
4328,epinephrine secretion (GO:0048242),1.7408852137786303e-11,0.0
4329,negative regulation of cell chemotaxis to fibroblast growth factor (GO:1904848),1.7408852137786303e-11,0.0
4330,Kupffer's vesicle development (GO:0070121),1.7408852137786303e-11,0.0
4331,cellular response to nitroglycerin (GO:1904843),1.7408852137786303e-11,0.0
4332,regulation of diacylglycerol biosynthetic process (GO:1900480),1.7408852137786303e-11,0.0
4333,enterobactin transport (GO:0042930),1.7408852137786303e-11,0.0
4334,swimming (GO:0036268),1.7408852137786303e-11,0.0
4335,peptidyl-arginine hydroxylation (GO:0030961),1.7408852137786303e-11,0.0
4336,beta-catenin-TCF complex assembly (GO:1904837),1.7408852137786303e-11,0.0
4337,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter (GO:1900477),1.7408852137786303e-11,0.0
4338,astral microtubule nucleation (GO:0030954),1.7408852137786303e-11,0.0
4339,response to methylamine (GO:0036255),1.7408852137786303e-11,0.0
4340,positive regulation of hydrogen sulfide biosynthetic process (GO:1904828),1.7408852137786303e-11,0.0
4341,regulation of hydrogen sulfide biosynthetic process (GO:1904826),1.7408852137786303e-11,0.0
4342,peroxisome transport along microtubule (GO:0036250),1.7408852137786303e-11,0.0
4343,inter-Golgi cisterna vesicle-mediated transport (GO:0048219),1.7408852137786303e-11,0.0
4344,Golgi vesicle docking (GO:0048211),1.7408852137786303e-11,0.0
4345,rRNA acetylation involved in maturation of SSU-rRNA (GO:1904812),1.7408852137786303e-11,0.0
4346,negative regulation of glutamate receptor signaling pathway (GO:1900450),1.7408852137786303e-11,0.0
4347,regulation of translation involved in cellular response to UV (GO:1904803),1.7408852137786303e-11,0.0
4348,negative regulation of neuron remodeling (GO:1904800),1.7408852137786303e-11,0.0
4349,contractile ring contraction (GO:0036213),1.7408852137786303e-11,0.0
4350,allantoin catabolic process (GO:0000256),1.7408852137786303e-11,0.0
4351,metanephric mesenchymal cell migration (GO:0035789),1.7408852137786303e-11,0.0
4352,"CD4-positive, alpha-beta T cell costimulation (GO:0035783)",1.7408852137786303e-11,0.0
4353,mature natural killer cell chemotaxis (GO:0035782),1.7408852137786303e-11,0.0
4354,CD80 biosynthetic process (GO:0035780),1.7408852137786303e-11,0.0
4355,positive regulation of CAMKK-AMPK signaling cascade (GO:1905291),1.7408852137786303e-11,0.0
4356,interleukin-13-mediated signaling pathway (GO:0035772),1.7408852137786303e-11,0.0
4357,vascular associated smooth muscle cell apoptotic process (GO:1905288),1.7408852137786303e-11,0.0
4358,fibrous ring of heart morphogenesis (GO:1905285),1.7408852137786303e-11,0.0
4359,"negative regulation of retrograde transport, endosome to Golgi (GO:1905280)",1.7408852137786303e-11,0.0
4360,memory T cell differentiation (GO:0043379),1.7408852137786303e-11,0.0
4361,endothelial cell chemotaxis to fibroblast growth factor (GO:0035768),1.7408852137786303e-11,0.0
4362,cell chemotaxis to fibroblast growth factor (GO:0035766),1.7408852137786303e-11,0.0
4363,nucleate erythrocyte differentiation (GO:0043363),1.7408852137786303e-11,0.0
4364,lysosomal lumen pH elevation (GO:0035752),1.7408852137786303e-11,0.0
4365,protein localization to myelin sheath abaxonal region (GO:0035750),1.7408852137786303e-11,0.0
4366,nitric oxide storage (GO:0035732),1.7408852137786303e-11,0.0
4367,negative regulation of natural killer cell degranulation (GO:0043322),1.7408852137786303e-11,0.0
4368,response to nitrogen dioxide (GO:0035713),1.7408852137786303e-11,0.0
4369,T-helper 2 cell activation (GO:0035712),1.7408852137786303e-11,0.0
4370,cellular response to thyrotropin-releasing hormone (GO:1905229),1.7408852137786303e-11,0.0
4371,regulation of adhesion of symbiont to host epithelial cell (GO:1905226),1.7408852137786303e-11,0.0
4372,cytotoxic T cell degranulation (GO:0043316),1.7408852137786303e-11,0.0
4373,T-helper 17 cell chemotaxis (GO:0035705),1.7408852137786303e-11,0.0
4374,negative regulation of eosinophil degranulation (GO:0043310),1.7408852137786303e-11,0.0
4375,response to astaxanthin (GO:1905217),1.7408852137786303e-11,0.0
4376,pyruvate oxidation (GO:0009444),1.7408852137786303e-11,0.0
4377,pyridoxal 5'-phosphate salvage (GO:0009443),1.7408852137786303e-11,0.0
4378,glucagon secretion (GO:0070091),1.7408852137786303e-11,0.0
4379,histone H4-R3 demethylation (GO:0070079),1.7408852137786303e-11,0.0
4380,histone H3-R2 demethylation (GO:0070078),1.7408852137786303e-11,0.0
4381,regulation of neuron remodeling (GO:1904799),1.7408852137786303e-11,0.0
4382,histone arginine demethylation (GO:0070077),1.7408852137786303e-11,0.0
4383,negative regulation of core promoter binding (GO:1904797),1.7408852137786303e-11,0.0
4384,toxin biosynthetic process (GO:0009403),1.7408852137786303e-11,0.0
4385,positive regulation of shelterin complex assembly (GO:1904792),1.7408852137786303e-11,0.0
4386,negative regulation of shelterin complex assembly (GO:1904791),1.7408852137786303e-11,0.0
4387,protein-tetrapyrrole linkage (GO:0017006),1.7408852137786303e-11,0.0
4388,protein-heme linkage (GO:0017003),1.7408852137786303e-11,0.0
4389,NLRP1 inflammasome complex assembly (GO:1904784),1.7408852137786303e-11,0.0
4390,'de novo' actin filament nucleation (GO:0070060),1.7408852137786303e-11,0.0
4391,D-glucuronate transmembrane transport (GO:0042874),1.7408852137786303e-11,0.0
4392,negative regulation of short-term neuronal synaptic plasticity (GO:0048174),1.7408852137786303e-11,0.0
4393,negative regulation of protein localization to cell cortex (GO:1904777),1.7408852137786303e-11,0.0
4394,"mRNA splicing, via endonucleolytic cleavage and ligation (GO:0070054)",1.7408852137786303e-11,0.0
4395,antisense RNA metabolic process (GO:0042868),1.7408852137786303e-11,0.0
4396,negative regulation of macroautophagy by TORC1 signaling (GO:1904766),1.7408852137786303e-11,0.0
4397,chaperone-mediated autophagy translocation complex disassembly (GO:1904764),1.7408852137786303e-11,0.0
4398,positive regulation of myofibroblast differentiation (GO:1904762),1.7408852137786303e-11,0.0
4399,negative regulation of protein localization to nucleolus (GO:1904750),1.7408852137786303e-11,0.0
4400,D-xylose catabolic process (GO:0042843),1.7408852137786303e-11,0.0
4401,D-glucuronate catabolic process (GO:0042840),1.7408852137786303e-11,0.0
4402,osteoclast maturation (GO:0036179),1.7408852137786303e-11,0.0
4403,D-glucuronate metabolic process (GO:0042839),1.7408852137786303e-11,0.0
4404,regulation of synaptic plasticity by receptor localization to synapse (GO:1900383),1.7408852137786303e-11,0.0
4405,positive regulation of polarized epithelial cell differentiation (GO:0030862),1.7408852137786303e-11,0.0
4406,phenotypic switching (GO:0036166),1.7408852137786303e-11,0.0
4407,cell-abiotic substrate adhesion (GO:0036164),1.7408852137786303e-11,0.0
4408,negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:1904736),1.7408852137786303e-11,0.0
4409,regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:1904735),1.7408852137786303e-11,0.0
4410,negative regulation of electron transfer activity (GO:1904733),1.7408852137786303e-11,0.0
4411,vitamin B6 catabolic process (GO:0042820),1.7408852137786303e-11,0.0
4412,triglyceride acyl-chain remodeling (GO:0036153),1.7408852137786303e-11,0.0
4413,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly (GO:1904723),1.7408852137786303e-11,0.0
4414,negative regulation of mRNA polyadenylation (GO:1900364),1.7408852137786303e-11,0.0
4415,phospholipase C-inhibiting G protein-coupled receptor signaling pathway (GO:0030845),1.7408852137786303e-11,0.0
4416,positive regulation of intermediate filament depolymerization (GO:0030844),1.7408852137786303e-11,0.0
4417,regulation of intermediate filament depolymerization (GO:0030842),1.7408852137786303e-11,0.0
4418,cellular response to mycotoxin (GO:0036146),1.7408852137786303e-11,0.0
4419,positive regulation of chaperone-mediated autophagy (GO:1904716),1.7408852137786303e-11,0.0
4420,regulation of Wnt-Frizzled-LRP5/6 complex assembly (GO:1904711),1.7408852137786303e-11,0.0
4421,positive regulation of granulosa cell apoptotic process (GO:1904710),1.7408852137786303e-11,0.0
4422,peptidyl-histidine hydroxylation (GO:0036138),1.7408852137786303e-11,0.0
4423,regulation of protein localization to adherens junction (GO:1904702),1.7408852137786303e-11,0.0
4424,regulation of cardiac endothelial to mesenchymal transition (GO:0061999),1.7408852137786303e-11,0.0
4425,long-chain fatty-acyl-CoA catabolic process (GO:0036116),1.7408852137786303e-11,0.0
4426,very long-chain fatty-acyl-CoA catabolic process (GO:0036113),1.7408852137786303e-11,0.0
4427,perichondral bone morphogenesis (GO:0061974),1.7408852137786303e-11,0.0
4428,membrane bone morphogenesis (GO:0061973),1.7408852137786303e-11,0.0
4429,regulation of heme oxygenase activity (GO:0061960),1.7408852137786303e-11,0.0
4430,penetration of cumulus oophorus (GO:0061956),1.7408852137786303e-11,0.0
4431,phosphorelay signal transduction system (GO:0000160),1.7408852137786303e-11,0.0
4432,mitophagy by induced vacuole formation (GO:0035695),1.7408852137786303e-11,0.0
4433,protein localization to somatodendritic compartment (GO:0061938),1.7408852137786303e-11,0.0
4434,macrophage migration inhibitory factor signaling pathway (GO:0035691),1.7408852137786303e-11,0.0
4435,positive regulation of erythrocyte enucleation (GO:0061931),1.7408852137786303e-11,0.0
4436,regulation of erythrocyte enucleation (GO:0061930),1.7408852137786303e-11,0.0
4437,peptidyl-lysine propionylation (GO:0061921),1.7408852137786303e-11,0.0
4438,manchette disassembly (GO:1905199),1.7408852137786303e-11,0.0
4439,posterior lateral line neuromast hair cell development (GO:0035677),1.7408852137786303e-11,0.0
4440,autophagosome-endosome fusion (GO:0061910),1.7408852137786303e-11,0.0
4441,positive regulation of metaphase/anaphase transition of meiosis I (GO:1905188),1.7408852137786303e-11,0.0
4442,regulation of metaphase/anaphase transition of meiosis I (GO:1905186),1.7408852137786303e-11,0.0
4443,negative regulation of protein serine/threonine phosphatase activity (GO:1905183),1.7408852137786303e-11,0.0
4444,TIRAP-dependent toll-like receptor 4 signaling pathway (GO:0035665),1.7408852137786303e-11,0.0
4445,TIRAP-dependent toll-like receptor signaling pathway (GO:0035664),1.7408852137786303e-11,0.0
4446,positive regulation of 1-phosphatidylinositol-3-kinase activity (GO:0061903),1.7408852137786303e-11,0.0
4447,regulation of 1-phosphatidylinositol-3-kinase activity (GO:0061901),1.7408852137786303e-11,0.0
4448,positive regulation of vascular associated smooth muscle cell dedifferentiation (GO:1905176),1.7408852137786303e-11,0.0
4449,positive regulation of phagosome maturation (GO:1905164),1.7408852137786303e-11,0.0
4450,enteric smooth muscle cell differentiation (GO:0035645),1.7408852137786303e-11,0.0
4451,phosphoanandamide dephosphorylation (GO:0035644),1.7408852137786303e-11,0.0
4452,sodium-dependent organic anion transport (GO:0043251),1.7408852137786303e-11,0.0
4453,negative regulation of membrane invagination (GO:1905154),1.7408852137786303e-11,0.0
4454,FMN biosynthetic process (GO:0009398),1.7408852137786303e-11,0.0
4455,negative regulation of voltage-gated sodium channel activity (GO:1905151),1.7408852137786303e-11,0.0
4456,eukaryotic translation initiation factor 2 complex assembly (GO:1905143),1.7408852137786303e-11,0.0
4457,positive regulation of meiotic chromosome separation (GO:1905134),1.7408852137786303e-11,0.0
4458,protein branching point deglutamylation (GO:0035611),1.7408852137786303e-11,0.0
4459,positive regulation of axo-dendritic protein transport (GO:1905128),1.7408852137786303e-11,0.0
4460,regulation of axo-dendritic protein transport (GO:1905126),1.7408852137786303e-11,0.0
4461,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development (GO:0035607),1.7408852137786303e-11,0.0
4462,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow (GO:0035604),1.7408852137786303e-11,0.0
4463,fibroblast growth factor receptor signaling pathway involved in hemopoiesis (GO:0035603),1.7408852137786303e-11,0.0
4464,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell (GO:0035602),1.7408852137786303e-11,0.0
4465,positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore (GO:1905116),1.7408852137786303e-11,0.0
4466,regulation of lateral attachment of mitotic spindle microtubules to kinetochore (GO:1905115),1.7408852137786303e-11,0.0
4467,regulation of acinar cell proliferation (GO:1904697),1.7408852137786303e-11,0.0
4468,positive regulation of vascular associated smooth muscle contraction (GO:1904695),1.7408852137786303e-11,0.0
4469,negative regulation of developmental pigmentation (GO:0048086),1.7408852137786303e-11,0.0
4470,negative regulation of cytoplasmic translational initiation (GO:1904689),1.7408852137786303e-11,0.0
4471,plasma membrane ATP synthesis coupled electron transport (GO:0042774),1.7408852137786303e-11,0.0
4472,positive regulation of eye pigmentation (GO:0048075),1.7408852137786303e-11,0.0
4473,negative regulation of eye pigmentation (GO:0048074),1.7408852137786303e-11,0.0
4474,myo-inositol import across plasma membrane (GO:1904679),1.7408852137786303e-11,0.0
4475,positive regulation of somatic stem cell division (GO:1904677),1.7408852137786303e-11,0.0
4476,regulation of somatic stem cell division (GO:1904675),1.7408852137786303e-11,0.0
4477,D-serine catabolic process (GO:0036088),1.7408852137786303e-11,0.0
4478,GDP-fucose import into Golgi lumen (GO:0036085),1.7408852137786303e-11,0.0
4479,positive regulation of fat cell apoptotic process (GO:1904651),1.7408852137786303e-11,0.0
4480,"circadian sleep/wake cycle, non-REM sleep (GO:0042748)",1.7408852137786303e-11,0.0
4481,"circadian sleep/wake cycle, REM sleep (GO:0042747)",1.7408852137786303e-11,0.0
4482,ligamentous ossification (GO:0036076),1.7408852137786303e-11,0.0
4483,response to methionine (GO:1904640),1.7408852137786303e-11,0.0
4484,"positive regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900281)",1.7408852137786303e-11,0.0
4485,"negative regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900280)",1.7408852137786303e-11,0.0
4486,response to glucoside (GO:1904631),1.7408852137786303e-11,0.0
4487,flavin-containing compound catabolic process (GO:0042728),1.7408852137786303e-11,0.0
4488,regulation of proteinase activated receptor activity (GO:1900276),1.7408852137786303e-11,0.0
4489,thiamine-containing compound biosynthetic process (GO:0042724),1.7408852137786303e-11,0.0
4490,negative regulation of RNA-directed 5'-3' RNA polymerase activity (GO:1900260),1.7408852137786303e-11,0.0
4491,peptidyl-lysine demalonylation (GO:0036047),1.7408852137786303e-11,0.0
4492,protein demalonylation (GO:0036046),1.7408852137786303e-11,0.0
4493,negative regulation of actin binding (GO:1904617),1.7408852137786303e-11,0.0
4494,regulation of RNA-directed 5'-3' RNA polymerase activity (GO:1900259),1.7408852137786303e-11,0.0
4495,eye photoreceptor cell fate commitment (GO:0042706),1.7408852137786303e-11,0.0
4496,positive regulation of astrocyte activation (GO:0061890),1.7408852137786303e-11,0.0
4497,positive regulation of anterograde axonal transport of mitochondrion (GO:0061881),1.7408852137786303e-11,0.0
4498,regulation of anterograde axonal transport of mitochondrion (GO:0061880),1.7408852137786303e-11,0.0
4499,vitelline membrane formation (GO:0030704),1.7408852137786303e-11,0.0
4500,positive regulation of hepatic stellate cell contraction (GO:0061874),1.7408852137786303e-11,0.0
4501,regulation of hepatic stellate cell contraction (GO:0061873),1.7408852137786303e-11,0.0
4502,mitotic anaphase (GO:0000090),1.7408852137786303e-11,0.0
4503,mesenchymal cell apoptotic process involved in metanephros development (GO:1900200),1.7408852137786303e-11,0.0
4504,mitotic prophase (GO:0000088),1.7408852137786303e-11,0.0
4505,mitotic G2 phase (GO:0000085),1.7408852137786303e-11,0.0
4506,negative regulation of neuroblast migration (GO:0061855),1.7408852137786303e-11,0.0
4507,regulation of neuroblast migration (GO:0061853),1.7408852137786303e-11,0.0
4508,response to cholecystokinin (GO:0061847),1.7408852137786303e-11,0.0
4509,neuropeptide processing (GO:0061837),1.7408852137786303e-11,0.0
4510,argininosuccinate metabolic process (GO:0000053),1.7408852137786303e-11,0.0
4511,cytosolic ciliogenesis (GO:0061824),1.7408852137786303e-11,0.0
4512,positive regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905091),1.7408852137786303e-11,0.0
4513,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905090),1.7408852137786303e-11,0.0
4514,N-terminal peptidyl-serine trimethylation (GO:0035573),1.7408852137786303e-11,0.0
4515,N-terminal peptidyl-serine dimethylation (GO:0035572),1.7408852137786303e-11,0.0
4516,vacuolar sequestering (GO:0043181),1.7408852137786303e-11,0.0
4517,N-terminal peptidyl-serine methylation (GO:0035570),1.7408852137786303e-11,0.0
4518,rhythmic excitation (GO:0043179),1.7408852137786303e-11,0.0
4519,N-terminal peptidyl-proline methylation (GO:0035568),1.7408852137786303e-11,0.0
4520,regulation of pronephros size (GO:0035565),1.7408852137786303e-11,0.0
4521,maltose catabolic process (GO:0000025),1.7408852137786303e-11,0.0
4522,D-alanine catabolic process (GO:0055130),1.7408852137786303e-11,0.0
4523,positive regulation of canonical Wnt signaling pathway involved in heart development (GO:1905068),1.7408852137786303e-11,0.0
4524,negative regulation of canonical Wnt signaling pathway involved in heart development (GO:1905067),1.7408852137786303e-11,0.0
4525,positive regulation of cardioblast proliferation (GO:1905062),1.7408852137786303e-11,0.0
4526,response to cation stress (GO:0043157),1.7408852137786303e-11,0.0
4527,positive regulation of SNARE complex assembly (GO:0035543),1.7408852137786303e-11,0.0
4528,diadenosine triphosphate catabolic process (GO:0015964),1.7408852137786303e-11,0.0
4529,diadenosine triphosphate metabolic process (GO:0015962),1.7408852137786303e-11,0.0
4530,epiboly involved in gastrulation with mouth forming second (GO:0055113),1.7408852137786303e-11,0.0
4531,ingression involved in gastrulation with mouth forming second (GO:0055111),1.7408852137786303e-11,0.0
4532,regulation of translation by machinery localization (GO:0043143),1.7408852137786303e-11,0.0
4533,otolith mineralization completed early in development (GO:0031173),1.7408852137786303e-11,0.0
4534,negative regulation of Schwann cell proliferation involved in axon regeneration (GO:1905045),1.7408852137786303e-11,0.0
4535,regulation of Schwann cell proliferation involved in axon regeneration (GO:1905044),1.7408852137786303e-11,0.0
4536,negative regulation of epithelium regeneration (GO:1905042),1.7408852137786303e-11,0.0
4537,otic placode development (GO:1905040),1.7408852137786303e-11,0.0
4538,negative regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905032),1.7408852137786303e-11,0.0
4539,positive regulation of 1-phosphatidylinositol 4-kinase activity (GO:0043128),1.7408852137786303e-11,0.0
4540,regulation of 1-phosphatidylinositol 4-kinase activity (GO:0043126),1.7408852137786303e-11,0.0
4541,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905025),1.7408852137786303e-11,0.0
4542,positive regulation of myosin-light-chain-phosphatase activity (GO:0035508),1.7408852137786303e-11,0.0
4543,regulation of 'de novo' NAD biosynthetic process from tryptophan (GO:1905012),1.7408852137786303e-11,0.0
4544,positive regulation of L-lysine import across plasma membrane (GO:1905010),1.7408852137786303e-11,0.0
4545,negative regulation of GTP cyclohydrolase I activity (GO:0043105),1.7408852137786303e-11,0.0
4546,regulation of L-lysine import across plasma membrane (GO:1905008),1.7408852137786303e-11,0.0
4547,picolinic acid biosynthetic process (GO:1905004),1.7408852137786303e-11,0.0
4548,picolinic acid metabolic process (GO:1905003),1.7408852137786303e-11,0.0
4549,regulation of membrane repolarization during atrial cardiac muscle cell action potential (GO:1905000),1.7408852137786303e-11,0.0
4550,inductive cell-cell signaling (GO:0031129),1.7408852137786303e-11,0.0
4551,tetracycline transmembrane transport (GO:0015904),1.7408852137786303e-11,0.0
4552,siderophore metabolic process (GO:0009237),1.7408852137786303e-11,0.0
4553,menaquinone biosynthetic process (GO:0009234),1.7408852137786303e-11,0.0
4554,riboflavin biosynthetic process (GO:0009231),1.7408852137786303e-11,0.0
4555,thiamine diphosphate biosynthetic process (GO:0009229),1.7408852137786303e-11,0.0
4556,dendrite regeneration (GO:0031104),1.7408852137786303e-11,0.0
4557,pyrimidine ribonucleoside triphosphate catabolic process (GO:0009210),1.7408852137786303e-11,0.0
4558,muscle cell fate specification (GO:0042694),1.7408852137786303e-11,0.0
4559,purine ribonucleoside triphosphate catabolic process (GO:0009207),1.7408852137786303e-11,0.0
4560,positive regulation of termination of RNA polymerase II transcription (GO:1904595),1.7408852137786303e-11,0.0
4561,regulation of cardioblast cell fate specification (GO:0042686),1.7408852137786303e-11,0.0
4562,cellular response to putrescine (GO:1904586),1.7408852137786303e-11,0.0
4563,response to putrescine (GO:1904585),1.7408852137786303e-11,0.0
4564,negative regulation of selenocysteine insertion sequence binding (GO:1904574),1.7408852137786303e-11,0.0
4565,regulation of selenocysteine insertion sequence binding (GO:1904573),1.7408852137786303e-11,0.0
4566,negative regulation of mRNA binding (GO:1904572),1.7408852137786303e-11,0.0
4567,negative regulation of selenocysteine incorporation (GO:1904570),1.7408852137786303e-11,0.0
4568,regulation of inner ear auditory receptor cell fate specification (GO:0042669),1.7408852137786303e-11,0.0
4569,auditory receptor cell fate determination (GO:0042668),1.7408852137786303e-11,0.0
4570,auditory receptor cell fate specification (GO:0042667),1.7408852137786303e-11,0.0
4571,negative regulation of ectodermal cell fate specification (GO:0042666),1.7408852137786303e-11,0.0
4572,regulation of ectodermal cell fate specification (GO:0042665),1.7408852137786303e-11,0.0
4573,negative regulation of endodermal cell fate specification (GO:0042664),1.7408852137786303e-11,0.0
4574,regulation of selenocysteine incorporation (GO:1904569),1.7408852137786303e-11,0.0
4575,cellular response to 1-oleoyl-sn-glycerol 3-phosphate (GO:1904566),1.7408852137786303e-11,0.0
4576,response to 1-oleoyl-sn-glycerol 3-phosphate (GO:1904565),1.7408852137786303e-11,0.0
4577,response to arachidonic acid (GO:1904550),1.7408852137786303e-11,0.0
4578,membrane bending (GO:0097753),1.7408852137786303e-11,0.0
4579,negative regulation of hair cycle (GO:0042636),1.7408852137786303e-11,0.0
4580,negative regulation of glycolytic process through fructose-6-phosphate (GO:1904539),1.7408852137786303e-11,0.0
4581,regulation of glycolytic process through fructose-6-phosphate (GO:1904538),1.7408852137786303e-11,0.0
4582,positive regulation of telomeric loop disassembly (GO:1904535),1.7408852137786303e-11,0.0
4583,negative regulation of actin filament binding (GO:1904530),1.7408852137786303e-11,0.0
4584,mating plug formation (GO:0042628),1.7408852137786303e-11,0.0
4585,positive regulation of phospholipid scramblase activity (GO:1900163),1.7408852137786303e-11,0.0
4586,regulation of phospholipid scramblase activity (GO:1900161),1.7408852137786303e-11,0.0
4587,protein localization to cytoplasmic microtubule plus-end (GO:1904518),1.7408852137786303e-11,0.0
4588,positive regulation of protein localization to basolateral plasma membrane (GO:1904510),1.7408852137786303e-11,0.0
4589,"vesicle targeting, trans-Golgi to periciliary membrane compartment (GO:0097712)",1.7408852137786303e-11,0.0
4590,regulation of protein localization to basolateral plasma membrane (GO:1904508),1.7408852137786303e-11,0.0
4591,positive regulation of Schwann cell migration (GO:1900149),1.7408852137786303e-11,0.0
4592,positive regulation of oligodendrocyte apoptotic process (GO:1900143),1.7408852137786303e-11,0.0
4593,negative regulation of oligodendrocyte apoptotic process (GO:1900142),1.7408852137786303e-11,0.0
4594,negative regulation of arachidonic acid secretion (GO:1900139),1.7408852137786303e-11,0.0
4595,negative regulation of renin secretion into blood stream (GO:1900134),1.7408852137786303e-11,0.0
4596,negative regulation of lipid binding (GO:1900131),1.7408852137786303e-11,0.0
4597,regulation of lipid binding (GO:1900130),1.7408852137786303e-11,0.0
4598,establishment or maintenance of polarity of follicular epithelium (GO:0016334),1.7408852137786303e-11,0.0
4599,morphogenesis of follicular epithelium (GO:0016333),1.7408852137786303e-11,0.0
4600,mitotic cohesin loading (GO:0061780),1.7408852137786303e-11,0.0
4601,xenobiotic transport across blood-nerve barrier (GO:0061772),1.7408852137786303e-11,0.0
4602,negative regulation of lung blood pressure (GO:0061767),1.7408852137786303e-11,0.0
4603,regulation of heart induction by canonical Wnt signaling pathway (GO:0100012),1.7408852137786303e-11,0.0
4604,leukocyte adhesion to arterial endothelial cell (GO:0061757),1.7408852137786303e-11,0.0
4605,negative regulation of protein kinase activity by protein phosphorylation (GO:0100002),1.7408852137786303e-11,0.0
4606,regulation of skeletal muscle contraction by action potential (GO:0100001),1.7408852137786303e-11,0.0
4607,carnosine biosynthetic process (GO:0035499),1.7408852137786303e-11,0.0
4608,engulfment of target by autophagosome (GO:0061736),1.7408852137786303e-11,0.0
4609,positive regulation of leukotriene production involved in inflammatory response (GO:0035491),1.7408852137786303e-11,0.0
4610,regulation of leukotriene production involved in inflammatory response (GO:0035490),1.7408852137786303e-11,0.0
4611,regulation of GTP cyclohydrolase I activity (GO:0043095),1.7408852137786303e-11,0.0
4612,anastral spindle assembly (GO:0055048),1.7408852137786303e-11,0.0
4613,pantothenate transmembrane transport (GO:0015887),1.7408852137786303e-11,0.0
4614,intercellular bridge organization (GO:0043063),1.7408852137786303e-11,0.0
4615,meiotic metaphase I plate congression (GO:0043060),1.7408852137786303e-11,0.0
4616,acetyl-CoA transport (GO:0015876),1.7408852137786303e-11,0.0
4617,acetylcholine transport (GO:0015870),1.7408852137786303e-11,0.0
4618,positive regulation of cardiac muscle fiber development (GO:0055020),1.7408852137786303e-11,0.0
4619,borate transmembrane transport (GO:0035445),1.7408852137786303e-11,0.0
4620,nickel cation transmembrane transport (GO:0035444),1.7408852137786303e-11,0.0
4621,cytidine transport (GO:0015861),1.7408852137786303e-11,0.0
4622,regulation of cardiac muscle fiber development (GO:0055018),1.7408852137786303e-11,0.0
4623,otic placode formation (GO:0043049),1.7408852137786303e-11,0.0
4624,dolichyl monophosphate biosynthetic process (GO:0043048),1.7408852137786303e-11,0.0
4625,deoxyribonucleoside diphosphate catabolic process (GO:0009192),1.7408852137786303e-11,0.0
4626,amino acid activation for nonribosomal peptide biosynthetic process (GO:0043041),1.7408852137786303e-11,0.0
4627,purine deoxyribonucleoside diphosphate catabolic process (GO:0009184),1.7408852137786303e-11,0.0
4628,putrescine transport (GO:0015847),1.7408852137786303e-11,0.0
4629,regulation of fusion of sperm to egg plasma membrane (GO:0043012),1.7408852137786303e-11,0.0
4630,threonine transport (GO:0015826),1.7408852137786303e-11,0.0
4631,methionine transport (GO:0015821),1.7408852137786303e-11,0.0
4632,cytoplasmic sequestering of CFTR protein (GO:0043004),1.7408852137786303e-11,0.0
4633,negative regulation of Golgi to plasma membrane CFTR protein transport (GO:0043002),1.7408852137786303e-11,0.0
4634,negative regulation of hemoglobin biosynthetic process (GO:0046986),1.7408852137786303e-11,0.0
4635,S-adenosyl-L-methionine transport (GO:0015805),1.7408852137786303e-11,0.0
4636,brexanolone catabolic process (GO:0062175),1.7408852137786303e-11,0.0
4637,xanthine catabolic process (GO:0009115),1.7408852137786303e-11,0.0
4638,hypoxanthine catabolic process (GO:0009114),1.7408852137786303e-11,0.0
4639,lutein catabolic process (GO:0062172),1.7408852137786303e-11,0.0
4640,lutein metabolic process (GO:0062170),1.7408852137786303e-11,0.0
4641,lipoate biosynthetic process (GO:0009107),1.7408852137786303e-11,0.0
4642,lipoate metabolic process (GO:0009106),1.7408852137786303e-11,0.0
4643,lipopolysaccharide catabolic process (GO:0009104),1.7408852137786303e-11,0.0
4644,vascular endothelial cell response to fluid shear stress (GO:0097699),1.7408852137786303e-11,0.0
4645,telomere maintenance via base-excision repair (GO:0097698),1.7408852137786303e-11,0.0
4646,histone H3-R26 methylation (GO:0034972),1.7408852137786303e-11,0.0
4647,cellular response to tetrahydrofolate (GO:1904482),1.7408852137786303e-11,0.0
4648,response to tetrahydrofolate (GO:1904481),1.7408852137786303e-11,0.0
4649,negative regulation of transport across blood-brain barrier (GO:0150202),1.7408852137786303e-11,0.0
4650,positive regulation of transport across blood-brain barrier (GO:0150201),1.7408852137786303e-11,0.0
4651,regulation of transport across blood-brain barrier (GO:0150200),1.7408852137786303e-11,0.0
4652,endothelin maturation (GO:0034959),1.7408852137786303e-11,0.0
4653,negative regulation of matrix metallopeptidase secretion (GO:1904465),1.7408852137786303e-11,0.0
4654,positive regulation of neuronal action potential (GO:1904457),1.7408852137786303e-11,0.0
4655,fatty acid primary amide metabolic process (GO:0062126),1.7408852137786303e-11,0.0
4656,negative regulation of neuronal action potential (GO:1904456),1.7408852137786303e-11,0.0
4657,tetrahydrofolylpolyglutamate biosynthetic process (GO:0046901),1.7408852137786303e-11,0.0
4658,protein N-linked glycosylation via arginine (GO:0042543),1.7408852137786303e-11,0.0
4659,regulation of eIF2 alpha phosphorylation by heme (GO:0010999),1.7408852137786303e-11,0.0
4660,negative regulation of establishment of Sertoli cell barrier (GO:1904445),1.7408852137786303e-11,0.0
4661,regulation of establishment of Sertoli cell barrier (GO:1904444),1.7408852137786303e-11,0.0
4662,fatty acid primary amide biosynthetic process (GO:0062112),1.7408852137786303e-11,0.0
4663,negative regulation of thyroid gland epithelial cell proliferation (GO:1904442),1.7408852137786303e-11,0.0
4664,regulation of thyroid gland epithelial cell proliferation (GO:1904441),1.7408852137786303e-11,0.0
4665,positive regulation of iron ion import across plasma membrane (GO:1904440),1.7408852137786303e-11,0.0
4666,negative regulation of peptidyl-tyrosine autophosphorylation (GO:1900085),1.7408852137786303e-11,0.0
4667,negative regulation of arginine catabolic process (GO:1900082),1.7408852137786303e-11,0.0
4668,regulation of arginine catabolic process (GO:1900081),1.7408852137786303e-11,0.0
4669,L-ornithine import across plasma membrane (GO:0097640),1.7408852137786303e-11,0.0
4670,negative regulation of iron ion import across plasma membrane (GO:1904439),1.7408852137786303e-11,0.0
4671,negative regulation of high-density lipoprotein particle clearance (GO:0010987),1.7408852137786303e-11,0.0
4672,L-lysine import across plasma membrane (GO:0097639),1.7408852137786303e-11,0.0
4673,regulation of arginine biosynthetic process (GO:1900079),1.7408852137786303e-11,0.0
4674,positive regulation of cardiac ventricle development (GO:1904414),1.7408852137786303e-11,0.0
4675,"O-glycan processing, core 3 (GO:0016269)",1.7408852137786303e-11,0.0
4676,"O-glycan processing, core 2 (GO:0016268)",1.7408852137786303e-11,0.0
4677,regulation of cardiac ventricle development (GO:1904412),1.7408852137786303e-11,0.0
4678,positive regulation of secretory granule organization (GO:1904411),1.7408852137786303e-11,0.0
4679,lipopolysaccharide metabolic process (GO:0008653),1.7408852137786303e-11,0.0
4680,selenocysteine catabolic process (GO:0016261),1.7408852137786303e-11,0.0
4681,positive regulation of retinoic acid biosynthetic process (GO:1900054),1.7408852137786303e-11,0.0
4682,positive regulation of histone exchange (GO:1900051),1.7408852137786303e-11,0.0
4683,embryonic genitalia morphogenesis (GO:0030538),1.7408852137786303e-11,0.0
4684,regulation of secretory granule organization (GO:1904409),1.7408852137786303e-11,0.0
4685,retina blood vessel maintenance (GO:0097601),1.7408852137786303e-11,0.0
4686,positive regulation of cellular response to hypoxia (GO:1900039),1.7408852137786303e-11,0.0
4687,positive regulation of cellular response to heat (GO:1900036),1.7408852137786303e-11,0.0
4688,negative regulation of cellular response to heat (GO:1900035),1.7408852137786303e-11,0.0
4689,cellular detoxification of hydrogen peroxide (GO:0061692),1.7408852137786303e-11,0.0
4690,detoxification of hydrogen peroxide (GO:0061691),1.7408852137786303e-11,0.0
4691,cytoplasmic microtubule depolymerization (GO:0010938),1.7408852137786303e-11,0.0
4692,positive regulation of macrophage tolerance induction (GO:0010933),1.7408852137786303e-11,0.0
4693,regulation of macrophage tolerance induction (GO:0010932),1.7408852137786303e-11,0.0
4694,granzyme-mediated apoptotic signaling pathway (GO:0008626),1.7408852137786303e-11,0.0
4695,seminal vesicle morphogenesis (GO:0061682),1.7408852137786303e-11,0.0
4696,regulation of D-erythro-sphingosine kinase activity (GO:1900022),1.7408852137786303e-11,0.0
4697,positive regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010925),1.7408852137786303e-11,0.0
4698,regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010924),1.7408852137786303e-11,0.0
4699,guanosine metabolic process (GO:0008617),1.7408852137786303e-11,0.0
4700,negative regulation of inositol phosphate biosynthetic process (GO:0010920),1.7408852137786303e-11,0.0
4701,evoked neurotransmitter secretion (GO:0061670),1.7408852137786303e-11,0.0
4702,negative regulation of corticotropin-releasing hormone receptor activity (GO:1900011),1.7408852137786303e-11,0.0
4703,regulation of corticotropin-releasing hormone receptor activity (GO:1900010),1.7408852137786303e-11,0.0
4704,negative regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903996),1.7408852137786303e-11,0.0
4705,negative regulation of UDP-glucose catabolic process (GO:0010905),1.7408852137786303e-11,0.0
4706,regulation of UDP-glucose catabolic process (GO:0010904),1.7408852137786303e-11,0.0
4707,negative regulation of phosphatidylcholine catabolic process (GO:0010900),1.7408852137786303e-11,0.0
4708,iron ion export across plasma membrane (GO:1903988),1.7408852137786303e-11,0.0
4709,muscle attachment (GO:0016203),1.7408852137786303e-11,0.0
4710,helper T cell enhancement of adaptive immune response (GO:0035397),1.7408852137786303e-11,0.0
4711,negative regulation of chemokine (C-X-C motif) ligand 9 production (GO:0035395),1.7408852137786303e-11,0.0
4712,regulation of chemokine (C-X-C motif) ligand 9 production (GO:0035394),1.7408852137786303e-11,0.0
4713,monounsaturated fatty acid catabolic process (GO:1903965),1.7408852137786303e-11,0.0
4714,sterol transmembrane transport (GO:0035382),1.7408852137786303e-11,0.0
4715,glycolytic process from galactose (GO:0061623),1.7408852137786303e-11,0.0
4716,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization (GO:1903954),1.7408852137786303e-11,0.0
4717,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization (GO:1903952),1.7408852137786303e-11,0.0
4718,positive regulation of atrial cardiac muscle cell action potential (GO:1903949),1.7408852137786303e-11,0.0
4719,negative regulation of ventricular cardiac muscle cell action potential (GO:1903946),1.7408852137786303e-11,0.0
4720,miRNA transcription (GO:0061614),1.7408852137786303e-11,0.0
4721,positive regulation of hepatocyte apoptotic process (GO:1903945),1.7408852137786303e-11,0.0
4722,mannose to fructose-6-phosphate metabolic process (GO:0061611),1.7408852137786303e-11,0.0
4723,mannitol transmembrane transport (GO:0015797),1.7408852137786303e-11,0.0
4724,negative regulation of TORC2 signaling (GO:1903940),1.7408852137786303e-11,0.0
4725,UDP-xylose transmembrane transport (GO:0015790),1.7408852137786303e-11,0.0
4726,thymine transport (GO:0035364),1.7408852137786303e-11,0.0
4727,GDP-fucose transmembrane transport (GO:0015783),1.7408852137786303e-11,0.0
4728,CMP-N-acetylneuraminate transmembrane transport (GO:0015782),1.7408852137786303e-11,0.0
4729,glucuronoside transport (GO:0015779),1.7408852137786303e-11,0.0
4730,positive regulation of actin filament severing (GO:1903920),1.7408852137786303e-11,0.0
4731,polysaccharide transport (GO:0015774),1.7408852137786303e-11,0.0
4732,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation (GO:1903917),1.7408852137786303e-11,0.0
4733,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation (GO:1903916),1.7408852137786303e-11,0.0
4734,inosine transport (GO:0035340),1.7408852137786303e-11,0.0
4735,negative regulation of fusion of virus membrane with host plasma membrane (GO:1903914),1.7408852137786303e-11,0.0
4736,regulation of fusion of virus membrane with host plasma membrane (GO:1903913),1.7408852137786303e-11,0.0
4737,negative regulation of receptor clustering (GO:1903910),1.7408852137786303e-11,0.0
4738,regulation of plasma membrane raft polarization (GO:1903906),1.7408852137786303e-11,0.0
4739,negative regulation of establishment of T cell polarity (GO:1903904),1.7408852137786303e-11,0.0
4740,methionine catabolic process (GO:0009087),1.7408852137786303e-11,0.0
4741,AV node cell-bundle of His cell adhesion involved in cell communication (GO:0086072),1.7408852137786303e-11,0.0
4742,fumarate transport (GO:0015741),1.7408852137786303e-11,0.0
4743,"non-replicative transposition, DNA-mediated (GO:0098038)",1.7408852137786303e-11,0.0
4744,glucuronate transmembrane transport (GO:0015738),1.7408852137786303e-11,0.0
4745,hexuronate transmembrane transport (GO:0015736),1.7408852137786303e-11,0.0
4746,uronic acid transmembrane transport (GO:0015735),1.7408852137786303e-11,0.0
4747,propanoate transport (GO:0015730),1.7408852137786303e-11,0.0
4748,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling (GO:0086055),1.7408852137786303e-11,0.0
4749,mevalonate transport (GO:0015728),1.7408852137786303e-11,0.0
4750,membrane repolarization during SA node cell action potential (GO:0086052),1.7408852137786303e-11,0.0
4751,membrane repolarization during bundle of His cell action potential (GO:0086050),1.7408852137786303e-11,0.0
4752,formate transport (GO:0015724),1.7408852137786303e-11,0.0
4753,bilirubin transport (GO:0015723),1.7408852137786303e-11,0.0
4754,regulation of phosphatidylserine metabolic process (GO:0150178),1.7408852137786303e-11,0.0
4755,regulation of phosphatidylethanolamine metabolic process (GO:0150175),1.7408852137786303e-11,0.0
4756,atrial cardiac muscle cell to AV node cell communication by electrical coupling (GO:0086044),1.7408852137786303e-11,0.0
4757,nitrite transport (GO:0015707),1.7408852137786303e-11,0.0
4758,nitrate transmembrane transport (GO:0015706),1.7408852137786303e-11,0.0
4759,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation (GO:0086030),1.7408852137786303e-11,0.0
4760,arsenite transport (GO:0015700),1.7408852137786303e-11,0.0
4761,positive regulation of interleukin-17A production (GO:0150153),1.7408852137786303e-11,0.0
4762,regulation of interleukin-17A production (GO:0150151),1.7408852137786303e-11,0.0
4763,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate (GO:0086024),1.7408852137786303e-11,0.0
4764,positive regulation of CD80 production (GO:0150145),1.7408852137786303e-11,0.0
4765,regulation of CD80 production (GO:0150143),1.7408852137786303e-11,0.0
4766,positive regulation of CD86 production (GO:0150142),1.7408852137786303e-11,0.0
4767,regulation of CD86 production (GO:0150140),1.7408852137786303e-11,0.0
4768,carotenoid transport (GO:0046867),1.7408852137786303e-11,0.0
4769,tetraterpenoid transport (GO:0046866),1.7408852137786303e-11,0.0
4770,positive regulation of interleukin-33 production (GO:0150129),1.7408852137786303e-11,0.0
4771,regulation of interleukin-33 production (GO:0150127),1.7408852137786303e-11,0.0
4772,negative regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904394),1.7408852137786303e-11,0.0
4773,positive regulation of protein localization to cell-cell junction (GO:0150107),1.7408852137786303e-11,0.0
4774,reactive gliosis (GO:0150103),1.7408852137786303e-11,0.0
4775,regulation of microtubule anchoring at centrosome (GO:0150101),1.7408852137786303e-11,0.0
4776,positive regulation of protein localization to actin cortical patch (GO:1904372),1.7408852137786303e-11,0.0
4777,regulation of protein localization to actin cortical patch (GO:1904370),1.7408852137786303e-11,0.0
4778,coreceptor-mediated virion attachment to host cell (GO:0046814),1.7408852137786303e-11,0.0
4779,negative regulation of stress granule assembly (GO:0062030),1.7408852137786303e-11,0.0
4780,negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process (GO:0062026),1.7408852137786303e-11,0.0
4781,regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0062025),1.7408852137786303e-11,0.0
4782,mitochondrial double-strand break repair via homologous recombination (GO:0097552),1.7408852137786303e-11,0.0
4783,"regulation of Wnt signaling pathway, calcium modulating pathway (GO:0008591)",1.7408852137786303e-11,0.0
4784,mitochondrial double-strand break repair (GO:0097551),1.7408852137786303e-11,0.0
4785,positive regulation of gastric mucosal blood circulation (GO:1904346),1.7408852137786303e-11,0.0
4786,regulation of gastric mucosal blood circulation (GO:1904344),1.7408852137786303e-11,0.0
4787,positive regulation of colon smooth muscle contraction (GO:1904343),1.7408852137786303e-11,0.0
4788,regulation of colon smooth muscle contraction (GO:1904341),1.7408852137786303e-11,0.0
4789,indole metabolic process (GO:0042431),1.7408852137786303e-11,0.0
4790,"negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity (GO:0062003)",1.7408852137786303e-11,0.0
4791,positive regulation of error-prone translesion synthesis (GO:1904333),1.7408852137786303e-11,0.0
4792,"regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity (GO:0062002)",1.7408852137786303e-11,0.0
4793,regulation of error-prone translesion synthesis (GO:1904331),1.7408852137786303e-11,0.0
4794,positive regulation of cardiac endothelial to mesenchymal transition (GO:0062000),1.7408852137786303e-11,0.0
4795,cholesterol transport involved in cholesterol storage (GO:0010879),1.7408852137786303e-11,0.0
4796,regulation of myofibroblast contraction (GO:1904328),1.7408852137786303e-11,0.0
4797,positive regulation of inhibitory G protein-coupled receptor phosphorylation (GO:1904325),1.7408852137786303e-11,0.0
4798,regulation of inhibitory G protein-coupled receptor phosphorylation (GO:1904323),1.7408852137786303e-11,0.0
4799,carnitine catabolic process (GO:0042413),1.7408852137786303e-11,0.0
4800,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (GO:1904317),1.7408852137786303e-11,0.0
4801,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (GO:1904316),1.7408852137786303e-11,0.0
4802,"base-excision repair, AP site formation via deaminated base removal (GO:0097510)",1.7408852137786303e-11,0.0
4803,positive regulation of maternal process involved in parturition (GO:1904303),1.7408852137786303e-11,0.0
4804,regulation of maternal process involved in parturition (GO:1904301),1.7408852137786303e-11,0.0
4805,defecation (GO:0030421),1.7408852137786303e-11,0.0
4806,"regulation of proton-transporting ATPase activity, rotational mechanism (GO:0010849)",1.7408852137786303e-11,0.0
4807,positive regulation of transcription by transcription factor localization (GO:0061586),1.7408852137786303e-11,0.0
4808,brassinosteroid biosynthetic process (GO:0016132),1.7408852137786303e-11,0.0
4809,brassinosteroid metabolic process (GO:0016131),1.7408852137786303e-11,0.0
4810,colon epithelial cell migration (GO:0061580),1.7408852137786303e-11,0.0
4811,DNA-templated viral transcription (GO:0039695),1.7408852137786303e-11,0.0
4812,single stranded viral RNA replication via double stranded DNA intermediate (GO:0039692),1.7408852137786303e-11,0.0
4813,phytosteroid biosynthetic process (GO:0016129),1.7408852137786303e-11,0.0
4814,phytosteroid metabolic process (GO:0016128),1.7408852137786303e-11,0.0
4815,xanthophyll catabolic process (GO:0016124),1.7408852137786303e-11,0.0
4816,xanthophyll biosynthetic process (GO:0016123),1.7408852137786303e-11,0.0
4817,actin filament bundle retrograde transport (GO:0061573),1.7408852137786303e-11,0.0
4818,TDP phosphorylation (GO:0061571),1.7408852137786303e-11,0.0
4819,dCDP phosphorylation (GO:0061570),1.7408852137786303e-11,0.0
4820,calcitonin catabolic process (GO:0010816),1.7408852137786303e-11,0.0
4821,UDP phosphorylation (GO:0061569),1.7408852137786303e-11,0.0
4822,carotenoid catabolic process (GO:0016118),1.7408852137786303e-11,0.0
4823,carotenoid biosynthetic process (GO:0016117),1.7408852137786303e-11,0.0
4824,GDP phosphorylation (GO:0061568),1.7408852137786303e-11,0.0
4825,dCMP phosphorylation (GO:0061567),1.7408852137786303e-11,0.0
4826,CMP phosphorylation (GO:0061566),1.7408852137786303e-11,0.0
4827,dAMP phosphorylation (GO:0061565),1.7408852137786303e-11,0.0
4828,positive regulation of ATF6-mediated unfolded protein response (GO:1903893),1.7408852137786303e-11,0.0
4829,tetraterpenoid catabolic process (GO:0016110),1.7408852137786303e-11,0.0
4830,positive regulation of synaptic vesicle priming (GO:0010808),1.7408852137786303e-11,0.0
4831,tetraterpenoid biosynthetic process (GO:0016109),1.7408852137786303e-11,0.0
4832,triterpenoid biosynthetic process (GO:0016104),1.7408852137786303e-11,0.0
4833,positive regulation of chemokine (C-C motif) ligand 20 production (GO:1903886),1.7408852137786303e-11,0.0
4834,regulation of chemokine (C-C motif) ligand 20 production (GO:1903884),1.7408852137786303e-11,0.0
4835,positive regulation of interleukin-17-mediated signaling pathway (GO:1903883),1.7408852137786303e-11,0.0
4836,regulation of interleukin-17-mediated signaling pathway (GO:1903881),1.7408852137786303e-11,0.0
4837,fusion of virus membrane with host endosome membrane (GO:0039654),1.7408852137786303e-11,0.0
4838,"glutamate secretion, neurotransmission (GO:0061535)",1.7408852137786303e-11,0.0
4839,"gamma-aminobutyric acid secretion, neurotransmission (GO:0061534)",1.7408852137786303e-11,0.0
4840,acetylcholine secretion (GO:0061526),1.7408852137786303e-11,0.0
4841,monocyte proliferation (GO:0061516),1.7408852137786303e-11,0.0
4842,interleukin-34-mediated signaling pathway (GO:0061514),1.7408852137786303e-11,0.0
4843,cellular response to arsenite(3-) (GO:1903841),1.7408852137786303e-11,0.0
4844,response to arsenite(3-) (GO:1903840),1.7408852137786303e-11,0.0
4845,lead ion transport (GO:0015692),1.7408852137786303e-11,0.0
4846,positive regulation of mRNA 3'-UTR binding (GO:1903839),1.7408852137786303e-11,0.0
4847,CDP phosphorylation (GO:0061508),1.7408852137786303e-11,0.0
4848,regulation of mRNA 3'-UTR binding (GO:1903837),1.7408852137786303e-11,0.0
4849,external genitalia morphogenesis (GO:0035261),1.7408852137786303e-11,0.0
4850,molybdate ion transport (GO:0015689),1.7408852137786303e-11,0.0
4851,negative regulation of telomere single strand break repair (GO:1903824),1.7408852137786303e-11,0.0
4852,plasma membrane copper ion transport (GO:0015679),1.7408852137786303e-11,0.0
4853,vanadium ion transport (GO:0015676),1.7408852137786303e-11,0.0
4854,nickel cation transport (GO:0015675),1.7408852137786303e-11,0.0
4855,L-asparagine import across plasma membrane (GO:1903811),1.7408852137786303e-11,0.0
4856,vitamin A biosynthetic process (GO:0035238),1.7408852137786303e-11,0.0
4857,L-isoleucine import across plasma membrane (GO:1903806),1.7408852137786303e-11,0.0
4858,positive regulation of glutamate-cysteine ligase activity (GO:0035229),1.7408852137786303e-11,0.0
4859,regulation of glutamate-cysteine ligase activity (GO:0035227),1.7408852137786303e-11,0.0
4860,"multiple spine synapse organization, single dendrite (GO:0150090)",1.7408852137786303e-11,0.0
4861,cell competition in a multicellular organism (GO:0035212),1.7408852137786303e-11,0.0
4862,multiple spine synapse organization (GO:0150089),1.7408852137786303e-11,0.0
4863,positive regulation of arginase activity (GO:0150072),1.7408852137786303e-11,0.0
4864,regulation of arginase activity (GO:0150070),1.7408852137786303e-11,0.0
4865,negative regulation of protein localization to lysosome (GO:0150033),1.7408852137786303e-11,0.0
4866,viral exocytosis (GO:0046754),1.7408852137786303e-11,0.0
4867,oxidised low-density lipoprotein particle clearance (GO:0150024),1.7408852137786303e-11,0.0
4868,viral capsid secondary envelopment (GO:0046745),1.7408852137786303e-11,0.0
4869,negative regulation of mitotic DNA damage checkpoint (GO:1904290),1.7408852137786303e-11,0.0
4870,blood vessel endothelial cell delamination (GO:0097497),1.7408852137786303e-11,0.0
4871,histone H4-K20 monomethylation (GO:0034771),1.7408852137786303e-11,0.0
4872,negative regulation of neuron projection arborization (GO:0150013),1.7408852137786303e-11,0.0
4873,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:1904283),1.7408852137786303e-11,0.0
4874,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:1904282),1.7408852137786303e-11,0.0
4875,vitamin K biosynthetic process (GO:0042371),1.7408852137786303e-11,0.0
4876,positive regulation of iron ion transmembrane transport (GO:0034761),1.7408852137786303e-11,0.0
4877,citric acid secretion (GO:0046720),1.7408852137786303e-11,0.0
4878,positive regulation of iron ion transport (GO:0034758),1.7408852137786303e-11,0.0
4879,fructoselysine metabolic process (GO:0030393),1.7408852137786303e-11,0.0
4880,fructosamine catabolic process (GO:0030392),1.7408852137786303e-11,0.0
4881,borate transport (GO:0046713),1.7408852137786303e-11,0.0
4882,GDP-L-fucose salvage (GO:0042352),1.7408852137786303e-11,0.0
4883,IDP catabolic process (GO:0046709),1.7408852137786303e-11,0.0
4884,IDP metabolic process (GO:0046707),1.7408852137786303e-11,0.0
4885,negative regulation of iron ion transmembrane transporter activity (GO:1904255),1.7408852137786303e-11,0.0
4886,regulation of iron ion transmembrane transporter activity (GO:1904254),1.7408852137786303e-11,0.0
4887,CDP biosynthetic process (GO:0046705),1.7408852137786303e-11,0.0
4888,CDP metabolic process (GO:0046704),1.7408852137786303e-11,0.0
4889,positive regulation of polynucleotide adenylyltransferase activity (GO:1904247),1.7408852137786303e-11,0.0
4890,negative regulation of polynucleotide adenylyltransferase activity (GO:1904246),1.7408852137786303e-11,0.0
4891,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904240),1.7408852137786303e-11,0.0
4892,chromatin organization (GO:0034724),1.7408852137786303e-11,0.0
4893,meiotic sister chromatid cohesion involved in meiosis I (GO:0010789),1.7408852137786303e-11,0.0
4894,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904239),1.7408852137786303e-11,0.0
4895,meiotic DNA double-strand break formation involved in reciprocal meiotic recombination (GO:0010780),1.7408852137786303e-11,0.0
4896,"negative regulation of circadian sleep/wake cycle, non-REM sleep (GO:0042323)",1.7408852137786303e-11,0.0
4897,"negative regulation of glycogen synthase activity, transferring glucose-1-phosphate (GO:1904227)",1.7408852137786303e-11,0.0
4898,"regulation of glycogen synthase activity, transferring glucose-1-phosphate (GO:1904226)",1.7408852137786303e-11,0.0
4899,meiotic strand invasion involved in reciprocal meiotic recombination (GO:0010774),1.7408852137786303e-11,0.0
4900,negative regulation of serine C-palmitoyltransferase activity (GO:1904221),1.7408852137786303e-11,0.0
4901,protein kinase C deactivation (GO:0042313),1.7408852137786303e-11,0.0
4902,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010768),1.7408852137786303e-11,0.0
4903,positive regulation of skeletal muscle hypertrophy (GO:1904206),1.7408852137786303e-11,0.0
4904,negative regulation of skeletal muscle hypertrophy (GO:1904205),1.7408852137786303e-11,0.0
4905,synaptic vesicle lumen acidification (GO:0097401),1.7408852137786303e-11,0.0
4906,absorption of visible light (GO:0016038),1.7408852137786303e-11,0.0
4907,light absorption (GO:0016037),1.7408852137786303e-11,0.0
4908,memory T cell proliferation (GO:0061485),1.7408852137786303e-11,0.0
4909,response to TNF agonist (GO:0061481),1.7408852137786303e-11,0.0
4910,deoxynucleotide transport (GO:0030302),1.7408852137786303e-11,0.0
4911,regulation of ferrochelatase activity (GO:0010722),1.7408852137786303e-11,0.0
4912,response to anticoagulant (GO:0061476),1.7408852137786303e-11,0.0
4913,negative regulation of collagen catabolic process (GO:0010711),1.7408852137786303e-11,0.0
4914,negative regulation of inorganic anion transmembrane transport (GO:1903796),1.7408852137786303e-11,0.0
4915,glycolysis from storage polysaccharide through glucose-1-phosphate (GO:0093001),1.7408852137786303e-11,0.0
4916,globoside biosynthetic process via lactosylceramide (GO:0010707),1.7408852137786303e-11,0.0
4917,positive regulation of glutathione biosynthetic process (GO:1903788),1.7408852137786303e-11,0.0
4918,retrotrapezoid nucleus neuron differentiation (GO:0061452),1.7408852137786303e-11,0.0
4919,retrotrapezoid nucleus development (GO:0061451),1.7408852137786303e-11,0.0
4920,trophoblast cell migration (GO:0061450),1.7408852137786303e-11,0.0
4921,positive regulation of cardiac conduction (GO:1903781),1.7408852137786303e-11,0.0
4922,negative regulation of cardiac conduction (GO:1903780),1.7408852137786303e-11,0.0
4923,charged-tRNA amino acid modification (GO:0019988),1.7408852137786303e-11,0.0
4924,protein localization to vacuolar membrane (GO:1903778),1.7408852137786303e-11,0.0
4925,endocardial cushion cell fate commitment (GO:0061445),1.7408852137786303e-11,0.0
4926,endocardial cushion cell development (GO:0061444),1.7408852137786303e-11,0.0
4927,positive regulation of beta-galactosidase activity (GO:1903771),1.7408852137786303e-11,0.0
4928,negative regulation of beta-galactosidase activity (GO:1903770),1.7408852137786303e-11,0.0
4929,cellular response to caloric restriction (GO:0061433),1.7408852137786303e-11,0.0
4930,positive regulation of SUMO transferase activity (GO:1903755),1.7408852137786303e-11,0.0
4931,negative regulation of anterograde synaptic vesicle transport (GO:1903743),1.7408852137786303e-11,0.0
4932,negative regulation of phosphatidate phosphatase activity (GO:1903741),1.7408852137786303e-11,0.0
4933,modulation by virus of host apoptotic process (GO:0039526),1.7408852137786303e-11,0.0
4934,regulation of phosphatidate phosphatase activity (GO:1903730),1.7408852137786303e-11,0.0
4935,negative regulation of I-kappaB phosphorylation (GO:1903720),1.7408852137786303e-11,0.0
4936,guanine transmembrane transport (GO:1903716),1.7408852137786303e-11,0.0
4937,isoleucine transmembrane transport (GO:1903714),1.7408852137786303e-11,0.0
4938,spermine transmembrane transport (GO:1903710),1.7408852137786303e-11,0.0
4939,"peptidyl-arginine methylation, to symmetrical-dimethyl arginine (GO:0019918)",1.7408852137786303e-11,0.0
4940,uterine gland development (GO:1903709),1.7408852137786303e-11,0.0
4941,negative regulation of siRNA production (GO:1903704),1.7408852137786303e-11,0.0
4942,enterocyte differentiation (GO:1903703),1.7408852137786303e-11,0.0
4943,substantia propria of cornea development (GO:1903701),1.7408852137786303e-11,0.0
4944,post-embryonic forelimb morphogenesis (GO:0035128),1.7408852137786303e-11,0.0
4945,post-embryonic limb morphogenesis (GO:0035127),1.7408852137786303e-11,0.0
4946,post-embryonic appendage morphogenesis (GO:0035120),1.7408852137786303e-11,0.0
4947,lipid tube assembly involved in organelle fusion (GO:0060989),1.7408852137786303e-11,0.0
4948,cell migration involved in coronary angiogenesis (GO:0060981),1.7408852137786303e-11,0.0
4949,cell migration involved in coronary vasculogenesis (GO:0060980),1.7408852137786303e-11,0.0
4950,cardioblast migration to the midline involved in heart field formation (GO:0060975),1.7408852137786303e-11,0.0
4951,sperm competition (GO:0046692),1.7408852137786303e-11,0.0
4952,response to chromate (GO:0046687),1.7408852137786303e-11,0.0
4953,endocardial cell fate commitment (GO:0060957),1.7408852137786303e-11,0.0
4954,cardiac neuron differentiation (GO:0060945),1.7408852137786303e-11,0.0
4955,sinoatrial node cell fate commitment (GO:0060930),1.7408852137786303e-11,0.0
4956,folic acid catabolic process (GO:0046657),1.7408852137786303e-11,0.0
4957,positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization (GO:1904199),1.7408852137786303e-11,0.0
4958,positive regulation of granulosa cell proliferation (GO:1904197),1.7408852137786303e-11,0.0
4959,regulation of granulosa cell proliferation (GO:1904195),1.7408852137786303e-11,0.0
4960,negative regulation of cholangiocyte apoptotic process (GO:1904193),1.7408852137786303e-11,0.0
4961,regulation of cholangiocyte apoptotic process (GO:1904192),1.7408852137786303e-11,0.0
4962,negative regulation of transformation of host cell by virus (GO:1904188),1.7408852137786303e-11,0.0
4963,regulation of transformation of host cell by virus (GO:1904187),1.7408852137786303e-11,0.0
4964,error-free postreplication DNA repair (GO:0042275),1.7408852137786303e-11,0.0
4965,dorsal spinal cord interneuron anterior axon guidance (GO:0097380),1.7408852137786303e-11,0.0
4966,regulation of protein folding in endoplasmic reticulum (GO:0060904),1.7408852137786303e-11,0.0
4967,regulation of hair cycle by canonical Wnt signaling pathway (GO:0060901),1.7408852137786303e-11,0.0
4968,dorsal spinal cord interneuron posterior axon guidance (GO:0097379),1.7408852137786303e-11,0.0
4969,peptidyl-asparagine hydroxylation (GO:0042265),1.7408852137786303e-11,0.0
4970,protein O-GlcNAcylation via threonine (GO:0097370),1.7408852137786303e-11,0.0
4971,mitochondrion migration along actin filament (GO:0034642),1.7408852137786303e-11,0.0
4972,DN4 thymocyte differentiation (GO:1904157),1.7408852137786303e-11,0.0
4973,DN3 thymocyte differentiation (GO:1904156),1.7408852137786303e-11,0.0
4974,negative regulation of mitotic centrosome separation (GO:0046603),1.7408852137786303e-11,0.0
4975,negative regulation of microglial cell mediated cytotoxicity (GO:1904150),1.7408852137786303e-11,0.0
4976,establishment of planar polarity of follicular epithelium (GO:0042247),1.7408852137786303e-11,0.0
4977,negative regulation of microglial cell migration (GO:1904140),1.7408852137786303e-11,0.0
4978,ripoptosome assembly (GO:0097343),1.7408852137786303e-11,0.0
4979,nuclear fragmentation involved in apoptotic nuclear change (GO:0030264),1.7408852137786303e-11,0.0
4980,positive regulation of otic vesicle morphogenesis (GO:1904120),1.7408852137786303e-11,0.0
4981,response to antineoplastic agent (GO:0097327),1.7408852137786303e-11,0.0
4982,melanocyte adhesion (GO:0097326),1.7408852137786303e-11,0.0
4983,regulation of otic vesicle morphogenesis (GO:1904118),1.7408852137786303e-11,0.0
4984,L-histidine transmembrane export from vacuole (GO:0089708),1.7408852137786303e-11,0.0
4985,cap2 mRNA methylation (GO:0097310),1.7408852137786303e-11,0.0
4986,protein localization to ciliary inversin compartment (GO:1904108),1.7408852137786303e-11,0.0
4987,positive regulation of cell communication by chemical coupling (GO:0010652),1.7408852137786303e-11,0.0
4988,negative regulation of antimicrobial humoral response (GO:0008348),1.7408852137786303e-11,0.0
4989,regulation of cell communication by chemical coupling (GO:0010645),1.7408852137786303e-11,0.0
4990,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance (GO:0061395),1.7408852137786303e-11,0.0
4991,heparin catabolic process (GO:0030211),1.7408852137786303e-11,0.0
4992,cell migration in diencephalon (GO:0061381),1.7408852137786303e-11,0.0
4993,dermatan sulfate catabolic process (GO:0030209),1.7408852137786303e-11,0.0
4994,positive regulation of Schwann cell proliferation (GO:0010625),1.7408852137786303e-11,0.0
4995,mammillothalamic axonal tract development (GO:0061374),1.7408852137786303e-11,0.0
4996,mammillary axonal complex development (GO:0061373),1.7408852137786303e-11,0.0
4997,negative regulation of testicular blood vessel morphogenesis (GO:0061369),1.7408852137786303e-11,0.0
4998,tarsal gland development (GO:1903699),1.7408852137786303e-11,0.0
4999,negative regulation of microvillus assembly (GO:1903697),1.7408852137786303e-11,0.0
5000,optic chiasma development (GO:0061360),1.7408852137786303e-11,0.0
5001,negative regulation of Wnt protein secretion (GO:0061358),1.7408852137786303e-11,0.0
5002,planar cell polarity pathway involved in pericardium morphogenesis (GO:0061354),1.7408852137786303e-11,0.0
5003,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis (GO:0061350),1.7408852137786303e-11,0.0
5004,planar cell polarity pathway involved in cardiac right atrium morphogenesis (GO:0061349),1.7408852137786303e-11,0.0
5005,planar cell polarity pathway involved in ventricular septum morphogenesis (GO:0061348),1.7408852137786303e-11,0.0
5006,planar cell polarity pathway involved in outflow tract morphogenesis (GO:0061347),1.7408852137786303e-11,0.0
5007,planar cell polarity pathway involved in heart morphogenesis (GO:0061346),1.7408852137786303e-11,0.0
5008,positive regulation of cap-dependent translational initiation (GO:1903676),1.7408852137786303e-11,0.0
5009,regulation of cap-dependent translational initiation (GO:1903674),1.7408852137786303e-11,0.0
5010,mitotic cleavage furrow formation (GO:1903673),1.7408852137786303e-11,0.0
5011,non-canonical Wnt signaling pathway involved in heart development (GO:0061341),1.7408852137786303e-11,0.0
5012,positive regulation of complement-dependent cytotoxicity (GO:1903661),1.7408852137786303e-11,0.0
5013,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation (GO:0061324),1.7408852137786303e-11,0.0
5014,negative regulation of gastrin-induced gastric acid secretion (GO:1903640),1.7408852137786303e-11,0.0
5015,regulation of gastrin-induced gastric acid secretion (GO:1903639),1.7408852137786303e-11,0.0
5016,positive regulation of protein insertion into mitochondrial outer membrane (GO:1903638),1.7408852137786303e-11,0.0
5017,regulation of protein insertion into mitochondrial outer membrane (GO:1903636),1.7408852137786303e-11,0.0
5018,negative regulation of leucine-tRNA ligase activity (GO:1903634),1.7408852137786303e-11,0.0
5019,regulation of leucine-tRNA ligase activity (GO:1903633),1.7408852137786303e-11,0.0
5020,positive regulation of aminoacyl-tRNA ligase activity (GO:1903632),1.7408852137786303e-11,0.0
5021,cerebellum vasculature morphogenesis (GO:0061301),1.7408852137786303e-11,0.0
5022,negative regulation of aminoacyl-tRNA ligase activity (GO:1903631),1.7408852137786303e-11,0.0
5023,positive regulation of dUTP diphosphatase activity (GO:1903629),1.7408852137786303e-11,0.0
5024,regulation of dUTP diphosphatase activity (GO:1903627),1.7408852137786303e-11,0.0
5025,protein localization to photoreceptor connecting cilium (GO:1903621),1.7408852137786303e-11,0.0
5026,positive regulation of transdifferentiation (GO:1903620),1.7408852137786303e-11,0.0
5027,regulation of transdifferentiation (GO:1903618),1.7408852137786303e-11,0.0
5028,positive regulation of calcium-dependent ATPase activity (GO:1903612),1.7408852137786303e-11,0.0
5029,negative regulation of calcium-dependent ATPase activity (GO:1903611),1.7408852137786303e-11,0.0
5030,male pronucleus assembly (GO:0035039),1.7408852137786303e-11,0.0
5031,sperm entry (GO:0035037),1.7408852137786303e-11,0.0
5032,negative regulation of inward rectifier potassium channel activity (GO:1903609),1.7408852137786303e-11,0.0
5033,cytochrome c metabolic process (GO:1903606),1.7408852137786303e-11,0.0
5034,cytochrome metabolic process (GO:1903604),1.7408852137786303e-11,0.0
5035,semicircular canal fusion (GO:0060879),1.7408852137786303e-11,0.0
5036,lateral semicircular canal development (GO:0060875),1.7408852137786303e-11,0.0
5037,anterior semicircular canal development (GO:0060873),1.7408852137786303e-11,0.0
5038,negative regulation of calcium-dependent cell-cell adhesion (GO:0046588),1.7408852137786303e-11,0.0
5039,positive regulation of calcium-dependent cell-cell adhesion (GO:0046587),1.7408852137786303e-11,0.0
5040,branching involved in lymph vessel morphogenesis (GO:0060854),1.7408852137786303e-11,0.0
5041,Notch signaling pathway involved in arterial endothelial cell fate commitment (GO:0060853),1.7408852137786303e-11,0.0
5042,venous endothelial cell differentiation (GO:0060843),1.7408852137786303e-11,0.0
5043,growth plate cartilage chondrocyte morphogenesis (GO:0003429),1.7408852137786303e-11,0.0
5044,growth plate cartilage axis specification (GO:0003421),1.7408852137786303e-11,0.0
5045,regulation of growth plate cartilage chondrocyte proliferation (GO:0003420),1.7408852137786303e-11,0.0
5046,chondrocyte morphogenesis involved in endochondral bone morphogenesis (GO:0003414),1.7408852137786303e-11,0.0
5047,establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis (GO:0003412),1.7408852137786303e-11,0.0
5048,photoreceptor cell fate commitment (GO:0046552),1.7408852137786303e-11,0.0
5049,hydroxyproline transport (GO:0034589),1.7408852137786303e-11,0.0
5050,halogenated hydrocarbon metabolic process (GO:0042197),1.7408852137786303e-11,0.0
5051,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060829),1.7408852137786303e-11,0.0
5052,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060827),1.7408852137786303e-11,0.0
5053,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060825),1.7408852137786303e-11,0.0
5054,optic cup structural organization (GO:0003409),1.7408852137786303e-11,0.0
5055,inactivation of X chromosome by heterochromatin formation (GO:0060820),1.7408852137786303e-11,0.0
5056,positive regulation of autophagic cell death (GO:1904094),1.7408852137786303e-11,0.0
5057,regulation of nucleus size (GO:0097298),1.7408852137786303e-11,0.0
5058,renal phosphate ion absorption (GO:0097291),1.7408852137786303e-11,0.0
5059,inactivation of paternal X chromosome (GO:0060817),1.7408852137786303e-11,0.0
5060,keratinocyte apoptotic process (GO:0097283),1.7408852137786303e-11,0.0
5061,immune complex formation (GO:0097281),1.7408852137786303e-11,0.0
5062,histamine secretion mediated by immunoglobulin (GO:0097280),1.7408852137786303e-11,0.0
5063,negative regulation of cell differentiation involved in embryonic placenta development (GO:0060806),1.7408852137786303e-11,0.0
5064,positive regulation of Wnt signaling pathway by BMP signaling pathway (GO:0060804),1.7408852137786303e-11,0.0
5065,BMP signaling pathway involved in mesodermal cell fate specification (GO:0060803),1.7408852137786303e-11,0.0
5066,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification (GO:0060802),1.7408852137786303e-11,0.0
5067,positive regulation of trophectodermal cell proliferation (GO:1904075),1.7408852137786303e-11,0.0
5068,regulation of trophectodermal cell proliferation (GO:1904073),1.7408852137786303e-11,0.0
5069,histamine secretion mediated by IgE immunoglobulin (GO:0097279),1.7408852137786303e-11,0.0
5070,sphingoid catabolic process (GO:0046521),1.7408852137786303e-11,0.0
5071,cellular urea homeostasis (GO:0097277),1.7408852137786303e-11,0.0
5072,cellular creatinine homeostasis (GO:0097276),1.7408852137786303e-11,0.0
5073,cellular ammonium homeostasis (GO:0097275),1.7408852137786303e-11,0.0
5074,lipoprotein oxidation (GO:0042161),1.7408852137786303e-11,0.0
5075,lipoprotein modification (GO:0042160),1.7408852137786303e-11,0.0
5076,positive regulation of cholangiocyte proliferation (GO:1904056),1.7408852137786303e-11,0.0
5077,negative regulation of cholangiocyte proliferation (GO:1904055),1.7408852137786303e-11,0.0
5078,positive regulation of spontaneous neurotransmitter secretion (GO:1904050),1.7408852137786303e-11,0.0
5079,"vacuole fusion, non-autophagic (GO:0042144)",1.7408852137786303e-11,0.0
5080,negative regulation of spontaneous neurotransmitter secretion (GO:1904049),1.7408852137786303e-11,0.0
5081,negative regulation of vascular endothelial growth factor production (GO:1904046),1.7408852137786303e-11,0.0
5082,negative regulation of cystathionine beta-synthase activity (GO:1904042),1.7408852137786303e-11,0.0
5083,regulation of cystathionine beta-synthase activity (GO:1904041),1.7408852137786303e-11,0.0
5084,sequestering of neurotransmitter (GO:0042137),1.7408852137786303e-11,0.0
5085,negative regulation of iron export across plasma membrane (GO:1904039),1.7408852137786303e-11,0.0
5086,regulation of iron export across plasma membrane (GO:1904038),1.7408852137786303e-11,0.0
5087,positive regulation of t-SNARE clustering (GO:1904034),1.7408852137786303e-11,0.0
5088,regulation of t-SNARE clustering (GO:1904032),1.7408852137786303e-11,0.0
5089,cellular response to methylglyoxal (GO:0097238),1.7408852137786303e-11,0.0
5090,regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway (GO:0010578),1.7408852137786303e-11,0.0
5091,positive regulation of glucose catabolic process to lactate via pyruvate (GO:1904025),1.7408852137786303e-11,0.0
5092,mitochondrial mRNA polyadenylation (GO:0097222),1.7408852137786303e-11,0.0
5093,cellular response to serotonin (GO:1904015),1.7408852137786303e-11,0.0
5094,response to serotonin (GO:1904014),1.7408852137786303e-11,0.0
5095,response to Aroclor 1254 (GO:1904010),1.7408852137786303e-11,0.0
5096,cellular response to monosodium glutamate (GO:1904009),1.7408852137786303e-11,0.0
5097,negative regulation of sebum secreting cell proliferation (GO:1904003),1.7408852137786303e-11,0.0
5098,myotube cell development involved in skeletal muscle regeneration (GO:0014906),1.7408852137786303e-11,0.0
5099,negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061296),1.7408852137786303e-11,0.0
5100,regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061295),1.7408852137786303e-11,0.0
5101,mature B cell apoptotic process (GO:0002901),1.7408852137786303e-11,0.0
5102,polyamine homeostasis (GO:0010509),1.7408852137786303e-11,0.0
5103,positive regulation of histone deubiquitination (GO:1903586),1.7408852137786303e-11,0.0
5104,regulation of histone deubiquitination (GO:1903584),1.7408852137786303e-11,0.0
5105,positive regulation of protein kinase D signaling (GO:1903572),1.7408852137786303e-11,0.0
5106,regulation of protein kinase D signaling (GO:1903570),1.7408852137786303e-11,0.0
5107,positive regulation of protein localization to ciliary membrane (GO:1903569),1.7408852137786303e-11,0.0
5108,negative regulation of protein localization to ciliary membrane (GO:1903568),1.7408852137786303e-11,0.0
5109,negative regulation of mesonephros development (GO:0061218),1.7408852137786303e-11,0.0
5110,cellular response to butyrate (GO:1903545),1.7408852137786303e-11,0.0
5111,pentacyclic triterpenoid metabolic process (GO:0019742),1.7408852137786303e-11,0.0
5112,negative regulation of single strand break repair (GO:1903517),1.7408852137786303e-11,0.0
5113,sweat gland development (GO:0060792),1.7408852137786303e-11,0.0
5114,cellular response to benomyl (GO:0072755),1.7408852137786303e-11,0.0
5115,cellular response to leptomycin B (GO:0072750),1.7408852137786303e-11,0.0
5116,regulation of cell proliferation involved in tissue homeostasis (GO:0060784),1.7408852137786303e-11,0.0
5117,lamellipodium assembly involved in ameboidal cell migration (GO:0003363),1.7408852137786303e-11,0.0
5118,cellular response to cytochalasin B (GO:0072749),1.7408852137786303e-11,0.0
5119,S-adenosylmethioninamine metabolic process (GO:0046499),1.7408852137786303e-11,0.0
5120,nicotinamide riboside metabolic process (GO:0046495),1.7408852137786303e-11,0.0
5121,L-methylmalonyl-CoA metabolic process (GO:0046491),1.7408852137786303e-11,0.0
5122,proepicardium cell migration involved in pericardium morphogenesis (GO:0003345),1.7408852137786303e-11,0.0
5123,cellular response to dithiothreitol (GO:0072721),1.7408852137786303e-11,0.0
5124,negative regulation of mast cell chemotaxis (GO:0060755),1.7408852137786303e-11,0.0
5125,cellular response to selenite ion (GO:0072715),1.7408852137786303e-11,0.0
5126,response to selenite ion (GO:0072714),1.7408852137786303e-11,0.0
5127,type B pancreatic cell fate commitment (GO:0003327),1.7408852137786303e-11,0.0
5128,pancreatic A cell development (GO:0003322),1.7408852137786303e-11,0.0
5129,cellular response to sodium dodecyl sulfate (GO:0072707),1.7408852137786303e-11,0.0
5130,response to sodium dodecyl sulfate (GO:0072706),1.7408852137786303e-11,0.0
5131,cellular response to methyl methanesulfonate (GO:0072703),1.7408852137786303e-11,0.0
5132,response to methyl methanesulfonate (GO:0072702),1.7408852137786303e-11,0.0
5133,mesenchymal-epithelial cell signaling involved in prostate gland development (GO:0060739),1.7408852137786303e-11,0.0
5134,regulation of eIF2 alpha phosphorylation by dsRNA (GO:0060735),1.7408852137786303e-11,0.0
5135,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:0060734),1.7408852137786303e-11,0.0
5136,positive regulation of intestinal epithelial structure maintenance (GO:0060731),1.7408852137786303e-11,0.0
5137,cell migration to the midline involved in heart development (GO:0003318),1.7408852137786303e-11,0.0
5138,hexadecanal metabolic process (GO:0046458),1.7408852137786303e-11,0.0
5139,regulation of cell proliferation involved in embryonic placenta development (GO:0060723),1.7408852137786303e-11,0.0
5140,regulation of spongiotrophoblast cell proliferation (GO:0060721),1.7408852137786303e-11,0.0
5141,creatinine metabolic process (GO:0046449),1.7408852137786303e-11,0.0
5142,tropane alkaloid metabolic process (GO:0046448),1.7408852137786303e-11,0.0
5143,FMN metabolic process (GO:0046444),1.7408852137786303e-11,0.0
5144,FAD metabolic process (GO:0046443),1.7408852137786303e-11,0.0
5145,U2 snRNA 3'-end processing (GO:0034474),1.7408852137786303e-11,0.0
5146,spongiotrophoblast layer development (GO:0060712),1.7408852137786303e-11,0.0
5147,smooth muscle hypertrophy (GO:0014895),1.7408852137786303e-11,0.0
5148,D-amino acid biosynthetic process (GO:0046437),1.7408852137786303e-11,0.0
5149,D-alanine metabolic process (GO:0046436),1.7408852137786303e-11,0.0
5150,dentin mineralization (GO:0097188),1.7408852137786303e-11,0.0
5151,cellular response to azide (GO:0097185),1.7408852137786303e-11,0.0
5152,response to azide (GO:0097184),1.7408852137786303e-11,0.0
5153,90S preribosome assembly (GO:0034463),1.7408852137786303e-11,0.0
5154,transition between slow and fast fiber (GO:0014886),1.7408852137786303e-11,0.0
5155,response to injury involved in regulation of muscle adaptation (GO:0014876),1.7408852137786303e-11,0.0
5156,mesenchymal stem cell proliferation (GO:0097168),1.7408852137786303e-11,0.0
5157,negative regulation of lipoprotein oxidation (GO:0034443),1.7408852137786303e-11,0.0
5158,plasma lipoprotein particle oxidation (GO:0034441),1.7408852137786303e-11,0.0
5159,regulation of skeletal muscle contraction via regulation of action potential (GO:0014861),1.7408852137786303e-11,0.0
5160,neurotransmitter secretion involved in regulation of skeletal muscle contraction (GO:0014860),1.7408852137786303e-11,0.0
5161,positive regulation of central B cell tolerance induction (GO:0002897),1.7408852137786303e-11,0.0
5162,regulation of central B cell tolerance induction (GO:0002895),1.7408852137786303e-11,0.0
5163,negative regulation of type II hypersensitivity (GO:0002893),1.7408852137786303e-11,0.0
5164,lipoprotein lipid oxidation (GO:0034439),1.7408852137786303e-11,0.0
5165,metal incorporation into metallo-molybdopterin complex (GO:0042040),1.7408852137786303e-11,0.0
5166,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction (GO:0014853),1.7408852137786303e-11,0.0
5167,positive regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002882),1.7408852137786303e-11,0.0
5168,regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002880),1.7408852137786303e-11,0.0
5169,growth factor dependent regulation of skeletal muscle satellite cell proliferation (GO:0014843),1.7408852137786303e-11,0.0
5170,negative regulation of chronic inflammatory response to antigenic stimulus (GO:0002875),1.7408852137786303e-11,0.0
5171,epidermal cell division (GO:0010481),1.7408852137786303e-11,0.0
5172,DNA endoreduplication (GO:0042023),1.7408852137786303e-11,0.0
5173,myoblast differentiation involved in skeletal muscle regeneration (GO:0014835),1.7408852137786303e-11,0.0
5174,gibberellin mediated signaling pathway (GO:0010476),1.7408852137786303e-11,0.0
5175,detection of wounding (GO:0014822),1.7408852137786303e-11,0.0
5176,positive regulation of peripheral T cell tolerance induction (GO:0002851),1.7408852137786303e-11,0.0
5177,neurexin clustering involved in presynaptic membrane assembly (GO:0097115),1.7408852137786303e-11,0.0
5178,positive regulation of translational initiation by iron (GO:0045994),1.7408852137786303e-11,0.0
5179,negative regulation of translational initiation by iron (GO:0045993),1.7408852137786303e-11,0.0
5180,translocation of peptides or proteins into host (GO:0042000),1.7408852137786303e-11,0.0
5181,actin filament reorganization involved in cell cycle (GO:0030037),1.7408852137786303e-11,0.0
5182,microvillar actin bundle assembly (GO:0030034),1.7408852137786303e-11,0.0
5183,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014810),1.7408852137786303e-11,0.0
5184,regulation of peripheral T cell tolerance induction (GO:0002849),1.7408852137786303e-11,0.0
5185,positive regulation of tolerance induction to tumor cell (GO:0002845),1.7408852137786303e-11,0.0
5186,regulation of tolerance induction to tumor cell (GO:0002843),1.7408852137786303e-11,0.0
5187,"positive regulation of mitotic cell cycle, embryonic (GO:0045977)",1.7408852137786303e-11,0.0
5188,taste bud development (GO:0061193),1.7408852137786303e-11,0.0
5189,negative regulation of dermatome development (GO:0061185),1.7408852137786303e-11,0.0
5190,negative regulation of growth rate (GO:0045967),1.7408852137786303e-11,0.0
5191,"positive regulation of complement activation, classical pathway (GO:0045960)",1.7408852137786303e-11,0.0
5192,regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria (GO:0002816),1.7408852137786303e-11,0.0
5193,DNA methylation on cytosine within a CG sequence (GO:0010424),1.7408852137786303e-11,0.0
5194,biosynthetic process of antibacterial peptides active against Gram-positive bacteria (GO:0002815),1.7408852137786303e-11,0.0
5195,biosynthetic process of antibacterial peptides active against Gram-negative bacteria (GO:0002812),1.7408852137786303e-11,0.0
5196,regulation of establishment of bipolar cell polarity (GO:0061172),1.7408852137786303e-11,0.0
5197,establishment of bipolar cell polarity (GO:0061171),1.7408852137786303e-11,0.0
5198,negative regulation of hair follicle placode formation (GO:0061170),1.7408852137786303e-11,0.0
5199,positive regulation of mitotic recombination (GO:0045951),1.7408852137786303e-11,0.0
5200,regulation of antibacterial peptide biosynthetic process (GO:0002808),1.7408852137786303e-11,0.0
5201,positive regulation of antimicrobial peptide biosynthetic process (GO:0002807),1.7408852137786303e-11,0.0
5202,regulation of antimicrobial peptide biosynthetic process (GO:0002805),1.7408852137786303e-11,0.0
5203,regulation of hair follicle placode formation (GO:0061168),1.7408852137786303e-11,0.0
5204,response to 11-deoxycorticosterone (GO:1903496),1.7408852137786303e-11,0.0
5205,cellular response to dehydroepiandrosterone (GO:1903495),1.7408852137786303e-11,0.0
5206,endoplasmic reticulum polarization (GO:0061163),1.7408852137786303e-11,0.0
5207,establishment of bipolar cell polarity involved in cell morphogenesis (GO:0061159),1.7408852137786303e-11,0.0
5208,pulmonary artery endothelial tube morphogenesis (GO:0061155),1.7408852137786303e-11,0.0
5209,BMP signaling pathway involved in renal system segmentation (GO:0061151),1.7408852137786303e-11,0.0
5210,renal system segmentation (GO:0061150),1.7408852137786303e-11,0.0
5211,neural plate mediolateral regionalization (GO:0021998),1.7408852137786303e-11,0.0
5212,initiation of neural tube closure (GO:0021993),1.7408852137786303e-11,0.0
5213,BMP signaling pathway involved in ureter morphogenesis (GO:0061149),1.7408852137786303e-11,0.0
5214,alveolar secondary septum development (GO:0061144),1.7408852137786303e-11,0.0
5215,alveolar primary septum development (GO:0061143),1.7408852137786303e-11,0.0
5216,lung ciliated cell differentiation (GO:0061141),1.7408852137786303e-11,0.0
5217,olfactory cortex development (GO:0021989),1.7408852137786303e-11,0.0
5218,"propionate metabolic process, methylmalonyl pathway (GO:0019678)",1.7408852137786303e-11,0.0
5219,positive regulation of cytolysis (GO:0045919),1.7408852137786303e-11,0.0
5220,negative regulation of mitotic cell cycle DNA replication (GO:1903464),1.7408852137786303e-11,0.0
5221,Okazaki fragment processing involved in mitotic DNA replication (GO:1903461),1.7408852137786303e-11,0.0
5222,corticospinal neuron axon guidance through spinal cord (GO:0021972),1.7408852137786303e-11,0.0
5223,lactate catabolic process (GO:1903457),1.7408852137786303e-11,0.0
5224,negative regulation of G1 to G0 transition (GO:1903451),1.7408852137786303e-11,0.0
5225,lung proximal/distal axis specification (GO:0061115),1.7408852137786303e-11,0.0
5226,branching involved in pancreas morphogenesis (GO:0061114),1.7408852137786303e-11,0.0
5227,response to lipoic acid (GO:1903442),1.7408852137786303e-11,0.0
5228,central nervous system interneuron axonogenesis (GO:0021956),1.7408852137786303e-11,0.0
5229,seminal vesicle epithelium development (GO:0061108),1.7408852137786303e-11,0.0
5230,negative regulation of stomach neuroendocrine cell differentiation (GO:0061106),1.7408852137786303e-11,0.0
5231,regulation of stomach neuroendocrine cell differentiation (GO:0061105),1.7408852137786303e-11,0.0
5232,positive regulation of constitutive secretory pathway (GO:1903435),1.7408852137786303e-11,0.0
5233,negative regulation of constitutive secretory pathway (GO:1903434),1.7408852137786303e-11,0.0
5234,neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration (GO:0021944),1.7408852137786303e-11,0.0
5235,protein localization to endoplasmic reticulum tubular network (GO:1903420),1.7408852137786303e-11,0.0
5236,"mitochondrial tRNA 3'-trailer cleavage, endonucleolytic (GO:0072684)",1.7408852137786303e-11,0.0
5237,protein localization to nuclear body (GO:1903405),1.7408852137786303e-11,0.0
5238,negative regulation of renal phosphate excretion (GO:1903403),1.7408852137786303e-11,0.0
5239,BMP signaling pathway involved in spinal cord dorsal/ventral patterning (GO:0021919),1.7408852137786303e-11,0.0
5240,2-oxobutyrate catabolic process (GO:0019606),1.7408852137786303e-11,0.0
5241,negative regulation of cholesterol transporter activity (GO:0060695),1.7408852137786303e-11,0.0
5242,jump response (GO:0007630),1.7408852137786303e-11,0.0
5243,smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003271),1.7408852137786303e-11,0.0
5244,forebrain-midbrain boundary formation (GO:0021905),1.7408852137786303e-11,0.0
5245,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003270),1.7408852137786303e-11,0.0
5246,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling (GO:0060683),1.7408852137786303e-11,0.0
5247,primary ureteric bud growth (GO:0060682),1.7408852137786303e-11,0.0
5248,branch elongation involved in ureteric bud branching (GO:0060681),1.7408852137786303e-11,0.0
5249,cardioblast migration (GO:0003260),1.7408852137786303e-11,0.0
5250,dichotomous subdivision of terminal units involved in ureteric bud branching (GO:0060678),1.7408852137786303e-11,0.0
5251,mating (GO:0007618),1.7408852137786303e-11,0.0
5252,cardioblast anterior-lateral migration (GO:0003259),1.7408852137786303e-11,0.0
5253,positive regulation of cell proliferation involved in heart valve morphogenesis (GO:0003251),1.7408852137786303e-11,0.0
5254,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling (GO:0060668),1.7408852137786303e-11,0.0
5255,negative regulation of phospholipid efflux (GO:1902999),1.7408852137786303e-11,0.0
5256,negative regulation of neurofibrillary tangle assembly (GO:1902997),1.7408852137786303e-11,0.0
5257,"phototransduction, UV (GO:0007604)",1.7408852137786303e-11,0.0
5258,submandibular salivary gland formation (GO:0060661),1.7408852137786303e-11,0.0
5259,cardiac chamber ballooning (GO:0003242),1.7408852137786303e-11,0.0
5260,N-acetylneuraminate biosynthetic process (GO:0046380),1.7408852137786303e-11,0.0
5261,nipple morphogenesis (GO:0060658),1.7408852137786303e-11,0.0
5262,neurofibrillary tangle assembly (GO:1902988),1.7408852137786303e-11,0.0
5263,DNA strand elongation involved in mitotic DNA replication (GO:1902983),1.7408852137786303e-11,0.0
5264,sinus venosus morphogenesis (GO:0003236),1.7408852137786303e-11,0.0
5265,sinus venosus development (GO:0003235),1.7408852137786303e-11,0.0
5266,mitotic DNA replication termination (GO:1902979),1.7408852137786303e-11,0.0
5267,mitotic DNA replication preinitiation complex assembly (GO:1902977),1.7408852137786303e-11,0.0
5268,right ventricular compact myocardium morphogenesis (GO:0003226),1.7408852137786303e-11,0.0
5269,2-oxobutyrate biosynthetic process (GO:0046360),1.7408852137786303e-11,0.0
5270,smooth muscle cell apoptotic process (GO:0034390),1.7408852137786303e-11,0.0
5271,butyrate catabolic process (GO:0046359),1.7408852137786303e-11,0.0
5272,positive regulation of early endosome to recycling endosome transport (GO:1902955),1.7408852137786303e-11,0.0
5273,nipple development (GO:0060618),1.7408852137786303e-11,0.0
5274,intermediate-density lipoprotein particle remodeling (GO:0034373),1.7408852137786303e-11,0.0
5275,mammary gland fat development (GO:0060611),1.7408852137786303e-11,0.0
5276,negative regulation of intracellular calcium activated chloride channel activity (GO:1902939),1.7408852137786303e-11,0.0
5277,plasma membrane selenite transport (GO:0097080),1.7408852137786303e-11,0.0
5278,NAD salvage (GO:0034355),1.7408852137786303e-11,0.0
5279,negative regulation of glucosylceramide biosynthetic process (GO:0046318),1.7408852137786303e-11,0.0
5280,regulation of glucosylceramide biosynthetic process (GO:0046317),1.7408852137786303e-11,0.0
5281,negative regulation of type III interferon production (GO:0034345),1.7408852137786303e-11,0.0
5282,type III interferon production (GO:0034343),1.7408852137786303e-11,0.0
5283,positive regulation of melanosome transport (GO:1902910),1.7408852137786303e-11,0.0
5284,RNA folding (GO:0034337),1.7408852137786303e-11,0.0
5285,negative regulation of antibacterial peptide production (GO:0002787),1.7408852137786303e-11,0.0
5286,negative regulation of antimicrobial peptide production (GO:0002785),1.7408852137786303e-11,0.0
5287,phosphatidylserine exposure on blood platelet (GO:0097045),1.7408852137786303e-11,0.0
5288,negative regulation of muscle hyperplasia (GO:0014740),1.7408852137786303e-11,0.0
5289,regulation of plasma membrane sterol distribution (GO:0097036),1.7408852137786303e-11,0.0
5290,positive regulation of muscle hyperplasia (GO:0014739),1.7408852137786303e-11,0.0
5291,negative regulation of muscle atrophy (GO:0014736),1.7408852137786303e-11,0.0
5292,skeletal muscle hypertrophy (GO:0014734),1.7408852137786303e-11,0.0
5293,dendritic cell dendrite assembly (GO:0097026),1.7408852137786303e-11,0.0
5294,eye pigment granule organization (GO:0008057),1.7408852137786303e-11,0.0
5295,sensory organ boundary specification (GO:0008052),1.7408852137786303e-11,0.0
5296,antigen processing and presentation following phagocytosis (GO:0002747),1.7408852137786303e-11,0.0
5297,male courtship behavior (GO:0008049),1.7408852137786303e-11,0.0
5298,negative regulation of plasmacytoid dendritic cell cytokine production (GO:0002737),1.7408852137786303e-11,0.0
5299,regulation of plasmacytoid dendritic cell cytokine production (GO:0002736),1.7408852137786303e-11,0.0
5300,synaptic target recognition (GO:0008039),1.7408852137786303e-11,0.0
5301,positive regulation of sequestering of zinc ion (GO:0061090),1.7408852137786303e-11,0.0
5302,response to non-ionic osmotic stress (GO:0010335),1.7408852137786303e-11,0.0
5303,regulation of B cell cytokine production (GO:0002721),1.7408852137786303e-11,0.0
5304,entry into host cell by a symbiont-containing vacuole (GO:0085017),1.7408852137786303e-11,0.0
5305,positive regulation of prostaglandin secretion involved in immune response (GO:0061078),1.7408852137786303e-11,0.0
5306,pH elevation (GO:0045852),1.7408852137786303e-11,0.0
5307,positive regulation of nitrogen utilization (GO:0045848),1.7408852137786303e-11,0.0
5308,protein localization to kinetochore involved in kinetochore assembly (GO:1903394),1.7408852137786303e-11,0.0
5309,positive regulation of homophilic cell adhesion (GO:1903387),1.7408852137786303e-11,0.0
5310,negative regulation of branching involved in lung morphogenesis (GO:0061048),1.7408852137786303e-11,0.0
5311,positive regulation of isoprenoid metabolic process (GO:0045828),1.7408852137786303e-11,0.0
5312,female gonad morphogenesis (GO:0061040),1.7408852137786303e-11,0.0
5313,positive regulation of glycogen catabolic process (GO:0045819),1.7408852137786303e-11,0.0
5314,negative regulation of glycogen catabolic process (GO:0045818),1.7408852137786303e-11,0.0
5315,"positive regulation of Wnt signaling pathway, calcium modulating pathway (GO:0045813)",1.7408852137786303e-11,0.0
5316,Wnt signaling pathway involved in forebrain neuroblast division (GO:0021874),1.7408852137786303e-11,0.0
5317,positive regulation of meiotic DNA double-strand break formation (GO:1903343),1.7408852137786303e-11,0.0
5318,regulation of meiotic DNA double-strand break formation (GO:1903341),1.7408852137786303e-11,0.0
5319,GABAergic neuron differentiation in basal ganglia (GO:0021858),1.7408852137786303e-11,0.0
5320,arginine catabolic process to glutamate (GO:0019544),1.7408852137786303e-11,0.0
5321,positive regulation of vacuolar transport (GO:1903337),1.7408852137786303e-11,0.0
5322,regulation of cell proliferation involved in kidney morphogenesis (GO:0061006),1.7408852137786303e-11,0.0
5323,propionate biosynthetic process (GO:0019542),1.7408852137786303e-11,0.0
5324,positive regulation of iron-sulfur cluster assembly (GO:1903331),1.7408852137786303e-11,0.0
5325,regulation of iron-sulfur cluster assembly (GO:1903329),1.7408852137786303e-11,0.0
5326,embryonic olfactory bulb interneuron precursor migration (GO:0021831),1.7408852137786303e-11,0.0
5327,pentitol catabolic process (GO:0019527),1.7408852137786303e-11,0.0
5328,regulation of nitrogen cycle metabolic process (GO:1903314),1.7408852137786303e-11,0.0
5329,negative regulation of cell motility involved in cerebral cortex radial glia guided migration (GO:0021822),1.7408852137786303e-11,0.0
5330,pentitol metabolic process (GO:0019519),1.7408852137786303e-11,0.0
5331,glycine receptor clustering (GO:0072579),1.7408852137786303e-11,0.0
5332,L-threonine catabolic process to glycine (GO:0019518),1.7408852137786303e-11,0.0
5333,S-adenosylhomocysteine catabolic process (GO:0019510),1.7408852137786303e-11,0.0
5334,regulation of pyruvate kinase activity (GO:1903302),1.7408852137786303e-11,0.0
5335,sinoatrial valve morphogenesis (GO:0003185),1.7408852137786303e-11,0.0
5336,coronary sinus valve morphogenesis (GO:0003182),1.7408852137786303e-11,0.0
5337,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration (GO:0021813),1.7408852137786303e-11,0.0
5338,hydrogen peroxide transmembrane transport (GO:0080170),1.7408852137786303e-11,0.0
5339,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis (GO:0060598),1.7408852137786303e-11,0.0
5340,coronary sinus valve development (GO:0003178),1.7408852137786303e-11,0.0
5341,cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration (GO:0021808),1.7408852137786303e-11,0.0
5342,initiation of movement involved in cerebral cortex radial glia guided migration (GO:0021806),1.7408852137786303e-11,0.0
5343,negative regulation of lipoprotein lipid oxidation (GO:0060588),1.7408852137786303e-11,0.0
5344,cell fate determination involved in pattern specification (GO:0060582),1.7408852137786303e-11,0.0
5345,visceral muscle development (GO:0007522),1.7408852137786303e-11,0.0
5346,ventral spinal cord interneuron fate determination (GO:0060580),1.7408852137786303e-11,0.0
5347,Purkinje myocyte differentiation (GO:0003168),1.7408852137786303e-11,0.0
5348,pulmonary vein morphogenesis (GO:0060577),1.7408852137786303e-11,0.0
5349,glycolate catabolic process (GO:0046296),1.7408852137786303e-11,0.0
5350,glycolate biosynthetic process (GO:0046295),1.7408852137786303e-11,0.0
5351,formaldehyde biosynthetic process (GO:0046293),1.7408852137786303e-11,0.0
5352,positive regulation of termination of DNA-templated transcription (GO:0060566),1.7408852137786303e-11,0.0
5353,neural crest cell migration involved in heart formation (GO:0003147),1.7408852137786303e-11,0.0
5354,embryonic heart tube formation (GO:0003144),1.7408852137786303e-11,0.0
5355,cardiogenic plate morphogenesis (GO:0003142),1.7408852137786303e-11,0.0
5356,protein localization to astral microtubule (GO:1902888),1.7408852137786303e-11,0.0
5357,"positive regulation of fructose 1,6-bisphosphate metabolic process (GO:0060552)",1.7408852137786303e-11,0.0
5358,"regulation of fructose 1,6-bisphosphate metabolic process (GO:0060551)",1.7408852137786303e-11,0.0
5359,"positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity (GO:0060550)",1.7408852137786303e-11,0.0
5360,negative regulation of heart induction by canonical Wnt signaling pathway (GO:0003136),1.7408852137786303e-11,0.0
5361,mesodermal-endodermal cell signaling (GO:0003131),1.7408852137786303e-11,0.0
5362,proteasome core complex assembly (GO:0080129),1.7408852137786303e-11,0.0
5363,flavonoid catabolic process (GO:0046275),1.7408852137786303e-11,0.0
5364,stilbene catabolic process (GO:0046272),1.7408852137786303e-11,0.0
5365,"regulation of fructose 1,6-bisphosphate 1-phosphatase activity (GO:0060549)",1.7408852137786303e-11,0.0
5366,regulation of strand invasion (GO:0060542),1.7408852137786303e-11,0.0
5367,regulation of retina development in camera-type eye (GO:1902866),1.7408852137786303e-11,0.0
5368,propionyl-CoA biosynthetic process (GO:1902860),1.7408852137786303e-11,0.0
5369,regulation of vasoconstriction by circulating norepinephrine (GO:0003117),1.7408852137786303e-11,0.0
5370,regulation of vasoconstriction by norepinephrine (GO:0003116),1.7408852137786303e-11,0.0
5371,activation of prostate induction by androgen receptor signaling pathway (GO:0060520),1.7408852137786303e-11,0.0
5372,negative regulation of the force of heart contraction by chemical signal (GO:0003108),1.7408852137786303e-11,0.0
5373,negative regulation of glomerular filtration by angiotensin (GO:0003106),1.7408852137786303e-11,0.0
5374,epithelial cell proliferation involved in prostatic bud elongation (GO:0060517),1.7408852137786303e-11,0.0
5375,regulation of neuronal signal transduction (GO:1902847),1.7408852137786303e-11,0.0
5376,positive regulation of mitotic spindle elongation (GO:1902846),1.7408852137786303e-11,0.0
5377,regulation of nuclear migration along microtubule (GO:1902838),1.7408852137786303e-11,0.0
5378,positive regulation of autophagy in response to ER overload (GO:0034263),1.7408852137786303e-11,0.0
5379,smoothened signaling pathway involved in lung development (GO:0060506),1.7408852137786303e-11,0.0
5380,bud dilation involved in lung branching (GO:0060503),1.7408852137786303e-11,0.0
5381,regulation of urea metabolic process (GO:0034255),1.7408852137786303e-11,0.0
5382,positive regulation of late endosome to lysosome transport (GO:1902824),1.7408852137786303e-11,0.0
5383,nitric oxide catabolic process (GO:0046210),1.7408852137786303e-11,0.0
5384,nor-spermidine metabolic process (GO:0046204),1.7408852137786303e-11,0.0
5385,macrophage fusion (GO:0034238),1.7408852137786303e-11,0.0
5386,islet amyloid polypeptide processing (GO:0034231),1.7408852137786303e-11,0.0
5387,negative regulation of synaptic vesicle transport (GO:1902804),1.7408852137786303e-11,0.0
5388,response to nitrogen compound (GO:1901698),1.67814651065599e-11,0.9693502824858757
5389,regulation of vesicle-mediated transport (GO:0060627),1.361344370574387e-11,0.7992624223602484
5390,hexose metabolic process (GO:0019318),1.2665979376516312e-11,0.9427197802197803
5391,phosphatidylinositol metabolic process (GO:0046488),1.2665979376516312e-11,0.9427197802197803
5392,lipid catabolic process (GO:0016042),1.2307821428767765e-11,0.9903318903318904
5393,cellular calcium ion homeostasis (GO:0006874),1.1884715434078e-11,0.7503279883381924
5394,negative regulation of blood vessel morphogenesis (GO:2000181),1.1455170145845513e-11,0.0
5395,developmental cell growth (GO:0048588),1.1455170145845513e-11,0.0
5396,regulation of dendrite development (GO:0050773),1.1455170145845513e-11,0.0
5397,regulation of cell killing (GO:0031341),1.1455170145845513e-11,0.0
5398,response to heat (GO:0009408),1.1455170145845513e-11,0.0
5399,response to hydrogen peroxide (GO:0042542),1.1455170145845513e-11,0.0
5400,blastocyst development (GO:0001824),1.094413448760483e-11,0.0
5401,double-strand break repair via homologous recombination (GO:0000724),1.094413448760483e-11,0.0
5402,DNA integrity checkpoint signaling (GO:0031570),1.094413448760483e-11,0.0
5403,response to amino acid (GO:0043200),1.094413448760483e-11,0.0
5404,respiratory electron transport chain (GO:0022904),1.094413448760483e-11,0.0
5405,cognition (GO:0050890),9.789502541982697e-12,0.9278503830554304
5406,import across plasma membrane (GO:0098739),9.76430047932346e-12,0.9488018433179723
5407,negative regulation of neuron apoptotic process (GO:0043524),9.76430047932346e-12,0.9488018433179723
5408,positive regulation of neuron projection development (GO:0010976),9.76430047932346e-12,0.9488018433179723
5409,negative regulation of cytoskeleton organization (GO:0051494),8.131495476992633e-12,0.9307866184448463
5410,regulation of actin polymerization or depolymerization (GO:0008064),8.131495476992633e-12,0.9307866184448463
5411,cellular response to light stimulus (GO:0071482),7.459699524786713e-12,0.0
5412,dendrite development (GO:0016358),7.459699524786713e-12,0.0
5413,positive regulation of establishment of protein localization (GO:1904951),6.6144867361336335e-12,0.9191517857142858
5414,glycolipid metabolic process (GO:0006664),5.694777982528494e-12,0.0
5415,regulation of signal transduction by p53 class mediator (GO:1901796),5.694777982528494e-12,0.0
5416,negative regulation of vasculature development (GO:1901343),5.694777982528494e-12,0.0
5417,organelle membrane fusion (GO:0090174),5.694777982528494e-12,0.0
5418,positive regulation of protein localization to membrane (GO:1905477),5.694777982528494e-12,0.0
5419,regulation of nervous system process (GO:0031644),5.470957020762812e-12,1.0004373177842565
5420,synapse assembly (GO:0007416),3.587796726385092e-12,0.0
5421,neural tube formation (GO:0001841),3.587796726385092e-12,0.0
5422,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),3.587796726385092e-12,0.0
5423,histone methylation (GO:0016571),3.587796726385092e-12,0.0
5424,positive regulation of stress-activated MAPK cascade (GO:0032874),1.6656676038465095e-12,0.0
5425,mRNA catabolic process (GO:0006402),1.6656676038465095e-12,0.0
5426,response to interleukin-1 (GO:0070555),1.6656676038465095e-12,0.0
5427,histone acetylation (GO:0016573),1.6656676038465095e-12,0.0
5428,negative regulation of cell motility (GO:2000146),1.4886980537209805e-12,0.9707213578500706
5429,regulation of cell projection assembly (GO:0060491),1.1315393066985997e-12,0.7353214285714286
5430,negative regulation of cell migration (GO:0030336),-5.975220318530807e-13,0.510639880952381
5431,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-1.9455548283512317e-12,0.7427489177489177
5432,regulation of kinase activity (GO:0043549),-3.996802888642576e-12,0.9391078270388616
5433,positive regulation of translation (GO:0045727),-5.7851501367000314e-12,0.0
5434,nucleus organization (GO:0006997),-5.7851501367000314e-12,0.0
5435,response to hexose (GO:0009746),-5.7851501367000314e-12,0.0
5436,positive regulation of autophagy (GO:0010508),-5.7851501367000314e-12,0.0
5437,signal transduction by p53 class mediator (GO:0072331),-6.118883177900367e-12,0.0
5438,positive regulation of mitotic cell cycle phase transition (GO:1901992),-6.118883177900367e-12,0.0
5439,endosome organization (GO:0007032),-6.118883177900367e-12,0.0
5440,regulation of protein depolymerization (GO:1901879),-6.118883177900367e-12,0.0
5441,RNA methylation (GO:0001510),-6.118883177900367e-12,0.0
5442,alpha-amino acid catabolic process (GO:1901606),-6.118883177900367e-12,0.0
5443,DNA duplex unwinding (GO:0032508),-6.118883177900367e-12,0.0
5444,positive regulation of protein polymerization (GO:0032273),-6.118883177900367e-12,0.0
5445,neutrophil migration (GO:1990266),-6.118883177900367e-12,0.0
5446,regulation of mitotic metaphase/anaphase transition (GO:0030071),-6.118883177900367e-12,0.0
5447,membrane docking (GO:0022406),-6.118883177900367e-12,0.0
5448,negative regulation of mRNA metabolic process (GO:1903312),-6.118883177900367e-12,0.0
5449,regulation of striated muscle contraction (GO:0006942),-6.707745470157774e-12,0.0
5450,regulation of fatty acid metabolic process (GO:0019217),-6.707745470157774e-12,0.0
5451,regulation of interleukin-1 beta production (GO:0032651),-6.707745470157774e-12,0.0
5452,regulation of chemokine production (GO:0032642),-6.707745470157774e-12,0.0
5453,regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-6.707745470157774e-12,0.0
5454,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-6.707745470157774e-12,0.0
5455,positive regulation of JNK cascade (GO:0046330),-6.707745470157774e-12,0.0
5456,tube closure (GO:0060606),-6.707745470157774e-12,0.0
5457,cation transmembrane transport (GO:0098655),-7.773115484580361e-12,0.8714920634920634
5458,detection of stimulus (GO:0051606),-1.0334844091577252e-11,0.8575177009579341
5459,cytosolic transport (GO:0016482),-1.0630829549939217e-11,0.9739356669820246
5460,morphogenesis of embryonic epithelium (GO:0016331),-1.0630829549939217e-11,0.9739356669820246
5461,monovalent inorganic cation homeostasis (GO:0055067),-1.0630829549939217e-11,0.9739356669820246
5462,positive regulation of epithelial cell migration (GO:0010634),-1.0630829549939217e-11,0.9739356669820246
5463,alcohol biosynthetic process (GO:0046165),-1.1089795748314271e-11,0.0
5464,transforming growth factor beta receptor signaling pathway (GO:0007179),-1.1089795748314271e-11,0.0
5465,lysosome organization (GO:0007040),-1.1089795748314271e-11,0.0
5466,maintenance of protein location (GO:0045185),-1.1089795748314271e-11,0.0
5467,spindle assembly (GO:0051225),-1.1089795748314271e-11,0.0
5468,purine ribonucleoside triphosphate biosynthetic process (GO:0009206),-1.1089795748314271e-11,0.0
5469,gene silencing by RNA (GO:0031047),-1.1089795748314271e-11,0.0
5470,female gonad development (GO:0008585),-1.1089795748314271e-11,0.0
5471,antigen processing and presentation (GO:0019882),-1.1089795748314271e-11,0.0
5472,lytic vacuole organization (GO:0080171),-1.1089795748314271e-11,0.0
5473,regulation of localization (GO:0032879),-1.2580381181158366e-11,0.9785646387832698
5474,positive regulation of cell cycle phase transition (GO:1901989),-1.3345990978929949e-11,0.0
5475,mitochondrial membrane organization (GO:0007006),-1.3345990978929949e-11,0.0
5476,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-1.3345990978929949e-11,0.0
5477,female sex differentiation (GO:0046660),-1.3345990978929949e-11,0.0
5478,heart contraction (GO:0060047),-1.34270372597265e-11,0.0
5479,cellular response to carbohydrate stimulus (GO:0071322),-1.34270372597265e-11,0.0
5480,protein tetramerization (GO:0051262),-1.34270372597265e-11,0.0
5481,amide transport (GO:0042886),-1.4388490399038515e-11,0.0
5482,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-1.4388490399038515e-11,0.0
5483,positive regulation of defense response (GO:0031349),-1.4538814596570586e-11,0.9936776061776061
5484,regulation of protein localization to plasma membrane (GO:1903076),-1.4636514222736175e-11,0.0
5485,organelle disassembly (GO:1903008),-1.4636514222736175e-11,0.0
5486,neuron death (GO:0070997),-1.4636514222736175e-11,0.0
5487,positive regulation of canonical Wnt signaling pathway (GO:0090263),-1.4636514222736175e-11,0.0
5488,epithelium migration (GO:0090132),-1.4636514222736175e-11,0.0
5489,regulation of phagocytosis (GO:0050764),-1.4636514222736175e-11,0.0
5490,DNA damage checkpoint signaling (GO:0000077),-1.4636514222736175e-11,0.0
5491,cell growth (GO:0016049),-1.4636514222736175e-11,0.0
5492,sphingolipid biosynthetic process (GO:0030148),-1.4636514222736175e-11,0.0
5493,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-1.4636514222736175e-11,0.0
5494,polyol metabolic process (GO:0019751),-1.4636514222736175e-11,0.0
5495,liposaccharide metabolic process (GO:1903509),-1.4636514222736175e-11,0.0
5496,reactive oxygen species metabolic process (GO:0072593),-1.4636514222736175e-11,0.0
5497,cellular response to organonitrogen compound (GO:0071417),-1.5286216736737098e-11,0.7633094414236282
5498,cellular response to lipid (GO:0071396),-1.5726309143691685e-11,0.8500825763831544
5499,positive regulation of protein transport (GO:0051222),-1.5780488027292537e-11,0.9675281954887219
5500,reproductive system development (GO:0061458),-1.5780488027292537e-11,0.9675281954887219
5501,enzyme-linked receptor protein signaling pathway (GO:0007167),-1.6090462295762943e-11,0.9191517857142858
5502,regulation of mRNA processing (GO:0050684),-1.8660628597725523e-11,0.0
5503,regulation of JNK cascade (GO:0046328),-1.8660628597725523e-11,0.0
5504,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-1.8660628597725523e-11,0.0
5505,regulation of actin filament-based process (GO:0032970),-2.0501378372517988e-11,0.7262433862433864
5506,regulation of reactive oxygen species metabolic process (GO:2000377),-2.0678347922639594e-11,0.0
5507,positive regulation of innate immune response (GO:0045089),-2.0678347922639594e-11,0.0
5508,cellular response to nitrogen compound (GO:1901699),-2.1458168575119873e-11,0.9177178515712058
5509,positive regulation of double-strand break repair (GO:2000781),-2.1940005367796738e-11,0.0
5510,positive regulation of protein binding (GO:0032092),-2.1940005367796738e-11,0.0
5511,regulation of fibroblast proliferation (GO:0048145),-2.1940005367796738e-11,0.0
5512,cholesterol homeostasis (GO:0042632),-2.1940005367796738e-11,0.0
5513,calcium ion transmembrane import into cytosol (GO:0097553),-2.1940005367796738e-11,0.0
5514,regulation of Rho protein signal transduction (GO:0035023),-2.1940005367796738e-11,0.0
5515,mucopolysaccharide metabolic process (GO:1903510),-2.1940005367796738e-11,0.0
5516,vascular transport (GO:0010232),-2.344258120929033e-11,0.0
5517,regulation of interleukin-8 production (GO:0032677),-2.344258120929033e-11,0.0
5518,nucleoside phosphate catabolic process (GO:1901292),-2.344258120929033e-11,0.0
5519,regulation of phosphatase activity (GO:0010921),-2.344258120929033e-11,0.0
5520,positive regulation of lipid biosynthetic process (GO:0046889),-2.344258120929033e-11,0.0
5521,transport across blood-brain barrier (GO:0150104),-2.344258120929033e-11,0.0
5522,associative learning (GO:0008306),-2.344258120929033e-11,0.0
5523,negative regulation of autophagy (GO:0010507),-2.344258120929033e-11,0.0
5524,aerobic electron transport chain (GO:0019646),-2.344258120929033e-11,0.0
5525,regulation of peptidyl-serine phosphorylation (GO:0033135),-2.38025155138653e-11,0.0
5526,membrane lipid biosynthetic process (GO:0046467),-2.38025155138653e-11,0.0
5527,production of molecular mediator of immune response (GO:0002440),-2.3816948413185085e-11,0.8702028740490281
5528,sensory perception of smell (GO:0007608),-2.505262663956269e-11,0.9387082066869302
5529,regulation of protein catabolic process (GO:0042176),-2.512989816207466e-11,0.8014402491241729
5530,formation of primary germ layer (GO:0001704),-2.5310864515084e-11,0.0
5531,mitotic sister chromatid segregation (GO:0000070),-2.5310864515084e-11,0.0
5532,regulation of mitotic nuclear division (GO:0007088),-2.564082279799419e-11,0.0
5533,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-2.564082279799419e-11,0.0
5534,regulation of cyclin-dependent protein kinase activity (GO:1904029),-2.564082279799419e-11,0.0
5535,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-2.6634916494217572e-11,0.9936776061776061
5536,intracellular receptor signaling pathway (GO:0030522),-2.6634916494217572e-11,0.9936776061776061
5537,angiogenesis (GO:0001525),-2.7765567622465077e-11,0.8994757536041939
5538,organic anion transport (GO:0015711),-2.7765567622465077e-11,0.8994757536041939
5539,neural tube closure (GO:0001843),-2.8003821483542992e-11,0.0
5540,tRNA modification (GO:0006400),-2.8003821483542992e-11,0.0
5541,regulation of cytokinesis (GO:0032465),-2.8003821483542992e-11,0.0
5542,regulation of leukocyte apoptotic process (GO:2000106),-2.8003821483542992e-11,0.0
5543,telomere maintenance (GO:0000723),-2.8003821483542992e-11,0.0
5544,neuron apoptotic process (GO:0051402),-2.8003821483542992e-11,0.0
5545,oogenesis (GO:0048477),-2.8003821483542992e-11,0.0
5546,negative regulation of protein binding (GO:0032091),-2.8003821483542992e-11,0.0
5547,positive regulation of calcium ion transmembrane transport (GO:1904427),-2.8003821483542992e-11,0.0
5548,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-2.8003821483542992e-11,0.0
5549,regulation of protein dephosphorylation (GO:0035304),-2.8003821483542992e-11,0.0
5550,regulation of response to oxidative stress (GO:1902882),-2.8003821483542992e-11,0.0
5551,respiratory burst involved in defense response (GO:0002679),-2.8805180462694667e-11,0.0
5552,regulation of T cell anergy (GO:0002667),-2.8805180462694667e-11,0.0
5553,regulation of germinal center formation (GO:0002634),-2.8805180462694667e-11,0.0
5554,positive regulation of action potential (GO:0045760),-2.8805180462694667e-11,0.0
5555,positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),-2.8805180462694667e-11,0.0
5556,regulation of potassium ion import (GO:1903286),-2.8805180462694667e-11,0.0
5557,positive regulation of oxidative stress-induced neuron death (GO:1903223),-2.8805180462694667e-11,0.0
5558,alditol catabolic process (GO:0019405),-2.8805180462694667e-11,0.0
5559,cerebellar granule cell differentiation (GO:0021707),-2.8805180462694667e-11,0.0
5560,regulation of pro-B cell differentiation (GO:2000973),-2.8805180462694667e-11,0.0
5561,positive regulation of AMPA receptor activity (GO:2000969),-2.8805180462694667e-11,0.0
5562,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-2.8805180462694667e-11,0.0
5563,aldehyde biosynthetic process (GO:0046184),-2.8805180462694667e-11,0.0
5564,regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-2.8805180462694667e-11,0.0
5565,tetrahydrobiopterin metabolic process (GO:0046146),-2.8805180462694667e-11,0.0
5566,regulation of lens fiber cell differentiation (GO:1902746),-2.8805180462694667e-11,0.0
5567,DNA damage induced protein phosphorylation (GO:0006975),-2.8805180462694667e-11,0.0
5568,"nucleotide-excision repair, DNA incision (GO:0033683)",-2.8805180462694667e-11,0.0
5569,cerebellar granular layer formation (GO:0021684),-2.8805180462694667e-11,0.0
5570,mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-2.8805180462694667e-11,0.0
5571,positive regulation of mammary gland epithelial cell proliferation (GO:0033601),-2.8805180462694667e-11,0.0
5572,facial nerve structural organization (GO:0021612),-2.8805180462694667e-11,0.0
5573,axonogenesis involved in innervation (GO:0060385),-2.8805180462694667e-11,0.0
5574,pole plasm assembly (GO:0007315),-2.8805180462694667e-11,0.0
5575,oocyte anterior/posterior axis specification (GO:0007314),-2.8805180462694667e-11,0.0
5576,regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),-2.8805180462694667e-11,0.0
5577,positive regulation of corticosteroid hormone secretion (GO:2000848),-2.8805180462694667e-11,0.0
5578,clathrin coat disassembly (GO:0072318),-2.8805180462694667e-11,0.0
5579,bone trabecula formation (GO:0060346),-2.8805180462694667e-11,0.0
5580,negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-2.8805180462694667e-11,0.0
5581,regulation of maintenance of sister chromatid cohesion (GO:0034091),-2.8805180462694667e-11,0.0
5582,negative regulation of response to interferon-gamma (GO:0060331),-2.8805180462694667e-11,0.0
5583,CMP metabolic process (GO:0046035),-2.8805180462694667e-11,0.0
5584,glutamine transport (GO:0006868),-2.8805180462694667e-11,0.0
5585,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-2.8805180462694667e-11,0.0
5586,positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-2.8805180462694667e-11,0.0
5587,olfactory nerve development (GO:0021553),-2.8805180462694667e-11,0.0
5588,response to pheromone (GO:0019236),-2.8805180462694667e-11,0.0
5589,metanephric nephron tubule morphogenesis (GO:0072282),-2.8805180462694667e-11,0.0
5590,cytoplasmic sequestering of NF-kappaB (GO:0007253),-2.8805180462694667e-11,0.0
5591,tachykinin receptor signaling pathway (GO:0007217),-2.8805180462694667e-11,0.0
5592,regulation of mesenchymal stem cell differentiation (GO:2000739),-2.8805180462694667e-11,0.0
5593,positive regulation of cardiac muscle cell differentiation (GO:2000727),-2.8805180462694667e-11,0.0
5594,positive regulation of endocytic recycling (GO:2001137),-2.8805180462694667e-11,0.0
5595,adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),-2.8805180462694667e-11,0.0
5596,signal complex assembly (GO:0007172),-2.8805180462694667e-11,0.0
5597,mesenchymal cell differentiation involved in kidney development (GO:0072161),-2.8805180462694667e-11,0.0
5598,inner cell mass cell differentiation (GO:0001826),-2.8805180462694667e-11,0.0
5599,ribonucleoprotein complex disassembly (GO:0032988),-2.8805180462694667e-11,0.0
5600,regulation of interleukin-1-mediated signaling pathway (GO:2000659),-2.8805180462694667e-11,0.0
5601,positive regulation of receptor catabolic process (GO:2000646),-2.8805180462694667e-11,0.0
5602,positive regulation of early endosome to late endosome transport (GO:2000643),-2.8805180462694667e-11,0.0
5603,phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),-2.8805180462694667e-11,0.0
5604,glomerular mesangium development (GO:0072109),-2.8805180462694667e-11,0.0
5605,"negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000623)",-2.8805180462694667e-11,0.0
5606,positive regulation of activin receptor signaling pathway (GO:0032927),-2.8805180462694667e-11,0.0
5607,galactosylceramide metabolic process (GO:0006681),-2.8805180462694667e-11,0.0
5608,positive regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902425),-2.8805180462694667e-11,0.0
5609,regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902423),-2.8805180462694667e-11,0.0
5610,positive regulation of mRNA binding (GO:1902416),-2.8805180462694667e-11,0.0
5611,diacylglycerol biosynthetic process (GO:0006651),-2.8805180462694667e-11,0.0
5612,"SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-2.8805180462694667e-11,0.0
5613,leukocyte chemotaxis involved in inflammatory response (GO:0002232),-2.8805180462694667e-11,0.0
5614,regulation of MHC class I biosynthetic process (GO:0045343),-2.8805180462694667e-11,0.0
5615,negative regulation of cellular glucuronidation (GO:2001030),-2.8805180462694667e-11,0.0
5616,mesenchymal cell differentiation involved in renal system development (GO:2001012),-2.8805180462694667e-11,0.0
5617,metaphase/anaphase transition of mitotic cell cycle (GO:0007091),-2.8805180462694667e-11,0.0
5618,meiotic cell cycle checkpoint signaling (GO:0033313),-2.8805180462694667e-11,0.0
5619,regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),-2.8805180462694667e-11,0.0
5620,tubulin complex assembly (GO:0007021),-2.8805180462694667e-11,0.0
5621,membrane hyperpolarization (GO:0060081),-2.8805180462694667e-11,0.0
5622,type III interferon signaling pathway (GO:0038196),-2.8805180462694667e-11,0.0
5623,"regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-2.8805180462694667e-11,0.0
5624,micturition (GO:0060073),-2.8805180462694667e-11,0.0
5625,positive regulation of T-helper 1 cell cytokine production (GO:2000556),-2.8805180462694667e-11,0.0
5626,regulation of T-helper 1 cell cytokine production (GO:2000554),-2.8805180462694667e-11,0.0
5627,ceramide 1-phosphate transport (GO:1902389),-2.8805180462694667e-11,0.0
5628,positive regulation of protein glycosylation (GO:0060050),-2.8805180462694667e-11,0.0
5629,negative regulation by host of viral genome replication (GO:0044828),-2.8805180462694667e-11,0.0
5630,regulation of cellular pH reduction (GO:0032847),-2.8805180462694667e-11,0.0
5631,hard palate development (GO:0060022),-2.8805180462694667e-11,0.0
5632,ERBB2-EGFR signaling pathway (GO:0038134),-2.8805180462694667e-11,0.0
5633,regulation of natural killer cell chemotaxis (GO:2000501),-2.8805180462694667e-11,0.0
5634,positive regulation of natural killer cell differentiation (GO:0032825),-2.8805180462694667e-11,0.0
5635,L-phenylalanine catabolic process (GO:0006559),-2.8805180462694667e-11,0.0
5636,L-phenylalanine metabolic process (GO:0006558),-2.8805180462694667e-11,0.0
5637,lysine metabolic process (GO:0006553),-2.8805180462694667e-11,0.0
5638,leucine metabolic process (GO:0006551),-2.8805180462694667e-11,0.0
5639,zinc ion import across plasma membrane (GO:0071578),-2.8805180462694667e-11,0.0
5640,histidine catabolic process (GO:0006548),-2.8805180462694667e-11,0.0
5641,glutamate catabolic process (GO:0006538),-2.8805180462694667e-11,0.0
5642,positive regulation of mitochondrial depolarization (GO:0051901),-2.8805180462694667e-11,0.0
5643,gastric acid secretion (GO:0001696),-2.8805180462694667e-11,0.0
5644,iron import into cell (GO:0033212),-2.8805180462694667e-11,0.0
5645,metaphase/anaphase transition of cell cycle (GO:0044784),-2.8805180462694667e-11,0.0
5646,positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),-2.8805180462694667e-11,0.0
5647,positive regulation of apoptotic cell clearance (GO:2000427),-2.8805180462694667e-11,0.0
5648,positive regulation of interleukin-18 production (GO:0032741),-2.8805180462694667e-11,0.0
5649,protein sulfation (GO:0006477),-2.8805180462694667e-11,0.0
5650,negative regulation of interleukin-5 production (GO:0032714),-2.8805180462694667e-11,0.0
5651,cellular response to laminar fluid shear stress (GO:0071499),-2.8805180462694667e-11,0.0
5652,cellular response to UV-B (GO:0071493),-2.8805180462694667e-11,0.0
5653,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),-2.8805180462694667e-11,0.0
5654,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),-2.8805180462694667e-11,0.0
5655,G protein-coupled opioid receptor signaling pathway (GO:0038003),-2.8805180462694667e-11,0.0
5656,translational readthrough (GO:0006451),-2.8805180462694667e-11,0.0
5657,cellular response to salt stress (GO:0071472),-2.8805180462694667e-11,0.0
5658,regulation of gamma-aminobutyric acid secretion (GO:0014052),-2.8805180462694667e-11,0.0
5659,regulation of cardioblast differentiation (GO:0051890),-2.8805180462694667e-11,0.0
5660,glutamate secretion (GO:0014047),-2.8805180462694667e-11,0.0
5661,regulation of neuron maturation (GO:0014041),-2.8805180462694667e-11,0.0
5662,cellular response to hydroperoxide (GO:0071447),-2.8805180462694667e-11,0.0
5663,succinate transmembrane transport (GO:0071422),-2.8805180462694667e-11,0.0
5664,regulation of L-glutamate import across plasma membrane (GO:0002036),-2.8805180462694667e-11,0.0
5665,presynaptic active zone organization (GO:1990709),-2.8805180462694667e-11,0.0
5666,nucleolar chromatin organization (GO:1990700),-2.8805180462694667e-11,0.0
5667,immunoglobulin V(D)J recombination (GO:0033152),-2.8805180462694667e-11,0.0
5668,protein localization to endoplasmic reticulum exit site (GO:0070973),-2.8805180462694667e-11,0.0
5669,histone H4 deacetylation (GO:0070933),-2.8805180462694667e-11,0.0
5670,regulation of neutrophil extravasation (GO:2000389),-2.8805180462694667e-11,0.0
5671,selenocysteine incorporation (GO:0001514),-2.8805180462694667e-11,0.0
5672,positive regulation of T-helper 17 cell differentiation (GO:2000321),-2.8805180462694667e-11,0.0
5673,transcription initiation at RNA polymerase III promoter (GO:0006384),-2.8805180462694667e-11,0.0
5674,7-methylguanosine mRNA capping (GO:0006370),-2.8805180462694667e-11,0.0
5675,intracellular transport of virus (GO:0075733),-2.8805180462694667e-11,0.0
5676,cellular response to ether (GO:0071362),-2.8805180462694667e-11,0.0
5677,cellular response to type III interferon (GO:0071358),-2.8805180462694667e-11,0.0
5678,cellular response to cocaine (GO:0071314),-2.8805180462694667e-11,0.0
5679,regulation of synaptic vesicle membrane organization (GO:1901632),-2.8805180462694667e-11,0.0
5680,depyrimidination (GO:0045008),-2.8805180462694667e-11,0.0
5681,double-strand break repair via synthesis-dependent strand annealing (GO:0045003),-2.8805180462694667e-11,0.0
5682,negative regulation of glycogen metabolic process (GO:0070874),-2.8805180462694667e-11,0.0
5683,regulation of neutrophil apoptotic process (GO:0033029),-2.8805180462694667e-11,0.0
5684,dehydroascorbic acid transport (GO:0070837),-2.8805180462694667e-11,0.0
5685,stress-induced premature senescence (GO:0090400),-2.8805180462694667e-11,0.0
5686,purine ribonucleotide salvage (GO:0106380),-2.8805180462694667e-11,0.0
5687,relaxation of smooth muscle (GO:0044557),-2.8805180462694667e-11,0.0
5688,regulation of long-chain fatty acid import into cell (GO:0140212),-2.8805180462694667e-11,0.0
5689,neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0099645),-2.8805180462694667e-11,0.0
5690,anterograde axonal protein transport (GO:0099641),-2.8805180462694667e-11,0.0
5691,axo-dendritic protein transport (GO:0099640),-2.8805180462694667e-11,0.0
5692,protein localization to postsynaptic specialization membrane (GO:0099633),-2.8805180462694667e-11,0.0
5693,pyrimidine dimer repair (GO:0006290),-2.8805180462694667e-11,0.0
5694,establishment of Golgi localization (GO:0051683),-2.8805180462694667e-11,0.0
5695,positive regulation of CoA-transferase activity (GO:1905920),-2.8805180462694667e-11,0.0
5696,regulation of CoA-transferase activity (GO:1905918),-2.8805180462694667e-11,0.0
5697,phosphatidylserine exposure on apoptotic cell surface (GO:0070782),-2.8805180462694667e-11,0.0
5698,negative regulation of oxidative phosphorylation (GO:0090324),-2.8805180462694667e-11,0.0
5699,histone H3-K27 methylation (GO:0070734),-2.8805180462694667e-11,0.0
5700,regulation of ribonucleoprotein complex localization (GO:2000197),-2.8805180462694667e-11,0.0
5701,negative regulation of fatty acid transport (GO:2000192),-2.8805180462694667e-11,0.0
5702,negative regulation of dendrite development (GO:2000171),-2.8805180462694667e-11,0.0
5703,response to bacterial lipoprotein (GO:0032493),-2.8805180462694667e-11,0.0
5704,regulation of Cdc42 protein signal transduction (GO:0032489),-2.8805180462694667e-11,0.0
5705,extracellular vesicle biogenesis (GO:0140112),-2.8805180462694667e-11,0.0
5706,purine ribonucleoside salvage (GO:0006166),-2.8805180462694667e-11,0.0
5707,embryonic cleavage (GO:0040016),-2.8805180462694667e-11,0.0
5708,histone H4-K12 acetylation (GO:0043983),-2.8805180462694667e-11,0.0
5709,regulation of glutamine family amino acid metabolic process (GO:0000820),-2.8805180462694667e-11,0.0
5710,positive regulation of spindle assembly (GO:1905832),-2.8805180462694667e-11,0.0
5711,cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),-2.8805180462694667e-11,0.0
5712,pronephros development (GO:0048793),-2.8805180462694667e-11,0.0
5713,response to interleukin-15 (GO:0070672),-2.8805180462694667e-11,0.0
5714,regulation of mast cell proliferation (GO:0070666),-2.8805180462694667e-11,0.0
5715,centromeric sister chromatid cohesion (GO:0070601),-2.8805180462694667e-11,0.0
5716,regulation of intracellular cholesterol transport (GO:0032383),-2.8805180462694667e-11,0.0
5717,regulation of intracellular sterol transport (GO:0032380),-2.8805180462694667e-11,0.0
5718,cell-cell adhesion mediated by cadherin (GO:0044331),-2.8805180462694667e-11,0.0
5719,positive regulation of male gonad development (GO:2000020),-2.8805180462694667e-11,0.0
5720,protein K27-linked ubiquitination (GO:0044314),-2.8805180462694667e-11,0.0
5721,regulation of aldosterone biosynthetic process (GO:0032347),-2.8805180462694667e-11,0.0
5722,regulation of aldosterone metabolic process (GO:0032344),-2.8805180462694667e-11,0.0
5723,regulation of transforming growth factor beta activation (GO:1901388),-2.8805180462694667e-11,0.0
5724,regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-2.8805180462694667e-11,0.0
5725,response to nitrosative stress (GO:0051409),-2.8805180462694667e-11,0.0
5726,regulation of store-operated calcium channel activity (GO:1901339),-2.8805180462694667e-11,0.0
5727,histone H2A K63-linked deubiquitination (GO:0070537),-2.8805180462694667e-11,0.0
5728,equilibrioception (GO:0050957),-2.8805180462694667e-11,0.0
5729,regulation of skeletal muscle tissue growth (GO:0048631),-2.8805180462694667e-11,0.0
5730,regulation of pigment cell differentiation (GO:0050932),-2.8805180462694667e-11,0.0
5731,'de novo' AMP biosynthetic process (GO:0044208),-2.8805180462694667e-11,0.0
5732,"regulation of synaptic transmission, dopaminergic (GO:0032225)",-2.8805180462694667e-11,0.0
5733,maintenance of postsynaptic specialization structure (GO:0098880),-2.8805180462694667e-11,0.0
5734,regulation of blood-brain barrier permeability (GO:1905603),-2.8805180462694667e-11,0.0
5735,foam cell differentiation (GO:0090077),-2.8805180462694667e-11,0.0
5736,alkaloid metabolic process (GO:0009820),-2.8805180462694667e-11,0.0
5737,regulation of ribosome biogenesis (GO:0090069),-2.8805180462694667e-11,0.0
5738,positive regulation of microtubule nucleation (GO:0090063),-2.8805180462694667e-11,0.0
5739,coumarin metabolic process (GO:0009804),-2.8805180462694667e-11,0.0
5740,positive regulation of B cell receptor signaling pathway (GO:0050861),-2.8805180462694667e-11,0.0
5741,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),-2.8805180462694667e-11,0.0
5742,centrosome separation (GO:0051299),-2.8805180462694667e-11,0.0
5743,positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-2.8805180462694667e-11,0.0
5744,polyadenylation-dependent ncRNA catabolic process (GO:0043634),-2.8805180462694667e-11,0.0
5745,regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-2.8805180462694667e-11,0.0
5746,regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031630),-2.8805180462694667e-11,0.0
5747,activated T cell proliferation (GO:0050798),-2.8805180462694667e-11,0.0
5748,mucociliary clearance (GO:0120197),-2.8805180462694667e-11,0.0
5749,regulation of translation in response to endoplasmic reticulum stress (GO:0036490),-2.8805180462694667e-11,0.0
5750,regulation of endodeoxyribonuclease activity (GO:0032071),-2.8805180462694667e-11,0.0
5751,"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-2.8805180462694667e-11,0.0
5752,postsynaptic specialization assembly (GO:0098698),-2.8805180462694667e-11,0.0
5753,regulation of histone H3-K36 methylation (GO:0000414),-2.8805180462694667e-11,0.0
5754,phenylpropanoid metabolic process (GO:0009698),-2.8805180462694667e-11,0.0
5755,dorsal aorta morphogenesis (GO:0035912),-2.8805180462694667e-11,0.0
5756,cornification (GO:0070268),-2.8805180462694667e-11,0.0
5757,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-2.8805180462694667e-11,0.0
5758,paraxial mesoderm formation (GO:0048341),-2.8805180462694667e-11,0.0
5759,protein poly-ADP-ribosylation (GO:0070212),-2.8805180462694667e-11,0.0
5760,histone H2A-K119 monoubiquitination (GO:0036353),-2.8805180462694667e-11,0.0
5761,protein localization to presynapse (GO:1905383),-2.8805180462694667e-11,0.0
5762,proton-transporting ATP synthase complex assembly (GO:0043461),-2.8805180462694667e-11,0.0
5763,N-terminal peptidyl-methionine acetylation (GO:0017196),-2.8805180462694667e-11,0.0
5764,negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-2.8805180462694667e-11,0.0
5765,negative regulation of morphogenesis of an epithelium (GO:1905331),-2.8805180462694667e-11,0.0
5766,peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-2.8805180462694667e-11,0.0
5767,peptidyl-diphthamide metabolic process (GO:0017182),-2.8805180462694667e-11,0.0
5768,microtubule severing (GO:0051013),-2.8805180462694667e-11,0.0
5769,negative regulation of nitric-oxide synthase activity (GO:0051001),-2.8805180462694667e-11,0.0
5770,positive regulation of tooth mineralization (GO:0070172),-2.8805180462694667e-11,0.0
5771,tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-2.8805180462694667e-11,0.0
5772,7-methylguanosine cap hypermethylation (GO:0036261),-2.8805180462694667e-11,0.0
5773,plasma membrane to endosome transport (GO:0048227),-2.8805180462694667e-11,0.0
5774,otic vesicle formation (GO:0030916),-2.8805180462694667e-11,0.0
5775,platelet-derived growth factor receptor-beta signaling pathway (GO:0035791),-2.8805180462694667e-11,0.0
5776,"CD8-positive, alpha-beta T cell differentiation (GO:0043374)",-2.8805180462694667e-11,0.0
5777,common myeloid progenitor cell proliferation (GO:0035726),-2.8805180462694667e-11,0.0
5778,regulation of neutrophil degranulation (GO:0043313),-2.8805180462694667e-11,0.0
5779,gamma-aminobutyric acid metabolic process (GO:0009448),-2.8805180462694667e-11,0.0
5780,response to water deprivation (GO:0009414),-2.8805180462694667e-11,0.0
5781,regulation of electron transfer activity (GO:1904732),-2.8805180462694667e-11,0.0
5782,positive regulation of granulocyte differentiation (GO:0030854),-2.8805180462694667e-11,0.0
5783,regulation of chaperone-mediated autophagy (GO:1904714),-2.8805180462694667e-11,0.0
5784,lysosomal protein catabolic process (GO:1905146),-2.8805180462694667e-11,0.0
5785,protein deglutamylation (GO:0035608),-2.8805180462694667e-11,0.0
5786,"post-translational protein targeting to membrane, translocation (GO:0031204)",-2.8805180462694667e-11,0.0
5787,snRNA transcription by RNA polymerase III (GO:0042796),-2.8805180462694667e-11,0.0
5788,tRNA transcription (GO:0009304),-2.8805180462694667e-11,0.0
5789,tRNA 3'-end processing (GO:0042780),-2.8805180462694667e-11,0.0
5790,post-embryonic eye morphogenesis (GO:0048050),-2.8805180462694667e-11,0.0
5791,cellular response to phorbol 13-acetate 12-myristate (GO:1904628),-2.8805180462694667e-11,0.0
5792,response to phorbol 13-acetate 12-myristate (GO:1904627),-2.8805180462694667e-11,0.0
5793,negative regulation of transcription by RNA polymerase I (GO:0016479),-2.8805180462694667e-11,0.0
5794,P granule organization (GO:0030719),-2.8805180462694667e-11,0.0
5795,negative regulation of NLRP3 inflammasome complex assembly (GO:1900226),-2.8805180462694667e-11,0.0
5796,positive regulation of amyloid-beta clearance (GO:1900223),-2.8805180462694667e-11,0.0
5797,cellular response to macrophage colony-stimulating factor stimulus (GO:0036006),-2.8805180462694667e-11,0.0
5798,telomeric D-loop disassembly (GO:0061820),-2.8805180462694667e-11,0.0
5799,negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-2.8805180462694667e-11,0.0
5800,diadenosine polyphosphate metabolic process (GO:0015959),-2.8805180462694667e-11,0.0
5801,nucleobase-containing small molecule interconversion (GO:0015949),-2.8805180462694667e-11,0.0
5802,pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-2.8805180462694667e-11,0.0
5803,regulation of hyaluronan biosynthetic process (GO:1900125),-2.8805180462694667e-11,0.0
5804,motor learning (GO:0061743),-2.8805180462694667e-11,0.0
5805,tripeptide transmembrane transport (GO:0035443),-2.8805180462694667e-11,0.0
5806,ribonucleoside diphosphate catabolic process (GO:0009191),-2.8805180462694667e-11,0.0
5807,post-embryonic camera-type eye development (GO:0031077),-2.8805180462694667e-11,0.0
5808,pyrimidine deoxyribonucleoside monophosphate catabolic process (GO:0009178),-2.8805180462694667e-11,0.0
5809,amine transport (GO:0015837),-2.8805180462694667e-11,0.0
5810,regulation of lysosome size (GO:0062196),-2.8805180462694667e-11,0.0
5811,peptidyl-lysine deacetylation (GO:0034983),-2.8805180462694667e-11,0.0
5812,negative regulation of low-density lipoprotein particle clearance (GO:0010989),-2.8805180462694667e-11,0.0
5813,positive regulation of xenophagy (GO:1904417),-2.8805180462694667e-11,0.0
5814,regulation of xenophagy (GO:1904415),-2.8805180462694667e-11,0.0
5815,gap junction assembly (GO:0016264),-2.8805180462694667e-11,0.0
5816,preassembly of GPI anchor in ER membrane (GO:0016254),-2.8805180462694667e-11,0.0
5817,chaperone-mediated autophagy (GO:0061684),-2.8805180462694667e-11,0.0
5818,positive regulation of isomerase activity (GO:0010912),-2.8805180462694667e-11,0.0
5819,regulation of isomerase activity (GO:0010911),-2.8805180462694667e-11,0.0
5820,mitochondrial ribosome assembly (GO:0061668),-2.8805180462694667e-11,0.0
5821,regulation of eating behavior (GO:1903998),-2.8805180462694667e-11,0.0
5822,positive regulation of microglial cell activation (GO:1903980),-2.8805180462694667e-11,0.0
5823,negative regulation of microglial cell activation (GO:1903979),-2.8805180462694667e-11,0.0
5824,fructose transmembrane transport (GO:0015755),-2.8805180462694667e-11,0.0
5825,urate transport (GO:0015747),-2.8805180462694667e-11,0.0
5826,succinate transport (GO:0015744),-2.8805180462694667e-11,0.0
5827,regulation of saliva secretion (GO:0046877),-2.8805180462694667e-11,0.0
5828,response to sodium phosphate (GO:1904383),-2.8805180462694667e-11,0.0
5829,outer ear morphogenesis (GO:0042473),-2.8805180462694667e-11,0.0
5830,negative regulation of telomere capping (GO:1904354),-2.8805180462694667e-11,0.0
5831,ethanolamine-containing compound metabolic process (GO:0042439),-2.8805180462694667e-11,0.0
5832,synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-2.8805180462694667e-11,0.0
5833,necroptotic signaling pathway (GO:0097527),-2.8805180462694667e-11,0.0
5834,siRNA processing (GO:0030422),-2.8805180462694667e-11,0.0
5835,positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-2.8805180462694667e-11,0.0
5836,regulation of synaptic vesicle priming (GO:0010807),-2.8805180462694667e-11,0.0
5837,microglial cell proliferation (GO:0061518),-2.8805180462694667e-11,0.0
5838,macrophage proliferation (GO:0061517),-2.8805180462694667e-11,0.0
5839,amyloid-beta clearance by cellular catabolic process (GO:0150094),-2.8805180462694667e-11,0.0
5840,viral mRNA export from host cell nucleus (GO:0046784),-2.8805180462694667e-11,0.0
5841,histone H4-K20 trimethylation (GO:0034773),-2.8805180462694667e-11,0.0
5842,positive regulation of neuron projection arborization (GO:0150012),-2.8805180462694667e-11,0.0
5843,regulation by virus of viral protein levels in host cell (GO:0046719),-2.8805180462694667e-11,0.0
5844,histone H3-K4 demethylation (GO:0034720),-2.8805180462694667e-11,0.0
5845,negative regulation of glucuronosyltransferase activity (GO:1904224),-2.8805180462694667e-11,0.0
5846,regulation of glucuronosyltransferase activity (GO:1904223),-2.8805180462694667e-11,0.0
5847,negative regulation of plasminogen activation (GO:0010757),-2.8805180462694667e-11,0.0
5848,positive regulation of plasminogen activation (GO:0010756),-2.8805180462694667e-11,0.0
5849,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-2.8805180462694667e-11,0.0
5850,regulation of hydrogen peroxide biosynthetic process (GO:0010728),-2.8805180462694667e-11,0.0
5851,kidney vasculature morphogenesis (GO:0061439),-2.8805180462694667e-11,0.0
5852,renal system vasculature morphogenesis (GO:0061438),-2.8805180462694667e-11,0.0
5853,negative regulation of RIG-I signaling pathway (GO:0039536),-2.8805180462694667e-11,0.0
5854,negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-2.8805180462694667e-11,0.0
5855,regulation of I-kappaB phosphorylation (GO:1903719),-2.8805180462694667e-11,0.0
5856,cardiac muscle cell fate commitment (GO:0060923),-2.8805180462694667e-11,0.0
5857,positive regulation of adipose tissue development (GO:1904179),-2.8805180462694667e-11,0.0
5858,inhibition of cysteine-type endopeptidase activity (GO:0097340),-2.8805180462694667e-11,0.0
5859,regulation of microglial cell migration (GO:1904139),-2.8805180462694667e-11,0.0
5860,"maternal determination of anterior/posterior axis, embryo (GO:0008358)",-2.8805180462694667e-11,0.0
5861,negative regulation of mitochondrial fusion (GO:0010637),-2.8805180462694667e-11,0.0
5862,negative regulation of Schwann cell proliferation (GO:0010626),-2.8805180462694667e-11,0.0
5863,regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-2.8805180462694667e-11,0.0
5864,"regulation of wound healing, spreading of epidermal cells (GO:1903689)",-2.8805180462694667e-11,0.0
5865,behavioral response to nicotine (GO:0035095),-2.8805180462694667e-11,0.0
5866,regulation of complement-dependent cytotoxicity (GO:1903659),-2.8805180462694667e-11,0.0
5867,chondrocyte development involved in endochondral bone morphogenesis (GO:0003433),-2.8805180462694667e-11,0.0
5868,endothelial cell fate commitment (GO:0060839),-2.8805180462694667e-11,0.0
5869,lymphatic endothelial cell differentiation (GO:0060836),-2.8805180462694667e-11,0.0
5870,intracellular mRNA localization (GO:0008298),-2.8805180462694667e-11,0.0
5871,miRNA catabolic process (GO:0010587),-2.8805180462694667e-11,0.0
5872,regulation of lymphocyte anergy (GO:0002911),-2.8805180462694667e-11,0.0
5873,spermidine metabolic process (GO:0008216),-2.8805180462694667e-11,0.0
5874,negative regulation of phospholipase activity (GO:0010519),-2.8805180462694667e-11,0.0
5875,brainstem development (GO:0003360),-2.8805180462694667e-11,0.0
5876,pericardium morphogenesis (GO:0003344),-2.8805180462694667e-11,0.0
5877,glyoxylate metabolic process (GO:0046487),-2.8805180462694667e-11,0.0
5878,regulation of mast cell chemotaxis (GO:0060753),-2.8805180462694667e-11,0.0
5879,mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337),-2.8805180462694667e-11,0.0
5880,platelet activating factor metabolic process (GO:0046469),-2.8805180462694667e-11,0.0
5881,U4 snRNA 3'-end processing (GO:0034475),-2.8805180462694667e-11,0.0
5882,urinary bladder smooth muscle contraction (GO:0014832),-2.8805180462694667e-11,0.0
5883,positive regulation of acute inflammatory response to antigenic stimulus (GO:0002866),-2.8805180462694667e-11,0.0
5884,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-2.8805180462694667e-11,0.0
5885,histone H3-K36 methylation (GO:0010452),-2.8805180462694667e-11,0.0
5886,negative regulation of striated muscle contraction (GO:0045988),-2.8805180462694667e-11,0.0
5887,protein maturation by protein folding (GO:0022417),-2.8805180462694667e-11,0.0
5888,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808),-2.8805180462694667e-11,0.0
5889,GDP-mannose metabolic process (GO:0019673),-2.8805180462694667e-11,0.0
5890,negative regulation of vasoconstriction (GO:0045906),-2.8805180462694667e-11,0.0
5891,negative regulation of cell maturation (GO:1903430),-2.8805180462694667e-11,0.0
5892,positive regulation of synaptic vesicle recycling (GO:1903423),-2.8805180462694667e-11,0.0
5893,T cell extravasation (GO:0072683),-2.8805180462694667e-11,0.0
5894,regulation of branching involved in salivary gland morphogenesis (GO:0060693),-2.8805180462694667e-11,0.0
5895,ventricular compact myocardium morphogenesis (GO:0003223),-2.8805180462694667e-11,0.0
5896,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-2.8805180462694667e-11,0.0
5897,dichotomous subdivision of an epithelial terminal unit (GO:0060600),-2.8805180462694667e-11,0.0
5898,regulation of antimicrobial peptide production (GO:0002784),-2.8805180462694667e-11,0.0
5899,positive regulation of antimicrobial humoral response (GO:0002760),-2.8805180462694667e-11,0.0
5900,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-2.8805180462694667e-11,0.0
5901,positive regulation of natural killer cell cytokine production (GO:0002729),-2.8805180462694667e-11,0.0
5902,negative regulation of striated muscle tissue development (GO:0045843),-2.8805180462694667e-11,0.0
5903,vascular wound healing (GO:0061042),-2.8805180462694667e-11,0.0
5904,hypothalamus gonadotrophin-releasing hormone neuron development (GO:0021888),-2.8805180462694667e-11,0.0
5905,hypothalamus gonadotrophin-releasing hormone neuron differentiation (GO:0021886),-2.8805180462694667e-11,0.0
5906,regulation of protein folding (GO:1903332),-2.8805180462694667e-11,0.0
5907,atrioventricular valve formation (GO:0003190),-2.8805180462694667e-11,0.0
5908,liver morphogenesis (GO:0072576),-2.8805180462694667e-11,0.0
5909,atrioventricular node development (GO:0003162),-2.8805180462694667e-11,0.0
5910,morphogenesis of an epithelial bud (GO:0060572),-2.8805180462694667e-11,0.0
5911,amino acid homeostasis (GO:0080144),-2.8805180462694667e-11,0.0
5912,membranous septum morphogenesis (GO:0003149),-2.8805180462694667e-11,0.0
5913,diaphragm development (GO:0060539),-2.8805180462694667e-11,0.0
5914,positive regulation of non-motile cilium assembly (GO:1902857),-2.8805180462694667e-11,0.0
5915,type I pneumocyte differentiation (GO:0060509),-2.8805180462694667e-11,0.0
5916,negative regulation of cellular extravasation (GO:0002692),-2.8805180462694667e-11,0.0
5917,long-chain fatty acid metabolic process (GO:0001676),-2.912026175707416e-11,0.0
5918,cytokinesis (GO:0000910),-2.912026175707416e-11,0.0
5919,regulation of chromosome separation (GO:1905818),-2.912026175707416e-11,0.0
5920,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-2.912026175707416e-11,0.0
5921,regulation of double-strand break repair (GO:2000779),-2.978040036749684e-11,0.0
5922,cell-matrix adhesion (GO:0007160),-2.978040036749684e-11,0.0
5923,peptidyl-lysine acetylation (GO:0018394),-2.978040036749684e-11,0.0
5924,signal transduction in response to DNA damage (GO:0042770),-2.978040036749684e-11,0.0
5925,regulation of dephosphorylation (GO:0035303),-2.978040036749684e-11,0.0
5926,regulation of cellular ketone metabolic process (GO:0010565),-2.978040036749684e-11,0.0
5927,tRNA processing (GO:0008033),-2.978040036749684e-11,0.0
5928,positive regulation of proteasomal protein catabolic process (GO:1901800),-3.015920846348759e-11,0.0
5929,oxidative phosphorylation (GO:0006119),-3.015920846348759e-11,0.0
5930,positive regulation of cell projection organization (GO:0031346),-3.022271322049423e-11,0.8379731379731379
5931,regulation of cytokine production (GO:0001817),-3.0462965483015824e-11,0.9909992298806315
5932,regulation of small molecule metabolic process (GO:0062012),-3.1407321187732766e-11,0.8832689832689833
5933,plasma membrane bounded cell projection assembly (GO:0120031),-3.2882141453597416e-11,0.7036568694463432
5934,supramolecular fiber organization (GO:0097435),-3.5664804442422537e-11,0.7606773399014779
5935,leukocyte chemotaxis (GO:0030595),-3.6806557800905676e-11,0.9804285714285715
5936,heart process (GO:0003015),-3.693023664584436e-11,0.0
5937,RNA 3'-end processing (GO:0031123),-3.693023664584436e-11,0.0
5938,cytoskeleton-dependent cytokinesis (GO:0061640),-3.693023664584436e-11,0.0
5939,epidermis development (GO:0008544),-3.6953107240150794e-11,0.9162883845126836
5940,response to peptide hormone (GO:0043434),-3.7072123148386203e-11,0.8102715466351831
5941,regulation of endothelial cell proliferation (GO:0001936),-3.761435607359288e-11,0.0
5942,DNA-templated DNA replication (GO:0006261),-3.761435607359288e-11,0.0
5943,sulfur compound biosynthetic process (GO:0044272),-3.761435607359288e-11,0.0
5944,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-3.761435607359288e-11,0.0
5945,myeloid leukocyte migration (GO:0097529),-3.761435607359288e-11,0.0
5946,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-3.859956798560771e-11,0.0
5947,negative regulation of response to DNA damage stimulus (GO:2001021),-3.859956798560771e-11,0.0
5948,organelle localization by membrane tethering (GO:0140056),-3.859956798560771e-11,0.0
5949,keratinization (GO:0031424),-3.859956798560771e-11,0.0
5950,sterol transport (GO:0015918),-3.859956798560771e-11,0.0
5951,chromosome localization (GO:0050000),-3.859956798560771e-11,0.0
5952,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-3.859956798560771e-11,0.0
5953,blood vessel morphogenesis (GO:0048514),-3.865863185051548e-11,0.698642687478792
5954,protein targeting to membrane (GO:0006612),-3.965316963593575e-11,0.0
5955,endoplasmic reticulum organization (GO:0007029),-3.965316963593575e-11,0.0
5956,cellular response to chemokine (GO:1990869),-3.965316963593575e-11,0.0
5957,response to chemokine (GO:1990868),-3.965316963593575e-11,0.0
5958,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-3.965316963593575e-11,0.0
5959,peptidyl-lysine methylation (GO:0018022),-3.965316963593575e-11,0.0
5960,regulation of postsynapse organization (GO:0099175),-3.965316963593575e-11,0.0
5961,postsynapse organization (GO:0099173),-3.965316963593575e-11,0.0
5962,regulation of blood vessel endothelial cell migration (GO:0043535),-3.965316963593575e-11,0.0
5963,regulation of purine nucleotide metabolic process (GO:1900542),-3.965316963593575e-11,0.0
5964,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-3.965316963593575e-11,0.0
5965,ATP synthesis coupled electron transport (GO:0042773),-3.965316963593575e-11,0.0
5966,regulation of cellular pH (GO:0030641),-3.965316963593575e-11,0.0
5967,nucleoside diphosphate metabolic process (GO:0009132),-3.965316963593575e-11,0.0
5968,negative regulation of protein serine/threonine kinase activity (GO:0071901),-4.090772165371165e-11,0.0
5969,regulation of interleukin-1 production (GO:0032652),-4.090772165371165e-11,0.0
5970,DNA-templated transcription initiation (GO:0006352),-4.090772165371165e-11,0.0
5971,nucleoside triphosphate biosynthetic process (GO:0009142),-4.090772165371165e-11,0.0
5972,cardiocyte differentiation (GO:0035051),-4.090772165371165e-11,0.0
5973,cytoplasmic translation (GO:0002181),-4.1822989515174765e-11,0.0
5974,protein secretion (GO:0009306),-4.1822989515174765e-11,0.0
5975,purine nucleoside bisphosphate metabolic process (GO:0034032),-4.208233761371632e-11,0.0
5976,positive regulation of protein ubiquitination (GO:0031398),-4.208233761371632e-11,0.0
5977,cholesterol metabolic process (GO:0008203),-4.208233761371632e-11,0.0
5978,positive regulation of mitotic cell cycle (GO:0045931),-4.208233761371632e-11,0.0
5979,ribonucleoside bisphosphate metabolic process (GO:0033875),-4.208233761371632e-11,0.0
5980,nucleoside bisphosphate metabolic process (GO:0033865),-4.208233761371632e-11,0.0
5981,positive regulation of chronic inflammatory response (GO:0002678),-4.402367359449229e-11,0.0
5982,negative regulation of dendritic cell antigen processing and presentation (GO:0002605),-4.402367359449229e-11,0.0
5983,"positive regulation of glutamate secretion, neurotransmission (GO:1903296)",-4.402367359449229e-11,0.0
5984,positive regulation of sodium ion export across plasma membrane (GO:1903278),-4.402367359449229e-11,0.0
5985,respiratory burst after phagocytosis (GO:0045728),-4.402367359449229e-11,0.0
5986,regulation of sodium ion export across plasma membrane (GO:1903276),-4.402367359449229e-11,0.0
5987,L-lysine catabolic process (GO:0019477),-4.402367359449229e-11,0.0
5988,L-lysine catabolic process to acetyl-CoA (GO:0019474),-4.402367359449229e-11,0.0
5989,4-hydroxyproline metabolic process (GO:0019471),-4.402367359449229e-11,0.0
5990,4-hydroxyproline catabolic process (GO:0019470),-4.402367359449229e-11,0.0
5991,striatal medium spiny neuron differentiation (GO:0021773),-4.402367359449229e-11,0.0
5992,globus pallidus development (GO:0021759),-4.402367359449229e-11,0.0
5993,L-cysteine catabolic process (GO:0019448),-4.402367359449229e-11,0.0
5994,negative regulation of leukocyte tethering or rolling (GO:1903237),-4.402367359449229e-11,0.0
5995,regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903233),-4.402367359449229e-11,0.0
5996,negative regulation of inner ear receptor cell differentiation (GO:2000981),-4.402367359449229e-11,0.0
5997,club cell differentiation (GO:0060486),-4.402367359449229e-11,0.0
5998,lobar bronchus epithelium development (GO:0060481),-4.402367359449229e-11,0.0
5999,pharynx development (GO:0060465),-4.402367359449229e-11,0.0
6000,response to intra-S DNA damage checkpoint signaling (GO:0072429),-4.402367359449229e-11,0.0
6001,mitochondrial large ribosomal subunit assembly (GO:1902775),-4.402367359449229e-11,0.0
6002,regulation of systemic arterial blood pressure by baroreceptor feedback (GO:0003025),-4.402367359449229e-11,0.0
6003,glycerol-3-phosphate biosynthetic process (GO:0046167),-4.402367359449229e-11,0.0
6004,activation of protein kinase A activity (GO:0034199),-4.402367359449229e-11,0.0
6005,triglyceride transport (GO:0034197),-4.402367359449229e-11,0.0
6006,acylglycerol transport (GO:0034196),-4.402367359449229e-11,0.0
6007,aorta smooth muscle tissue morphogenesis (GO:0060414),-4.402367359449229e-11,0.0
6008,positive regulation of vitamin metabolic process (GO:0046136),-4.402367359449229e-11,0.0
6009,pyrimidine nucleoside biosynthetic process (GO:0046134),-4.402367359449229e-11,0.0
6010,negative regulation of toll-like receptor 9 signaling pathway (GO:0034164),-4.402367359449229e-11,0.0
6011,purine deoxyribonucleoside catabolic process (GO:0046124),-4.402367359449229e-11,0.0
6012,negative regulation of satellite cell differentiation (GO:1902725),-4.402367359449229e-11,0.0
6013,negative regulation of skeletal muscle satellite cell proliferation (GO:1902723),-4.402367359449229e-11,0.0
6014,hypoxanthine metabolic process (GO:0046100),-4.402367359449229e-11,0.0
6015,nitrobenzene metabolic process (GO:0018916),-4.402367359449229e-11,0.0
6016,regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002586),-4.402367359449229e-11,0.0
6017,negative regulation of antigen processing and presentation of peptide antigen (GO:0002584),-4.402367359449229e-11,0.0
6018,regulation of MyD88-dependent toll-like receptor signaling pathway (GO:0034124),-4.402367359449229e-11,0.0
6019,negative regulation of cell adhesion involved in substrate-bound cell migration (GO:0006933),-4.402367359449229e-11,0.0
6020,wax metabolic process (GO:0010166),-4.402367359449229e-11,0.0
6021,histamine secretion by mast cell (GO:0002553),-4.402367359449229e-11,0.0
6022,mast cell chemotaxis (GO:0002551),-4.402367359449229e-11,0.0
6023,thiamine transmembrane transport (GO:0071934),-4.402367359449229e-11,0.0
6024,regulation of cohesin loading (GO:0071922),-4.402367359449229e-11,0.0
6025,positive regulation of luteinizing hormone secretion (GO:0033686),-4.402367359449229e-11,0.0
6026,peptide antigen assembly with MHC class I protein complex (GO:0002502),-4.402367359449229e-11,0.0
6027,glucuronoside catabolic process (GO:0019391),-4.402367359449229e-11,0.0
6028,negative regulation of mechanoreceptor differentiation (GO:0045632),-4.402367359449229e-11,0.0
6029,glucuronoside metabolic process (GO:0019389),-4.402367359449229e-11,0.0
6030,third ventricle development (GO:0021678),-4.402367359449229e-11,0.0
6031,pyridine nucleotide catabolic process (GO:0019364),-4.402367359449229e-11,0.0
6032,negative regulation of inner ear auditory receptor cell differentiation (GO:0045608),-4.402367359449229e-11,0.0
6033,lipoxin biosynthetic process (GO:2001301),-4.402367359449229e-11,0.0
6034,regulation of TRAIL-activated apoptotic signaling pathway (GO:1903121),-4.402367359449229e-11,0.0
6035,trigeminal nerve structural organization (GO:0021637),-4.402367359449229e-11,0.0
6036,trigeminal nerve morphogenesis (GO:0021636),-4.402367359449229e-11,0.0
6037,pentose catabolic process (GO:0019323),-4.402367359449229e-11,0.0
6038,glossopharyngeal nerve morphogenesis (GO:0021615),-4.402367359449229e-11,0.0
6039,guanine metabolic process (GO:0046098),-4.402367359449229e-11,0.0
6040,UDP-galactose transmembrane transport (GO:0072334),-4.402367359449229e-11,0.0
6041,regulation of corticosterone secretion (GO:2000852),-4.402367359449229e-11,0.0
6042,negative regulation of glucocorticoid secretion (GO:2000850),-4.402367359449229e-11,0.0
6043,frontal suture morphogenesis (GO:0060364),-4.402367359449229e-11,0.0
6044,negative regulation of corticosteroid hormone secretion (GO:2000847),-4.402367359449229e-11,0.0
6045,positive regulation of receptor localization to synapse (GO:1902685),-4.402367359449229e-11,0.0
6046,dTTP metabolic process (GO:0046075),-4.402367359449229e-11,0.0
6047,negative regulation of steroid hormone secretion (GO:2000832),-4.402367359449229e-11,0.0
6048,cGMP catabolic process (GO:0046069),-4.402367359449229e-11,0.0
6049,positive regulation of axon guidance (GO:1902669),-4.402367359449229e-11,0.0
6050,dAMP catabolic process (GO:0046059),-4.402367359449229e-11,0.0
6051,dGMP catabolic process (GO:0046055),-4.402367359449229e-11,0.0
6052,negative regulation of barbed-end actin filament capping (GO:2000813),-4.402367359449229e-11,0.0
6053,maintenance of mitotic sister chromatid cohesion (GO:0034088),-4.402367359449229e-11,0.0
6054,maintenance of sister chromatid cohesion (GO:0034086),-4.402367359449229e-11,0.0
6055,primitive erythrocyte differentiation (GO:0060319),-4.402367359449229e-11,0.0
6056,regulation of cytokine activity (GO:0060300),-4.402367359449229e-11,0.0
6057,regulation of membrane hyperpolarization (GO:1902630),-4.402367359449229e-11,0.0
6058,carnitine shuttle (GO:0006853),-4.402367359449229e-11,0.0
6059,negative regulation of apoptotic process in bone marrow cell (GO:0071866),-4.402367359449229e-11,0.0
6060,regulation of apoptotic process in bone marrow cell (GO:0071865),-4.402367359449229e-11,0.0
6061,regulation of lipid transporter activity (GO:0110112),-4.402367359449229e-11,0.0
6062,antigen processing and presentation of exogenous peptide antigen via MHC class Ib (GO:0002477),-4.402367359449229e-11,0.0
6063,dendritic cell antigen processing and presentation (GO:0002468),-4.402367359449229e-11,0.0
6064,T cell antigen processing and presentation (GO:0002457),-4.402367359449229e-11,0.0
6065,interkinetic nuclear migration (GO:0022027),-4.402367359449229e-11,0.0
6066,malonyl-CoA catabolic process (GO:2001294),-4.402367359449229e-11,0.0
6067,eosinophil mediated immunity (GO:0002447),-4.402367359449229e-11,0.0
6068,histamine secretion involved in inflammatory response (GO:0002441),-4.402367359449229e-11,0.0
6069,response to aluminum ion (GO:0010044),-4.402367359449229e-11,0.0
6070,response to iron(III) ion (GO:0010041),-4.402367359449229e-11,0.0
6071,wax biosynthetic process (GO:0010025),-4.402367359449229e-11,0.0
6072,regulation of histone H3-K36 trimethylation (GO:2001253),-4.402367359449229e-11,0.0
6073,positive regulation of protein lipidation (GO:1903061),-4.402367359449229e-11,0.0
6074,vitellogenesis (GO:0007296),-4.402367359449229e-11,0.0
6075,spermatid nucleus elongation (GO:0007290),-4.402367359449229e-11,0.0
6076,positive regulation of osteoclast development (GO:2001206),-4.402367359449229e-11,0.0
6077,positive regulation of dendritic cell differentiation (GO:2001200),-4.402367359449229e-11,0.0
6078,oculomotor nerve development (GO:0021557),-4.402367359449229e-11,0.0
6079,lactate biosynthetic process (GO:0019249),-4.402367359449229e-11,0.0
6080,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione (GO:0019243),-4.402367359449229e-11,0.0
6081,citrulline biosynthetic process (GO:0019240),-4.402367359449229e-11,0.0
6082,floor plate morphogenesis (GO:0033505),-4.402367359449229e-11,0.0
6083,metanephric nephron tubule formation (GO:0072289),-4.402367359449229e-11,0.0
6084,intestinal D-glucose absorption (GO:0001951),-4.402367359449229e-11,0.0
6085,pattern specification involved in metanephros development (GO:0072268),-4.402367359449229e-11,0.0
6086,positive regulation of sarcomere organization (GO:0060298),-4.402367359449229e-11,0.0
6087,B-1 B cell homeostasis (GO:0001922),-4.402367359449229e-11,0.0
6088,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-4.402367359449229e-11,0.0
6089,regulation of ovulation (GO:0060278),-4.402367359449229e-11,0.0
6090,positive regulation of mesenchymal stem cell differentiation (GO:2000741),-4.402367359449229e-11,0.0
6091,metanephric ascending thin limb development (GO:0072218),-4.402367359449229e-11,0.0
6092,negative regulation of hippocampal neuron apoptotic process (GO:0110091),-4.402367359449229e-11,0.0
6093,negative regulation of cell proliferation involved in contact inhibition (GO:0060244),-4.402367359449229e-11,0.0
6094,regulation of eosinophil activation (GO:1902566),-4.402367359449229e-11,0.0
6095,endocardium formation (GO:0060214),-4.402367359449229e-11,0.0
6096,thiamine metabolic process (GO:0006772),-4.402367359449229e-11,0.0
6097,cellular response to prostaglandin D stimulus (GO:0071799),-4.402367359449229e-11,0.0
6098,response to prostaglandin D (GO:0071798),-4.402367359449229e-11,0.0
6099,endoplasmic reticulum tubular network formation (GO:0071787),-4.402367359449229e-11,0.0
6100,regulation of G2/MI transition of meiotic cell cycle (GO:0110030),-4.402367359449229e-11,0.0
6101,MHC class I protein complex assembly (GO:0002397),-4.402367359449229e-11,0.0
6102,basolateral protein secretion (GO:0110010),-4.402367359449229e-11,0.0
6103,plasma kallikrein-kinin cascade (GO:0002353),-4.402367359449229e-11,0.0
6104,mineralocorticoid biosynthetic process (GO:0006705),-4.402367359449229e-11,0.0
6105,progesterone biosynthetic process (GO:0006701),-4.402367359449229e-11,0.0
6106,histamine production involved in inflammatory response (GO:0002349),-4.402367359449229e-11,0.0
6107,cellular response to diacyl bacterial lipopeptide (GO:0071726),-4.402367359449229e-11,0.0
6108,response to diacyl bacterial lipopeptide (GO:0071724),-4.402367359449229e-11,0.0
6109,pro-B cell differentiation (GO:0002328),-4.402367359449229e-11,0.0
6110,galactose catabolic process via UDP-galactose (GO:0033499),-4.402367359449229e-11,0.0
6111,cholesterol biosynthetic process via lathosterol (GO:0033490),-4.402367359449229e-11,0.0
6112,plasma cell differentiation (GO:0002317),-4.402367359449229e-11,0.0
6113,follicular B cell differentiation (GO:0002316),-4.402367359449229e-11,0.0
6114,cholesterol biosynthetic process via desmosterol (GO:0033489),-4.402367359449229e-11,0.0
6115,Mullerian duct regression (GO:0001880),-4.402367359449229e-11,0.0
6116,NK T cell differentiation (GO:0001865),-4.402367359449229e-11,0.0
6117,calcium-independent cell-matrix adhesion (GO:0007161),-4.402367359449229e-11,0.0
6118,mesonephric duct morphogenesis (GO:0072180),-4.402367359449229e-11,0.0
6119,negative regulation of epithelial cell differentiation involved in kidney development (GO:2000697),-4.402367359449229e-11,0.0
6120,positive regulation of dendritic cell apoptotic process (GO:2000670),-4.402367359449229e-11,0.0
6121,condensed mesenchymal cell proliferation (GO:0072137),-4.402367359449229e-11,0.0
6122,regulation of adenosine receptor signaling pathway (GO:0060167),-4.402367359449229e-11,0.0
6123,regulation of sperm capacitation (GO:1902490),-4.402367359449229e-11,0.0
6124,protein insertion into mitochondrial inner membrane from matrix (GO:0032979),-4.402367359449229e-11,0.0
6125,protein insertion into membrane from inner side (GO:0032978),-4.402367359449229e-11,0.0
6126,regulation of muscle filament sliding (GO:0032971),-4.402367359449229e-11,0.0
6127,urinary bladder development (GO:0060157),-4.402367359449229e-11,0.0
6128,positive regulation of miRNA catabolic process (GO:2000627),-4.402367359449229e-11,0.0
6129,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0072108),-4.402367359449229e-11,0.0
6130,inner ear receptor cell fate commitment (GO:0060120),-4.402367359449229e-11,0.0
6131,deactivation of mitotic spindle assembly checkpoint (GO:1902426),-4.402367359449229e-11,0.0
6132,platelet activating factor biosynthetic process (GO:0006663),-4.402367359449229e-11,0.0
6133,phosphatidylserine catabolic process (GO:0006660),-4.402367359449229e-11,0.0
6134,phosphatidylserine biosynthetic process (GO:0006659),-4.402367359449229e-11,0.0
6135,T-helper 1 cell lineage commitment (GO:0002296),-4.402367359449229e-11,0.0
6136,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:0002291),-4.402367359449229e-11,0.0
6137,positive regulation of smooth muscle cell chemotaxis (GO:0071673),-4.402367359449229e-11,0.0
6138,triglyceride mobilization (GO:0006642),-4.402367359449229e-11,0.0
6139,regulation of IP-10 production (GO:0071658),-4.402367359449229e-11,0.0
6140,positive regulation of granulocyte colony-stimulating factor production (GO:0071657),-4.402367359449229e-11,0.0
6141,astrocyte activation involved in immune response (GO:0002265),-4.402367359449229e-11,0.0
6142,"SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition (GO:0006617)",-4.402367359449229e-11,0.0
6143,ATP generation from poly-ADP-D-ribose (GO:1990966),-4.402367359449229e-11,0.0
6144,ribosomal protein import into nucleus (GO:0006610),-4.402367359449229e-11,0.0
6145,kinin cascade (GO:0002254),-4.402367359449229e-11,0.0
6146,positive regulation of meiotic cell cycle phase transition (GO:1901995),-4.402367359449229e-11,0.0
6147,negative regulation of meiotic cell cycle phase transition (GO:1901994),-4.402367359449229e-11,0.0
6148,phosphocreatine metabolic process (GO:0006603),-4.402367359449229e-11,0.0
6149,lymphocyte anergy (GO:0002249),-4.402367359449229e-11,0.0
6150,negative regulation of granulocyte chemotaxis (GO:0071623),-4.402367359449229e-11,0.0
6151,endothelial cell-cell adhesion (GO:0071603),-4.402367359449229e-11,0.0
6152,response to psychosocial stress (GO:1990911),-4.402367359449229e-11,0.0
6153,farnesyl diphosphate biosynthetic process (GO:0045337),-4.402367359449229e-11,0.0
6154,protein localization to secretory granule (GO:0033366),-4.402367359449229e-11,0.0
6155,late viral transcription (GO:0019086),-4.402367359449229e-11,0.0
6156,carnitine biosynthetic process (GO:0045329),-4.402367359449229e-11,0.0
6157,negative regulation of endothelial cell chemotaxis (GO:2001027),-4.402367359449229e-11,0.0
6158,epithelial cell proliferation involved in renal tubule morphogenesis (GO:2001013),-4.402367359449229e-11,0.0
6159,fusion of virus membrane with host plasma membrane (GO:0019064),-4.402367359449229e-11,0.0
6160,regulation of type IIa hypersensitivity (GO:0001796),-4.402367359449229e-11,0.0
6161,traversing start control point of mitotic cell cycle (GO:0007089),-4.402367359449229e-11,0.0
6162,viral latency (GO:0019042),-4.402367359449229e-11,0.0
6163,DNA repair complex assembly (GO:0090735),-4.402367359449229e-11,0.0
6164,mitotic chromosome movement towards spindle pole (GO:0007079),-4.402367359449229e-11,0.0
6165,regulation of branch elongation involved in ureteric bud branching (GO:0072095),-4.402367359449229e-11,0.0
6166,metanephric renal vesicle formation (GO:0072093),-4.402367359449229e-11,0.0
6167,male meiosis chromosome segregation (GO:0007060),-4.402367359449229e-11,0.0
6168,specification of loop of Henle identity (GO:0072086),-4.402367359449229e-11,0.0
6169,spindle assembly involved in female meiosis I (GO:0007057),-4.402367359449229e-11,0.0
6170,regulation of metanephric mesenchymal cell migration (GO:2000589),-4.402367359449229e-11,0.0
6171,negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587),-4.402367359449229e-11,0.0
6172,mitotic cytokinesis checkpoint signaling (GO:0044878),-4.402367359449229e-11,0.0
6173,"positive regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000566)",-4.402367359449229e-11,0.0
6174,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072040),-4.402367359449229e-11,0.0
6175,neuropilin signaling pathway (GO:0038189),-4.402367359449229e-11,0.0
6176,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072039),-4.402367359449229e-11,0.0
6177,negative regulation of T-helper 2 cell cytokine production (GO:2000552),-4.402367359449229e-11,0.0
6178,protein localization to bicellular tight junction (GO:1902396),-4.402367359449229e-11,0.0
6179,Spemann organizer formation (GO:0060061),-4.402367359449229e-11,0.0
6180,positive regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000546),-4.402367359449229e-11,0.0
6181,ascending thin limb development (GO:0072021),-4.402367359449229e-11,0.0
6182,erythropoietin-mediated signaling pathway (GO:0038162),-4.402367359449229e-11,0.0
6183,glomerular endothelium development (GO:0072011),-4.402367359449229e-11,0.0
6184,C-X-C chemokine receptor CXCR4 signaling pathway (GO:0038159),-4.402367359449229e-11,0.0
6185,granulocyte-macrophage colony-stimulating factor signaling pathway (GO:0038157),-4.402367359449229e-11,0.0
6186,interleukin-3-mediated signaling pathway (GO:0038156),-4.402367359449229e-11,0.0
6187,regulation of immunological synapse formation (GO:2000520),-4.402367359449229e-11,0.0
6188,macrophage colony-stimulating factor signaling pathway (GO:0038145),-4.402367359449229e-11,0.0
6189,oxaloacetate(2-) transmembrane transport (GO:1902356),-4.402367359449229e-11,0.0
6190,phosphagen metabolic process (GO:0006599),-4.402367359449229e-11,0.0
6191,ERBB2-ERBB3 signaling pathway (GO:0038133),-4.402367359449229e-11,0.0
6192,negative regulation by host of symbiont catalytic activity (GO:0052403),-4.402367359449229e-11,0.0
6193,regulation of natural killer cell differentiation involved in immune response (GO:0032826),-4.402367359449229e-11,0.0
6194,ERBB3 signaling pathway (GO:0038129),-4.402367359449229e-11,0.0
6195,vestibular reflex (GO:0060005),-4.402367359449229e-11,0.0
6196,valine catabolic process (GO:0006574),-4.402367359449229e-11,0.0
6197,chemokine (C-C motif) ligand 21 signaling pathway (GO:0038116),-4.402367359449229e-11,0.0
6198,proline catabolic process (GO:0006562),-4.402367359449229e-11,0.0
6199,negative regulation of appetite by leptin-mediated signaling pathway (GO:0038108),-4.402367359449229e-11,0.0
6200,S-adenosylmethionine biosynthetic process (GO:0006556),-4.402367359449229e-11,0.0
6201,isoleucine catabolic process (GO:0006550),-4.402367359449229e-11,0.0
6202,regulation of peptidyl-serine dephosphorylation (GO:1902308),-4.402367359449229e-11,0.0
6203,aspartate catabolic process (GO:0006533),-4.402367359449229e-11,0.0
6204,protein localization to paranode region of axon (GO:0002175),-4.402367359449229e-11,0.0
6205,arginine biosynthetic process (GO:0006526),-4.402367359449229e-11,0.0
6206,desmosome assembly (GO:0002159),-4.402367359449229e-11,0.0
6207,tRNA wobble position uridine thiolation (GO:0002143),-4.402367359449229e-11,0.0
6208,regulation of glutamate uptake involved in transmission of nerve impulse (GO:0051946),-4.402367359449229e-11,0.0
6209,regulation of amino acid uptake involved in synaptic transmission (GO:0051941),-4.402367359449229e-11,0.0
6210,negative regulation of calcium ion binding (GO:1901877),-4.402367359449229e-11,0.0
6211,regulation of calcium ion binding (GO:1901876),-4.402367359449229e-11,0.0
6212,gamma-aminobutyric acid reuptake (GO:0051936),-4.402367359449229e-11,0.0
6213,negative regulation of post-translational protein modification (GO:1901874),-4.402367359449229e-11,0.0
6214,cellular response to nitrosative stress (GO:0071500),-4.402367359449229e-11,0.0
6215,positive regulation of mitochondrial DNA metabolic process (GO:1901860),-4.402367359449229e-11,0.0
6216,positive regulation of fibrinolysis (GO:0051919),-4.402367359449229e-11,0.0
6217,endoplasmic reticulum tubular network membrane organization (GO:1990809),-4.402367359449229e-11,0.0
6218,positive regulation of high voltage-gated calcium channel activity (GO:1901843),-4.402367359449229e-11,0.0
6219,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901837),-4.402367359449229e-11,0.0
6220,telomerase RNA stabilization (GO:0090669),-4.402367359449229e-11,0.0
6221,neurotransmitter receptor metabolic process (GO:0045213),-4.402367359449229e-11,0.0
6222,negative regulation of mitotic spindle assembly checkpoint signaling (GO:0140499),-4.402367359449229e-11,0.0
6223,HRI-mediated signaling (GO:0140468),-4.402367359449229e-11,0.0
6224,regulation of peroxidase activity (GO:2000468),-4.402367359449229e-11,0.0
6225,positive regulation of mast cell cytokine production (GO:0032765),-4.402367359449229e-11,0.0
6226,positive regulation of monocyte extravasation (GO:2000439),-4.402367359449229e-11,0.0
6227,chromatin reprogramming in the zygote (GO:0044725),-4.402367359449229e-11,0.0
6228,positive regulation of eosinophil migration (GO:2000418),-4.402367359449229e-11,0.0
6229,regulation of thymocyte migration (GO:2000410),-4.402367359449229e-11,0.0
6230,N-terminal protein myristoylation (GO:0006499),-4.402367359449229e-11,0.0
6231,insulin receptor signaling pathway via phosphatidylinositol 3-kinase (GO:0038028),-4.402367359449229e-11,0.0
6232,regulation of macrophage colony-stimulating factor signaling pathway (GO:1902226),-4.402367359449229e-11,0.0
6233,negative regulation of interleukin-18 production (GO:0032701),-4.402367359449229e-11,0.0
6234,regulation of hepatocyte growth factor receptor signaling pathway (GO:1902202),-4.402367359449229e-11,0.0
6235,positive regulation of gamma-aminobutyric acid secretion (GO:0014054),-4.402367359449229e-11,0.0
6236,negative regulation of hh target transcription factor activity (GO:1990787),-4.402367359449229e-11,0.0
6237,phenylalanyl-tRNA aminoacylation (GO:0006432),-4.402367359449229e-11,0.0
6238,mitochondrial depolarization (GO:0051882),-4.402367359449229e-11,0.0
6239,notochord formation (GO:0014028),-4.402367359449229e-11,0.0
6240,snRNA export from nucleus (GO:0006408),-4.402367359449229e-11,0.0
6241,RNA import into nucleus (GO:0006404),-4.402367359449229e-11,0.0
6242,malate transmembrane transport (GO:0071423),-4.402367359449229e-11,0.0
6243,microglia development (GO:0014005),-4.402367359449229e-11,0.0
6244,positive regulation of L-glutamate import across plasma membrane (GO:0002038),-4.402367359449229e-11,0.0
6245,clustering of voltage-gated potassium channels (GO:0045163),-4.402367359449229e-11,0.0
6246,negative regulation of histone ubiquitination (GO:0033183),-4.402367359449229e-11,0.0
6247,male anatomical structure morphogenesis (GO:0090598),-4.402367359449229e-11,0.0
6248,conditioned place preference (GO:1990708),-4.402367359449229e-11,0.0
6249,sucrose metabolic process (GO:0005985),-4.402367359449229e-11,0.0
6250,regulation of neutrophil mediated killing of symbiont cell (GO:0070949),-4.402367359449229e-11,0.0
6251,neutrophil-mediated killing of gram-negative bacterium (GO:0070945),-4.402367359449229e-11,0.0
6252,cyclic-GMP-AMP transmembrane import across plasma membrane (GO:0140361),-4.402367359449229e-11,0.0
6253,ovarian cumulus expansion (GO:0001550),-4.402367359449229e-11,0.0
6254,mitochondrial tRNA methylation (GO:0070901),-4.402367359449229e-11,0.0
6255,negative regulation of binding of sperm to zona pellucida (GO:2000360),-4.402367359449229e-11,0.0
6256,negative regulation of hepatocyte proliferation (GO:2000346),-4.402367359449229e-11,0.0
6257,negative regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000342),-4.402367359449229e-11,0.0
6258,positive regulation of T-helper 17 cell lineage commitment (GO:2000330),-4.402367359449229e-11,0.0
6259,positive regulation of keratinocyte apoptotic process (GO:1902174),-4.402367359449229e-11,0.0
6260,protein myristoylation (GO:0018377),-4.402367359449229e-11,0.0
6261,transcription initiation at mitochondrial promoter (GO:0006391),-4.402367359449229e-11,0.0
6262,induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration (GO:0099703),-4.402367359449229e-11,0.0
6263,protein succinylation (GO:0018335),-4.402367359449229e-11,0.0
6264,cellular response to jasmonic acid stimulus (GO:0071395),-4.402367359449229e-11,0.0
6265,transcription elongation by RNA polymerase I (GO:0006362),-4.402367359449229e-11,0.0
6266,viral penetration into host nucleus (GO:0075732),-4.402367359449229e-11,0.0
6267,negative regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902109),-4.402367359449229e-11,0.0
6268,regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902102),-4.402367359449229e-11,0.0
6269,regulation of timing of catagen (GO:0051794),-4.402367359449229e-11,0.0
6270,glutathione derivative biosynthetic process (GO:1901687),-4.402367359449229e-11,0.0
6271,glutathione derivative metabolic process (GO:1901685),-4.402367359449229e-11,0.0
6272,cellular response to isoquinoline alkaloid (GO:0071317),-4.402367359449229e-11,0.0
6273,cellular response to morphine (GO:0071315),-4.402367359449229e-11,0.0
6274,positive regulation of superoxide dismutase activity (GO:1901671),-4.402367359449229e-11,0.0
6275,cellular response to vitamin K (GO:0071307),-4.402367359449229e-11,0.0
6276,regulation of postsynaptic membrane organization (GO:1901626),-4.402367359449229e-11,0.0
6277,positive regulation of vesicle transport along microtubule (GO:1901610),-4.402367359449229e-11,0.0
6278,depurination (GO:0045007),-4.402367359449229e-11,0.0
6279,acinar cell differentiation (GO:0090425),-4.402367359449229e-11,0.0
6280,caveola assembly (GO:0070836),-4.402367359449229e-11,0.0
6281,oxidative stress-induced premature senescence (GO:0090403),-4.402367359449229e-11,0.0
6282,oncogene-induced cell senescence (GO:0090402),-4.402367359449229e-11,0.0
6283,peripheral nervous system neuron axonogenesis (GO:0048936),-4.402367359449229e-11,0.0
6284,regulation of oxidative phosphorylation uncoupler activity (GO:2000275),-4.402367359449229e-11,0.0
6285,negative regulation of male germ cell proliferation (GO:2000255),-4.402367359449229e-11,0.0
6286,negative regulation of long-chain fatty acid import into cell (GO:0140213),-4.402367359449229e-11,0.0
6287,NLRP3 inflammasome complex assembly (GO:0044546),-4.402367359449229e-11,0.0
6288,regulation of calcium ion import into sarcoplasmic reticulum (GO:1902080),-4.402367359449229e-11,0.0
6289,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-4.402367359449229e-11,0.0
6290,lagging strand elongation (GO:0006273),-4.402367359449229e-11,0.0
6291,leading strand elongation (GO:0006272),-4.402367359449229e-11,0.0
6292,mitochondrial RNA 5'-end processing (GO:0000964),-4.402367359449229e-11,0.0
6293,negative regulation of cilium-dependent cell motility (GO:1902020),-4.402367359449229e-11,0.0
6294,cellular response to lead ion (GO:0071284),-4.402367359449229e-11,0.0
6295,mitochondrial RNA catabolic process (GO:0000957),-4.402367359449229e-11,0.0
6296,cellular response to cobalt ion (GO:0071279),-4.402367359449229e-11,0.0
6297,peptidyl-glycine modification (GO:0018201),-4.402367359449229e-11,0.0
6298,dTTP biosynthetic process (GO:0006235),-4.402367359449229e-11,0.0
6299,dTMP biosynthetic process (GO:0006231),-4.402367359449229e-11,0.0
6300,UDP biosynthetic process (GO:0006225),-4.402367359449229e-11,0.0
6301,nuclear pore localization (GO:0051664),-4.402367359449229e-11,0.0
6302,cellular response to tumor cell (GO:0071228),-4.402367359449229e-11,0.0
6303,cellular response to molecule of fungal origin (GO:0071226),-4.402367359449229e-11,0.0
6304,negative regulation of gonad development (GO:1905940),-4.402367359449229e-11,0.0
6305,negative regulation of germ cell proliferation (GO:1905937),-4.402367359449229e-11,0.0
6306,protein targeting to vacuole involved in autophagy (GO:0071211),-4.402367359449229e-11,0.0
6307,protein localization to juxtaparanode region of axon (GO:0071205),-4.402367359449229e-11,0.0
6308,negative regulation of calcium ion export across plasma membrane (GO:1905913),-4.402367359449229e-11,0.0
6309,regulation of calcium ion export across plasma membrane (GO:1905912),-4.402367359449229e-11,0.0
6310,regulation of serotonin uptake (GO:0051611),-4.402367359449229e-11,0.0
6311,positive regulation of amyloid fibril formation (GO:1905908),-4.402367359449229e-11,0.0
6312,positive regulation of anion channel activity (GO:1901529),-4.402367359449229e-11,0.0
6313,diencephalon morphogenesis (GO:0048852),-4.402367359449229e-11,0.0
6314,"regulation of protein catabolic process at postsynapse, modulating synaptic transmission (GO:0099576)",-4.402367359449229e-11,0.0
6315,detection of lipopolysaccharide (GO:0032497),-4.402367359449229e-11,0.0
6316,male genitalia morphogenesis (GO:0048808),-4.402367359449229e-11,0.0
6317,peptidyl-glutamine modification (GO:0018199),-4.402367359449229e-11,0.0
6318,regulation of protein homooligomerization (GO:0032462),-4.402367359449229e-11,0.0
6319,negative regulation of cell proliferation involved in heart morphogenesis (GO:2000137),-4.402367359449229e-11,0.0
6320,positive regulation of presynaptic cytosolic calcium concentration (GO:0099533),-4.402367359449229e-11,0.0
6321,presynaptic dense core vesicle exocytosis (GO:0099525),-4.402367359449229e-11,0.0
6322,protein urmylation (GO:0032447),-4.402367359449229e-11,0.0
6323,polar body extrusion after meiotic divisions (GO:0040038),-4.402367359449229e-11,0.0
6324,regulation of mismatch repair (GO:0032423),-4.402367359449229e-11,0.0
6325,peptidyl-arginine ADP-ribosylation (GO:0018120),-4.402367359449229e-11,0.0
6326,adenosine catabolic process (GO:0006154),-4.402367359449229e-11,0.0
6327,regulation of arginine metabolic process (GO:0000821),-4.402367359449229e-11,0.0
6328,histone H2B acetylation (GO:0043969),-4.402367359449229e-11,0.0
6329,epididymis development (GO:1905867),-4.402367359449229e-11,0.0
6330,positive regulation of transcription factor catabolic process (GO:1901485),-4.402367359449229e-11,0.0
6331,regulation of transcription factor catabolic process (GO:1901483),-4.402367359449229e-11,0.0
6332,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990441),-4.402367359449229e-11,0.0
6333,positive regulation of osteoclast proliferation (GO:0090290),-4.402367359449229e-11,0.0
6334,positive regulation of fibroblast growth factor production (GO:0090271),-4.402367359449229e-11,0.0
6335,negative regulation of mitochondrial fission (GO:0090258),-4.402367359449229e-11,0.0
6336,regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),-4.402367359449229e-11,0.0
6337,positive regulation of tetrapyrrole metabolic process (GO:1901403),-4.402367359449229e-11,0.0
6338,positive regulation of mast cell proliferation (GO:0070668),-4.402367359449229e-11,0.0
6339,negative regulation of mast cell proliferation (GO:0070667),-4.402367359449229e-11,0.0
6340,mast cell proliferation (GO:0070662),-4.402367359449229e-11,0.0
6341,negative regulation of spindle checkpoint (GO:0090233),-4.402367359449229e-11,0.0
6342,regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090215),-4.402367359449229e-11,0.0
6343,regulation of establishment of blood-brain barrier (GO:0090210),-4.402367359449229e-11,0.0
6344,regulation of smooth muscle cell-matrix adhesion (GO:2000097),-4.402367359449229e-11,0.0
6345,regulation of centromeric sister chromatid cohesion (GO:0070602),-4.402367359449229e-11,0.0
6346,negative regulation of cortisol biosynthetic process (GO:2000065),-4.402367359449229e-11,0.0
6347,positive regulation of intracellular cholesterol transport (GO:0032385),-4.402367359449229e-11,0.0
6348,positive regulation of intracellular sterol transport (GO:0032382),-4.402367359449229e-11,0.0
6349,canonical Wnt signaling pathway involved in regulation of cell proliferation (GO:0044340),-4.402367359449229e-11,0.0
6350,negative regulation of aldosterone biosynthetic process (GO:0032348),-4.402367359449229e-11,0.0
6351,negative regulation of aldosterone metabolic process (GO:0032345),-4.402367359449229e-11,0.0
6352,regulation of determination of dorsal identity (GO:2000015),-4.402367359449229e-11,0.0
6353,molybdopterin cofactor biosynthetic process (GO:0032324),-4.402367359449229e-11,0.0
6354,DNA recombinase assembly (GO:0000730),-4.402367359449229e-11,0.0
6355,pyrimidine dimer repair by nucleotide-excision repair (GO:0000720),-4.402367359449229e-11,0.0
6356,polyadenylation-dependent mRNA catabolic process (GO:0071047),-4.402367359449229e-11,0.0
6357,nuclear polyadenylation-dependent mRNA catabolic process (GO:0071042),-4.402367359449229e-11,0.0
6358,positive regulation of cortisol secretion (GO:0051464),-4.402367359449229e-11,0.0
6359,meiotic DNA double-strand break processing (GO:0000706),-4.402367359449229e-11,0.0
6360,telomeric 3' overhang formation (GO:0031860),-4.402367359449229e-11,0.0
6361,epidermal cell fate specification (GO:0009957),-4.402367359449229e-11,0.0
6362,regulation of atrial cardiac muscle cell action potential (GO:0098910),-4.402367359449229e-11,0.0
6363,regulation of inhibitory synapse assembly (GO:1905702),-4.402367359449229e-11,0.0
6364,proximal/distal axis specification (GO:0009946),-4.402367359449229e-11,0.0
6365,negative regulation of pancreatic juice secretion (GO:0090188),-4.402367359449229e-11,0.0
6366,regulation of Golgi inheritance (GO:0090170),-4.402367359449229e-11,0.0
6367,regulation of odontoblast differentiation (GO:1901329),-4.402367359449229e-11,0.0
6368,positive regulation of heart induction (GO:1901321),-4.402367359449229e-11,0.0
6369,negative regulation of flagellated sperm motility (GO:1901318),-4.402367359449229e-11,0.0
6370,negative regulation of histone H2A K63-linked ubiquitination (GO:1901315),-4.402367359449229e-11,0.0
6371,auditory receptor cell fate commitment (GO:0009912),-4.402367359449229e-11,0.0
6372,regulation of histone H2A K63-linked ubiquitination (GO:1901314),-4.402367359449229e-11,0.0
6373,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis (GO:0090113),-4.402367359449229e-11,0.0
6374,negative regulation of skeletal muscle tissue development (GO:0048642),-4.402367359449229e-11,0.0
6375,cell wall disruption in another organism (GO:0044278),-4.402367359449229e-11,0.0
6376,myoblast development (GO:0048627),-4.402367359449229e-11,0.0
6377,histone succinylation (GO:0106077),-4.402367359449229e-11,0.0
6378,regulation of negative chemotaxis (GO:0050923),-4.402367359449229e-11,0.0
6379,positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106071),-4.402367359449229e-11,0.0
6380,central nervous system myelin maintenance (GO:0032286),-4.402367359449229e-11,0.0
6381,polysaccharide digestion (GO:0044245),-4.402367359449229e-11,0.0
6382,luteinizing hormone secretion (GO:0032275),-4.402367359449229e-11,0.0
6383,regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900825),-4.402367359449229e-11,0.0
6384,'de novo' UMP biosynthetic process (GO:0044205),-4.402367359449229e-11,0.0
6385,telomere assembly (GO:0032202),-4.402367359449229e-11,0.0
6386,negative regulation of neurotrophin TRK receptor signaling pathway (GO:0051387),-4.402367359449229e-11,0.0
6387,modification of postsynaptic actin cytoskeleton (GO:0098885),-4.402367359449229e-11,0.0
6388,histone glutamine methylation (GO:1990258),-4.402367359449229e-11,0.0
6389,positive regulation of DNA methylation (GO:1905643),-4.402367359449229e-11,0.0
6390,positive regulation of macrophage colony-stimulating factor production (GO:1901258),-4.402367359449229e-11,0.0
6391,regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905600),-4.402367359449229e-11,0.0
6392,mitotic sister chromatid separation (GO:0051306),-4.402367359449229e-11,0.0
6393,negative regulation of protein deubiquitination (GO:0090086),-4.402367359449229e-11,0.0
6394,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway (GO:0090082),-4.402367359449229e-11,0.0
6395,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway (GO:0090080),-4.402367359449229e-11,0.0
6396,post-embryonic camera-type eye morphogenesis (GO:0048597),-4.402367359449229e-11,0.0
6397,sensory processing (GO:0050893),-4.402367359449229e-11,0.0
6398,negative regulation of protein kinase C signaling (GO:0090038),-4.402367359449229e-11,0.0
6399,prolactin secretion (GO:0070459),-4.402367359449229e-11,0.0
6400,negative regulation of neutrophil chemotaxis (GO:0090024),-4.402367359449229e-11,0.0
6401,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070428),-4.402367359449229e-11,0.0
6402,"transposition, RNA-mediated (GO:0032197)",-4.402367359449229e-11,0.0
6403,septin cytoskeleton organization (GO:0032185),-4.402367359449229e-11,0.0
6404,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-4.402367359449229e-11,0.0
6405,protein localization to motile cilium (GO:0120229),-4.402367359449229e-11,0.0
6406,regulation of blastocyst development (GO:0120222),-4.402367359449229e-11,0.0
6407,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-4.402367359449229e-11,0.0
6408,positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900738),-4.402367359449229e-11,0.0
6409,cellular alcohol biosynthetic process (GO:0044108),-4.402367359449229e-11,0.0
6410,cellular alcohol metabolic process (GO:0044107),-4.402367359449229e-11,0.0
6411,sequestering of zinc ion (GO:0032119),-4.402367359449229e-11,0.0
6412,global gene silencing by mRNA cleavage (GO:0098795),-4.402367359449229e-11,0.0
6413,exosomal secretion (GO:1990182),-4.402367359449229e-11,0.0
6414,protein K33-linked deubiquitination (GO:1990168),-4.402367359449229e-11,0.0
6415,protein K27-linked deubiquitination (GO:1990167),-4.402367359449229e-11,0.0
6416,regulation of blood vessel branching (GO:1905553),-4.402367359449229e-11,0.0
6417,regulation of protein localization to endoplasmic reticulum (GO:1905550),-4.402367359449229e-11,0.0
6418,"regulation of mitotic cell cycle, embryonic (GO:0009794)",-4.402367359449229e-11,0.0
6419,cortical microtubule organization (GO:0043622),-4.402367359449229e-11,0.0
6420,response to jasmonic acid (GO:0009753),-4.402367359449229e-11,0.0
6421,formamide metabolic process (GO:0043606),-4.402367359449229e-11,0.0
6422,cellular amide catabolic process (GO:0043605),-4.402367359449229e-11,0.0
6423,Harderian gland development (GO:0070384),-4.402367359449229e-11,0.0
6424,positive regulation of fat cell proliferation (GO:0070346),-4.402367359449229e-11,0.0
6425,fat cell proliferation (GO:0070341),-4.402367359449229e-11,0.0
6426,neuron death in response to oxidative stress (GO:0036475),-4.402367359449229e-11,0.0
6427,cell death in response to hydrogen peroxide (GO:0036474),-4.402367359449229e-11,0.0
6428,positive regulation of lipoprotein metabolic process (GO:0050747),-4.402367359449229e-11,0.0
6429,"trans-synaptic signaling by BDNF, modulating synaptic transmission (GO:0099183)",-4.402367359449229e-11,0.0
6430,regulation of synaptic membrane adhesion (GO:0099179),-4.402367359449229e-11,0.0
6431,positive regulation of endodeoxyribonuclease activity (GO:0032079),-4.402367359449229e-11,0.0
6432,positive regulation of translational initiation in response to stress (GO:0032058),-4.402367359449229e-11,0.0
6433,negative regulation of translation in response to stress (GO:0032055),-4.402367359449229e-11,0.0
6434,rRNA 2'-O-methylation (GO:0000451),-4.402367359449229e-11,0.0
6435,lens fiber cell apoptotic process (GO:1990086),-4.402367359449229e-11,0.0
6436,response to interleukin-13 (GO:0035962),-4.402367359449229e-11,0.0
6437,cartilage homeostasis (GO:1990079),-4.402367359449229e-11,0.0
6438,wybutosine biosynthetic process (GO:0031591),-4.402367359449229e-11,0.0
6439,wybutosine metabolic process (GO:0031590),-4.402367359449229e-11,0.0
6440,positive regulation of histone H3-K36 methylation (GO:0000416),-4.402367359449229e-11,0.0
6441,"positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031587)",-4.402367359449229e-11,0.0
6442,negative regulation of lymphoid progenitor cell differentiation (GO:1905457),-4.402367359449229e-11,0.0
6443,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905451),-4.402367359449229e-11,0.0
6444,corticosteroid hormone secretion (GO:0035930),-4.402367359449229e-11,0.0
6445,positive regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905448),-4.402367359449229e-11,0.0
6446,retrograde neuronal dense core vesicle transport (GO:1990049),-4.402367359449229e-11,0.0
6447,protein localization to lipid droplet (GO:1990044),-4.402367359449229e-11,0.0
6448,positive regulation of NK T cell differentiation (GO:0051138),-4.402367359449229e-11,0.0
6449,calcium ion import into sarcoplasmic reticulum (GO:1990036),-4.402367359449229e-11,0.0
6450,ascending aorta morphogenesis (GO:0035910),-4.402367359449229e-11,0.0
6451,regulation of termination of DNA-templated transcription (GO:0031554),-4.402367359449229e-11,0.0
6452,skeletal muscle fiber adaptation (GO:0043503),-4.402367359449229e-11,0.0
6453,pericentric heterochromatin formation (GO:0031508),-4.402367359449229e-11,0.0
6454,extracellular matrix constituent secretion (GO:0070278),-4.402367359449229e-11,0.0
6455,regulation of leukocyte adhesion to arterial endothelial cell (GO:1904997),-4.402367359449229e-11,0.0
6456,negative regulation of fermentation (GO:1901003),-4.402367359449229e-11,0.0
6457,regulation of response to salt stress (GO:1901000),-4.402367359449229e-11,0.0
6458,lymphatic endothelial cell migration (GO:1904977),-4.402367359449229e-11,0.0
6459,regulation of activation-induced cell death of T cells (GO:0070235),-4.402367359449229e-11,0.0
6460,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904954),-4.402367359449229e-11,0.0
6461,calcitriol biosynthetic process from calciol (GO:0036378),-4.402367359449229e-11,0.0
6462,light adaption (GO:0036367),-4.402367359449229e-11,0.0
6463,axial mesoderm morphogenesis (GO:0048319),-4.402367359449229e-11,0.0
6464,psychomotor behavior (GO:0036343),-4.402367359449229e-11,0.0
6465,sphingolipid translocation (GO:0099039),-4.402367359449229e-11,0.0
6466,neuronal dense core vesicle exocytosis (GO:0099011),-4.402367359449229e-11,0.0
6467,malate-aspartate shuttle (GO:0043490),-4.402367359449229e-11,0.0
6468,positive regulation of snRNA transcription by RNA polymerase II (GO:1905382),-4.402367359449229e-11,0.0
6469,cloaca development (GO:0035844),-4.402367359449229e-11,0.0
6470,positive regulation of protein localization to kinetochore (GO:1905342),-4.402367359449229e-11,0.0
6471,regulation of protein localization to kinetochore (GO:1905340),-4.402367359449229e-11,0.0
6472,gene conversion (GO:0035822),-4.402367359449229e-11,0.0
6473,negative regulation of renal sodium excretion (GO:0035814),-4.402367359449229e-11,0.0
6474,telomerase holoenzyme complex assembly (GO:1905323),-4.402367359449229e-11,0.0
6475,positive regulation of mesenchymal stem cell migration (GO:1905322),-4.402367359449229e-11,0.0
6476,regulation of mesenchymal stem cell migration (GO:1905320),-4.402367359449229e-11,0.0
6477,positive regulation of isotype switching to IgE isotypes (GO:0048295),-4.402367359449229e-11,0.0
6478,positive regulation of amyloid precursor protein biosynthetic process (GO:0042986),-4.402367359449229e-11,0.0
6479,negative regulation of adiponectin secretion (GO:0070164),-4.402367359449229e-11,0.0
6480,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904878),-4.402367359449229e-11,0.0
6481,epinephrine transport (GO:0048241),-4.402367359449229e-11,0.0
6482,positive regulation of cell chemotaxis to fibroblast growth factor (GO:1904849),-4.402367359449229e-11,0.0
6483,mitochondrial translational termination (GO:0070126),-4.402367359449229e-11,0.0
6484,mitochondrial translational elongation (GO:0070125),-4.402367359449229e-11,0.0
6485,response to L-glutamine (GO:1904844),-4.402367359449229e-11,0.0
6486,establishment or maintenance of microtubule cytoskeleton polarity (GO:0030951),-4.402367359449229e-11,0.0
6487,Golgi vesicle fusion to target membrane (GO:0048210),-4.402367359449229e-11,0.0
6488,9-cis-retinoic acid metabolic process (GO:0042905),-4.402367359449229e-11,0.0
6489,9-cis-retinoic acid biosynthetic process (GO:0042904),-4.402367359449229e-11,0.0
6490,interleukin-4-mediated signaling pathway (GO:0035771),-4.402367359449229e-11,0.0
6491,regulation of CAMKK-AMPK signaling cascade (GO:1905289),-4.402367359449229e-11,0.0
6492,regulation of modification of postsynaptic actin cytoskeleton (GO:1905274),-4.402367359449229e-11,0.0
6493,negative regulation of aspartic-type peptidase activity (GO:1905246),-4.402367359449229e-11,0.0
6494,interleukin-12-mediated signaling pathway (GO:0035722),-4.402367359449229e-11,0.0
6495,cellular response to L-glutamate (GO:1905232),-4.402367359449229e-11,0.0
6496,atrioventricular canal morphogenesis (GO:1905222),-4.402367359449229e-11,0.0
6497,positive regulation of neutrophil degranulation (GO:0043315),-4.402367359449229e-11,0.0
6498,negative regulation of vesicle fusion (GO:0031339),-4.402367359449229e-11,0.0
6499,negative regulation of glucagon secretion (GO:0070093),-4.402367359449229e-11,0.0
6500,response to tetrachloromethane (GO:1904772),-4.402367359449229e-11,0.0
6501,pyruvate biosynthetic process (GO:0042866),-4.402367359449229e-11,0.0
6502,fused antrum stage (GO:0048165),-4.402367359449229e-11,0.0
6503,negative regulation of myofibroblast differentiation (GO:1904761),-4.402367359449229e-11,0.0
6504,L-alanine catabolic process (GO:0042853),-4.402367359449229e-11,0.0
6505,L-alanine metabolic process (GO:0042851),-4.402367359449229e-11,0.0
6506,regulation of telomeric DNA binding (GO:1904742),-4.402367359449229e-11,0.0
6507,positive regulation of intestinal lipid absorption (GO:1904731),-4.402367359449229e-11,0.0
6508,pyridoxal phosphate metabolic process (GO:0042822),-4.402367359449229e-11,0.0
6509,acylglycerol acyl-chain remodeling (GO:0036155),-4.402367359449229e-11,0.0
6510,positive regulation of mRNA polyadenylation (GO:1900365),-4.402367359449229e-11,0.0
6511,"protein import into peroxisome matrix, docking (GO:0016560)",-4.402367359449229e-11,0.0
6512,histone H3-K9 dimethylation (GO:0036123),-4.402367359449229e-11,0.0
6513,medium-chain fatty-acyl-CoA catabolic process (GO:0036114),-4.402367359449229e-11,0.0
6514,monocyte extravasation (GO:0035696),-4.402367359449229e-11,0.0
6515,B cell costimulation (GO:0031296),-4.402367359449229e-11,0.0
6516,positive regulation of lysosomal protein catabolic process (GO:1905167),-4.402367359449229e-11,0.0
6517,negative regulation of lysosomal protein catabolic process (GO:1905166),-4.402367359449229e-11,0.0
6518,folic acid-containing compound catabolic process (GO:0009397),-4.402367359449229e-11,0.0
6519,ER to Golgi ceramide transport (GO:0035621),-4.402367359449229e-11,0.0
6520,pseudopodium organization (GO:0031268),-4.402367359449229e-11,0.0
6521,regulation of meiotic chromosome separation (GO:1905132),-4.402367359449229e-11,0.0
6522,histone H2B conserved C-terminal lysine deubiquitination (GO:0035616),-4.402367359449229e-11,0.0
6523,negative regulation of metalloendopeptidase activity (GO:1904684),-4.402367359449229e-11,0.0
6524,negative regulation of somatic stem cell population maintenance (GO:1904673),-4.402367359449229e-11,0.0
6525,eye pigmentation (GO:0048069),-4.402367359449229e-11,0.0
6526,N-glycan fucosylation (GO:0036071),-4.402367359449229e-11,0.0
6527,D-xylose metabolic process (GO:0042732),-4.402367359449229e-11,0.0
6528,cellular response to ionomycin (GO:1904637),-4.402367359449229e-11,0.0
6529,response to ionomycin (GO:1904636),-4.402367359449229e-11,0.0
6530,Tie signaling pathway (GO:0048014),-4.402367359449229e-11,0.0
6531,regulation of actin binding (GO:1904616),-4.402367359449229e-11,0.0
6532,sequestering of triglyceride (GO:0030730),-4.402367359449229e-11,0.0
6533,positive regulation of MDA-5 signaling pathway (GO:1900245),-4.402367359449229e-11,0.0
6534,germ-line stem cell population maintenance (GO:0030718),-4.402367359449229e-11,0.0
6535,regulation of cardiolipin metabolic process (GO:1900208),-4.402367359449229e-11,0.0
6536,calcium-mediated signaling using extracellular calcium source (GO:0035585),-4.402367359449229e-11,0.0
6537,sequestering of TGFbeta in extracellular matrix (GO:0035583),-4.402367359449229e-11,0.0
6538,sequestering of BMP in extracellular matrix (GO:0035582),-4.402367359449229e-11,0.0
6539,electron transport coupled proton transport (GO:0015990),-4.402367359449229e-11,0.0
6540,"energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)",-4.402367359449229e-11,0.0
6541,allantois development (GO:1905069),-4.402367359449229e-11,0.0
6542,"DNA replication, removal of RNA primer (GO:0043137)",-4.402367359449229e-11,0.0
6543,regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905031),-4.402367359449229e-11,0.0
6544,pantothenate metabolic process (GO:0015939),-4.402367359449229e-11,0.0
6545,metanephric part of ureteric bud development (GO:0035502),-4.402367359449229e-11,0.0
6546,long-chain fatty acid import across plasma membrane (GO:0015911),-4.402367359449229e-11,0.0
6547,long-chain fatty acid import into peroxisome (GO:0015910),-4.402367359449229e-11,0.0
6548,positive regulation of microtubule depolymerization (GO:0031117),-4.402367359449229e-11,0.0
6549,purine deoxyribonucleoside triphosphate catabolic process (GO:0009217),-4.402367359449229e-11,0.0
6550,pyrimidine deoxyribonucleoside triphosphate biosynthetic process (GO:0009212),-4.402367359449229e-11,0.0
6551,follicle-stimulating hormone signaling pathway (GO:0042699),-4.402367359449229e-11,0.0
6552,positive regulation of protein import (GO:1904591),-4.402367359449229e-11,0.0
6553,regulation of intracellular mRNA localization (GO:1904580),-4.402367359449229e-11,0.0
6554,L-alanine transmembrane transport (GO:1904557),-4.402367359449229e-11,0.0
6555,negative regulation of oocyte maturation (GO:1900194),-4.402367359449229e-11,0.0
6556,regulation of DNA stability (GO:0097752),-4.402367359449229e-11,0.0
6557,membrane tubulation (GO:0097749),-4.402367359449229e-11,0.0
6558,negative regulation of clathrin-dependent endocytosis (GO:1900186),-4.402367359449229e-11,0.0
6559,negative regulation of bone mineralization involved in bone maturation (GO:1900158),-4.402367359449229e-11,0.0
6560,negative regulation of telomere maintenance in response to DNA damage (GO:1904506),-4.402367359449229e-11,0.0
6561,regulation of Schwann cell migration (GO:1900147),-4.402367359449229e-11,0.0
6562,negative regulation of phospholipase A2 activity (GO:1900138),-4.402367359449229e-11,0.0
6563,positive regulation of hyaluronan biosynthetic process (GO:1900127),-4.402367359449229e-11,0.0
6564,negative regulation of hyaluronan biosynthetic process (GO:1900126),-4.402367359449229e-11,0.0
6565,positive regulation of histone H3-K9 trimethylation (GO:1900114),-4.402367359449229e-11,0.0
6566,regulation of histone H3-K9 dimethylation (GO:1900109),-4.402367359449229e-11,0.0
6567,negative regulation of nodal signaling pathway (GO:1900108),-4.402367359449229e-11,0.0
6568,CAMKK-AMPK signaling cascade (GO:0061762),-4.402367359449229e-11,0.0
6569,protein lipidation involved in autophagosome assembly (GO:0061739),-4.402367359449229e-11,0.0
6570,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:0061734),-4.402367359449229e-11,0.0
6571,positive regulation of Notch signaling pathway involved in heart induction (GO:0035481),-4.402367359449229e-11,0.0
6572,regulation of Notch signaling pathway involved in heart induction (GO:0035480),-4.402367359449229e-11,0.0
6573,glycophagy (GO:0061723),-4.402367359449229e-11,0.0
6574,creatine transmembrane transport (GO:0015881),-4.402367359449229e-11,0.0
6575,cell migration involved in vasculogenesis (GO:0035441),-4.402367359449229e-11,0.0
6576,purine nucleoside transmembrane transport (GO:0015860),-4.402367359449229e-11,0.0
6577,pyrimidine ribonucleoside diphosphate biosynthetic process (GO:0009194),-4.402367359449229e-11,0.0
6578,deoxyribonucleoside diphosphate biosynthetic process (GO:0009189),-4.402367359449229e-11,0.0
6579,purine deoxyribonucleoside diphosphate metabolic process (GO:0009182),-4.402367359449229e-11,0.0
6580,aminergic neurotransmitter loading into synaptic vesicle (GO:0015842),-4.402367359449229e-11,0.0
6581,myosin filament assembly (GO:0031034),-4.402367359449229e-11,0.0
6582,myosin filament organization (GO:0031033),-4.402367359449229e-11,0.0
6583,pyrimidine nucleoside triphosphate catabolic process (GO:0009149),-4.402367359449229e-11,0.0
6584,cytosol to endoplasmic reticulum transport (GO:0046967),-4.402367359449229e-11,0.0
6585,positive regulation of intestinal absorption (GO:1904480),-4.402367359449229e-11,0.0
6586,pteridine-containing compound catabolic process (GO:0042560),-4.402367359449229e-11,0.0
6587,Cajal body organization (GO:0030576),-4.402367359449229e-11,0.0
6588,regulation of translational initiation by eIF2 alpha phosphorylation (GO:0010998),-4.402367359449229e-11,0.0
6589,positive regulation of peptidyl-tyrosine autophosphorylation (GO:1900086),-4.402367359449229e-11,0.0
6590,regulation of high-density lipoprotein particle clearance (GO:0010982),-4.402367359449229e-11,0.0
6591,regulation of cellular hyperosmotic salinity response (GO:1900069),-4.402367359449229e-11,0.0
6592,regulation of peroxisome organization (GO:1900063),-4.402367359449229e-11,0.0
6593,serine phosphorylation of STAT protein (GO:0042501),-4.402367359449229e-11,0.0
6594,hormone-mediated apoptotic signaling pathway (GO:0008628),-4.402367359449229e-11,0.0
6595,negative regulation of very-low-density lipoprotein particle clearance (GO:0010916),-4.402367359449229e-11,0.0
6596,regulation of very-low-density lipoprotein particle clearance (GO:0010915),-4.402367359449229e-11,0.0
6597,regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-4.402367359449229e-11,0.0
6598,regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010908),-4.402367359449229e-11,0.0
6599,negative regulation of very-low-density lipoprotein particle remodeling (GO:0010903),-4.402367359449229e-11,0.0
6600,myo-inositol transport (GO:0015798),-4.402367359449229e-11,0.0
6601,positive regulation of respiratory gaseous exchange (GO:1903942),-4.402367359449229e-11,0.0
6602,NAD transmembrane transport (GO:0035352),-4.402367359449229e-11,0.0
6603,cellular response to bisphenol A (GO:1903926),-4.402367359449229e-11,0.0
6604,response to bisphenol A (GO:1903925),-4.402367359449229e-11,0.0
6605,oligosaccharide transport (GO:0015772),-4.402367359449229e-11,0.0
6606,sucrose transport (GO:0015770),-4.402367359449229e-11,0.0
6607,disaccharide transport (GO:0015766),-4.402367359449229e-11,0.0
6608,cysteine catabolic process (GO:0009093),-4.402367359449229e-11,0.0
6609,positive regulation of establishment of T cell polarity (GO:1903905),-4.402367359449229e-11,0.0
6610,malate transport (GO:0015743),-4.402367359449229e-11,0.0
6611,"pentose-phosphate shunt, oxidative branch (GO:0009051)",-4.402367359449229e-11,0.0
6612,thiosulfate transport (GO:0015709),-4.402367359449229e-11,0.0
6613,quinolinate metabolic process (GO:0046874),-4.402367359449229e-11,0.0
6614,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0086023),-4.402367359449229e-11,0.0
6615,regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904393),-4.402367359449229e-11,0.0
6616,regulation of transepithelial transport (GO:0150111),-4.402367359449229e-11,0.0
6617,negative regulation of protein catabolic process in the vacuole (GO:1904351),-4.402367359449229e-11,0.0
6618,regulation of Toll signaling pathway (GO:0008592),-4.402367359449229e-11,0.0
6619,choline catabolic process (GO:0042426),-4.402367359449229e-11,0.0
6620,positive regulation of cholesterol esterification (GO:0010873),-4.402367359449229e-11,0.0
6621,positive regulation of reciprocal meiotic recombination (GO:0010845),-4.402367359449229e-11,0.0
6622,"regulation of circadian sleep/wake cycle, wakefulness (GO:0010840)",-4.402367359449229e-11,0.0
6623,calcium activated galactosylceramide scrambling (GO:0061591),-4.402367359449229e-11,0.0
6624,negative regulation of protein ADP-ribosylation (GO:0010836),-4.402367359449229e-11,0.0
6625,calcium activated phosphatidylserine scrambling (GO:0061589),-4.402367359449229e-11,0.0
6626,positive regulation of centrosome duplication (GO:0010825),-4.402367359449229e-11,0.0
6627,neuropeptide catabolic process (GO:0010813),-4.402367359449229e-11,0.0
6628,positive regulation of PERK-mediated unfolded protein response (GO:1903899),-4.402367359449229e-11,0.0
6629,regulation of ATF6-mediated unfolded protein response (GO:1903891),-4.402367359449229e-11,0.0
6630,trigeminal ganglion development (GO:0061551),-4.402367359449229e-11,0.0
6631,membrane fusion involved in viral entry into host cell (GO:0039663),-4.402367359449229e-11,0.0
6632,central nervous system segmentation (GO:0035283),-4.402367359449229e-11,0.0
6633,Langerhans cell differentiation (GO:0061520),-4.402367359449229e-11,0.0
6634,regulation of cristae formation (GO:1903850),-4.402367359449229e-11,0.0
6635,negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),-4.402367359449229e-11,0.0
6636,cellular response to arsenite ion (GO:1903843),-4.402367359449229e-11,0.0
6637,response to arsenite ion (GO:1903842),-4.402367359449229e-11,0.0
6638,peptidyl-arginine omega-N-methylation (GO:0035247),-4.402367359449229e-11,0.0
6639,glial cell-neuron signaling (GO:0150098),-4.402367359449229e-11,0.0
6640,complement-mediated synapse pruning (GO:0150062),-4.402367359449229e-11,0.0
6641,phosphagen biosynthetic process (GO:0042396),-4.402367359449229e-11,0.0
6642,sympathetic neuron axon guidance (GO:0097492),-4.402367359449229e-11,0.0
6643,sympathetic neuron projection guidance (GO:0097491),-4.402367359449229e-11,0.0
6644,sympathetic neuron projection extension (GO:0097490),-4.402367359449229e-11,0.0
6645,vitamin K catabolic process (GO:0042377),-4.402367359449229e-11,0.0
6646,phylloquinone catabolic process (GO:0042376),-4.402367359449229e-11,0.0
6647,phylloquinone metabolic process (GO:0042374),-4.402367359449229e-11,0.0
6648,clathrin-dependent synaptic vesicle endocytosis (GO:0150007),-4.402367359449229e-11,0.0
6649,positive regulation by virus of viral protein levels in host cell (GO:0046726),-4.402367359449229e-11,0.0
6650,vitamin D catabolic process (GO:0042369),-4.402367359449229e-11,0.0
6651,spinal cord motor neuron migration (GO:0097476),-4.402367359449229e-11,0.0
6652,vitamin D biosynthetic process (GO:0042368),-4.402367359449229e-11,0.0
6653,regulation of iron ion transmembrane transport (GO:0034759),-4.402367359449229e-11,0.0
6654,menaquinone catabolic process (GO:0042361),-4.402367359449229e-11,0.0
6655,sperm mitochondrion organization (GO:0030382),-4.402367359449229e-11,0.0
6656,synaptic vesicle targeting (GO:0016080),-4.402367359449229e-11,0.0
6657,"negative regulation of circadian sleep/wake cycle, sleep (GO:0042321)",-4.402367359449229e-11,0.0
6658,"regulation of circadian sleep/wake cycle, REM sleep (GO:0042320)",-4.402367359449229e-11,0.0
6659,regulation of serine C-palmitoyltransferase activity (GO:1904220),-4.402367359449229e-11,0.0
6660,hypoxia-inducible factor-1alpha signaling pathway (GO:0097411),-4.402367359449229e-11,0.0
6661,negative regulation of long-chain fatty acid import across plasma membrane (GO:0010748),-4.402367359449229e-11,0.0
6662,negative regulation of extracellular matrix disassembly (GO:0010716),-4.402367359449229e-11,0.0
6663,regulation of collagen catabolic process (GO:0010710),-4.402367359449229e-11,0.0
6664,regulation of viral budding via host ESCRT complex (GO:1903772),-4.402367359449229e-11,0.0
6665,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903760),-4.402367359449229e-11,0.0
6666,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061428),-4.402367359449229e-11,0.0
6667,negative regulation of MDA-5 signaling pathway (GO:0039534),-4.402367359449229e-11,0.0
6668,MDA-5 signaling pathway (GO:0039530),-4.402367359449229e-11,0.0
6669,response to fungicide (GO:0060992),-4.402367359449229e-11,0.0
6670,vasculogenesis involved in coronary vascular morphogenesis (GO:0060979),-4.402367359449229e-11,0.0
6671,regulation of retinal cell programmed cell death (GO:0046668),-4.402367359449229e-11,0.0
6672,retinal cell programmed cell death (GO:0046666),-4.402367359449229e-11,0.0
6673,cardiac fibroblast cell development (GO:0060936),-4.402367359449229e-11,0.0
6674,cardiac fibroblast cell differentiation (GO:0060935),-4.402367359449229e-11,0.0
6675,His-Purkinje system cell differentiation (GO:0060932),-4.402367359449229e-11,0.0
6676,atrioventricular node cell development (GO:0060928),-4.402367359449229e-11,0.0
6677,atrioventricular node cell differentiation (GO:0060922),-4.402367359449229e-11,0.0
6678,cardiac cell fate determination (GO:0060913),-4.402367359449229e-11,0.0
6679,regulation of pyruvate dehydrogenase activity (GO:1904182),-4.402367359449229e-11,0.0
6680,interneuron axon guidance (GO:0097376),-4.402367359449229e-11,0.0
6681,regulation of cytolysis (GO:0042268),-4.402367359449229e-11,0.0
6682,DN2 thymocyte differentiation (GO:1904155),-4.402367359449229e-11,0.0
6683,positive regulation of microglial cell mediated cytotoxicity (GO:1904151),-4.402367359449229e-11,0.0
6684,establishment of planar polarity of embryonic epithelium (GO:0042249),-4.402367359449229e-11,0.0
6685,protein to membrane docking (GO:0022615),-4.402367359449229e-11,0.0
6686,negative regulation of transcription by transcription factor localization (GO:0010621),-4.402367359449229e-11,0.0
6687,"positive regulation of wound healing, spreading of epidermal cells (GO:1903691)",-4.402367359449229e-11,0.0
6688,"negative regulation of wound healing, spreading of epidermal cells (GO:1903690)",-4.402367359449229e-11,0.0
6689,regulation of Wnt protein secretion (GO:0061356),-4.402367359449229e-11,0.0
6690,nuclear speck organization (GO:0035063),-4.402367359449229e-11,0.0
6691,neural plate regionalization (GO:0060897),-4.402367359449229e-11,0.0
6692,endothelial cell fate specification (GO:0060847),-4.402367359449229e-11,0.0
6693,regulation of COPII vesicle coating (GO:0003400),-4.402367359449229e-11,0.0
6694,regulation of cell differentiation involved in embryonic placenta development (GO:0060800),-4.402367359449229e-11,0.0
6695,mitochondrial respiratory chain complex II assembly (GO:0034553),-4.402367359449229e-11,0.0
6696,respiratory chain complex II assembly (GO:0034552),-4.402367359449229e-11,0.0
6697,nitric oxide transport (GO:0030185),-4.402367359449229e-11,0.0
6698,negative regulation of lamellipodium assembly (GO:0010593),-4.402367359449229e-11,0.0
6699,nitrate metabolic process (GO:0042126),-4.402367359449229e-11,0.0
6700,positive regulation of collagen fibril organization (GO:1904028),-4.402367359449229e-11,0.0
6701,regulation of glucose catabolic process to lactate via pyruvate (GO:1904023),-4.402367359449229e-11,0.0
6702,positive regulation of eating behavior (GO:1904000),-4.402367359449229e-11,0.0
6703,tRNA N2-guanine methylation (GO:0002940),-4.402367359449229e-11,0.0
6704,regulation of reciprocal meiotic recombination (GO:0010520),-4.402367359449229e-11,0.0
6705,negative regulation of mature B cell apoptotic process (GO:0002906),-4.402367359449229e-11,0.0
6706,regulation of mature B cell apoptotic process (GO:0002905),-4.402367359449229e-11,0.0
6707,regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-4.402367359449229e-11,0.0
6708,positive regulation of histamine secretion by mast cell (GO:1903595),-4.402367359449229e-11,0.0
6709,regulation of histamine secretion by mast cell (GO:1903593),-4.402367359449229e-11,0.0
6710,cellular response to L-arginine (GO:1903577),-4.402367359449229e-11,0.0
6711,positive regulation of extracellular exosome assembly (GO:1903553),-4.402367359449229e-11,0.0
6712,negative regulation of exosomal secretion (GO:1903542),-4.402367359449229e-11,0.0
6713,regulation of isoprenoid metabolic process (GO:0019747),-4.402367359449229e-11,0.0
6714,paramesonephric duct development (GO:0061205),-4.402367359449229e-11,0.0
6715,positive regulation of membrane tubulation (GO:1903527),-4.402367359449229e-11,0.0
6716,apical constriction (GO:0003383),-4.402367359449229e-11,0.0
6717,cellular response to camptothecin (GO:0072757),-4.402367359449229e-11,0.0
6718,negative regulation of cilium movement (GO:0003354),-4.402367359449229e-11,0.0
6719,response to anisomycin (GO:0072739),-4.402367359449229e-11,0.0
6720,mammary duct terminal end bud growth (GO:0060763),-4.402367359449229e-11,0.0
6721,regulation of branching involved in mammary gland duct morphogenesis (GO:0060762),-4.402367359449229e-11,0.0
6722,epithelial cell proliferation involved in mammary gland duct elongation (GO:0060750),-4.402367359449229e-11,0.0
6723,negative regulation of extracellular matrix constituent secretion (GO:0003332),-4.402367359449229e-11,0.0
6724,cellular response to cisplatin (GO:0072719),-4.402367359449229e-11,0.0
6725,cellular response to actinomycin D (GO:0072717),-4.402367359449229e-11,0.0
6726,Wnt signaling pathway involved in heart development (GO:0003306),-4.402367359449229e-11,0.0
6727,L-lysine metabolic process (GO:0046440),-4.402367359449229e-11,0.0
6728,L-cysteine metabolic process (GO:0046439),-4.402367359449229e-11,0.0
6729,response to carbon monoxide (GO:0034465),-4.402367359449229e-11,0.0
6730,response to muscle activity involved in regulation of muscle adaptation (GO:0014873),-4.402367359449229e-11,0.0
6731,circadian regulation of translation (GO:0097167),-4.402367359449229e-11,0.0
6732,regulation of type II hypersensitivity (GO:0002892),-4.402367359449229e-11,0.0
6733,T cell anergy (GO:0002870),-4.402367359449229e-11,0.0
6734,myoblast migration involved in skeletal muscle regeneration (GO:0014839),-4.402367359449229e-11,0.0
6735,actin modification (GO:0030047),-4.402367359449229e-11,0.0
6736,intestine smooth muscle contraction (GO:0014827),-4.402367359449229e-11,0.0
6737,vein smooth muscle contraction (GO:0014826),-4.402367359449229e-11,0.0
6738,actin filament fragmentation (GO:0030043),-4.402367359449229e-11,0.0
6739,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014809),-4.402367359449229e-11,0.0
6740,smooth muscle adaptation (GO:0014805),-4.402367359449229e-11,0.0
6741,negative regulation of immune response to tumor cell (GO:0002838),-4.402367359449229e-11,0.0
6742,negative regulation of response to tumor cell (GO:0002835),-4.402367359449229e-11,0.0
6743,regulation of dermatome development (GO:0061183),-4.402367359449229e-11,0.0
6744,negative regulation of mitotic recombination (GO:0045950),-4.402367359449229e-11,0.0
6745,positive regulation of translational termination (GO:0045905),-4.402367359449229e-11,0.0
6746,positive regulation of translational fidelity (GO:0045903),-4.402367359449229e-11,0.0
6747,positive regulation of translational elongation (GO:0045901),-4.402367359449229e-11,0.0
6748,regulation of G1 to G0 transition (GO:1903450),-4.402367359449229e-11,0.0
6749,pancreas morphogenesis (GO:0061113),-4.402367359449229e-11,0.0
6750,cardiac septum cell differentiation (GO:0003292),-4.402367359449229e-11,0.0
6751,smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021910),-4.402367359449229e-11,0.0
6752,regulation of endoribonuclease activity (GO:0060699),-4.402367359449229e-11,0.0
6753,cell migration involved in endocardial cushion formation (GO:0003273),-4.402367359449229e-11,0.0
6754,negative regulation of prostatic bud formation (GO:0060686),-4.402367359449229e-11,0.0
6755,negative regulation of female receptivity (GO:0007621),-4.402367359449229e-11,0.0
6756,dichotomous subdivision of terminal units involved in salivary gland branching (GO:0060666),-4.402367359449229e-11,0.0
6757,positive regulation of phospholipid efflux (GO:1902995),-4.402367359449229e-11,0.0
6758,regulation of phospholipid efflux (GO:1902994),-4.402367359449229e-11,0.0
6759,GDP-L-fucose metabolic process (GO:0046368),-4.402367359449229e-11,0.0
6760,regulation of meiosis I (GO:0060631),-4.402367359449229e-11,0.0
6761,cardiac right ventricle formation (GO:0003219),-4.402367359449229e-11,0.0
6762,disaccharide catabolic process (GO:0046352),-4.402367359449229e-11,0.0
6763,disaccharide biosynthetic process (GO:0046351),-4.402367359449229e-11,0.0
6764,positive regulation of ER to Golgi vesicle-mediated transport (GO:1902953),-4.402367359449229e-11,0.0
6765,positive regulation of dendritic spine maintenance (GO:1902952),-4.402367359449229e-11,0.0
6766,diacylglycerol catabolic process (GO:0046340),-4.402367359449229e-11,0.0
6767,chylomicron assembly (GO:0034378),-4.402367359449229e-11,0.0
6768,phosphatidylethanolamine catabolic process (GO:0046338),-4.402367359449229e-11,0.0
6769,methyl-branched fatty acid metabolic process (GO:0097089),-4.402367359449229e-11,0.0
6770,phosphocreatine biosynthetic process (GO:0046314),-4.402367359449229e-11,0.0
6771,selenocysteinyl-tRNA(Sec) biosynthetic process (GO:0097056),-4.402367359449229e-11,0.0
6772,L-kynurenine catabolic process (GO:0097053),-4.402367359449229e-11,0.0
6773,mature conventional dendritic cell differentiation (GO:0097029),-4.402367359449229e-11,0.0
6774,primary alcohol biosynthetic process (GO:0034309),-4.402367359449229e-11,0.0
6775,lymphocyte migration into lymph node (GO:0097022),-4.402367359449229e-11,0.0
6776,regulation of twitch skeletal muscle contraction (GO:0014724),-4.402367359449229e-11,0.0
6777,negative regulation of anion channel activity (GO:0010360),-4.402367359449229e-11,0.0
6778,ciliary body morphogenesis (GO:0061073),-4.402367359449229e-11,0.0
6779,pH reduction (GO:0045851),-4.402367359449229e-11,0.0
6780,sclerotome development (GO:0061056),-4.402367359449229e-11,0.0
6781,myotome development (GO:0061055),-4.402367359449229e-11,0.0
6782,positive regulation of endoplasmic reticulum tubular network organization (GO:1903373),-4.402367359449229e-11,0.0
6783,epithelial cell differentiation involved in mammary gland alveolus development (GO:0061030),-4.402367359449229e-11,0.0
6784,cardiac muscle tissue regeneration (GO:0061026),-4.402367359449229e-11,0.0
6785,histidine catabolic process to glutamate and formate (GO:0019557),-4.402367359449229e-11,0.0
6786,histidine catabolic process to glutamate and formamide (GO:0019556),-4.402367359449229e-11,0.0
6787,negative regulation of bicellular tight junction assembly (GO:1903347),-4.402367359449229e-11,0.0
6788,propionate metabolic process (GO:0019541),-4.402367359449229e-11,0.0
6789,negative regulation of protein folding (GO:1903333),-4.402367359449229e-11,0.0
6790,response to phenylpropanoid (GO:0080184),-4.402367359449229e-11,0.0
6791,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration (GO:0021815),-4.402367359449229e-11,0.0
6792,type B pancreatic cell maturation (GO:0072560),-4.402367359449229e-11,0.0
6793,somatic muscle development (GO:0007525),-4.402367359449229e-11,0.0
6794,positive regulation of prostaglandin-endoperoxide synthase activity (GO:0060585),-4.402367359449229e-11,0.0
6795,regulation of prostaglandin-endoperoxide synthase activity (GO:0060584),-4.402367359449229e-11,0.0
6796,intestinal epithelial cell maturation (GO:0060574),-4.402367359449229e-11,0.0
6797,muscular septum morphogenesis (GO:0003150),-4.402367359449229e-11,0.0
6798,formaldehyde metabolic process (GO:0046292),-4.402367359449229e-11,0.0
6799,positive regulation of secondary heart field cardioblast proliferation (GO:0072513),-4.402367359449229e-11,0.0
6800,CAAX-box protein maturation (GO:0080120),-4.402367359449229e-11,0.0
6801,propionyl-CoA metabolic process (GO:1902858),-4.402367359449229e-11,0.0
6802,negative regulation of glomerular filtration (GO:0003105),-4.402367359449229e-11,0.0
6803,epithelial cell proliferation involved in lung morphogenesis (GO:0060502),-4.402367359449229e-11,0.0
6804,negative regulation of syncytium formation by plasma membrane fusion (GO:0034242),-4.402367359449229e-11,0.0
6805,regulation of nuclear division (GO:0051783),-4.431766065140005e-11,0.0
6806,response to topologically incorrect protein (GO:0035966),-4.431766065140005e-11,0.0
6807,organophosphate ester transport (GO:0015748),-4.431766065140005e-11,0.0
6808,protein hexamerization (GO:0034214),-4.4527270758439966e-11,0.0
6809,positive regulation of T cell tolerance induction (GO:0002666),-4.4527270758439966e-11,0.0
6810,amyloid-beta formation (GO:0034205),-4.4527270758439966e-11,0.0
6811,negative regulation of cell size (GO:0045792),-4.4527270758439966e-11,0.0
6812,regulation of inner ear receptor cell differentiation (GO:2000980),-4.4527270758439966e-11,0.0
6813,regulation of vascular associated smooth muscle contraction (GO:0003056),-4.4527270758439966e-11,0.0
6814,positive regulation of cardiac muscle contraction (GO:0060452),-4.4527270758439966e-11,0.0
6815,lung saccule development (GO:0060430),-4.4527270758439966e-11,0.0
6816,toll-like receptor 9 signaling pathway (GO:0034162),-4.4527270758439966e-11,0.0
6817,positive regulation of chondrocyte proliferation (GO:1902732),-4.4527270758439966e-11,0.0
6818,regulation of toll-like receptor 3 signaling pathway (GO:0034139),-4.4527270758439966e-11,0.0
6819,toll-like receptor 3 signaling pathway (GO:0034138),-4.4527270758439966e-11,0.0
6820,"substrate-dependent cell migration, cell extension (GO:0006930)",-4.4527270758439966e-11,0.0
6821,negative regulation of antigen processing and presentation (GO:0002578),-4.4527270758439966e-11,0.0
6822,platelet degranulation (GO:0002576),-4.4527270758439966e-11,0.0
6823,negative regulation of erythrocyte differentiation (GO:0045647),-4.4527270758439966e-11,0.0
6824,regulation of mechanoreceptor differentiation (GO:0045631),-4.4527270758439966e-11,0.0
6825,galactolipid metabolic process (GO:0019374),-4.4527270758439966e-11,0.0
6826,negative regulation of keratinocyte differentiation (GO:0045617),-4.4527270758439966e-11,0.0
6827,cyclooxygenase pathway (GO:0019371),-4.4527270758439966e-11,0.0
6828,regulation of inner ear auditory receptor cell differentiation (GO:0045607),-4.4527270758439966e-11,0.0
6829,negative regulation of endothelial cell differentiation (GO:0045602),-4.4527270758439966e-11,0.0
6830,fucose catabolic process (GO:0019317),-4.4527270758439966e-11,0.0
6831,negative regulation of SMAD protein signal transduction (GO:0060392),-4.4527270758439966e-11,0.0
6832,rescue of stalled ribosome (GO:0072344),-4.4527270758439966e-11,0.0
6833,oocyte axis specification (GO:0007309),-4.4527270758439966e-11,0.0
6834,oocyte construction (GO:0007308),-4.4527270758439966e-11,0.0
6835,regulation of cell adhesion molecule production (GO:0060353),-4.4527270758439966e-11,0.0
6836,dUMP metabolic process (GO:0046078),-4.4527270758439966e-11,0.0
6837,vesicle uncoating (GO:0072319),-4.4527270758439966e-11,0.0
6838,regulation of heart morphogenesis (GO:2000826),-4.4527270758439966e-11,0.0
6839,positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-4.4527270758439966e-11,0.0
6840,purine nucleobase transport (GO:0006863),-4.4527270758439966e-11,0.0
6841,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-4.4527270758439966e-11,0.0
6842,serotonin transport (GO:0006837),-4.4527270758439966e-11,0.0
6843,regulation of gamma-delta T cell differentiation (GO:0045586),-4.4527270758439966e-11,0.0
6844,positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),-4.4527270758439966e-11,0.0
6845,positive regulation of cholesterol biosynthetic process (GO:0045542),-4.4527270758439966e-11,0.0
6846,protein localization to membrane raft (GO:1903044),-4.4527270758439966e-11,0.0
6847,neuronal action potential propagation (GO:0019227),-4.4527270758439966e-11,0.0
6848,regulation of bone development (GO:1903010),-4.4527270758439966e-11,0.0
6849,Notch receptor processing (GO:0007220),-4.4527270758439966e-11,0.0
6850,positive regulation of respiratory burst (GO:0060267),-4.4527270758439966e-11,0.0
6851,cellular detoxification of aldehyde (GO:0110095),-4.4527270758439966e-11,0.0
6852,contact inhibition (GO:0060242),-4.4527270758439966e-11,0.0
6853,regulation of serine-type peptidase activity (GO:1902571),-4.4527270758439966e-11,0.0
6854,protein localization to nucleolus (GO:1902570),-4.4527270758439966e-11,0.0
6855,protoporphyrinogen IX biosynthetic process (GO:0006782),-4.4527270758439966e-11,0.0
6856,vitamin A metabolic process (GO:0006776),-4.4527270758439966e-11,0.0
6857,androgen biosynthetic process (GO:0006702),-4.4527270758439966e-11,0.0
6858,"positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-4.4527270758439966e-11,0.0
6859,marginal zone B cell differentiation (GO:0002315),-4.4527270758439966e-11,0.0
6860,germinal center B cell differentiation (GO:0002314),-4.4527270758439966e-11,0.0
6861,adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway (GO:0007196),-4.4527270758439966e-11,0.0
6862,mesonephric duct development (GO:0072177),-4.4527270758439966e-11,0.0
6863,regulation of type B pancreatic cell apoptotic process (GO:2000674),-4.4527270758439966e-11,0.0
6864,negative regulation of dendritic cell apoptotic process (GO:2000669),-4.4527270758439966e-11,0.0
6865,ubiquitin-dependent protein catabolic process via the C-end degron rule pathway (GO:0140627),-4.4527270758439966e-11,0.0
6866,glomerulus morphogenesis (GO:0072102),-4.4527270758439966e-11,0.0
6867,SREBP signaling pathway (GO:0032933),-4.4527270758439966e-11,0.0
6868,regulation of transforming growth factor beta2 production (GO:0032909),-4.4527270758439966e-11,0.0
6869,protein retention in ER lumen (GO:0006621),-4.4527270758439966e-11,0.0
6870,regulation of meiotic cell cycle phase transition (GO:1901993),-4.4527270758439966e-11,0.0
6871,otic vesicle morphogenesis (GO:0071600),-4.4527270758439966e-11,0.0
6872,regulation of cellular glucuronidation (GO:2001029),-4.4527270758439966e-11,0.0
6873,mitotic nuclear membrane reassembly (GO:0007084),-4.4527270758439966e-11,0.0
6874,establishment of T cell polarity (GO:0001768),-4.4527270758439966e-11,0.0
6875,membrane raft assembly (GO:0001765),-4.4527270758439966e-11,0.0
6876,renal system pattern specification (GO:0072048),-4.4527270758439966e-11,0.0
6877,granzyme-mediated programmed cell death signaling pathway (GO:0140507),-4.4527270758439966e-11,0.0
6878,mammary gland involution (GO:0060056),-4.4527270758439966e-11,0.0
6879,neurofilament cytoskeleton organization (GO:0060052),-4.4527270758439966e-11,0.0
6880,ornithine metabolic process (GO:0006591),-4.4527270758439966e-11,0.0
6881,ERBB4 signaling pathway (GO:0038130),-4.4527270758439966e-11,0.0
6882,righting reflex (GO:0060013),-4.4527270758439966e-11,0.0
6883,tryptophan catabolic process (GO:0006569),-4.4527270758439966e-11,0.0
6884,arginine catabolic process (GO:0006527),-4.4527270758439966e-11,0.0
6885,retinoic acid biosynthetic process (GO:0002138),-4.4527270758439966e-11,0.0
6886,T-tubule organization (GO:0033292),-4.4527270758439966e-11,0.0
6887,regulation of mitochondrial DNA metabolic process (GO:1901858),-4.4527270758439966e-11,0.0
6888,positive regulation of cellular amine metabolic process (GO:0033240),-4.4527270758439966e-11,0.0
6889,regulation of glycogen (starch) synthase activity (GO:2000465),-4.4527270758439966e-11,0.0
6890,reelin-mediated signaling pathway (GO:0038026),-4.4527270758439966e-11,0.0
6891,glandular epithelial cell maturation (GO:0002071),-4.4527270758439966e-11,0.0
6892,regulation of blood volume by renin-angiotensin (GO:0002016),-4.4527270758439966e-11,0.0
6893,angiotensin maturation (GO:0002003),-4.4527270758439966e-11,0.0
6894,inflammatory response to wounding (GO:0090594),-4.4527270758439966e-11,0.0
6895,regulation of histone deacetylase activity (GO:1901725),-4.4527270758439966e-11,0.0
6896,positive regulation of cell proliferation involved in kidney development (GO:1901724),-4.4527270758439966e-11,0.0
6897,vesicle tethering involved in exocytosis (GO:0090522),-4.4527270758439966e-11,0.0
6898,antral ovarian follicle growth (GO:0001547),-4.4527270758439966e-11,0.0
6899,RISC complex assembly (GO:0070922),-4.4527270758439966e-11,0.0
6900,mitochondrial tRNA modification (GO:0070900),-4.4527270758439966e-11,0.0
6901,regulation of interleukin-1 alpha production (GO:0032650),-4.4527270758439966e-11,0.0
6902,DNA dealkylation involved in DNA repair (GO:0006307),-4.4527270758439966e-11,0.0
6903,regulation of killing of cells of another organism (GO:0051709),-4.4527270758439966e-11,0.0
6904,daunorubicin metabolic process (GO:0044597),-4.4527270758439966e-11,0.0
6905,"neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-4.4527270758439966e-11,0.0
6906,neurotransmitter receptor diffusion trapping (GO:0099628),-4.4527270758439966e-11,0.0
6907,protein localization to axon (GO:0099612),-4.4527270758439966e-11,0.0
6908,protein O-linked glycosylation via threonine (GO:0018243),-4.4527270758439966e-11,0.0
6909,positive regulation of hematopoietic stem cell proliferation (GO:1902035),-4.4527270758439966e-11,0.0
6910,regulation of NADP metabolic process (GO:1902031),-4.4527270758439966e-11,0.0
6911,cellular response to iron ion (GO:0071281),-4.4527270758439966e-11,0.0
6912,cellular response to muramyl dipeptide (GO:0071225),-4.4527270758439966e-11,0.0
6913,positive regulation of gonad development (GO:1905941),-4.4527270758439966e-11,0.0
6914,endoplasmic reticulum localization (GO:0051643),-4.4527270758439966e-11,0.0
6915,negative regulation of excitatory postsynaptic potential (GO:0090394),-4.4527270758439966e-11,0.0
6916,histamine transport (GO:0051608),-4.4527270758439966e-11,0.0
6917,positive regulation of DNA demethylation (GO:1901537),-4.4527270758439966e-11,0.0
6918,icosanoid catabolic process (GO:1901523),-4.4527270758439966e-11,0.0
6919,leukemia inhibitory factor signaling pathway (GO:0048861),-4.4527270758439966e-11,0.0
6920,venous blood vessel morphogenesis (GO:0048845),-4.4527270758439966e-11,0.0
6921,meiotic spindle assembly (GO:0090306),-4.4527270758439966e-11,0.0
6922,regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-4.4527270758439966e-11,0.0
6923,regulation of hair follicle maturation (GO:0048819),-4.4527270758439966e-11,0.0
6924,negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),-4.4527270758439966e-11,0.0
6925,trans-synaptic signaling by trans-synaptic complex (GO:0099545),-4.4527270758439966e-11,0.0
6926,synaptic vesicle endosomal processing (GO:0099532),-4.4527270758439966e-11,0.0
6927,translocation of molecules into host (GO:0044417),-4.4527270758439966e-11,0.0
6928,cAMP catabolic process (GO:0006198),-4.4527270758439966e-11,0.0
6929,purine nucleoside catabolic process (GO:0006152),-4.4527270758439966e-11,0.0
6930,mRNA pseudouridine synthesis (GO:1990481),-4.4527270758439966e-11,0.0
6931,malate metabolic process (GO:0006108),-4.4527270758439966e-11,0.0
6932,oxaloacetate metabolic process (GO:0006107),-4.4527270758439966e-11,0.0
6933,succinyl-CoA metabolic process (GO:0006104),-4.4527270758439966e-11,0.0
6934,regulation of tetrapyrrole biosynthetic process (GO:1901463),-4.4527270758439966e-11,0.0
6935,regulation of glucocorticoid biosynthetic process (GO:0031946),-4.4527270758439966e-11,0.0
6936,negative regulation of calcium ion import (GO:0090281),-4.4527270758439966e-11,0.0
6937,positive regulation of synaptic plasticity (GO:0031915),-4.4527270758439966e-11,0.0
6938,"positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)",-4.4527270758439966e-11,0.0
6939,positive regulation of skeletal muscle fiber development (GO:0048743),-4.4527270758439966e-11,0.0
6940,regulation of type B pancreatic cell development (GO:2000074),-4.4527270758439966e-11,0.0
6941,embryonic neurocranium morphogenesis (GO:0048702),-4.4527270758439966e-11,0.0
6942,regulation of intracellular lipid transport (GO:0032377),-4.4527270758439966e-11,0.0
6943,regulation of male gonad development (GO:2000018),-4.4527270758439966e-11,0.0
6944,positive regulation of sterol biosynthetic process (GO:0106120),-4.4527270758439966e-11,0.0
6945,ethanol oxidation (GO:0006069),-4.4527270758439966e-11,0.0
6946,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-4.4527270758439966e-11,0.0
6947,postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),-4.4527270758439966e-11,0.0
6948,mannose metabolic process (GO:0006013),-4.4527270758439966e-11,0.0
6949,galactose metabolic process (GO:0006012),-4.4527270758439966e-11,0.0
6950,receptor diffusion trapping (GO:0098953),-4.4527270758439966e-11,0.0
6951,anterograde dendritic transport (GO:0098937),-4.4527270758439966e-11,0.0
6952,protein localization to perinuclear region of cytoplasm (GO:1905719),-4.4527270758439966e-11,0.0
6953,cellular response to insulin-like growth factor stimulus (GO:1990314),-4.4527270758439966e-11,0.0
6954,lactone metabolic process (GO:1901334),-4.4527270758439966e-11,0.0
6955,regulation of vitamin D receptor signaling pathway (GO:0070562),-4.4527270758439966e-11,0.0
6956,positive regulation of synapse maturation (GO:0090129),-4.4527270758439966e-11,0.0
6957,smooth muscle cell proliferation (GO:0048659),-4.4527270758439966e-11,0.0
6958,negative regulation of muscle organ development (GO:0048635),-4.4527270758439966e-11,0.0
6959,mitochondrial RNA modification (GO:1900864),-4.4527270758439966e-11,0.0
6960,peripheral nervous system myelin maintenance (GO:0032287),-4.4527270758439966e-11,0.0
6961,"neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-4.4527270758439966e-11,0.0
6962,action potential propagation (GO:0098870),-4.4527270758439966e-11,0.0
6963,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-4.4527270758439966e-11,0.0
6964,mitotic interphase (GO:0051329),-4.4527270758439966e-11,0.0
6965,interphase (GO:0051325),-4.4527270758439966e-11,0.0
6966,spontaneous synaptic transmission (GO:0098814),-4.4527270758439966e-11,0.0
6967,positive regulation of extracellular matrix disassembly (GO:0090091),-4.4527270758439966e-11,0.0
6968,thrombin-activated receptor signaling pathway (GO:0070493),-4.4527270758439966e-11,0.0
6969,positive regulation of deacetylase activity (GO:0090045),-4.4527270758439966e-11,0.0
6970,regulation of heme biosynthetic process (GO:0070453),-4.4527270758439966e-11,0.0
6971,nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),-4.4527270758439966e-11,0.0
6972,progesterone receptor signaling pathway (GO:0050847),-4.4527270758439966e-11,0.0
6973,bone marrow development (GO:0048539),-4.4527270758439966e-11,0.0
6974,protein desumoylation (GO:0016926),-4.4527270758439966e-11,0.0
6975,xenophagy (GO:0098792),-4.4527270758439966e-11,0.0
6976,nuclear pore complex assembly (GO:0051292),-4.4527270758439966e-11,0.0
6977,polyadenylation-dependent RNA catabolic process (GO:0043633),-4.4527270758439966e-11,0.0
6978,positive regulation of heat generation (GO:0031652),-4.4527270758439966e-11,0.0
6979,regulation of fever generation (GO:0031620),-4.4527270758439966e-11,0.0
6980,mitotic nuclear membrane organization (GO:0101024),-4.4527270758439966e-11,0.0
6981,DNA cytosine deamination (GO:0070383),-4.4527270758439966e-11,0.0
6982,replication fork protection (GO:0048478),-4.4527270758439966e-11,0.0
6983,negative regulation of dendrite morphogenesis (GO:0050774),-4.4527270758439966e-11,0.0
6984,response to zinc ion starvation (GO:0120127),-4.4527270758439966e-11,0.0
6985,positive regulation of translation in response to stress (GO:0032056),-4.4527270758439966e-11,0.0
6986,cardiolipin biosynthetic process (GO:0032049),-4.4527270758439966e-11,0.0
6987,"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-4.4527270758439966e-11,0.0
6988,exonucleolytic trimming involved in rRNA processing (GO:0000459),-4.4527270758439966e-11,0.0
6989,regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0098696),-4.4527270758439966e-11,0.0
6990,regulation of synaptic vesicle cycle (GO:0098693),-4.4527270758439966e-11,0.0
6991,glucosamine-containing compound catabolic process (GO:1901072),-4.4527270758439966e-11,0.0
6992,negative regulation of actin nucleation (GO:0051126),-4.4527270758439966e-11,0.0
6993,hepoxilin biosynthetic process (GO:0051122),-4.4527270758439966e-11,0.0
6994,hepoxilin metabolic process (GO:0051121),-4.4527270758439966e-11,0.0
6995,N-acylphosphatidylethanolamine metabolic process (GO:0070292),-4.4527270758439966e-11,0.0
6996,dermatan sulfate proteoglycan metabolic process (GO:0050655),-4.4527270758439966e-11,0.0
6997,axial mesoderm development (GO:0048318),-4.4527270758439966e-11,0.0
6998,learned vocalization behavior or vocal learning (GO:0098598),-4.4527270758439966e-11,0.0
6999,glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),-4.4527270758439966e-11,0.0
7000,chromatin organization (GO:0031497),-4.4527270758439966e-11,0.0
7001,"retrograde transport, vesicle recycling within Golgi (GO:0000301)",-4.4527270758439966e-11,0.0
7002,peptidyl-lysine hydroxylation (GO:0017185),-4.4527270758439966e-11,0.0
7003,regulation of skeletal muscle tissue regeneration (GO:0043416),-4.4527270758439966e-11,0.0
7004,positive regulation of lipoprotein lipase activity (GO:0051006),-4.4527270758439966e-11,0.0
7005,vesicle fusion with Golgi apparatus (GO:0048280),-4.4527270758439966e-11,0.0
7006,synaptic vesicle budding (GO:0070142),-4.4527270758439966e-11,0.0
7007,peptidyl-serine autophosphorylation (GO:0036289),-4.4527270758439966e-11,0.0
7008,deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-4.4527270758439966e-11,0.0
7009,allantoin metabolic process (GO:0000255),-4.4527270758439966e-11,0.0
7010,positive regulation of memory T cell differentiation (GO:0043382),-4.4527270758439966e-11,0.0
7011,enucleate erythrocyte differentiation (GO:0043353),-4.4527270758439966e-11,0.0
7012,"CD4-positive, alpha-beta T cell proliferation (GO:0035739)",-4.4527270758439966e-11,0.0
7013,positive regulation of aspartic-type peptidase activity (GO:1905247),-4.4527270758439966e-11,0.0
7014,regulation of modification of synaptic structure (GO:1905244),-4.4527270758439966e-11,0.0
7015,positive regulation of vesicle fusion (GO:0031340),-4.4527270758439966e-11,0.0
7016,positive regulation of RNA binding (GO:1905216),-4.4527270758439966e-11,0.0
7017,7-methylguanosine RNA capping (GO:0009452),-4.4527270758439966e-11,0.0
7018,putrescine metabolic process (GO:0009445),-4.4527270758439966e-11,0.0
7019,proton-transporting V-type ATPase complex assembly (GO:0070070),-4.4527270758439966e-11,0.0
7020,regulation of protein localization to cell cortex (GO:1904776),-4.4527270758439966e-11,0.0
7021,positive regulation of secondary metabolite biosynthetic process (GO:1900378),-4.4527270758439966e-11,0.0
7022,phosphatidylserine acyl-chain remodeling (GO:0036150),-4.4527270758439966e-11,0.0
7023,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-4.4527270758439966e-11,0.0
7024,autophagosome-lysosome fusion (GO:0061909),-4.4527270758439966e-11,0.0
7025,sulfur amino acid transport (GO:0000101),-4.4527270758439966e-11,0.0
7026,folic acid-containing compound biosynthetic process (GO:0009396),-4.4527270758439966e-11,0.0
7027,positive regulation of developmental pigmentation (GO:0048087),-4.4527270758439966e-11,0.0
7028,positive regulation of melanin biosynthetic process (GO:0048023),-4.4527270758439966e-11,0.0
7029,hepatocyte growth factor receptor signaling pathway (GO:0048012),-4.4527270758439966e-11,0.0
7030,osteoclast development (GO:0036035),-4.4527270758439966e-11,0.0
7031,negative regulation of amyloid-beta clearance (GO:1900222),-4.4527270758439966e-11,0.0
7032,sulfur amino acid catabolic process (GO:0000098),-4.4527270758439966e-11,0.0
7033,negative regulation of chromatin binding (GO:0035562),-4.4527270758439966e-11,0.0
7034,proline transmembrane transport (GO:0035524),-4.4527270758439966e-11,0.0
7035,aminophospholipid transport (GO:0015917),-4.4527270758439966e-11,0.0
7036,pyrimidine ribonucleotide catabolic process (GO:0009222),-4.4527270758439966e-11,0.0
7037,deoxyribonucleoside triphosphate metabolic process (GO:0009200),-4.4527270758439966e-11,0.0
7038,response to glycoprotein (GO:1904587),-4.4527270758439966e-11,0.0
7039,positive regulation of receptor binding (GO:1900122),-4.4527270758439966e-11,0.0
7040,positive regulation of execution phase of apoptosis (GO:1900119),-4.4527270758439966e-11,0.0
7041,cobalamin transport (GO:0015889),-4.4527270758439966e-11,0.0
7042,folic acid transport (GO:0015884),-4.4527270758439966e-11,0.0
7043,choline transport (GO:0015871),-4.4527270758439966e-11,0.0
7044,ADP transport (GO:0015866),-4.4527270758439966e-11,0.0
7045,ribonucleoside diphosphate biosynthetic process (GO:0009188),-4.4527270758439966e-11,0.0
7046,L-serine transport (GO:0015825),-4.4527270758439966e-11,0.0
7047,proline transport (GO:0015824),-4.4527270758439966e-11,0.0
7048,pyrimidine nucleoside diphosphate metabolic process (GO:0009138),-4.4527270758439966e-11,0.0
7049,pyrimidine nucleoside monophosphate catabolic process (GO:0009131),-4.4527270758439966e-11,0.0
7050,cellular ketone body metabolic process (GO:0046950),-4.4527270758439966e-11,0.0
7051,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-4.4527270758439966e-11,0.0
7052,protein localization to ciliary transition zone (GO:1904491),-4.4527270758439966e-11,0.0
7053,histone H3-K4 monomethylation (GO:0097692),-4.4527270758439966e-11,0.0
7054,calcitonin family receptor signaling pathway (GO:0097646),-4.4527270758439966e-11,0.0
7055,negative regulation of cellular response to hypoxia (GO:1900038),-4.4527270758439966e-11,0.0
7056,lysosomal microautophagy (GO:0016237),-4.4527270758439966e-11,0.0
7057,regulation of serine-type endopeptidase activity (GO:1900003),-4.4527270758439966e-11,0.0
7058,glycerol transmembrane transport (GO:0015793),-4.4527270758439966e-11,0.0
7059,positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),-4.4527270758439966e-11,0.0
7060,peroxisome proliferator activated receptor signaling pathway (GO:0035357),-4.4527270758439966e-11,0.0
7061,positive regulation of hippo signaling (GO:0035332),-4.4527270758439966e-11,0.0
7062,SA node cell to atrial cardiac muscle cell communication (GO:0086070),-4.4527270758439966e-11,0.0
7063,gamma-delta T cell differentiation (GO:0042492),-4.4527270758439966e-11,0.0
7064,positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-4.4527270758439966e-11,0.0
7065,positive regulation of triglyceride catabolic process (GO:0010898),-4.4527270758439966e-11,0.0
7066,positive regulation of sequestering of triglyceride (GO:0010890),-4.4527270758439966e-11,0.0
7067,indole-containing compound catabolic process (GO:0042436),-4.4527270758439966e-11,0.0
7068,dopamine catabolic process (GO:0042420),-4.4527270758439966e-11,0.0
7069,dopamine biosynthetic process (GO:0042416),-4.4527270758439966e-11,0.0
7070,vitamin K metabolic process (GO:0042373),-4.4527270758439966e-11,0.0
7071,L-fucose catabolic process (GO:0042355),-4.4527270758439966e-11,0.0
7072,"fructose 1,6-bisphosphate metabolic process (GO:0030388)",-4.4527270758439966e-11,0.0
7073,polyprenol metabolic process (GO:0016093),-4.4527270758439966e-11,0.0
7074,interleukin-17-mediated signaling pathway (GO:0097400),-4.4527270758439966e-11,0.0
7075,transepithelial chloride transport (GO:0030321),-4.4527270758439966e-11,0.0
7076,poly-N-acetyllactosamine metabolic process (GO:0030309),-4.4527270758439966e-11,0.0
7077,coronary artery morphogenesis (GO:0060982),-4.4527270758439966e-11,0.0
7078,cardiac pacemaker cell development (GO:0060926),-4.4527270758439966e-11,0.0
7079,positive regulation of gamma-delta T cell activation (GO:0046645),-4.4527270758439966e-11,0.0
7080,"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-4.4527270758439966e-11,0.0
7081,regulation of mitotic centrosome separation (GO:0046602),-4.4527270758439966e-11,0.0
7082,positive regulation of centriole replication (GO:0046601),-4.4527270758439966e-11,0.0
7083,glutathione transport (GO:0034635),-4.4527270758439966e-11,0.0
7084,regulation of alkaline phosphatase activity (GO:0010692),-4.4527270758439966e-11,0.0
7085,zymogen inhibition (GO:0097341),-4.4527270758439966e-11,0.0
7086,germ cell migration (GO:0008354),-4.4527270758439966e-11,0.0
7087,mammalian oogenesis stage (GO:0022605),-4.4527270758439966e-11,0.0
7088,regulation of Schwann cell proliferation (GO:0010624),-4.4527270758439966e-11,0.0
7089,pyrimidine nucleobase biosynthetic process (GO:0019856),-4.4527270758439966e-11,0.0
7090,L-ascorbic acid metabolic process (GO:0019852),-4.4527270758439966e-11,0.0
7091,cardiac neural crest cell development involved in outflow tract morphogenesis (GO:0061309),-4.4527270758439966e-11,0.0
7092,semicircular canal development (GO:0060872),-4.4527270758439966e-11,0.0
7093,renal tubular secretion (GO:0097254),-4.4527270758439966e-11,0.0
7094,proteoglycan catabolic process (GO:0030167),-4.4527270758439966e-11,0.0
7095,myotube differentiation involved in skeletal muscle regeneration (GO:0014908),-4.4527270758439966e-11,0.0
7096,regulation of activation of Janus kinase activity (GO:0010533),-4.4527270758439966e-11,0.0
7097,opsonization (GO:0008228),-4.4527270758439966e-11,0.0
7098,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),-4.4527270758439966e-11,0.0
7099,RNA secondary structure unwinding (GO:0010501),-4.4527270758439966e-11,0.0
7100,release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514),-4.4527270758439966e-11,0.0
7101,early endosome to Golgi transport (GO:0034498),-4.4527270758439966e-11,0.0
7102,regulation of Wnt signaling pathway involved in heart development (GO:0003307),-4.4527270758439966e-11,0.0
7103,chorion development (GO:0060717),-4.4527270758439966e-11,0.0
7104,response to denervation involved in regulation of muscle adaptation (GO:0014894),-4.4527270758439966e-11,0.0
7105,striated muscle atrophy (GO:0014891),-4.4527270758439966e-11,0.0
7106,regulation of ribonuclease activity (GO:0060700),-4.4527270758439966e-11,0.0
7107,response to muscle inactivity involved in regulation of muscle adaptation (GO:0014877),-4.4527270758439966e-11,0.0
7108,skeletal myofibril assembly (GO:0014866),-4.4527270758439966e-11,0.0
7109,regulation of hypersensitivity (GO:0002883),-4.4527270758439966e-11,0.0
7110,regulation of natural killer cell mediated immune response to tumor cell (GO:0002855),-4.4527270758439966e-11,0.0
7111,regulation of T cell mediated immune response to tumor cell (GO:0002840),-4.4527270758439966e-11,0.0
7112,"negative regulation of complement activation, classical pathway (GO:0045959)",-4.4527270758439966e-11,0.0
7113,NAD metabolic process (GO:0019674),-4.4527270758439966e-11,0.0
7114,multinuclear osteoclast differentiation (GO:0072674),-4.4527270758439966e-11,0.0
7115,positive regulation of protein localization to early endosome (GO:1902966),-4.4527270758439966e-11,0.0
7116,regulation of protein localization to early endosome (GO:1902965),-4.4527270758439966e-11,0.0
7117,synaptic vesicle clustering (GO:0097091),-4.4527270758439966e-11,0.0
7118,very-low-density lipoprotein particle remodeling (GO:0034372),-4.4527270758439966e-11,0.0
7119,lateral sprouting from an epithelium (GO:0060601),-4.4527270758439966e-11,0.0
7120,negative regulation of glial cell apoptotic process (GO:0034351),-4.4527270758439966e-11,0.0
7121,ncRNA export from nucleus (GO:0097064),-4.4527270758439966e-11,0.0
7122,response to type III interferon (GO:0034342),-4.4527270758439966e-11,0.0
7123,immune response-inhibiting cell surface receptor signaling pathway (GO:0002767),-4.4527270758439966e-11,0.0
7124,cell surface pattern recognition receptor signaling pathway (GO:0002752),-4.4527270758439966e-11,0.0
7125,positive regulation of sister chromatid cohesion (GO:0045876),-4.4527270758439966e-11,0.0
7126,protein K6-linked ubiquitination (GO:0085020),-4.4527270758439966e-11,0.0
7127,regulation of natural killer cell cytokine production (GO:0002727),-4.4527270758439966e-11,0.0
7128,iris morphogenesis (GO:0061072),-4.4527270758439966e-11,0.0
7129,negative regulation of meiotic nuclear division (GO:0045835),-4.4527270758439966e-11,0.0
7130,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-4.4527270758439966e-11,0.0
7131,pattern specification involved in kidney development (GO:0061004),-4.4527270758439966e-11,0.0
7132,multicellular organismal iron ion homeostasis (GO:0060586),-4.4527270758439966e-11,0.0
7133,gonadal mesoderm development (GO:0007506),-4.4527270758439966e-11,0.0
7134,mesodermal cell fate specification (GO:0007501),-4.4527270758439966e-11,0.0
7135,cellular response to zinc ion starvation (GO:0034224),-4.4527270758439966e-11,0.0
7136,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-4.7197135087936094e-11,0.0
7137,ceramide metabolic process (GO:0006672),-4.7197135087936094e-11,0.0
7138,pattern recognition receptor signaling pathway (GO:0002221),-4.7197135087936094e-11,0.0
7139,mitochondrial respiratory chain complex assembly (GO:0033108),-4.7197135087936094e-11,0.0
7140,cellular response to interleukin-1 (GO:0071347),-4.7197135087936094e-11,0.0
7141,ERAD pathway (GO:0036503),-4.7197135087936094e-11,0.0
7142,regulation of pH (GO:0006885),-4.728240021622328e-11,0.0
7143,primary neural tube formation (GO:0014020),-4.728240021622328e-11,0.0
7144,meiotic chromosome segregation (GO:0045132),-4.728240021622328e-11,0.0
7145,DNA modification (GO:0006304),-4.728240021622328e-11,0.0
7146,regulation of NIK/NF-kappaB signaling (GO:1901222),-4.728240021622328e-11,0.0
7147,cellular response to topologically incorrect protein (GO:0035967),-4.728240021622328e-11,0.0
7148,development of primary female sexual characteristics (GO:0046545),-4.728240021622328e-11,0.0
7149,positive regulation of endocytosis (GO:0045807),-4.728240021622328e-11,0.0
7150,positive regulation of leukocyte chemotaxis (GO:0002690),-4.728240021622328e-11,0.0
7151,regulation of actin cytoskeleton organization (GO:0032956),-4.9216186680422074e-11,0.8080455259026686
7152,negative regulation of protein phosphorylation (GO:0001933),-5.115641243815962e-11,0.9134427684117125
7153,response to calcium ion (GO:0051592),-5.1520121501008155e-11,0.9870086289549377
7154,negative regulation of chronic inflammatory response (GO:0002677),-5.23499021895699e-11,0.0
7155,heat acclimation (GO:0010286),-5.23499021895699e-11,0.0
7156,positive regulation of T cell anergy (GO:0002669),-5.23499021895699e-11,0.0
7157,response to oleic acid (GO:0034201),-5.23499021895699e-11,0.0
7158,negative regulation of cell volume (GO:0045794),-5.23499021895699e-11,0.0
7159,"regulation of glutamate secretion, neurotransmission (GO:1903294)",-5.23499021895699e-11,0.0
7160,protein localization to Golgi membrane (GO:1903292),-5.23499021895699e-11,0.0
7161,branchiomotor neuron axon guidance (GO:0021785),-5.23499021895699e-11,0.0
7162,amygdala development (GO:0021764),-5.23499021895699e-11,0.0
7163,tryptophan catabolic process to kynurenine (GO:0019441),-5.23499021895699e-11,0.0
7164,alditol biosynthetic process (GO:0019401),-5.23499021895699e-11,0.0
7165,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure (GO:0003072),-5.23499021895699e-11,0.0
7166,regulation of forebrain neuron differentiation (GO:2000977),-5.23499021895699e-11,0.0
7167,lobar bronchus development (GO:0060482),-5.23499021895699e-11,0.0
7168,detection of oxygen (GO:0003032),-5.23499021895699e-11,0.0
7169,positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-5.23499021895699e-11,0.0
7170,lung vasculature development (GO:0060426),-5.23499021895699e-11,0.0
7171,negative regulation of chondrocyte proliferation (GO:1902731),-5.23499021895699e-11,0.0
7172,positive regulation of proteoglycan biosynthetic process (GO:1902730),-5.23499021895699e-11,0.0
7173,pyrimidine deoxyribonucleoside metabolic process (GO:0046125),-5.23499021895699e-11,0.0
7174,purine deoxyribonucleoside metabolic process (GO:0046122),-5.23499021895699e-11,0.0
7175,toll-like receptor 7 signaling pathway (GO:0034154),-5.23499021895699e-11,0.0
7176,nucleobase catabolic process (GO:0046113),-5.23499021895699e-11,0.0
7177,thymidine metabolic process (GO:0046104),-5.23499021895699e-11,0.0
7178,inosine metabolic process (GO:0046102),-5.23499021895699e-11,0.0
7179,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002580),-5.23499021895699e-11,0.0
7180,somatic diversification of T cell receptor genes (GO:0002568),-5.23499021895699e-11,0.0
7181,replication fork reversal (GO:0071932),-5.23499021895699e-11,0.0
7182,positive regulation of melanocyte differentiation (GO:0045636),-5.23499021895699e-11,0.0
7183,galactose catabolic process (GO:0019388),-5.23499021895699e-11,0.0
7184,lipoxin A4 metabolic process (GO:2001302),-5.23499021895699e-11,0.0
7185,compartment pattern specification (GO:0007386),-5.23499021895699e-11,0.0
7186,vestibulocochlear nerve formation (GO:0021650),-5.23499021895699e-11,0.0
7187,transsulfuration (GO:0019346),-5.23499021895699e-11,0.0
7188,negative regulation of dopamine secretion (GO:0033602),-5.23499021895699e-11,0.0
7189,minus-end-directed organelle transport along microtubule (GO:0072385),-5.23499021895699e-11,0.0
7190,thorax and anterior abdomen determination (GO:0007356),-5.23499021895699e-11,0.0
7191,regulation of mitochondrial transcription (GO:1903108),-5.23499021895699e-11,0.0
7192,positive regulation of glucocorticoid secretion (GO:2000851),-5.23499021895699e-11,0.0
7193,positive regulation of androgen receptor activity (GO:2000825),-5.23499021895699e-11,0.0
7194,positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-5.23499021895699e-11,0.0
7195,dGMP metabolic process (GO:0046054),-5.23499021895699e-11,0.0
7196,UMP catabolic process (GO:0046050),-5.23499021895699e-11,0.0
7197,protein localization to adherens junction (GO:0071896),-5.23499021895699e-11,0.0
7198,odontoblast differentiation (GO:0071895),-5.23499021895699e-11,0.0
7199,negative regulation of neutrophil migration (GO:1902623),-5.23499021895699e-11,0.0
7200,response to fluoride (GO:1902617),-5.23499021895699e-11,0.0
7201,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071878),-5.23499021895699e-11,0.0
7202,tricarboxylic acid transport (GO:0006842),-5.23499021895699e-11,0.0
7203,mRNA alternative polyadenylation (GO:0110104),-5.23499021895699e-11,0.0
7204,TNFSF11-mediated signaling pathway (GO:0071847),-5.23499021895699e-11,0.0
7205,negative regulation of regulatory T cell differentiation (GO:0045590),-5.23499021895699e-11,0.0
7206,triglyceride-rich lipoprotein particle clearance (GO:0071830),-5.23499021895699e-11,0.0
7207,central nervous system vasculogenesis (GO:0022009),-5.23499021895699e-11,0.0
7208,podosome assembly (GO:0071800),-5.23499021895699e-11,0.0
7209,negative regulation of cholesterol biosynthetic process (GO:0045541),-5.23499021895699e-11,0.0
7210,regulation of phosphatidylcholine biosynthetic process (GO:2001245),-5.23499021895699e-11,0.0
7211,regulation of systemic arterial blood pressure by vasopressin (GO:0001992),-5.23499021895699e-11,0.0
7212,negative regulation of osteoclast development (GO:2001205),-5.23499021895699e-11,0.0
7213,glossopharyngeal nerve development (GO:0021563),-5.23499021895699e-11,0.0
7214,corpus callosum morphogenesis (GO:0021540),-5.23499021895699e-11,0.0
7215,proprioception (GO:0019230),-5.23499021895699e-11,0.0
7216,metanephric S-shaped body morphogenesis (GO:0072284),-5.23499021895699e-11,0.0
7217,somatic motor neuron differentiation (GO:0021523),-5.23499021895699e-11,0.0
7218,flavonoid glucuronidation (GO:0052696),-5.23499021895699e-11,0.0
7219,B-1 B cell differentiation (GO:0001923),-5.23499021895699e-11,0.0
7220,negative regulation of receptor recycling (GO:0001920),-5.23499021895699e-11,0.0
7221,negative regulation of respiratory burst involved in inflammatory response (GO:0060266),-5.23499021895699e-11,0.0
7222,metanephric distal convoluted tubule development (GO:0072221),-5.23499021895699e-11,0.0
7223,negative regulation of neutrophil activation (GO:1902564),-5.23499021895699e-11,0.0
7224,riboflavin metabolic process (GO:0006771),-5.23499021895699e-11,0.0
7225,positive regulation of protein monoubiquitination (GO:1902527),-5.23499021895699e-11,0.0
7226,"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0002361)",-5.23499021895699e-11,0.0
7227,androgen catabolic process (GO:0006710),-5.23499021895699e-11,0.0
7228,B cell selection (GO:0002339),-5.23499021895699e-11,0.0
7229,pre-B cell differentiation (GO:0002329),-5.23499021895699e-11,0.0
7230,T cell proliferation involved in immune response (GO:0002309),-5.23499021895699e-11,0.0
7231,metanephric mesenchymal cell differentiation (GO:0072162),-5.23499021895699e-11,0.0
7232,glomerular mesangial cell development (GO:0072144),-5.23499021895699e-11,0.0
7233,negative regulation of interleukin-1-mediated signaling pathway (GO:2000660),-5.23499021895699e-11,0.0
7234,regulation of genetic imprinting (GO:2000653),-5.23499021895699e-11,0.0
7235,positive regulation of dopamine receptor signaling pathway (GO:0060161),-5.23499021895699e-11,0.0
7236,positive regulation of inositol trisphosphate biosynthetic process (GO:0032962),-5.23499021895699e-11,0.0
7237,regulation of miRNA catabolic process (GO:2000625),-5.23499021895699e-11,0.0
7238,positive regulation of mesenchymal stem cell proliferation (GO:1902462),-5.23499021895699e-11,0.0
7239,regulation of mesenchymal stem cell proliferation (GO:1902460),-5.23499021895699e-11,0.0
7240,somatotropin secreting cell differentiation (GO:0060126),-5.23499021895699e-11,0.0
7241,glucosylceramide metabolic process (GO:0006678),-5.23499021895699e-11,0.0
7242,transforming growth factor beta1 production (GO:0032905),-5.23499021895699e-11,0.0
7243,cellular response to indole-3-methanol (GO:0071681),-5.23499021895699e-11,0.0
7244,microglial cell activation involved in immune response (GO:0002282),-5.23499021895699e-11,0.0
7245,regulation of granulocyte colony-stimulating factor production (GO:0071655),-5.23499021895699e-11,0.0
7246,protein processing involved in protein targeting to mitochondrion (GO:0006627),-5.23499021895699e-11,0.0
7247,connective tissue replacement involved in inflammatory response wound healing (GO:0002248),-5.23499021895699e-11,0.0
7248,response to molecule of fungal origin (GO:0002238),-5.23499021895699e-11,0.0
7249,regulation of inward rectifier potassium channel activity (GO:1901979),-5.23499021895699e-11,0.0
7250,negative regulation of skeletal muscle cell differentiation (GO:2001015),-5.23499021895699e-11,0.0
7251,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911),-5.23499021895699e-11,0.0
7252,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910),-5.23499021895699e-11,0.0
7253,diadenosine hexaphosphate catabolic process (GO:1901909),-5.23499021895699e-11,0.0
7254,diadenosine hexaphosphate metabolic process (GO:1901908),-5.23499021895699e-11,0.0
7255,diadenosine pentaphosphate catabolic process (GO:1901907),-5.23499021895699e-11,0.0
7256,diadenosine pentaphosphate metabolic process (GO:1901906),-5.23499021895699e-11,0.0
7257,natural killer cell proliferation (GO:0001787),-5.23499021895699e-11,0.0
7258,somite specification (GO:0001757),-5.23499021895699e-11,0.0
7259,specification of nephron tubule identity (GO:0072081),-5.23499021895699e-11,0.0
7260,regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000583),-5.23499021895699e-11,0.0
7261,post-chaperonin tubulin folding pathway (GO:0007023),-5.23499021895699e-11,0.0
7262,protein localization to plasma membrane raft (GO:0044860),-5.23499021895699e-11,0.0
7263,comma-shaped body morphogenesis (GO:0072049),-5.23499021895699e-11,0.0
7264,proximal/distal pattern formation involved in nephron development (GO:0072047),-5.23499021895699e-11,0.0
7265,oviduct development (GO:0060066),-5.23499021895699e-11,0.0
7266,distal convoluted tubule development (GO:0072025),-5.23499021895699e-11,0.0
7267,thrombopoietin-mediated signaling pathway (GO:0038163),-5.23499021895699e-11,0.0
7268,meiotic telomere tethering at nuclear periphery (GO:0044821),-5.23499021895699e-11,0.0
7269,modulation by host of symbiont catalytic activity (GO:0052422),-5.23499021895699e-11,0.0
7270,convergent extension involved in organogenesis (GO:0060029),-5.23499021895699e-11,0.0
7271,convergent extension involved in axis elongation (GO:0060028),-5.23499021895699e-11,0.0
7272,soft palate development (GO:0060023),-5.23499021895699e-11,0.0
7273,polyamine catabolic process (GO:0006598),-5.23499021895699e-11,0.0
7274,ERBB2-ERBB4 signaling pathway (GO:0038135),-5.23499021895699e-11,0.0
7275,"synaptic transmission, glycinergic (GO:0060012)",-5.23499021895699e-11,0.0
7276,interleukin-2-mediated signaling pathway (GO:0038110),-5.23499021895699e-11,0.0
7277,lymphocyte aggregation (GO:0071593),-5.23499021895699e-11,0.0
7278,threonine catabolic process (GO:0006567),-5.23499021895699e-11,0.0
7279,L-serine catabolic process (GO:0006565),-5.23499021895699e-11,0.0
7280,nuclear cell cycle DNA replication initiation (GO:1902315),-5.23499021895699e-11,0.0
7281,glutamate biosynthetic process (GO:0006537),-5.23499021895699e-11,0.0
7282,histone H3-K27 demethylation (GO:0071557),-5.23499021895699e-11,0.0
7283,asparagine metabolic process (GO:0006528),-5.23499021895699e-11,0.0
7284,alanine catabolic process (GO:0006524),-5.23499021895699e-11,0.0
7285,alanine metabolic process (GO:0006522),-5.23499021895699e-11,0.0
7286,diphosphoinositol polyphosphate metabolic process (GO:0071543),-5.23499021895699e-11,0.0
7287,osteoclast proliferation (GO:0002158),-5.23499021895699e-11,0.0
7288,cementum mineralization (GO:0071529),-5.23499021895699e-11,0.0
7289,response to odorant (GO:1990834),-5.23499021895699e-11,0.0
7290,cellular response to heparin (GO:0071504),-5.23499021895699e-11,0.0
7291,secretion of lysosomal enzymes (GO:0033299),-5.23499021895699e-11,0.0
7292,cellular response to temperature stimulus (GO:0071502),-5.23499021895699e-11,0.0
7293,negative regulation of high voltage-gated calcium channel activity (GO:1901842),-5.23499021895699e-11,0.0
7294,negative regulation of mitochondrial depolarization (GO:0051902),-5.23499021895699e-11,0.0
7295,RNA localization to nucleus (GO:0090685),-5.23499021895699e-11,0.0
7296,RNA localization to Cajal body (GO:0090670),-5.23499021895699e-11,0.0
7297,scaRNA localization to Cajal body (GO:0090666),-5.23499021895699e-11,0.0
7298,negative regulation of cellular amine metabolic process (GO:0033239),-5.23499021895699e-11,0.0
7299,cellular response to oxygen-glucose deprivation (GO:0090650),-5.23499021895699e-11,0.0
7300,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway (GO:0090611),-5.23499021895699e-11,0.0
7301,positive regulation of hepatic stellate cell activation (GO:2000491),-5.23499021895699e-11,0.0
7302,positive regulation of glycogen (starch) synthase activity (GO:2000467),-5.23499021895699e-11,0.0
7303,response to human chorionic gonadotropin (GO:0044752),-5.23499021895699e-11,0.0
7304,cell cycle DNA replication initiation (GO:1902292),-5.23499021895699e-11,0.0
7305,regulation of monocyte extravasation (GO:2000437),-5.23499021895699e-11,0.0
7306,positive regulation of protein neddylation (GO:2000436),-5.23499021895699e-11,0.0
7307,negative regulation of protein neddylation (GO:2000435),-5.23499021895699e-11,0.0
7308,regulation of polyamine transmembrane transport (GO:1902267),-5.23499021895699e-11,0.0
7309,apoptotic process involved in blood vessel morphogenesis (GO:1902262),-5.23499021895699e-11,0.0
7310,positive regulation of delayed rectifier potassium channel activity (GO:1902261),-5.23499021895699e-11,0.0
7311,regulation of T cell extravasation (GO:2000407),-5.23499021895699e-11,0.0
7312,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),-5.23499021895699e-11,0.0
7313,non-canonical Wnt signaling pathway via JNK cascade (GO:0038031),-5.23499021895699e-11,0.0
7314,dolichyl diphosphate biosynthetic process (GO:0006489),-5.23499021895699e-11,0.0
7315,apolipoprotein A-I-mediated signaling pathway (GO:0038027),-5.23499021895699e-11,0.0
7316,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902219),-5.23499021895699e-11,0.0
7317,cellular response to light intensity (GO:0071484),-5.23499021895699e-11,0.0
7318,negative regulation of serotonin secretion (GO:0014063),-5.23499021895699e-11,0.0
7319,gamma-aminobutyric acid secretion (GO:0014051),-5.23499021895699e-11,0.0
7320,negative regulation of glutamate secretion (GO:0014050),-5.23499021895699e-11,0.0
7321,inhibition of neuroepithelial cell differentiation (GO:0002085),-5.23499021895699e-11,0.0
7322,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-5.23499021895699e-11,0.0
7323,regulation of timing of anagen (GO:0051884),-5.23499021895699e-11,0.0
7324,microglia differentiation (GO:0014004),-5.23499021895699e-11,0.0
7325,brain renin-angiotensin system (GO:0002035),-5.23499021895699e-11,0.0
7326,maintenance of blood vessel diameter homeostasis by renin-angiotensin (GO:0002034),-5.23499021895699e-11,0.0
7327,regulation of glycogen catabolic process (GO:0005981),-5.23499021895699e-11,0.0
7328,T cell receptor V(D)J recombination (GO:0033153),-5.23499021895699e-11,0.0
7329,regulation of integrin biosynthetic process (GO:0045113),-5.23499021895699e-11,0.0
7330,error-free translesion synthesis (GO:0070987),-5.23499021895699e-11,0.0
7331,positive regulation of glucokinase activity (GO:0033133),-5.23499021895699e-11,0.0
7332,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-5.23499021895699e-11,0.0
7333,regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-5.23499021895699e-11,0.0
7334,positive regulation of clathrin-dependent endocytosis (GO:2000370),-5.23499021895699e-11,0.0
7335,regulation of binding of sperm to zona pellucida (GO:2000359),-5.23499021895699e-11,0.0
7336,positive regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000340),-5.23499021895699e-11,0.0
7337,"positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902164)",-5.23499021895699e-11,0.0
7338,protein C-linked glycosylation via tryptophan (GO:0018317),-5.23499021895699e-11,0.0
7339,cellular response to corticotropin-releasing hormone stimulus (GO:0071376),-5.23499021895699e-11,0.0
7340,negative regulation of hair follicle development (GO:0051799),-5.23499021895699e-11,0.0
7341,medium-chain fatty acid catabolic process (GO:0051793),-5.23499021895699e-11,0.0
7342,cellular response to interleukin-2 (GO:0071352),-5.23499021895699e-11,0.0
7343,cellular response to interleukin-18 (GO:0071351),-5.23499021895699e-11,0.0
7344,"meiotic sister chromatid cohesion, centromeric (GO:0051754)",-5.23499021895699e-11,0.0
7345,regulation of superoxide dismutase activity (GO:1901668),-5.23499021895699e-11,0.0
7346,quinone catabolic process (GO:1901662),-5.23499021895699e-11,0.0
7347,constitutive secretory pathway (GO:0045054),-5.23499021895699e-11,0.0
7348,protein retention in Golgi apparatus (GO:0045053),-5.23499021895699e-11,0.0
7349,glycoside transport (GO:1901656),-5.23499021895699e-11,0.0
7350,immature T cell proliferation in thymus (GO:0033080),-5.23499021895699e-11,0.0
7351,immature T cell proliferation (GO:0033079),-5.23499021895699e-11,0.0
7352,glutamate homeostasis (GO:0090461),-5.23499021895699e-11,0.0
7353,regulation of vesicle transport along microtubule (GO:1901608),-5.23499021895699e-11,0.0
7354,positive regulation of neutrophil apoptotic process (GO:0033031),-5.23499021895699e-11,0.0
7355,activation of meiosis (GO:0090427),-5.23499021895699e-11,0.0
7356,regulation of translation at synapse (GO:0140243),-5.23499021895699e-11,0.0
7357,hydrogen sulfide metabolic process (GO:0070813),-5.23499021895699e-11,0.0
7358,protein transport into membrane raft (GO:0032596),-5.23499021895699e-11,0.0
7359,dipeptide import across plasma membrane (GO:0140206),-5.23499021895699e-11,0.0
7360,oligopeptide import across plasma membrane (GO:0140205),-5.23499021895699e-11,0.0
7361,atrial cardiac muscle cell membrane repolarization (GO:0099624),-5.23499021895699e-11,0.0
7362,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-5.23499021895699e-11,0.0
7363,rRNA 5'-end processing (GO:0000967),-5.23499021895699e-11,0.0
7364,mitochondrial RNA 3'-end processing (GO:0000965),-5.23499021895699e-11,0.0
7365,regulation of mitochondrial RNA catabolic process (GO:0000960),-5.23499021895699e-11,0.0
7366,peptidyl-tryptophan modification (GO:0018211),-5.23499021895699e-11,0.0
7367,CMP catabolic process (GO:0006248),-5.23499021895699e-11,0.0
7368,protein delipidation (GO:0051697),-5.23499021895699e-11,0.0
7369,protein K69-linked ufmylation (GO:1990592),-5.23499021895699e-11,0.0
7370,cellular response to ammonium ion (GO:0071242),-5.23499021895699e-11,0.0
7371,actomyosin contractile ring assembly (GO:0000915),-5.23499021895699e-11,0.0
7372,assembly of actomyosin apparatus involved in cytokinesis (GO:0000912),-5.23499021895699e-11,0.0
7373,UDP-N-acetylglucosamine transmembrane transport (GO:1990569),-5.23499021895699e-11,0.0
7374,protein polyufmylation (GO:1990564),-5.23499021895699e-11,0.0
7375,IMP catabolic process (GO:0006204),-5.23499021895699e-11,0.0
7376,negative regulation of calcium ion import across plasma membrane (GO:1905949),-5.23499021895699e-11,0.0
7377,response to camptothecin (GO:1901563),-5.23499021895699e-11,0.0
7378,exocyst localization (GO:0051601),-5.23499021895699e-11,0.0
7379,D-aspartate import across plasma membrane (GO:0070779),-5.23499021895699e-11,0.0
7380,D-aspartate transport (GO:0070777),-5.23499021895699e-11,0.0
7381,regulation of endothelial tube morphogenesis (GO:1901509),-5.23499021895699e-11,0.0
7382,regulation of locomotion involved in locomotory behavior (GO:0090325),-5.23499021895699e-11,0.0
7383,regulation of branching morphogenesis of a nerve (GO:2000172),-5.23499021895699e-11,0.0
7384,positive regulation of hair follicle maturation (GO:0048818),-5.23499021895699e-11,0.0
7385,otolith morphogenesis (GO:0032474),-5.23499021895699e-11,0.0
7386,peptidyl-aspartic acid modification (GO:0018197),-5.23499021895699e-11,0.0
7387,"regulation of translation at synapse, modulating synaptic transmission (GO:0099547)",-5.23499021895699e-11,0.0
7388,trans-synaptic signaling by endocannabinoid (GO:0099542),-5.23499021895699e-11,0.0
7389,trans-synaptic signaling by lipid (GO:0099541),-5.23499021895699e-11,0.0
7390,regulation of sodium-dependent phosphate transport (GO:2000118),-5.23499021895699e-11,0.0
7391,negative regulation of macrophage apoptotic process (GO:2000110),-5.23499021895699e-11,0.0
7392,AMP catabolic process (GO:0006196),-5.23499021895699e-11,0.0
7393,positive regulation of phospholipase A2 activity (GO:0032430),-5.23499021895699e-11,0.0
7394,ADP biosynthetic process (GO:0006172),-5.23499021895699e-11,0.0
7395,response to hydrostatic pressure (GO:0051599),-5.23499021895699e-11,0.0
7396,methylglyoxal catabolic process (GO:0051596),-5.23499021895699e-11,0.0
7397,viral translational termination-reinitiation (GO:0075525),-5.23499021895699e-11,0.0
7398,protein C-linked glycosylation (GO:0018103),-5.23499021895699e-11,0.0
7399,positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),-5.23499021895699e-11,0.0
7400,"mitochondrial electron transport, succinate to ubiquinone (GO:0006121)",-5.23499021895699e-11,0.0
7401,NADH oxidation (GO:0006116),-5.23499021895699e-11,0.0
7402,glycerol biosynthetic process (GO:0006114),-5.23499021895699e-11,0.0
7403,succinate metabolic process (GO:0006105),-5.23499021895699e-11,0.0
7404,citrate metabolic process (GO:0006101),-5.23499021895699e-11,0.0
7405,regulation of lymphangiogenesis (GO:1901490),-5.23499021895699e-11,0.0
7406,ossification involved in bone remodeling (GO:0043932),-5.23499021895699e-11,0.0
7407,positive regulation of chromosome condensation (GO:1905821),-5.23499021895699e-11,0.0
7408,negative regulation of glucocorticoid biosynthetic process (GO:0031947),-5.23499021895699e-11,0.0
7409,negative regulation of glucocorticoid metabolic process (GO:0031944),-5.23499021895699e-11,0.0
7410,adrenomedullin receptor signaling pathway (GO:1990410),-5.23499021895699e-11,0.0
7411,regulation of mitochondrial DNA replication (GO:0090296),-5.23499021895699e-11,0.0
7412,Wnt signaling pathway involved in somitogenesis (GO:0090244),-5.23499021895699e-11,0.0
7413,regulation of centromere complex assembly (GO:0090230),-5.23499021895699e-11,0.0
7414,negative regulation of cholesterol metabolic process (GO:0090206),-5.23499021895699e-11,0.0
7415,glucose import in response to insulin stimulus (GO:0044381),-5.23499021895699e-11,0.0
7416,positive regulation of intracellular lipid transport (GO:0032379),-5.23499021895699e-11,0.0
7417,aldosterone metabolic process (GO:0032341),-5.23499021895699e-11,0.0
7418,negative regulation of sterol biosynthetic process (GO:0106119),-5.23499021895699e-11,0.0
7419,peptidyl-lysine oxidation (GO:0018057),-5.23499021895699e-11,0.0
7420,prostaglandin secretion (GO:0032310),-5.23499021895699e-11,0.0
7421,glucuronate catabolic process (GO:0006064),-5.23499021895699e-11,0.0
7422,RNA 3' uridylation (GO:0071076),-5.23499021895699e-11,0.0
7423,"DNA catabolic process, exonucleolytic (GO:0000738)",-5.23499021895699e-11,0.0
7424,regulation of anaphase-promoting complex-dependent catabolic process (GO:1905784),-5.23499021895699e-11,0.0
7425,regulation of DNA helicase activity (GO:1905774),-5.23499021895699e-11,0.0
7426,lipid transport across blood-brain barrier (GO:1990379),-5.23499021895699e-11,0.0
7427,anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-5.23499021895699e-11,0.0
7428,CUT metabolic process (GO:0071043),-5.23499021895699e-11,0.0
7429,exocytic insertion of neurotransmitter receptor to postsynaptic membrane (GO:0098967),-5.23499021895699e-11,0.0
7430,dendritic transport of messenger ribonucleoprotein complex (GO:0098963),-5.23499021895699e-11,0.0
7431,UDP-glucose metabolic process (GO:0006011),-5.23499021895699e-11,0.0
7432,regulation of cortisol secretion (GO:0051462),-5.23499021895699e-11,0.0
7433,dendritic transport of ribonucleoprotein complex (GO:0098961),-5.23499021895699e-11,0.0
7434,positive regulation of corticotropin secretion (GO:0051461),-5.23499021895699e-11,0.0
7435,CUT catabolic process (GO:0071034),-5.23499021895699e-11,0.0
7436,negative regulation of cell fate specification (GO:0009996),-5.23499021895699e-11,0.0
7437,anterograde axonal transport of mitochondrion (GO:0098957),-5.23499021895699e-11,0.0
7438,"fructose 2,6-bisphosphate metabolic process (GO:0006003)",-5.23499021895699e-11,0.0
7439,intracellular pH elevation (GO:0051454),-5.23499021895699e-11,0.0
7440,regulation of endosome to plasma membrane protein transport (GO:1905749),-5.23499021895699e-11,0.0
7441,regulation of chorionic trophoblast cell proliferation (GO:1901382),-5.23499021895699e-11,0.0
7442,microtubule nucleation by microtubule organizing center (GO:0051418),-5.23499021895699e-11,0.0
7443,response to rapamycin (GO:1901355),-5.23499021895699e-11,0.0
7444,membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),-5.23499021895699e-11,0.0
7445,response to cortisol (GO:0051414),-5.23499021895699e-11,0.0
7446,detoxification of nitrogen compound (GO:0051410),-5.23499021895699e-11,0.0
7447,positive regulation of glomerulus development (GO:0090193),-5.23499021895699e-11,0.0
7448,regulation of neuronal action potential (GO:0098908),-5.23499021895699e-11,0.0
7449,regulation of membrane depolarization during action potential (GO:0098902),-5.23499021895699e-11,0.0
7450,negative regulation of kidney development (GO:0090185),-5.23499021895699e-11,0.0
7451,Golgi reassembly (GO:0090168),-5.23499021895699e-11,0.0
7452,cellular sphingolipid homeostasis (GO:0090156),-5.23499021895699e-11,0.0
7453,cadmium ion transmembrane transport (GO:0070574),-5.23499021895699e-11,0.0
7454,positive regulation of hydrogen peroxide-mediated programmed cell death (GO:1901300),-5.23499021895699e-11,0.0
7455,positive regulation of vitamin D receptor signaling pathway (GO:0070564),-5.23499021895699e-11,0.0
7456,mesenchyme migration (GO:0090131),-5.23499021895699e-11,0.0
7457,detection of temperature stimulus involved in thermoception (GO:0050960),-5.23499021895699e-11,0.0
7458,vesicle-mediated cholesterol transport (GO:0090119),-5.23499021895699e-11,0.0
7459,C-5 methylation of cytosine (GO:0090116),-5.23499021895699e-11,0.0
7460,skeletal muscle tissue growth (GO:0048630),-5.23499021895699e-11,0.0
7461,IMP salvage (GO:0032264),-5.23499021895699e-11,0.0
7462,GMP salvage (GO:0032263),-5.23499021895699e-11,0.0
7463,sperm mitochondrial sheath assembly (GO:0120317),-5.23499021895699e-11,0.0
7464,AMP salvage (GO:0044209),-5.23499021895699e-11,0.0
7465,activation of store-operated calcium channel activity (GO:0032237),-5.23499021895699e-11,0.0
7466,regulation of inflammatory response to wounding (GO:0106014),-5.23499021895699e-11,0.0
7467,"positive regulation of synaptic transmission, cholinergic (GO:0032224)",-5.23499021895699e-11,0.0
7468,intestinal hexose absorption (GO:0106001),-5.23499021895699e-11,0.0
7469,positive regulation of neurotrophin TRK receptor signaling pathway (GO:0051388),-5.23499021895699e-11,0.0
7470,positive regulation of artery morphogenesis (GO:1905653),-5.23499021895699e-11,0.0
7471,regulation of artery morphogenesis (GO:1905651),-5.23499021895699e-11,0.0
7472,positive regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051343),-5.23499021895699e-11,0.0
7473,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1905636),-5.23499021895699e-11,0.0
7474,positive regulation of blood-brain barrier permeability (GO:1905605),-5.23499021895699e-11,0.0
7475,regulation of heart induction by regulation of canonical Wnt signaling pathway (GO:0090081),-5.23499021895699e-11,0.0
7476,negative regulation of ribosome biogenesis (GO:0090071),-5.23499021895699e-11,0.0
7477,positive regulation of steroid hormone biosynthetic process (GO:0090031),-5.23499021895699e-11,0.0
7478,cellular detoxification of nitrogen compound (GO:0070458),-5.23499021895699e-11,0.0
7479,negative regulation of pinocytosis (GO:0048550),-5.23499021895699e-11,0.0
7480,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070434),-5.23499021895699e-11,0.0
7481,negative regulation of heterochromatin organization (GO:0120262),-5.23499021895699e-11,0.0
7482,regulation of acyl-CoA biosynthetic process (GO:0050812),-5.23499021895699e-11,0.0
7483,regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900736),-5.23499021895699e-11,0.0
7484,positive regulation of appetite (GO:0032100),-5.23499021895699e-11,0.0
7485,positive regulation of low-density lipoprotein receptor activity (GO:1905599),-5.23499021895699e-11,0.0
7486,negative regulation of low-density lipoprotein receptor activity (GO:1905598),-5.23499021895699e-11,0.0
7487,establishment of meiotic spindle localization (GO:0051295),-5.23499021895699e-11,0.0
7488,negative regulation of vascular endothelial cell proliferation (GO:1905563),-5.23499021895699e-11,0.0
7489,protein localization to site of double-strand break (GO:1990166),-5.23499021895699e-11,0.0
7490,regulation of asymmetric cell division (GO:0009786),-5.23499021895699e-11,0.0
7491,positive regulation of the force of heart contraction (GO:0098735),-5.23499021895699e-11,0.0
7492,primary amino compound biosynthetic process (GO:1901162),-5.23499021895699e-11,0.0
7493,positive regulation of fertilization (GO:1905516),-5.23499021895699e-11,0.0
7494,xylulose 5-phosphate biosynthetic process (GO:1901159),-5.23499021895699e-11,0.0
7495,carbohydrate mediated signaling (GO:0009756),-5.23499021895699e-11,0.0
7496,glucose import across plasma membrane (GO:0098708),-5.23499021895699e-11,0.0
7497,sequestering of calcium ion (GO:0051208),-5.23499021895699e-11,0.0
7498,maintenance of animal organ identity (GO:0048496),-5.23499021895699e-11,0.0
7499,cellular heat acclimation (GO:0070370),-5.23499021895699e-11,0.0
7500,positive regulation of translation in response to endoplasmic reticulum stress (GO:0036493),-5.23499021895699e-11,0.0
7501,regulation of bile acid secretion (GO:0120188),-5.23499021895699e-11,0.0
7502,trans-synaptic signaling by BDNF (GO:0099191),-5.23499021895699e-11,0.0
7503,negative regulation of lipoprotein metabolic process (GO:0050748),-5.23499021895699e-11,0.0
7504,positive regulation of response to food (GO:0032097),-5.23499021895699e-11,0.0
7505,regulation of modification of postsynaptic structure (GO:0099159),-5.23499021895699e-11,0.0
7506,positive regulation of deoxyribonuclease activity (GO:0032077),-5.23499021895699e-11,0.0
7507,negative regulation of translational initiation in response to stress (GO:0032057),-5.23499021895699e-11,0.0
7508,ciliary basal body organization (GO:0032053),-5.23499021895699e-11,0.0
7509,"endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-5.23499021895699e-11,0.0
7510,tendon development (GO:0035989),-5.23499021895699e-11,0.0
7511,protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-5.23499021895699e-11,0.0
7512,xylulose 5-phosphate metabolic process (GO:0051167),-5.23499021895699e-11,0.0
7513,"regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031585)",-5.23499021895699e-11,0.0
7514,negative regulation of autophagosome maturation (GO:1901097),-5.23499021895699e-11,0.0
7515,activation of protein kinase C activity (GO:1990051),-5.23499021895699e-11,0.0
7516,RNA import into mitochondrion (GO:0035927),-5.23499021895699e-11,0.0
7517,calcium ion export across plasma membrane (GO:1990034),-5.23499021895699e-11,0.0
7518,ascending aorta development (GO:0035905),-5.23499021895699e-11,0.0
7519,brain-derived neurotrophic factor receptor signaling pathway (GO:0031547),-5.23499021895699e-11,0.0
7520,positive regulation of DNA ligation (GO:0051106),-5.23499021895699e-11,0.0
7521,DNA ligation involved in DNA repair (GO:0051103),-5.23499021895699e-11,0.0
7522,response to herbicide (GO:0009635),-5.23499021895699e-11,0.0
7523,renal water absorption (GO:0070295),-5.23499021895699e-11,0.0
7524,N-acylethanolamine metabolic process (GO:0070291),-5.23499021895699e-11,0.0
7525,response to symbiotic bacterium (GO:0009609),-5.23499021895699e-11,0.0
7526,response to symbiont (GO:0009608),-5.23499021895699e-11,0.0
7527,negative regulation of leukocyte adhesion to vascular endothelial cell (GO:1904995),-5.23499021895699e-11,0.0
7528,positive regulation of retinoic acid receptor signaling pathway (GO:0048386),-5.23499021895699e-11,0.0
7529,positive regulation of mucus secretion (GO:0070257),-5.23499021895699e-11,0.0
7530,regulation of endosome organization (GO:1904978),-5.23499021895699e-11,0.0
7531,brush border assembly (GO:1904970),-5.23499021895699e-11,0.0
7532,positive regulation of thymocyte apoptotic process (GO:0070245),-5.23499021895699e-11,0.0
7533,regulation of midbrain dopaminergic neuron differentiation (GO:1904956),-5.23499021895699e-11,0.0
7534,intestinal stem cell homeostasis (GO:0036335),-5.23499021895699e-11,0.0
7535,positive regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904906),-5.23499021895699e-11,0.0
7536,vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324),-5.23499021895699e-11,0.0
7537,ameloblast differentiation (GO:0036305),-5.23499021895699e-11,0.0
7538,spliceosomal conformational changes to generate catalytic conformation (GO:0000393),-5.23499021895699e-11,0.0
7539,calmodulin dependent kinase signaling pathway (GO:0099004),-5.23499021895699e-11,0.0
7540,negative regulation of helicase activity (GO:0051097),-5.23499021895699e-11,0.0
7541,regulation of snRNA transcription by RNA polymerase II (GO:1905380),-5.23499021895699e-11,0.0
7542,pigment metabolic process involved in pigmentation (GO:0043474),-5.23499021895699e-11,0.0
7543,regulation of fermentation (GO:0043465),-5.23499021895699e-11,0.0
7544,response to corticotropin-releasing hormone (GO:0043435),-5.23499021895699e-11,0.0
7545,negative regulation of heterochromatin formation (GO:0031452),-5.23499021895699e-11,0.0
7546,rRNA transport (GO:0051029),-5.23499021895699e-11,0.0
7547,meiotic attachment of telomere to nuclear envelope (GO:0070197),-5.23499021895699e-11,0.0
7548,positive regulation of isotype switching to IgA isotypes (GO:0048298),-5.23499021895699e-11,0.0
7549,positive regulation of enamel mineralization (GO:0070175),-5.23499021895699e-11,0.0
7550,determination of dorsal identity (GO:0048263),-5.23499021895699e-11,0.0
7551,snoRNA localization (GO:0048254),-5.23499021895699e-11,0.0
7552,ciliary neurotrophic factor-mediated signaling pathway (GO:0070120),-5.23499021895699e-11,0.0
7553,dipeptide transport (GO:0042938),-5.23499021895699e-11,0.0
7554,regulation of interleukin-6-mediated signaling pathway (GO:0070103),-5.23499021895699e-11,0.0
7555,purine nucleobase transmembrane transport (GO:1904823),-5.23499021895699e-11,0.0
7556,negative regulation of defense response to bacterium (GO:1900425),-5.23499021895699e-11,0.0
7557,"positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)",-5.23499021895699e-11,0.0
7558,negative regulation of chromatin organization (GO:1905268),-5.23499021895699e-11,0.0
7559,positive regulation of natural killer cell degranulation (GO:0043323),-5.23499021895699e-11,0.0
7560,regulation of natural killer cell degranulation (GO:0043321),-5.23499021895699e-11,0.0
7561,neutrophil degranulation (GO:0043312),-5.23499021895699e-11,0.0
7562,putrescine biosynthetic process (GO:0009446),-5.23499021895699e-11,0.0
7563,protein import (GO:0017038),-5.23499021895699e-11,0.0
7564,regulation of myofibroblast differentiation (GO:1904760),-5.23499021895699e-11,0.0
7565,regulation of myeloid dendritic cell activation (GO:0030885),-5.23499021895699e-11,0.0
7566,negative regulation of secondary metabolite biosynthetic process (GO:1900377),-5.23499021895699e-11,0.0
7567,vitamin B6 metabolic process (GO:0042816),-5.23499021895699e-11,0.0
7568,phosphatidylinositol acyl-chain remodeling (GO:0036149),-5.23499021895699e-11,0.0
7569,autophagic cell death (GO:0048102),-5.23499021895699e-11,0.0
7570,leukotriene B4 catabolic process (GO:0036101),-5.23499021895699e-11,0.0
7571,articular cartilage development (GO:0061975),-5.23499021895699e-11,0.0
7572,regulation of protein K48-linked ubiquitination (GO:0061945),-5.23499021895699e-11,0.0
7573,manchette assembly (GO:1905198),-5.23499021895699e-11,0.0
7574,interleukin-18-mediated signaling pathway (GO:0035655),-5.23499021895699e-11,0.0
7575,response to stilbenoid (GO:0035634),-5.23499021895699e-11,0.0
7576,stress granule disassembly (GO:0035617),-5.23499021895699e-11,0.0
7577,positive regulation of cytoplasmic translational initiation (GO:1904690),-5.23499021895699e-11,0.0
7578,long-chain fatty acid catabolic process (GO:0042758),-5.23499021895699e-11,0.0
7579,circadian sleep/wake cycle (GO:0042745),-5.23499021895699e-11,0.0
7580,protein O-linked fucosylation (GO:0036066),-5.23499021895699e-11,0.0
7581,negative regulation of melanin biosynthetic process (GO:0048022),-5.23499021895699e-11,0.0
7582,"antigen processing and presentation, endogenous lipid antigen via MHC class Ib (GO:0048006)",-5.23499021895699e-11,0.0
7583,regulation of astrocyte activation (GO:0061888),-5.23499021895699e-11,0.0
7584,regulation of kidney size (GO:0035564),-5.23499021895699e-11,0.0
7585,negative regulation of cardiac muscle contraction (GO:0055118),-5.23499021895699e-11,0.0
7586,GDP-mannose biosynthetic process (GO:0009298),-5.23499021895699e-11,0.0
7587,peptide modification (GO:0031179),-5.23499021895699e-11,0.0
7588,NAD transport (GO:0043132),-5.23499021895699e-11,0.0
7589,protein K29-linked deubiquitination (GO:0035523),-5.23499021895699e-11,0.0
7590,regulation of antifungal innate immune response (GO:1905034),-5.23499021895699e-11,0.0
7591,oxidative RNA demethylation (GO:0035513),-5.23499021895699e-11,0.0
7592,negative regulation of myosin-light-chain-phosphatase activity (GO:0035509),-5.23499021895699e-11,0.0
7593,regulation of axon diameter (GO:0031133),-5.23499021895699e-11,0.0
7594,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-5.23499021895699e-11,0.0
7595,isopentenyl diphosphate biosynthetic process (GO:0009240),-5.23499021895699e-11,0.0
7596,menaquinone metabolic process (GO:0009233),-5.23499021895699e-11,0.0
7597,thelarche (GO:0042695),-5.23499021895699e-11,0.0
7598,deoxyribonucleoside triphosphate catabolic process (GO:0009204),-5.23499021895699e-11,0.0
7599,regulation of protein import (GO:1904589),-5.23499021895699e-11,0.0
7600,regulation of mesodermal cell fate specification (GO:0042661),-5.23499021895699e-11,0.0
7601,positive regulation of TORC2 signaling (GO:1904515),-5.23499021895699e-11,0.0
7602,positive regulation of lipophagy (GO:1904504),-5.23499021895699e-11,0.0
7603,regulation of lipophagy (GO:1904502),-5.23499021895699e-11,0.0
7604,leukotriene signaling pathway (GO:0061737),-5.23499021895699e-11,0.0
7605,mitochondrial acetyl-CoA biosynthetic process from pyruvate (GO:0061732),-5.23499021895699e-11,0.0
7606,methylglyoxal catabolic process to lactate (GO:0061727),-5.23499021895699e-11,0.0
7607,penile erection (GO:0043084),-5.23499021895699e-11,0.0
7608,positive regulation of vascular wound healing (GO:0035470),-5.23499021895699e-11,0.0
7609,determination of pancreatic left/right asymmetry (GO:0035469),-5.23499021895699e-11,0.0
7610,thiamine transport (GO:0015888),-5.23499021895699e-11,0.0
7611,regulation of cardiac muscle tissue development (GO:0055024),-5.23499021895699e-11,0.0
7612,dipeptide transmembrane transport (GO:0035442),-5.23499021895699e-11,0.0
7613,deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),-5.23499021895699e-11,0.0
7614,pyrimidine nucleoside transport (GO:0015864),-5.23499021895699e-11,0.0
7615,uridine transport (GO:0015862),-5.23499021895699e-11,0.0
7616,pyrimidine nucleobase transport (GO:0015855),-5.23499021895699e-11,0.0
7617,adenine transport (GO:0015853),-5.23499021895699e-11,0.0
7618,extracellular matrix-cell signaling (GO:0035426),-5.23499021895699e-11,0.0
7619,purine ribonucleoside diphosphate catabolic process (GO:0009181),-5.23499021895699e-11,0.0
7620,purine ribonucleoside diphosphate biosynthetic process (GO:0009180),-5.23499021895699e-11,0.0
7621,pyrimidine deoxyribonucleoside monophosphate biosynthetic process (GO:0009177),-5.23499021895699e-11,0.0
7622,purine deoxyribonucleotide biosynthetic process (GO:0009153),-5.23499021895699e-11,0.0
7623,L-cystine transport (GO:0015811),-5.23499021895699e-11,0.0
7624,purine nucleoside triphosphate catabolic process (GO:0009146),-5.23499021895699e-11,0.0
7625,purine nucleoside diphosphate catabolic process (GO:0009137),-5.23499021895699e-11,0.0
7626,habituation (GO:0046959),-5.23499021895699e-11,0.0
7627,glutamate receptor clustering (GO:0097688),-5.23499021895699e-11,0.0
7628,double-strand break repair via alternative nonhomologous end joining (GO:0097681),-5.23499021895699e-11,0.0
7629,histone H3-K36 dimethylation (GO:0097676),-5.23499021895699e-11,0.0
7630,regulation of plasma cell differentiation (GO:1900098),-5.23499021895699e-11,0.0
7631,folate import across plasma membrane (GO:1904447),-5.23499021895699e-11,0.0
7632,zinc ion import into organelle (GO:0062111),-5.23499021895699e-11,0.0
7633,negative regulation of SMAD protein complex assembly (GO:0010991),-5.23499021895699e-11,0.0
7634,regulation of peptidyl-tyrosine autophosphorylation (GO:1900084),-5.23499021895699e-11,0.0
7635,L-arginine import across plasma membrane (GO:0097638),-5.23499021895699e-11,0.0
7636,negative regulation of ceramide biosynthetic process (GO:1900060),-5.23499021895699e-11,0.0
7637,cellular magnesium ion homeostasis (GO:0010961),-5.23499021895699e-11,0.0
7638,negative regulation of vitamin D biosynthetic process (GO:0010957),-5.23499021895699e-11,0.0
7639,Roundabout signaling pathway (GO:0035385),-5.23499021895699e-11,0.0
7640,cellular response to sodium arsenite (GO:1903936),-5.23499021895699e-11,0.0
7641,positive regulation of DNA primase activity (GO:1903934),-5.23499021895699e-11,0.0
7642,regulation of DNA primase activity (GO:1903932),-5.23499021895699e-11,0.0
7643,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:1903912),-5.23499021895699e-11,0.0
7644,homoserine metabolic process (GO:0009092),-5.23499021895699e-11,0.0
7645,galactose transmembrane transport (GO:0015757),-5.23499021895699e-11,0.0
7646,branched-chain amino acid biosynthetic process (GO:0009082),-5.23499021895699e-11,0.0
7647,pyruvate family amino acid catabolic process (GO:0009080),-5.23499021895699e-11,0.0
7648,citrate transport (GO:0015746),-5.23499021895699e-11,0.0
7649,alpha-ketoglutarate transport (GO:0015742),-5.23499021895699e-11,0.0
7650,pyruvate family amino acid metabolic process (GO:0009078),-5.23499021895699e-11,0.0
7651,sialic acid transport (GO:0015739),-5.23499021895699e-11,0.0
7652,oxaloacetate transport (GO:0015729),-5.23499021895699e-11,0.0
7653,response to cycloheximide (GO:0046898),-5.23499021895699e-11,0.0
7654,membrane depolarization during SA node cell action potential (GO:0086046),-5.23499021895699e-11,0.0
7655,membrane depolarization during AV node cell action potential (GO:0086045),-5.23499021895699e-11,0.0
7656,bundle of His cell action potential (GO:0086043),-5.23499021895699e-11,0.0
7657,Purkinje myocyte to ventricular cardiac muscle cell signaling (GO:0086029),-5.23499021895699e-11,0.0
7658,bundle of His cell to Purkinje myocyte signaling (GO:0086028),-5.23499021895699e-11,0.0
7659,terpenoid transport (GO:0046865),-5.23499021895699e-11,0.0
7660,isoprenoid transport (GO:0046864),-5.23499021895699e-11,0.0
7661,detection of bacterial lipoprotein (GO:0042494),-5.23499021895699e-11,0.0
7662,mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-5.23499021895699e-11,0.0
7663,positive regulation of RNA export from nucleus (GO:0046833),-5.23499021895699e-11,0.0
7664,regulation of stress granule assembly (GO:0062028),-5.23499021895699e-11,0.0
7665,photoreceptor cell morphogenesis (GO:0008594),-5.23499021895699e-11,0.0
7666,negative regulation of triglyceride catabolic process (GO:0010897),-5.23499021895699e-11,0.0
7667,axon midline choice point recognition (GO:0016199),-5.23499021895699e-11,0.0
7668,positive regulation of dopaminergic neuron differentiation (GO:1904340),-5.23499021895699e-11,0.0
7669,indole-containing compound biosynthetic process (GO:0042435),-5.23499021895699e-11,0.0
7670,synaptic vesicle coating (GO:0016183),-5.23499021895699e-11,0.0
7671,positive regulation of gastro-intestinal system smooth muscle contraction (GO:1904306),-5.23499021895699e-11,0.0
7672,regulation of gastro-intestinal system smooth muscle contraction (GO:1904304),-5.23499021895699e-11,0.0
7673,receptor localization to non-motile cilium (GO:0097500),-5.23499021895699e-11,0.0
7674,calcium activated phosphatidylcholine scrambling (GO:0061590),-5.23499021895699e-11,0.0
7675,negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-5.23499021895699e-11,0.0
7676,cranial ganglion development (GO:0061550),-5.23499021895699e-11,0.0
7677,cilium disassembly (GO:0061523),-5.23499021895699e-11,0.0
7678,cadmium ion transport (GO:0015691),-5.23499021895699e-11,0.0
7679,peptidyl-arginine N-methylation (GO:0035246),-5.23499021895699e-11,0.0
7680,neuron-glial cell signaling (GO:0150099),-5.23499021895699e-11,0.0
7681,positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-5.23499021895699e-11,0.0
7682,ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-5.23499021895699e-11,0.0
7683,regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-5.23499021895699e-11,0.0
7684,snRNA catabolic process (GO:0016076),-5.23499021895699e-11,0.0
7685,positive regulation of nitric oxide mediated signal transduction (GO:0010750),-5.23499021895699e-11,0.0
7686,positive regulation of hydrogen peroxide biosynthetic process (GO:0010729),-5.23499021895699e-11,0.0
7687,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-5.23499021895699e-11,0.0
7688,post-embryonic hemopoiesis (GO:0035166),-5.23499021895699e-11,0.0
7689,positive regulation of centriole elongation (GO:1903724),-5.23499021895699e-11,0.0
7690,operant conditioning (GO:0035106),-5.23499021895699e-11,0.0
7691,angiogenesis involved in coronary vascular morphogenesis (GO:0060978),-5.23499021895699e-11,0.0
7692,embryonic heart tube left/right pattern formation (GO:0060971),-5.23499021895699e-11,0.0
7693,sinoatrial node cell development (GO:0060931),-5.23499021895699e-11,0.0
7694,cortisol metabolic process (GO:0034650),-5.23499021895699e-11,0.0
7695,mature ribosome assembly (GO:0042256),-5.23499021895699e-11,0.0
7696,neutrophil clearance (GO:0097350),-5.23499021895699e-11,0.0
7697,regulation of microglial cell mediated cytotoxicity (GO:1904149),-5.23499021895699e-11,0.0
7698,apoptotic chromosome condensation (GO:0030263),-5.23499021895699e-11,0.0
7699,melanocyte proliferation (GO:0097325),-5.23499021895699e-11,0.0
7700,ectodermal cell differentiation (GO:0010668),-5.23499021895699e-11,0.0
7701,membrane to membrane docking (GO:0022614),-5.23499021895699e-11,0.0
7702,positive regulation of platelet-derived growth factor receptor signaling pathway (GO:0010641),-5.23499021895699e-11,0.0
7703,dermatan sulfate biosynthetic process (GO:0030208),-5.23499021895699e-11,0.0
7704,testosterone biosynthetic process (GO:0061370),-5.23499021895699e-11,0.0
7705,negative regulation of Rac protein signal transduction (GO:0035021),-5.23499021895699e-11,0.0
7706,growth plate cartilage chondrocyte development (GO:0003431),-5.23499021895699e-11,0.0
7707,chondrocyte hypertrophy (GO:0003415),-5.23499021895699e-11,0.0
7708,retinal pigment epithelium development (GO:0003406),-5.23499021895699e-11,0.0
7709,planar cell polarity pathway involved in axis elongation (GO:0003402),-5.23499021895699e-11,0.0
7710,saliva secretion (GO:0046541),-5.23499021895699e-11,0.0
7711,strand invasion (GO:0042148),-5.23499021895699e-11,0.0
7712,hematopoietic stem cell migration to bone marrow (GO:0097241),-5.23499021895699e-11,0.0
7713,regulation of G protein-coupled receptor internalization (GO:1904020),-5.23499021895699e-11,0.0
7714,response to Thyroglobulin triiodothyronine (GO:1904016),-5.23499021895699e-11,0.0
7715,tRNA threonylcarbamoyladenosine modification (GO:0002949),-5.23499021895699e-11,0.0
7716,tRNA dihydrouridine synthesis (GO:0002943),-5.23499021895699e-11,0.0
7717,myoblast fusion involved in skeletal muscle regeneration (GO:0014905),-5.23499021895699e-11,0.0
7718,negative regulation of calcium ion transport into cytosol (GO:0010523),-5.23499021895699e-11,0.0
7719,positive regulation of lymphocyte anergy (GO:0002913),-5.23499021895699e-11,0.0
7720,regulation of phosphatidylinositol biosynthetic process (GO:0010511),-5.23499021895699e-11,0.0
7721,response to L-arginine (GO:1903576),-5.23499021895699e-11,0.0
7722,cornified envelope assembly (GO:1903575),-5.23499021895699e-11,0.0
7723,hair follicle placode formation (GO:0060789),-5.23499021895699e-11,0.0
7724,isopentenyl diphosphate metabolic process (GO:0046490),-5.23499021895699e-11,0.0
7725,cellular response to staurosporine (GO:0072734),-5.23499021895699e-11,0.0
7726,response to staurosporine (GO:0072733),-5.23499021895699e-11,0.0
7727,branch elongation involved in mammary gland duct branching (GO:0060751),-5.23499021895699e-11,0.0
7728,positive regulation of extracellular matrix constituent secretion (GO:0003331),-5.23499021895699e-11,0.0
7729,response to cisplatin (GO:0072718),-5.23499021895699e-11,0.0
7730,response to actinomycin D (GO:0072716),-5.23499021895699e-11,0.0
7731,mammary gland branching involved in thelarche (GO:0060744),-5.23499021895699e-11,0.0
7732,dolichyl diphosphate metabolic process (GO:0046465),-5.23499021895699e-11,0.0
7733,cellular response to sorbitol (GO:0072709),-5.23499021895699e-11,0.0
7734,late endosome to Golgi transport (GO:0034499),-5.23499021895699e-11,0.0
7735,intestinal epithelial structure maintenance (GO:0060729),-5.23499021895699e-11,0.0
7736,ncRNA 5'-end processing (GO:0034471),-5.23499021895699e-11,0.0
7737,epoxide metabolic process (GO:0097176),-5.23499021895699e-11,0.0
7738,negative regulation of skeletal muscle cell proliferation (GO:0014859),-5.23499021895699e-11,0.0
7739,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration (GO:0014834),-5.23499021895699e-11,0.0
7740,negative regulation of acute inflammatory response to antigenic stimulus (GO:0002865),-5.23499021895699e-11,0.0
7741,gephyrin clustering involved in postsynaptic density assembly (GO:0097116),-5.23499021895699e-11,0.0
7742,NMDA glutamate receptor clustering (GO:0097114),-5.23499021895699e-11,0.0
7743,AMPA glutamate receptor clustering (GO:0097113),-5.23499021895699e-11,0.0
7744,gamma-aminobutyric acid receptor clustering (GO:0097112),-5.23499021895699e-11,0.0
7745,microspike assembly (GO:0030035),-5.23499021895699e-11,0.0
7746,skeletal muscle satellite cell differentiation (GO:0014816),-5.23499021895699e-11,0.0
7747,fungiform papilla morphogenesis (GO:0061197),-5.23499021895699e-11,0.0
7748,positive regulation of antibacterial peptide production (GO:0002803),-5.23499021895699e-11,0.0
7749,"positive regulation of circadian sleep/wake cycle, sleep (GO:0045938)",-5.23499021895699e-11,0.0
7750,positive regulation of complement activation (GO:0045917),-5.23499021895699e-11,0.0
7751,negative regulation of translational elongation (GO:0045900),-5.23499021895699e-11,0.0
7752,glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-5.23499021895699e-11,0.0
7753,hindbrain tangential cell migration (GO:0021934),-5.23499021895699e-11,0.0
7754,cellular response to bile acid (GO:1903413),-5.23499021895699e-11,0.0
7755,atrial septum primum morphogenesis (GO:0003289),-5.23499021895699e-11,0.0
7756,septum primum development (GO:0003284),-5.23499021895699e-11,0.0
7757,apoptotic process involved in heart morphogenesis (GO:0003278),-5.23499021895699e-11,0.0
7758,endocardial cushion fusion (GO:0003274),-5.23499021895699e-11,0.0
7759,maintenance of protein location in mitochondrion (GO:0072656),-5.23499021895699e-11,0.0
7760,regulation of branching involved in prostate gland morphogenesis (GO:0060687),-5.23499021895699e-11,0.0
7761,mitotic DNA replication initiation (GO:1902975),-5.23499021895699e-11,0.0
7762,telomere tethering at nuclear periphery (GO:0034398),-5.23499021895699e-11,0.0
7763,negative regulation of transcription initiation by RNA polymerase II (GO:0060633),-5.23499021895699e-11,0.0
7764,chylomicron remnant clearance (GO:0034382),-5.23499021895699e-11,0.0
7765,"regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902956)",-5.23499021895699e-11,0.0
7766,negative regulation of dendritic spine maintenance (GO:1902951),-5.23499021895699e-11,0.0
7767,ductus arteriosus closure (GO:0097070),-5.23499021895699e-11,0.0
7768,response to thyroxine (GO:0097068),-5.23499021895699e-11,0.0
7769,glial cell apoptotic process (GO:0034349),-5.23499021895699e-11,0.0
7770,anterior head development (GO:0097065),-5.23499021895699e-11,0.0
7771,regulation of type III interferon production (GO:0034344),-5.23499021895699e-11,0.0
7772,COP9 signalosome assembly (GO:0010387),-5.23499021895699e-11,0.0
7773,Fc receptor mediated inhibitory signaling pathway (GO:0002774),-5.23499021895699e-11,0.0
7774,regulation of skeletal muscle contraction by calcium ion signaling (GO:0014722),-5.23499021895699e-11,0.0
7775,positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-5.23499021895699e-11,0.0
7776,renal protein absorption (GO:0097017),-5.23499021895699e-11,0.0
7777,skeletal muscle satellite cell activation (GO:0014719),-5.23499021895699e-11,0.0
7778,negative regulation of sister chromatid cohesion (GO:0045875),-5.23499021895699e-11,0.0
7779,regulation of sequestering of zinc ion (GO:0061088),-5.23499021895699e-11,0.0
7780,negative regulation of histone H3-K27 methylation (GO:0061086),-5.23499021895699e-11,0.0
7781,regulation of adherens junction organization (GO:1903391),-5.23499021895699e-11,0.0
7782,positive regulation of cell growth involved in cardiac muscle cell development (GO:0061051),-5.23499021895699e-11,0.0
7783,negative regulation of isotype switching (GO:0045829),-5.23499021895699e-11,0.0
7784,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-5.23499021895699e-11,0.0
7785,negative regulation of vascular wound healing (GO:0061044),-5.23499021895699e-11,0.0
7786,forebrain neuroblast division (GO:0021873),-5.23499021895699e-11,0.0
7787,forebrain ventricular zone progenitor cell division (GO:0021869),-5.23499021895699e-11,0.0
7788,common bile duct development (GO:0061009),-5.23499021895699e-11,0.0
7789,caveolin-mediated endocytosis (GO:0072584),-5.23499021895699e-11,0.0
7790,tricuspid valve morphogenesis (GO:0003186),-5.23499021895699e-11,0.0
7791,L-methionine salvage from methylthioadenosine (GO:0019509),-5.23499021895699e-11,0.0
7792,terminal button organization (GO:0072553),-5.23499021895699e-11,0.0
7793,prostatic bud formation (GO:0060513),-5.23499021895699e-11,0.0
7794,positive regulation of epithelial cell proliferation involved in lung morphogenesis (GO:0060501),-5.23499021895699e-11,0.0
7795,negative regulation of protein localization to microtubule (GO:1902817),-5.23499021895699e-11,0.0
7796,regulation of protein localization to microtubule (GO:1902816),-5.23499021895699e-11,0.0
7797,positive regulation of macrophage fusion (GO:0034241),-5.23499021895699e-11,0.0
7798,regulation of macrophage fusion (GO:0034239),-5.23499021895699e-11,0.0
7799,regulation of skeletal muscle fiber differentiation (GO:1902809),-5.23499021895699e-11,0.0
7800,somatic recombination of T cell receptor gene segments (GO:0002681),-5.23499021895699e-11,0.0
7801,tRNA thio-modification (GO:0034227),-5.23499021895699e-11,0.0
7802,positive regulation of DNA biosynthetic process (GO:2000573),-5.3013149424446026e-11,0.0
7803,cellular response to ionizing radiation (GO:0071479),-5.3013149424446026e-11,0.0
7804,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-5.3013149424446026e-11,0.0
7805,endocytic recycling (GO:0032456),-5.3013149424446026e-11,0.0
7806,protein deacylation (GO:0035601),-5.3013149424446026e-11,0.0
7807,autophagosome assembly (GO:0000045),-5.3013149424446026e-11,0.0
7808,cellular amino acid biosynthetic process (GO:0008652),-5.3013149424446026e-11,0.0
7809,positive regulation of macroautophagy (GO:0016239),-5.3013149424446026e-11,0.0
7810,positive regulation of carbohydrate metabolic process (GO:0045913),-5.3013149424446026e-11,0.0
7811,establishment of protein localization to mitochondrion (GO:0072655),-5.3013149424446026e-11,0.0
7812,peptide secretion (GO:0002790),-5.3013149424446026e-11,0.0
7813,regulation of protein maturation (GO:1903317),-5.3013149424446026e-11,0.0
7814,cellular glucose homeostasis (GO:0001678),-5.3759219296954304e-11,0.0
7815,positive regulation of tumor necrosis factor production (GO:0032760),-5.3759219296954304e-11,0.0
7816,regulation of telomere maintenance (GO:0032204),-5.3759219296954304e-11,0.0
7817,regulation of oxidoreductase activity (GO:0051341),-5.3759219296954304e-11,0.0
7818,protein polymerization (GO:0051258),-5.3759219296954304e-11,0.0
7819,phospholipid transport (GO:0015914),-5.3759219296954304e-11,0.0
7820,regulation of cell morphogenesis involved in differentiation (GO:0010769),-5.3759219296954304e-11,0.0
7821,regulation of cell cycle G2/M phase transition (GO:1902749),-5.7002624840914615e-11,0.0
7822,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-5.7002624840914615e-11,0.0
7823,mitochondrial translation (GO:0032543),-5.7002624840914615e-11,0.0
7824,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-5.7002624840914615e-11,0.0
7825,cellular amino acid catabolic process (GO:0009063),-5.7002624840914615e-11,0.0
7826,carbohydrate catabolic process (GO:0016052),-5.7002624840914615e-11,0.0
7827,extrinsic apoptotic signaling pathway (GO:0097191),-5.7002624840914615e-11,0.0
7828,vesicle budding from membrane (GO:0006900),-5.7678084529057825e-11,0.0
7829,cardiac muscle contraction (GO:0060048),-5.7678084529057825e-11,0.0
7830,DNA methylation or demethylation (GO:0044728),-5.7678084529057825e-11,0.0
7831,cellular response to mechanical stimulus (GO:0071260),-5.7678084529057825e-11,0.0
7832,stress-activated MAPK cascade (GO:0051403),-5.7678084529057825e-11,0.0
7833,negative regulation of protein polymerization (GO:0032272),-5.7678084529057825e-11,0.0
7834,carbohydrate derivative transport (GO:1901264),-5.7678084529057825e-11,0.0
7835,establishment of chromosome localization (GO:0051303),-5.7678084529057825e-11,0.0
7836,positive regulation of phagocytosis (GO:0050766),-5.7678084529057825e-11,0.0
7837,regulation of defense response to virus (GO:0050688),-5.7678084529057825e-11,0.0
7838,regulation of cardiac muscle contraction (GO:0055117),-5.7678084529057825e-11,0.0
7839,positive regulation of mitochondrion organization (GO:0010822),-5.7678084529057825e-11,0.0
7840,ribosomal large subunit biogenesis (GO:0042273),-5.7678084529057825e-11,0.0
7841,regulation of tolerance induction dependent upon immune response (GO:0002652),-5.818456827286248e-11,0.0
7842,positive regulation of intestinal cholesterol absorption (GO:0045797),-5.818456827286248e-11,0.0
7843,glucose mediated signaling pathway (GO:0010255),-5.818456827286248e-11,0.0
7844,negative regulation of cellular amino acid metabolic process (GO:0045763),-5.818456827286248e-11,0.0
7845,forebrain anterior/posterior pattern specification (GO:0021797),-5.818456827286248e-11,0.0
7846,regulation of calcium:sodium antiporter activity (GO:1903279),-5.818456827286248e-11,0.0
7847,beta-alanine metabolic process (GO:0019482),-5.818456827286248e-11,0.0
7848,positive regulation of integrin biosynthetic process (GO:0045726),-5.818456827286248e-11,0.0
7849,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification (GO:0021776),-5.818456827286248e-11,0.0
7850,smoothened signaling pathway involved in ventral spinal cord interneuron specification (GO:0021775),-5.818456827286248e-11,0.0
7851,glycine decarboxylation via glycine cleavage system (GO:0019464),-5.818456827286248e-11,0.0
7852,orbitofrontal cortex development (GO:0021769),-5.818456827286248e-11,0.0
7853,pronephric nephron development (GO:0039019),-5.818456827286248e-11,0.0
7854,cochlear nucleus development (GO:0021747),-5.818456827286248e-11,0.0
7855,mesenchymal stem cell differentiation (GO:0072497),-5.818456827286248e-11,0.0
7856,positive regulation of endodermal cell differentiation (GO:1903226),-5.818456827286248e-11,0.0
7857,negative regulation of endodermal cell differentiation (GO:1903225),-5.818456827286248e-11,0.0
7858,pressure natriuresis (GO:0003095),-5.818456827286248e-11,0.0
7859,sulfide oxidation (GO:0019418),-5.818456827286248e-11,0.0
7860,lung induction (GO:0060492),-5.818456827286248e-11,0.0
7861,negative regulation of forebrain neuron differentiation (GO:2000978),-5.818456827286248e-11,0.0
7862,negative regulation of pro-B cell differentiation (GO:2000974),-5.818456827286248e-11,0.0
7863,lung goblet cell differentiation (GO:0060480),-5.818456827286248e-11,0.0
7864,positive regulation of flagellated sperm motility involved in capacitation (GO:0060474),-5.818456827286248e-11,0.0
7865,axon target recognition (GO:0007412),-5.818456827286248e-11,0.0
7866,angiotensin-mediated drinking behavior (GO:0003051),-5.818456827286248e-11,0.0
7867,involuntary skeletal muscle contraction (GO:0003011),-5.818456827286248e-11,0.0
7868,negative regulation of maintenance of mitotic sister chromatid cohesion (GO:0034183),-5.818456827286248e-11,0.0
7869,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response (GO:0006990),-5.818456827286248e-11,0.0
7870,response to lipid hydroperoxide (GO:0006982),-5.818456827286248e-11,0.0
7871,positive regulation of toll-like receptor 8 signaling pathway (GO:0034161),-5.818456827286248e-11,0.0
7872,negative regulation of growth hormone receptor signaling pathway (GO:0060400),-5.818456827286248e-11,0.0
7873,regulation of toll-like receptor 8 signaling pathway (GO:0034159),-5.818456827286248e-11,0.0
7874,negative regulation of toll-like receptor 3 signaling pathway (GO:0034140),-5.818456827286248e-11,0.0
7875,inosine biosynthetic process (GO:0046103),-5.818456827286248e-11,0.0
7876,hypoxanthine biosynthetic process (GO:0046101),-5.818456827286248e-11,0.0
7877,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002581),-5.818456827286248e-11,0.0
7878,"mitotic sister chromatid cohesion, centromeric (GO:0071962)",-5.818456827286248e-11,0.0
7879,sugar mediated signaling pathway (GO:0010182),-5.818456827286248e-11,0.0
7880,positive regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071931),-5.818456827286248e-11,0.0
7881,negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930),-5.818456827286248e-11,0.0
7882,specification of animal organ position (GO:0010159),-5.818456827286248e-11,0.0
7883,response to chlorate (GO:0010157),-5.818456827286248e-11,0.0
7884,activation of blood coagulation via clotting cascade (GO:0002543),-5.818456827286248e-11,0.0
7885,Factor XII activation (GO:0002542),-5.818456827286248e-11,0.0
7886,endocannabinoid signaling pathway (GO:0071926),-5.818456827286248e-11,0.0
7887,proline catabolic process to glutamate (GO:0010133),-5.818456827286248e-11,0.0
7888,leukocyte migration involved in immune response (GO:0002522),-5.818456827286248e-11,0.0
7889,neurofilament bundle assembly (GO:0033693),-5.818456827286248e-11,0.0
7890,natural killer cell tolerance induction (GO:0002519),-5.818456827286248e-11,0.0
7891,regulation of neutrophil differentiation (GO:0045658),-5.818456827286248e-11,0.0
7892,regulation of dopamine biosynthetic process (GO:1903179),-5.818456827286248e-11,0.0
7893,negative regulation of T-helper 1 cell differentiation (GO:0045626),-5.818456827286248e-11,0.0
7894,nerve maturation (GO:0021682),-5.818456827286248e-11,0.0
7895,galactolipid catabolic process (GO:0019376),-5.818456827286248e-11,0.0
7896,lipoxin A4 biosynthetic process (GO:2001303),-5.818456827286248e-11,0.0
7897,negative regulation of integrin activation (GO:0033624),-5.818456827286248e-11,0.0
7898,cysteine biosynthetic process (GO:0019344),-5.818456827286248e-11,0.0
7899,zygotic specification of dorsal/ventral axis (GO:0007352),-5.818456827286248e-11,0.0
7900,olfactory nerve morphogenesis (GO:0021627),-5.818456827286248e-11,0.0
7901,positive regulation of growth hormone receptor signaling pathway (GO:0060399),-5.818456827286248e-11,0.0
7902,regulation of estradiol secretion (GO:2000864),-5.818456827286248e-11,0.0
7903,positive regulation of aldosterone secretion (GO:2000860),-5.818456827286248e-11,0.0
7904,cytosol to Golgi apparatus transport (GO:0140820),-5.818456827286248e-11,0.0
7905,positive regulation of mineralocorticoid secretion (GO:2000857),-5.818456827286248e-11,0.0
7906,deoxyadenosine metabolic process (GO:0046090),-5.818456827286248e-11,0.0
7907,adenine metabolic process (GO:0046083),-5.818456827286248e-11,0.0
7908,dibenzo-p-dioxin metabolic process (GO:0018894),-5.818456827286248e-11,0.0
7909,cell adhesion molecule production (GO:0060352),-5.818456827286248e-11,0.0
7910,dTMP catabolic process (GO:0046074),-5.818456827286248e-11,0.0
7911,dGTP metabolic process (GO:0046070),-5.818456827286248e-11,0.0
7912,dGDP metabolic process (GO:0046066),-5.818456827286248e-11,0.0
7913,dATP metabolic process (GO:0046060),-5.818456827286248e-11,0.0
7914,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820),-5.818456827286248e-11,0.0
7915,biphenyl metabolic process (GO:0018879),-5.818456827286248e-11,0.0
7916,positive regulation of metanephric glomerulus development (GO:0072300),-5.818456827286248e-11,0.0
7917,negative regulation of maintenance of sister chromatid cohesion (GO:0034092),-5.818456827286248e-11,0.0
7918,positive regulation of glucose mediated signaling pathway (GO:1902661),-5.818456827286248e-11,0.0
7919,dADP metabolic process (GO:0046056),-5.818456827286248e-11,0.0
7920,regulation of glucose mediated signaling pathway (GO:1902659),-5.818456827286248e-11,0.0
7921,cytoplasmic actin-based contraction involved in cell motility (GO:0060327),-5.818456827286248e-11,0.0
7922,"regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000804)",-5.818456827286248e-11,0.0
7923,definitive erythrocyte differentiation (GO:0060318),-5.818456827286248e-11,0.0
7924,tertiary alcohol biosynthetic process (GO:1902645),-5.818456827286248e-11,0.0
7925,GMP catabolic process (GO:0046038),-5.818456827286248e-11,0.0
7926,elastin catabolic process (GO:0060309),-5.818456827286248e-11,0.0
7927,NAD-cap decapping (GO:0110155),-5.818456827286248e-11,0.0
7928,"1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process (GO:1902635)",-5.818456827286248e-11,0.0
7929,"1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process (GO:1902633)",-5.818456827286248e-11,0.0
7930,response to anoxia (GO:0034059),-5.818456827286248e-11,0.0
7931,histone H2B conserved C-terminal lysine ubiquitination (GO:0071894),-5.818456827286248e-11,0.0
7932,asparagine transport (GO:0006867),-5.818456827286248e-11,0.0
7933,regulation of T cell homeostatic proliferation (GO:0046013),-5.818456827286248e-11,0.0
7934,"positive regulation of circadian sleep/wake cycle, non-REM sleep (GO:0046010)",-5.818456827286248e-11,0.0
7935,macrophage apoptotic process (GO:0071888),-5.818456827286248e-11,0.0
7936,Norrin signaling pathway (GO:0110135),-5.818456827286248e-11,0.0
7937,mitochondrial pyruvate transmembrane transport (GO:0006850),-5.818456827286248e-11,0.0
7938,regulation of large conductance calcium-activated potassium channel activity (GO:1902606),-5.818456827286248e-11,0.0
7939,response to silicon dioxide (GO:0034021),-5.818456827286248e-11,0.0
7940,response to triglyceride (GO:0034014),-5.818456827286248e-11,0.0
7941,myeloid dendritic cell antigen processing and presentation (GO:0002469),-5.818456827286248e-11,0.0
7942,tolerance induction dependent upon immune response (GO:0002461),-5.818456827286248e-11,0.0
7943,regulation of nitrogen utilization (GO:0006808),-5.818456827286248e-11,0.0
7944,type II hypersensitivity (GO:0002445),-5.818456827286248e-11,0.0
7945,regulation of cytotoxic T cell differentiation (GO:0045583),-5.818456827286248e-11,0.0
7946,positive regulation of caveolin-mediated endocytosis (GO:2001288),-5.818456827286248e-11,0.0
7947,chronic inflammatory response to antigenic stimulus (GO:0002439),-5.818456827286248e-11,0.0
7948,response to mycotoxin (GO:0010046),-5.818456827286248e-11,0.0
7949,immune complex clearance (GO:0002434),-5.818456827286248e-11,0.0
7950,basophil activation (GO:0045575),-5.818456827286248e-11,0.0
7951,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001272),-5.818456827286248e-11,0.0
7952,response to carbon dioxide (GO:0010037),-5.818456827286248e-11,0.0
7953,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001271),-5.818456827286248e-11,0.0
7954,T cell mediated immune response to tumor cell (GO:0002424),-5.818456827286248e-11,0.0
7955,response to hydroxyisoflavone (GO:0033594),-5.818456827286248e-11,0.0
7956,T cell mediated cytotoxicity directed against tumor cell target (GO:0002419),-5.818456827286248e-11,0.0
7957,regulation of semaphorin-plexin signaling pathway (GO:2001260),-5.818456827286248e-11,0.0
7958,immunoglobulin transcytosis in epithelial cells (GO:0002414),-5.818456827286248e-11,0.0
7959,positive regulation of histone H3-K36 trimethylation (GO:2001255),-5.818456827286248e-11,0.0
7960,myeloid dendritic cell chemotaxis (GO:0002408),-5.818456827286248e-11,0.0
7961,regulation of protein K48-linked deubiquitination (GO:1903093),-5.818456827286248e-11,0.0
7962,positive regulation of phosphatidylcholine biosynthetic process (GO:2001247),-5.818456827286248e-11,0.0
7963,"tyrosine biosynthetic process, by oxidation of phenylalanine (GO:0019293)",-5.818456827286248e-11,0.0
7964,gamma-tubulin complex localization (GO:0033566),-5.818456827286248e-11,0.0
7965,"isopentenyl diphosphate biosynthetic process, mevalonate pathway (GO:0019287)",-5.818456827286248e-11,0.0
7966,L-methionine salvage from S-adenosylmethionine (GO:0019284),-5.818456827286248e-11,0.0
7967,negative regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903070),-5.818456827286248e-11,0.0
7968,negative regulation of chloride transport (GO:2001226),-5.818456827286248e-11,0.0
7969,UDP-N-acetylgalactosamine metabolic process (GO:0019276),-5.818456827286248e-11,0.0
7970,rhombomere 5 development (GO:0021571),-5.818456827286248e-11,0.0
7971,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure (GO:0001999),-5.818456827286248e-11,0.0
7972,rhombomere 3 development (GO:0021569),-5.818456827286248e-11,0.0
7973,vagus nerve development (GO:0021564),-5.818456827286248e-11,0.0
7974,"carnitine metabolic process, CoA-linked (GO:0019254)",-5.818456827286248e-11,0.0
7975,spermatogonial cell division (GO:0007284),-5.818456827286248e-11,0.0
7976,midbrain-hindbrain boundary morphogenesis (GO:0021555),-5.818456827286248e-11,0.0
7977,central nervous system morphogenesis (GO:0021551),-5.818456827286248e-11,0.0
7978,L-lysine catabolic process to acetyl-CoA via saccharopine (GO:0033512),-5.818456827286248e-11,0.0
7979,regulation of metanephric glomerulus development (GO:0072298),-5.818456827286248e-11,0.0
7980,regulation of activation of membrane attack complex (GO:0001969),-5.818456827286248e-11,0.0
7981,epithalamus development (GO:0021538),-5.818456827286248e-11,0.0
7982,regulation of exo-alpha-sialidase activity (GO:1903015),-5.818456827286248e-11,0.0
7983,positive regulation of bone development (GO:1903012),-5.818456827286248e-11,0.0
7984,visceral motor neuron differentiation (GO:0021524),-5.818456827286248e-11,0.0
7985,metanephric comma-shaped body morphogenesis (GO:0072278),-5.818456827286248e-11,0.0
7986,metanephric glomerular capillary formation (GO:0072277),-5.818456827286248e-11,0.0
7987,metanephric glomerulus vasculature morphogenesis (GO:0072276),-5.818456827286248e-11,0.0
7988,metanephric glomerulus morphogenesis (GO:0072275),-5.818456827286248e-11,0.0
7989,floor plate formation (GO:0021508),-5.818456827286248e-11,0.0
7990,neural fold elevation formation (GO:0021502),-5.818456827286248e-11,0.0
7991,regulation of oocyte development (GO:0060281),-5.818456827286248e-11,0.0
7992,positive regulation of nephron tubule epithelial cell differentiation (GO:2000768),-5.818456827286248e-11,0.0
7993,positive regulation of ovulation (GO:0060279),-5.818456827286248e-11,0.0
7994,metanephric proximal tubule development (GO:0072237),-5.818456827286248e-11,0.0
7995,phospholipase C-activating serotonin receptor signaling pathway (GO:0007208),-5.818456827286248e-11,0.0
7996,phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway (GO:0007207),-5.818456827286248e-11,0.0
7997,metanephric glomerular mesangium development (GO:0072223),-5.818456827286248e-11,0.0
7998,positive regulation of metanephros development (GO:0072216),-5.818456827286248e-11,0.0
7999,positive regulation of serine-type peptidase activity (GO:1902573),-5.818456827286248e-11,0.0
8000,lens induction in camera-type eye (GO:0060235),-5.818456827286248e-11,0.0
8001,vesicle-mediated intercellular transport (GO:0110077),-5.818456827286248e-11,0.0
8002,regulation of dense core granule biogenesis (GO:2000705),-5.818456827286248e-11,0.0
8003,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060212),-5.818456827286248e-11,0.0
8004,positive regulation of protein K48-linked ubiquitination (GO:1902524),-5.818456827286248e-11,0.0
8005,biotin metabolic process (GO:0006768),-5.818456827286248e-11,0.0
8006,positive regulation of G2/MI transition of meiotic cell cycle (GO:0110032),-5.818456827286248e-11,0.0
8007,positive regulation of cardiac muscle myoblast proliferation (GO:0110024),-5.818456827286248e-11,0.0
8008,regulation of cardiac muscle myoblast proliferation (GO:0110022),-5.818456827286248e-11,0.0
8009,NADP catabolic process (GO:0006742),-5.818456827286248e-11,0.0
8010,formin-nucleated actin cable organization (GO:0110009),-5.818456827286248e-11,0.0
8011,eye pigment biosynthetic process (GO:0006726),-5.818456827286248e-11,0.0
8012,sesquiterpenoid metabolic process (GO:0006714),-5.818456827286248e-11,0.0
8013,detection of tumor cell (GO:0002355),-5.818456827286248e-11,0.0
8014,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001190),-5.818456827286248e-11,0.0
8015,B cell affinity maturation (GO:0002344),-5.818456827286248e-11,0.0
8016,peripheral B cell selection (GO:0002343),-5.818456827286248e-11,0.0
8017,cellular response to triacyl bacterial lipopeptide (GO:0071727),-5.818456827286248e-11,0.0
8018,response to triacyl bacterial lipopeptide (GO:0071725),-5.818456827286248e-11,0.0
8019,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001189),-5.818456827286248e-11,0.0
8020,pre-B cell allelic exclusion (GO:0002331),-5.818456827286248e-11,0.0
8021,negative regulation of ATP biosynthetic process (GO:2001170),-5.818456827286248e-11,0.0
8022,regulation of histone H3-K79 methylation (GO:2001160),-5.818456827286248e-11,0.0
8023,nitric oxide homeostasis (GO:0033484),-5.818456827286248e-11,0.0
8024,"CD8-positive, gamma-delta intraepithelial T cell differentiation (GO:0002305)",-5.818456827286248e-11,0.0
8025,gamma-delta intraepithelial T cell differentiation (GO:0002304),-5.818456827286248e-11,0.0
8026,transforming growth factor beta receptor complex assembly (GO:0007181),-5.818456827286248e-11,0.0
8027,ureter smooth muscle cell differentiation (GO:0072193),-5.818456827286248e-11,0.0
8028,ureter smooth muscle development (GO:0072191),-5.818456827286248e-11,0.0
8029,ureter urothelium development (GO:0072190),-5.818456827286248e-11,0.0
8030,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),-5.818456827286248e-11,0.0
8031,trophectodermal cell proliferation (GO:0001834),-5.818456827286248e-11,0.0
8032,cloacal septation (GO:0060197),-5.818456827286248e-11,0.0
8033,positive regulation of type B pancreatic cell apoptotic process (GO:2000676),-5.818456827286248e-11,0.0
8034,distal tubule morphogenesis (GO:0072156),-5.818456827286248e-11,0.0
8035,inner cell mass cellular morphogenesis (GO:0001828),-5.818456827286248e-11,0.0
8036,inner cell mass cell fate commitment (GO:0001827),-5.818456827286248e-11,0.0
8037,cell cycle switching (GO:0060184),-5.818456827286248e-11,0.0
8038,apelin receptor signaling pathway (GO:0060183),-5.818456827286248e-11,0.0
8039,endomitotic cell cycle (GO:0007113),-5.818456827286248e-11,0.0
8040,glomerular parietal epithelial cell differentiation (GO:0072139),-5.818456827286248e-11,0.0
8041,mesenchymal cell proliferation involved in ureteric bud development (GO:0072138),-5.818456827286248e-11,0.0
8042,regulation of type IV hypersensitivity (GO:0001807),-5.818456827286248e-11,0.0
8043,metanephric mesenchyme morphogenesis (GO:0072133),-5.818456827286248e-11,0.0
8044,kidney mesenchyme morphogenesis (GO:0072131),-5.818456827286248e-11,0.0
8045,positive regulation of protein autoubiquitination (GO:1902499),-5.818456827286248e-11,0.0
8046,positive regulation of adenosine receptor signaling pathway (GO:0060168),-5.818456827286248e-11,0.0
8047,negative regulation of dopamine receptor signaling pathway (GO:0060160),-5.818456827286248e-11,0.0
8048,negative regulation of receptor catabolic process (GO:2000645),-5.818456827286248e-11,0.0
8049,negative regulation of glomerular mesangial cell proliferation (GO:0072125),-5.818456827286248e-11,0.0
8050,negative regulation of SREBP signaling pathway (GO:2000639),-5.818456827286248e-11,0.0
8051,negative regulation of primary miRNA processing (GO:2000635),-5.818456827286248e-11,0.0
8052,regulation of primary miRNA processing (GO:2000634),-5.818456827286248e-11,0.0
8053,regulation of pre-miRNA processing (GO:2000631),-5.818456827286248e-11,0.0
8054,inositol trisphosphate biosynthetic process (GO:0032959),-5.818456827286248e-11,0.0
8055,regulation of cytokinetic process (GO:0032954),-5.818456827286248e-11,0.0
8056,regulation of histone H3-K27 trimethylation (GO:1902464),-5.818456827286248e-11,0.0
8057,protein localization to cell leading edge (GO:1902463),-5.818456827286248e-11,0.0
8058,negative regulation of histone H4-K16 acetylation (GO:2000619),-5.818456827286248e-11,0.0
8059,negative regulation of histone H3-K9 acetylation (GO:2000616),-5.818456827286248e-11,0.0
8060,corticotropin hormone secreting cell differentiation (GO:0060128),-5.818456827286248e-11,0.0
8061,vestibular receptor cell development (GO:0060118),-5.818456827286248e-11,0.0
8062,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death (GO:1902445),-5.818456827286248e-11,0.0
8063,vestibular receptor cell differentiation (GO:0060114),-5.818456827286248e-11,0.0
8064,negative regulation of superoxide anion generation (GO:0032929),-5.818456827286248e-11,0.0
8065,glucosylceramide catabolic process (GO:0006680),-5.818456827286248e-11,0.0
8066,positive regulation of transforming growth factor beta2 production (GO:0032915),-5.818456827286248e-11,0.0
8067,regulation of transforming growth factor beta3 production (GO:0032910),-5.818456827286248e-11,0.0
8068,olfactory placode morphogenesis (GO:0071699),-5.818456827286248e-11,0.0
8069,olfactory placode development (GO:0071698),-5.818456827286248e-11,0.0
8070,cardiac muscle thin filament assembly (GO:0071691),-5.818456827286248e-11,0.0
8071,sphinganine metabolic process (GO:0006667),-5.818456827286248e-11,0.0
8072,striated muscle myosin thick filament assembly (GO:0071688),-5.818456827286248e-11,0.0
8073,negative regulation of smooth muscle cell chemotaxis (GO:0071672),-5.818456827286248e-11,0.0
8074,positive regulation of granzyme B production (GO:0071663),-5.818456827286248e-11,0.0
8075,regulation of granzyme B production (GO:0071661),-5.818456827286248e-11,0.0
8076,eosinophil activation involved in immune response (GO:0002278),-5.818456827286248e-11,0.0
8077,myeloid dendritic cell activation involved in immune response (GO:0002277),-5.818456827286248e-11,0.0
8078,plasmacytoid dendritic cell activation (GO:0002270),-5.818456827286248e-11,0.0
8079,negative regulation of IP-10 production (GO:0071659),-5.818456827286248e-11,0.0
8080,follicular dendritic cell activation (GO:0002266),-5.818456827286248e-11,0.0
8081,negative regulation of macrophage inflammatory protein 1 alpha production (GO:0071641),-5.818456827286248e-11,0.0
8082,nuclear protein quality control by the ubiquitin-proteasome system (GO:0071630),-5.818456827286248e-11,0.0
8083,eosinophil homeostasis (GO:1990959),-5.818456827286248e-11,0.0
8084,creatine metabolic process (GO:0006600),-5.818456827286248e-11,0.0
8085,mastication (GO:0071626),-5.818456827286248e-11,0.0
8086,calcium ion regulated lysosome exocytosis (GO:1990927),-5.818456827286248e-11,0.0
8087,short-term synaptic potentiation (GO:1990926),-5.818456827286248e-11,0.0
8088,defense response to nematode (GO:0002215),-5.818456827286248e-11,0.0
8089,putrescine biosynthetic process from ornithine (GO:0033387),-5.818456827286248e-11,0.0
8090,geranyl diphosphate metabolic process (GO:0033383),-5.818456827286248e-11,0.0
8091,positive regulation of mesenchymal cell apoptotic process (GO:2001055),-5.818456827286248e-11,0.0
8092,negative regulation of integrin-mediated signaling pathway (GO:2001045),-5.818456827286248e-11,0.0
8093,positive regulation of type IIa hypersensitivity (GO:0001798),-5.818456827286248e-11,0.0
8094,type IIa hypersensitivity (GO:0001794),-5.818456827286248e-11,0.0
8095,antibody-dependent cellular cytotoxicity (GO:0001788),-5.818456827286248e-11,0.0
8096,cerebrospinal fluid secretion (GO:0033326),-5.818456827286248e-11,0.0
8097,establishment of viral latency (GO:0019043),-5.818456827286248e-11,0.0
8098,ascorbate homeostasis (GO:0140576),-5.818456827286248e-11,0.0
8099,membrane raft polarization (GO:0001766),-5.818456827286248e-11,0.0
8100,ureteric bud invasion (GO:0072092),-5.818456827286248e-11,0.0
8101,nephrogenic mesenchyme development (GO:0072076),-5.818456827286248e-11,0.0
8102,positive regulation of metanephric mesenchymal cell migration (GO:2000591),-5.818456827286248e-11,0.0
8103,positive regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000588),-5.818456827286248e-11,0.0
8104,modulation by host of viral molecular function (GO:0044868),-5.818456827286248e-11,0.0
8105,circadian temperature homeostasis (GO:0060086),-5.818456827286248e-11,0.0
8106,synaptic transmission involved in micturition (GO:0060084),-5.818456827286248e-11,0.0
8107,smooth muscle contraction involved in micturition (GO:0060083),-5.818456827286248e-11,0.0
8108,regulation of neurotrophin production (GO:0032899),-5.818456827286248e-11,0.0
8109,urokinase plasminogen activator signaling pathway (GO:0038195),-5.818456827286248e-11,0.0
8110,renal vesicle induction (GO:0072034),-5.818456827286248e-11,0.0
8111,regulation of DNA endoreduplication (GO:0032875),-5.818456827286248e-11,0.0
8112,regulation of dendritic cell dendrite assembly (GO:2000547),-5.818456827286248e-11,0.0
8113,interleukin-33-mediated signaling pathway (GO:0038172),-5.818456827286248e-11,0.0
8114,positive regulation of apoptotic process involved in mammary gland involution (GO:0060058),-5.818456827286248e-11,0.0
8115,CXCL12-activated CXCR4 signaling pathway (GO:0038160),-5.818456827286248e-11,0.0
8116,retinal bipolar neuron differentiation (GO:0060040),-5.818456827286248e-11,0.0
8117,interleukin-23-mediated signaling pathway (GO:0038155),-5.818456827286248e-11,0.0
8118,positive regulation of T cell costimulation (GO:2000525),-5.818456827286248e-11,0.0
8119,interleukin-11-mediated signaling pathway (GO:0038154),-5.818456827286248e-11,0.0
8120,negative regulation of T cell costimulation (GO:2000524),-5.818456827286248e-11,0.0
8121,kidney rudiment formation (GO:0072003),-5.818456827286248e-11,0.0
8122,regulation of synaptic activity (GO:0060025),-5.818456827286248e-11,0.0
8123,rhythmic synaptic transmission (GO:0060024),-5.818456827286248e-11,0.0
8124,spermine biosynthetic process (GO:0006597),-5.818456827286248e-11,0.0
8125,astrocyte fate commitment (GO:0060018),-5.818456827286248e-11,0.0
8126,octopamine biosynthetic process (GO:0006589),-5.818456827286248e-11,0.0
8127,negative regulation of chromosome condensation (GO:1902340),-5.818456827286248e-11,0.0
8128,negative regulation of natural killer cell differentiation involved in immune response (GO:0032827),-5.818456827286248e-11,0.0
8129,acetylcholine catabolic process (GO:0006581),-5.818456827286248e-11,0.0
8130,negative regulation of natural killer cell differentiation (GO:0032824),-5.818456827286248e-11,0.0
8131,positive regulation of retinal ganglion cell axon guidance (GO:1902336),-5.818456827286248e-11,0.0
8132,amino-acid betaine catabolic process (GO:0006579),-5.818456827286248e-11,0.0
8133,tyrosine biosynthetic process (GO:0006571),-5.818456827286248e-11,0.0
8134,ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596),-5.818456827286248e-11,0.0
8135,positive regulation of low-density lipoprotein particle receptor catabolic process (GO:0032805),-5.818456827286248e-11,0.0
8136,Kit signaling pathway (GO:0038109),-5.818456827286248e-11,0.0
8137,nodal signaling pathway involved in determination of left/right asymmetry (GO:0038107),-5.818456827286248e-11,0.0
8138,CAAX-box protein processing (GO:0071586),-5.818456827286248e-11,0.0
8139,negative regulation of peptidyl-serine dephosphorylation (GO:1902309),-5.818456827286248e-11,0.0
8140,glycine catabolic process (GO:0006546),-5.818456827286248e-11,0.0
8141,glutamine catabolic process (GO:0006543),-5.818456827286248e-11,0.0
8142,aspartate biosynthetic process (GO:0006532),-5.818456827286248e-11,0.0
8143,male germ cell proliferation (GO:0002176),-5.818456827286248e-11,0.0
8144,positive regulation of thyroid hormone mediated signaling pathway (GO:0002157),-5.818456827286248e-11,0.0
8145,thyroid hormone mediated signaling pathway (GO:0002154),-5.818456827286248e-11,0.0
8146,otolith mineralization (GO:0045299),-5.818456827286248e-11,0.0
8147,extracellular polysaccharide biosynthetic process (GO:0045226),-5.818456827286248e-11,0.0
8148,zonula adherens maintenance (GO:0045218),-5.818456827286248e-11,0.0
8149,establishment of neuroblast polarity (GO:0045200),-5.818456827286248e-11,0.0
8150,dsRNA transport (GO:0033227),-5.818456827286248e-11,0.0
8151,conditioned taste aversion (GO:0001661),-5.818456827286248e-11,0.0
8152,fever generation (GO:0001660),-5.818456827286248e-11,0.0
8153,response to Gram-positive bacterium (GO:0140459),-5.818456827286248e-11,0.0
8154,regulation of glutamine transport (GO:2000485),-5.818456827286248e-11,0.0
8155,cytokine precursor processing (GO:0140447),-5.818456827286248e-11,0.0
8156,meiotic cell cycle phase transition (GO:0044771),-5.818456827286248e-11,0.0
8157,regulation of opioid receptor signaling pathway (GO:2000474),-5.818456827286248e-11,0.0
8158,sequestering of BMP from receptor via BMP binding (GO:0038098),-5.818456827286248e-11,0.0
8159,negative regulation of glycogen (starch) synthase activity (GO:2000466),-5.818456827286248e-11,0.0
8160,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway (GO:0038091),-5.818456827286248e-11,0.0
8161,VEGF-activated platelet-derived growth factor receptor signaling pathway (GO:0038086),-5.818456827286248e-11,0.0
8162,"regulation of CD8-positive, alpha-beta T cell extravasation (GO:2000449)",-5.818456827286248e-11,0.0
8163,regulation of macrophage migration inhibitory factor signaling pathway (GO:2000446),-5.818456827286248e-11,0.0
8164,negative regulation of mast cell cytokine production (GO:0032764),-5.818456827286248e-11,0.0
8165,positive regulation of lymphotoxin A production (GO:0032761),-5.818456827286248e-11,0.0
8166,nitric oxide-cGMP-mediated signaling pathway (GO:0038060),-5.818456827286248e-11,0.0
8167,DNA demethylation of male pronucleus (GO:0044727),-5.818456827286248e-11,0.0
8168,negative regulation of polyamine transmembrane transport (GO:1902268),-5.818456827286248e-11,0.0
8169,apoptotic process involved in embryonic digit morphogenesis (GO:1902263),-5.818456827286248e-11,0.0
8170,positive regulation of thymocyte migration (GO:2000412),-5.818456827286248e-11,0.0
8171,regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902256),-5.818456827286248e-11,0.0
8172,positive regulation of T cell extravasation (GO:2000409),-5.818456827286248e-11,0.0
8173,regulation of positive thymic T cell selection (GO:1902232),-5.818456827286248e-11,0.0
8174,insulin receptor internalization (GO:0038016),-5.818456827286248e-11,0.0
8175,negative regulation of macrophage colony-stimulating factor signaling pathway (GO:1902227),-5.818456827286248e-11,0.0
8176,cellular response to absence of light (GO:0071485),-5.818456827286248e-11,0.0
8177,regulation of interleukin-4-mediated signaling pathway (GO:1902214),-5.818456827286248e-11,0.0
8178,cellular hypotonic salinity response (GO:0071477),-5.818456827286248e-11,0.0
8179,cellular hyperosmotic salinity response (GO:0071475),-5.818456827286248e-11,0.0
8180,"regulation of acetylcholine secretion, neurotransmission (GO:0014056)",-5.818456827286248e-11,0.0
8181,negative regulation of gamma-aminobutyric acid secretion (GO:0014053),-5.818456827286248e-11,0.0
8182,cellular response to hydrostatic pressure (GO:0071464),-5.818456827286248e-11,0.0
8183,threonyl-tRNA aminoacylation (GO:0006435),-5.818456827286248e-11,0.0
8184,negative regulation of neuron maturation (GO:0014043),-5.818456827286248e-11,0.0
8185,positive regulation of neuron maturation (GO:0014042),-5.818456827286248e-11,0.0
8186,regulation of Schwann cell differentiation (GO:0014038),-5.818456827286248e-11,0.0
8187,histidyl-tRNA aminoacylation (GO:0006427),-5.818456827286248e-11,0.0
8188,asparaginyl-tRNA aminoacylation (GO:0006421),-5.818456827286248e-11,0.0
8189,arginyl-tRNA aminoacylation (GO:0006420),-5.818456827286248e-11,0.0
8190,alanyl-tRNA aminoacylation (GO:0006419),-5.818456827286248e-11,0.0
8191,general adaptation syndrome (GO:0051866),-5.818456827286248e-11,0.0
8192,osteoblast fate commitment (GO:0002051),-5.818456827286248e-11,0.0
8193,establishment or maintenance of neuroblast polarity (GO:0045196),-5.818456827286248e-11,0.0
8194,tRNA export from nucleus (GO:0006409),-5.818456827286248e-11,0.0
8195,Schwann cell proliferation (GO:0014010),-5.818456827286248e-11,0.0
8196,response to manganese-induced endoplasmic reticulum stress (GO:1990737),-5.818456827286248e-11,0.0
8197,positive regulation of synapse structural plasticity (GO:0051835),-5.818456827286248e-11,0.0
8198,cell-cell signaling involved in cell fate commitment (GO:0045168),-5.818456827286248e-11,0.0
8199,cellular response to high density lipoprotein particle stimulus (GO:0071403),-5.818456827286248e-11,0.0
8200,cellular response to oleic acid (GO:0071400),-5.818456827286248e-11,0.0
8201,regulation of renal output by angiotensin (GO:0002019),-5.818456827286248e-11,0.0
8202,renin-angiotensin regulation of aldosterone production (GO:0002018),-5.818456827286248e-11,0.0
8203,renin secretion into blood stream (GO:0002001),-5.818456827286248e-11,0.0
8204,lactose metabolic process (GO:0005988),-5.818456827286248e-11,0.0
8205,negative regulation of myoblast fusion (GO:1901740),-5.818456827286248e-11,0.0
8206,negative regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033140),-5.818456827286248e-11,0.0
8207,"nuclear-transcribed mRNA catabolic process, no-go decay (GO:0070966)",-5.818456827286248e-11,0.0
8208,positive regulation of neutrophil mediated killing of symbiont cell (GO:0070961),-5.818456827286248e-11,0.0
8209,positive regulation of neutrophil mediated cytotoxicity (GO:0070960),-5.818456827286248e-11,0.0
8210,regulation of cell growth by extracellular stimulus (GO:0001560),-5.818456827286248e-11,0.0
8211,antibacterial innate immune response (GO:0140367),-5.818456827286248e-11,0.0
8212,preantral ovarian follicle growth (GO:0001546),-5.818456827286248e-11,0.0
8213,endocardial cushion to mesenchymal transition (GO:0090500),-5.818456827286248e-11,0.0
8214,negative regulation of mesoderm development (GO:2000381),-5.818456827286248e-11,0.0
8215,regulation of oxygen metabolic process (GO:2000374),-5.818456827286248e-11,0.0
8216,regulation of acrosomal vesicle exocytosis (GO:2000367),-5.818456827286248e-11,0.0
8217,positive regulation of prostaglandin-E synthase activity (GO:2000363),-5.818456827286248e-11,0.0
8218,regulation of prostaglandin-E synthase activity (GO:2000361),-5.818456827286248e-11,0.0
8219,regulation of lymphotoxin A production (GO:0032681),-5.818456827286248e-11,0.0
8220,serine import into mitochondrion (GO:0140300),-5.818456827286248e-11,0.0
8221,negative regulation of T-helper 17 cell lineage commitment (GO:2000329),-5.818456827286248e-11,0.0
8222,regulation of connective tissue growth factor production (GO:0032643),-5.818456827286248e-11,0.0
8223,regulation of kainate selective glutamate receptor activity (GO:2000312),-5.818456827286248e-11,0.0
8224,regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000307),-5.818456827286248e-11,0.0
8225,protein farnesylation (GO:0018343),-5.818456827286248e-11,0.0
8226,termination of RNA polymerase I transcription (GO:0006363),-5.818456827286248e-11,0.0
8227,cellular response to corticosterone stimulus (GO:0071386),-5.818456827286248e-11,0.0
8228,negative regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902103),-5.818456827286248e-11,0.0
8229,positive regulation of timing of catagen (GO:0051795),-5.818456827286248e-11,0.0
8230,short-chain fatty acid biosynthetic process (GO:0051790),-5.818456827286248e-11,0.0
8231,response to melanocyte-stimulating hormone (GO:1990680),-5.818456827286248e-11,0.0
8232,negative regulation of nitric-oxide synthase biosynthetic process (GO:0051771),-5.818456827286248e-11,0.0
8233,diphosphate metabolic process (GO:0071344),-5.818456827286248e-11,0.0
8234,meiotic gene conversion (GO:0006311),-5.818456827286248e-11,0.0
8235,cellular response to fructose stimulus (GO:0071332),-5.818456827286248e-11,0.0
8236,response to iron ion starvation (GO:1990641),-5.818456827286248e-11,0.0
8237,response to prolactin (GO:1990637),-5.818456827286248e-11,0.0
8238,negative regulation of histone H3-K27 acetylation (GO:1901675),-5.818456827286248e-11,0.0
8239,"germline cell cycle switching, mitotic to meiotic cell cycle (GO:0051729)",-5.818456827286248e-11,0.0
8240,"cell cycle switching, mitotic to meiotic cell cycle (GO:0051728)",-5.818456827286248e-11,0.0
8241,positive regulation of NAD+ ADP-ribosyltransferase activity (GO:1901666),-5.818456827286248e-11,0.0
8242,regulation of NAD+ ADP-ribosyltransferase activity (GO:1901664),-5.818456827286248e-11,0.0
8243,calcium ion export (GO:1901660),-5.818456827286248e-11,0.0
8244,protein import into mitochondrial intermembrane space (GO:0045041),-5.818456827286248e-11,0.0
8245,isoquinoline alkaloid metabolic process (GO:0033076),-5.818456827286248e-11,0.0
8246,positive regulation of synoviocyte proliferation (GO:1901647),-5.818456827286248e-11,0.0
8247,regulation of synoviocyte proliferation (GO:1901645),-5.818456827286248e-11,0.0
8248,dark adaptation (GO:1990603),-5.818456827286248e-11,0.0
8249,positive regulation of synaptic vesicle membrane organization (GO:1901634),-5.818456827286248e-11,0.0
8250,G0 to G1 transition (GO:0045023),-5.818456827286248e-11,0.0
8251,directional locomotion (GO:0033058),-5.818456827286248e-11,0.0
8252,negative regulation of lymphocyte chemotaxis (GO:1901624),-5.818456827286248e-11,0.0
8253,peptidyl-glutamate ADP-deribosylation (GO:0140291),-5.818456827286248e-11,0.0
8254,regulation of mast cell apoptotic process (GO:0033025),-5.818456827286248e-11,0.0
8255,mast cell homeostasis (GO:0033023),-5.818456827286248e-11,0.0
8256,endosome fission (GO:0140285),-5.818456827286248e-11,0.0
8257,positive regulation of bile acid biosynthetic process (GO:0070859),-5.818456827286248e-11,0.0
8258,negative regulation of bile acid biosynthetic process (GO:0070858),-5.818456827286248e-11,0.0
8259,negative regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000299),-5.818456827286248e-11,0.0
8260,negative regulation of synapse maturation (GO:2000297),-5.818456827286248e-11,0.0
8261,regulation of hydrogen peroxide catabolic process (GO:2000295),-5.818456827286248e-11,0.0
8262,butyryl-CoA catabolic process (GO:0044580),-5.818456827286248e-11,0.0
8263,receptor internalization involved in canonical Wnt signaling pathway (GO:2000286),-5.818456827286248e-11,0.0
8264,regulation of cellular amino acid biosynthetic process (GO:2000282),-5.818456827286248e-11,0.0
8265,regulation of translation at postsynapse (GO:0140245),-5.818456827286248e-11,0.0
8266,hydrogen sulfide biosynthetic process (GO:0070814),-5.818456827286248e-11,0.0
8267,dAMP salvage (GO:0106383),-5.818456827286248e-11,0.0
8268,purine deoxyribonucleotide salvage (GO:0106381),-5.818456827286248e-11,0.0
8269,lateral line system development (GO:0048925),-5.818456827286248e-11,0.0
8270,dendritic cell proliferation (GO:0044565),-5.818456827286248e-11,0.0
8271,regulation of protein activation cascade (GO:2000257),-5.818456827286248e-11,0.0
8272,positive regulation of long-chain fatty acid import into cell (GO:0140214),-5.818456827286248e-11,0.0
8273,negative regulation of rRNA processing (GO:2000233),-5.818456827286248e-11,0.0
8274,regulation of testosterone biosynthetic process (GO:2000224),-5.818456827286248e-11,0.0
8275,regulation of glutamate metabolic process (GO:2000211),-5.818456827286248e-11,0.0
8276,regulation of Fas signaling pathway (GO:1902044),-5.818456827286248e-11,0.0
8277,positive regulation of mitochondrial RNA catabolic process (GO:0000962),-5.818456827286248e-11,0.0
8278,cellular response to mercury ion (GO:0071288),-5.818456827286248e-11,0.0
8279,mitochondrial mRNA catabolic process (GO:0000958),-5.818456827286248e-11,0.0
8280,UDP catabolic process (GO:0006256),-5.818456827286248e-11,0.0
8281,protein carboxylation (GO:0018214),-5.818456827286248e-11,0.0
8282,maintenance of Golgi location (GO:0051684),-5.818456827286248e-11,0.0
8283,dUMP biosynthetic process (GO:0006226),-5.818456827286248e-11,0.0
8284,mitochondrial L-ornithine transmembrane transport (GO:1990575),-5.818456827286248e-11,0.0
8285,5-methylcytosine catabolic process (GO:0006211),-5.818456827286248e-11,0.0
8286,thymine catabolic process (GO:0006210),-5.818456827286248e-11,0.0
8287,pyrimidine nucleobase catabolic process (GO:0006208),-5.818456827286248e-11,0.0
8288,regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905930),-5.818456827286248e-11,0.0
8289,bone regeneration (GO:1990523),-5.818456827286248e-11,0.0
8290,regulation of cell differentiation involved in phenotypic switching (GO:1905915),-5.818456827286248e-11,0.0
8291,histamine uptake (GO:0051615),-5.818456827286248e-11,0.0
8292,negative regulation of serotonin uptake (GO:0051612),-5.818456827286248e-11,0.0
8293,dense core granule maturation (GO:1990502),-5.818456827286248e-11,0.0
8294,regulation of platelet-derived growth factor production (GO:0090361),-5.818456827286248e-11,0.0
8295,positive regulation of acylglycerol transport (GO:1901508),-5.818456827286248e-11,0.0
8296,regulation of acylglycerol transport (GO:1901506),-5.818456827286248e-11,0.0
8297,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140199),-5.818456827286248e-11,0.0
8298,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140192),-5.818456827286248e-11,0.0
8299,hypophysis morphogenesis (GO:0048850),-5.818456827286248e-11,0.0
8300,negative regulation of DNA methylation-dependent heterochromatin formation (GO:0090310),-5.818456827286248e-11,0.0
8301,negative regulation of female gonad development (GO:2000195),-5.818456827286248e-11,0.0
8302,ammonium import across plasma membrane (GO:0140157),-5.818456827286248e-11,0.0
8303,regulation of progesterone biosynthetic process (GO:2000182),-5.818456827286248e-11,0.0
8304,positive regulation of peptidyl-cysteine S-nitrosylation (GO:2000170),-5.818456827286248e-11,0.0
8305,"regulation of translation at postsynapse, modulating synaptic transmission (GO:0099578)",-5.818456827286248e-11,0.0
8306,regulation of Rap protein signal transduction (GO:0032487),-5.818456827286248e-11,0.0
8307,regulation of Ral protein signal transduction (GO:0032485),-5.818456827286248e-11,0.0
8308,positive regulation of ubiquitin-specific protease activity (GO:2000158),-5.818456827286248e-11,0.0
8309,female genitalia morphogenesis (GO:0048807),-5.818456827286248e-11,0.0
8310,"trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission (GO:0099557)",-5.818456827286248e-11,0.0
8311,"trans-synaptic signaling by endocannabinoid, modulating synaptic transmission (GO:0099553)",-5.818456827286248e-11,0.0
8312,"trans-synaptic signaling by lipid, modulating synaptic transmission (GO:0099552)",-5.818456827286248e-11,0.0
8313,positive regulation of endoplasmic reticulum calcium ion concentration (GO:0032470),-5.818456827286248e-11,0.0
8314,trans-synaptic signaling by nitric oxide (GO:0099548),-5.818456827286248e-11,0.0
8315,trans-synaptic signaling by soluble gas (GO:0099543),-5.818456827286248e-11,0.0
8316,regulation of endocannabinoid signaling pathway (GO:2000124),-5.818456827286248e-11,0.0
8317,positive regulation of sodium-dependent phosphate transport (GO:2000120),-5.818456827286248e-11,0.0
8318,peptidyl-cysteine oxidation (GO:0018171),-5.818456827286248e-11,0.0
8319,positive regulation of macrophage apoptotic process (GO:2000111),-5.818456827286248e-11,0.0
8320,calcium-dependent activation of synaptic vesicle fusion (GO:0099502),-5.818456827286248e-11,0.0
8321,positive regulation of mismatch repair (GO:0032425),-5.818456827286248e-11,0.0
8322,dAMP biosynthetic process (GO:0006170),-5.818456827286248e-11,0.0
8323,positive regulation of growth rate (GO:0040010),-5.818456827286248e-11,0.0
8324,deoxyadenosine catabolic process (GO:0006157),-5.818456827286248e-11,0.0
8325,meiotic recombination checkpoint signaling (GO:0051598),-5.818456827286248e-11,0.0
8326,purine nucleobase catabolic process (GO:0006145),-5.818456827286248e-11,0.0
8327,detection of glucose (GO:0051594),-5.818456827286248e-11,0.0
8328,positive regulation of triglyceride transport (GO:1905885),-5.818456827286248e-11,0.0
8329,DNA replication preinitiation complex assembly (GO:0071163),-5.818456827286248e-11,0.0
8330,regulation of triglyceride transport (GO:1905883),-5.818456827286248e-11,0.0
8331,negative regulation of neurotransmitter uptake (GO:0051581),-5.818456827286248e-11,0.0
8332,histone H3-K9 acetylation (GO:0043970),-5.818456827286248e-11,0.0
8333,regulation of oogenesis (GO:1905879),-5.818456827286248e-11,0.0
8334,negative regulation of mitochondrial calcium ion concentration (GO:0051562),-5.818456827286248e-11,0.0
8335,positive regulation of pentose-phosphate shunt (GO:1905857),-5.818456827286248e-11,0.0
8336,fumarate metabolic process (GO:0006106),-5.818456827286248e-11,0.0
8337,negative regulation of lymphangiogenesis (GO:1901491),-5.818456827286248e-11,0.0
8338,response to interleukin-9 (GO:0071104),-5.818456827286248e-11,0.0
8339,miRNA transport (GO:1990428),-5.818456827286248e-11,0.0
8340,positive regulation of tetrapyrrole biosynthetic process (GO:1901465),-5.818456827286248e-11,0.0
8341,response to insulin-like growth factor stimulus (GO:1990418),-5.818456827286248e-11,0.0
8342,positive regulation of mitochondrial DNA replication (GO:0090297),-5.818456827286248e-11,0.0
8343,nuclear matrix anchoring at nuclear membrane (GO:0090292),-5.818456827286248e-11,0.0
8344,calcitonin gene-related peptide receptor signaling pathway (GO:1990408),-5.818456827286248e-11,0.0
8345,embryonic liver development (GO:1990402),-5.818456827286248e-11,0.0
8346,negative regulation of synaptic plasticity (GO:0031914),-5.818456827286248e-11,0.0
8347,regulation of immune complex clearance by monocytes and macrophages (GO:0090264),-5.818456827286248e-11,0.0
8348,proteasome regulatory particle assembly (GO:0070682),-5.818456827286248e-11,0.0
8349,glutaminyl-tRNAGln biosynthesis via transamidation (GO:0070681),-5.818456827286248e-11,0.0
8350,positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409),-5.818456827286248e-11,0.0
8351,axis elongation involved in somitogenesis (GO:0090245),-5.818456827286248e-11,0.0
8352,regulation of kinetochore assembly (GO:0090234),-5.818456827286248e-11,0.0
8353,sarcomerogenesis (GO:0048769),-5.818456827286248e-11,0.0
8354,formin-nucleated actin cable assembly (GO:0070649),-5.818456827286248e-11,0.0
8355,negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090217),-5.818456827286248e-11,0.0
8356,transepithelial ammonium transport (GO:0070634),-5.818456827286248e-11,0.0
8357,protein localization to nuclear pore (GO:0090204),-5.818456827286248e-11,0.0
8358,regulation of peroxisome size (GO:0044375),-5.818456827286248e-11,0.0
8359,positive regulation of type B pancreatic cell development (GO:2000078),-5.818456827286248e-11,0.0
8360,canonical Wnt signaling pathway involved in osteoblast differentiation (GO:0044339),-5.818456827286248e-11,0.0
8361,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation (GO:0044338),-5.818456827286248e-11,0.0
8362,N-terminal peptidyl-lysine acetylation (GO:0018076),-5.818456827286248e-11,0.0
8363,protein K6-linked deubiquitination (GO:0044313),-5.818456827286248e-11,0.0
8364,positive regulation of aldosterone biosynthetic process (GO:0032349),-5.818456827286248e-11,0.0
8365,positive regulation of aldosterone metabolic process (GO:0032346),-5.818456827286248e-11,0.0
8366,aldosterone biosynthetic process (GO:0032342),-5.818456827286248e-11,0.0
8367,negative regulation of icosanoid secretion (GO:0032304),-5.818456827286248e-11,0.0
8368,peptidyl-histidine methylation (GO:0018021),-5.818456827286248e-11,0.0
8369,N-acetylglucosamine catabolic process (GO:0006046),-5.818456827286248e-11,0.0
8370,glucosamine metabolic process (GO:0006041),-5.818456827286248e-11,0.0
8371,positive regulation of anaphase-promoting complex-dependent catabolic process (GO:1905786),-5.818456827286248e-11,0.0
8372,positive regulation of DNA helicase activity (GO:1905776),-5.818456827286248e-11,0.0
8373,negative regulation of mesodermal cell differentiation (GO:1905771),-5.818456827286248e-11,0.0
8374,inositol biosynthetic process (GO:0006021),-5.818456827286248e-11,0.0
8375,negative regulation of protection from non-homologous end joining at telomere (GO:1905765),-5.818456827286248e-11,0.0
8376,regulation of protection from non-homologous end joining at telomere (GO:1905764),-5.818456827286248e-11,0.0
8377,meiotic DNA repair synthesis (GO:0000711),-5.818456827286248e-11,0.0
8378,D-ribose metabolic process (GO:0006014),-5.818456827286248e-11,0.0
8379,retrograde axonal transport of mitochondrion (GO:0098958),-5.818456827286248e-11,0.0
8380,fructose catabolic process (GO:0006001),-5.818456827286248e-11,0.0
8381,hard palate morphogenesis (GO:1905748),-5.818456827286248e-11,0.0
8382,negative regulation of saliva secretion (GO:1905747),-5.818456827286248e-11,0.0
8383,retrograde trans-synaptic signaling by trans-synaptic protein complex (GO:0098942),-5.818456827286248e-11,0.0
8384,acetate ester transport (GO:1901374),-5.818456827286248e-11,0.0
8385,membrane depolarization during atrial cardiac muscle cell action potential (GO:0098912),-5.818456827286248e-11,0.0
8386,regulation of mitochondrial ATP synthesis coupled proton transport (GO:1905706),-5.818456827286248e-11,0.0
8387,regulation of AV node cell action potential (GO:0098904),-5.818456827286248e-11,0.0
8388,positive regulation of pancreatic juice secretion (GO:0090187),-5.818456827286248e-11,0.0
8389,microtubule cytoskeleton organization involved in establishment of planar polarity (GO:0090176),-5.818456827286248e-11,0.0
8390,regulation of collateral sprouting in absence of injury (GO:0048696),-5.818456827286248e-11,0.0
8391,vitamin D receptor signaling pathway (GO:0070561),-5.818456827286248e-11,0.0
8392,collateral sprouting in absence of injury (GO:0048669),-5.818456827286248e-11,0.0
8393,response to linoleic acid (GO:0070543),-5.818456827286248e-11,0.0
8394,detection of chemical stimulus involved in sensory perception of pain (GO:0050968),-5.818456827286248e-11,0.0
8395,receptor-mediated endocytosis involved in cholesterol transport (GO:0090118),-5.818456827286248e-11,0.0
8396,regulation of high-density lipoprotein particle assembly (GO:0090107),-5.818456827286248e-11,0.0
8397,positive regulation of muscle organ development (GO:0048636),-5.818456827286248e-11,0.0
8398,glial cell projection elongation (GO:0106091),-5.818456827286248e-11,0.0
8399,peripheral nervous system myelin formation (GO:0032290),-5.818456827286248e-11,0.0
8400,embryonic hindgut morphogenesis (GO:0048619),-5.818456827286248e-11,0.0
8401,CTP salvage (GO:0044211),-5.818456827286248e-11,0.0
8402,negative regulation of nucleobase-containing compound transport (GO:0032240),-5.818456827286248e-11,0.0
8403,adenosine transport (GO:0032238),-5.818456827286248e-11,0.0
8404,negative regulation of inflammatory response to wounding (GO:0106015),-5.818456827286248e-11,0.0
8405,"positive regulation of synaptic transmission, dopaminergic (GO:0032226)",-5.818456827286248e-11,0.0
8406,RNA 5'-cap (guanine-N7)-methylation (GO:0106005),-5.818456827286248e-11,0.0
8407,positive regulation of plasma membrane repair (GO:1905686),-5.818456827286248e-11,0.0
8408,regulation of telomerase RNA reverse transcriptase activity (GO:1905661),-5.818456827286248e-11,0.0
8409,proline import across plasma membrane (GO:1905647),-5.818456827286248e-11,0.0
8410,regulation of intracellular transport of viral material (GO:1901252),-5.818456827286248e-11,0.0
8411,negative regulation of blood-brain barrier permeability (GO:1905604),-5.818456827286248e-11,0.0
8412,regulation of lung ciliated cell differentiation (GO:1901246),-5.818456827286248e-11,0.0
8413,relaxation of skeletal muscle (GO:0090076),-5.818456827286248e-11,0.0
8414,unidimensional cell growth (GO:0009826),-5.818456827286248e-11,0.0
8415,negative regulation of thrombin-activated receptor signaling pathway (GO:0070495),-5.818456827286248e-11,0.0
8416,regulation of thrombin-activated receptor signaling pathway (GO:0070494),-5.818456827286248e-11,0.0
8417,alkaloid catabolic process (GO:0009822),-5.818456827286248e-11,0.0
8418,monocyte aggregation (GO:0070487),-5.818456827286248e-11,0.0
8419,tubulin deacetylation (GO:0090042),-5.818456827286248e-11,0.0
8420,positive regulation of heme biosynthetic process (GO:0070455),-5.818456827286248e-11,0.0
8421,establishment of anatomical structure orientation (GO:0048560),-5.818456827286248e-11,0.0
8422,positive regulation of oligodendrocyte progenitor proliferation (GO:0070447),-5.818456827286248e-11,0.0
8423,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070433),-5.818456827286248e-11,0.0
8424,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070430),-5.818456827286248e-11,0.0
8425,nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070427),-5.818456827286248e-11,0.0
8426,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070425),-5.818456827286248e-11,0.0
8427,hydrocarbon catabolic process (GO:0120253),-5.818456827286248e-11,0.0
8428,astrocyte-dopaminergic neuron signaling (GO:0036520),-5.818456827286248e-11,0.0
8429,dopaminergic neuron axon guidance (GO:0036514),-5.818456827286248e-11,0.0
8430,trimming of terminal mannose on C branch (GO:0036510),-5.818456827286248e-11,0.0
8431,maintenance of unfolded protein (GO:0036506),-5.818456827286248e-11,0.0
8432,co-translational protein modification (GO:0043686),-5.818456827286248e-11,0.0
8433,positive regulation of low-density lipoprotein particle clearance (GO:1905581),-5.818456827286248e-11,0.0
8434,mitochondrial tRNA 3'-end processing (GO:1990180),-5.818456827286248e-11,0.0
8435,protein localization to nucleoplasm (GO:1990173),-5.818456827286248e-11,0.0
8436,positive regulation of blood vessel branching (GO:1905555),-5.818456827286248e-11,0.0
8437,cellular response to interleukin-8 (GO:0098759),-5.818456827286248e-11,0.0
8438,response to interleukin-8 (GO:0098758),-5.818456827286248e-11,0.0
8439,cerebellar neuron development (GO:0098749),-5.818456827286248e-11,0.0
8440,intrinsic apoptotic signaling pathway in response to hypoxia (GO:1990144),-5.818456827286248e-11,0.0
8441,regulation of leucine import across plasma membrane (GO:1905532),-5.818456827286248e-11,0.0
8442,germline stem cell asymmetric division (GO:0098728),-5.818456827286248e-11,0.0
8443,asymmetric stem cell division (GO:0098722),-5.818456827286248e-11,0.0
8444,messenger ribonucleoprotein complex assembly (GO:1990120),-5.818456827286248e-11,0.0
8445,hexose mediated signaling (GO:0009757),-5.818456827286248e-11,0.0
8446,leucine import across plasma membrane (GO:0098713),-5.818456827286248e-11,0.0
8447,iron ion import across plasma membrane (GO:0098711),-5.818456827286248e-11,0.0
8448,positive regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031632),-5.818456827286248e-11,0.0
8449,protein linear deubiquitination (GO:1990108),-5.818456827286248e-11,0.0
8450,insulin catabolic process (GO:1901143),-5.818456827286248e-11,0.0
8451,detection of hexose stimulus (GO:0009732),-5.818456827286248e-11,0.0
8452,detection of carbohydrate stimulus (GO:0009730),-5.818456827286248e-11,0.0
8453,detection of endogenous stimulus (GO:0009726),-5.818456827286248e-11,0.0
8454,tRNA-guanine transglycosylation (GO:0101030),-5.818456827286248e-11,0.0
8455,regulation of ERK5 cascade (GO:0070376),-5.818456827286248e-11,0.0
8456,regulation of white fat cell proliferation (GO:0070350),-5.818456827286248e-11,0.0
8457,regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036491),-5.818456827286248e-11,0.0
8458,detection of bacterial lipopeptide (GO:0070340),-5.818456827286248e-11,0.0
8459,positive regulation of protein localization to chromatin (GO:0120187),-5.818456827286248e-11,0.0
8460,ventral trunk neural crest cell migration (GO:0036486),-5.818456827286248e-11,0.0
8461,postsynaptic intermediate filament cytoskeleton organization (GO:0099185),-5.818456827286248e-11,0.0
8462,synaptic signaling by nitric oxide (GO:0099163),-5.818456827286248e-11,0.0
8463,"regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0099152)",-5.818456827286248e-11,0.0
8464,hypomethylation of CpG island (GO:0044029),-5.818456827286248e-11,0.0
8465,DNA hypomethylation (GO:0044028),-5.818456827286248e-11,0.0
8466,DNA hypermethylation (GO:0044026),-5.818456827286248e-11,0.0
8467,positive regulation of monocyte aggregation (GO:1900625),-5.818456827286248e-11,0.0
8468,regulation of monocyte aggregation (GO:1900623),-5.818456827286248e-11,0.0
8469,acetate ester biosynthetic process (GO:1900620),-5.818456827286248e-11,0.0
8470,box C/D RNA 3'-end processing (GO:0000494),-5.818456827286248e-11,0.0
8471,deltoid tuberosity development (GO:0035993),-5.818456827286248e-11,0.0
8472,snoRNA guided rRNA pseudouridine synthesis (GO:0000454),-5.818456827286248e-11,0.0
8473,cellular response to trichostatin A (GO:0035984),-5.818456827286248e-11,0.0
8474,response to trichostatin A (GO:0035983),-5.818456827286248e-11,0.0
8475,nose morphogenesis (GO:0043585),-5.818456827286248e-11,0.0
8476,nuclear matrix organization (GO:0043578),-5.818456827286248e-11,0.0
8477,cellular response to interleukin-13 (GO:0035963),-5.818456827286248e-11,0.0
8478,positive regulation of sulfur metabolic process (GO:0051176),-5.818456827286248e-11,0.0
8479,polyuridylation-dependent mRNA catabolic process (GO:1990074),-5.818456827286248e-11,0.0
8480,positive regulation of DNA duplex unwinding (GO:1905464),-5.818456827286248e-11,0.0
8481,negative regulation of DNA duplex unwinding (GO:1905463),-5.818456827286248e-11,0.0
8482,negative regulation of vascular associated smooth muscle cell apoptotic process (GO:1905460),-5.818456827286248e-11,0.0
8483,positive regulation of lymphoid progenitor cell differentiation (GO:1905458),-5.818456827286248e-11,0.0
8484,regulation of myeloid progenitor cell differentiation (GO:1905453),-5.818456827286248e-11,0.0
8485,glucocorticoid secretion (GO:0035933),-5.818456827286248e-11,0.0
8486,anterograde neuronal dense core vesicle transport (GO:1990048),-5.818456827286248e-11,0.0
8487,rRNA import into mitochondrion (GO:0035928),-5.818456827286248e-11,0.0
8488,positive regulation of relaxation of muscle (GO:1901079),-5.818456827286248e-11,0.0
8489,regulation of engulfment of apoptotic cell (GO:1901074),-5.818456827286248e-11,0.0
8490,response to glycine (GO:1905429),-5.818456827286248e-11,0.0
8491,response to isolation stress (GO:0035900),-5.818456827286248e-11,0.0
8492,regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031548),-5.818456827286248e-11,0.0
8493,"regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905402)",-5.818456827286248e-11,0.0
8494,response to absence of light (GO:0009646),-5.818456827286248e-11,0.0
8495,response to high light intensity (GO:0009644),-5.818456827286248e-11,0.0
8496,inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001),-5.818456827286248e-11,0.0
8497,cold acclimation (GO:0009631),-5.818456827286248e-11,0.0
8498,negative regulation of defense response to virus by host (GO:0050689),-5.818456827286248e-11,0.0
8499,lateral mesoderm formation (GO:0048370),-5.818456827286248e-11,0.0
8500,positive regulation of viral translation (GO:1904973),-5.818456827286248e-11,0.0
8501,regulation of viral translation (GO:1904971),-5.818456827286248e-11,0.0
8502,lateral mesoderm morphogenesis (GO:0048369),-5.818456827286248e-11,0.0
8503,positive regulation of cytochrome-c oxidase activity (GO:1904960),-5.818456827286248e-11,0.0
8504,negative regulation of activation-induced cell death of T cells (GO:0070236),-5.818456827286248e-11,0.0
8505,positive regulation of midbrain dopaminergic neuron differentiation (GO:1904958),-5.818456827286248e-11,0.0
8506,"sulfide oxidation, using sulfide:quinone oxidoreductase (GO:0070221)",-5.818456827286248e-11,0.0
8507,transforming growth factor beta activation (GO:0036363),-5.818456827286248e-11,0.0
8508,planar cell polarity pathway involved in axon guidance (GO:1904938),-5.818456827286248e-11,0.0
8509,axial mesoderm formation (GO:0048320),-5.818456827286248e-11,0.0
8510,mitochondrion-derived vesicle mediated transport (GO:0099075),-5.818456827286248e-11,0.0
8511,mitochondrion to lysosome transport (GO:0099074),-5.818456827286248e-11,0.0
8512,stereocilium maintenance (GO:0120045),-5.818456827286248e-11,0.0
8513,spliceosomal complex disassembly (GO:0000390),-5.818456827286248e-11,0.0
8514,tRNA-type intron splice site recognition and cleavage (GO:0000379),-5.818456827286248e-11,0.0
8515,embryonic nail plate morphogenesis (GO:0035880),-5.818456827286248e-11,0.0
8516,plasma membrane lactate transport (GO:0035879),-5.818456827286248e-11,0.0
8517,learned vocalization behavior (GO:0098583),-5.818456827286248e-11,0.0
8518,oviduct epithelium development (GO:0035846),-5.818456827286248e-11,0.0
8519,positive regulation of aggrephagy (GO:1905337),-5.818456827286248e-11,0.0
8520,regulation of aggrephagy (GO:1905335),-5.818456827286248e-11,0.0
8521,regulation of gastric motility (GO:1905333),-5.818456827286248e-11,0.0
8522,peptidyl-glutamic acid carboxylation (GO:0017187),-5.818456827286248e-11,0.0
8523,renal sodium excretion (GO:0035812),-5.818456827286248e-11,0.0
8524,anthranilate metabolic process (GO:0043420),-5.818456827286248e-11,0.0
8525,homocysteine catabolic process (GO:0043418),-5.818456827286248e-11,0.0
8526,egg coat formation (GO:0035803),-5.818456827286248e-11,0.0
8527,adrenal cortex development (GO:0035801),-5.818456827286248e-11,0.0
8528,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905312),-5.818456827286248e-11,0.0
8529,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905310),-5.818456827286248e-11,0.0
8530,regulation of macropinocytosis (GO:1905301),-5.818456827286248e-11,0.0
8531,endothelial to hematopoietic transition (GO:0098508),-5.818456827286248e-11,0.0
8532,negative regulation of isotype switching to IgE isotypes (GO:0048294),-5.818456827286248e-11,0.0
8533,positive regulation of excitatory synapse assembly (GO:1904891),-5.818456827286248e-11,0.0
8534,isotype switching to IgE isotypes (GO:0048289),-5.818456827286248e-11,0.0
8535,positive regulation of adiponectin secretion (GO:0070165),-5.818456827286248e-11,0.0
8536,beta-catenin destruction complex disassembly (GO:1904886),-5.818456827286248e-11,0.0
8537,response to hydrogen sulfide (GO:1904880),-5.818456827286248e-11,0.0
8538,regulation of centriole-centriole cohesion (GO:0030997),-5.818456827286248e-11,0.0
8539,lauric acid metabolic process (GO:0048252),-5.818456827286248e-11,0.0
8540,glucoside transport (GO:0042946),-5.818456827286248e-11,0.0
8541,cellular response to L-glutamine (GO:1904845),-5.818456827286248e-11,0.0
8542,establishment or maintenance of actin cytoskeleton polarity (GO:0030950),-5.818456827286248e-11,0.0
8543,positive regulation of interleukin-6-mediated signaling pathway (GO:0070105),-5.818456827286248e-11,0.0
8544,positive regulation of chemokine-mediated signaling pathway (GO:0070101),-5.818456827286248e-11,0.0
8545,negative regulation of long-term synaptic depression (GO:1900453),-5.818456827286248e-11,0.0
8546,olfactory placode formation (GO:0030910),-5.818456827286248e-11,0.0
8547,cellular response to stem cell factor stimulus (GO:0036216),-5.818456827286248e-11,0.0
8548,response to stem cell factor (GO:0036215),-5.818456827286248e-11,0.0
8549,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:0035793),-5.818456827286248e-11,0.0
8550,regulation of corticotropin-releasing hormone secretion (GO:0043397),-5.818456827286248e-11,0.0
8551,cell migration involved in kidney development (GO:0035787),-5.818456827286248e-11,0.0
8552,"positive regulation of proton-transporting ATP synthase activity, rotational mechanism (GO:1905273)",-5.818456827286248e-11,0.0
8553,"regulation of proton-transporting ATP synthase activity, rotational mechanism (GO:1905271)",-5.818456827286248e-11,0.0
8554,beta selection (GO:0043366),-5.818456827286248e-11,0.0
8555,endonucleolytic cleavage involved in tRNA processing (GO:1905267),-5.818456827286248e-11,0.0
8556,natural killer cell chemotaxis (GO:0035747),-5.818456827286248e-11,0.0
8557,"response to 3,3',5-triiodo-L-thyronine (GO:1905242)",-5.818456827286248e-11,0.0
8558,protein unfolding (GO:0043335),-5.818456827286248e-11,0.0
8559,pigment metabolic process involved in developmental pigmentation (GO:0043324),-5.818456827286248e-11,0.0
8560,T-helper 1 cell activation (GO:0035711),-5.818456827286248e-11,0.0
8561,negative regulation of cytotoxic T cell degranulation (GO:0043318),-5.818456827286248e-11,0.0
8562,regulation of cytotoxic T cell degranulation (GO:0043317),-5.818456827286248e-11,0.0
8563,monocyte homeostasis (GO:0035702),-5.818456827286248e-11,0.0
8564,regulation of eosinophil degranulation (GO:0043309),-5.818456827286248e-11,0.0
8565,eosinophil degranulation (GO:0043308),-5.818456827286248e-11,0.0
8566,eosinophil activation (GO:0043307),-5.818456827286248e-11,0.0
8567,positive regulation of connective tissue replacement (GO:1905205),-5.818456827286248e-11,0.0
8568,putrescine catabolic process (GO:0009447),-5.818456827286248e-11,0.0
8569,glycolate metabolic process (GO:0009441),-5.818456827286248e-11,0.0
8570,glyoxylate catabolic process (GO:0009436),-5.818456827286248e-11,0.0
8571,positive regulation of glucagon secretion (GO:0070094),-5.818456827286248e-11,0.0
8572,ubiquitin-dependent endocytosis (GO:0070086),-5.818456827286248e-11,0.0
8573,protein initiator methionine removal (GO:0070084),-5.818456827286248e-11,0.0
8574,cysteine transport (GO:0042883),-5.818456827286248e-11,0.0
8575,multi-layer follicle stage (GO:0048162),-5.818456827286248e-11,0.0
8576,negative regulation of myeloid dendritic cell activation (GO:0030886),-5.818456827286248e-11,0.0
8577,male germ-line stem cell asymmetric division (GO:0048133),-5.818456827286248e-11,0.0
8578,vascular associated smooth muscle cell migration (GO:1904738),-5.818456827286248e-11,0.0
8579,positive regulation of electron transfer activity (GO:1904734),-5.818456827286248e-11,0.0
8580,positive regulation of viral transcription (GO:0050434),-5.818456827286248e-11,0.0
8581,catecholamine secretion (GO:0050432),-5.818456827286248e-11,0.0
8582,vitamin B6 biosynthetic process (GO:0042819),-5.818456827286248e-11,0.0
8583,negative regulation of chaperone-mediated autophagy (GO:1904715),-5.818456827286248e-11,0.0
8584,"protein import into peroxisome matrix, translocation (GO:0016561)",-5.818456827286248e-11,0.0
8585,establishment of body hair planar orientation (GO:0048105),-5.818456827286248e-11,0.0
8586,establishment of body hair or bristle planar orientation (GO:0048104),-5.818456827286248e-11,0.0
8587,Schwann cell migration (GO:0036135),-5.818456827286248e-11,0.0
8588,regulation of granulosa cell apoptotic process (GO:1904708),-5.818456827286248e-11,0.0
8589,peroxisome membrane biogenesis (GO:0016557),-5.818456827286248e-11,0.0
8590,helper T cell extravasation (GO:0035684),-5.818456827286248e-11,0.0
8591,TRAM-dependent toll-like receptor 4 signaling pathway (GO:0035669),-5.818456827286248e-11,0.0
8592,TRAM-dependent toll-like receptor signaling pathway (GO:0035668),-5.818456827286248e-11,0.0
8593,Ran protein signal transduction (GO:0031291),-5.818456827286248e-11,0.0
8594,regulation of phagosome maturation (GO:1905162),-5.818456827286248e-11,0.0
8595,negative regulation of guanylate cyclase activity (GO:0031283),-5.818456827286248e-11,0.0
8596,renal glucose absorption (GO:0035623),-5.818456827286248e-11,0.0
8597,pseudopodium assembly (GO:0031269),-5.818456827286248e-11,0.0
8598,negative regulation of meiotic chromosome separation (GO:1905133),-5.818456827286248e-11,0.0
8599,negative regulation of vascular associated smooth muscle contraction (GO:1904694),-5.818456827286248e-11,0.0
8600,midbrain morphogenesis (GO:1904693),-5.818456827286248e-11,0.0
8601,positive regulation of type B pancreatic cell proliferation (GO:1904692),-5.818456827286248e-11,0.0
8602,negative regulation of type B pancreatic cell proliferation (GO:1904691),-5.818456827286248e-11,0.0
8603,tRNA 3'-trailer cleavage (GO:0042779),-5.818456827286248e-11,0.0
8604,regulation of eye pigmentation (GO:0048073),-5.818456827286248e-11,0.0
8605,ATP export (GO:1904669),-5.818456827286248e-11,0.0
8606,germ cell proliferation (GO:0036093),-5.818456827286248e-11,0.0
8607,negative regulation of transcription by RNA polymerase III (GO:0016480),-5.818456827286248e-11,0.0
8608,regulation of embryonic cell shape (GO:0016476),-5.818456827286248e-11,0.0
8609,"response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904612)",-5.818456827286248e-11,0.0
8610,regulation of phenotypic switching (GO:1900239),-5.818456827286248e-11,0.0
8611,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:1900238),-5.818456827286248e-11,0.0
8612,negative regulation of astrocyte activation (GO:0061889),-5.818456827286248e-11,0.0
8613,negative regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900212),-5.818456827286248e-11,0.0
8614,regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900211),-5.818456827286248e-11,0.0
8615,protein localization to tricellular tight junction (GO:0061833),-5.818456827286248e-11,0.0
8616,telomeric DNA-containing double minutes formation (GO:0061819),-5.818456827286248e-11,0.0
8617,histone H4-K20 demethylation (GO:0035574),-5.818456827286248e-11,0.0
8618,positive regulation of tight junction disassembly (GO:1905075),-5.818456827286248e-11,0.0
8619,regulation of tight junction disassembly (GO:1905073),-5.818456827286248e-11,0.0
8620,cardiac jelly development (GO:1905072),-5.818456827286248e-11,0.0
8621,maltose metabolic process (GO:0000023),-5.818456827286248e-11,0.0
8622,cell envelope organization (GO:0043163),-5.818456827286248e-11,0.0
8623,oxidative single-stranded RNA demethylation (GO:0035553),-5.818456827286248e-11,0.0
8624,oxidative single-stranded DNA demethylation (GO:0035552),-5.818456827286248e-11,0.0
8625,positive regulation of antifungal innate immune response (GO:1905036),-5.818456827286248e-11,0.0
8626,coenzyme A catabolic process (GO:0015938),-5.818456827286248e-11,0.0
8627,regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905024),-5.818456827286248e-11,0.0
8628,replication fork arrest (GO:0043111),-5.818456827286248e-11,0.0
8629,10-formyltetrahydrofolate catabolic process (GO:0009258),-5.818456827286248e-11,0.0
8630,sister chromatid biorientation (GO:0031134),-5.818456827286248e-11,0.0
8631,short-chain fatty acid transport (GO:0015912),-5.818456827286248e-11,0.0
8632,snRNA pseudouridine synthesis (GO:0031120),-5.818456827286248e-11,0.0
8633,CMP biosynthetic process (GO:0009224),-5.818456827286248e-11,0.0
8634,pyrimidine deoxyribonucleoside triphosphate catabolic process (GO:0009213),-5.818456827286248e-11,0.0
8635,regulation of termination of RNA polymerase II transcription (GO:1904594),-5.818456827286248e-11,0.0
8636,cellular response to glycoprotein (GO:1904588),-5.818456827286248e-11,0.0
8637,positive regulation of intracellular mRNA localization (GO:1904582),-5.818456827286248e-11,0.0
8638,negative regulation of mesodermal cell fate specification (GO:0042662),-5.818456827286248e-11,0.0
8639,L-proline transmembrane transport (GO:1904555),-5.818456827286248e-11,0.0
8640,positive regulation of oocyte maturation (GO:1900195),-5.818456827286248e-11,0.0
8641,mitochondrial tRNA 5'-end processing (GO:0097745),-5.818456827286248e-11,0.0
8642,renal urate salt excretion (GO:0097744),-5.818456827286248e-11,0.0
8643,cellular response to water deprivation (GO:0042631),-5.818456827286248e-11,0.0
8644,regulation of telomeric loop disassembly (GO:1904533),-5.818456827286248e-11,0.0
8645,regulation of actin filament binding (GO:1904529),-5.818456827286248e-11,0.0
8646,positive regulation of glial cell-derived neurotrophic factor production (GO:1900168),-5.818456827286248e-11,0.0
8647,regulation of glial cell-derived neurotrophic factor production (GO:1900166),-5.818456827286248e-11,0.0
8648,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900164),-5.818456827286248e-11,0.0
8649,negative regulation of Schwann cell migration (GO:1900148),-5.818456827286248e-11,0.0
8650,meiotic chromosome movement towards spindle pole (GO:0016344),-5.818456827286248e-11,0.0
8651,secretory granule maturation (GO:0061792),-5.818456827286248e-11,0.0
8652,regulation of renin secretion into blood stream (GO:1900133),-5.818456827286248e-11,0.0
8653,dense core granule priming (GO:0061789),-5.818456827286248e-11,0.0
8654,response to caloric restriction (GO:0061771),-5.818456827286248e-11,0.0
8655,positive regulation of hyaluranon cable assembly (GO:1900106),-5.818456827286248e-11,0.0
8656,regulation of hyaluranon cable assembly (GO:1900104),-5.818456827286248e-11,0.0
8657,positive regulation of plasma cell differentiation (GO:1900100),-5.818456827286248e-11,0.0
8658,low-density lipoprotein particle mediated signaling (GO:0055096),-5.818456827286248e-11,0.0
8659,lipoprotein particle mediated signaling (GO:0055095),-5.818456827286248e-11,0.0
8660,substrate localization to autophagosome (GO:0061753),-5.818456827286248e-11,0.0
8661,protein targeting to lysosome involved in chaperone-mediated autophagy (GO:0061740),-5.818456827286248e-11,0.0
8662,cadmium ion homeostasis (GO:0055073),-5.818456827286248e-11,0.0
8663,manganese ion homeostasis (GO:0055071),-5.818456827286248e-11,0.0
8664,late endosomal microautophagy (GO:0061738),-5.818456827286248e-11,0.0
8665,SNARE complex disassembly (GO:0035494),-5.818456827286248e-11,0.0
8666,purine nucleobase salvage (GO:0043096),-5.818456827286248e-11,0.0
8667,gastric emptying (GO:0035483),-5.818456827286248e-11,0.0
8668,gastric motility (GO:0035482),-5.818456827286248e-11,0.0
8669,anterior neural tube closure (GO:0061713),-5.818456827286248e-11,0.0
8670,L-ascorbic acid transmembrane transport (GO:0015882),-5.818456827286248e-11,0.0
8671,biotin transport (GO:0015878),-5.818456827286248e-11,0.0
8672,atrial cardiac muscle cell development (GO:0055014),-5.818456827286248e-11,0.0
8673,atrial cardiac muscle cell differentiation (GO:0055011),-5.818456827286248e-11,0.0
8674,pyrimidine ribonucleoside diphosphate catabolic process (GO:0009195),-5.818456827286248e-11,0.0
8675,ventricular cardiac myofibril assembly (GO:0055005),-5.818456827286248e-11,0.0
8676,polyamine transport (GO:0015846),-5.818456827286248e-11,0.0
8677,purine deoxyribonucleoside monophosphate biosynthetic process (GO:0009171),-5.818456827286248e-11,0.0
8678,peptidoglycan transport (GO:0015835),-5.818456827286248e-11,0.0
8679,small non-coding RNA-dependent heterochromatin formation (GO:0031048),-5.818456827286248e-11,0.0
8680,phenylalanine transport (GO:0015823),-5.818456827286248e-11,0.0
8681,pyrimidine nucleoside diphosphate catabolic process (GO:0009140),-5.818456827286248e-11,0.0
8682,peptide antigen transport (GO:0046968),-5.818456827286248e-11,0.0
8683,ketone body catabolic process (GO:0046952),-5.818456827286248e-11,0.0
8684,endothelin receptor signaling pathway involved in heart process (GO:0086101),-5.818456827286248e-11,0.0
8685,histone H3-R17 methylation (GO:0034971),-5.818456827286248e-11,0.0
8686,response to 17alpha-ethynylestradiol (GO:1904486),-5.818456827286248e-11,0.0
8687,box C/D RNA processing (GO:0034963),-5.818456827286248e-11,0.0
8688,negative regulation of intestinal absorption (GO:1904479),-5.818456827286248e-11,0.0
8689,DNA ADP-ribosylation (GO:0030592),-5.818456827286248e-11,0.0
8690,positive regulation of matrix metallopeptidase secretion (GO:1904466),-5.818456827286248e-11,0.0
8691,hypotonic salinity response (GO:0042539),-5.818456827286248e-11,0.0
8692,positive regulation of high-density lipoprotein particle clearance (GO:0010983),-5.818456827286248e-11,0.0
8693,positive regulation of t-circle formation (GO:1904431),-5.818456827286248e-11,0.0
8694,positive regulation of vitamin D 24-hydroxylase activity (GO:0010980),-5.818456827286248e-11,0.0
8695,negative regulation of t-circle formation (GO:1904430),-5.818456827286248e-11,0.0
8696,positive regulation of neuromuscular synaptic transmission (GO:1900075),-5.818456827286248e-11,0.0
8697,regulation of neuromuscular synaptic transmission (GO:1900073),-5.818456827286248e-11,0.0
8698,regulation of vitamin D 24-hydroxylase activity (GO:0010979),-5.818456827286248e-11,0.0
8699,positive regulation of GTP binding (GO:1904426),-5.818456827286248e-11,0.0
8700,negative regulation of GTP binding (GO:1904425),-5.818456827286248e-11,0.0
8701,"O-glycan processing, core 1 (GO:0016267)",-5.818456827286248e-11,0.0
8702,regulation of retinoic acid biosynthetic process (GO:1900052),-5.818456827286248e-11,0.0
8703,negative regulation of calcidiol 1-monooxygenase activity (GO:0010956),-5.818456827286248e-11,0.0
8704,selenocysteine metabolic process (GO:0016259),-5.818456827286248e-11,0.0
8705,response to Thyroid stimulating hormone (GO:1904400),-5.818456827286248e-11,0.0
8706,regulation of histone exchange (GO:1900049),-5.818456827286248e-11,0.0
8707,intrinsic apoptotic signaling pathway in response to osmotic stress (GO:0008627),-5.818456827286248e-11,0.0
8708,inorganic diphosphate transport (GO:0030505),-5.818456827286248e-11,0.0
8709,positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-5.818456827286248e-11,0.0
8710,positive regulation of serine-type endopeptidase activity (GO:1900005),-5.818456827286248e-11,0.0
8711,positive regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010909),-5.818456827286248e-11,0.0
8712,positive regulation of TRAIL-activated apoptotic signaling pathway (GO:1903984),-5.818456827286248e-11,0.0
8713,monounsaturated fatty acid metabolic process (GO:1903964),-5.818456827286248e-11,0.0
8714,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-5.818456827286248e-11,0.0
8715,transepithelial water transport (GO:0035377),-5.818456827286248e-11,0.0
8716,UDP-N-acetylgalactosamine transmembrane transport (GO:0015789),-5.818456827286248e-11,0.0
8717,UDP-glucuronic acid transmembrane transport (GO:0015787),-5.818456827286248e-11,0.0
8718,negative regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035359),-5.818456827286248e-11,0.0
8719,angiotensin-activated signaling pathway involved in heart process (GO:0086098),-5.818456827286248e-11,0.0
8720,valine biosynthetic process (GO:0009099),-5.818456827286248e-11,0.0
8721,isoleucine biosynthetic process (GO:0009097),-5.818456827286248e-11,0.0
8722,"aromatic amino acid family biosynthetic process, prephenate pathway (GO:0009095)",-5.818456827286248e-11,0.0
8723,aromatic amino acid family biosynthetic process (GO:0009073),-5.818456827286248e-11,0.0
8724,positive regulation of phosphatidylcholine metabolic process (GO:0150173),-5.818456827286248e-11,0.0
8725,membrane depolarization during bundle of His cell action potential (GO:0086048),-5.818456827286248e-11,0.0
8726,membrane depolarization during Purkinje myocyte cell action potential (GO:0086047),-5.818456827286248e-11,0.0
8727,negative regulation of follicle-stimulating hormone secretion (GO:0046882),-5.818456827286248e-11,0.0
8728,positive regulation of saliva secretion (GO:0046878),-5.818456827286248e-11,0.0
8729,Purkinje myocyte action potential (GO:0086017),-5.818456827286248e-11,0.0
8730,Golgi apparatus mannose trimming (GO:1904381),-5.818456827286248e-11,0.0
8731,regulation of protein localization to cell-cell junction (GO:0150106),-5.818456827286248e-11,0.0
8732,negative regulation of monocyte activation (GO:0150102),-5.818456827286248e-11,0.0
8733,maintenance of unfolded protein involved in ERAD pathway (GO:1904378),-5.818456827286248e-11,0.0
8734,eye pigment metabolic process (GO:0042441),-5.818456827286248e-11,0.0
8735,nuclear migration along microtubule (GO:0030473),-5.818456827286248e-11,0.0
8736,regulation of phosphatidylcholine catabolic process (GO:0010899),-5.818456827286248e-11,0.0
8737,positive regulation of small intestine smooth muscle contraction (GO:1904349),-5.818456827286248e-11,0.0
8738,regulation of small intestine smooth muscle contraction (GO:1904347),-5.818456827286248e-11,0.0
8739,synaptic vesicle to endosome fusion (GO:0016189),-5.818456827286248e-11,0.0
8740,serotonin biosynthetic process (GO:0042427),-5.818456827286248e-11,0.0
8741,epinephrine metabolic process (GO:0042414),-5.818456827286248e-11,0.0
8742,negative regulation of triglyceride biosynthetic process (GO:0010868),-5.818456827286248e-11,0.0
8743,"positive regulation of circadian sleep/wake cycle, wakefulness (GO:0010841)",-5.818456827286248e-11,0.0
8744,calcium ion transmembrane transport via high voltage-gated calcium channel (GO:0061577),-5.818456827286248e-11,0.0
8745,negative stranded viral RNA replication (GO:0039689),-5.818456827286248e-11,0.0
8746,substance P catabolic process (GO:0010814),-5.818456827286248e-11,0.0
8747,carotenoid metabolic process (GO:0016116),-5.818456827286248e-11,0.0
8748,tetraterpenoid metabolic process (GO:0016108),-5.818456827286248e-11,0.0
8749,negative regulation of dendrite extension (GO:1903860),-5.818456827286248e-11,0.0
8750,brain segmentation (GO:0035284),-5.818456827286248e-11,0.0
8751,positive regulation of cristae formation (GO:1903852),-5.818456827286248e-11,0.0
8752,macrophage homeostasis (GO:0061519),-5.818456827286248e-11,0.0
8753,glycine import across plasma membrane (GO:1903804),-5.818456827286248e-11,0.0
8754,L-glutamine import across plasma membrane (GO:1903803),-5.818456827286248e-11,0.0
8755,L-leucine import across plasma membrane (GO:1903801),-5.818456827286248e-11,0.0
8756,vertebrate eye-specific patterning (GO:0150064),-5.818456827286248e-11,0.0
8757,regulation of protein localization to lysosome (GO:0150031),-5.818456827286248e-11,0.0
8758,basal dendrite arborization (GO:0150020),-5.818456827286248e-11,0.0
8759,basal dendrite morphogenesis (GO:0150019),-5.818456827286248e-11,0.0
8760,basal dendrite development (GO:0150018),-5.818456827286248e-11,0.0
8761,regulation of mitotic DNA damage checkpoint (GO:1904289),-5.818456827286248e-11,0.0
8762,basement membrane disassembly (GO:0034769),-5.818456827286248e-11,0.0
8763,negative regulation of iron ion transmembrane transport (GO:0034760),-5.818456827286248e-11,0.0
8764,L-alanine import across plasma membrane (GO:1904273),-5.818456827286248e-11,0.0
8765,L-proline import across plasma membrane (GO:1904271),-5.818456827286248e-11,0.0
8766,lateral motor column neuron migration (GO:0097477),-5.818456827286248e-11,0.0
8767,negative regulation of iron ion transport (GO:0034757),-5.818456827286248e-11,0.0
8768,programmed cell death in response to reactive oxygen species (GO:0097468),-5.818456827286248e-11,0.0
8769,GDP-L-fucose biosynthetic process (GO:0042350),-5.818456827286248e-11,0.0
8770,positive regulation of bile acid metabolic process (GO:1904253),-5.818456827286248e-11,0.0
8771,negative regulation of bile acid metabolic process (GO:1904252),-5.818456827286248e-11,0.0
8772,polyprenol catabolic process (GO:0016095),-5.818456827286248e-11,0.0
8773,polyprenol biosynthetic process (GO:0016094),-5.818456827286248e-11,0.0
8774,cuticle development (GO:0042335),-5.818456827286248e-11,0.0
8775,"positive regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904237)",-5.818456827286248e-11,0.0
8776,"regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904235)",-5.818456827286248e-11,0.0
8777,positive regulation of aconitate hydratase activity (GO:1904234),-5.818456827286248e-11,0.0
8778,regulation of aconitate hydratase activity (GO:1904232),-5.818456827286248e-11,0.0
8779,positive regulation of succinate dehydrogenase activity (GO:1904231),-5.818456827286248e-11,0.0
8780,regulation of succinate dehydrogenase activity (GO:1904229),-5.818456827286248e-11,0.0
8781,sno(s)RNA catabolic process (GO:0016077),-5.818456827286248e-11,0.0
8782,negative regulation of nitric oxide mediated signal transduction (GO:0010751),-5.818456827286248e-11,0.0
8783,neuroblast migration (GO:0097402),-5.818456827286248e-11,0.0
8784,prenylated protein catabolic process (GO:0030327),-5.818456827286248e-11,0.0
8785,detection of fungus (GO:0016046),-5.818456827286248e-11,0.0
8786,cellular response to phosphate starvation (GO:0016036),-5.818456827286248e-11,0.0
8787,negative regulation of hydrogen peroxide biosynthetic process (GO:0010730),-5.818456827286248e-11,0.0
8788,positive regulation of inorganic anion transmembrane transport (GO:1903797),-5.818456827286248e-11,0.0
8789,positive regulation of viral budding via host ESCRT complex (GO:1903774),-5.818456827286248e-11,0.0
8790,positive regulation of potassium ion export across plasma membrane (GO:1903766),-5.818456827286248e-11,0.0
8791,negative regulation of potassium ion export across plasma membrane (GO:1903765),-5.818456827286248e-11,0.0
8792,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903751),-5.818456827286248e-11,0.0
8793,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903750),-5.818456827286248e-11,0.0
8794,regulation of anterograde synaptic vesicle transport (GO:1903742),-5.818456827286248e-11,0.0
8795,cysteine transmembrane transport (GO:1903712),-5.818456827286248e-11,0.0
8796,"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)",-5.818456827286248e-11,0.0
8797,lipid tube assembly (GO:0060988),-5.818456827286248e-11,0.0
8798,response to pyrethroid (GO:0046684),-5.818456827286248e-11,0.0
8799,cardiac vascular smooth muscle cell development (GO:0060948),-5.818456827286248e-11,0.0
8800,response to prostaglandin F (GO:0034696),-5.818456827286248e-11,0.0
8801,epicardium-derived cardiac fibroblast cell development (GO:0060939),-5.818456827286248e-11,0.0
8802,epicardium-derived cardiac fibroblast cell differentiation (GO:0060938),-5.818456827286248e-11,0.0
8803,cardiac pacemaker cell fate commitment (GO:0060927),-5.818456827286248e-11,0.0
8804,positive regulation of pyruvate dehydrogenase activity (GO:1904184),-5.818456827286248e-11,0.0
8805,susceptibility to natural killer cell mediated cytotoxicity (GO:0042271),-5.818456827286248e-11,0.0
8806,negative regulation of adipose tissue development (GO:1904178),-5.818456827286248e-11,0.0
8807,spinal cord interneuron axon guidance (GO:0097377),-5.818456827286248e-11,0.0
8808,sensory neuron axon guidance (GO:0097374),-5.818456827286248e-11,0.0
8809,cortisol biosynthetic process (GO:0034651),-5.818456827286248e-11,0.0
8810,establishment of Sertoli cell barrier (GO:0097368),-5.818456827286248e-11,0.0
8811,"positive regulation of retrograde protein transport, ER to cytosol (GO:1904154)",-5.818456827286248e-11,0.0
8812,positive regulation of mitotic centrosome separation (GO:0046604),-5.818456827286248e-11,0.0
8813,protein localization to heterochromatin (GO:0097355),-5.818456827286248e-11,0.0
8814,retinol transport (GO:0034633),-5.818456827286248e-11,0.0
8815,negative regulation of alkaline phosphatase activity (GO:0010693),-5.818456827286248e-11,0.0
8816,melanocyte migration (GO:0097324),-5.818456827286248e-11,0.0
8817,terpene metabolic process (GO:0042214),-5.818456827286248e-11,0.0
8818,skeletal muscle myosin thick filament assembly (GO:0030241),-5.818456827286248e-11,0.0
8819,protein kinase D signaling (GO:0089700),-5.818456827286248e-11,0.0
8820,positive regulation of protein O-linked glycosylation (GO:1904100),-5.818456827286248e-11,0.0
8821,positive regulation of cell communication by electrical coupling (GO:0010650),-5.818456827286248e-11,0.0
8822,eosinophil differentiation (GO:0030222),-5.818456827286248e-11,0.0
8823,positive regulation of mitochondrial fusion (GO:0010636),-5.818456827286248e-11,0.0
8824,chondroitin sulfate catabolic process (GO:0030207),-5.818456827286248e-11,0.0
8825,behavioral response to formalin induced pain (GO:0061368),-5.818456827286248e-11,0.0
8826,regulation of mRNA stability involved in response to stress (GO:0010610),-5.818456827286248e-11,0.0
8827,behavioral response to chemical pain (GO:0061366),-5.818456827286248e-11,0.0
8828,apoptotic process involved in luteolysis (GO:0061364),-5.818456827286248e-11,0.0
8829,mRNA localization resulting in post-transcriptional regulation of gene expression (GO:0010609),-5.818456827286248e-11,0.0
8830,positive regulation of Wnt protein secretion (GO:0061357),-5.818456827286248e-11,0.0
8831,positive regulation of cap-independent translational initiation (GO:1903679),-5.818456827286248e-11,0.0
8832,regulation of cap-independent translational initiation (GO:1903677),-5.818456827286248e-11,0.0
8833,negative regulation of complement-dependent cytotoxicity (GO:1903660),-5.818456827286248e-11,0.0
8834,cell proliferation involved in heart morphogenesis (GO:0061323),-5.818456827286248e-11,0.0
8835,uracil metabolic process (GO:0019860),-5.818456827286248e-11,0.0
8836,negative regulation of cytoplasmic transport (GO:1903650),-5.818456827286248e-11,0.0
8837,thymine metabolic process (GO:0019859),-5.818456827286248e-11,0.0
8838,5-methylcytosine metabolic process (GO:0019857),-5.818456827286248e-11,0.0
8839,canonical Wnt signaling pathway involved in heart development (GO:0061316),-5.818456827286248e-11,0.0
8840,regulation of chaperone-mediated protein folding (GO:1903644),-5.818456827286248e-11,0.0
8841,embryonic heart tube anterior/posterior pattern specification (GO:0035054),-5.818456827286248e-11,0.0
8842,negative regulation of DNA catabolic process (GO:1903625),-5.818456827286248e-11,0.0
8843,positive regulation of protein tyrosine phosphatase activity (GO:1903615),-5.818456827286248e-11,0.0
8844,negative regulation of protein tyrosine phosphatase activity (GO:1903614),-5.818456827286248e-11,0.0
8845,quinolinate biosynthetic process (GO:0019805),-5.818456827286248e-11,0.0
8846,termination of signal transduction (GO:0023021),-5.818456827286248e-11,0.0
8847,growth plate cartilage chondrocyte growth (GO:0003430),-5.818456827286248e-11,0.0
8848,blood vessel endothelial cell fate commitment (GO:0060846),-5.818456827286248e-11,0.0
8849,lymphatic endothelial cell fate commitment (GO:0060838),-5.818456827286248e-11,0.0
8850,growth plate cartilage chondrocyte proliferation (GO:0003419),-5.818456827286248e-11,0.0
8851,regulation of protein O-linked glycosylation (GO:1904098),-5.818456827286248e-11,0.0
8852,regulation of autophagic cell death (GO:1904092),-5.818456827286248e-11,0.0
8853,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296),-5.818456827286248e-11,0.0
8854,mesodermal to mesenchymal transition involved in gastrulation (GO:0060809),-5.818456827286248e-11,0.0
8855,presynaptic active zone assembly (GO:1904071),-5.818456827286248e-11,0.0
8856,complement-dependent cytotoxicity (GO:0097278),-5.818456827286248e-11,0.0
8857,urea homeostasis (GO:0097274),-5.818456827286248e-11,0.0
8858,regulation of locomotor rhythm (GO:1904059),-5.818456827286248e-11,0.0
8859,negative regulation of sensory perception of pain (GO:1904057),-5.818456827286248e-11,0.0
8860,regulation of cholangiocyte proliferation (GO:1904054),-5.818456827286248e-11,0.0
8861,spermidine biosynthetic process (GO:0008295),-5.818456827286248e-11,0.0
8862,acetylcholine biosynthetic process (GO:0008292),-5.818456827286248e-11,0.0
8863,negative regulation of glucose catabolic process to lactate via pyruvate (GO:1904024),-5.818456827286248e-11,0.0
8864,positive regulation of G protein-coupled receptor internalization (GO:1904022),-5.818456827286248e-11,0.0
8865,cellular response to Thyroglobulin triiodothyronine (GO:1904017),-5.818456827286248e-11,0.0
8866,regulation of lysosomal membrane permeability (GO:0097213),-5.818456827286248e-11,0.0
8867,regulation of lung blood pressure (GO:0014916),-5.818456827286248e-11,0.0
8868,tRNA C5-cytosine methylation (GO:0002946),-5.818456827286248e-11,0.0
8869,tRNA N1-guanine methylation (GO:0002939),-5.818456827286248e-11,0.0
8870,tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation (GO:0002926),-5.818456827286248e-11,0.0
8871,"negative regulation of transposition, RNA-mediated (GO:0010526)",-5.818456827286248e-11,0.0
8872,"regulation of transposition, RNA-mediated (GO:0010525)",-5.818456827286248e-11,0.0
8873,positive regulation of B cell apoptotic process (GO:0002904),-5.818456827286248e-11,0.0
8874,positive regulation of phosphatidylinositol biosynthetic process (GO:0010513),-5.818456827286248e-11,0.0
8875,negative regulation of protein localization to cilium (GO:1903565),-5.818456827286248e-11,0.0
8876,cell proliferation involved in mesonephros development (GO:0061209),-5.818456827286248e-11,0.0
8877,regulation of single strand break repair (GO:1903516),-5.818456827286248e-11,0.0
8878,cellular response to rapamycin (GO:0072752),-5.818456827286248e-11,0.0
8879,establishment of cell polarity involved in ameboidal cell migration (GO:0003365),-5.818456827286248e-11,0.0
8880,cellular response to anisomycin (GO:0072740),-5.818456827286248e-11,0.0
8881,S-adenosylhomocysteine metabolic process (GO:0046498),-5.818456827286248e-11,0.0
8882,corneocyte development (GO:0003335),-5.818456827286248e-11,0.0
8883,tertiary branching involved in mammary gland duct morphogenesis (GO:0060748),-5.818456827286248e-11,0.0
8884,epithelial cell maturation involved in prostate gland development (GO:0060743),-5.818456827286248e-11,0.0
8885,prostate gland stromal morphogenesis (GO:0060741),-5.818456827286248e-11,0.0
8886,dihydrofolate metabolic process (GO:0046452),-5.818456827286248e-11,0.0
8887,histone H3-K36 trimethylation (GO:0097198),-5.818456827286248e-11,0.0
8888,pilomotor reflex (GO:0097195),-5.818456827286248e-11,0.0
8889,U5 snRNA 3'-end processing (GO:0034476),-5.818456827286248e-11,0.0
8890,U1 snRNA 3'-end processing (GO:0034473),-5.818456827286248e-11,0.0
8891,syncytiotrophoblast cell differentiation involved in labyrinthine layer development (GO:0060715),-5.818456827286248e-11,0.0
8892,germ-line stem cell division (GO:0042078),-5.818456827286248e-11,0.0
8893,small-subunit processome assembly (GO:0034462),-5.818456827286248e-11,0.0
8894,response to electrical stimulus involved in regulation of muscle adaptation (GO:0014878),-5.818456827286248e-11,0.0
8895,D-amino acid metabolic process (GO:0046416),-5.818456827286248e-11,0.0
8896,very-low-density lipoprotein particle clearance (GO:0034447),-5.818456827286248e-11,0.0
8897,regulation of skeletal muscle contraction by chemo-mechanical energy conversion (GO:0014862),-5.818456827286248e-11,0.0
8898,positive regulation of type II hypersensitivity (GO:0002894),-5.818456827286248e-11,0.0
8899,fasciculation of sensory neuron axon (GO:0097155),-5.818456827286248e-11,0.0
8900,glycoprotein transport (GO:0034436),-5.818456827286248e-11,0.0
8901,cholesterol esterification (GO:0034435),-5.818456827286248e-11,0.0
8902,sterol esterification (GO:0034434),-5.818456827286248e-11,0.0
8903,steroid esterification (GO:0034433),-5.818456827286248e-11,0.0
8904,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-5.818456827286248e-11,0.0
8905,post-translational protein acetylation (GO:0034421),-5.818456827286248e-11,0.0
8906,regulation of chronic inflammatory response to antigenic stimulus (GO:0002874),-5.818456827286248e-11,0.0
8907,regulation of epidermal cell division (GO:0010482),-5.818456827286248e-11,0.0
8908,neuroligin clustering involved in postsynaptic membrane assembly (GO:0097118),-5.818456827286248e-11,0.0
8909,blood vessel endothelial cell fate specification (GO:0097101),-5.818456827286248e-11,0.0
8910,circadian sleep/wake cycle process (GO:0022410),-5.818456827286248e-11,0.0
8911,response to alkaline pH (GO:0010446),-5.818456827286248e-11,0.0
8912,fungiform papilla formation (GO:0061198),-5.818456827286248e-11,0.0
8913,positive regulation of dermatome development (GO:0061184),-5.818456827286248e-11,0.0
8914,negative regulation of chondrocyte development (GO:0061182),-5.818456827286248e-11,0.0
8915,"negative regulation of complement activation, alternative pathway (GO:0045957)",-5.818456827286248e-11,0.0
8916,box H/ACA RNA metabolic process (GO:0033979),-5.818456827286248e-11,0.0
8917,regulation of lactation (GO:1903487),-5.818456827286248e-11,0.0
8918,box C/D RNA metabolic process (GO:0033967),-5.818456827286248e-11,0.0
8919,neural plate anterior/posterior regionalization (GO:0021999),-5.818456827286248e-11,0.0
8920,habenula development (GO:0021986),-5.818456827286248e-11,0.0
8921,NAD catabolic process (GO:0019677),-5.818456827286248e-11,0.0
8922,negative regulation of cytolysis (GO:0045918),-5.818456827286248e-11,0.0
8923,spinal cord ventral commissure morphogenesis (GO:0021965),-5.818456827286248e-11,0.0
8924,negative regulation of brown fat cell differentiation (GO:1903444),-5.818456827286248e-11,0.0
8925,formation of radial glial scaffolds (GO:0021943),-5.818456827286248e-11,0.0
8926,radial glia guided migration of Purkinje cell (GO:0021942),-5.818456827286248e-11,0.0
8927,thymocyte migration (GO:0072679),-5.818456827286248e-11,0.0
8928,positive regulation of P-type sodium:potassium-exchanging transporter activity (GO:1903408),-5.818456827286248e-11,0.0
8929,regulation of P-type sodium:potassium-exchanging transporter activity (GO:1903406),-5.818456827286248e-11,0.0
8930,septum secundum development (GO:0003285),-5.818456827286248e-11,0.0
8931,positive regulation of phospholipid catabolic process (GO:0060697),-5.818456827286248e-11,0.0
8932,courtship behavior (GO:0007619),-5.818456827286248e-11,0.0
8933,epithelial cell morphogenesis involved in placental branching (GO:0060672),-5.818456827286248e-11,0.0
8934,epithelial cell differentiation involved in embryonic placenta development (GO:0060671),-5.818456827286248e-11,0.0
8935,regulation of cell proliferation involved in heart valve morphogenesis (GO:0003250),-5.818456827286248e-11,0.0
8936,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling (GO:0060665),-5.818456827286248e-11,0.0
8937,regulation of neurofibrillary tangle assembly (GO:1902996),-5.818456827286248e-11,0.0
8938,mitotic telomere maintenance via semi-conservative replication (GO:1902990),-5.818456827286248e-11,0.0
8939,extracellular polysaccharide metabolic process (GO:0046379),-5.818456827286248e-11,0.0
8940,mammary gland bud morphogenesis (GO:0060648),-5.818456827286248e-11,0.0
8941,right ventricular cardiac muscle tissue morphogenesis (GO:0003221),-5.818456827286248e-11,0.0
8942,left ventricular cardiac muscle tissue morphogenesis (GO:0003220),-5.818456827286248e-11,0.0
8943,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902960),-5.818456827286248e-11,0.0
8944,cardiac right atrium morphogenesis (GO:0003213),-5.818456827286248e-11,0.0
8945,acetyl-CoA catabolic process (GO:0046356),-5.818456827286248e-11,0.0
8946,"positive regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902958)",-5.818456827286248e-11,0.0
8947,regulation of cholesterol import (GO:0060620),-5.818456827286248e-11,0.0
8948,negative regulation of tau-protein kinase activity (GO:1902948),-5.818456827286248e-11,0.0
8949,chylomicron remodeling (GO:0034371),-5.818456827286248e-11,0.0
8950,octopamine metabolic process (GO:0046333),-5.818456827286248e-11,0.0
8951,lateral inhibition (GO:0046331),-5.818456827286248e-11,0.0
8952,regulation of intracellular calcium activated chloride channel activity (GO:1902938),-5.818456827286248e-11,0.0
8953,establishment of protein localization to endoplasmic reticulum membrane (GO:0097051),-5.818456827286248e-11,0.0
8954,type B pancreatic cell apoptotic process (GO:0097050),-5.818456827286248e-11,0.0
8955,antibacterial peptide biosynthetic process (GO:0002780),-5.818456827286248e-11,0.0
8956,histone H3-K56 acetylation (GO:0097043),-5.818456827286248e-11,0.0
8957,antibacterial peptide production (GO:0002778),-5.818456827286248e-11,0.0
8958,antimicrobial peptide biosynthetic process (GO:0002777),-5.818456827286248e-11,0.0
8959,antimicrobial peptide production (GO:0002775),-5.818456827286248e-11,0.0
8960,protein linear polyubiquitination (GO:0097039),-5.818456827286248e-11,0.0
8961,heme export (GO:0097037),-5.818456827286248e-11,0.0
8962,regulation of muscle atrophy (GO:0014735),-5.818456827286248e-11,0.0
8963,natural killer cell inhibitory signaling pathway (GO:0002769),-5.818456827286248e-11,0.0
8964,Toll signaling pathway (GO:0008063),-5.818456827286248e-11,0.0
8965,regulation of the force of skeletal muscle contraction (GO:0014728),-5.818456827286248e-11,0.0
8966,regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014717),-5.818456827286248e-11,0.0
8967,branchiomeric skeletal muscle development (GO:0014707),-5.818456827286248e-11,0.0
8968,positive regulation of striated muscle tissue development (GO:0045844),-5.818456827286248e-11,0.0
8969,negative regulation of adherens junction organization (GO:1903392),-5.818456827286248e-11,0.0
8970,regulation of homophilic cell adhesion (GO:1903385),-5.818456827286248e-11,0.0
8971,negative regulation of NAD(P)H oxidase activity (GO:0033861),-5.818456827286248e-11,0.0
8972,secretion by lung epithelial cell involved in lung growth (GO:0061033),-5.818456827286248e-11,0.0
8973,"blood coagulation, extrinsic pathway (GO:0007598)",-5.818456827286248e-11,0.0
8974,pyramidal neuron migration to cerebral cortex (GO:0021852),-5.818456827286248e-11,0.0
8975,regulation of vacuolar transport (GO:1903335),-5.818456827286248e-11,0.0
8976,neuroblast division in subventricular zone (GO:0021849),-5.818456827286248e-11,0.0
8977,chemorepulsion involved in interneuron migration from the subpallium to the cortex (GO:0021842),-5.818456827286248e-11,0.0
8978,directional guidance of interneurons involved in migration from the subpallium to the cortex (GO:0021840),-5.818456827286248e-11,0.0
8979,oxygen metabolic process (GO:0072592),-5.818456827286248e-11,0.0
8980,mitral valve formation (GO:0003192),-5.818456827286248e-11,0.0
8981,primary sex determination (GO:0007538),-5.818456827286248e-11,0.0
8982,mammary placode formation (GO:0060596),-5.818456827286248e-11,0.0
8983,mammary gland specification (GO:0060594),-5.818456827286248e-11,0.0
8984,atrioventricular bundle cell differentiation (GO:0003167),-5.818456827286248e-11,0.0
8985,Purkinje myocyte development (GO:0003165),-5.818456827286248e-11,0.0
8986,formaldehyde catabolic process (GO:0046294),-5.818456827286248e-11,0.0
8987,mesoderm migration involved in gastrulation (GO:0007509),-5.818456827286248e-11,0.0
8988,terminal web assembly (GO:1902896),-5.818456827286248e-11,0.0
8989,mesodermal cell fate determination (GO:0007500),-5.818456827286248e-11,0.0
8990,positive regulation of calcidiol 1-monooxygenase activity (GO:0060559),-5.818456827286248e-11,0.0
8991,primary heart field specification (GO:0003138),-5.818456827286248e-11,0.0
8992,endodermal-mesodermal cell signaling involved in heart induction (GO:0003134),-5.818456827286248e-11,0.0
8993,endodermal-mesodermal cell signaling (GO:0003133),-5.818456827286248e-11,0.0
8994,BMP signaling pathway involved in heart induction (GO:0003130),-5.818456827286248e-11,0.0
8995,positive regulation of amacrine cell differentiation (GO:1902871),-5.818456827286248e-11,0.0
8996,heart induction (GO:0003129),-5.818456827286248e-11,0.0
8997,negative regulation of amacrine cell differentiation (GO:1902870),-5.818456827286248e-11,0.0
8998,detection of nodal flow (GO:0003127),-5.818456827286248e-11,0.0
8999,trachea cartilage morphogenesis (GO:0060535),-5.818456827286248e-11,0.0
9000,detection of monosaccharide stimulus (GO:0034287),-5.818456827286248e-11,0.0
9001,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528),-5.818456827286248e-11,0.0
9002,negative regulation of non-motile cilium assembly (GO:1902856),-5.818456827286248e-11,0.0
9003,positive regulation of glomerular filtration (GO:0003104),-5.818456827286248e-11,0.0
9004,regulation of late endosome to lysosome transport (GO:1902822),-5.818456827286248e-11,0.0
9005,positive regulation of skeletal muscle fiber differentiation (GO:1902811),-5.818456827286248e-11,0.0
9006,regulation of translational initiation (GO:0006446),-5.891886978130656e-11,0.0
9007,RNA export from nucleus (GO:0006405),-5.891886978130656e-11,0.0
9008,glycosyl compound metabolic process (GO:1901657),-5.891886978130656e-11,0.0
9009,regulation of response to endoplasmic reticulum stress (GO:1905897),-5.891886978130656e-11,0.0
9010,regulation of cellular response to oxidative stress (GO:1900407),-5.891886978130656e-11,0.0
9011,cardiac muscle cell differentiation (GO:0055007),-5.891886978130656e-11,0.0
9012,pyrimidine-containing compound metabolic process (GO:0072527),-5.891886978130656e-11,0.0
9013,negative regulation of cell cycle G1/S phase transition (GO:1902807),-5.891886978130656e-11,0.0
9014,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903298),-5.940825609053238e-11,0.0
9015,regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903297),-5.940825609053238e-11,0.0
9016,negative regulation of protein targeting to mitochondrion (GO:1903215),-5.940825609053238e-11,0.0
9017,negative regulation of hydrogen peroxide-induced neuron death (GO:1903208),-5.940825609053238e-11,0.0
9018,regulation of hydrogen peroxide-induced neuron death (GO:1903207),-5.940825609053238e-11,0.0
9019,positive regulation of behavioral fear response (GO:2000987),-5.940825609053238e-11,0.0
9020,regulation of heart rate by chemical signal (GO:0003062),-5.940825609053238e-11,0.0
9021,acrosomal vesicle exocytosis (GO:0060478),-5.940825609053238e-11,0.0
9022,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",-5.940825609053238e-11,0.0
9023,lung growth (GO:0060437),-5.940825609053238e-11,0.0
9024,bronchiole development (GO:0060435),-5.940825609053238e-11,0.0
9025,negative regulation of lens fiber cell differentiation (GO:1902747),-5.940825609053238e-11,0.0
9026,negative regulation of lamellipodium organization (GO:1902744),-5.940825609053238e-11,0.0
9027,imidazole-containing compound metabolic process (GO:0052803),-5.940825609053238e-11,0.0
9028,positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-5.940825609053238e-11,0.0
9029,deoxyribonucleoside catabolic process (GO:0046121),-5.940825609053238e-11,0.0
9030,positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),-5.940825609053238e-11,0.0
9031,positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),-5.940825609053238e-11,0.0
9032,toll-like receptor 2 signaling pathway (GO:0034134),-5.940825609053238e-11,0.0
9033,response to ozone (GO:0010193),-5.940825609053238e-11,0.0
9034,regulation of antigen processing and presentation of peptide antigen (GO:0002583),-5.940825609053238e-11,0.0
9035,determination of liver left/right asymmetry (GO:0071910),-5.940825609053238e-11,0.0
9036,pyrimidine ribonucleotide salvage (GO:0010138),-5.940825609053238e-11,0.0
9037,T cell tolerance induction (GO:0002517),-5.940825609053238e-11,0.0
9038,tolerance induction to self antigen (GO:0002513),-5.940825609053238e-11,0.0
9039,regulation of luteinizing hormone secretion (GO:0033684),-5.940825609053238e-11,0.0
9040,regulation of melanocyte differentiation (GO:0045634),-5.940825609053238e-11,0.0
9041,galactolipid biosynthetic process (GO:0019375),-5.940825609053238e-11,0.0
9042,positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),-5.940825609053238e-11,0.0
9043,cell-cell adhesion mediated by integrin (GO:0033631),-5.940825609053238e-11,0.0
9044,lipoxin metabolic process (GO:2001300),-5.940825609053238e-11,0.0
9045,positive regulation of establishment of endothelial barrier (GO:1903142),-5.940825609053238e-11,0.0
9046,dolichol metabolic process (GO:0019348),-5.940825609053238e-11,0.0
9047,positive regulation of dopamine secretion (GO:0033603),-5.940825609053238e-11,0.0
9048,optic nerve morphogenesis (GO:0021631),-5.940825609053238e-11,0.0
9049,plus-end-directed vesicle transport along microtubule (GO:0072383),-5.940825609053238e-11,0.0
9050,"zygotic determination of anterior/posterior axis, embryo (GO:0007354)",-5.940825609053238e-11,0.0
9051,regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),-5.940825609053238e-11,0.0
9052,regulation of aldosterone secretion (GO:2000858),-5.940825609053238e-11,0.0
9053,regulation of mineralocorticoid secretion (GO:2000855),-5.940825609053238e-11,0.0
9054,positive regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060369),-5.940825609053238e-11,0.0
9055,response to ammonium ion (GO:0060359),-5.940825609053238e-11,0.0
9056,negative regulation of cell adhesion molecule production (GO:0060354),-5.940825609053238e-11,0.0
9057,dUMP catabolic process (GO:0046079),-5.940825609053238e-11,0.0
9058,dCMP metabolic process (GO:0046063),-5.940825609053238e-11,0.0
9059,regulation of grooming behavior (GO:2000821),-5.940825609053238e-11,0.0
9060,positive regulation of interferon-gamma-mediated signaling pathway (GO:0060335),-5.940825609053238e-11,0.0
9061,positive regulation of response to interferon-gamma (GO:0060332),-5.940825609053238e-11,0.0
9062,regulation of barbed-end actin filament capping (GO:2000812),-5.940825609053238e-11,0.0
9063,establishment of meiotic sister chromatid cohesion (GO:0034089),-5.940825609053238e-11,0.0
9064,regulation of synaptic vesicle clustering (GO:2000807),-5.940825609053238e-11,0.0
9065,intracellular sequestering of iron ion (GO:0006880),-5.940825609053238e-11,0.0
9066,regulation of phosphatidylinositol dephosphorylation (GO:0060304),-5.940825609053238e-11,0.0
9067,purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-5.940825609053238e-11,0.0
9068,carnitine transmembrane transport (GO:1902603),-5.940825609053238e-11,0.0
9069,pyruvate transport (GO:0006848),-5.940825609053238e-11,0.0
9070,positive regulation of cell proliferation in bone marrow (GO:0071864),-5.940825609053238e-11,0.0
9071,antigen processing and presentation of endogenous peptide antigen via MHC class Ib (GO:0002476),-5.940825609053238e-11,0.0
9072,tangential migration from the subventricular zone to the olfactory bulb (GO:0022028),-5.940825609053238e-11,0.0
9073,malonyl-CoA metabolic process (GO:2001293),-5.940825609053238e-11,0.0
9074,regulation of caveolin-mediated endocytosis (GO:2001286),-5.940825609053238e-11,0.0
9075,response to iron(II) ion (GO:0010040),-5.940825609053238e-11,0.0
9076,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),-5.940825609053238e-11,0.0
9077,meiotic chromosome condensation (GO:0010032),-5.940825609053238e-11,0.0
9078,response to L-ascorbic acid (GO:0033591),-5.940825609053238e-11,0.0
9079,N-acetylneuraminate catabolic process (GO:0019262),-5.940825609053238e-11,0.0
9080,neuron-neuron synaptic transmission (GO:0007270),-5.940825609053238e-11,0.0
9081,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026),-5.940825609053238e-11,0.0
9082,positive regulation of protein deubiquitination (GO:1903003),-5.940825609053238e-11,0.0
9083,osmosensory signaling pathway (GO:0007231),-5.940825609053238e-11,0.0
9084,metanephric loop of Henle development (GO:0072236),-5.940825609053238e-11,0.0
9085,negative regulation of respiratory burst (GO:0060268),-5.940825609053238e-11,0.0
9086,regulation of metanephros development (GO:0072215),-5.940825609053238e-11,0.0
9087,Mo-molybdopterin cofactor biosynthetic process (GO:0006777),-5.940825609053238e-11,0.0
9088,regulation of protein monoubiquitination (GO:1902525),-5.940825609053238e-11,0.0
9089,positive regulation of apoptotic DNA fragmentation (GO:1902512),-5.940825609053238e-11,0.0
9090,negative regulation of dendritic cell differentiation (GO:2001199),-5.940825609053238e-11,0.0
9091,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),-5.940825609053238e-11,0.0
9092,"negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",-5.940825609053238e-11,0.0
9093,B cell lineage commitment (GO:0002326),-5.940825609053238e-11,0.0
9094,B cell proliferation involved in immune response (GO:0002322),-5.940825609053238e-11,0.0
9095,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),-5.940825609053238e-11,0.0
9096,metanephric tubule formation (GO:0072174),-5.940825609053238e-11,0.0
9097,radial glia-guided pyramidal neuron migration (GO:0140650),-5.940825609053238e-11,0.0
9098,neural plate morphogenesis (GO:0001839),-5.940825609053238e-11,0.0
9099,negative regulation of type B pancreatic cell apoptotic process (GO:2000675),-5.940825609053238e-11,0.0
9100,histamine secretion (GO:0001821),-5.940825609053238e-11,0.0
9101,mesangial cell development (GO:0072143),-5.940825609053238e-11,0.0
9102,regulation of protein autoubiquitination (GO:1902498),-5.940825609053238e-11,0.0
9103,mitotic centrosome separation (GO:0007100),-5.940825609053238e-11,0.0
9104,regulation of inositol trisphosphate biosynthetic process (GO:0032960),-5.940825609053238e-11,0.0
9105,positive regulation of protein localization to synapse (GO:1902474),-5.940825609053238e-11,0.0
9106,glomerular capillary formation (GO:0072104),-5.940825609053238e-11,0.0
9107,glomerulus vasculature morphogenesis (GO:0072103),-5.940825609053238e-11,0.0
9108,maternal process involved in parturition (GO:0060137),-5.940825609053238e-11,0.0
9109,regulation of histone H4-K16 acetylation (GO:2000618),-5.940825609053238e-11,0.0
9110,thyroid-stimulating hormone-secreting cell differentiation (GO:0060129),-5.940825609053238e-11,0.0
9111,sphingomyelin catabolic process (GO:0006685),-5.940825609053238e-11,0.0
9112,galactosylceramide biosynthetic process (GO:0006682),-5.940825609053238e-11,0.0
9113,negative regulation of transforming growth factor beta1 production (GO:0032911),-5.940825609053238e-11,0.0
9114,response to indole-3-methanol (GO:0071680),-5.940825609053238e-11,0.0
9115,regulation of smooth muscle cell chemotaxis (GO:0071671),-5.940825609053238e-11,0.0
9116,negative regulation of chemokine (C-C motif) ligand 5 production (GO:0071650),-5.940825609053238e-11,0.0
9117,regulation of macrophage inflammatory protein 1 alpha production (GO:0071640),-5.940825609053238e-11,0.0
9118,xenobiotic transport across blood-brain barrier (GO:1990962),-5.940825609053238e-11,0.0
9119,negative regulation of monocyte chemotactic protein-1 production (GO:0071638),-5.940825609053238e-11,0.0
9120,double-strand break repair involved in meiotic recombination (GO:1990918),-5.940825609053238e-11,0.0
9121,negative regulation of MHC class II biosynthetic process (GO:0045347),-5.940825609053238e-11,0.0
9122,positive regulation of MHC class I biosynthetic process (GO:0045345),-5.940825609053238e-11,0.0
9123,farnesyl diphosphate metabolic process (GO:0045338),-5.940825609053238e-11,0.0
9124,viral transcription (GO:0019083),-5.940825609053238e-11,0.0
9125,positive regulation of skeletal muscle cell differentiation (GO:2001016),-5.940825609053238e-11,0.0
9126,spindle assembly involved in female meiosis (GO:0007056),-5.940825609053238e-11,0.0
9127,endodermal cell fate specification (GO:0001714),-5.940825609053238e-11,0.0
9128,plasma membrane raft assembly (GO:0044854),-5.940825609053238e-11,0.0
9129,renal vesicle formation (GO:0072033),-5.940825609053238e-11,0.0
9130,embryonic retina morphogenesis in camera-type eye (GO:0060059),-5.940825609053238e-11,0.0
9131,actomyosin contractile ring organization (GO:0044837),-5.940825609053238e-11,0.0
9132,modulation by host of viral RNA genome replication (GO:0044830),-5.940825609053238e-11,0.0
9133,glomerular mesangial cell differentiation (GO:0072008),-5.940825609053238e-11,0.0
9134,regulation of T cell costimulation (GO:2000523),-5.940825609053238e-11,0.0
9135,positive regulation of cellular pH reduction (GO:0032849),-5.940825609053238e-11,0.0
9136,chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),-5.940825609053238e-11,0.0
9137,ERBB4-ERBB4 signaling pathway (GO:0038138),-5.940825609053238e-11,0.0
9138,positive regulation of natural killer cell chemotaxis (GO:2000503),-5.940825609053238e-11,0.0
9139,Sertoli cell proliferation (GO:0060011),-5.940825609053238e-11,0.0
9140,positive regulation of apoptotic process involved in morphogenesis (GO:1902339),-5.940825609053238e-11,0.0
9141,negative regulation of apoptotic process involved in morphogenesis (GO:1902338),-5.940825609053238e-11,0.0
9142,amino-acid betaine biosynthetic process (GO:0006578),-5.940825609053238e-11,0.0
9143,tyrosine catabolic process (GO:0006572),-5.940825609053238e-11,0.0
9144,threonine metabolic process (GO:0006566),-5.940825609053238e-11,0.0
9145,proline biosynthetic process (GO:0006561),-5.940825609053238e-11,0.0
9146,regulation of low-density lipoprotein particle receptor catabolic process (GO:0032803),-5.940825609053238e-11,0.0
9147,leucine catabolic process (GO:0006552),-5.940825609053238e-11,0.0
9148,cap-dependent translational initiation (GO:0002191),-5.940825609053238e-11,0.0
9149,protein ufmylation (GO:0071569),-5.940825609053238e-11,0.0
9150,vascular associated smooth muscle cell proliferation (GO:1990874),-5.940825609053238e-11,0.0
9151,negative regulation of transmission of nerve impulse (GO:0051970),-5.940825609053238e-11,0.0
9152,regulation of thyroid hormone mediated signaling pathway (GO:0002155),-5.940825609053238e-11,0.0
9153,regulation of relaxation of cardiac muscle (GO:1901897),-5.940825609053238e-11,0.0
9154,positive regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901896),-5.940825609053238e-11,0.0
9155,negative regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901895),-5.940825609053238e-11,0.0
9156,genomic imprinting (GO:0071514),-5.940825609053238e-11,0.0
9157,catecholamine uptake involved in synaptic transmission (GO:0051934),-5.940825609053238e-11,0.0
9158,regulation of post-translational protein modification (GO:1901873),-5.940825609053238e-11,0.0
9159,amino acid neurotransmitter reuptake (GO:0051933),-5.940825609053238e-11,0.0
9160,cell proliferation in midbrain (GO:0033278),-5.940825609053238e-11,0.0
9161,histamine metabolic process (GO:0001692),-5.940825609053238e-11,0.0
9162,positive regulation of cAMP-dependent protein kinase activity (GO:2000481),-5.940825609053238e-11,0.0
9163,negative regulation of CREB transcription factor activity (GO:0032792),-5.940825609053238e-11,0.0
9164,bile acid secretion (GO:0032782),-5.940825609053238e-11,0.0
9165,regulation of eosinophil migration (GO:2000416),-5.940825609053238e-11,0.0
9166,N-terminal protein lipidation (GO:0006498),-5.940825609053238e-11,0.0
9167,negative regulation of T cell migration (GO:2000405),-5.940825609053238e-11,0.0
9168,non-canonical Wnt signaling pathway via MAPK cascade (GO:0038030),-5.940825609053238e-11,0.0
9169,cellular response to UV-C (GO:0071494),-5.940825609053238e-11,0.0
9170,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902218),-5.940825609053238e-11,0.0
9171,positive regulation of cardioblast differentiation (GO:0051891),-5.940825609053238e-11,0.0
9172,cellular response to water stimulus (GO:0071462),-5.940825609053238e-11,0.0
9173,cellular response to hyperoxia (GO:0071455),-5.940825609053238e-11,0.0
9174,"regulation of circadian sleep/wake cycle, non-REM sleep (GO:0045188)",-5.940825609053238e-11,0.0
9175,protein sialylation (GO:1990743),-5.940825609053238e-11,0.0
9176,reduction of food intake in response to dietary excess (GO:0002023),-5.940825609053238e-11,0.0
9177,positive regulation of histone deacetylase activity (GO:1901727),-5.940825609053238e-11,0.0
9178,regulation of neutrophil mediated cytotoxicity (GO:0070948),-5.940825609053238e-11,0.0
9179,regulation of mesoderm development (GO:2000380),-5.940825609053238e-11,0.0
9180,negative regulation of interferon-alpha production (GO:0032687),-5.940825609053238e-11,0.0
9181,regulation of ovarian follicle development (GO:2000354),-5.940825609053238e-11,0.0
9182,regulation of CD40 signaling pathway (GO:2000348),-5.940825609053238e-11,0.0
9183,regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000338),-5.940825609053238e-11,0.0
9184,negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),-5.940825609053238e-11,0.0
9185,"regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902162)",-5.940825609053238e-11,0.0
9186,peptidyl-glutamine methylation (GO:0018364),-5.940825609053238e-11,0.0
9187,mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-5.940825609053238e-11,0.0
9188,positive regulation of ceramide biosynthetic process (GO:2000304),-5.940825609053238e-11,0.0
9189,negative regulation of synaptic vesicle exocytosis (GO:2000301),-5.940825609053238e-11,0.0
9190,protein geranylgeranylation (GO:0018344),-5.940825609053238e-11,0.0
9191,cellular response to progesterone stimulus (GO:0071393),-5.940825609053238e-11,0.0
9192,cellular response to luteinizing hormone stimulus (GO:0071373),-5.940825609053238e-11,0.0
9193,medium-chain fatty acid biosynthetic process (GO:0051792),-5.940825609053238e-11,0.0
9194,cellular response to interleukin-15 (GO:0071350),-5.940825609053238e-11,0.0
9195,cellular response to interleukin-12 (GO:0071349),-5.940825609053238e-11,0.0
9196,cellular response to cGMP (GO:0071321),-5.940825609053238e-11,0.0
9197,regulation of histone H3-K27 acetylation (GO:1901674),-5.940825609053238e-11,0.0
9198,protein de-ADP-ribosylation (GO:0051725),-5.940825609053238e-11,0.0
9199,negative regulation of immature T cell proliferation in thymus (GO:0033088),-5.940825609053238e-11,0.0
9200,negative regulation of immature T cell proliferation (GO:0033087),-5.940825609053238e-11,0.0
9201,positive regulation of killing of cells of another organism (GO:0051712),-5.940825609053238e-11,0.0
9202,protein import into peroxisome membrane (GO:0045046),-5.940825609053238e-11,0.0
9203,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901621),-5.940825609053238e-11,0.0
9204,double-strand break repair via single-strand annealing (GO:0045002),-5.940825609053238e-11,0.0
9205,hexose import across plasma membrane (GO:0140271),-5.940825609053238e-11,0.0
9206,aggresome assembly (GO:0070842),-5.940825609053238e-11,0.0
9207,regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000298),-5.940825609053238e-11,0.0
9208,[2Fe-2S] cluster assembly (GO:0044571),-5.940825609053238e-11,0.0
9209,regulation of male germ cell proliferation (GO:2000254),-5.940825609053238e-11,0.0
9210,negative regulation of feeding behavior (GO:2000252),-5.940825609053238e-11,0.0
9211,negative regulation of peptidyl-cysteine S-nitrosylation (GO:1902083),-5.940825609053238e-11,0.0
9212,regulation of microvillus assembly (GO:0032534),-5.940825609053238e-11,0.0
9213,negative regulation of hematopoietic stem cell differentiation (GO:1902037),-5.940825609053238e-11,0.0
9214,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-5.940825609053238e-11,0.0
9215,"DNA replication, synthesis of RNA primer (GO:0006269)",-5.940825609053238e-11,0.0
9216,dCMP catabolic process (GO:0006249),-5.940825609053238e-11,0.0
9217,maintenance of centrosome location (GO:0051661),-5.940825609053238e-11,0.0
9218,cellular response to bacterial lipopeptide (GO:0071221),-5.940825609053238e-11,0.0
9219,cellular response to bacterial lipoprotein (GO:0071220),-5.940825609053238e-11,0.0
9220,mitochondrial ATP transmembrane transport (GO:1990544),-5.940825609053238e-11,0.0
9221,norepinephrine uptake (GO:0051620),-5.940825609053238e-11,0.0
9222,positive regulation of endothelial cell development (GO:1901552),-5.940825609053238e-11,0.0
9223,piRNA biosynthetic process (GO:1990511),-5.940825609053238e-11,0.0
9224,dense core granule exocytosis (GO:1990504),-5.940825609053238e-11,0.0
9225,phagosome acidification (GO:0090383),-5.940825609053238e-11,0.0
9226,regulation of heart induction (GO:0090381),-5.940825609053238e-11,0.0
9227,positive regulation of hematopoietic progenitor cell differentiation (GO:1901534),-5.940825609053238e-11,0.0
9228,positive regulation of mitophagy (GO:1901526),-5.940825609053238e-11,0.0
9229,negative regulation of mitophagy (GO:1901525),-5.940825609053238e-11,0.0
9230,negative regulation of protein targeting to membrane (GO:0090315),-5.940825609053238e-11,0.0
9231,cyclic nucleotide transport (GO:0070729),-5.940825609053238e-11,0.0
9232,hair follicle maturation (GO:0048820),-5.940825609053238e-11,0.0
9233,maintenance of postsynaptic density structure (GO:0099562),-5.940825609053238e-11,0.0
9234,regulation of ubiquitin-specific protease activity (GO:2000152),-5.940825609053238e-11,0.0
9235,negative regulation of DNA-templated transcription initiation (GO:2000143),-5.940825609053238e-11,0.0
9236,regulation of removal of superoxide radicals (GO:2000121),-5.940825609053238e-11,0.0
9237,'de novo' IMP biosynthetic process (GO:0006189),-5.940825609053238e-11,0.0
9238,regulation of growth rate (GO:0040009),-5.940825609053238e-11,0.0
9239,peptidyl-cysteine S-nitrosylation (GO:0018119),-5.940825609053238e-11,0.0
9240,response to methylmercury (GO:0051597),-5.940825609053238e-11,0.0
9241,histone H4-R3 methylation (GO:0043985),-5.940825609053238e-11,0.0
9242,dopamine uptake involved in synaptic transmission (GO:0051583),-5.940825609053238e-11,0.0
9243,negative regulation of histone H3-K4 methylation (GO:0051572),-5.940825609053238e-11,0.0
9244,negative regulation of fatty acid beta-oxidation (GO:0031999),-5.940825609053238e-11,0.0
9245,regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),-5.940825609053238e-11,0.0
9246,locomotion involved in locomotory behavior (GO:0031987),-5.940825609053238e-11,0.0
9247,resolution of recombination intermediates (GO:0071139),-5.940825609053238e-11,0.0
9248,isocitrate metabolic process (GO:0006102),-5.940825609053238e-11,0.0
9249,flavone metabolic process (GO:0051552),-5.940825609053238e-11,0.0
9250,keratinocyte migration (GO:0051546),-5.940825609053238e-11,0.0
9251,elastin metabolic process (GO:0051541),-5.940825609053238e-11,0.0
9252,pyruvate transmembrane transport (GO:1901475),-5.940825609053238e-11,0.0
9253,regulation of osteoclast proliferation (GO:0090289),-5.940825609053238e-11,0.0
9254,regulation of fibroblast growth factor production (GO:0090270),-5.940825609053238e-11,0.0
9255,positive regulation of inclusion body assembly (GO:0090261),-5.940825609053238e-11,0.0
9256,regulation of retinal ganglion cell axon guidance (GO:0090259),-5.940825609053238e-11,0.0
9257,maintenance of presynaptic active zone structure (GO:0048790),-5.940825609053238e-11,0.0
9258,negative regulation of histone H4 acetylation (GO:0090241),-5.940825609053238e-11,0.0
9259,vitamin D3 metabolic process (GO:0070640),-5.940825609053238e-11,0.0
9260,branching morphogenesis of a nerve (GO:0048755),-5.940825609053238e-11,0.0
9261,mitochondrial ADP transmembrane transport (GO:0140021),-5.940825609053238e-11,0.0
9262,negative regulation of non-canonical Wnt signaling pathway (GO:2000051),-5.940825609053238e-11,0.0
9263,sodium-dependent phosphate transport (GO:0044341),-5.940825609053238e-11,0.0
9264,L-aspartate import across plasma membrane (GO:0140009),-5.940825609053238e-11,0.0
9265,positive regulation of DNA damage checkpoint (GO:2000003),-5.940825609053238e-11,0.0
9266,negative regulation of DNA damage checkpoint (GO:2000002),-5.940825609053238e-11,0.0
9267,negative regulation of phospholipid biosynthetic process (GO:0071072),-5.940825609053238e-11,0.0
9268,negative regulation of filopodium assembly (GO:0051490),-5.940825609053238e-11,0.0
9269,chitin catabolic process (GO:0006032),-5.940825609053238e-11,0.0
9270,chitin metabolic process (GO:0006030),-5.940825609053238e-11,0.0
9271,5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015),-5.940825609053238e-11,0.0
9272,regulation of corticotropin secretion (GO:0051459),-5.940825609053238e-11,0.0
9273,gap junction-mediated intercellular transport (GO:1990349),-5.940825609053238e-11,0.0
9274,protein localization to microtubule end (GO:1905725),-5.940825609053238e-11,0.0
9275,regulation of glomerulus development (GO:0090192),-5.940825609053238e-11,0.0
9276,positive regulation of store-operated calcium channel activity (GO:1901341),-5.940825609053238e-11,0.0
9277,negative regulation of sphingolipid biosynthetic process (GO:0090155),-5.940825609053238e-11,0.0
9278,positive regulation of sphingolipid biosynthetic process (GO:0090154),-5.940825609053238e-11,0.0
9279,positive regulation of skeletal muscle tissue growth (GO:0048633),-5.940825609053238e-11,0.0
9280,myoblast fate commitment (GO:0048625),-5.940825609053238e-11,0.0
9281,central nervous system myelin formation (GO:0032289),-5.940825609053238e-11,0.0
9282,gonadotropin secretion (GO:0032274),-5.940825609053238e-11,0.0
9283,pyrimidine nucleotide salvage (GO:0032262),-5.940825609053238e-11,0.0
9284,positive regulation of nucleobase-containing compound transport (GO:0032241),-5.940825609053238e-11,0.0
9285,UMP salvage (GO:0044206),-5.940825609053238e-11,0.0
9286,"negative regulation of synaptic transmission, GABAergic (GO:0032229)",-5.940825609053238e-11,0.0
9287,riboflavin transport (GO:0032218),-5.940825609053238e-11,0.0
9288,regulation of plasma membrane repair (GO:1905684),-5.940825609053238e-11,0.0
9289,regulation of lysosome organization (GO:1905671),-5.940825609053238e-11,0.0
9290,negative regulation of hydrogen peroxide-mediated programmed cell death (GO:1901299),-5.940825609053238e-11,0.0
9291,succinyl-CoA catabolic process (GO:1901289),-5.940825609053238e-11,0.0
9292,negative regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051344),-5.940825609053238e-11,0.0
9293,modulation of inhibitory postsynaptic potential (GO:0098828),-5.940825609053238e-11,0.0
9294,S phase (GO:0051320),-5.940825609053238e-11,0.0
9295,regulation of macrophage colony-stimulating factor production (GO:1901256),-5.940825609053238e-11,0.0
9296,abscission (GO:0009838),-5.940825609053238e-11,0.0
9297,negative regulation of steroid hormone biosynthetic process (GO:0090032),-5.940825609053238e-11,0.0
9298,negative regulation of monocyte chemotaxis (GO:0090027),-5.940825609053238e-11,0.0
9299,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070426),-5.940825609053238e-11,0.0
9300,positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),-5.940825609053238e-11,0.0
9301,positive regulation of response to nutrient levels (GO:0032109),-5.940825609053238e-11,0.0
9302,positive regulation of response to extracellular stimulus (GO:0032106),-5.940825609053238e-11,0.0
9303,cell dedifferentiation (GO:0043697),-5.940825609053238e-11,0.0
9304,dedifferentiation (GO:0043696),-5.940825609053238e-11,0.0
9305,neural crest cell migration involved in autonomic nervous system development (GO:1901166),-5.940825609053238e-11,0.0
9306,negative regulation of trophoblast cell migration (GO:1901164),-5.940825609053238e-11,0.0
9307,ribosome-associated ubiquitin-dependent protein catabolic process (GO:1990116),-5.940825609053238e-11,0.0
9308,carbohydrate import across plasma membrane (GO:0098704),-5.940825609053238e-11,0.0
9309,negative regulation of fat cell proliferation (GO:0070345),-5.940825609053238e-11,0.0
9310,response to bacterial lipopeptide (GO:0070339),-5.940825609053238e-11,0.0
9311,positive regulation of focal adhesion disassembly (GO:0120183),-5.940825609053238e-11,0.0
9312,regulation of focal adhesion disassembly (GO:0120182),-5.940825609053238e-11,0.0
9313,synaptic vesicle recycling via endosome (GO:0036466),-5.940825609053238e-11,0.0
9314,positive regulation of G0 to G1 transition (GO:0070318),-5.940825609053238e-11,0.0
9315,negative regulation of G0 to G1 transition (GO:0070317),-5.940825609053238e-11,0.0
9316,lens fiber cell morphogenesis (GO:0070309),-5.940825609053238e-11,0.0
9317,acetate ester metabolic process (GO:1900619),-5.940825609053238e-11,0.0
9318,enzyme-directed rRNA pseudouridine synthesis (GO:0000455),-5.940825609053238e-11,0.0
9319,aggrephagy (GO:0035973),-5.940825609053238e-11,0.0
9320,prosthetic group metabolic process (GO:0051189),-5.940825609053238e-11,0.0
9321,cardiolipin acyl-chain remodeling (GO:0035965),-5.940825609053238e-11,0.0
9322,COPI-coated vesicle budding (GO:0035964),-5.940825609053238e-11,0.0
9323,maintenance of DNA repeat elements (GO:0043570),-5.940825609053238e-11,0.0
9324,regulation of DNA duplex unwinding (GO:1905462),-5.940825609053238e-11,0.0
9325,negative regulation of phosphatidylinositol 3-kinase activity (GO:0043553),-5.940825609053238e-11,0.0
9326,activation of phospholipase D activity (GO:0031584),-5.940825609053238e-11,0.0
9327,hemidesmosome assembly (GO:0031581),-5.940825609053238e-11,0.0
9328,membrane raft distribution (GO:0031580),-5.940825609053238e-11,0.0
9329,molybdopterin cofactor metabolic process (GO:0043545),-5.940825609053238e-11,0.0
9330,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-5.940825609053238e-11,0.0
9331,regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905446),-5.940825609053238e-11,0.0
9332,steroid hormone secretion (GO:0035929),-5.940825609053238e-11,0.0
9333,regulation of NK T cell differentiation (GO:0051136),-5.940825609053238e-11,0.0
9334,mitochondrial DNA repair (GO:0043504),-5.940825609053238e-11,0.0
9335,positive regulation of exit from mitosis (GO:0031536),-5.940825609053238e-11,0.0
9336,retinal cell apoptotic process (GO:1990009),-5.940825609053238e-11,0.0
9337,regulation of DNA ligation (GO:0051105),-5.940825609053238e-11,0.0
9338,response to blue light (GO:0009637),-5.940825609053238e-11,0.0
9339,establishment of protein localization to telomere (GO:0070200),-5.940825609053238e-11,0.0
9340,positive regulation of macrophage proliferation (GO:0120041),-5.940825609053238e-11,0.0
9341,regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904904),-5.940825609053238e-11,0.0
9342,vesicle tethering to Golgi (GO:0099041),-5.940825609053238e-11,0.0
9343,mRNA 5'-splice site recognition (GO:0000395),-5.940825609053238e-11,0.0
9344,mRNA 3'-splice site recognition (GO:0000389),-5.940825609053238e-11,0.0
9345,imitative learning (GO:0098596),-5.940825609053238e-11,0.0
9346,regulation of pentose-phosphate shunt (GO:0043456),-5.940825609053238e-11,0.0
9347,detection of virus (GO:0009597),-5.940825609053238e-11,0.0
9348,tRNA transport (GO:0051031),-5.940825609053238e-11,0.0
9349,snRNA transport (GO:0051030),-5.940825609053238e-11,0.0
9350,positive regulation of skeletal muscle tissue regeneration (GO:0043415),-5.940825609053238e-11,0.0
9351,negative regulation of lipoprotein lipase activity (GO:0051005),-5.940825609053238e-11,0.0
9352,positive regulation of Golgi to plasma membrane protein transport (GO:0042998),-5.940825609053238e-11,0.0
9353,negative regulation of Golgi to plasma membrane protein transport (GO:0042997),-5.940825609053238e-11,0.0
9354,regulation of isotype switching to IgA isotypes (GO:0048296),-5.940825609053238e-11,0.0
9355,activation of Janus kinase activity (GO:0042976),-5.940825609053238e-11,0.0
9356,determination of dorsal/ventral asymmetry (GO:0048262),-5.940825609053238e-11,0.0
9357,glucocorticoid receptor signaling pathway (GO:0042921),-5.940825609053238e-11,0.0
9358,protein localization to microtubule plus-end (GO:1904825),-5.940825609053238e-11,0.0
9359,COPI coating of Golgi vesicle (GO:0048205),-5.940825609053238e-11,0.0
9360,Golgi transport vesicle coating (GO:0048200),-5.940825609053238e-11,0.0
9361,regulation of glutamate receptor signaling pathway (GO:1900449),-5.940825609053238e-11,0.0
9362,paranodal junction assembly (GO:0030913),-5.940825609053238e-11,0.0
9363,peptidoglycan metabolic process (GO:0000270),-5.940825609053238e-11,0.0
9364,B cell chemotaxis (GO:0035754),-5.940825609053238e-11,0.0
9365,interleukin-15-mediated signaling pathway (GO:0035723),-5.940825609053238e-11,0.0
9366,regulation of connective tissue replacement (GO:1905203),-5.940825609053238e-11,0.0
9367,gamma-aminobutyric acid biosynthetic process (GO:0009449),-5.940825609053238e-11,0.0
9368,positive regulation of core promoter binding (GO:1904798),-5.940825609053238e-11,0.0
9369,protein nitrosylation (GO:0017014),-5.940825609053238e-11,0.0
9370,positive regulation of NMDA glutamate receptor activity (GO:1904783),-5.940825609053238e-11,0.0
9371,positive regulation of long-term neuronal synaptic plasticity (GO:0048170),-5.940825609053238e-11,0.0
9372,positive regulation of protein localization to cell cortex (GO:1904778),-5.940825609053238e-11,0.0
9373,positive regulation of protein localization to nucleolus (GO:1904751),-5.940825609053238e-11,0.0
9374,positive regulation of apoptotic process involved in development (GO:1904747),-5.940825609053238e-11,0.0
9375,negative regulation of apoptotic process involved in development (GO:1904746),-5.940825609053238e-11,0.0
9376,negative regulation of purine nucleotide biosynthetic process (GO:1900372),-5.940825609053238e-11,0.0
9377,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-5.940825609053238e-11,0.0
9378,histone H3-K9 trimethylation (GO:0036124),-5.940825609053238e-11,0.0
9379,fatty-acyl-CoA catabolic process (GO:0036115),-5.940825609053238e-11,0.0
9380,medium-chain fatty-acyl-CoA metabolic process (GO:0036112),-5.940825609053238e-11,0.0
9381,negative regulation of nucleotide biosynthetic process (GO:0030809),-5.940825609053238e-11,0.0
9382,leukotriene B4 metabolic process (GO:0036102),-5.940825609053238e-11,0.0
9383,mitochondrial protein catabolic process (GO:0035694),-5.940825609053238e-11,0.0
9384,protein side chain deglutamylation (GO:0035610),-5.940825609053238e-11,0.0
9385,C-terminal protein deglutamylation (GO:0035609),-5.940825609053238e-11,0.0
9386,5S class rRNA transcription by RNA polymerase III (GO:0042791),-5.940825609053238e-11,0.0
9387,nucleolar large rRNA transcription by RNA polymerase I (GO:0042790),-5.940825609053238e-11,0.0
9388,regulation of cytoplasmic translational initiation (GO:1904688),-5.940825609053238e-11,0.0
9389,flavin-containing compound metabolic process (GO:0042726),-5.940825609053238e-11,0.0
9390,positive regulation of synaptic vesicle endocytosis (GO:1900244),-5.940825609053238e-11,0.0
9391,cellular response to erythropoietin (GO:0036018),-5.940825609053238e-11,0.0
9392,mitotic S phase (GO:0000084),-5.940825609053238e-11,0.0
9393,negative regulation of guanyl-nucleotide exchange factor activity (GO:1905098),-5.940825609053238e-11,0.0
9394,endoplasmic reticulum-plasma membrane tethering (GO:0061817),-5.940825609053238e-11,0.0
9395,L-proline biosynthetic process (GO:0055129),-5.940825609053238e-11,0.0
9396,positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-5.940825609053238e-11,0.0
9397,induction of bacterial agglutination (GO:0043152),-5.940825609053238e-11,0.0
9398,diadenosine polyphosphate catabolic process (GO:0015961),-5.940825609053238e-11,0.0
9399,positive regulation of metallopeptidase activity (GO:1905050),-5.940825609053238e-11,0.0
9400,formate metabolic process (GO:0015942),-5.940825609053238e-11,0.0
9401,oxidative DNA demethylation (GO:0035511),-5.940825609053238e-11,0.0
9402,10-formyltetrahydrofolate metabolic process (GO:0009256),-5.940825609053238e-11,0.0
9403,peptidoglycan catabolic process (GO:0009253),-5.940825609053238e-11,0.0
9404,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-5.940825609053238e-11,0.0
9405,protein lipoylation (GO:0009249),-5.940825609053238e-11,0.0
9406,tRNA pseudouridine synthesis (GO:0031119),-5.940825609053238e-11,0.0
9407,extracellular exosome biogenesis (GO:0097734),-5.940825609053238e-11,0.0
9408,positive regulation of microtubule binding (GO:1904528),-5.940825609053238e-11,0.0
9409,regulation of bone mineralization involved in bone maturation (GO:1900157),-5.940825609053238e-11,0.0
9410,connective tissue replacement (GO:0097709),-5.940825609053238e-11,0.0
9411,female meiosis chromosome segregation (GO:0016321),-5.940825609053238e-11,0.0
9412,asymmetric neuroblast division (GO:0055059),-5.940825609053238e-11,0.0
9413,norepinephrine transport (GO:0015874),-5.940825609053238e-11,0.0
9414,copper ion transmembrane transport (GO:0035434),-5.940825609053238e-11,0.0
9415,atrial cardiac muscle tissue morphogenesis (GO:0055009),-5.940825609053238e-11,0.0
9416,deoxyribonucleoside diphosphate metabolic process (GO:0009186),-5.940825609053238e-11,0.0
9417,pyrimidine ribonucleoside monophosphate catabolic process (GO:0009175),-5.940825609053238e-11,0.0
9418,purine deoxyribonucleoside monophosphate catabolic process (GO:0009172),-5.940825609053238e-11,0.0
9419,tryptophan transport (GO:0015827),-5.940825609053238e-11,0.0
9420,leucine transport (GO:0015820),-5.940825609053238e-11,0.0
9421,positive regulation of hemoglobin biosynthetic process (GO:0046985),-5.940825609053238e-11,0.0
9422,pyrimidine nucleoside diphosphate biosynthetic process (GO:0009139),-5.940825609053238e-11,0.0
9423,purine nucleoside diphosphate biosynthetic process (GO:0009136),-5.940825609053238e-11,0.0
9424,R-loop disassembly (GO:0062176),-5.940825609053238e-11,0.0
9425,ketone body biosynthetic process (GO:0046951),-5.940825609053238e-11,0.0
9426,double-strand break repair via classical nonhomologous end joining (GO:0097680),-5.940825609053238e-11,0.0
9427,regulation of matrix metallopeptidase secretion (GO:1904464),-5.940825609053238e-11,0.0
9428,hemoglobin biosynthetic process (GO:0042541),-5.940825609053238e-11,0.0
9429,ubiquitin-dependent SMAD protein catabolic process (GO:0030579),-5.940825609053238e-11,0.0
9430,regulation of SMAD protein complex assembly (GO:0010990),-5.940825609053238e-11,0.0
9431,positive regulation of lipoprotein particle clearance (GO:0010986),-5.940825609053238e-11,0.0
9432,regulation of t-circle formation (GO:1904429),-5.940825609053238e-11,0.0
9433,negative regulation of tubulin deacetylation (GO:1904428),-5.940825609053238e-11,0.0
9434,attachment of GPI anchor to protein (GO:0016255),-5.940825609053238e-11,0.0
9435,regulation of very-low-density lipoprotein particle remodeling (GO:0010901),-5.940825609053238e-11,0.0
9436,negative regulation of glial cell migration (GO:1903976),-5.940825609053238e-11,0.0
9437,chemorepulsion of axon (GO:0061643),-5.940825609053238e-11,0.0
9438,regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903972),-5.940825609053238e-11,0.0
9439,regulation of response to macrophage colony-stimulating factor (GO:1903969),-5.940825609053238e-11,0.0
9440,negative regulation of hepatocyte apoptotic process (GO:1903944),-5.940825609053238e-11,0.0
9441,regulation of TORC2 signaling (GO:1903939),-5.940825609053238e-11,0.0
9442,response to sodium arsenite (GO:1903935),-5.940825609053238e-11,0.0
9443,glucose-6-phosphate transport (GO:0015760),-5.940825609053238e-11,0.0
9444,regulation of establishment of T cell polarity (GO:1903903),-5.940825609053238e-11,0.0
9445,bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),-5.940825609053238e-11,0.0
9446,Purkinje myocyte to ventricular cardiac muscle cell communication (GO:0086068),-5.940825609053238e-11,0.0
9447,"pentose-phosphate shunt, non-oxidative branch (GO:0009052)",-5.940825609053238e-11,0.0
9448,hexose phosphate transport (GO:0015712),-5.940825609053238e-11,0.0
9449,positive regulation of follicle-stimulating hormone secretion (GO:0046881),-5.940825609053238e-11,0.0
9450,regulation of follicle-stimulating hormone secretion (GO:0046880),-5.940825609053238e-11,0.0
9451,iodide transport (GO:0015705),-5.940825609053238e-11,0.0
9452,positive regulation of odontogenesis (GO:0042482),-5.940825609053238e-11,0.0
9453,response to L-phenylalanine derivative (GO:1904386),-5.940825609053238e-11,0.0
9454,negative regulation of protein export from nucleus (GO:0046826),-5.940825609053238e-11,0.0
9455,positive regulation of protein catabolic process in the vacuole (GO:1904352),-5.940825609053238e-11,0.0
9456,negative regulation of sequestering of triglyceride (GO:0010891),-5.940825609053238e-11,0.0
9457,"regulation of complement activation, alternative pathway (GO:0030451)",-5.940825609053238e-11,0.0
9458,regulation of cholesterol esterification (GO:0010872),-5.940825609053238e-11,0.0
9459,calcium activated phospholipid scrambling (GO:0061588),-5.940825609053238e-11,0.0
9460,viral RNA genome replication (GO:0039694),-5.940825609053238e-11,0.0
9461,negative regulation of PERK-mediated unfolded protein response (GO:1903898),-5.940825609053238e-11,0.0
9462,copper ion import (GO:0015677),-5.940825609053238e-11,0.0
9463,negative regulation of ERAD pathway (GO:1904293),-5.940825609053238e-11,0.0
9464,regulation of spontaneous synaptic transmission (GO:0150003),-5.940825609053238e-11,0.0
9465,vitamin E metabolic process (GO:0042360),-5.940825609053238e-11,0.0
9466,regulation of mRNA export from nucleus (GO:0010793),-5.940825609053238e-11,0.0
9467,monoterpenoid metabolic process (GO:0016098),-5.940825609053238e-11,0.0
9468,DNA double-strand break processing involved in repair via single-strand annealing (GO:0010792),-5.940825609053238e-11,0.0
9469,negative regulation of cGMP-mediated signaling (GO:0010754),-5.940825609053238e-11,0.0
9470,positive regulation of cGMP-mediated signaling (GO:0010753),-5.940825609053238e-11,0.0
9471,rhodopsin mediated signaling pathway (GO:0016056),-5.940825609053238e-11,0.0
9472,regulation of long-chain fatty acid import across plasma membrane (GO:0010746),-5.940825609053238e-11,0.0
9473,positive regulation of hydrogen peroxide metabolic process (GO:0010726),-5.940825609053238e-11,0.0
9474,T follicular helper cell differentiation (GO:0061470),-5.940825609053238e-11,0.0
9475,regulation of inorganic anion transmembrane transport (GO:1903795),-5.940825609053238e-11,0.0
9476,guanine nucleotide transmembrane transport (GO:1903790),-5.940825609053238e-11,0.0
9477,ganglioside biosynthetic process via lactosylceramide (GO:0010706),-5.940825609053238e-11,0.0
9478,endocardial cell differentiation (GO:0060956),-5.940825609053238e-11,0.0
9479,vocal learning (GO:0042297),-5.940825609053238e-11,0.0
9480,sinoatrial node cell differentiation (GO:0060921),-5.940825609053238e-11,0.0
9481,negative regulation of membrane depolarization (GO:1904180),-5.940825609053238e-11,0.0
9482,protection from natural killer cell mediated cytotoxicity (GO:0042270),-5.940825609053238e-11,0.0
9483,DNA protection (GO:0042262),-5.940825609053238e-11,0.0
9484,axonemal central apparatus assembly (GO:1904158),-5.940825609053238e-11,0.0
9485,positive regulation of alkaline phosphatase activity (GO:0010694),-5.940825609053238e-11,0.0
9486,growth hormone secretion (GO:0030252),-5.940825609053238e-11,0.0
9487,autophagy of peroxisome (GO:0030242),-5.940825609053238e-11,0.0
9488,skeletal muscle thin filament assembly (GO:0030240),-5.940825609053238e-11,0.0
9489,L-histidine transmembrane transport (GO:0089709),-5.940825609053238e-11,0.0
9490,dermatan sulfate metabolic process (GO:0030205),-5.940825609053238e-11,0.0
9491,positive regulation of cytoplasmic mRNA processing body assembly (GO:0010606),-5.940825609053238e-11,0.0
9492,cell adhesion involved in heart morphogenesis (GO:0061343),-5.940825609053238e-11,0.0
9493,retinal blood vessel morphogenesis (GO:0061304),-5.940825609053238e-11,0.0
9494,regulation of protein tyrosine phosphatase activity (GO:1903613),-5.940825609053238e-11,0.0
9495,positive regulation of Rac protein signal transduction (GO:0035022),-5.940825609053238e-11,0.0
9496,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800),-5.940825609053238e-11,0.0
9497,neural plate pattern specification (GO:0060896),-5.940825609053238e-11,0.0
9498,arterial endothelial cell differentiation (GO:0060842),-5.940825609053238e-11,0.0
9499,negative regulation of photoreceptor cell differentiation (GO:0046533),-5.940825609053238e-11,0.0
9500,regulation of photoreceptor cell differentiation (GO:0046532),-5.940825609053238e-11,0.0
9501,acetylcholine metabolic process (GO:0008291),-5.940825609053238e-11,0.0
9502,positive regulation of nuclear cell cycle DNA replication (GO:0010571),-5.940825609053238e-11,0.0
9503,cellular response to gonadotropin-releasing hormone (GO:0097211),-5.940825609053238e-11,0.0
9504,spermine metabolic process (GO:0008215),-5.940825609053238e-11,0.0
9505,mineralocorticoid metabolic process (GO:0008212),-5.940825609053238e-11,0.0
9506,regulation of extracellular exosome assembly (GO:1903551),-5.940825609053238e-11,0.0
9507,regulation of membrane tubulation (GO:1903525),-5.940825609053238e-11,0.0
9508,Mo-molybdopterin cofactor metabolic process (GO:0019720),-5.940825609053238e-11,0.0
9509,negative regulation of epithelial cell proliferation involved in prostate gland development (GO:0060770),-5.940825609053238e-11,0.0
9510,cardiac endothelial cell differentiation (GO:0003348),-5.940825609053238e-11,0.0
9511,positive regulation of mast cell chemotaxis (GO:0060754),-5.940825609053238e-11,0.0
9512,chorionic trophoblast cell differentiation (GO:0060718),-5.940825609053238e-11,0.0
9513,positive regulation of inhibitory postsynaptic potential (GO:0097151),-5.940825609053238e-11,0.0
9514,positive regulation of hypersensitivity (GO:0002885),-5.940825609053238e-11,0.0
9515,gastro-intestinal system smooth muscle contraction (GO:0014831),-5.940825609053238e-11,0.0
9516,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),-5.940825609053238e-11,0.0
9517,postsynaptic density protein 95 clustering (GO:0097119),-5.940825609053238e-11,0.0
9518,positive regulation of T cell mediated immune response to tumor cell (GO:0002842),-5.940825609053238e-11,0.0
9519,regulation of somitogenesis (GO:0014807),-5.940825609053238e-11,0.0
9520,fungiform papilla development (GO:0061196),-5.940825609053238e-11,0.0
9521,regulation of chondrocyte development (GO:0061181),-5.940825609053238e-11,0.0
9522,choline metabolic process (GO:0019695),-5.940825609053238e-11,0.0
9523,glyceraldehyde-3-phosphate metabolic process (GO:0019682),-5.940825609053238e-11,0.0
9524,anterior commissure morphogenesis (GO:0021960),-5.940825609053238e-11,0.0
9525,response to glycoside (GO:1903416),-5.940825609053238e-11,0.0
9526,response to bile acid (GO:1903412),-5.940825609053238e-11,0.0
9527,osteoclast fusion (GO:0072675),-5.940825609053238e-11,0.0
9528,neutrophil extravasation (GO:0072672),-5.940825609053238e-11,0.0
9529,ureteric bud elongation (GO:0060677),-5.940825609053238e-11,0.0
9530,5-phosphoribose 1-diphosphate metabolic process (GO:0046391),-5.940825609053238e-11,0.0
9531,'de novo' NAD biosynthetic process from tryptophan (GO:0034354),-5.940825609053238e-11,0.0
9532,regulation of antibacterial peptide production (GO:0002786),-5.940825609053238e-11,0.0
9533,positive regulation of muscle adaptation (GO:0014744),-5.940825609053238e-11,0.0
9534,mesodermal cell migration (GO:0008078),-5.940825609053238e-11,0.0
9535,positive regulation of myeloid dendritic cell cytokine production (GO:0002735),-5.940825609053238e-11,0.0
9536,regulation of myeloid dendritic cell cytokine production (GO:0002733),-5.940825609053238e-11,0.0
9537,positive regulation of phospholipid translocation (GO:0061092),-5.940825609053238e-11,0.0
9538,positive regulation of histone H3-K27 methylation (GO:0061087),-5.940825609053238e-11,0.0
9539,olfactory bulb interneuron development (GO:0021891),-5.940825609053238e-11,0.0
9540,regulation of branching involved in lung morphogenesis (GO:0061046),-5.940825609053238e-11,0.0
9541,regulation of endoplasmic reticulum tubular network organization (GO:1903371),-5.940825609053238e-11,0.0
9542,uterus morphogenesis (GO:0061038),-5.940825609053238e-11,0.0
9543,L-ornithine transmembrane transport (GO:1903352),-5.940825609053238e-11,0.0
9544,hypothalamic tangential migration using cell-axon interactions (GO:0021856),-5.940825609053238e-11,0.0
9545,cerebral cortex GABAergic interneuron migration (GO:0021853),-5.940825609053238e-11,0.0
9546,gonadotrophin-releasing hormone neuronal migration to the hypothalamus (GO:0021828),-5.940825609053238e-11,0.0
9547,positive regulation of hexokinase activity (GO:1903301),-5.940825609053238e-11,0.0
9548,tricuspid valve development (GO:0003175),-5.940825609053238e-11,0.0
9549,cerebral cortex tangential migration (GO:0021800),-5.940825609053238e-11,0.0
9550,bundle of His development (GO:0003166),-5.940825609053238e-11,0.0
9551,endocardium morphogenesis (GO:0003160),-5.940825609053238e-11,0.0
9552,fibroblast activation (GO:0072537),-5.940825609053238e-11,0.0
9553,positive regulation of necroptotic process (GO:0060545),-5.940825609053238e-11,0.0
9554,regulation of amacrine cell differentiation (GO:1902869),-5.940825609053238e-11,0.0
9555,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:0060527),-5.940825609053238e-11,0.0
9556,prostate glandular acinus morphogenesis (GO:0060526),-5.940825609053238e-11,0.0
9557,regulation of systemic arterial blood pressure by endothelin (GO:0003100),-5.940825609053238e-11,0.0
9558,type II pneumocyte differentiation (GO:0060510),-5.940825609053238e-11,0.0
9559,regulation of synaptic vesicle transport (GO:1902803),-5.940825609053238e-11,0.0
9560,positive regulation of cell size (GO:0045793),-6.054312606623615e-11,0.0
9561,positive regulation of tolerance induction (GO:0002645),-6.054312606623615e-11,0.0
9562,positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-6.054312606623615e-11,0.0
9563,positive regulation of leukocyte tethering or rolling (GO:1903238),-6.054312606623615e-11,0.0
9564,phospholipid efflux (GO:0033700),-6.054312606623615e-11,0.0
9565,cellular response to nitrogen starvation (GO:0006995),-6.054312606623615e-11,0.0
9566,response to sterol depletion (GO:0006991),-6.054312606623615e-11,0.0
9567,ER overload response (GO:0006983),-6.054312606623615e-11,0.0
9568,hypotonic response (GO:0006971),-6.054312606623615e-11,0.0
9569,purine ribonucleoside biosynthetic process (GO:0046129),-6.054312606623615e-11,0.0
9570,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-6.054312606623615e-11,0.0
9571,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-6.054312606623615e-11,0.0
9572,nitrogen cycle metabolic process (GO:0071941),-6.054312606623615e-11,0.0
9573,negative regulation of osteoblast proliferation (GO:0033689),-6.054312606623615e-11,0.0
9574,lateral ventricle development (GO:0021670),-6.054312606623615e-11,0.0
9575,negative regulation of cell adhesion mediated by integrin (GO:0033629),-6.054312606623615e-11,0.0
9576,pentose metabolic process (GO:0019321),-6.054312606623615e-11,0.0
9577,cytidine metabolic process (GO:0046087),-6.054312606623615e-11,0.0
9578,positive regulation of steroid hormone secretion (GO:2000833),-6.054312606623615e-11,0.0
9579,glomerular epithelial cell development (GO:0072310),-6.054312606623615e-11,0.0
9580,regulation of axon guidance (GO:1902667),-6.054312606623615e-11,0.0
9581,interferon-gamma-mediated signaling pathway (GO:0060333),-6.054312606623615e-11,0.0
9582,UTP metabolic process (GO:0046051),-6.054312606623615e-11,0.0
9583,establishment of sister chromatid cohesion (GO:0034085),-6.054312606623615e-11,0.0
9584,cellular response to epinephrine stimulus (GO:0071872),-6.054312606623615e-11,0.0
9585,regulation of unsaturated fatty acid biosynthetic process (GO:2001279),-6.054312606623615e-11,0.0
9586,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-6.054312606623615e-11,0.0
9587,positive regulation of vasculogenesis (GO:2001214),-6.054312606623615e-11,0.0
9588,suckling behavior (GO:0001967),-6.054312606623615e-11,0.0
9589,I-kappaB phosphorylation (GO:0007252),-6.054312606623615e-11,0.0
9590,positive regulation of cellular senescence (GO:2000774),-6.054312606623615e-11,0.0
9591,positive regulation of receptor recycling (GO:0001921),-6.054312606623615e-11,0.0
9592,alditol phosphate metabolic process (GO:0052646),-6.054312606623615e-11,0.0
9593,regulation of apoptotic DNA fragmentation (GO:1902510),-6.054312606623615e-11,0.0
9594,regulation of dendritic cell differentiation (GO:2001198),-6.054312606623615e-11,0.0
9595,ER-associated misfolded protein catabolic process (GO:0071712),-6.054312606623615e-11,0.0
9596,endothelial cell morphogenesis (GO:0001886),-6.054312606623615e-11,0.0
9597,receptor recycling (GO:0001881),-6.054312606623615e-11,0.0
9598,regulation of receptor catabolic process (GO:2000644),-6.054312606623615e-11,0.0
9599,"regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000622)",-6.054312606623615e-11,0.0
9600,ectodermal placode morphogenesis (GO:0071697),-6.054312606623615e-11,0.0
9601,regulation of transforming growth factor beta1 production (GO:0032908),-6.054312606623615e-11,0.0
9602,T-helper cell lineage commitment (GO:0002295),-6.054312606623615e-11,0.0
9603,regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-6.054312606623615e-11,0.0
9604,Leydig cell differentiation (GO:0033327),-6.054312606623615e-11,0.0
9605,immunological synapse formation (GO:0001771),-6.054312606623615e-11,0.0
9606,loop of Henle development (GO:0072070),-6.054312606623615e-11,0.0
9607,bile acid signaling pathway (GO:0038183),-6.054312606623615e-11,0.0
9608,nerve growth factor signaling pathway (GO:0038180),-6.054312606623615e-11,0.0
9609,outer mitochondrial membrane organization (GO:0007008),-6.054312606623615e-11,0.0
9610,distal tubule development (GO:0072017),-6.054312606623615e-11,0.0
9611,convergent extension (GO:0060026),-6.054312606623615e-11,0.0
9612,regulation of dendritic cell chemotaxis (GO:2000508),-6.054312606623615e-11,0.0
9613,mitochondrial tRNA processing (GO:0090646),-6.054312606623615e-11,0.0
9614,nodal signaling pathway (GO:0038092),-6.054312606623615e-11,0.0
9615,negative regulation of monooxygenase activity (GO:0032769),-6.054312606623615e-11,0.0
9616,collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-6.054312606623615e-11,0.0
9617,negative regulation of delayed rectifier potassium channel activity (GO:1902260),-6.054312606623615e-11,0.0
9618,cellular response to X-ray (GO:0071481),-6.054312606623615e-11,0.0
9619,regulation of respiratory gaseous exchange by nervous system process (GO:0002087),-6.054312606623615e-11,0.0
9620,positive regulation of glutamate secretion (GO:0014049),-6.054312606623615e-11,0.0
9621,columnar/cuboidal epithelial cell maturation (GO:0002069),-6.054312606623615e-11,0.0
9622,G protein-coupled receptor internalization (GO:0002031),-6.054312606623615e-11,0.0
9623,leukotriene D4 metabolic process (GO:1901748),-6.054312606623615e-11,0.0
9624,disaccharide metabolic process (GO:0005984),-6.054312606623615e-11,0.0
9625,glycogen catabolic process (GO:0005980),-6.054312606623615e-11,0.0
9626,positive regulation of platelet aggregation (GO:1901731),-6.054312606623615e-11,0.0
9627,azole transmembrane transport (GO:0045117),-6.054312606623615e-11,0.0
9628,positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),-6.054312606623615e-11,0.0
9629,lipid import into cell (GO:0140354),-6.054312606623615e-11,0.0
9630,adhesion of symbiont to host cell (GO:0044650),-6.054312606623615e-11,0.0
9631,positive regulation of acrosome reaction (GO:2000344),-6.054312606623615e-11,0.0
9632,negative regulation of T-helper 17 type immune response (GO:2000317),-6.054312606623615e-11,0.0
9633,regulation of ceramide biosynthetic process (GO:2000303),-6.054312606623615e-11,0.0
9634,cellular response to follicle-stimulating hormone stimulus (GO:0071372),-6.054312606623615e-11,0.0
9635,positive regulation of hair follicle development (GO:0051798),-6.054312606623615e-11,0.0
9636,protein insertion into mitochondrial outer membrane (GO:0045040),-6.054312606623615e-11,0.0
9637,protein mono-ADP-ribosylation (GO:0140289),-6.054312606623615e-11,0.0
9638,positive regulation of myoblast proliferation (GO:2000288),-6.054312606623615e-11,0.0
9639,endosome to plasma membrane protein transport (GO:0099638),-6.054312606623615e-11,0.0
9640,response to L-glutamate (GO:1902065),-6.054312606623615e-11,0.0
9641,"base-excision repair, AP site formation (GO:0006285)",-6.054312606623615e-11,0.0
9642,somite rostral/caudal axis specification (GO:0032525),-6.054312606623615e-11,0.0
9643,cellular response to manganese ion (GO:0071287),-6.054312606623615e-11,0.0
9644,fatty acid transmembrane transport (GO:1902001),-6.054312606623615e-11,0.0
9645,cytidine catabolic process (GO:0006216),-6.054312606623615e-11,0.0
9646,actin filament network formation (GO:0051639),-6.054312606623615e-11,0.0
9647,ether biosynthetic process (GO:1901503),-6.054312606623615e-11,0.0
9648,negative regulation of platelet aggregation (GO:0090331),-6.054312606623615e-11,0.0
9649,positive regulation of DNA methylation-dependent heterochromatin formation (GO:0090309),-6.054312606623615e-11,0.0
9650,detection of molecule of bacterial origin (GO:0032490),-6.054312606623615e-11,0.0
9651,modification of synaptic structure (GO:0099563),-6.054312606623615e-11,0.0
9652,protein oxidation (GO:0018158),-6.054312606623615e-11,0.0
9653,regulation of presynaptic cytosolic calcium ion concentration (GO:0099509),-6.054312606623615e-11,0.0
9654,cGMP biosynthetic process (GO:0006182),-6.054312606623615e-11,0.0
9655,positive regulation of keratinocyte migration (GO:0051549),-6.054312606623615e-11,0.0
9656,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-6.054312606623615e-11,0.0
9657,negative regulation of protein autophosphorylation (GO:0031953),-6.054312606623615e-11,0.0
9658,positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-6.054312606623615e-11,0.0
9659,positive regulation of spindle checkpoint (GO:0090232),-6.054312606623615e-11,0.0
9660,negative regulation of hormone metabolic process (GO:0032351),-6.054312606623615e-11,0.0
9661,negative regulation of protein localization to cell surface (GO:2000009),-6.054312606623615e-11,0.0
9662,serine transport (GO:0032329),-6.054312606623615e-11,0.0
9663,ethanol catabolic process (GO:0006068),-6.054312606623615e-11,0.0
9664,peptidyl-lysine monomethylation (GO:0018026),-6.054312606623615e-11,0.0
9665,double-strand break repair via break-induced replication (GO:0000727),-6.054312606623615e-11,0.0
9666,cytidine deamination (GO:0009972),-6.054312606623615e-11,0.0
9667,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-6.054312606623615e-11,0.0
9668,planar cell polarity pathway involved in neural tube closure (GO:0090179),-6.054312606623615e-11,0.0
9669,collateral sprouting (GO:0048668),-6.054312606623615e-11,0.0
9670,regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),-6.054312606623615e-11,0.0
9671,positive regulation of calcium ion import across plasma membrane (GO:1905665),-6.054312606623615e-11,0.0
9672,regulation of ligase activity (GO:0051340),-6.054312606623615e-11,0.0
9673,regulation of protein deubiquitination (GO:0090085),-6.054312606623615e-11,0.0
9674,post-embryonic animal organ morphogenesis (GO:0048563),-6.054312606623615e-11,0.0
9675,regulation of pinocytosis (GO:0048548),-6.054312606623615e-11,0.0
9676,cellular response to cold (GO:0070417),-6.054312606623615e-11,0.0
9677,negative regulation of behavior (GO:0048521),-6.054312606623615e-11,0.0
9678,olefinic compound biosynthetic process (GO:0120255),-6.054312606623615e-11,0.0
9679,regulation of heat generation (GO:0031650),-6.054312606623615e-11,0.0
9680,negative regulation of macrophage migration (GO:1905522),-6.054312606623615e-11,0.0
9681,insulin metabolic process (GO:1901142),-6.054312606623615e-11,0.0
9682,regulation of postsynaptic density assembly (GO:0099151),-6.054312606623615e-11,0.0
9683,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-6.054312606623615e-11,0.0
9684,chondrocyte proliferation (GO:0035988),-6.054312606623615e-11,0.0
9685,hemoglobin metabolic process (GO:0020027),-6.054312606623615e-11,0.0
9686,skin morphogenesis (GO:0043589),-6.054312606623615e-11,0.0
9687,cellular response to nitrogen levels (GO:0043562),-6.054312606623615e-11,0.0
9688,regulation of lymphoid progenitor cell differentiation (GO:1905456),-6.054312606623615e-11,0.0
9689,homocysteine metabolic process (GO:0050667),-6.054312606623615e-11,0.0
9690,midbrain dopaminergic neuron differentiation (GO:1904948),-6.054312606623615e-11,0.0
9691,protein auto-ADP-ribosylation (GO:0070213),-6.054312606623615e-11,0.0
9692,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-6.054312606623615e-11,0.0
9693,regulation of establishment of protein localization to chromosome (GO:0070202),-6.054312606623615e-11,0.0
9694,Golgi inheritance (GO:0048313),-6.054312606623615e-11,0.0
9695,organelle inheritance (GO:0048308),-6.054312606623615e-11,0.0
9696,regulation of helicase activity (GO:0051095),-6.054312606623615e-11,0.0
9697,cellular pigment accumulation (GO:0043482),-6.054312606623615e-11,0.0
9698,pigment accumulation (GO:0043476),-6.054312606623615e-11,0.0
9699,regulation of tooth mineralization (GO:0070170),-6.054312606623615e-11,0.0
9700,elastic fiber assembly (GO:0048251),-6.054312606623615e-11,0.0
9701,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-6.054312606623615e-11,0.0
9702,insulin secretion involved in cellular response to glucose stimulus (GO:0035773),-6.054312606623615e-11,0.0
9703,regulation of memory T cell differentiation (GO:0043380),-6.054312606623615e-11,0.0
9704,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-6.054312606623615e-11,0.0
9705,cytidine to uridine editing (GO:0016554),-6.054312606623615e-11,0.0
9706,anoikis (GO:0043276),-6.054312606623615e-11,0.0
9707,membrane protein intracellular domain proteolysis (GO:0031293),-6.054312606623615e-11,0.0
9708,auditory behavior (GO:0031223),-6.054312606623615e-11,0.0
9709,"CD8-positive, alpha-beta T cell activation (GO:0036037)",-6.054312606623615e-11,0.0
9710,protein localization to endosome (GO:0036010),-6.054312606623615e-11,0.0
9711,positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-6.054312606623615e-11,0.0
9712,response to macrophage colony-stimulating factor (GO:0036005),-6.054312606623615e-11,0.0
9713,sno(s)RNA 3'-end processing (GO:0031126),-6.054312606623615e-11,0.0
9714,cobalamin metabolic process (GO:0009235),-6.054312606623615e-11,0.0
9715,regulation of vitamin metabolic process (GO:0030656),-6.054312606623615e-11,0.0
9716,"negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900152)",-6.054312606623615e-11,0.0
9717,positive regulation of telomere maintenance in response to DNA damage (GO:1904507),-6.054312606623615e-11,0.0
9718,extracellular negative regulation of signal transduction (GO:1900116),-6.054312606623615e-11,0.0
9719,extracellular regulation of signal transduction (GO:1900115),-6.054312606623615e-11,0.0
9720,SNARE complex assembly (GO:0035493),-6.054312606623615e-11,0.0
9721,pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174),-6.054312606623615e-11,0.0
9722,nucleoside diphosphate catabolic process (GO:0009134),-6.054312606623615e-11,0.0
9723,nucleoside monophosphate phosphorylation (GO:0046940),-6.054312606623615e-11,0.0
9724,negative regulation of neurotransmitter secretion (GO:0046929),-6.054312606623615e-11,0.0
9725,negative regulation of macrophage cytokine production (GO:0010936),-6.054312606623615e-11,0.0
9726,positive regulation of mitochondrial membrane potential (GO:0010918),-6.054312606623615e-11,0.0
9727,regulation of protein complex stability (GO:0061635),-6.054312606623615e-11,0.0
9728,polyol transmembrane transport (GO:0015791),-6.054312606623615e-11,0.0
9729,nucleotide-sugar transmembrane transport (GO:0015780),-6.054312606623615e-11,0.0
9730,methionine biosynthetic process (GO:0009086),-6.054312606623615e-11,0.0
9731,vacuole fusion (GO:0097576),-6.054312606623615e-11,0.0
9732,ribonucleoside biosynthetic process (GO:0042455),-6.054312606623615e-11,0.0
9733,purine nucleoside biosynthetic process (GO:0042451),-6.054312606623615e-11,0.0
9734,regulation of protein catabolic process in the vacuole (GO:1904350),-6.054312606623615e-11,0.0
9735,hormone catabolic process (GO:0042447),-6.054312606623615e-11,0.0
9736,synaptic vesicle maturation (GO:0016188),-6.054312606623615e-11,0.0
9737,peristalsis (GO:0030432),-6.054312606623615e-11,0.0
9738,regulation of protein ADP-ribosylation (GO:0010835),-6.054312606623615e-11,0.0
9739,negative regulation of centrosome duplication (GO:0010826),-6.054312606623615e-11,0.0
9740,extraembryonic membrane development (GO:1903867),-6.054312606623615e-11,0.0
9741,positive regulation of miRNA maturation (GO:1903800),-6.054312606623615e-11,0.0
9742,regulation of deacetylase activity (GO:0150065),-6.054312606623615e-11,0.0
9743,membrane disassembly (GO:0030397),-6.054312606623615e-11,0.0
9744,tRNA catabolic process (GO:0016078),-6.054312606623615e-11,0.0
9745,regulation of adipose tissue development (GO:1904177),-6.054312606623615e-11,0.0
9746,negative regulation of centrosome cycle (GO:0046606),-6.054312606623615e-11,0.0
9747,mitochondrial outer membrane permeabilization (GO:0097345),-6.054312606623615e-11,0.0
9748,lipid glycosylation (GO:0030259),-6.054312606623615e-11,0.0
9749,regulation of mitochondrial fusion (GO:0010635),-6.054312606623615e-11,0.0
9750,cardiac neural crest cell development involved in heart development (GO:0061308),-6.054312606623615e-11,0.0
9751,cardiac neural crest cell differentiation involved in heart development (GO:0061307),-6.054312606623615e-11,0.0
9752,retinal cone cell development (GO:0046549),-6.054312606623615e-11,0.0
9753,neurotransmitter catabolic process (GO:0042135),-6.054312606623615e-11,0.0
9754,negative regulation of glycoprotein biosynthetic process (GO:0010561),-6.054312606623615e-11,0.0
9755,negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-6.054312606623615e-11,0.0
9756,ectodermal placode formation (GO:0060788),-6.054312606623615e-11,0.0
9757,response to hydroxyurea (GO:0072710),-6.054312606623615e-11,0.0
9758,urate metabolic process (GO:0046415),-6.054312606623615e-11,0.0
9759,negative regulation of myeloid leukocyte mediated immunity (GO:0002887),-6.054312606623615e-11,0.0
9760,regulation of skeletal muscle satellite cell proliferation (GO:0014842),-6.054312606623615e-11,0.0
9761,actin filament depolymerization (GO:0030042),-6.054312606623615e-11,0.0
9762,hypothalamus cell differentiation (GO:0021979),-6.054312606623615e-11,0.0
9763,urea metabolic process (GO:0019627),-6.054312606623615e-11,0.0
9764,mitotic DNA replication (GO:1902969),-6.054312606623615e-11,0.0
9765,positive regulation of smooth muscle cell apoptotic process (GO:0034393),-6.054312606623615e-11,0.0
9766,high-density lipoprotein particle assembly (GO:0034380),-6.054312606623615e-11,0.0
9767,regulation of dendritic spine maintenance (GO:1902950),-6.054312606623615e-11,0.0
9768,vascular associated smooth muscle cell development (GO:0097084),-6.054312606623615e-11,0.0
9769,regulation of skeletal muscle adaptation (GO:0014733),-6.054312606623615e-11,0.0
9770,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-6.054312606623615e-11,0.0
9771,pyramidal neuron development (GO:0021860),-6.054312606623615e-11,0.0
9772,sinoatrial node development (GO:0003163),-6.054312606623615e-11,0.0
9773,endocardium development (GO:0003157),-6.054312606623615e-11,0.0
9774,heart field specification (GO:0003128),-6.054312606623615e-11,0.0
9775,regulation of non-motile cilium assembly (GO:1902855),-6.054312606623615e-11,0.0
9776,positive regulation of endothelial cell proliferation (GO:0001938),-6.344080816032818e-11,0.0
9777,acylglycerol metabolic process (GO:0006639),-6.344080816032818e-11,0.0
9778,mitotic spindle organization (GO:0007052),-6.344080816032818e-11,0.0
9779,maintenance of location in cell (GO:0051651),-6.344080816032818e-11,0.0
9780,regulation of nucleotide metabolic process (GO:0006140),-6.344080816032818e-11,0.0
9781,purine nucleoside triphosphate biosynthetic process (GO:0009145),-6.344080816032818e-11,0.0
9782,regulation of axon extension (GO:0030516),-6.344080816032818e-11,0.0
9783,xenobiotic metabolic process (GO:0006805),-6.401434937481299e-11,0.0
9784,steroid biosynthetic process (GO:0006694),-6.401434937481299e-11,0.0
9785,recombinational repair (GO:0000725),-6.401434937481299e-11,0.0
9786,cellular response to reactive oxygen species (GO:0034614),-6.401434937481299e-11,0.0
9787,glycosaminoglycan metabolic process (GO:0030203),-6.401434937481299e-11,0.0
9788,positive regulation of proteolysis (GO:0045862),-6.442313349245371e-11,0.7885484488701646
9789,multicellular organismal homeostasis (GO:0048871),-6.675748842387746e-11,0.7740225563909774
9790,protein-containing complex disassembly (GO:0032984),-6.760125792253589e-11,0.0
9791,internal protein amino acid acetylation (GO:0006475),-6.760125792253589e-11,0.0
9792,acyl-CoA metabolic process (GO:0006637),-6.879852243221001e-11,0.0
9793,centrosome cycle (GO:0007098),-6.879852243221001e-11,0.0
9794,leukocyte homeostasis (GO:0001776),-6.879852243221001e-11,0.0
9795,protein O-linked glycosylation (GO:0006493),-6.879852243221001e-11,0.0
9796,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-6.879852243221001e-11,0.0
9797,mitochondrial transmembrane transport (GO:1990542),-6.879852243221001e-11,0.0
9798,dicarboxylic acid metabolic process (GO:0043648),-6.879852243221001e-11,0.0
9799,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-6.879852243221001e-11,0.0
9800,sterol homeostasis (GO:0055092),-6.879852243221001e-11,0.0
9801,thioester metabolic process (GO:0035383),-6.879852243221001e-11,0.0
9802,cellular response to UV (GO:0034644),-6.879852243221001e-11,0.0
9803,lipoprotein biosynthetic process (GO:0042158),-6.879852243221001e-11,0.0
9804,lipid oxidation (GO:0034440),-6.879852243221001e-11,0.0
9805,positive regulation of cellular catabolic process (GO:0031331),-6.881695213441752e-11,0.7156412930135558
9806,tissue migration (GO:0090130),-6.915046313099191e-11,0.0
9807,regulation of extent of cell growth (GO:0061387),-6.915046313099191e-11,0.0
9808,regulation of DNA replication (GO:0006275),-6.935207963224987e-11,0.0
9809,cellular response to decreased oxygen levels (GO:0036294),-6.935207963224987e-11,0.0
9810,positive regulation of B cell tolerance induction (GO:0002663),-6.948841501966438e-11,0.0
9811,regulation of B cell tolerance induction (GO:0002661),-6.948841501966438e-11,0.0
9812,positive regulation of peripheral tolerance induction (GO:0002660),-6.948841501966438e-11,0.0
9813,regulation of peripheral tolerance induction (GO:0002658),-6.948841501966438e-11,0.0
9814,response to vitamin B1 (GO:0010266),-6.948841501966438e-11,0.0
9815,SCF complex assembly (GO:0010265),-6.948841501966438e-11,0.0
9816,positive regulation of tolerance induction dependent upon immune response (GO:0002654),-6.948841501966438e-11,0.0
9817,negative regulation of intestinal cholesterol absorption (GO:0045796),-6.948841501966438e-11,0.0
9818,positive regulation of germinal center formation (GO:0002636),-6.948841501966438e-11,0.0
9819,negative regulation of germinal center formation (GO:0002635),-6.948841501966438e-11,0.0
9820,regulation of T cell antigen processing and presentation (GO:0002625),-6.948841501966438e-11,0.0
9821,positive regulation of cellular amino acid metabolic process (GO:0045764),-6.948841501966438e-11,0.0
9822,regulation of glutathione peroxidase activity (GO:1903282),-6.948841501966438e-11,0.0
9823,positive regulation of calcium:sodium antiporter activity (GO:1903281),-6.948841501966438e-11,0.0
9824,beta-alanine biosynthetic process (GO:0019483),-6.948841501966438e-11,0.0
9825,negative regulation of integrin biosynthetic process (GO:0045720),-6.948841501966438e-11,0.0
9826,postganglionic parasympathetic fiber development (GO:0021784),-6.948841501966438e-11,0.0
9827,D-amino acid catabolic process (GO:0019478),-6.948841501966438e-11,0.0
9828,posterior midgut development (GO:0007497),-6.948841501966438e-11,0.0
9829,endodermal cell fate determination (GO:0007493),-6.948841501966438e-11,0.0
9830,positive regulation of cardiac muscle hypertrophy in response to stress (GO:1903244),-6.948841501966438e-11,0.0
9831,facial nucleus development (GO:0021754),-6.948841501966438e-11,0.0
9832,pronephric nephron tubule development (GO:0039020),-6.948841501966438e-11,0.0
9833,pattern specification involved in pronephros development (GO:0039017),-6.948841501966438e-11,0.0
9834,principal sensory nucleus of trigeminal nerve development (GO:0021740),-6.948841501966438e-11,0.0
9835,pronephric field specification (GO:0039003),-6.948841501966438e-11,0.0
9836,acetyl-CoA biosynthetic process from acetate (GO:0019427),-6.948841501966438e-11,0.0
9837,trigeminal sensory nucleus development (GO:0021730),-6.948841501966438e-11,0.0
9838,negative regulation of protein processing involved in protein targeting to mitochondrion (GO:1903217),-6.948841501966438e-11,0.0
9839,regulation of protein processing involved in protein targeting to mitochondrion (GO:1903216),-6.948841501966438e-11,0.0
9840,podocyte apoptotic process (GO:1903210),-6.948841501966438e-11,0.0
9841,superior olivary nucleus maturation (GO:0021722),-6.948841501966438e-11,0.0
9842,sulfur oxidation (GO:0019417),-6.948841501966438e-11,0.0
9843,superior olivary nucleus development (GO:0021718),-6.948841501966438e-11,0.0
9844,dolichol biosynthetic process (GO:0019408),-6.948841501966438e-11,0.0
9845,regulation of ATP citrate synthase activity (GO:2000983),-6.948841501966438e-11,0.0
9846,positive regulation of inner ear receptor cell differentiation (GO:2000982),-6.948841501966438e-11,0.0
9847,ectodermal digestive tract development (GO:0007439),-6.948841501966438e-11,0.0
9848,cell-cell signaling involved in lung development (GO:0060495),-6.948841501966438e-11,0.0
9849,regulation of heart rate by hormone (GO:0003064),-6.948841501966438e-11,0.0
9850,cortical granule exocytosis (GO:0060471),-6.948841501966438e-11,0.0
9851,regulation of systemic arterial blood pressure by atrial natriuretic peptide (GO:0003050),-6.948841501966438e-11,0.0
9852,ganglion mother cell fate determination (GO:0007402),-6.948841501966438e-11,0.0
9853,somatic sex determination (GO:0018993),-6.948841501966438e-11,0.0
9854,germ-line sex determination (GO:0018992),-6.948841501966438e-11,0.0
9855,positive regulation of gastric acid secretion (GO:0060454),-6.948841501966438e-11,0.0
9856,D-gluconate catabolic process (GO:0046177),-6.948841501966438e-11,0.0
9857,aldonic acid catabolic process (GO:0046176),-6.948841501966438e-11,0.0
9858,dichotomous subdivision of terminal units involved in lung branching (GO:0060448),-6.948841501966438e-11,0.0
9859,glycerol-3-phosphate catabolic process (GO:0046168),-6.948841501966438e-11,0.0
9860,glyceraldehyde-3-phosphate biosynthetic process (GO:0046166),-6.948841501966438e-11,0.0
9861,heme a metabolic process (GO:0046160),-6.948841501966438e-11,0.0
9862,isoprenoid biosynthetic process via mevalonate (GO:1902767),-6.948841501966438e-11,0.0
9863,skeletal muscle satellite cell migration (GO:1902766),-6.948841501966438e-11,0.0
9864,bronchus morphogenesis (GO:0060434),-6.948841501966438e-11,0.0
9865,positive regulation of chondrocyte development (GO:1902761),-6.948841501966438e-11,0.0
9866,lymph circulation (GO:0003017),-6.948841501966438e-11,0.0
9867,voluntary skeletal muscle contraction (GO:0003010),-6.948841501966438e-11,0.0
9868,phthalate metabolic process (GO:0018963),-6.948841501966438e-11,0.0
9869,pyrimidine deoxyribonucleoside biosynthetic process (GO:0046126),-6.948841501966438e-11,0.0
9870,deoxyribonucleoside biosynthetic process (GO:0046120),-6.948841501966438e-11,0.0
9871,toll-like receptor 8 signaling pathway (GO:0034158),-6.948841501966438e-11,0.0
9872,xanthine metabolic process (GO:0046110),-6.948841501966438e-11,0.0
9873,uridine metabolic process (GO:0046108),-6.948841501966438e-11,0.0
9874,thymidine biosynthetic process (GO:0046105),-6.948841501966438e-11,0.0
9875,negative regulation of antigen processing and presentation of peptide antigen via MHC class I (GO:0002590),-6.948841501966438e-11,0.0
9876,regulation of antigen processing and presentation of peptide antigen via MHC class I (GO:0002589),-6.948841501966438e-11,0.0
9877,positive regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002588),-6.948841501966438e-11,0.0
9878,negative regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002587),-6.948841501966438e-11,0.0
9879,positive regulation of antigen processing and presentation of peptide antigen (GO:0002585),-6.948841501966438e-11,0.0
9880,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002582),-6.948841501966438e-11,0.0
9881,regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),-6.948841501966438e-11,0.0
9882,negative regulation of MyD88-dependent toll-like receptor signaling pathway (GO:0034125),-6.948841501966438e-11,0.0
9883,establishment or maintenance of cell polarity regulating cell shape (GO:0071963),-6.948841501966438e-11,0.0
9884,recycling endosome to Golgi transport (GO:0071955),-6.948841501966438e-11,0.0
9885,serotonin secretion by platelet (GO:0002554),-6.948841501966438e-11,0.0
9886,leukotriene production involved in inflammatory response (GO:0002540),-6.948841501966438e-11,0.0
9887,alpha-tubulin acetylation (GO:0071929),-6.948841501966438e-11,0.0
9888,cohesin loading (GO:0071921),-6.948841501966438e-11,0.0
9889,arachidonic acid metabolite production involved in inflammatory response (GO:0002538),-6.948841501966438e-11,0.0
9890,"farnesyl diphosphate biosynthetic process, mevalonate pathway (GO:0010142)",-6.948841501966438e-11,0.0
9891,phenylacetate catabolic process (GO:0010124),-6.948841501966438e-11,0.0
9892,negative regulation of neutrophil differentiation (GO:0045659),-6.948841501966438e-11,0.0
9893,negative regulation of luteinizing hormone secretion (GO:0033685),-6.948841501966438e-11,0.0
9894,central tolerance induction (GO:0002508),-6.948841501966438e-11,0.0
9895,positive regulation of eosinophil differentiation (GO:0045645),-6.948841501966438e-11,0.0
9896,regulation of eosinophil differentiation (GO:0045643),-6.948841501966438e-11,0.0
9897,positive regulation of mechanoreceptor differentiation (GO:0045633),-6.948841501966438e-11,0.0
9898,positive regulation of dopamine biosynthetic process (GO:1903181),-6.948841501966438e-11,0.0
9899,cerebellar cortex structural organization (GO:0021698),-6.948841501966438e-11,0.0
9900,cerebellar Purkinje cell layer structural organization (GO:0021693),-6.948841501966438e-11,0.0
9901,cerebellar Purkinje cell layer maturation (GO:0021691),-6.948841501966438e-11,0.0
9902,fatty alcohol metabolic process (GO:1903173),-6.948841501966438e-11,0.0
9903,cerebellar molecular layer morphogenesis (GO:0021687),-6.948841501966438e-11,0.0
9904,cerebellar molecular layer development (GO:0021679),-6.948841501966438e-11,0.0
9905,lysobisphosphatidic acid metabolic process (GO:2001311),-6.948841501966438e-11,0.0
9906,positive regulation of inner ear auditory receptor cell differentiation (GO:0045609),-6.948841501966438e-11,0.0
9907,negative regulation of cell-cell adhesion mediated by integrin (GO:0033633),-6.948841501966438e-11,0.0
9908,lipoxin B4 metabolic process (GO:2001304),-6.948841501966438e-11,0.0
9909,negative regulation of establishment of endothelial barrier (GO:1903141),-6.948841501966438e-11,0.0
9910,positive regulation of integrin activation by cell surface receptor linked signal transduction (GO:0033626),-6.948841501966438e-11,0.0
9911,rhombomere 3 morphogenesis (GO:0021658),-6.948841501966438e-11,0.0
9912,cysteine biosynthetic process via cystathionine (GO:0019343),-6.948841501966438e-11,0.0
9913,vestibulocochlear nerve structural organization (GO:0021649),-6.948841501966438e-11,0.0
9914,vagus nerve morphogenesis (GO:0021644),-6.948841501966438e-11,0.0
9915,optic nerve structural organization (GO:0021633),-6.948841501966438e-11,0.0
9916,olfactory nerve maturation (GO:0021630),-6.948841501966438e-11,0.0
9917,flavin adenine dinucleotide metabolic process (GO:0072387),-6.948841501966438e-11,0.0
9918,positive regulation of actin filament-based movement (GO:1903116),-6.948841501966438e-11,0.0
9919,pentose biosynthetic process (GO:0019322),-6.948841501966438e-11,0.0
9920,olfactory nerve formation (GO:0021628),-6.948841501966438e-11,0.0
9921,oculomotor nerve formation (GO:0021623),-6.948841501966438e-11,0.0
9922,oculomotor nerve morphogenesis (GO:0021622),-6.948841501966438e-11,0.0
9923,positive regulation of mitochondrial transcription (GO:1903109),-6.948841501966438e-11,0.0
9924,D-ribose catabolic process (GO:0019303),-6.948841501966438e-11,0.0
9925,positive regulation of dipeptide transport (GO:2000880),-6.948841501966438e-11,0.0
9926,cranial nerve maturation (GO:0021605),-6.948841501966438e-11,0.0
9927,positive regulation of oligopeptide transport (GO:2000878),-6.948841501966438e-11,0.0
9928,regulation of progesterone secretion (GO:2000870),-6.948841501966438e-11,0.0
9929,positive regulation of estradiol secretion (GO:2000866),-6.948841501966438e-11,0.0
9930,regulation of mast cell differentiation (GO:0060375),-6.948841501966438e-11,0.0
9931,susceptibility to T cell mediated cytotoxicity (GO:0060370),-6.948841501966438e-11,0.0
9932,deoxyinosine metabolic process (GO:0046094),-6.948841501966438e-11,0.0
9933,cellular lactam metabolic process (GO:0072338),-6.948841501966438e-11,0.0
9934,adenine biosynthetic process (GO:0046084),-6.948841501966438e-11,0.0
9935,positive regulation of testosterone secretion (GO:2000845),-6.948841501966438e-11,0.0
9936,dUTP catabolic process (GO:0046081),-6.948841501966438e-11,0.0
9937,regulation of testosterone secretion (GO:2000843),-6.948841501966438e-11,0.0
9938,dUTP metabolic process (GO:0046080),-6.948841501966438e-11,0.0
9939,negative regulation of leucine import (GO:0060358),-6.948841501966438e-11,0.0
9940,regulation of leucine import (GO:0060357),-6.948841501966438e-11,0.0
9941,inositol phosphorylation (GO:0052746),-6.948841501966438e-11,0.0
9942,positive regulation of cell adhesion molecule production (GO:0060355),-6.948841501966438e-11,0.0
9943,dUDP metabolic process (GO:0046077),-6.948841501966438e-11,0.0
9944,dTDP metabolic process (GO:0046072),-6.948841501966438e-11,0.0
9945,metanephric glomerular epithelial cell development (GO:0072313),-6.948841501966438e-11,0.0
9946,metanephric glomerular epithelial cell differentiation (GO:0072312),-6.948841501966438e-11,0.0
9947,dATP catabolic process (GO:0046061),-6.948841501966438e-11,0.0
9948,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072305),-6.948841501966438e-11,0.0
9949,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072304),-6.948841501966438e-11,0.0
9950,regulation of metanephric glomerular mesangial cell proliferation (GO:0072301),-6.948841501966438e-11,0.0
9951,negative regulation of axon guidance (GO:1902668),-6.948841501966438e-11,0.0
9952,arsonoacetate metabolic process (GO:0018872),-6.948841501966438e-11,0.0
9953,negative regulation of myoblast proliferation (GO:2000818),-6.948841501966438e-11,0.0
9954,regulation of mRNA stability involved in response to oxidative stress (GO:2000815),-6.948841501966438e-11,0.0
9955,establishment of mitotic sister chromatid cohesion (GO:0034087),-6.948841501966438e-11,0.0
9956,calcium ion import into cytosol (GO:1902656),-6.948841501966438e-11,0.0
9957,positive regulation of synaptic vesicle clustering (GO:2000809),-6.948841501966438e-11,0.0
9958,"negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000805)",-6.948841501966438e-11,0.0
9959,ITP metabolic process (GO:0046041),-6.948841501966438e-11,0.0
9960,negative regulation of blood vessel remodeling (GO:0060313),-6.948841501966438e-11,0.0
9961,ADP catabolic process (GO:0046032),-6.948841501966438e-11,0.0
9962,negative regulation of cytokine activity (GO:0060302),-6.948841501966438e-11,0.0
9963,negative regulation of membrane hyperpolarization (GO:1902631),-6.948841501966438e-11,0.0
9964,cellular cadmium ion homeostasis (GO:0006876),-6.948841501966438e-11,0.0
9965,pyrimidine nucleotide transport (GO:0006864),-6.948841501966438e-11,0.0
9966,cellular response to fluoride (GO:1902618),-6.948841501966438e-11,0.0
9967,antigen processing and presentation of endogenous peptide antigen via MHC class II (GO:0002491),-6.948841501966438e-11,0.0
9968,positive regulation of large conductance calcium-activated potassium channel activity (GO:1902608),-6.948841501966438e-11,0.0
9969,cellular response to norepinephrine stimulus (GO:0071874),-6.948841501966438e-11,0.0
9970,response to norepinephrine (GO:0071873),-6.948841501966438e-11,0.0
9971,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent (GO:0002485)",-6.948841501966438e-11,0.0
9972,"antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent (GO:0002481)",-6.948841501966438e-11,0.0
9973,positive regulation of lipid transporter activity (GO:0110113),-6.948841501966438e-11,0.0
9974,negative regulation of animal organ morphogenesis (GO:0110111),-6.948841501966438e-11,0.0
9975,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-6.948841501966438e-11,0.0
9976,polarity specification of proximal/distal axis (GO:0010085),-6.948841501966438e-11,0.0
9977,peripheral tolerance induction (GO:0002465),-6.948841501966438e-11,0.0
9978,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling (GO:0071848),-6.948841501966438e-11,0.0
9979,actin filament debranching (GO:0071846),-6.948841501966438e-11,0.0
9980,malonyl-CoA biosynthetic process (GO:2001295),-6.948841501966438e-11,0.0
9981,serotonin secretion involved in inflammatory response (GO:0002442),-6.948841501966438e-11,0.0
9982,positive regulation of cytotoxic T cell differentiation (GO:0045585),-6.948841501966438e-11,0.0
9983,negative regulation of caveolin-mediated endocytosis (GO:2001287),-6.948841501966438e-11,0.0
9984,granuloma formation (GO:0002432),-6.948841501966438e-11,0.0
9985,positive regulation of fever generation by positive regulation of prostaglandin secretion (GO:0071812),-6.948841501966438e-11,0.0
9986,convergent extension involved in neural plate elongation (GO:0022007),-6.948841501966438e-11,0.0
9987,response to genistein (GO:0033595),-6.948841501966438e-11,0.0
9988,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor (GO:0002415),-6.948841501966438e-11,0.0
9989,negative regulation of protein K48-linked deubiquitination (GO:1903094),-6.948841501966438e-11,0.0
9990,"DNA replication, Okazaki fragment processing (GO:0033567)",-6.948841501966438e-11,0.0
9991,dorsal/ventral axon guidance (GO:0033563),-6.948841501966438e-11,0.0
9992,abducens nerve formation (GO:0021599),-6.948841501966438e-11,0.0
9993,abducens nerve morphogenesis (GO:0021598),-6.948841501966438e-11,0.0
9994,rhombomere morphogenesis (GO:0021593),-6.948841501966438e-11,0.0
9995,glycine betaine biosynthetic process from choline (GO:0019285),-6.948841501966438e-11,0.0
9996,cerebellum structural organization (GO:0021589),-6.948841501966438e-11,0.0
9997,pons maturation (GO:0021586),-6.948841501966438e-11,0.0
9998,negative regulation of protein lipidation (GO:1903060),-6.948841501966438e-11,0.0
9999,hindbrain structural organization (GO:0021577),-6.948841501966438e-11,0.0
10000,negative regulation of vasculogenesis (GO:2001213),-6.948841501966438e-11,0.0
10001,rhombomere 4 development (GO:0021570),-6.948841501966438e-11,0.0
10002,"glycine biosynthetic process, by transamination of glyoxylate (GO:0019265)",-6.948841501966438e-11,0.0
10003,glycine biosynthetic process from serine (GO:0019264),-6.948841501966438e-11,0.0
10004,regulation of melanosome organization (GO:1903056),-6.948841501966438e-11,0.0
10005,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001994),-6.948841501966438e-11,0.0
10006,rhombomere 2 development (GO:0021568),-6.948841501966438e-11,0.0
10007,abducens nerve development (GO:0021560),-6.948841501966438e-11,0.0
10008,regulation of acetylcholine-gated cation channel activity (GO:1903048),-6.948841501966438e-11,0.0
10009,baroreceptor response to increased systemic arterial blood pressure (GO:0001983),-6.948841501966438e-11,0.0
10010,trochlear nerve development (GO:0021558),-6.948841501966438e-11,0.0
10011,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback (GO:0001978),-6.948841501966438e-11,0.0
10012,positive regulation of microtubule plus-end binding (GO:1903033),-6.948841501966438e-11,0.0
10013,regulation of microtubule plus-end binding (GO:1903031),-6.948841501966438e-11,0.0
10014,negative regulation of activation of membrane attack complex (GO:0001971),-6.948841501966438e-11,0.0
10015,positive regulation of activation of membrane attack complex (GO:0001970),-6.948841501966438e-11,0.0
10016,thigmotaxis (GO:0001966),-6.948841501966438e-11,0.0
10017,negative regulation of exo-alpha-sialidase activity (GO:1903016),-6.948841501966438e-11,0.0
10018,JUN phosphorylation (GO:0007258),-6.948841501966438e-11,0.0
10019,medial motor column neuron differentiation (GO:0021526),-6.948841501966438e-11,0.0
10020,sebaceous gland cell differentiation (GO:0001949),-6.948841501966438e-11,0.0
10021,positive regulation of protein K63-linked deubiquitination (GO:1903006),-6.948841501966438e-11,0.0
10022,negative regulation of mesenchymal cell proliferation involved in lung development (GO:2000791),-6.948841501966438e-11,0.0
10023,regulation of mesenchymal cell proliferation involved in lung development (GO:2000790),-6.948841501966438e-11,0.0
10024,proximal/distal pattern formation involved in metanephric nephron development (GO:0072272),-6.948841501966438e-11,0.0
10025,regulation of protein K63-linked deubiquitination (GO:1903004),-6.948841501966438e-11,0.0
10026,negative regulation of lncRNA transcription (GO:0140744),-6.948841501966438e-11,0.0
10027,regulation of lncRNA transcription (GO:0140743),-6.948841501966438e-11,0.0
10028,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia (GO:2000777),-6.948841501966438e-11,0.0
10029,metanephric glomerular mesangial cell differentiation (GO:0072254),-6.948841501966438e-11,0.0
10030,positive regulation of oocyte development (GO:0060282),-6.948841501966438e-11,0.0
10031,metanephric podocyte development (GO:0072249),-6.948841501966438e-11,0.0
10032,metanephric podocyte differentiation (GO:0072248),-6.948841501966438e-11,0.0
10033,metanephric glomerular epithelium development (GO:0072244),-6.948841501966438e-11,0.0
10034,positive regulation of sphingomyelin catabolic process (GO:2000755),-6.948841501966438e-11,0.0
10035,regulation of sphingomyelin catabolic process (GO:2000754),-6.948841501966438e-11,0.0
10036,metanephric thick ascending limb development (GO:0072233),-6.948841501966438e-11,0.0
10037,phospholipase C-activating G protein-coupled glutamate receptor signaling pathway (GO:0007206),-6.948841501966438e-11,0.0
10038,positive regulation of respiratory burst involved in inflammatory response (GO:0060265),-6.948841501966438e-11,0.0
10039,regulation of DNA replication origin binding (GO:1902595),-6.948841501966438e-11,0.0
10040,metanephric proximal convoluted tubule development (GO:0072229),-6.948841501966438e-11,0.0
10041,positive regulation of anterior head development (GO:2000744),-6.948841501966438e-11,0.0
10042,regulation of anterior head development (GO:2000742),-6.948841501966438e-11,0.0
10043,negative regulation of mesenchymal stem cell differentiation (GO:2000740),-6.948841501966438e-11,0.0
10044,regulation of calcium import into the mitochondrion (GO:0110097),-6.948841501966438e-11,0.0
10045,positive regulation of hippocampal neuron apoptotic process (GO:0110090),-6.948841501966438e-11,0.0
10046,metanephric mesangial cell differentiation (GO:0072209),-6.948841501966438e-11,0.0
10047,metanephric smooth muscle tissue development (GO:0072208),-6.948841501966438e-11,0.0
10048,regulation of cardiac vascular smooth muscle cell differentiation (GO:2000722),-6.948841501966438e-11,0.0
10049,hippocampal neuron apoptotic process (GO:0110088),-6.948841501966438e-11,0.0
10050,positive regulation of eosinophil activation (GO:1902568),-6.948841501966438e-11,0.0
10051,negative regulation of eosinophil activation (GO:1902567),-6.948841501966438e-11,0.0
10052,negative regulation of ferroptosis (GO:0110076),-6.948841501966438e-11,0.0
10053,regulation of ferroptosis (GO:0110075),-6.948841501966438e-11,0.0
10054,3'-phospho-5'-adenylyl sulfate transmembrane transport (GO:1902559),-6.948841501966438e-11,0.0
10055,regulation of catalase activity (GO:1902551),-6.948841501966438e-11,0.0
10056,positive regulation of dense core granule biogenesis (GO:2000707),-6.948841501966438e-11,0.0
10057,lncRNA catabolic process (GO:0110064),-6.948841501966438e-11,0.0
10058,regulation of angiotensin-activated signaling pathway (GO:0110061),-6.948841501966438e-11,0.0
10059,regulation of DNA N-glycosylase activity (GO:1902544),-6.948841501966438e-11,0.0
10060,bilirubin conjugation (GO:0006789),-6.948841501966438e-11,0.0
10061,heme oxidation (GO:0006788),-6.948841501966438e-11,0.0
10062,heme A biosynthetic process (GO:0006784),-6.948841501966438e-11,0.0
10063,uroporphyrinogen III biosynthetic process (GO:0006780),-6.948841501966438e-11,0.0
10064,positive regulation of protein linear polyubiquitination (GO:1902530),-6.948841501966438e-11,0.0
10065,regulation of protein linear polyubiquitination (GO:1902528),-6.948841501966438e-11,0.0
10066,negative regulation of apoptotic DNA fragmentation (GO:1902511),-6.948841501966438e-11,0.0
10067,immune response in nasopharyngeal-associated lymphoid tissue (GO:0002395),-6.948841501966438e-11,0.0
10068,NADP biosynthetic process (GO:0006741),-6.948841501966438e-11,0.0
10069,immune response in gut-associated lymphoid tissue (GO:0002387),-6.948841501966438e-11,0.0
10070,hepatic immune response (GO:0002384),-6.948841501966438e-11,0.0
10071,triterpenoid metabolic process (GO:0006722),-6.948841501966438e-11,0.0
10072,cytokine production involved in immune response (GO:0002367),-6.948841501966438e-11,0.0
10073,"CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment (GO:0002362)",-6.948841501966438e-11,0.0
10074,B cell homeostatic proliferation (GO:0002358),-6.948841501966438e-11,0.0
10075,B cell negative selection (GO:0002352),-6.948841501966438e-11,0.0
10076,serotonin production involved in inflammatory response (GO:0002351),-6.948841501966438e-11,0.0
10077,B-1a B cell differentiation (GO:0002337),-6.948841501966438e-11,0.0
10078,transitional stage B cell differentiation (GO:0002332),-6.948841501966438e-11,0.0
10079,immunoglobulin heavy chain V-D-J recombination (GO:0071707),-6.948841501966438e-11,0.0
10080,positive regulation of histone H3-K79 methylation (GO:2001162),-6.948841501966438e-11,0.0
10081,positive regulation of dipeptide transmembrane transport (GO:2001150),-6.948841501966438e-11,0.0
10082,regulation of dipeptide transmembrane transport (GO:2001148),-6.948841501966438e-11,0.0
10083,"negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001145)",-6.948841501966438e-11,0.0
10084,"regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001144)",-6.948841501966438e-11,0.0
10085,negative regulation of endocytic recycling (GO:2001136),-6.948841501966438e-11,0.0
10086,regulation of cellular response to hepatocyte growth factor stimulus (GO:2001112),-6.948841501966438e-11,0.0
10087,positive regulation of lens epithelial cell proliferation (GO:2001111),-6.948841501966438e-11,0.0
10088,G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199),-6.948841501966438e-11,0.0
10089,regulation of lens epithelial cell proliferation (GO:2001109),-6.948841501966438e-11,0.0
10090,positive regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001108),-6.948841501966438e-11,0.0
10091,negative regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001107),-6.948841501966438e-11,0.0
10092,regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001106),-6.948841501966438e-11,0.0
10093,selenium compound metabolic process (GO:0001887),-6.948841501966438e-11,0.0
10094,detection of yeast (GO:0001879),-6.948841501966438e-11,0.0
10095,mesenchymal cell proliferation involved in ureter development (GO:0072198),-6.948841501966438e-11,0.0
10096,"negative regulation of complement activation, lectin pathway (GO:0001869)",-6.948841501966438e-11,0.0
10097,"regulation of complement activation, lectin pathway (GO:0001868)",-6.948841501966438e-11,0.0
10098,kidney smooth muscle tissue development (GO:0072194),-6.948841501966438e-11,0.0
10099,NK T cell proliferation (GO:0001866),-6.948841501966438e-11,0.0
10100,negative regulation of nephron tubule epithelial cell differentiation (GO:0072183),-6.948841501966438e-11,0.0
10101,mesonephric duct formation (GO:0072181),-6.948841501966438e-11,0.0
10102,posterior mesonephric tubule development (GO:0072166),-6.948841501966438e-11,0.0
10103,P450-containing electron transport chain (GO:0140647),-6.948841501966438e-11,0.0
10104,male germ-line sex determination (GO:0019100),-6.948841501966438e-11,0.0
10105,nephron tubule epithelial cell differentiation (GO:0072160),-6.948841501966438e-11,0.0
10106,trophectodermal cellular morphogenesis (GO:0001831),-6.948841501966438e-11,0.0
10107,positive regulation of motor neuron apoptotic process (GO:2000673),-6.948841501966438e-11,0.0
10108,serotonin secretion (GO:0001820),-6.948841501966438e-11,0.0
10109,renal interstitial fibroblast development (GO:0072141),-6.948841501966438e-11,0.0
10110,regulation of antibody-dependent cellular cytotoxicity (GO:0001813),-6.948841501966438e-11,0.0
10111,regulation of angiotensin metabolic process (GO:0060177),-6.948841501966438e-11,0.0
10112,regulation of type I hypersensitivity (GO:0001810),-6.948841501966438e-11,0.0
10113,nephrogenic mesenchyme morphogenesis (GO:0072134),-6.948841501966438e-11,0.0
10114,positive regulation of type III hypersensitivity (GO:0001805),-6.948841501966438e-11,0.0
10115,regulation of type III hypersensitivity (GO:0001803),-6.948841501966438e-11,0.0
10116,regulation of muscle filament sliding speed (GO:0032972),-6.948841501966438e-11,0.0
10117,negative regulation of early endosome to late endosome transport (GO:2000642),-6.948841501966438e-11,0.0
10118,positive regulation of SREBP signaling pathway (GO:2000640),-6.948841501966438e-11,0.0
10119,cytotoxic T cell pyroptotic process (GO:1902483),-6.948841501966438e-11,0.0
10120,microtubule-based peroxisome localization (GO:0060152),-6.948841501966438e-11,0.0
10121,peroxisome localization (GO:0060151),-6.948841501966438e-11,0.0
10122,negative regulation of pre-miRNA processing (GO:2000632),-6.948841501966438e-11,0.0
10123,pronephros morphogenesis (GO:0072114),-6.948841501966438e-11,0.0
10124,glomerular mesangial cell proliferation (GO:0072110),-6.948841501966438e-11,0.0
10125,ureteric peristalsis (GO:0072105),-6.948841501966438e-11,0.0
10126,positive regulation of histone H4-K16 acetylation (GO:2000620),-6.948841501966438e-11,0.0
10127,positive regulation of histone H3-K27 trimethylation (GO:1902466),-6.948841501966438e-11,0.0
10128,prolactin secreting cell differentiation (GO:0060127),-6.948841501966438e-11,0.0
10129,negative regulation of growth hormone secretion (GO:0060125),-6.948841501966438e-11,0.0
10130,vestibular receptor cell morphogenesis (GO:0060116),-6.948841501966438e-11,0.0
10131,generation of ovulation cycle rhythm (GO:0060112),-6.948841501966438e-11,0.0
10132,galactosylceramide catabolic process (GO:0006683),-6.948841501966438e-11,0.0
10133,positive regulation of male mating behavior (GO:1902437),-6.948841501966438e-11,0.0
10134,regulation of male mating behavior (GO:1902435),-6.948841501966438e-11,0.0
10135,glucosylceramide biosynthetic process (GO:0006679),-6.948841501966438e-11,0.0
10136,spermidine acetylation (GO:0032918),-6.948841501966438e-11,0.0
10137,polyamine acetylation (GO:0032917),-6.948841501966438e-11,0.0
10138,negative regulation of transforming growth factor beta2 production (GO:0032912),-6.948841501966438e-11,0.0
10139,sphinganine-1-phosphate metabolic process (GO:0006668),-6.948841501966438e-11,0.0
10140,nerve growth factor production (GO:0032902),-6.948841501966438e-11,0.0
10141,smooth muscle cell chemotaxis (GO:0071670),-6.948841501966438e-11,0.0
10142,phospholipid transfer to membrane (GO:0006649),-6.948841501966438e-11,0.0
10143,monocyte activation involved in immune response (GO:0002280),-6.948841501966438e-11,0.0
10144,basophil activation involved in immune response (GO:0002276),-6.948841501966438e-11,0.0
10145,plasmacytoid dendritic cell differentiation (GO:0002273),-6.948841501966438e-11,0.0
10146,vacuolar protein processing (GO:0006624),-6.948841501966438e-11,0.0
10147,follicular dendritic cell differentiation (GO:0002268),-6.948841501966438e-11,0.0
10148,positive regulation of macrophage inflammatory protein 1 alpha production (GO:0071642),-6.948841501966438e-11,0.0
10149,intramanchette transport (GO:1990953),-6.948841501966438e-11,0.0
10150,creatine biosynthetic process (GO:0006601),-6.948841501966438e-11,0.0
10151,phosphorylation of RNA polymerase II C-terminal domain serine 5 residues (GO:0071620),-6.948841501966438e-11,0.0
10152,positive regulation of inward rectifier potassium channel activity (GO:1901980),-6.948841501966438e-11,0.0
10153,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:0071619),-6.948841501966438e-11,0.0
10154,positive regulation of metanephric ureteric bud development (GO:2001076),-6.948841501966438e-11,0.0
10155,regulation of metanephric ureteric bud development (GO:2001074),-6.948841501966438e-11,0.0
10156,stimulatory killer cell immunoglobulin-like receptor signaling pathway (GO:0002222),-6.948841501966438e-11,0.0
10157,regulation of cell proliferation involved in outflow tract morphogenesis (GO:1901963),-6.948841501966438e-11,0.0
10158,geranylgeranyl diphosphate metabolic process (GO:0033385),-6.948841501966438e-11,0.0
10159,geranyl diphosphate biosynthetic process (GO:0033384),-6.948841501966438e-11,0.0
10160,positive regulation of anterograde dense core granule transport (GO:1901953),-6.948841501966438e-11,0.0
10161,regulation of anterograde dense core granule transport (GO:1901951),-6.948841501966438e-11,0.0
10162,response to hypobaric hypoxia (GO:1990910),-6.948841501966438e-11,0.0
10163,MHC class II biosynthetic process (GO:0045342),-6.948841501966438e-11,0.0
10164,mast cell secretory granule organization (GO:0033364),-6.948841501966438e-11,0.0
10165,positive regulation of tongue muscle cell differentiation (GO:2001037),-6.948841501966438e-11,0.0
10166,regulation of tongue muscle cell differentiation (GO:2001035),-6.948841501966438e-11,0.0
10167,early viral transcription (GO:0019085),-6.948841501966438e-11,0.0
10168,virus maturation (GO:0019075),-6.948841501966438e-11,0.0
10169,viral RNA genome packaging (GO:0019074),-6.948841501966438e-11,0.0
10170,viral genome packaging (GO:0019072),-6.948841501966438e-11,0.0
10171,regulation of collagen binding (GO:0033341),-6.948841501966438e-11,0.0
10172,intracellular transport of viral protein in host cell (GO:0019060),-6.948841501966438e-11,0.0
10173,neutrophil apoptotic process (GO:0001781),-6.948841501966438e-11,0.0
10174,release from viral latency (GO:0019046),-6.948841501966438e-11,0.0
10175,latent virus replication (GO:0019045),-6.948841501966438e-11,0.0
10176,anterior/posterior pattern specification involved in kidney development (GO:0072098),-6.948841501966438e-11,0.0
10177,phytol metabolic process (GO:0033306),-6.948841501966438e-11,0.0
10178,extraction of mislocalized protein from membrane (GO:0140568),-6.948841501966438e-11,0.0
10179,immunological memory formation process (GO:0090715),-6.948841501966438e-11,0.0
10180,immunological memory process (GO:0090713),-6.948841501966438e-11,0.0
10181,positive regulation of metanephric DCT cell differentiation (GO:2000594),-6.948841501966438e-11,0.0
10182,regulation of metanephric DCT cell differentiation (GO:2000592),-6.948841501966438e-11,0.0
10183,kidney interstitial fibroblast differentiation (GO:0072071),-6.948841501966438e-11,0.0
10184,lens placode formation (GO:0001743),-6.948841501966438e-11,0.0
10185,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000584),-6.948841501966438e-11,0.0
10186,inner medullary collecting duct development (GO:0072061),-6.948841501966438e-11,0.0
10187,negative regulation by host of viral glycoprotein metabolic process (GO:0044871),-6.948841501966438e-11,0.0
10188,modulation by host of viral glycoprotein metabolic process (GO:0044870),-6.948841501966438e-11,0.0
10189,renal outer medulla development (GO:0072054),-6.948841501966438e-11,0.0
10190,renal inner medulla development (GO:0072053),-6.948841501966438e-11,0.0
10191,juxtaglomerular apparatus development (GO:0072051),-6.948841501966438e-11,0.0
10192,negative regulation by host of viral exo-alpha-sialidase activity (GO:0044869),-6.948841501966438e-11,0.0
10193,modulation by host of viral catalytic activity (GO:0044867),-6.948841501966438e-11,0.0
10194,modulation by host of viral exo-alpha-sialidase activity (GO:0044866),-6.948841501966438e-11,0.0
10195,modulation by host of symbiont transcription (GO:0052472),-6.948841501966438e-11,0.0
10196,protein transport into plasma membrane raft (GO:0044861),-6.948841501966438e-11,0.0
10197,neurotrophin production (GO:0032898),-6.948841501966438e-11,0.0
10198,positive regulation of memory T cell activation (GO:2000568),-6.948841501966438e-11,0.0
10199,regulation of memory T cell activation (GO:2000567),-6.948841501966438e-11,0.0
10200,thyroid-stimulating hormone signaling pathway (GO:0038194),-6.948841501966438e-11,0.0
10201,establishment of planar polarity involved in nephron morphogenesis (GO:0072046),-6.948841501966438e-11,0.0
10202,gastric inhibitory peptide signaling pathway (GO:0038192),-6.948841501966438e-11,0.0
10203,VEGF-activated neuropilin signaling pathway (GO:0038190),-6.948841501966438e-11,0.0
10204,cholecystokinin signaling pathway (GO:0038188),-6.948841501966438e-11,0.0
10205,positive regulation of immunoglobulin production in mucosal tissue (GO:2000558),-6.948841501966438e-11,0.0
10206,regulation of immunoglobulin production in mucosal tissue (GO:2000557),-6.948841501966438e-11,0.0
10207,mesenchymal stem cell maintenance involved in nephron morphogenesis (GO:0072038),-6.948841501966438e-11,0.0
10208,ectoderm formation (GO:0001705),-6.948841501966438e-11,0.0
10209,cervix development (GO:0060067),-6.948841501966438e-11,0.0
10210,post-embryonic retina morphogenesis in camera-type eye (GO:0060060),-6.948841501966438e-11,0.0
10211,positive regulation of DNA endoreduplication (GO:0032877),-6.948841501966438e-11,0.0
10212,complement component C5a signaling pathway (GO:0038178),-6.948841501966438e-11,0.0
10213,thick ascending limb development (GO:0072023),-6.948841501966438e-11,0.0
10214,apoptotic process involved in mammary gland involution (GO:0060057),-6.948841501966438e-11,0.0
10215,positive regulation of B cell chemotaxis (GO:2000538),-6.948841501966438e-11,0.0
10216,regulation of B cell chemotaxis (GO:2000537),-6.948841501966438e-11,0.0
10217,proximal convoluted tubule development (GO:0072019),-6.948841501966438e-11,0.0
10218,negative regulation of entry of bacterium into host cell (GO:2000536),-6.948841501966438e-11,0.0
10219,regulation of renal albumin absorption (GO:2000532),-6.948841501966438e-11,0.0
10220,negative regulation of tRNA catabolic process (GO:1902371),-6.948841501966438e-11,0.0
10221,regulation of tRNA catabolic process (GO:1902370),-6.948841501966438e-11,0.0
10222,positive regulation of myeloid dendritic cell chemotaxis (GO:2000529),-6.948841501966438e-11,0.0
10223,granulocyte colony-stimulating factor signaling pathway (GO:0038158),-6.948841501966438e-11,0.0
10224,regulation of myeloid dendritic cell chemotaxis (GO:2000527),-6.948841501966438e-11,0.0
10225,positive regulation of immunological synapse formation (GO:2000522),-6.948841501966438e-11,0.0
10226,kidney field specification (GO:0072004),-6.948841501966438e-11,0.0
10227,negative regulation of immunological synapse formation (GO:2000521),-6.948841501966438e-11,0.0
10228,negative regulation of Notch signaling pathway involved in somitogenesis (GO:1902367),-6.948841501966438e-11,0.0
10229,regulation of Notch signaling pathway involved in somitogenesis (GO:1902366),-6.948841501966438e-11,0.0
10230,notochord regression (GO:0060032),-6.948841501966438e-11,0.0
10231,melanocyte apoptotic process (GO:1902362),-6.948841501966438e-11,0.0
10232,mediolateral intercalation (GO:0060031),-6.948841501966438e-11,0.0
10233,"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response (GO:0032834)",-6.948841501966438e-11,0.0
10234,"regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response (GO:0032832)",-6.948841501966438e-11,0.0
10235,positive regulation of blood vessel remodeling (GO:2000504),-6.948841501966438e-11,0.0
10236,negative regulation of natural killer cell chemotaxis (GO:2000502),-6.948841501966438e-11,0.0
10237,response to chloroquine (GO:1902349),-6.948841501966438e-11,0.0
10238,granulosa cell differentiation (GO:0060014),-6.948841501966438e-11,0.0
10239,melanin biosynthetic process from tyrosine (GO:0006583),-6.948841501966438e-11,0.0
10240,toll-like receptor TLR6:TLR2 signaling pathway (GO:0038124),-6.948841501966438e-11,0.0
10241,copper ion export (GO:0060003),-6.948841501966438e-11,0.0
10242,positive regulation of epinephrine secretion (GO:0032812),-6.948841501966438e-11,0.0
10243,interleukin-8-mediated signaling pathway (GO:0038112),-6.948841501966438e-11,0.0
10244,interleukin-7-mediated signaling pathway (GO:0038111),-6.948841501966438e-11,0.0
10245,negative regulation of low-density lipoprotein particle receptor catabolic process (GO:0032804),-6.948841501966438e-11,0.0
10246,detoxification of cadmium ion (GO:0071585),-6.948841501966438e-11,0.0
10247,regulation of zinc ion transport (GO:0071579),-6.948841501966438e-11,0.0
10248,glutamine biosynthetic process (GO:0006542),-6.948841501966438e-11,0.0
10249,glutamate decarboxylation to succinate (GO:0006540),-6.948841501966438e-11,0.0
10250,translation reinitiation (GO:0002188),-6.948841501966438e-11,0.0
10251,cytoplasmic translational elongation (GO:0002182),-6.948841501966438e-11,0.0
10252,death-inducing signaling complex assembly (GO:0071550),-6.948841501966438e-11,0.0
10253,asparagine biosynthetic process (GO:0006529),-6.948841501966438e-11,0.0
10254,lysophospholipid transport (GO:0051977),-6.948841501966438e-11,0.0
10255,positive regulation of relaxation of cardiac muscle (GO:1901899),-6.948841501966438e-11,0.0
10256,negative regulation of relaxation of cardiac muscle (GO:1901898),-6.948841501966438e-11,0.0
10257,methotrexate transport (GO:0051958),-6.948841501966438e-11,0.0
10258,N-terminal protein palmitoylation (GO:0006500),-6.948841501966438e-11,0.0
10259,positive regulation of glutamate uptake involved in transmission of nerve impulse (GO:0051951),-6.948841501966438e-11,0.0
10260,positive regulation of amino acid uptake involved in synaptic transmission (GO:0051943),-6.948841501966438e-11,0.0
10261,response to endothelin (GO:1990839),-6.948841501966438e-11,0.0
10262,glutamate reuptake (GO:0051935),-6.948841501966438e-11,0.0
10263,inter-male aggressive behavior (GO:0002121),-6.948841501966438e-11,0.0
10264,cellular response to mycophenolic acid (GO:0071506),-6.948841501966438e-11,0.0
10265,response to mycophenolic acid (GO:0071505),-6.948841501966438e-11,0.0
10266,negative regulation of mitochondrial DNA metabolic process (GO:1901859),-6.948841501966438e-11,0.0
10267,tRNA wobble cytosine modification (GO:0002101),-6.948841501966438e-11,0.0
10268,abortive mitotic cell cycle (GO:0033277),-6.948841501966438e-11,0.0
10269,positive regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901846),-6.948841501966438e-11,0.0
10270,intermicrovillar adhesion (GO:0090675),-6.948841501966438e-11,0.0
10271,zeaxanthin metabolic process (GO:1901825),-6.948841501966438e-11,0.0
10272,galanin-activated signaling pathway (GO:0090663),-6.948841501966438e-11,0.0
10273,histamine biosynthetic process (GO:0001694),-6.948841501966438e-11,0.0
10274,MAPK export from nucleus (GO:0045204),-6.948841501966438e-11,0.0
10275,beta-glucoside catabolic process (GO:1901805),-6.948841501966438e-11,0.0
10276,beta-glucoside metabolic process (GO:1901804),-6.948841501966438e-11,0.0
10277,GCN2-mediated signaling (GO:0140469),-6.948841501966438e-11,0.0
10278,DNA clamp unloading (GO:0090618),-6.948841501966438e-11,0.0
10279,mitochondrial mRNA processing (GO:0090615),-6.948841501966438e-11,0.0
10280,negative regulation of hepatic stellate cell activation (GO:2000490),-6.948841501966438e-11,0.0
10281,Leydig cell proliferation (GO:0160024),-6.948841501966438e-11,0.0
10282,sneeze reflex (GO:0160023),-6.948841501966438e-11,0.0
10283,positive regulation of glutamine transport (GO:2000487),-6.948841501966438e-11,0.0
10284,meiotic spindle checkpoint signaling (GO:0044779),-6.948841501966438e-11,0.0
10285,meiotic DNA integrity checkpoint signaling (GO:0044778),-6.948841501966438e-11,0.0
10286,positive regulation of hematopoietic stem cell migration (GO:2000473),-6.948841501966438e-11,0.0
10287,regulation of hematopoietic stem cell migration (GO:2000471),-6.948841501966438e-11,0.0
10288,positive regulation of peroxidase activity (GO:2000470),-6.948841501966438e-11,0.0
10289,uropod organization (GO:0032796),-6.948841501966438e-11,0.0
10290,cellular response to human chorionic gonadotropin stimulus (GO:0044751),-6.948841501966438e-11,0.0
10291,regulation of astrocyte chemotaxis (GO:2000458),-6.948841501966438e-11,0.0
10292,"regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation (GO:2000452)",-6.948841501966438e-11,0.0
10293,"positive regulation of CD8-positive, alpha-beta T cell extravasation (GO:2000451)",-6.948841501966438e-11,0.0
10294,cell cycle DNA replication maintenance of fidelity (GO:1902298),-6.948841501966438e-11,0.0
10295,DNA methylation on adenine (GO:0032775),-6.948841501966438e-11,0.0
10296,positive regulation of tyrosinase activity (GO:0032773),-6.948841501966438e-11,0.0
10297,positive regulation of macrophage migration inhibitory factor signaling pathway (GO:2000448),-6.948841501966438e-11,0.0
10298,regulation of tyrosinase activity (GO:0032771),-6.948841501966438e-11,0.0
10299,negative regulation of primary amine oxidase activity (GO:1902283),-6.948841501966438e-11,0.0
10300,(R)-carnitine transmembrane transport (GO:1902270),-6.948841501966438e-11,0.0
10301,positive regulation of TRAIL production (GO:0032759),-6.948841501966438e-11,0.0
10302,negative regulation of apoptotic cell clearance (GO:2000426),-6.948841501966438e-11,0.0
10303,positive regulation of eosinophil chemotaxis (GO:2000424),-6.948841501966438e-11,0.0
10304,regulation of eosinophil chemotaxis (GO:2000422),-6.948841501966438e-11,0.0
10305,positive regulation of polyamine transmembrane transport (GO:1902269),-6.948841501966438e-11,0.0
10306,positive regulation of interleukin-21 production (GO:0032745),-6.948841501966438e-11,0.0
10307,negative regulation of eosinophil migration (GO:2000417),-6.948841501966438e-11,0.0
10308,interleukin-5-mediated signaling pathway (GO:0038043),-6.948841501966438e-11,0.0
10309,cross-receptor inhibition within G protein-coupled receptor heterodimer (GO:0038041),-6.948841501966438e-11,0.0
10310,negative regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902257),-6.948841501966438e-11,0.0
10311,phytoalexin metabolic process (GO:0052314),-6.948841501966438e-11,0.0
10312,C-terminal protein methylation (GO:0006481),-6.948841501966438e-11,0.0
10313,N-terminal protein amino acid methylation (GO:0006480),-6.948841501966438e-11,0.0
10314,positive regulation of fractalkine production (GO:0032724),-6.948841501966438e-11,0.0
10315,positive regulation of connective tissue growth factor production (GO:0032723),-6.948841501966438e-11,0.0
10316,peptidyl-tyrosine sulfation (GO:0006478),-6.948841501966438e-11,0.0
10317,Wnt receptor catabolic process (GO:0038018),-6.948841501966438e-11,0.0
10318,negative regulation of interleukin-23 production (GO:0032707),-6.948841501966438e-11,0.0
10319,epidermal growth factor receptor ligand maturation (GO:0038004),-6.948841501966438e-11,0.0
10320,cellular response to high light intensity (GO:0071486),-6.948841501966438e-11,0.0
10321,positive regulation of interleukin-4-mediated signaling pathway (GO:1902216),-6.948841501966438e-11,0.0
10322,cellular response to blue light (GO:0071483),-6.948841501966438e-11,0.0
10323,"positive regulation of acetylcholine secretion, neurotransmission (GO:0014057)",-6.948841501966438e-11,0.0
10324,regulation of translational initiation by iron (GO:0006447),-6.948841501966438e-11,0.0
10325,negative regulation of cardioblast differentiation (GO:0051892),-6.948841501966438e-11,0.0
10326,cellular response to glial cell derived neurotrophic factor (GO:1990792),-6.948841501966438e-11,0.0
10327,response to glial cell derived neurotrophic factor (GO:1990790),-6.948841501966438e-11,0.0
10328,diaphragm contraction (GO:0002086),-6.948841501966438e-11,0.0
10329,cellular response to alkaline pH (GO:0071469),-6.948841501966438e-11,0.0
10330,cellular response to redox state (GO:0071461),-6.948841501966438e-11,0.0
10331,valyl-tRNA aminoacylation (GO:0006438),-6.948841501966438e-11,0.0
10332,tyrosyl-tRNA aminoacylation (GO:0006437),-6.948841501966438e-11,0.0
10333,tryptophanyl-tRNA aminoacylation (GO:0006436),-6.948841501966438e-11,0.0
10334,establishment of endothelial blood-brain barrier (GO:0014045),-6.948841501966438e-11,0.0
10335,cellular response to dsDNA (GO:1990786),-6.948841501966438e-11,0.0
10336,seryl-tRNA aminoacylation (GO:0006434),-6.948841501966438e-11,0.0
10337,positive regulation of timing of anagen (GO:0051885),-6.948841501966438e-11,0.0
10338,response to water-immersion restraint stress (GO:1990785),-6.948841501966438e-11,0.0
10339,prolyl-tRNA aminoacylation (GO:0006433),-6.948841501966438e-11,0.0
10340,response to dsDNA (GO:1990784),-6.948841501966438e-11,0.0
10341,methionyl-tRNA aminoacylation (GO:0006431),-6.948841501966438e-11,0.0
10342,positive regulation of Schwann cell differentiation (GO:0014040),-6.948841501966438e-11,0.0
10343,extraocular skeletal muscle development (GO:0002074),-6.948841501966438e-11,0.0
10344,leucyl-tRNA aminoacylation (GO:0006429),-6.948841501966438e-11,0.0
10345,isoleucyl-tRNA aminoacylation (GO:0006428),-6.948841501966438e-11,0.0
10346,pigment granule aggregation in cell center (GO:0051877),-6.948841501966438e-11,0.0
10347,glutaminyl-tRNA aminoacylation (GO:0006425),-6.948841501966438e-11,0.0
10348,glutamyl-tRNA aminoacylation (GO:0006424),-6.948841501966438e-11,0.0
10349,cysteinyl-tRNA aminoacylation (GO:0006423),-6.948841501966438e-11,0.0
10350,aspartyl-tRNA aminoacylation (GO:0006422),-6.948841501966438e-11,0.0
10351,"general adaptation syndrome, behavioral process (GO:0051867)",-6.948841501966438e-11,0.0
10352,neural plate elongation (GO:0014022),-6.948841501966438e-11,0.0
10353,rRNA export from nucleus (GO:0006407),-6.948841501966438e-11,0.0
10354,zonula adherens assembly (GO:0045186),-6.948841501966438e-11,0.0
10355,negative regulation of L-glutamate import across plasma membrane (GO:0002037),-6.948841501966438e-11,0.0
10356,desensitization of G protein-coupled receptor signaling pathway by arrestin (GO:0002032),-6.948841501966438e-11,0.0
10357,cellular response to amine stimulus (GO:0071418),-6.948841501966438e-11,0.0
10358,cellular response to cycloheximide (GO:0071409),-6.948841501966438e-11,0.0
10359,regulation of blood volume by renal aldosterone (GO:0002017),-6.948841501966438e-11,0.0
10360,leukotriene A4 metabolic process (GO:1901751),-6.948841501966438e-11,0.0
10361,xylulose metabolic process (GO:0005997),-6.948841501966438e-11,0.0
10362,trehalose metabolic process (GO:0005991),-6.948841501966438e-11,0.0
10363,leukotriene D4 catabolic process (GO:1901749),-6.948841501966438e-11,0.0
10364,cholangiocyte proliferation (GO:1990705),-6.948841501966438e-11,0.0
10365,lactose biosynthetic process (GO:0005989),-6.948841501966438e-11,0.0
10366,sucrose biosynthetic process (GO:0005986),-6.948841501966438e-11,0.0
10367,detection of oxidative stress (GO:0070994),-6.948841501966438e-11,0.0
10368,negative regulation of histone deacetylase activity (GO:1901726),-6.948841501966438e-11,0.0
10369,L-asparagine metabolic process (GO:0070982),-6.948841501966438e-11,0.0
10370,intermediate filament polymerization or depolymerization (GO:0045105),-6.948841501966438e-11,0.0
10371,mesenchymal cell differentiation involved in bone development (GO:1901706),-6.948841501966438e-11,0.0
10372,detection of chemical stimulus involved in sensory perception of sweet taste (GO:0001582),-6.948841501966438e-11,0.0
10373,detection of chemical stimulus involved in sensory perception of sour taste (GO:0001581),-6.948841501966438e-11,0.0
10374,positive regulation of neutrophil mediated killing of fungus (GO:0070965),-6.948841501966438e-11,0.0
10375,medium-chain fatty acid transport (GO:0001579),-6.948841501966438e-11,0.0
10376,globoside biosynthetic process (GO:0001576),-6.948841501966438e-11,0.0
10377,globoside metabolic process (GO:0001575),-6.948841501966438e-11,0.0
10378,lactosylceramide biosynthetic process (GO:0001572),-6.948841501966438e-11,0.0
10379,regulation of neutrophil mediated killing of fungus (GO:0070953),-6.948841501966438e-11,0.0
10380,regulation of neutrophil mediated killing of gram-negative bacterium (GO:0070951),-6.948841501966438e-11,0.0
10381,regulation of neutrophil mediated killing of bacterium (GO:0070950),-6.948841501966438e-11,0.0
10382,oocyte growth (GO:0001555),-6.948841501966438e-11,0.0
10383,ovarian follicle atresia (GO:0001552),-6.948841501966438e-11,0.0
10384,positive regulation of ubiquitin-dependent endocytosis (GO:2000397),-6.948841501966438e-11,0.0
10385,regulation of ubiquitin-dependent endocytosis (GO:2000395),-6.948841501966438e-11,0.0
10386,negative regulation of lamellipodium morphogenesis (GO:2000393),-6.948841501966438e-11,0.0
10387,primary ovarian follicle growth (GO:0001545),-6.948841501966438e-11,0.0
10388,initiation of primordial ovarian follicle growth (GO:0001544),-6.948841501966438e-11,0.0
10389,regulation of siRNA production (GO:0070921),-6.948841501966438e-11,0.0
10390,positive regulation of ovarian follicle development (GO:2000386),-6.948841501966438e-11,0.0
10391,positive regulation of mesoderm development (GO:2000382),-6.948841501966438e-11,0.0
10392,global genome nucleotide-excision repair (GO:0070911),-6.948841501966438e-11,0.0
10393,positive regulation of oxygen metabolic process (GO:2000376),-6.948841501966438e-11,0.0
10394,mitochondrial tRNA pseudouridine synthesis (GO:0070902),-6.948841501966438e-11,0.0
10395,positive regulation of acrosomal vesicle exocytosis (GO:2000368),-6.948841501966438e-11,0.0
10396,negative regulation of interleukin-1 alpha production (GO:0032690),-6.948841501966438e-11,0.0
10397,peptide amidation (GO:0001519),-6.948841501966438e-11,0.0
10398,negative regulation of ovarian follicle development (GO:2000355),-6.948841501966438e-11,0.0
10399,acetylcholine catabolic process in synaptic cleft (GO:0001507),-6.948841501966438e-11,0.0
10400,regulation of TRAIL production (GO:0032679),-6.948841501966438e-11,0.0
10401,negative regulation of CD40 signaling pathway (GO:2000349),-6.948841501966438e-11,0.0
10402,regulation of interleukin-3 production (GO:0032672),-6.948841501966438e-11,0.0
10403,regulation of interleukin-21 production (GO:0032665),-6.948841501966438e-11,0.0
10404,positive regulation of blood microparticle formation (GO:2000334),-6.948841501966438e-11,0.0
10405,regulation of blood microparticle formation (GO:2000332),-6.948841501966438e-11,0.0
10406,regulation of fractalkine production (GO:0032644),-6.948841501966438e-11,0.0
10407,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000313),-6.948841501966438e-11,0.0
10408,regulation of cyclic nucleotide-gated ion channel activity (GO:1902159),-6.948841501966438e-11,0.0
10409,termination of mitochondrial transcription (GO:0006393),-6.948841501966438e-11,0.0
10410,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000309),-6.948841501966438e-11,0.0
10411,protein-pyridoxal-5-phosphate linkage (GO:0018352),-6.948841501966438e-11,0.0
10412,cellular response to cortisol stimulus (GO:0071387),-6.948841501966438e-11,0.0
10413,peptidyl-serine ADP-ribosylation (GO:0018312),-6.948841501966438e-11,0.0
10414,DNA double-strand break attachment to nuclear envelope (GO:1990683),-6.948841501966438e-11,0.0
10415,"transposition, DNA-mediated (GO:0006313)",-6.948841501966438e-11,0.0
10416,cellular response to prolactin (GO:1990646),-6.948841501966438e-11,0.0
10417,cellular response to vitamin E (GO:0071306),-6.948841501966438e-11,0.0
10418,regulation of extrathymic T cell differentiation (GO:0033082),-6.948841501966438e-11,0.0
10419,positive regulation of presynaptic membrane organization (GO:1901631),-6.948841501966438e-11,0.0
10420,regulation of presynaptic membrane organization (GO:1901629),-6.948841501966438e-11,0.0
10421,positive regulation of postsynaptic membrane organization (GO:1901628),-6.948841501966438e-11,0.0
10422,negative regulation of transposon integration (GO:0070895),-6.948841501966438e-11,0.0
10423,regulation of transposon integration (GO:0070894),-6.948841501966438e-11,0.0
10424,mitochondrial magnesium ion transmembrane transport (GO:0045016),-6.948841501966438e-11,0.0
10425,platelet alpha granule organization (GO:0070889),-6.948841501966438e-11,0.0
10426,regulation of proline transport (GO:0070881),-6.948841501966438e-11,0.0
10427,DNA replication proofreading (GO:0045004),-6.948841501966438e-11,0.0
10428,polysaccharide localization (GO:0033037),-6.948841501966438e-11,0.0
10429,negative regulation of neutrophil apoptotic process (GO:0033030),-6.948841501966438e-11,0.0
10430,mast cell apoptotic process (GO:0033024),-6.948841501966438e-11,0.0
10431,negative regulation of hydrogen peroxide catabolic process (GO:2000296),-6.948841501966438e-11,0.0
10432,negative regulation of oxidative phosphorylation uncoupler activity (GO:2000276),-6.948841501966438e-11,0.0
10433,positive regulation of male germ cell proliferation (GO:2000256),-6.948841501966438e-11,0.0
10434,retrograde axonal protein transport (GO:0099642),-6.948841501966438e-11,0.0
10435,positive regulation of calcium ion import into sarcoplasmic reticulum (GO:1902082),-6.948841501966438e-11,0.0
10436,negative regulation of calcium ion import into sarcoplasmic reticulum (GO:1902081),-6.948841501966438e-11,0.0
10437,iron incorporation into metallo-sulfur cluster (GO:0018283),-6.948841501966438e-11,0.0
10438,metal incorporation into metallo-sulfur cluster (GO:0018282),-6.948841501966438e-11,0.0
10439,regulation of pancreatic stellate cell proliferation (GO:2000229),-6.948841501966438e-11,0.0
10440,negative regulation of testosterone biosynthetic process (GO:2000225),-6.948841501966438e-11,0.0
10441,protein deamination (GO:0018277),-6.948841501966438e-11,0.0
10442,regulation of sphingolipid mediated signaling pathway (GO:1902068),-6.948841501966438e-11,0.0
10443,isopeptide cross-linking (GO:0018262),-6.948841501966438e-11,0.0
10444,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-6.948841501966438e-11,0.0
10445,regulation of ribosomal subunit export from nucleus (GO:2000200),-6.948841501966438e-11,0.0
10446,polyamine transmembrane transport (GO:1902047),-6.948841501966438e-11,0.0
10447,negative regulation of hematopoietic stem cell proliferation (GO:1902034),-6.948841501966438e-11,0.0
10448,post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973),-6.948841501966438e-11,0.0
10449,L-histidine transport (GO:1902024),-6.948841501966438e-11,0.0
10450,negative regulation of mitochondrial RNA catabolic process (GO:0000961),-6.948841501966438e-11,0.0
10451,actin filament uncapping (GO:0051695),-6.948841501966438e-11,0.0
10452,cellular oligosaccharide catabolic process (GO:0051692),-6.948841501966438e-11,0.0
10453,cellular oligosaccharide metabolic process (GO:0051691),-6.948841501966438e-11,0.0
10454,positive regulation of translational initiation in response to starvation (GO:0071264),-6.948841501966438e-11,0.0
10455,regulation of translational initiation in response to starvation (GO:0071262),-6.948841501966438e-11,0.0
10456,dTDP biosynthetic process (GO:0006233),-6.948841501966438e-11,0.0
10457,dUDP biosynthetic process (GO:0006227),-6.948841501966438e-11,0.0
10458,uridine catabolic process (GO:0006218),-6.948841501966438e-11,0.0
10459,uracil catabolic process (GO:0006212),-6.948841501966438e-11,0.0
10460,cellular response to folic acid (GO:0071231),-6.948841501966438e-11,0.0
10461,maintenance of mitochondrion location (GO:0051659),-6.948841501966438e-11,0.0
10462,dGTP catabolic process (GO:0006203),-6.948841501966438e-11,0.0
10463,mitochondrial NAD transmembrane transport (GO:1990549),-6.948841501966438e-11,0.0
10464,positive regulation of germ cell proliferation (GO:1905938),-6.948841501966438e-11,0.0
10465,regulation of cell fate determination (GO:1905933),-6.948841501966438e-11,0.0
10466,negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905931),-6.948841501966438e-11,0.0
10467,epinephrine uptake (GO:0051625),-6.948841501966438e-11,0.0
10468,regulation of norepinephrine uptake (GO:0051621),-6.948841501966438e-11,0.0
10469,negative regulation of cell differentiation involved in phenotypic switching (GO:1905916),-6.948841501966438e-11,0.0
10470,pyrimidine nucleotide import into mitochondrion (GO:1990519),-6.948841501966438e-11,0.0
10471,negative regulation of endothelial cell development (GO:1901551),-6.948841501966438e-11,0.0
10472,response to raffinose (GO:1901545),-6.948841501966438e-11,0.0
10473,mitotic DNA replication maintenance of fidelity (GO:1990505),-6.948841501966438e-11,0.0
10474,phagolysosome assembly involved in apoptotic cell clearance (GO:0090387),-6.948841501966438e-11,0.0
10475,phagosome maturation involved in apoptotic cell clearance (GO:0090386),-6.948841501966438e-11,0.0
10476,positive regulation of platelet-derived growth factor production (GO:0090362),-6.948841501966438e-11,0.0
10477,response to biotin (GO:0070781),-6.948841501966438e-11,0.0
10478,ether catabolic process (GO:1901502),-6.948841501966438e-11,0.0
10479,neuromast hair cell differentiation (GO:0048886),-6.948841501966438e-11,0.0
10480,neuromast development (GO:0048884),-6.948841501966438e-11,0.0
10481,lateral line development (GO:0048882),-6.948841501966438e-11,0.0
10482,negative regulation of locomotion involved in locomotory behavior (GO:0090327),-6.948841501966438e-11,0.0
10483,cAMP transport (GO:0070730),-6.948841501966438e-11,0.0
10484,mitochondrial potassium ion transmembrane transport (GO:0140141),-6.948841501966438e-11,0.0
10485,mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication (GO:0070716),-6.948841501966438e-11,0.0
10486,enucleate erythrocyte development (GO:0048822),-6.948841501966438e-11,0.0
10487,"regulation of protein catabolic process at presynapse, modulating synaptic transmission (GO:0099575)",-6.948841501966438e-11,0.0
10488,detection of peptidoglycan (GO:0032499),-6.948841501966438e-11,0.0
10489,negative regulation of hair follicle maturation (GO:0048817),-6.948841501966438e-11,0.0
10490,Ral protein signal transduction (GO:0032484),-6.948841501966438e-11,0.0
10491,negative regulation of ubiquitin-specific protease activity (GO:2000157),-6.948841501966438e-11,0.0
10492,"regulation of retrograde vesicle-mediated transport, Golgi to ER (GO:2000156)",-6.948841501966438e-11,0.0
10493,"trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0099555)",-6.948841501966438e-11,0.0
10494,"trans-synaptic signaling by soluble gas, modulating synaptic transmission (GO:0099554)",-6.948841501966438e-11,0.0
10495,Golgi calcium ion transport (GO:0032472),-6.948841501966438e-11,0.0
10496,interleukin-10-mediated signaling pathway (GO:0140105),-6.948841501966438e-11,0.0
10497,Golgi calcium ion homeostasis (GO:0032468),-6.948841501966438e-11,0.0
10498,positive regulation of protein homooligomerization (GO:0032464),-6.948841501966438e-11,0.0
10499,negative regulation of protein homooligomerization (GO:0032463),-6.948841501966438e-11,0.0
10500,negative regulation of protein oligomerization (GO:0032460),-6.948841501966438e-11,0.0
10501,synaptic signaling via neuropeptide (GO:0099538),-6.948841501966438e-11,0.0
10502,slow endocytic recycling (GO:0032458),-6.948841501966438e-11,0.0
10503,protein depropionylation (GO:0106230),-6.948841501966438e-11,0.0
10504,protein nucleotidylation (GO:0018175),-6.948841501966438e-11,0.0
10505,presynapse to nucleus signaling pathway (GO:0099526),-6.948841501966438e-11,0.0
10506,activation of phospholipase A2 activity (GO:0032431),-6.948841501966438e-11,0.0
10507,tRNA C3-cytosine methylation (GO:0106217),-6.948841501966438e-11,0.0
10508,negative regulation of sodium:proton antiporter activity (GO:0032416),-6.948841501966438e-11,0.0
10509,deoxyguanosine catabolic process (GO:0006161),-6.948841501966438e-11,0.0
10510,peptidyl-cysteine methylation (GO:0018125),-6.948841501966438e-11,0.0
10511,protein adenylylation (GO:0018117),-6.948841501966438e-11,0.0
10512,deoxyinosine catabolic process (GO:0006149),-6.948841501966438e-11,0.0
10513,inosine catabolic process (GO:0006148),-6.948841501966438e-11,0.0
10514,guanine catabolic process (GO:0006147),-6.948841501966438e-11,0.0
10515,response to methylglyoxal (GO:0051595),-6.948841501966438e-11,0.0
10516,histone H2A-K5 acetylation (GO:0043977),-6.948841501966438e-11,0.0
10517,regulation of protein localization to cell leading edge (GO:1905871),-6.948841501966438e-11,0.0
10518,glycerophosphate shuttle (GO:0006127),-6.948841501966438e-11,0.0
10519,response to ultrasound (GO:1990478),-6.948841501966438e-11,0.0
10520,entry of viral genome into host nucleus through nuclear pore complex via importin (GO:0075506),-6.948841501966438e-11,0.0
10521,mRNA export from nucleus in response to heat stress (GO:0031990),-6.948841501966438e-11,0.0
10522,resolution of mitotic recombination intermediates (GO:0071140),-6.948841501966438e-11,0.0
10523,fermentation (GO:0006113),-6.948841501966438e-11,0.0
10524,smooth endoplasmic reticulum calcium ion homeostasis (GO:0051563),-6.948841501966438e-11,0.0
10525,bombesin receptor signaling pathway (GO:0031989),-6.948841501966438e-11,0.0
10526,positive regulation of lymphangiogenesis (GO:1901492),-6.948841501966438e-11,0.0
10527,negative regulation of keratinocyte migration (GO:0051548),-6.948841501966438e-11,0.0
10528,peptidyl-threonine autophosphorylation (GO:1990443),-6.948841501966438e-11,0.0
10529,negative regulation of telomeric D-loop disassembly (GO:1905839),-6.948841501966438e-11,0.0
10530,regulation of telomeric D-loop disassembly (GO:1905838),-6.948841501966438e-11,0.0
10531,modulation by host of viral transcription (GO:0043921),-6.948841501966438e-11,0.0
10532,superior temporal gyrus development (GO:0071109),-6.948841501966438e-11,0.0
10533,"adenosine 3',5'-bisphosphate transmembrane transport (GO:0071106)",-6.948841501966438e-11,0.0
10534,response to interleukin-11 (GO:0071105),-6.948841501966438e-11,0.0
10535,mitotic recombination-dependent replication fork processing (GO:1990426),-6.948841501966438e-11,0.0
10536,mitochondria-nucleus signaling pathway (GO:0031930),-6.948841501966438e-11,0.0
10537,negative regulation of osteoclast proliferation (GO:0090291),-6.948841501966438e-11,0.0
10538,embryonic lung development (GO:1990401),-6.948841501966438e-11,0.0
10539,regulation of somatostatin secretion (GO:0090273),-6.948841501966438e-11,0.0
10540,negative regulation of fibroblast growth factor production (GO:0090272),-6.948841501966438e-11,0.0
10541,positive regulation of immune complex clearance by monocytes and macrophages (GO:0090265),-6.948841501966438e-11,0.0
10542,negative regulation of retinal ganglion cell axon guidance (GO:0090260),-6.948841501966438e-11,0.0
10543,protein localization involved in establishment of planar polarity (GO:0090251),-6.948841501966438e-11,0.0
10544,intralumenal vesicle formation (GO:0070676),-6.948841501966438e-11,0.0
10545,regulation of cell migration involved in somitogenic axis elongation (GO:0090249),-6.948841501966438e-11,0.0
10546,centrosome-templated microtubule nucleation (GO:0090222),-6.948841501966438e-11,0.0
10547,negative regulation of establishment of blood-brain barrier (GO:0090212),-6.948841501966438e-11,0.0
10548,negative regulation of smooth muscle cell-matrix adhesion (GO:2000098),-6.948841501966438e-11,0.0
10549,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000079),-6.948841501966438e-11,0.0
10550,negative regulation of type B pancreatic cell development (GO:2000077),-6.948841501966438e-11,0.0
10551,cell-cell adhesion in response to extracellular stimulus (GO:0140039),-6.948841501966438e-11,0.0
10552,negative regulation of intracellular cholesterol transport (GO:0032384),-6.948841501966438e-11,0.0
10553,negative regulation of intracellular sterol transport (GO:0032381),-6.948841501966438e-11,0.0
10554,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000054),-6.948841501966438e-11,0.0
10555,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000053),-6.948841501966438e-11,0.0
10556,negative regulation of intracellular lipid transport (GO:0032378),-6.948841501966438e-11,0.0
10557,regulation of cardiac cell fate specification (GO:2000043),-6.948841501966438e-11,0.0
10558,negative regulation of planar cell polarity pathway involved in axis elongation (GO:2000041),-6.948841501966438e-11,0.0
10559,regulation of planar cell polarity pathway involved in axis elongation (GO:2000040),-6.948841501966438e-11,0.0
10560,canonical Wnt signaling pathway involved in neural crest cell differentiation (GO:0044335),-6.948841501966438e-11,0.0
10561,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition (GO:0044334),-6.948841501966438e-11,0.0
10562,negative regulation of glycine import across plasma membrane (GO:1900924),-6.948841501966438e-11,0.0
10563,regulation of glycine import across plasma membrane (GO:1900923),-6.948841501966438e-11,0.0
10564,positive regulation of determination of dorsal identity (GO:2000017),-6.948841501966438e-11,0.0
10565,negative regulation of determination of dorsal identity (GO:2000016),-6.948841501966438e-11,0.0
10566,glyoxylate cycle (GO:0006097),-6.948841501966438e-11,0.0
10567,acetate metabolic process (GO:0006083),-6.948841501966438e-11,0.0
10568,hexitol metabolic process (GO:0006059),-6.948841501966438e-11,0.0
10569,N-acetylmannosamine metabolic process (GO:0006051),-6.948841501966438e-11,0.0
10570,mannosamine metabolic process (GO:0006050),-6.948841501966438e-11,0.0
10571,regulation of intraciliary retrograde transport (GO:1905799),-6.948841501966438e-11,0.0
10572,protein localization to pericentriolar material (GO:1905793),-6.948841501966438e-11,0.0
10573,N-acetylglucosamine biosynthetic process (GO:0006045),-6.948841501966438e-11,0.0
10574,glucosamine catabolic process (GO:0006043),-6.948841501966438e-11,0.0
10575,protein K33-linked ubiquitination (GO:1990390),-6.948841501966438e-11,0.0
10576,N-terminal peptidyl-L-cysteine N-palmitoylation (GO:0018009),-6.948841501966438e-11,0.0
10577,N-terminal peptidyl-glycine N-myristoylation (GO:0018008),-6.948841501966438e-11,0.0
10578,peptidyl-lysine N6-acetylation (GO:0018003),-6.948841501966438e-11,0.0
10579,N-terminal peptidyl-glutamic acid acetylation (GO:0018002),-6.948841501966438e-11,0.0
10580,positive regulation of phosphatidylserine exposure on apoptotic cell surface (GO:1905782),-6.948841501966438e-11,0.0
10581,regulation of phosphatidylserine exposure on apoptotic cell surface (GO:1905780),-6.948841501966438e-11,0.0
10582,negative regulation of exonuclease activity (GO:1905778),-6.948841501966438e-11,0.0
10583,regulation of exonuclease activity (GO:1905777),-6.948841501966438e-11,0.0
10584,negative regulation of DNA helicase activity (GO:1905775),-6.948841501966438e-11,0.0
10585,positive regulation of mesodermal cell differentiation (GO:1905772),-6.948841501966438e-11,0.0
10586,inhibitory chemical synaptic transmission (GO:0098977),-6.948841501966438e-11,0.0
10587,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-6.948841501966438e-11,0.0
10588,meiotic mismatch repair (GO:0000710),-6.948841501966438e-11,0.0
10589,positive regulation of corticotropin-releasing hormone secretion (GO:0051466),-6.948841501966438e-11,0.0
10590,anterograde dendritic transport of messenger ribonucleoprotein complex (GO:0098964),-6.948841501966438e-11,0.0
10591,nuclear polyadenylation-dependent CUT catabolic process (GO:0071039),-6.948841501966438e-11,0.0
10592,nuclear polyadenylation-dependent snRNA catabolic process (GO:0071037),-6.948841501966438e-11,0.0
10593,nuclear polyadenylation-dependent snoRNA catabolic process (GO:0071036),-6.948841501966438e-11,0.0
10594,protein localization to cytoplasmic microtubule (GO:1905755),-6.948841501966438e-11,0.0
10595,positive regulation of endosome to plasma membrane protein transport (GO:1905751),-6.948841501966438e-11,0.0
10596,stress response to zinc ion (GO:1990359),-6.948841501966438e-11,0.0
10597,corticotropin secretion (GO:0051458),-6.948841501966438e-11,0.0
10598,positive regulation of transforming growth factor beta activation (GO:1901390),-6.948841501966438e-11,0.0
10599,negative regulation of chorionic trophoblast cell proliferation (GO:1901383),-6.948841501966438e-11,0.0
10600,positive regulation of L-proline import across plasma membrane (GO:1905737),-6.948841501966438e-11,0.0
10601,regulation of L-proline import across plasma membrane (GO:1905735),-6.948841501966438e-11,0.0
10602,dendritic transport of mitochondrion (GO:0098939),-6.948841501966438e-11,0.0
10603,organic heteropentacyclic compound catabolic process (GO:1901377),-6.948841501966438e-11,0.0
10604,presynaptic signal transduction (GO:0098928),-6.948841501966438e-11,0.0
10605,retrograde trans-synaptic signaling by nitric oxide (GO:0098924),-6.948841501966438e-11,0.0
10606,retrograde trans-synaptic signaling by soluble gas (GO:0098923),-6.948841501966438e-11,0.0
10607,retrograde trans-synaptic signaling by endocannabinoid (GO:0098921),-6.948841501966438e-11,0.0
10608,retrograde trans-synaptic signaling by lipid (GO:0098920),-6.948841501966438e-11,0.0
10609,negative regulation of branching involved in ureteric bud morphogenesis (GO:0090191),-6.948841501966438e-11,0.0
10610,positive regulation of inhibitory synapse assembly (GO:1905704),-6.948841501966438e-11,0.0
10611,regulation of bundle of His cell action potential (GO:0098905),-6.948841501966438e-11,0.0
10612,regulation of secretion of lysosomal enzymes (GO:0090182),-6.948841501966438e-11,0.0
10613,thioester transport (GO:1901337),-6.948841501966438e-11,0.0
10614,lactone biosynthetic process (GO:1901336),-6.948841501966438e-11,0.0
10615,asymmetric Golgi ribbon formation (GO:0090164),-6.948841501966438e-11,0.0
10616,positive regulation of collateral sprouting in absence of injury (GO:0048697),-6.948841501966438e-11,0.0
10617,negative regulation of axon extension involved in regeneration (GO:0048692),-6.948841501966438e-11,0.0
10618,regulation of axon extension involved in regeneration (GO:0048690),-6.948841501966438e-11,0.0
10619,regulation of cargo loading into COPII-coated vesicle (GO:1901301),-6.948841501966438e-11,0.0
10620,dimethylallyl diphosphate metabolic process (GO:0050993),-6.948841501966438e-11,0.0
10621,dimethylallyl diphosphate biosynthetic process (GO:0050992),-6.948841501966438e-11,0.0
10622,negative regulation of sprouting of injured axon (GO:0048688),-6.948841501966438e-11,0.0
10623,mitochondrial membrane fission (GO:0090149),-6.948841501966438e-11,0.0
10624,regulation of sprouting of injured axon (GO:0048686),-6.948841501966438e-11,0.0
10625,sprouting of injured axon (GO:0048682),-6.948841501966438e-11,0.0
10626,negative regulation of vitamin D receptor signaling pathway (GO:0070563),-6.948841501966438e-11,0.0
10627,protein secretion by platelet (GO:0070560),-6.948841501966438e-11,0.0
10628,axon extension involved in regeneration (GO:0048677),-6.948841501966438e-11,0.0
10629,cell migration involved in mesendoderm migration (GO:0090134),-6.948841501966438e-11,0.0
10630,RNA-templated transcription (GO:0001172),-6.948841501966438e-11,0.0
10631,mesendoderm migration (GO:0090133),-6.948841501966438e-11,0.0
10632,cell-cell adhesion involved in synapse maturation (GO:0090125),-6.948841501966438e-11,0.0
10633,response to platinum ion (GO:0070541),-6.948841501966438e-11,0.0
10634,endosome to lysosome transport of low-density lipoprotein particle (GO:0090117),-6.948841501966438e-11,0.0
10635,histone H2A K63-linked ubiquitination (GO:0070535),-6.948841501966438e-11,0.0
10636,positive regulation of high-density lipoprotein particle assembly (GO:0090108),-6.948841501966438e-11,0.0
10637,negative regulation of skeletal muscle tissue growth (GO:0048632),-6.948841501966438e-11,0.0
10638,glycerol ether catabolic process (GO:0044269),-6.948841501966438e-11,0.0
10639,protein-DNA complex remodeling (GO:0001120),-6.948841501966438e-11,0.0
10640,positive regulation of DNA-templated DNA replication initiation (GO:0032298),-6.948841501966438e-11,0.0
10641,negative regulation of negative chemotaxis (GO:0050925),-6.948841501966438e-11,0.0
10642,DNA-templated transcription open complex formation (GO:0001112),-6.948841501966438e-11,0.0
10643,embryonic ectodermal digestive tract development (GO:0048611),-6.948841501966438e-11,0.0
10644,leukocyte adhesive activation (GO:0050902),-6.948841501966438e-11,0.0
10645,protein maturation by [2Fe-2S] cluster transfer (GO:0106034),-6.948841501966438e-11,0.0
10646,'de novo' CTP biosynthetic process (GO:0044210),-6.948841501966438e-11,0.0
10647,regulation of nucleoside transport (GO:0032242),-6.948841501966438e-11,0.0
10648,regulation of vesicle docking (GO:0106020),-6.948841501966438e-11,0.0
10649,positive regulation of inflammatory response to wounding (GO:0106016),-6.948841501966438e-11,0.0
10650,"negative regulation of synaptic transmission, dopaminergic (GO:0032227)",-6.948841501966438e-11,0.0
10651,tRNA (guanine-N7)-methylation (GO:0106004),-6.948841501966438e-11,0.0
10652,negative regulation of telomere maintenance via semi-conservative replication (GO:0032214),-6.948841501966438e-11,0.0
10653,regulation of telomere maintenance via semi-conservative replication (GO:0032213),-6.948841501966438e-11,0.0
10654,regulation of polysome binding (GO:1905696),-6.948841501966438e-11,0.0
10655,modification of dendritic spine (GO:0098886),-6.948841501966438e-11,0.0
10656,positive regulation of telomerase RNA reverse transcriptase activity (GO:1905663),-6.948841501966438e-11,0.0
10657,response to gold nanoparticle (GO:1990268),-6.948841501966438e-11,0.0
10658,response to transition metal nanoparticle (GO:1990267),-6.948841501966438e-11,0.0
10659,cellular response to potassium ion starvation (GO:0051365),-6.948841501966438e-11,0.0
10660,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901295),-6.948841501966438e-11,0.0
10661,negative regulation of ligase activity (GO:0051352),-6.948841501966438e-11,0.0
10662,negative regulation of DNA methylation (GO:1905642),-6.948841501966438e-11,0.0
10663,paranodal junction maintenance (GO:1990227),-6.948841501966438e-11,0.0
10664,G1 phase (GO:0051318),-6.948841501966438e-11,0.0
10665,nucleotide-excision repair involved in interstrand cross-link repair (GO:1901255),-6.948841501966438e-11,0.0
10666,negative regulation of intracellular transport of viral material (GO:1901253),-6.948841501966438e-11,0.0
10667,meiotic metaphase plate congression (GO:0051311),-6.948841501966438e-11,0.0
10668,positive regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905602),-6.948841501966438e-11,0.0
10669,negative regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905601),-6.948841501966438e-11,0.0
10670,female meiosis chromosome separation (GO:0051309),-6.948841501966438e-11,0.0
10671,positive regulation of lung ciliated cell differentiation (GO:1901248),-6.948841501966438e-11,0.0
10672,regulation of dipeptide transport (GO:0090089),-6.948841501966438e-11,0.0
10673,regulation of oligopeptide transport (GO:0090088),-6.948841501966438e-11,0.0
10674,T cell aggregation (GO:0070489),-6.948841501966438e-11,0.0
10675,neutrophil aggregation (GO:0070488),-6.948841501966438e-11,0.0
10676,detection of hypoxia (GO:0070483),-6.948841501966438e-11,0.0
10677,rRNA (guanine-N7)-methylation (GO:0070476),-6.948841501966438e-11,0.0
10678,regulation of heart looping (GO:1901207),-6.948841501966438e-11,0.0
10679,thyroid-stimulating hormone secretion (GO:0070460),-6.948841501966438e-11,0.0
10680,establishment of animal organ orientation (GO:0048561),-6.948841501966438e-11,0.0
10681,regulation of liquid surface tension (GO:0050828),-6.948841501966438e-11,0.0
10682,(R)-carnitine transport (GO:1900749),-6.948841501966438e-11,0.0
10683,"circadian sleep/wake cycle, sleep (GO:0050802)",-6.948841501966438e-11,0.0
10684,protein deglycation (GO:0036525),-6.948841501966438e-11,0.0
10685,larynx development (GO:0120224),-6.948841501966438e-11,0.0
10686,larynx morphogenesis (GO:0120223),-6.948841501966438e-11,0.0
10687,chemorepulsion of dopaminergic neuron axon (GO:0036518),-6.948841501966438e-11,0.0
10688,serotonergic neuron axon guidance (GO:0036515),-6.948841501966438e-11,0.0
10689,trimming of second mannose on A branch (GO:0036512),-6.948841501966438e-11,0.0
10690,trimming of first mannose on A branch (GO:0036511),-6.948841501966438e-11,0.0
10691,trimming of terminal mannose on B branch (GO:0036509),-6.948841501966438e-11,0.0
10692,regulation of low-density lipoprotein particle receptor binding (GO:1905595),-6.948841501966438e-11,0.0
10693,fibronectin fibril organization (GO:1905590),-6.948841501966438e-11,0.0
10694,outer hair cell apoptotic process (GO:1905584),-6.948841501966438e-11,0.0
10695,G protein-coupled receptor catabolic process (GO:1990172),-6.948841501966438e-11,0.0
10696,stress response to cadmium ion (GO:1990170),-6.948841501966438e-11,0.0
10697,positive regulation of protein localization to endoplasmic reticulum (GO:1905552),-6.948841501966438e-11,0.0
10698,negative regulation of protein localization to endoplasmic reticulum (GO:1905551),-6.948841501966438e-11,0.0
10699,meiotic spindle midzone assembly (GO:0051257),-6.948841501966438e-11,0.0
10700,regulation of L-arginine import across plasma membrane (GO:1905541),-6.948841501966438e-11,0.0
10701,blue light signaling pathway (GO:0009785),-6.948841501966438e-11,0.0
10702,regulation of ephrin receptor signaling pathway (GO:1901187),-6.948841501966438e-11,0.0
10703,maintenance of translational fidelity (GO:1990145),-6.948841501966438e-11,0.0
10704,negative regulation of leucine import across plasma membrane (GO:1905533),-6.948841501966438e-11,0.0
10705,ncRNA polyadenylation (GO:0043629),-6.948841501966438e-11,0.0
10706,spindle disassembly (GO:0051230),-6.948841501966438e-11,0.0
10707,regulation of Golgi lumen acidification (GO:1905526),-6.948841501966438e-11,0.0
10708,negative regulation of protein autoubiquitination (GO:1905524),-6.948841501966438e-11,0.0
10709,mitotic spindle disassembly (GO:0051228),-6.948841501966438e-11,0.0
10710,serine import across plasma membrane (GO:0098718),-6.948841501966438e-11,0.0
10711,adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:0031635),-6.948841501966438e-11,0.0
10712,telomeric loop formation (GO:0031627),-6.948841501966438e-11,0.0
10713,vascular endothelial cell proliferation (GO:0101023),-6.948841501966438e-11,0.0
10714,positive regulation of ERK5 cascade (GO:0070378),-6.948841501966438e-11,0.0
10715,ERK5 cascade (GO:0070375),-6.948841501966438e-11,0.0
10716,regulation of hepatocyte differentiation (GO:0070366),-6.948841501966438e-11,0.0
10717,positive regulation of white fat cell proliferation (GO:0070352),-6.948841501966438e-11,0.0
10718,regulation of translational initiation by eIF2 alpha dephosphorylation (GO:0036496),-6.948841501966438e-11,0.0
10719,eiF2alpha phosphorylation in response to endoplasmic reticulum stress (GO:0036492),-6.948841501966438e-11,0.0
10720,negative regulation of termination of RNA polymerase II transcription (GO:0120191),-6.948841501966438e-11,0.0
10721,brown fat cell proliferation (GO:0070342),-6.948841501966438e-11,0.0
10722,intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:0036481),-6.948841501966438e-11,0.0
10723,detection of cold stimulus involved in thermoception (GO:0120169),-6.948841501966438e-11,0.0
10724,zinc ion import into synaptic vesicle (GO:0099180),-6.948841501966438e-11,0.0
10725,olefin metabolic process (GO:1900673),-6.948841501966438e-11,0.0
10726,regulation of retrograde trans-synaptic signaling by endocanabinoid (GO:0099178),-6.948841501966438e-11,0.0
10727,cap mRNA methylation (GO:0036451),-6.948841501966438e-11,0.0
10728,negative regulation of deoxyribonuclease activity (GO:0032076),-6.948841501966438e-11,0.0
10729,hypermethylation of CpG island (GO:0044027),-6.948841501966438e-11,0.0
10730,tRNA stabilization (GO:0036416),-6.948841501966438e-11,0.0
10731,regulation of tRNA stability (GO:0036415),-6.948841501966438e-11,0.0
10732,box H/ACA RNA 3'-end processing (GO:0000495),-6.948841501966438e-11,0.0
10733,box H/ACA snoRNP assembly (GO:0000493),-6.948841501966438e-11,0.0
10734,positive regulation of ARF protein signal transduction (GO:0032014),-6.948841501966438e-11,0.0
10735,tendon formation (GO:0035992),-6.948841501966438e-11,0.0
10736,tendon cell differentiation (GO:0035990),-6.948841501966438e-11,0.0
10737,"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000448)",-6.948841501966438e-11,0.0
10738,pexophagy (GO:0000425),-6.948841501966438e-11,0.0
10739,negative regulation of histone H3-K36 methylation (GO:0000415),-6.948841501966438e-11,0.0
10740,inorganic anion import across plasma membrane (GO:0098658),-6.948841501966438e-11,0.0
10741,negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905450),-6.948841501966438e-11,0.0
10742,corticosterone secretion (GO:0035934),-6.948841501966438e-11,0.0
10743,negative regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905447),-6.948841501966438e-11,0.0
10744,positive regulation of clathrin coat assembly (GO:1905445),-6.948841501966438e-11,0.0
10745,regulation of clathrin coat assembly (GO:1905443),-6.948841501966438e-11,0.0
10746,stress-induced mitochondrial fusion (GO:1990046),-6.948841501966438e-11,0.0
10747,regulation of relaxation of smooth muscle (GO:1901080),-6.948841501966438e-11,0.0
10748,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1905438),-6.948841501966438e-11,0.0
10749,positive regulation of histone H3-K4 trimethylation (GO:1905437),-6.948841501966438e-11,0.0
10750,regulation of histone H3-K4 trimethylation (GO:1905435),-6.948841501966438e-11,0.0
10751,cellular response to glycine (GO:1905430),-6.948841501966438e-11,0.0
10752,positive regulation of engulfment of apoptotic cell (GO:1901076),-6.948841501966438e-11,0.0
10753,negative regulation of NK T cell activation (GO:0051134),-6.948841501966438e-11,0.0
10754,pore formation in membrane of another organism (GO:0035915),-6.948841501966438e-11,0.0
10755,glucosamine-containing compound biosynthetic process (GO:1901073),-6.948841501966438e-11,0.0
10756,NK T cell activation (GO:0051132),-6.948841501966438e-11,0.0
10757,positive regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031550),-6.948841501966438e-11,0.0
10758,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905426),-6.948841501966438e-11,0.0
10759,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905424),-6.948841501966438e-11,0.0
10760,trans-Golgi network membrane organization (GO:0098629),-6.948841501966438e-11,0.0
10761,synaptic assembly at neuromuscular junction (GO:0051124),-6.948841501966438e-11,0.0
10762,regulation of dense core granule exocytosis (GO:1905413),-6.948841501966438e-11,0.0
10763,sarcosine metabolic process (GO:1901052),-6.948841501966438e-11,0.0
10764,negative regulation of creatine transmembrane transporter activity (GO:1905408),-6.948841501966438e-11,0.0
10765,regulation of creatine transmembrane transporter activity (GO:1905407),-6.948841501966438e-11,0.0
10766,"negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905403)",-6.948841501966438e-11,0.0
10767,positive regulation of leukocyte adhesion to arterial endothelial cell (GO:1904999),-6.948841501966438e-11,0.0
10768,intermediate mesoderm development (GO:0048389),-6.948841501966438e-11,0.0
10769,lateral mesodermal cell differentiation (GO:0048371),-6.948841501966438e-11,0.0
10770,negative regulation of endosome organization (GO:1904979),-6.948841501966438e-11,0.0
10771,negative regulation of mucus secretion (GO:0070256),-6.948841501966438e-11,0.0
10772,cellular response to bleomycin (GO:1904976),-6.948841501966438e-11,0.0
10773,response to bleomycin (GO:1904975),-6.948841501966438e-11,0.0
10774,"chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0050653)",-6.948841501966438e-11,0.0
10775,paraxial mesodermal cell fate commitment (GO:0048343),-6.948841501966438e-11,0.0
10776,paraxial mesodermal cell differentiation (GO:0048342),-6.948841501966438e-11,0.0
10777,calcium export from the mitochondrion (GO:0099093),-6.948841501966438e-11,0.0
10778,opsin transport (GO:0036372),-6.948841501966438e-11,0.0
10779,protein localization to T-tubule (GO:0036371),-6.948841501966438e-11,0.0
10780,transcription factor catabolic process (GO:0036369),-6.948841501966438e-11,0.0
10781,transforming growth factor beta1 activation (GO:0036364),-6.948841501966438e-11,0.0
10782,regulation of cell proliferation in midbrain (GO:1904933),-6.948841501966438e-11,0.0
10783,renal potassium excretion (GO:0036359),-6.948841501966438e-11,0.0
10784,positive regulation of small intestinal transit (GO:0120058),-6.948841501966438e-11,0.0
10785,regulation of small intestinal transit (GO:0120057),-6.948841501966438e-11,0.0
10786,snRNA (adenine-N6)-methylation (GO:0120049),-6.948841501966438e-11,0.0
10787,platelet maturation (GO:0036345),-6.948841501966438e-11,0.0
10788,Fas signaling pathway (GO:0036337),-6.948841501966438e-11,0.0
10789,"negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904908)",-6.948841501966438e-11,0.0
10790,"regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904907)",-6.948841501966438e-11,0.0
10791,vesicle tethering to endoplasmic reticulum (GO:0099044),-6.948841501966438e-11,0.0
10792,ceramide translocation (GO:0099040),-6.948841501966438e-11,0.0
10793,ghrelin secretion (GO:0036321),-6.948841501966438e-11,0.0
10794,palmitic acid biosynthetic process (GO:1900535),-6.948841501966438e-11,0.0
10795,palmitic acid metabolic process (GO:1900533),-6.948841501966438e-11,0.0
10796,SREBP-SCAP complex retention in endoplasmic reticulum (GO:0036316),-6.948841501966438e-11,0.0
10797,protein localization to M-band (GO:0036309),-6.948841501966438e-11,0.0
10798,umbilical cord morphogenesis (GO:0036304),-6.948841501966438e-11,0.0
10799,cis assembly of pre-catalytic spliceosome (GO:0000354),-6.948841501966438e-11,0.0
10800,generation of catalytic spliceosome for second transesterification step (GO:0000350),-6.948841501966438e-11,0.0
10801,regulation of protein homodimerization activity (GO:0043496),-6.948841501966438e-11,0.0
10802,generation of catalytic spliceosome for first transesterification step (GO:0000349),-6.948841501966438e-11,0.0
10803,response to flavonoid (GO:1905395),-6.948841501966438e-11,0.0
10804,positive regulation of protein localization to presynapse (GO:1905386),-6.948841501966438e-11,0.0
10805,regulation of protein localization to presynapse (GO:1905384),-6.948841501966438e-11,0.0
10806,'de novo' cotranslational protein folding (GO:0051083),-6.948841501966438e-11,0.0
10807,re-entry into mitotic cell cycle (GO:0000320),-6.948841501966438e-11,0.0
10808,eosinophil fate commitment (GO:0035854),-6.948841501966438e-11,0.0
10809,negative regulation of intralumenal vesicle formation (GO:1905366),-6.948841501966438e-11,0.0
10810,regulation of intralumenal vesicle formation (GO:1905365),-6.948841501966438e-11,0.0
10811,dihydrobiopterin metabolic process (GO:0051066),-6.948841501966438e-11,0.0
10812,cellular alkene metabolic process (GO:0043449),-6.948841501966438e-11,0.0
10813,detection of gravity (GO:0009590),-6.948841501966438e-11,0.0
10814,ciliary transition zone assembly (GO:1905349),-6.948841501966438e-11,0.0
10815,prostaglandin catabolic process (GO:1905344),-6.948841501966438e-11,0.0
10816,N-terminal peptidyl-aspartic acid acetylation (GO:0017190),-6.948841501966438e-11,0.0
10817,regulation of calcium-independent cell-cell adhesion (GO:0051040),-6.948841501966438e-11,0.0
10818,glycine betaine transport (GO:0031460),-6.948841501966438e-11,0.0
10819,"peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (GO:0017186)",-6.948841501966438e-11,0.0
10820,glycine betaine biosynthetic process (GO:0031456),-6.948841501966438e-11,0.0
10821,glycine betaine metabolic process (GO:0031455),-6.948841501966438e-11,0.0
10822,adrenal cortex formation (GO:0035802),-6.948841501966438e-11,0.0
10823,regulation of slow-twitch skeletal muscle fiber contraction (GO:0031449),-6.948841501966438e-11,0.0
10824,positive regulation of fast-twitch skeletal muscle fiber contraction (GO:0031448),-6.948841501966438e-11,0.0
10825,regulation of fast-twitch skeletal muscle fiber contraction (GO:0031446),-6.948841501966438e-11,0.0
10826,negative regulation of mRNA 3'-end processing (GO:0031441),-6.948841501966438e-11,0.0
10827,microtubule sliding (GO:0051012),-6.948841501966438e-11,0.0
10828,positive regulation of macropinocytosis (GO:1905303),-6.948841501966438e-11,0.0
10829,synaptonemal complex disassembly (GO:0070194),-6.948841501966438e-11,0.0
10830,oxylipin biosynthetic process (GO:0031408),-6.948841501966438e-11,0.0
10831,oxylipin metabolic process (GO:0031407),-6.948841501966438e-11,0.0
10832,nucleologenesis (GO:0017126),-6.948841501966438e-11,0.0
10833,D-serine metabolic process (GO:0070178),-6.948841501966438e-11,0.0
10834,negative regulation of tooth mineralization (GO:0070171),-6.948841501966438e-11,0.0
10835,positive regulation of telomerase catalytic core complex assembly (GO:1904884),-6.948841501966438e-11,0.0
10836,regulation of telomerase catalytic core complex assembly (GO:1904882),-6.948841501966438e-11,0.0
10837,cellular response to hydrogen sulfide (GO:1904881),-6.948841501966438e-11,0.0
10838,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904879),-6.948841501966438e-11,0.0
10839,regulation of DNA ligase activity (GO:1904875),-6.948841501966438e-11,0.0
10840,recombinational interstrand cross-link repair (GO:0036298),-6.948841501966438e-11,0.0
10841,negative regulation of beta-catenin-TCF complex assembly (GO:1904864),-6.948841501966438e-11,0.0
10842,regulation of beta-catenin-TCF complex assembly (GO:1904863),-6.948841501966438e-11,0.0
10843,iron import into the mitochondrion (GO:0048250),-6.948841501966438e-11,0.0
10844,D-serine transport (GO:0042942),-6.948841501966438e-11,0.0
10845,thiamine pyrophosphate transmembrane transport (GO:0030974),-6.948841501966438e-11,0.0
10846,mitochondrial translational initiation (GO:0070124),-6.948841501966438e-11,0.0
10847,response to nitroglycerin (GO:1904842),-6.948841501966438e-11,0.0
10848,negative regulation of DNA recombination at telomere (GO:0048239),-6.948841501966438e-11,0.0
10849,swimming behavior (GO:0036269),-6.948841501966438e-11,0.0
10850,dorsal root ganglion morphogenesis (GO:1904835),-6.948841501966438e-11,0.0
10851,positive regulation of aortic smooth muscle cell differentiation (GO:1904831),-6.948841501966438e-11,0.0
10852,regulation of aortic smooth muscle cell differentiation (GO:1904829),-6.948841501966438e-11,0.0
10853,negative regulation of interleukin-6-mediated signaling pathway (GO:0070104),-6.948841501966438e-11,0.0
10854,Golgi vesicle prefusion complex stabilization (GO:0048213),-6.948841501966438e-11,0.0
10855,cellular response to menadione (GO:0036245),-6.948841501966438e-11,0.0
10856,"negative regulation of protein localization to chromosome, telomeric region (GO:1904815)",-6.948841501966438e-11,0.0
10857,positive regulation of dense core granule transport (GO:1904811),-6.948841501966438e-11,0.0
10858,positive regulation of glutamate receptor signaling pathway (GO:1900451),-6.948841501966438e-11,0.0
10859,"vesicle targeting, trans-Golgi to endosome (GO:0048203)",-6.948841501966438e-11,0.0
10860,regulation of dense core granule transport (GO:1904809),-6.948841501966438e-11,0.0
10861,positive regulation of protein oxidation (GO:1904808),-6.948841501966438e-11,0.0
10862,regulation of protein oxidation (GO:1904806),-6.948841501966438e-11,0.0
10863,protein localization to nuclear inner membrane (GO:0036228),-6.948841501966438e-11,0.0
10864,spermine transport (GO:0000296),-6.948841501966438e-11,0.0
10865,"nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay (GO:0000294)",-6.948841501966438e-11,0.0
10866,negative regulation of cellular response to oxidative stress (GO:1900408),-6.948841501966438e-11,0.0
10867,M phase (GO:0000279),-6.948841501966438e-11,0.0
10868,platelet-derived growth factor receptor-alpha signaling pathway (GO:0035790),-6.948841501966438e-11,0.0
10869,cell migration involved in metanephros development (GO:0035788),-6.948841501966438e-11,0.0
10870,CD86 biosynthetic process (GO:0035781),-6.948841501966438e-11,0.0
10871,mycotoxin catabolic process (GO:0043387),-6.948841501966438e-11,0.0
10872,negative regulation of memory T cell differentiation (GO:0043381),-6.948841501966438e-11,0.0
10873,"positive regulation of retrograde transport, endosome to Golgi (GO:1905281)",-6.948841501966438e-11,0.0
10874,"negative regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043377)",-6.948841501966438e-11,0.0
10875,"CD8-positive, alpha-beta T cell lineage commitment (GO:0043375)",-6.948841501966438e-11,0.0
10876,mesangial cell-matrix adhesion (GO:0035759),-6.948841501966438e-11,0.0
10877,negative regulation of prostaglandin biosynthetic process (GO:0031393),-6.948841501966438e-11,0.0
10878,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905259),-6.948841501966438e-11,0.0
10879,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905258),-6.948841501966438e-11,0.0
10880,hepatic stellate cell activation (GO:0035733),-6.948841501966438e-11,0.0
10881,"cellular response to 3,3',5-triiodo-L-thyronine (GO:1905243)",-6.948841501966438e-11,0.0
10882,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905240),-6.948841501966438e-11,0.0
10883,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905239),-6.948841501966438e-11,0.0
10884,response to thyrotropin-releasing hormone (GO:1905225),-6.948841501966438e-11,0.0
10885,clathrin-coated pit assembly (GO:1905224),-6.948841501966438e-11,0.0
10886,epicardium morphogenesis (GO:1905223),-6.948841501966438e-11,0.0
10887,positive regulation of platelet formation (GO:1905221),-6.948841501966438e-11,0.0
10888,memory T cell activation (GO:0035709),-6.948841501966438e-11,0.0
10889,negative regulation of neutrophil degranulation (GO:0043314),-6.948841501966438e-11,0.0
10890,positive regulation of eosinophil degranulation (GO:0043311),-6.948841501966438e-11,0.0
10891,regulation of platelet formation (GO:1905219),-6.948841501966438e-11,0.0
10892,negative regulation of RNA binding (GO:1905215),-6.948841501966438e-11,0.0
10893,negative regulation of mitotic chromosome condensation (GO:1905213),-6.948841501966438e-11,0.0
10894,gamma-aminobutyric acid catabolic process (GO:0009450),-6.948841501966438e-11,0.0
10895,regulation of sulfur amino acid metabolic process (GO:0031335),-6.948841501966438e-11,0.0
10896,negative regulation of connective tissue replacement (GO:1905204),-6.948841501966438e-11,0.0
10897,negative regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0017055),-6.948841501966438e-11,0.0
10898,cyanate catabolic process (GO:0009440),-6.948841501966438e-11,0.0
10899,cyanate metabolic process (GO:0009439),-6.948841501966438e-11,0.0
10900,toxin catabolic process (GO:0009407),-6.948841501966438e-11,0.0
10901,tear secretion (GO:0070075),-6.948841501966438e-11,0.0
10902,regulation of shelterin complex assembly (GO:1904790),-6.948841501966438e-11,0.0
10903,negative regulation of NMDA glutamate receptor activity (GO:1904782),-6.948841501966438e-11,0.0
10904,negative regulation of protein localization to centrosome (GO:1904780),-6.948841501966438e-11,0.0
10905,primary follicle stage (GO:0048160),-6.948841501966438e-11,0.0
10906,positive regulation of myeloid dendritic cell activation (GO:0030887),-6.948841501966438e-11,0.0
10907,positive regulation of telomeric DNA binding (GO:1904744),-6.948841501966438e-11,0.0
10908,negative regulation of telomeric DNA binding (GO:1904743),-6.948841501966438e-11,0.0
10909,protein arginylation (GO:0016598),-6.948841501966438e-11,0.0
10910,spermatocyte division (GO:0048137),-6.948841501966438e-11,0.0
10911,regulation of polarized epithelial cell differentiation (GO:0030860),-6.948841501966438e-11,0.0
10912,negative regulation of intestinal lipid absorption (GO:1904730),-6.948841501966438e-11,0.0
10913,pyridoxal phosphate biosynthetic process (GO:0042823),-6.948841501966438e-11,0.0
10914,dendritic cell homeostasis (GO:0036145),-6.948841501966438e-11,0.0
10915,positive regulation of AMPA glutamate receptor clustering (GO:1904719),-6.948841501966438e-11,0.0
10916,very long-chain fatty-acyl-CoA metabolic process (GO:0036111),-6.948841501966438e-11,0.0
10917,negative regulation of protein K48-linked ubiquitination (GO:0061944),-6.948841501966438e-11,0.0
10918,helper T cell diapedesis (GO:0035685),-6.948841501966438e-11,0.0
10919,memory T cell extravasation (GO:0035683),-6.948841501966438e-11,0.0
10920,neuromast hair cell development (GO:0035675),-6.948841501966438e-11,0.0
10921,tricarboxylic acid transmembrane transport (GO:0035674),-6.948841501966438e-11,0.0
10922,positive regulation of protein serine/threonine phosphatase activity (GO:1905184),-6.948841501966438e-11,0.0
10923,negative regulation of cardiac muscle tissue regeneration (GO:1905179),-6.948841501966438e-11,0.0
10924,regulation of cardiac muscle tissue regeneration (GO:1905178),-6.948841501966438e-11,0.0
10925,regulation of vascular associated smooth muscle cell dedifferentiation (GO:1905174),-6.948841501966438e-11,0.0
10926,positive regulation of protein localization to phagocytic vesicle (GO:1905171),-6.948841501966438e-11,0.0
10927,regulation of protein localization to phagocytic vesicle (GO:1905169),-6.948841501966438e-11,0.0
10928,regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0000117),-6.948841501966438e-11,0.0
10929,histidine biosynthetic process (GO:0000105),-6.948841501966438e-11,0.0
10930,sulfate assimilation (GO:0000103),-6.948841501966438e-11,0.0
10931,entry of bacterium into host cell (GO:0035635),-6.948841501966438e-11,0.0
10932,translational attenuation (GO:0009386),-6.948841501966438e-11,0.0
10933,intrahepatic bile duct development (GO:0035622),-6.948841501966438e-11,0.0
10934,biotin import across plasma membrane (GO:1905135),-6.948841501966438e-11,0.0
10935,regulation of glucosylceramidase activity (GO:1905123),-6.948841501966438e-11,0.0
10936,peptidyl-cysteine S-trans-nitrosylation (GO:0035606),-6.948841501966438e-11,0.0
10937,tRNA methylthiolation (GO:0035600),-6.948841501966438e-11,0.0
10938,actin rod assembly (GO:0031247),-6.948841501966438e-11,0.0
10939,positive regulation of metalloendopeptidase activity (GO:1904685),-6.948841501966438e-11,0.0
10940,positive regulation of somatic stem cell population maintenance (GO:1904674),-6.948841501966438e-11,0.0
10941,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0036091),-6.948841501966438e-11,0.0
10942,cleavage furrow ingression (GO:0036090),-6.948841501966438e-11,0.0
10943,regulation of fat cell apoptotic process (GO:1904649),-6.948841501966438e-11,0.0
10944,slit diaphragm assembly (GO:0036060),-6.948841501966438e-11,0.0
10945,positive regulation of podocyte apoptotic process (GO:1904635),-6.948841501966438e-11,0.0
10946,regulation of podocyte apoptotic process (GO:1904633),-6.948841501966438e-11,0.0
10947,farnesol catabolic process (GO:0016488),-6.948841501966438e-11,0.0
10948,farnesol metabolic process (GO:0016487),-6.948841501966438e-11,0.0
10949,"regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900279)",-6.948841501966438e-11,0.0
10950,flavin-containing compound biosynthetic process (GO:0042727),-6.948841501966438e-11,0.0
10951,negative regulation of phospholipase C activity (GO:1900275),-6.948841501966438e-11,0.0
10952,filtration diaphragm assembly (GO:0036058),-6.948841501966438e-11,0.0
10953,peptidyl-lysine desuccinylation (GO:0036049),-6.948841501966438e-11,0.0
10954,protein desuccinylation (GO:0036048),-6.948841501966438e-11,0.0
10955,positive regulation of actin binding (GO:1904618),-6.948841501966438e-11,0.0
10956,"cellular response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904613)",-6.948841501966438e-11,0.0
10957,uterine wall breakdown (GO:0042704),-6.948841501966438e-11,0.0
10958,progesterone secretion (GO:0042701),-6.948841501966438e-11,0.0
10959,luteinizing hormone signaling pathway (GO:0042700),-6.948841501966438e-11,0.0
10960,recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex (GO:0036031),-6.948841501966438e-11,0.0
10961,negative regulation of cytoplasmic translational elongation (GO:1900248),-6.948841501966438e-11,0.0
10962,negative regulation of phenotypic switching (GO:1900240),-6.948841501966438e-11,0.0
10963,negative regulation of Kit signaling pathway (GO:1900235),-6.948841501966438e-11,0.0
10964,regulation of Kit signaling pathway (GO:1900234),-6.948841501966438e-11,0.0
10965,negative regulation of single-species biofilm formation in or on host organism (GO:1900229),-6.948841501966438e-11,0.0
10966,regulation of single-species biofilm formation in or on host organism (GO:1900228),-6.948841501966438e-11,0.0
10967,positive regulation of mini excitatory postsynaptic potential (GO:0061885),-6.948841501966438e-11,0.0
10968,regulation of mini excitatory postsynaptic potential (GO:0061884),-6.948841501966438e-11,0.0
10969,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900224),-6.948841501966438e-11,0.0
10970,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis (GO:1900220),-6.948841501966438e-11,0.0
10971,negative regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900218),-6.948841501966438e-11,0.0
10972,regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900217),-6.948841501966438e-11,0.0
10973,negative regulation of apoptotic process involved in metanephric collecting duct development (GO:1900215),-6.948841501966438e-11,0.0
10974,regulation of apoptotic process involved in metanephric collecting duct development (GO:1900214),-6.948841501966438e-11,0.0
10975,positive regulation of hepatic stellate cell migration (GO:0061870),-6.948841501966438e-11,0.0
10976,positive regulation of cardiolipin metabolic process (GO:1900210),-6.948841501966438e-11,0.0
10977,regulation of hepatic stellate cell migration (GO:0061869),-6.948841501966438e-11,0.0
10978,mitotic M phase (GO:0000087),-6.948841501966438e-11,0.0
10979,mitotic G1 phase (GO:0000080),-6.948841501966438e-11,0.0
10980,endoplasmic reticulum stress-induced pre-emptive quality control (GO:0061857),-6.948841501966438e-11,0.0
10981,positive regulation of guanyl-nucleotide exchange factor activity (GO:1905099),-6.948841501966438e-11,0.0
10982,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905089),-6.948841501966438e-11,0.0
10983,regulation of metanephros size (GO:0035566),-6.948841501966438e-11,0.0
10984,protein initiator methionine removal involved in protein maturation (GO:0035551),-6.948841501966438e-11,0.0
10985,regulation of canonical Wnt signaling pathway involved in heart development (GO:1905066),-6.948841501966438e-11,0.0
10986,alpha-glucoside transport (GO:0000017),-6.948841501966438e-11,0.0
10987,determination of left/right asymmetry in nervous system (GO:0035545),-6.948841501966438e-11,0.0
10988,negative regulation of SNARE complex assembly (GO:0035544),-6.948841501966438e-11,0.0
10989,diadenosine tetraphosphate biosynthetic process (GO:0015966),-6.948841501966438e-11,0.0
10990,diadenosine tetraphosphate metabolic process (GO:0015965),-6.948841501966438e-11,0.0
10991,diadenosine polyphosphate biosynthetic process (GO:0015960),-6.948841501966438e-11,0.0
10992,positive regulation of base-excision repair (GO:1905053),-6.948841501966438e-11,0.0
10993,regulation of base-excision repair (GO:1905051),-6.948841501966438e-11,0.0
10994,Golgi to secretory granule transport (GO:0055107),-6.948841501966438e-11,0.0
10995,regulation of epithelium regeneration (GO:1905041),-6.948841501966438e-11,0.0
10996,"retrograde transport, plasma membrane to Golgi (GO:0035526)",-6.948841501966438e-11,0.0
10997,phosphatidylinositol catabolic process (GO:0031161),-6.948841501966438e-11,0.0
10998,negative regulation of antifungal innate immune response (GO:1905035),-6.948841501966438e-11,0.0
10999,positive regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905033),-6.948841501966438e-11,0.0
11000,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905026),-6.948841501966438e-11,0.0
11001,positive regulation of myosin light chain kinase activity (GO:0035505),-6.948841501966438e-11,0.0
11002,regulation of myosin light chain kinase activity (GO:0035504),-6.948841501966438e-11,0.0
11003,proteasome localization (GO:0031144),-6.948841501966438e-11,0.0
11004,lipopolysaccharide transport (GO:0015920),-6.948841501966438e-11,0.0
11005,10-formyltetrahydrofolate biosynthetic process (GO:0009257),-6.948841501966438e-11,0.0
11006,hypoxanthine salvage (GO:0043103),-6.948841501966438e-11,0.0
11007,fatty-acyl-CoA transport (GO:0015916),-6.948841501966438e-11,0.0
11008,short-chain fatty acid import (GO:0015913),-6.948841501966438e-11,0.0
11009,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905006),-6.948841501966438e-11,0.0
11010,nucleotide-sugar catabolic process (GO:0009227),-6.948841501966438e-11,0.0
11011,septin ring organization (GO:0031106),-6.948841501966438e-11,0.0
11012,purine deoxyribonucleoside triphosphate biosynthetic process (GO:0009216),-6.948841501966438e-11,0.0
11013,negative regulation of connective tissue replacement involved in inflammatory response wound healing (GO:1904597),-6.948841501966438e-11,0.0
11014,regulation of connective tissue replacement involved in inflammatory response wound healing (GO:1904596),-6.948841501966438e-11,0.0
11015,ribonucleoside triphosphate catabolic process (GO:0009203),-6.948841501966438e-11,0.0
11016,deoxyribonucleoside triphosphate biosynthetic process (GO:0009202),-6.948841501966438e-11,0.0
11017,regulation of endodermal cell fate specification (GO:0042663),-6.948841501966438e-11,0.0
11018,positive regulation of cell fate specification (GO:0042660),-6.948841501966438e-11,0.0
11019,platelet activating factor catabolic process (GO:0062234),-6.948841501966438e-11,0.0
11020,prostanoid catabolic process (GO:0062232),-6.948841501966438e-11,0.0
11021,phosphatidylinositol 5-phosphate metabolic process (GO:1904562),-6.948841501966438e-11,0.0
11022,L-tryptophan transmembrane transport (GO:1904556),-6.948841501966438e-11,0.0
11023,negative regulation of single-species biofilm formation (GO:1900191),-6.948841501966438e-11,0.0
11024,endosome membrane tubulation (GO:0097750),-6.948841501966438e-11,0.0
11025,regulation of single-species biofilm formation (GO:1900190),-6.948841501966438e-11,0.0
11026,positive regulation of free ubiquitin chain polymerization (GO:1904544),-6.948841501966438e-11,0.0
11027,regulation of free ubiquitin chain polymerization (GO:1904542),-6.948841501966438e-11,0.0
11028,positive regulation of hair cycle (GO:0042635),-6.948841501966438e-11,0.0
11029,negative regulation of telomeric loop disassembly (GO:1904534),-6.948841501966438e-11,0.0
11030,positive regulation of actin filament binding (GO:1904531),-6.948841501966438e-11,0.0
11031,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900176),-6.948841501966438e-11,0.0
11032,negative regulation of microtubule binding (GO:1904527),-6.948841501966438e-11,0.0
11033,positive regulation of bone mineralization involved in bone maturation (GO:1900159),-6.948841501966438e-11,0.0
11034,negative regulation of bone trabecula formation (GO:1900155),-6.948841501966438e-11,0.0
11035,regulation of bone trabecula formation (GO:1900154),-6.948841501966438e-11,0.0
11036,ciliary basal body-plasma membrane docking (GO:0097711),-6.948841501966438e-11,0.0
11037,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900146),-6.948841501966438e-11,0.0
11038,regulation of oligodendrocyte apoptotic process (GO:1900141),-6.948841501966438e-11,0.0
11039,positive regulation of renin secretion into blood stream (GO:1900135),-6.948841501966438e-11,0.0
11040,calcium-dependent cell-matrix adhesion (GO:0016340),-6.948841501966438e-11,0.0
11041,establishment or maintenance of polarity of embryonic epithelium (GO:0016332),-6.948841501966438e-11,0.0
11042,endoplasmic reticulum membrane fusion (GO:0016320),-6.948841501966438e-11,0.0
11043,positive regulation of histone H3-K9 dimethylation (GO:1900111),-6.948841501966438e-11,0.0
11044,negative regulation of histone H3-K9 dimethylation (GO:1900110),-6.948841501966438e-11,0.0
11045,late endosome to lysosome transport via multivesicular body sorting pathway (GO:0061764),-6.948841501966438e-11,0.0
11046,carnosine metabolic process (GO:0035498),-6.948841501966438e-11,0.0
11047,pyrimidine nucleoside salvage (GO:0043097),-6.948841501966438e-11,0.0
11048,amino acid import (GO:0043090),-6.948841501966438e-11,0.0
11049,lipophagy (GO:0061724),-6.948841501966438e-11,0.0
11050,FAD transport (GO:0015883),-6.948841501966438e-11,0.0
11051,coenzyme A transport (GO:0015880),-6.948841501966438e-11,0.0
11052,negative regulation of cardiac muscle tissue development (GO:0055026),-6.948841501966438e-11,0.0
11053,positive regulation of cardiac muscle tissue development (GO:0055025),-6.948841501966438e-11,0.0
11054,thermotaxis (GO:0043052),-6.948841501966438e-11,0.0
11055,pyrimidine deoxyribonucleoside diphosphate biosynthetic process (GO:0009197),-6.948841501966438e-11,0.0
11056,pyrimidine deoxyribonucleoside diphosphate metabolic process (GO:0009196),-6.948841501966438e-11,0.0
11057,guanine transport (GO:0015854),-6.948841501966438e-11,0.0
11058,purine deoxyribonucleoside diphosphate biosynthetic process (GO:0009183),-6.948841501966438e-11,0.0
11059,valine transport (GO:0015829),-6.948841501966438e-11,0.0
11060,tyrosine transport (GO:0015828),-6.948841501966438e-11,0.0
11061,maintenance of rDNA (GO:0043007),-6.948841501966438e-11,0.0
11062,Golgi to plasma membrane CFTR protein transport (GO:0043000),-6.948841501966438e-11,0.0
11063,lysine transport (GO:0015819),-6.948841501966438e-11,0.0
11064,isoleucine transport (GO:0015818),-6.948841501966438e-11,0.0
11065,histidine transport (GO:0015817),-6.948841501966438e-11,0.0
11066,nuclear migration along microfilament (GO:0031022),-6.948841501966438e-11,0.0
11067,3'-phosphoadenosine 5'-phosphosulfate transport (GO:0046963),-6.948841501966438e-11,0.0
11068,sensitization (GO:0046960),-6.948841501966438e-11,0.0
11069,radial spoke assembly (GO:0062177),-6.948841501966438e-11,0.0
11070,brexanolone metabolic process (GO:0062173),-6.948841501966438e-11,0.0
11071,behavioral response to starvation (GO:0042595),-6.948841501966438e-11,0.0
11072,hydroxylysine biosynthetic process (GO:0046947),-6.948841501966438e-11,0.0
11073,hydroxylysine metabolic process (GO:0046946),-6.948841501966438e-11,0.0
11074,establishment of protein-containing complex localization to telomere (GO:0097695),-6.948841501966438e-11,0.0
11075,establishment of RNA localization to telomere (GO:0097694),-6.948841501966438e-11,0.0
11076,histone H3-R2 methylation (GO:0034970),-6.948841501966438e-11,0.0
11077,box H/ACA RNA processing (GO:0034964),-6.948841501966438e-11,0.0
11078,positive regulation of endothelin production (GO:1904472),-6.948841501966438e-11,0.0
11079,regulation of endothelin production (GO:1904470),-6.948841501966438e-11,0.0
11080,symbiont intracellular protein transport in host (GO:0030581),-6.948841501966438e-11,0.0
11081,negative regulation of plasma cell differentiation (GO:1900099),-6.948841501966438e-11,0.0
11082,positive regulation of aspartate secretion (GO:1904450),-6.948841501966438e-11,0.0
11083,tetrahydrofolylpolyglutamate metabolic process (GO:0046900),-6.948841501966438e-11,0.0
11084,bile acid catabolic process (GO:0030573),-6.948841501966438e-11,0.0
11085,regulation of aspartate secretion (GO:1904448),-6.948841501966438e-11,0.0
11086,regulation of iron ion import across plasma membrane (GO:1904438),-6.948841501966438e-11,0.0
11087,positive regulation of transferrin receptor binding (GO:1904437),-6.948841501966438e-11,0.0
11088,regulation of transferrin receptor binding (GO:1904435),-6.948841501966438e-11,0.0
11089,positive regulation of ferrous iron binding (GO:1904434),-6.948841501966438e-11,0.0
11090,regulation of ferrous iron binding (GO:1904432),-6.948841501966438e-11,0.0
11091,regulation of polyamine biosynthetic process (GO:0010967),-6.948841501966438e-11,0.0
11092,selenocysteine biosynthetic process (GO:0016260),-6.948841501966438e-11,0.0
11093,negative regulation of retinoic acid biosynthetic process (GO:1900053),-6.948841501966438e-11,0.0
11094,cellular response to Thyroid stimulating hormone (GO:1904401),-6.948841501966438e-11,0.0
11095,N-glycan processing to lysosome (GO:0016256),-6.948841501966438e-11,0.0
11096,negative regulation of intestinal phytosterol absorption (GO:0010949),-6.948841501966438e-11,0.0
11097,protein deglutarylation (GO:0061698),-6.948841501966438e-11,0.0
11098,regulation of autophagosome size (GO:0016243),-6.948841501966438e-11,0.0
11099,pyridoxine biosynthetic process (GO:0008615),-6.948841501966438e-11,0.0
11100,pyridoxine metabolic process (GO:0008614),-6.948841501966438e-11,0.0
11101,peptidyl-lysine modification to peptidyl-hypusine (GO:0008612),-6.948841501966438e-11,0.0
11102,negative regulation of eating behavior (GO:1903999),-6.948841501966438e-11,0.0
11103,positive regulation of very-low-density lipoprotein particle remodeling (GO:0010902),-6.948841501966438e-11,0.0
11104,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization (GO:0061646),-6.948841501966438e-11,0.0
11105,positive regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903974),-6.948841501966438e-11,0.0
11106,chemoattraction of axon (GO:0061642),-6.948841501966438e-11,0.0
11107,positive regulation of response to macrophage colony-stimulating factor (GO:1903971),-6.948841501966438e-11,0.0
11108,monounsaturated fatty acid biosynthetic process (GO:1903966),-6.948841501966438e-11,0.0
11109,glycolytic process through glucose-1-phosphate (GO:0061622),-6.948841501966438e-11,0.0
11110,carbon dioxide transmembrane transport (GO:0035378),-6.948841501966438e-11,0.0
11111,response to acrylamide (GO:1903937),-6.948841501966438e-11,0.0
11112,UDP-glucose transmembrane transport (GO:0015786),-6.948841501966438e-11,0.0
11113,primary palate development (GO:1903929),-6.948841501966438e-11,0.0
11114,heme transmembrane transport (GO:0035351),-6.948841501966438e-11,0.0
11115,FAD transmembrane transport (GO:0035350),-6.948841501966438e-11,0.0
11116,positive regulation of protein processing in phagocytic vesicle (GO:1903923),-6.948841501966438e-11,0.0
11117,regulation of protein processing in phagocytic vesicle (GO:1903921),-6.948841501966438e-11,0.0
11118,coenzyme A transmembrane transport (GO:0035349),-6.948841501966438e-11,0.0
11119,negative regulation of actin filament severing (GO:1903919),-6.948841501966438e-11,0.0
11120,hypoxanthine transport (GO:0035344),-6.948841501966438e-11,0.0
11121,regulation of actin filament severing (GO:1903918),-6.948841501966438e-11,0.0
11122,phospholipase C-activating angiotensin-activated signaling pathway (GO:0086097),-6.948841501966438e-11,0.0
11123,regulation of the force of heart contraction by cardiac conduction (GO:0086092),-6.948841501966438e-11,0.0
11124,leucine biosynthetic process (GO:0009098),-6.948841501966438e-11,0.0
11125,fucose transmembrane transport (GO:0015756),-6.948841501966438e-11,0.0
11126,pentose transmembrane transport (GO:0015750),-6.948841501966438e-11,0.0
11127,lysine biosynthetic process (GO:0009085),-6.948841501966438e-11,0.0
11128,bundle of His cell to Purkinje myocyte communication by electrical coupling (GO:0086054),-6.948841501966438e-11,0.0
11129,AV node cell to bundle of His cell communication by electrical coupling (GO:0086053),-6.948841501966438e-11,0.0
11130,canalicular bile acid transport (GO:0015722),-6.948841501966438e-11,0.0
11131,negative regulation of phosphatidylcholine metabolic process (GO:0150174),-6.948841501966438e-11,0.0
11132,follicle-stimulating hormone secretion (GO:0046884),-6.948841501966438e-11,0.0
11133,SA node cell to atrial cardiac muscle cell communication by electrical coupling (GO:0086021),-6.948841501966438e-11,0.0
11134,cell-cell junction disassembly (GO:0150147),-6.948841501966438e-11,0.0
11135,detection of diacyl bacterial lipopeptide (GO:0042496),-6.948841501966438e-11,0.0
11136,detection of triacyl bacterial lipopeptide (GO:0042495),-6.948841501966438e-11,0.0
11137,positive regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904395),-6.948841501966438e-11,0.0
11138,negative regulation of odontogenesis of dentin-containing tooth (GO:0042489),-6.948841501966438e-11,0.0
11139,positive regulation of odontogenesis of dentin-containing tooth (GO:0042488),-6.948841501966438e-11,0.0
11140,negative regulation of odontogenesis (GO:0042483),-6.948841501966438e-11,0.0
11141,cellular response to L-phenylalanine derivative (GO:1904387),-6.948841501966438e-11,0.0
11142,negative regulation of RNA export from nucleus (GO:0046832),-6.948841501966438e-11,0.0
11143,protein localization to cytosolic proteasome complex involved in ERAD pathway (GO:1904379),-6.948841501966438e-11,0.0
11144,negative regulation of cardiac epithelial to mesenchymal transition (GO:0062044),-6.948841501966438e-11,0.0
11145,response to kainic acid (GO:1904373),-6.948841501966438e-11,0.0
11146,sensory perception of cold stimulus (GO:0062035),-6.948841501966438e-11,0.0
11147,deoxyguanosine metabolic process (GO:0042453),-6.948841501966438e-11,0.0
11148,arginine biosynthetic process via ornithine (GO:0042450),-6.948841501966438e-11,0.0
11149,positive regulation of stress granule assembly (GO:0062029),-6.948841501966438e-11,0.0
11150,thymus epithelium morphogenesis (GO:0097536),-6.948841501966438e-11,0.0
11151,lymphoid lineage cell migration into thymus (GO:0097535),-6.948841501966438e-11,0.0
11152,synaptic vesicle budding from endosome (GO:0016182),-6.948841501966438e-11,0.0
11153,lymphoid lineage cell migration (GO:0097534),-6.948841501966438e-11,0.0
11154,cellular stress response to acid chemical (GO:0097533),-6.948841501966438e-11,0.0
11155,stress response to acid chemical (GO:0097532),-6.948841501966438e-11,0.0
11156,cholesterol storage (GO:0010878),-6.948841501966438e-11,0.0
11157,protein localization to cytosolic proteasome complex (GO:1904327),-6.948841501966438e-11,0.0
11158,lipid transport involved in lipid storage (GO:0010877),-6.948841501966438e-11,0.0
11159,execution phase of necroptosis (GO:0097528),-6.948841501966438e-11,0.0
11160,epinephrine biosynthetic process (GO:0042418),-6.948841501966438e-11,0.0
11161,taurine biosynthetic process (GO:0042412),-6.948841501966438e-11,0.0
11162,response to methamphetamine hydrochloride (GO:1904313),-6.948841501966438e-11,0.0
11163,thyroid hormone catabolic process (GO:0042404),-6.948841501966438e-11,0.0
11164,positive regulation of transcytosis (GO:1904300),-6.948841501966438e-11,0.0
11165,intestinal epithelial cell migration (GO:0061582),-6.948841501966438e-11,0.0
11166,xanthophyll metabolic process (GO:0016122),-6.948841501966438e-11,0.0
11167,carotene catabolic process (GO:0016121),-6.948841501966438e-11,0.0
11168,carotene metabolic process (GO:0016119),-6.948841501966438e-11,0.0
11169,negative regulation of ATF6-mediated unfolded protein response (GO:1903892),-6.948841501966438e-11,0.0
11170,sesquiterpenoid catabolic process (GO:0016107),-6.948841501966438e-11,0.0
11171,ganglion morphogenesis (GO:0061552),-6.948841501966438e-11,0.0
11172,positive regulation of oxidative phosphorylation (GO:1903862),-6.948841501966438e-11,0.0
11173,pre-miRNA export from nucleus (GO:0035281),-6.948841501966438e-11,0.0
11174,miRNA-mediated gene silencing by mRNA destabilization (GO:0035279),-6.948841501966438e-11,0.0
11175,positive regulation of aorta morphogenesis (GO:1903849),-6.948841501966438e-11,0.0
11176,regulation of aorta morphogenesis (GO:1903847),-6.948841501966438e-11,0.0
11177,centriole elongation (GO:0061511),-6.948841501966438e-11,0.0
11178,gonad morphogenesis (GO:0035262),-6.948841501966438e-11,0.0
11179,early endosome to recycling endosome transport (GO:0061502),-6.948841501966438e-11,0.0
11180,protein maturation by copper ion transfer (GO:0015680),-6.948841501966438e-11,0.0
11181,L-serine import across plasma membrane (GO:1903812),-6.948841501966438e-11,0.0
11182,L-histidine import across plasma membrane (GO:1903810),-6.948841501966438e-11,0.0
11183,positive regulation of protein-glutamine gamma-glutamyltransferase activity (GO:0150074),-6.948841501966438e-11,0.0
11184,regulation of protein-glutamine gamma-glutamyltransferase activity (GO:0150073),-6.948841501966438e-11,0.0
11185,negative regulation of deacetylase activity (GO:0150066),-6.948841501966438e-11,0.0
11186,positive regulation of protein localization to lysosome (GO:0150032),-6.948841501966438e-11,0.0
11187,regulation of transcytosis (GO:1904298),-6.948841501966438e-11,0.0
11188,positive regulation of mitotic DNA damage checkpoint (GO:1904291),-6.948841501966438e-11,0.0
11189,endothelial tube lumen extension (GO:0097498),-6.948841501966438e-11,0.0
11190,histone H4-K20 dimethylation (GO:0034772),-6.948841501966438e-11,0.0
11191,tricellular tight junction assembly (GO:1904274),-6.948841501966438e-11,0.0
11192,negative regulation by virus of viral protein levels in host cell (GO:0046725),-6.948841501966438e-11,0.0
11193,oxalic acid secretion (GO:0046724),-6.948841501966438e-11,0.0
11194,pyroptosome complex assembly (GO:1904270),-6.948841501966438e-11,0.0
11195,retinal cone cell apoptotic process (GO:0097474),-6.948841501966438e-11,0.0
11196,retinal rod cell apoptotic process (GO:0097473),-6.948841501966438e-11,0.0
11197,water-soluble vitamin catabolic process (GO:0042365),-6.948841501966438e-11,0.0
11198,GDP catabolic process (GO:0046712),-6.948841501966438e-11,0.0
11199,thiamine diphosphate metabolic process (GO:0042357),-6.948841501966438e-11,0.0
11200,'de novo' GDP-L-fucose biosynthetic process (GO:0042351),-6.948841501966438e-11,0.0
11201,fructosamine metabolic process (GO:0030389),-6.948841501966438e-11,0.0
11202,zinc ion import into Golgi lumen (GO:1904257),-6.948841501966438e-11,0.0
11203,keratan sulfate catabolic process (GO:0042340),-6.948841501966438e-11,0.0
11204,regulation of multivesicular body size (GO:0010796),-6.948841501966438e-11,0.0
11205,regulation of ubiquinone biosynthetic process (GO:0010795),-6.948841501966438e-11,0.0
11206,regulation of polynucleotide adenylyltransferase activity (GO:1904245),-6.948841501966438e-11,0.0
11207,histone H3-K79 methylation (GO:0034729),-6.948841501966438e-11,0.0
11208,"negative regulation of circadian sleep/wake cycle, REM sleep (GO:0042322)",-6.948841501966438e-11,0.0
11209,positive regulation of serine C-palmitoyltransferase activity (GO:1904222),-6.948841501966438e-11,0.0
11210,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity (GO:1904219),-6.948841501966438e-11,0.0
11211,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity (GO:1904217),-6.948841501966438e-11,0.0
11212,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010767),-6.948841501966438e-11,0.0
11213,"membrane protein proteolysis involved in retrograde protein transport, ER to cytosol (GO:1904211)",-6.948841501966438e-11,0.0
11214,homoiothermy (GO:0042309),-6.948841501966438e-11,0.0
11215,adaptation of rhodopsin mediated signaling (GO:0016062),-6.948841501966438e-11,0.0
11216,regulation of skeletal muscle hypertrophy (GO:1904204),-6.948841501966438e-11,0.0
11217,iodide transmembrane transport (GO:1904200),-6.948841501966438e-11,0.0
11218,cellular response to raffinose (GO:0097403),-6.948841501966438e-11,0.0
11219,prenylcysteine metabolic process (GO:0030329),-6.948841501966438e-11,0.0
11220,prenylcysteine catabolic process (GO:0030328),-6.948841501966438e-11,0.0
11221,positive regulation of long-chain fatty acid import across plasma membrane (GO:0010747),-6.948841501966438e-11,0.0
11222,negative regulation of protein glutathionylation (GO:0010734),-6.948841501966438e-11,0.0
11223,regulation of protein glutathionylation (GO:0010732),-6.948841501966438e-11,0.0
11224,tRNA import into mitochondrion (GO:0016031),-6.948841501966438e-11,0.0
11225,regulation of primitive erythrocyte differentiation (GO:0010725),-6.948841501966438e-11,0.0
11226,regulation of definitive erythrocyte differentiation (GO:0010724),-6.948841501966438e-11,0.0
11227,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination (GO:0010705),-6.948841501966438e-11,0.0
11228,regulation of glutathione biosynthetic process (GO:1903786),-6.948841501966438e-11,0.0
11229,regulation of DNA double-strand break processing (GO:1903775),-6.948841501966438e-11,0.0
11230,endocardial cushion cell differentiation (GO:0061443),-6.948841501966438e-11,0.0
11231,renal artery morphogenesis (GO:0061441),-6.948841501966438e-11,0.0
11232,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903762),-6.948841501966438e-11,0.0
11233,positive regulation of anterograde synaptic vesicle transport (GO:1903744),-6.948841501966438e-11,0.0
11234,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH (GO:0061402),-6.948841501966438e-11,0.0
11235,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion (GO:0061400),-6.948841501966438e-11,0.0
11236,negative regulation of centriole elongation (GO:1903723),-6.948841501966438e-11,0.0
11237,asparagine transmembrane transport (GO:1903713),-6.948841501966438e-11,0.0
11238,cell migration involved in heart formation (GO:0060974),-6.948841501966438e-11,0.0
11239,negative regulation of retinal cell programmed cell death (GO:0046671),-6.948841501966438e-11,0.0
11240,epithelial to mesenchymal transition involved in cardiac fibroblast development (GO:0060940),-6.948841501966438e-11,0.0
11241,atrioventricular node cell fate commitment (GO:0060929),-6.948841501966438e-11,0.0
11242,mesenchymal cell differentiation involved in lung development (GO:0060915),-6.948841501966438e-11,0.0
11243,cardiac cell fate specification (GO:0060912),-6.948841501966438e-11,0.0
11244,positive regulation of meiosis I (GO:0060903),-6.948841501966438e-11,0.0
11245,positive regulation of bleb assembly (GO:1904172),-6.948841501966438e-11,0.0
11246,dorsal spinal cord interneuron axon guidance (GO:0097378),-6.948841501966438e-11,0.0
11247,regulation of bleb assembly (GO:1904170),-6.948841501966438e-11,0.0
11248,peptidyl-aspartic acid hydroxylation (GO:0042264),-6.948841501966438e-11,0.0
11249,lens placode formation involved in camera-type eye formation (GO:0046619),-6.948841501966438e-11,0.0
11250,DNA synthesis involved in UV-damage excision repair (GO:1904161),-6.948841501966438e-11,0.0
11251,UDP-glucosylation (GO:0097359),-6.948841501966438e-11,0.0
11252,RNA repair (GO:0042245),-6.948841501966438e-11,0.0
11253,response to clozapine (GO:0097338),-6.948841501966438e-11,0.0
11254,response to antipsychotic drug (GO:0097332),-6.948841501966438e-11,0.0
11255,B cell adhesion (GO:0097323),-6.948841501966438e-11,0.0
11256,olfactory learning (GO:0008355),-6.948841501966438e-11,0.0
11257,female sex determination (GO:0030237),-6.948841501966438e-11,0.0
11258,protein localization to microvillus (GO:1904106),-6.948841501966438e-11,0.0
11259,cap1 mRNA methylation (GO:0097309),-6.948841501966438e-11,0.0
11260,basophil differentiation (GO:0030221),-6.948841501966438e-11,0.0
11261,cell communication by chemical coupling (GO:0010643),-6.948841501966438e-11,0.0
11262,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance (GO:0061394),-6.948841501966438e-11,0.0
11263,closure of optic fissure (GO:0061386),-6.948841501966438e-11,0.0
11264,inferior colliculus development (GO:0061379),-6.948841501966438e-11,0.0
11265,corpora quadrigemina development (GO:0061378),-6.948841501966438e-11,0.0
11266,G2/MI transition of meiotic cell cycle (GO:0008315),-6.948841501966438e-11,0.0
11267,positive regulation of cardiac muscle adaptation (GO:0010615),-6.948841501966438e-11,0.0
11268,negative regulation of cytoplasmic mRNA processing body assembly (GO:0010607),-6.948841501966438e-11,0.0
11269,Wnt protein secretion (GO:0061355),-6.948841501966438e-11,0.0
11270,lysine biosynthetic process via aminoadipic acid (GO:0019878),-6.948841501966438e-11,0.0
11271,cell proliferation involved in outflow tract morphogenesis (GO:0061325),-6.948841501966438e-11,0.0
11272,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues involved in positive regulation of transcription elongation from RNA polymerase II promoter (GO:1903655),-6.948841501966438e-11,0.0
11273,phosphorylation of RNA polymerase II C-terminal domain serine 5 residues involved in positive regulation of transcription elongation from RNA polymerase II promoter (GO:1903654),-6.948841501966438e-11,0.0
11274,cytosine metabolic process (GO:0019858),-6.948841501966438e-11,0.0
11275,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:0061317),-6.948841501966438e-11,0.0
11276,L-ascorbic acid biosynthetic process (GO:0019853),-6.948841501966438e-11,0.0
11277,negative regulation of chaperone-mediated protein folding (GO:1903645),-6.948841501966438e-11,0.0
11278,smooth muscle cell-matrix adhesion (GO:0061302),-6.948841501966438e-11,0.0
11279,cerebellum vasculature development (GO:0061300),-6.948841501966438e-11,0.0
11280,regulation of aminoacyl-tRNA ligase activity (GO:1903630),-6.948841501966438e-11,0.0
11281,regulation of calcium-dependent ATPase activity (GO:1903610),-6.948841501966438e-11,0.0
11282,female pronucleus assembly (GO:0035038),-6.948841501966438e-11,0.0
11283,leading edge cell differentiation (GO:0035026),-6.948841501966438e-11,0.0
11284,limb epidermis development (GO:0060887),-6.948841501966438e-11,0.0
11285,semicircular canal formation (GO:0060876),-6.948841501966438e-11,0.0
11286,regulation of calcium-dependent cell-cell adhesion (GO:0046586),-6.948841501966438e-11,0.0
11287,arterial endothelial cell fate commitment (GO:0060844),-6.948841501966438e-11,0.0
11288,growth plate cartilage morphogenesis (GO:0003422),-6.948841501966438e-11,0.0
11289,ciliary receptor clustering involved in smoothened signaling pathway (GO:0060830),-6.948841501966438e-11,0.0
11290,optic cup formation involved in camera-type eye development (GO:0003408),-6.948841501966438e-11,0.0
11291,optic vesicle morphogenesis (GO:0003404),-6.948841501966438e-11,0.0
11292,negative regulation of autophagic cell death (GO:1904093),-6.948841501966438e-11,0.0
11293,development of secondary male sexual characteristics (GO:0046544),-6.948841501966438e-11,0.0
11294,inactivation of X chromosome by genomic imprinting (GO:0060819),-6.948841501966438e-11,0.0
11295,random inactivation of X chromosome (GO:0060816),-6.948841501966438e-11,0.0
11296,creatinine homeostasis (GO:0097273),-6.948841501966438e-11,0.0
11297,sphinganine biosynthetic process (GO:0046511),-6.948841501966438e-11,0.0
11298,melatonin biosynthetic process (GO:0030187),-6.948841501966438e-11,0.0
11299,melatonin metabolic process (GO:0030186),-6.948841501966438e-11,0.0
11300,uroporphyrinogen III metabolic process (GO:0046502),-6.948841501966438e-11,0.0
11301,oligodendrocyte apoptotic process (GO:0097252),-6.948841501966438e-11,0.0
11302,regulation of spontaneous neurotransmitter secretion (GO:1904048),-6.948841501966438e-11,0.0
11303,glutamine secretion (GO:0010585),-6.948841501966438e-11,0.0
11304,response to vitamin B6 (GO:0034516),-6.948841501966438e-11,0.0
11305,mitochondrial unfolded protein response (GO:0034514),-6.948841501966438e-11,0.0
11306,negative regulation of collagen fibril organization (GO:1904027),-6.948841501966438e-11,0.0
11307,negative regulation of G protein-coupled receptor internalization (GO:1904021),-6.948841501966438e-11,0.0
11308,positive regulation of lysosomal membrane permeability (GO:0097214),-6.948841501966438e-11,0.0
11309,response to monosodium glutamate (GO:1904008),-6.948841501966438e-11,0.0
11310,regulation of sebum secreting cell proliferation (GO:1904002),-6.948841501966438e-11,0.0
11311,satellite cell activation involved in skeletal muscle regeneration (GO:0014901),-6.948841501966438e-11,0.0
11312,muscle hyperplasia (GO:0014900),-6.948841501966438e-11,0.0
11313,trabecular meshwork development (GO:0002930),-6.948841501966438e-11,0.0
11314,vasopressin secretion (GO:0030103),-6.948841501966438e-11,0.0
11315,negative regulation of phosphatidylinositol biosynthetic process (GO:0010512),-6.948841501966438e-11,0.0
11316,negative regulation of gap junction assembly (GO:1903597),-6.948841501966438e-11,0.0
11317,regulation of protein localization to ciliary membrane (GO:1903567),-6.948841501966438e-11,0.0
11318,pattern specification involved in mesonephros development (GO:0061227),-6.948841501966438e-11,0.0
11319,regulation of growth hormone activity (GO:1903547),-6.948841501966438e-11,0.0
11320,response to butyrate (GO:1903544),-6.948841501966438e-11,0.0
11321,regulation of meiotic cell cycle process involved in oocyte maturation (GO:1903538),-6.948841501966438e-11,0.0
11322,meiotic cell cycle process involved in oocyte maturation (GO:1903537),-6.948841501966438e-11,0.0
11323,nitrogen utilization (GO:0019740),-6.948841501966438e-11,0.0
11324,negative regulation of membrane tubulation (GO:1903526),-6.948841501966438e-11,0.0
11325,positive regulation of single strand break repair (GO:1903518),-6.948841501966438e-11,0.0
11326,calcium ion transport from cytosol to endoplasmic reticulum (GO:1903515),-6.948841501966438e-11,0.0
11327,phytanic acid metabolic process (GO:1903512),-6.948841501966438e-11,0.0
11328,dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-6.948841501966438e-11,0.0
11329,dynamin family protein polymerization involved in membrane fission (GO:0003373),-6.948841501966438e-11,0.0
11330,regulation of apoptosis involved in tissue homeostasis (GO:0060785),-6.948841501966438e-11,0.0
11331,cell-matrix adhesion involved in ameboidal cell migration (GO:0003366),-6.948841501966438e-11,0.0
11332,planar cell polarity pathway involved in gastrula mediolateral intercalation (GO:0060775),-6.948841501966438e-11,0.0
11333,pulmonary myocardium development (GO:0003350),-6.948841501966438e-11,0.0
11334,cellular response to diamide (GO:0072738),-6.948841501966438e-11,0.0
11335,response to diamide (GO:0072737),-6.948841501966438e-11,0.0
11336,cell-cell signaling involved in mammary gland development (GO:0060764),-6.948841501966438e-11,0.0
11337,septum transversum development (GO:0003343),-6.948841501966438e-11,0.0
11338,proepicardium development (GO:0003342),-6.948841501966438e-11,0.0
11339,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003340),-6.948841501966438e-11,0.0
11340,response to dithiothreitol (GO:0072720),-6.948841501966438e-11,0.0
11341,corneocyte desquamation (GO:0003336),-6.948841501966438e-11,0.0
11342,lactosylceramide metabolic process (GO:0046478),-6.948841501966438e-11,0.0
11343,pancreatic PP cell fate commitment (GO:0003329),-6.948841501966438e-11,0.0
11344,pancreatic A cell fate commitment (GO:0003326),-6.948841501966438e-11,0.0
11345,regulation of intestinal epithelial structure maintenance (GO:0060730),-6.948841501966438e-11,0.0
11346,pancreatic PP cell differentiation (GO:0003312),-6.948841501966438e-11,0.0
11347,pancreatic D cell differentiation (GO:0003311),-6.948841501966438e-11,0.0
11348,vacuolar transmembrane transport (GO:0034486),-6.948841501966438e-11,0.0
11349,phosphatidylglycerol catabolic process (GO:0034478),-6.948841501966438e-11,0.0
11350,U6 snRNA 3'-end processing (GO:0034477),-6.948841501966438e-11,0.0
11351,negative regulation of endoribonuclease activity (GO:0060702),-6.948841501966438e-11,0.0
11352,negative regulation of ribonuclease activity (GO:0060701),-6.948841501966438e-11,0.0
11353,negative regulation of plasma lipoprotein oxidation (GO:0034445),-6.948841501966438e-11,0.0
11354,regulation of plasma lipoprotein oxidation (GO:0034444),-6.948841501966438e-11,0.0
11355,regulation of lipoprotein oxidation (GO:0034442),-6.948841501966438e-11,0.0
11356,fasciculation of motor neuron axon (GO:0097156),-6.948841501966438e-11,0.0
11357,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction (GO:0014852),-6.948841501966438e-11,0.0
11358,negative regulation of hypersensitivity (GO:0002884),-6.948841501966438e-11,0.0
11359,"peptidyl-histidine methylation, to form tele-methylhistidine (GO:0042038)",-6.948841501966438e-11,0.0
11360,ureter smooth muscle contraction (GO:0014849),-6.948841501966438e-11,0.0
11361,esophagus smooth muscle contraction (GO:0014846),-6.948841501966438e-11,0.0
11362,skeletal muscle satellite cell proliferation (GO:0014841),-6.948841501966438e-11,0.0
11363,positive regulation of acute inflammatory response to non-antigenic stimulus (GO:0002879),-6.948841501966438e-11,0.0
11364,regulation of acute inflammatory response to non-antigenic stimulus (GO:0002877),-6.948841501966438e-11,0.0
11365,positive regulation of chronic inflammatory response to antigenic stimulus (GO:0002876),-6.948841501966438e-11,0.0
11366,urate biosynthetic process (GO:0034418),-6.948841501966438e-11,0.0
11367,"tRNA 3'-trailer cleavage, endonucleolytic (GO:0034414)",-6.948841501966438e-11,0.0
11368,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex (GO:0034402),-6.948841501966438e-11,0.0
11369,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002859),-6.948841501966438e-11,0.0
11370,negative regulation of natural killer cell mediated immune response to tumor cell (GO:0002856),-6.948841501966438e-11,0.0
11371,positive regulation of T cell mediated cytotoxicity directed against tumor cell target (GO:0002854),-6.948841501966438e-11,0.0
11372,regulation of T cell mediated cytotoxicity directed against tumor cell target (GO:0002852),-6.948841501966438e-11,0.0
11373,guanylate kinase-associated protein clustering (GO:0097117),-6.948841501966438e-11,0.0
11374,endoplasmic reticulum-Golgi intermediate compartment organization (GO:0097111),-6.948841501966438e-11,0.0
11375,negative regulation of embryonic development (GO:0045992),-6.948841501966438e-11,0.0
11376,negative regulation of T cell mediated immune response to tumor cell (GO:0002841),-6.948841501966438e-11,0.0
11377,endothelial tip cell fate specification (GO:0097102),-6.948841501966438e-11,0.0
11378,cellular manganese ion homeostasis (GO:0030026),-6.948841501966438e-11,0.0
11379,smooth muscle hyperplasia (GO:0014806),-6.948841501966438e-11,0.0
11380,"negative regulation of mitotic cell cycle, embryonic (GO:0045976)",-6.948841501966438e-11,0.0
11381,negative regulation of ribosomal DNA heterochromatin formation (GO:0061188),-6.948841501966438e-11,0.0
11382,regulation of rDNA heterochromatin formation (GO:0061187),-6.948841501966438e-11,0.0
11383,negative regulation of dopamine metabolic process (GO:0045963),-6.948841501966438e-11,0.0
11384,hydrogen peroxide-mediated programmed cell death (GO:0010421),-6.948841501966438e-11,0.0
11385,response to dehydroepiandrosterone (GO:1903494),-6.948841501966438e-11,0.0
11386,positive regulation of lactation (GO:1903489),-6.948841501966438e-11,0.0
11387,trachea gland development (GO:0061153),-6.948841501966438e-11,0.0
11388,trachea submucosa development (GO:0061152),-6.948841501966438e-11,0.0
11389,neural plate axis specification (GO:0021997),-6.948841501966438e-11,0.0
11390,lung smooth muscle development (GO:0061145),-6.948841501966438e-11,0.0
11391,neurohypophysis development (GO:0021985),-6.948841501966438e-11,0.0
11392,ammonia assimilation cycle (GO:0019676),-6.948841501966438e-11,0.0
11393,negative regulation of catecholamine metabolic process (GO:0045914),-6.948841501966438e-11,0.0
11394,regulation of mitotic cell cycle DNA replication (GO:1903463),-6.948841501966438e-11,0.0
11395,glucose catabolic process to lactate via pyruvate (GO:0019661),-6.948841501966438e-11,0.0
11396,glycolytic fermentation (GO:0019660),-6.948841501966438e-11,0.0
11397,corticospinal neuron axon guidance (GO:0021966),-6.948841501966438e-11,0.0
11398,glucose catabolic process to lactate (GO:0019659),-6.948841501966438e-11,0.0
11399,protein transport from ciliary membrane to plasma membrane (GO:1903445),-6.948841501966438e-11,0.0
11400,positive regulation of mitotic cytokinetic process (GO:1903438),-6.948841501966438e-11,0.0
11401,seminal vesicle development (GO:0061107),-6.948841501966438e-11,0.0
11402,regulation of mitotic cytokinetic process (GO:1903436),-6.948841501966438e-11,0.0
11403,regulation of constitutive secretory pathway (GO:1903433),-6.948841501966438e-11,0.0
11404,protein localization to cell cortex (GO:0072697),-6.948841501966438e-11,0.0
11405,regulation of DNA recombination at telomere (GO:0072695),-6.948841501966438e-11,0.0
11406,negative regulation of synaptic vesicle recycling (GO:1903422),-6.948841501966438e-11,0.0
11407,cerebellar granule cell precursor tangential migration (GO:0021935),-6.948841501966438e-11,0.0
11408,atrial septum secundum morphogenesis (GO:0003290),-6.948841501966438e-11,0.0
11409,regulation of renal phosphate excretion (GO:1903402),-6.948841501966438e-11,0.0
11410,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021914),-6.948841501966438e-11,0.0
11411,butyrate metabolic process (GO:0019605),-6.948841501966438e-11,0.0
11412,maintenance of protein location in plasma membrane (GO:0072660),-6.948841501966438e-11,0.0
11413,regulation of cholesterol transporter activity (GO:0060694),-6.948841501966438e-11,0.0
11414,optokinetic behavior (GO:0007634),-6.948841501966438e-11,0.0
11415,apoptotic process involved in outflow tract morphogenesis (GO:0003275),-6.948841501966438e-11,0.0
11416,maintenance of protein location in membrane (GO:0072658),-6.948841501966438e-11,0.0
11417,cell differentiation involved in salivary gland development (GO:0060689),-6.948841501966438e-11,0.0
11418,ultradian rhythm (GO:0007624),-6.948841501966438e-11,0.0
11419,negative regulation of cell proliferation involved in heart valve morphogenesis (GO:0003252),-6.948841501966438e-11,0.0
11420,UDP-glucuronate metabolic process (GO:0046398),-6.948841501966438e-11,0.0
11421,branch elongation involved in salivary gland morphogenesis (GO:0060667),-6.948841501966438e-11,0.0
11422,positive regulation of neurofibrillary tangle assembly (GO:1902998),-6.948841501966438e-11,0.0
11423,CMP-N-acetylneuraminate metabolic process (GO:0046381),-6.948841501966438e-11,0.0
11424,L-arabinose metabolic process (GO:0046373),-6.948841501966438e-11,0.0
11425,fructose biosynthetic process (GO:0046370),-6.948841501966438e-11,0.0
11426,2-oxobutyrate metabolic process (GO:0046361),-6.948841501966438e-11,0.0
11427,regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034395),-6.948841501966438e-11,0.0
11428,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902963),-6.948841501966438e-11,0.0
11429,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902962),-6.948841501966438e-11,0.0
11430,cardiac left ventricle formation (GO:0003218),-6.948841501966438e-11,0.0
11431,cardiac atrium formation (GO:0003210),-6.948841501966438e-11,0.0
11432,regulation of homologous chromosome segregation (GO:0060629),-6.948841501966438e-11,0.0
11433,"negative regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902957)",-6.948841501966438e-11,0.0
11434,regulation of early endosome to recycling endosome transport (GO:1902954),-6.948841501966438e-11,0.0
11435,negative regulation of cholesterol import (GO:0060621),-6.948841501966438e-11,0.0
11436,mammary gland bud formation (GO:0060615),-6.948841501966438e-11,0.0
11437,protein localization to early endosome (GO:1902946),-6.948841501966438e-11,0.0
11438,positive regulation of voltage-gated chloride channel activity (GO:1902943),-6.948841501966438e-11,0.0
11439,regulation of voltage-gated chloride channel activity (GO:1902941),-6.948841501966438e-11,0.0
11440,glycerol biosynthetic process from pyruvate (GO:0046327),-6.948841501966438e-11,0.0
11441,positive regulation of glial cell apoptotic process (GO:0034352),-6.948841501966438e-11,0.0
11442,cellular response to thyroxine stimulus (GO:0097069),-6.948841501966438e-11,0.0
11443,positive regulation of type III interferon production (GO:0034346),-6.948841501966438e-11,0.0
11444,positive regulation of neuroepithelial cell differentiation (GO:1902913),-6.948841501966438e-11,0.0
11445,alkanesulfonate biosynthetic process (GO:0046305),-6.948841501966438e-11,0.0
11446,agmatine biosynthetic process (GO:0097055),-6.948841501966438e-11,0.0
11447,regulation of melanosome transport (GO:1902908),-6.948841501966438e-11,0.0
11448,dendritic cell apoptotic process (GO:0097048),-6.948841501966438e-11,0.0
11449,regulation of muscle hyperplasia (GO:0014738),-6.948841501966438e-11,0.0
11450,positive regulation of muscle atrophy (GO:0014737),-6.948841501966438e-11,0.0
11451,twitch skeletal muscle contraction (GO:0014721),-6.948841501966438e-11,0.0
11452,renal albumin absorption (GO:0097018),-6.948841501966438e-11,0.0
11453,female courtship behavior (GO:0008050),-6.948841501966438e-11,0.0
11454,eukaryotic translation initiation factor 4F complex assembly (GO:0097010),-6.948841501966438e-11,0.0
11455,positive regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014718),-6.948841501966438e-11,0.0
11456,negative regulation of dendritic cell cytokine production (GO:0002731),-6.948841501966438e-11,0.0
11457,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045870),-6.948841501966438e-11,0.0
11458,negative regulation of natural killer cell cytokine production (GO:0002728),-6.948841501966438e-11,0.0
11459,negative regulation of protein refolding (GO:0061084),-6.948841501966438e-11,0.0
11460,regulation of protein refolding (GO:0061083),-6.948841501966438e-11,0.0
11461,detoxification of zinc ion (GO:0010312),-6.948841501966438e-11,0.0
11462,positive regulation of adherens junction organization (GO:1903393),-6.948841501966438e-11,0.0
11463,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384),-6.948841501966438e-11,0.0
11464,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903383),-6.948841501966438e-11,0.0
11465,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903382),-6.948841501966438e-11,0.0
11466,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903381),-6.948841501966438e-11,0.0
11467,forebrain astrocyte development (GO:0021897),-6.948841501966438e-11,0.0
11468,forebrain astrocyte differentiation (GO:0021896),-6.948841501966438e-11,0.0
11469,cerebral cortex GABAergic interneuron fate commitment (GO:0021893),-6.948841501966438e-11,0.0
11470,regulation of mitotic chromosome condensation (GO:1903379),-6.948841501966438e-11,0.0
11471,positive regulation of branching involved in lung morphogenesis (GO:0061047),-6.948841501966438e-11,0.0
11472,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903378),-6.948841501966438e-11,0.0
11473,negative regulation of isoprenoid metabolic process (GO:0045827),-6.948841501966438e-11,0.0
11474,facioacoustic ganglion development (GO:1903375),-6.948841501966438e-11,0.0
11475,olfactory bulb mitral cell layer development (GO:0061034),-6.948841501966438e-11,0.0
11476,visceral serous pericardium development (GO:0061032),-6.948841501966438e-11,0.0
11477,endodermal digestive tract morphogenesis (GO:0061031),-6.948841501966438e-11,0.0
11478,Cajal-Retzius cell differentiation (GO:0021870),-6.948841501966438e-11,0.0
11479,arabinose metabolic process (GO:0019566),-6.948841501966438e-11,0.0
11480,umbilical cord development (GO:0061027),-6.948841501966438e-11,0.0
11481,hepatoblast differentiation (GO:0061017),-6.948841501966438e-11,0.0
11482,snRNA import into nucleus (GO:0061015),-6.948841501966438e-11,0.0
11483,glutamate catabolic process to 2-oxoglutarate (GO:0019551),-6.948841501966438e-11,0.0
11484,glutamate catabolic process to aspartate (GO:0019550),-6.948841501966438e-11,0.0
11485,gall bladder development (GO:0061010),-6.948841501966438e-11,0.0
11486,arginine catabolic process to ornithine (GO:0019547),-6.948841501966438e-11,0.0
11487,propionate catabolic process (GO:0019543),-6.948841501966438e-11,0.0
11488,negative regulation of vacuolar transport (GO:1903336),-6.948841501966438e-11,0.0
11489,positive regulation of protein folding (GO:1903334),-6.948841501966438e-11,0.0
11490,ventricular zone neuroblast division (GO:0021847),-6.948841501966438e-11,0.0
11491,negative regulation of tRNA metabolic process (GO:1903327),-6.948841501966438e-11,0.0
11492,regulation of tRNA metabolic process (GO:1903326),-6.948841501966438e-11,0.0
11493,chemorepulsion involved in postnatal olfactory bulb interneuron migration (GO:0021836),-6.948841501966438e-11,0.0
11494,D-gluconate metabolic process (GO:0019521),-6.948841501966438e-11,0.0
11495,aldonic acid metabolic process (GO:0019520),-6.948841501966438e-11,0.0
11496,endocardial cushion to mesenchymal transition involved in heart valve formation (GO:0003199),-6.948841501966438e-11,0.0
11497,tricuspid valve formation (GO:0003195),-6.948841501966438e-11,0.0
11498,pulmonary valve formation (GO:0003193),-6.948841501966438e-11,0.0
11499,postnatal olfactory bulb interneuron migration (GO:0021827),-6.948841501966438e-11,0.0
11500,substrate-dependent cerebral cortex tangential migration (GO:0021825),-6.948841501966438e-11,0.0
11501,cerebral cortex tangential migration using cell-cell interactions (GO:0021823),-6.948841501966438e-11,0.0
11502,lactate oxidation (GO:0019516),-6.948841501966438e-11,0.0
11503,tolerance induction to lipopolysaccharide (GO:0072573),-6.948841501966438e-11,0.0
11504,"primary sex determination, germ-line (GO:0007542)",-6.948841501966438e-11,0.0
11505,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration (GO:0021817),-6.948841501966438e-11,0.0
11506,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration (GO:0021816),-6.948841501966438e-11,0.0
11507,neuronal-glial interaction involved in cerebral cortex radial glia guided migration (GO:0021812),-6.948841501966438e-11,0.0
11508,lateral sprouting involved in mammary gland duct morphogenesis (GO:0060599),-6.948841501966438e-11,0.0
11509,fibroblast growth factor receptor signaling pathway involved in mammary gland specification (GO:0060595),-6.948841501966438e-11,0.0
11510,sinoatrial valve development (GO:0003172),-6.948841501966438e-11,0.0
11511,regulation of protein serine/threonine phosphatase activity (GO:0080163),-6.948841501966438e-11,0.0
11512,blood vessel lumenization (GO:0072554),-6.948841501966438e-11,0.0
11513,establishment of synaptic specificity at neuromuscular junction (GO:0007529),-6.948841501966438e-11,0.0
11514,regulation of lipoprotein lipid oxidation (GO:0060587),-6.948841501966438e-11,0.0
11515,muscle cell fate determination (GO:0007521),-6.948841501966438e-11,0.0
11516,coronary vein morphogenesis (GO:0003169),-6.948841501966438e-11,0.0
11517,myoblast fate determination (GO:0007518),-6.948841501966438e-11,0.0
11518,negative regulation of termination of DNA-templated transcription (GO:0060567),-6.948841501966438e-11,0.0
11519,regulation of postsynaptic density protein 95 clustering (GO:1902897),-6.948841501966438e-11,0.0
11520,protein localization to spindle microtubule (GO:1902889),-6.948841501966438e-11,0.0
11521,positive regulation of vitamin D biosynthetic process (GO:0060557),-6.948841501966438e-11,0.0
11522,phenylpropanoid catabolic process (GO:0046271),-6.948841501966438e-11,0.0
11523,AMP transport (GO:0080121),-6.948841501966438e-11,0.0
11524,bronchus cartilage development (GO:0060532),-6.948841501966438e-11,0.0
11525,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development (GO:0060529),-6.948841501966438e-11,0.0
11526,propionyl-CoA catabolic process (GO:1902859),-6.948841501966438e-11,0.0
11527,terpene catabolic process (GO:0046247),-6.948841501966438e-11,0.0
11528,kynurenic acid biosynthetic process (GO:0034276),-6.948841501966438e-11,0.0
11529,kynurenic acid metabolic process (GO:0034275),-6.948841501966438e-11,0.0
11530,positive regulation of proline import across plasma membrane (GO:1902836),-6.948841501966438e-11,0.0
11531,regulation of proline import across plasma membrane (GO:1902834),-6.948841501966438e-11,0.0
11532,coumarin catabolic process (GO:0046226),-6.948841501966438e-11,0.0
11533,aflatoxin catabolic process (GO:0046223),-6.948841501966438e-11,0.0
11534,negative regulation of late endosome to lysosome transport (GO:1902823),-6.948841501966438e-11,0.0
11535,indolalkylamine biosynthetic process (GO:0046219),-6.948841501966438e-11,0.0
11536,snoRNA splicing (GO:0034247),-6.948841501966438e-11,0.0
11537,spermine catabolic process (GO:0046208),-6.948841501966438e-11,0.0
11538,spermidine catabolic process (GO:0046203),-6.948841501966438e-11,0.0
11539,positive regulation of synaptic vesicle transport (GO:1902805),-6.948841501966438e-11,0.0
11540,enkephalin processing (GO:0034230),-6.948841501966438e-11,0.0
11541,mRNA transport (GO:0051028),-7.405009938291684e-11,0.0
11542,keratinocyte differentiation (GO:0030216),-7.405009938291684e-11,0.0
11543,circadian rhythm (GO:0007623),-7.405009938291684e-11,0.0
11544,detection of chemical stimulus involved in sensory perception (GO:0050907),-7.518563549241871e-11,0.9022348816827345
11545,post-Golgi vesicle-mediated transport (GO:0006892),-7.552913849621185e-11,0.0
11546,DNA biosynthetic process (GO:0071897),-7.552913849621185e-11,0.0
11547,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-7.552913849621185e-11,0.0
11548,regulation of steroid metabolic process (GO:0019218),-7.552913849621185e-11,0.0
11549,neutral lipid metabolic process (GO:0006638),-7.552913849621185e-11,0.0
11550,positive regulation of interleukin-6 production (GO:0032755),-7.552913849621185e-11,0.0
11551,DNA geometric change (GO:0032392),-7.552913849621185e-11,0.0
11552,peptide transport (GO:0015833),-7.552913849621185e-11,0.0
11553,regulation of mitotic sister chromatid separation (GO:0010965),-7.552913849621185e-11,0.0
11554,actin filament-based movement (GO:0030048),-7.552913849621185e-11,0.0
11555,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-7.552913849621185e-11,0.0
11556,primary alcohol metabolic process (GO:0034308),-7.552913849621185e-11,0.0
11557,regulation of chronic inflammatory response (GO:0002676),-7.582845462362813e-11,0.0
11558,regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),-7.582845462362813e-11,0.0
11559,regulation of glomerular filtration (GO:0003093),-7.582845462362813e-11,0.0
11560,bronchus development (GO:0060433),-7.582845462362813e-11,0.0
11561,positive regulation of antigen processing and presentation (GO:0002579),-7.582845462362813e-11,0.0
11562,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-7.582845462362813e-11,0.0
11563,urea transmembrane transport (GO:0071918),-7.582845462362813e-11,0.0
11564,positive regulation of monocyte differentiation (GO:0045657),-7.582845462362813e-11,0.0
11565,cerebellar granular layer morphogenesis (GO:0021683),-7.582845462362813e-11,0.0
11566,integrin activation (GO:0033622),-7.582845462362813e-11,0.0
11567,egg activation (GO:0007343),-7.582845462362813e-11,0.0
11568,penetration of zona pellucida (GO:0007341),-7.582845462362813e-11,0.0
11569,facial nerve morphogenesis (GO:0021610),-7.582845462362813e-11,0.0
11570,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-7.582845462362813e-11,0.0
11571,adenosine metabolic process (GO:0046085),-7.582845462362813e-11,0.0
11572,regulation of behavioral fear response (GO:2000822),-7.582845462362813e-11,0.0
11573,germinal center formation (GO:0002467),-7.582845462362813e-11,0.0
11574,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),-7.582845462362813e-11,0.0
11575,transferrin transport (GO:0033572),-7.582845462362813e-11,0.0
11576,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241),-7.582845462362813e-11,0.0
11577,regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-7.582845462362813e-11,0.0
11578,vestibulocochlear nerve development (GO:0021562),-7.582845462362813e-11,0.0
11579,facial nerve development (GO:0021561),-7.582845462362813e-11,0.0
11580,histone H2B ubiquitination (GO:0033523),-7.582845462362813e-11,0.0
11581,G protein-coupled adenosine receptor signaling pathway (GO:0001973),-7.582845462362813e-11,0.0
11582,regulation of cilium beat frequency involved in ciliary motility (GO:0060296),-7.582845462362813e-11,0.0
11583,negative regulation of T cell mediated cytotoxicity (GO:0001915),-7.582845462362813e-11,0.0
11584,constitutive heterochromatin formation (GO:0140719),-7.582845462362813e-11,0.0
11585,detection of cell density (GO:0060245),-7.582845462362813e-11,0.0
11586,regulation of organelle transport along microtubule (GO:1902513),-7.582845462362813e-11,0.0
11587,cholesterol catabolic process (GO:0006707),-7.582845462362813e-11,0.0
11588,C21-steroid hormone biosynthetic process (GO:0006700),-7.582845462362813e-11,0.0
11589,gas homeostasis (GO:0033483),-7.582845462362813e-11,0.0
11590,adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),-7.582845462362813e-11,0.0
11591,"complement activation, lectin pathway (GO:0001867)",-7.582845462362813e-11,0.0
11592,receptor guanylyl cyclase signaling pathway (GO:0007168),-7.582845462362813e-11,0.0
11593,neural plate development (GO:0001840),-7.582845462362813e-11,0.0
11594,regulation of glomerular mesangial cell proliferation (GO:0072124),-7.582845462362813e-11,0.0
11595,negative regulation of collagen biosynthetic process (GO:0032966),-7.582845462362813e-11,0.0
11596,collagen biosynthetic process (GO:0032964),-7.582845462362813e-11,0.0
11597,positive regulation of growth hormone secretion (GO:0060124),-7.582845462362813e-11,0.0
11598,positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-7.582845462362813e-11,0.0
11599,regulation of mRNA binding (GO:1902415),-7.582845462362813e-11,0.0
11600,regulation of mitotic cytokinesis (GO:1902412),-7.582845462362813e-11,0.0
11601,phosphatidylethanolamine biosynthetic process (GO:0006646),-7.582845462362813e-11,0.0
11602,negative regulation of cell cycle checkpoint (GO:1901977),-7.582845462362813e-11,0.0
11603,mitotic DNA replication checkpoint signaling (GO:0033314),-7.582845462362813e-11,0.0
11604,establishment of lymphocyte polarity (GO:0001767),-7.582845462362813e-11,0.0
11605,protein catabolic process in the vacuole (GO:0007039),-7.582845462362813e-11,0.0
11606,"positive regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000563)",-7.582845462362813e-11,0.0
11607,plasma membrane raft organization (GO:0044857),-7.582845462362813e-11,0.0
11608,regulation of resting membrane potential (GO:0060075),-7.582845462362813e-11,0.0
11609,vagina development (GO:0060068),-7.582845462362813e-11,0.0
11610,positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),-7.582845462362813e-11,0.0
11611,positive regulation by host of viral genome replication (GO:0044829),-7.582845462362813e-11,0.0
11612,positive regulation of dendritic cell chemotaxis (GO:2000510),-7.582845462362813e-11,0.0
11613,negative regulation of natural killer cell activation (GO:0032815),-7.582845462362813e-11,0.0
11614,proline metabolic process (GO:0006560),-7.582845462362813e-11,0.0
11615,histidine metabolic process (GO:0006547),-7.582845462362813e-11,0.0
11616,cellular response to sterol depletion (GO:0071501),-7.582845462362813e-11,0.0
11617,negative regulation of cellular respiration (GO:1901856),-7.582845462362813e-11,0.0
11618,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-7.582845462362813e-11,0.0
11619,telomeric loop disassembly (GO:0090657),-7.582845462362813e-11,0.0
11620,negative regulation of protein sumoylation (GO:0033234),-7.582845462362813e-11,0.0
11621,negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-7.582845462362813e-11,0.0
11622,regulation of apoptotic cell clearance (GO:2000425),-7.582845462362813e-11,0.0
11623,ketone body metabolic process (GO:1902224),-7.582845462362813e-11,0.0
11624,netrin-activated signaling pathway (GO:0038007),-7.582845462362813e-11,0.0
11625,cellular hypotonic response (GO:0071476),-7.582845462362813e-11,0.0
11626,protein depalmitoylation (GO:0002084),-7.582845462362813e-11,0.0
11627,peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-7.582845462362813e-11,0.0
11628,translational termination (GO:0006415),-7.582845462362813e-11,0.0
11629,manganese ion transmembrane transport (GO:0071421),-7.582845462362813e-11,0.0
11630,response to vitamin E (GO:0033197),-7.582845462362813e-11,0.0
11631,leukotriene D4 biosynthetic process (GO:1901750),-7.582845462362813e-11,0.0
11632,regulation of angiotensin levels in blood (GO:0002002),-7.582845462362813e-11,0.0
11633,meiotic telomere clustering (GO:0045141),-7.582845462362813e-11,0.0
11634,development of secondary sexual characteristics (GO:0045136),-7.582845462362813e-11,0.0
11635,luteinization (GO:0001553),-7.582845462362813e-11,0.0
11636,ovulation from ovarian follicle (GO:0001542),-7.582845462362813e-11,0.0
11637,positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),-7.582845462362813e-11,0.0
11638,regulation of interleukin-23 production (GO:0032667),-7.582845462362813e-11,0.0
11639,cellular response to testosterone stimulus (GO:0071394),-7.582845462362813e-11,0.0
11640,cellular response to glucagon stimulus (GO:0071377),-7.582845462362813e-11,0.0
11641,apoptotic DNA fragmentation (GO:0006309),-7.582845462362813e-11,0.0
11642,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-7.582845462362813e-11,0.0
11643,positive regulation of myeloid cell apoptotic process (GO:0033034),-7.582845462362813e-11,0.0
11644,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-7.582845462362813e-11,0.0
11645,negative regulation of mast cell activation involved in immune response (GO:0033007),-7.582845462362813e-11,0.0
11646,doxorubicin metabolic process (GO:0044598),-7.582845462362813e-11,0.0
11647,basement membrane assembly (GO:0070831),-7.582845462362813e-11,0.0
11648,positive regulation of fibroblast apoptotic process (GO:2000271),-7.582845462362813e-11,0.0
11649,long-chain fatty acid import into cell (GO:0044539),-7.582845462362813e-11,0.0
11650,positive regulation of rRNA processing (GO:2000234),-7.582845462362813e-11,0.0
11651,transcription-coupled nucleotide-excision repair (GO:0006283),-7.582845462362813e-11,0.0
11652,protein O-linked glycosylation via serine (GO:0018242),-7.582845462362813e-11,0.0
11653,DNA ligation (GO:0006266),-7.582845462362813e-11,0.0
11654,DNA topological change (GO:0006265),-7.582845462362813e-11,0.0
11655,mitochondrial DNA replication (GO:0006264),-7.582845462362813e-11,0.0
11656,UTP biosynthetic process (GO:0006228),-7.582845462362813e-11,0.0
11657,establishment of centrosome localization (GO:0051660),-7.582845462362813e-11,0.0
11658,changes to DNA methylation involved in embryo development (GO:1901538),-7.582845462362813e-11,0.0
11659,otolith development (GO:0048840),-7.582845462362813e-11,0.0
11660,regulation of postsynaptic cytosolic calcium ion concentration (GO:0099566),-7.582845462362813e-11,0.0
11661,postsynapse to nucleus signaling pathway (GO:0099527),-7.582845462362813e-11,0.0
11662,regulation of macrophage apoptotic process (GO:2000109),-7.582845462362813e-11,0.0
11663,cAMP biosynthetic process (GO:0006171),-7.582845462362813e-11,0.0
11664,regulation of tetrapyrrole metabolic process (GO:1901401),-7.582845462362813e-11,0.0
11665,pigment granule maturation (GO:0048757),-7.582845462362813e-11,0.0
11666,negative regulation of lipid kinase activity (GO:0090219),-7.582845462362813e-11,0.0
11667,dendrite arborization (GO:0140059),-7.582845462362813e-11,0.0
11668,negative regulation of triglyceride metabolic process (GO:0090209),-7.582845462362813e-11,0.0
11669,sebaceous gland development (GO:0048733),-7.582845462362813e-11,0.0
11670,embryonic viscerocranium morphogenesis (GO:0048703),-7.582845462362813e-11,0.0
11671,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-7.582845462362813e-11,0.0
11672,negative regulation of hormone biosynthetic process (GO:0032353),-7.582845462362813e-11,0.0
11673,glycerol-3-phosphate metabolic process (GO:0006072),-7.582845462362813e-11,0.0
11674,excitatory chemical synaptic transmission (GO:0098976),-7.582845462362813e-11,0.0
11675,nuclear mRNA surveillance (GO:0071028),-7.582845462362813e-11,0.0
11676,Golgi ribbon formation (GO:0090161),-7.582845462362813e-11,0.0
11677,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-7.582845462362813e-11,0.0
11678,positive regulation of axon regeneration (GO:0048680),-7.582845462362813e-11,0.0
11679,histone H3-K36 demethylation (GO:0070544),-7.582845462362813e-11,0.0
11680,purine nucleotide salvage (GO:0032261),-7.582845462362813e-11,0.0
11681,secretory granule localization (GO:0032252),-7.582845462362813e-11,0.0
11682,positive regulation of ligase activity (GO:0051351),-7.582845462362813e-11,0.0
11683,regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-7.582845462362813e-11,0.0
11684,positive regulation of extracellular matrix assembly (GO:1901203),-7.582845462362813e-11,0.0
11685,positive regulation of protein kinase C signaling (GO:0090037),-7.582845462362813e-11,0.0
11686,mitochondrial fragmentation involved in apoptotic process (GO:0043653),-7.582845462362813e-11,0.0
11687,positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-7.582845462362813e-11,0.0
11688,thyroid hormone transport (GO:0070327),-7.582845462362813e-11,0.0
11689,calcium import into the mitochondrion (GO:0036444),-7.582845462362813e-11,0.0
11690,regulation of deoxyribonuclease activity (GO:0032070),-7.582845462362813e-11,0.0
11691,bleb assembly (GO:0032060),-7.582845462362813e-11,0.0
11692,box C/D snoRNP assembly (GO:0000492),-7.582845462362813e-11,0.0
11693,response to cobalt ion (GO:0032025),-7.582845462362813e-11,0.0
11694,tetrahydrofolate interconversion (GO:0035999),-7.582845462362813e-11,0.0
11695,"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-7.582845462362813e-11,0.0
11696,tongue morphogenesis (GO:0043587),-7.582845462362813e-11,0.0
11697,regulation of translational initiation in response to stress (GO:0043558),-7.582845462362813e-11,0.0
11698,regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),-7.582845462362813e-11,0.0
11699,positive regulation of NK T cell proliferation (GO:0051142),-7.582845462362813e-11,0.0
11700,dorsal aorta development (GO:0035907),-7.582845462362813e-11,0.0
11701,response to gravity (GO:0009629),-7.582845462362813e-11,0.0
11702,renal sodium ion absorption (GO:0070294),-7.582845462362813e-11,0.0
11703,mesendoderm development (GO:0048382),-7.582845462362813e-11,0.0
11704,mucus secretion (GO:0070254),-7.582845462362813e-11,0.0
11705,negative regulation of thymocyte apoptotic process (GO:0070244),-7.582845462362813e-11,0.0
11706,hydrogen peroxide biosynthetic process (GO:0050665),-7.582845462362813e-11,0.0
11707,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-7.582845462362813e-11,0.0
11708,positive regulation of isotype switching to IgG isotypes (GO:0048304),-7.582845462362813e-11,0.0
11709,ESCRT III complex disassembly (GO:1904903),-7.582845462362813e-11,0.0
11710,nail development (GO:0035878),-7.582845462362813e-11,0.0
11711,endosome to pigment granule transport (GO:0043485),-7.582845462362813e-11,0.0
11712,protein K11-linked deubiquitination (GO:0035871),-7.582845462362813e-11,0.0
11713,positive regulation of mRNA 3'-end processing (GO:0031442),-7.582845462362813e-11,0.0
11714,ESCRT complex disassembly (GO:1904896),-7.582845462362813e-11,0.0
11715,positive regulation of establishment of protein localization to telomere (GO:1904851),-7.582845462362813e-11,0.0
11716,tripeptide transport (GO:0042939),-7.582845462362813e-11,0.0
11717,endothelial cell chemotaxis (GO:0035767),-7.582845462362813e-11,0.0
11718,regulation of prostaglandin biosynthetic process (GO:0031392),-7.582845462362813e-11,0.0
11719,respiratory chain complex III assembly (GO:0017062),-7.582845462362813e-11,0.0
11720,regulation of chemokine-mediated signaling pathway (GO:0070099),-7.582845462362813e-11,0.0
11721,regulation of glucagon secretion (GO:0070092),-7.582845462362813e-11,0.0
11722,Golgi vesicle budding (GO:0048194),-7.582845462362813e-11,0.0
11723,regulation of protein localization to centrosome (GO:1904779),-7.582845462362813e-11,0.0
11724,regulation of protein localization to nucleolus (GO:1904749),-7.582845462362813e-11,0.0
11725,negative regulation of granulocyte differentiation (GO:0030853),-7.582845462362813e-11,0.0
11726,peroxisome fission (GO:0016559),-7.582845462362813e-11,0.0
11727,alpha-linolenic acid metabolic process (GO:0036109),-7.582845462362813e-11,0.0
11728,regulation of lysosomal protein catabolic process (GO:1905165),-7.582845462362813e-11,0.0
11729,endosome to melanosome transport (GO:0035646),-7.582845462362813e-11,0.0
11730,regulation of somatic stem cell population maintenance (GO:1904672),-7.582845462362813e-11,0.0
11731,regulation of sulfur metabolic process (GO:0042762),-7.582845462362813e-11,0.0
11732,G protein-coupled purinergic receptor signaling pathway (GO:0035588),-7.582845462362813e-11,0.0
11733,sequestering of extracellular ligand from receptor (GO:0035581),-7.582845462362813e-11,0.0
11734,regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-7.582845462362813e-11,0.0
11735,nucleoside salvage (GO:0043174),-7.582845462362813e-11,0.0
11736,rRNA 3'-end processing (GO:0031125),-7.582845462362813e-11,0.0
11737,rRNA pseudouridine synthesis (GO:0031118),-7.582845462362813e-11,0.0
11738,regulation of microtubule binding (GO:1904526),-7.582845462362813e-11,0.0
11739,aminoglycoside antibiotic metabolic process (GO:0030647),-7.582845462362813e-11,0.0
11740,cellular phosphate ion homeostasis (GO:0030643),-7.582845462362813e-11,0.0
11741,polyketide metabolic process (GO:0030638),-7.582845462362813e-11,0.0
11742,Golgi lumen acidification (GO:0061795),-7.582845462362813e-11,0.0
11743,ventricular cardiac muscle cell development (GO:0055015),-7.582845462362813e-11,0.0
11744,DNA methylation involved in embryo development (GO:0043045),-7.582845462362813e-11,0.0
11745,nucleobase transport (GO:0015851),-7.582845462362813e-11,0.0
11746,purine deoxyribonucleoside monophosphate metabolic process (GO:0009170),-7.582845462362813e-11,0.0
11747,amino-acid betaine transport (GO:0015838),-7.582845462362813e-11,0.0
11748,purine ribonucleoside monophosphate catabolic process (GO:0009169),-7.582845462362813e-11,0.0
11749,deoxyribonucleoside monophosphate biosynthetic process (GO:0009157),-7.582845462362813e-11,0.0
11750,purine deoxyribonucleotide catabolic process (GO:0009155),-7.582845462362813e-11,0.0
11751,purine nucleoside monophosphate catabolic process (GO:0009128),-7.582845462362813e-11,0.0
11752,purine nucleobase biosynthetic process (GO:0009113),-7.582845462362813e-11,0.0
11753,ubiquitin recycling (GO:0010992),-7.582845462362813e-11,0.0
11754,negative regulation of mitochondrial membrane potential (GO:0010917),-7.582845462362813e-11,0.0
11755,positive regulation of glial cell migration (GO:1903977),-7.582845462362813e-11,0.0
11756,negative regulation of anion transmembrane transport (GO:1903960),-7.582845462362813e-11,0.0
11757,pharyngeal arch artery morphogenesis (GO:0061626),-7.582845462362813e-11,0.0
11758,AV node cell to bundle of His cell communication (GO:0086067),-7.582845462362813e-11,0.0
11759,regulation of phosphatidylcholine metabolic process (GO:0150172),-7.582845462362813e-11,0.0
11760,positive regulation of hormone biosynthetic process (GO:0046886),-7.582845462362813e-11,0.0
11761,regulation of cardiac epithelial to mesenchymal transition (GO:0062042),-7.582845462362813e-11,0.0
11762,negative regulation of cholesterol storage (GO:0010887),-7.582845462362813e-11,0.0
11763,catecholamine catabolic process (GO:0042424),-7.582845462362813e-11,0.0
11764,"regulation of complement activation, classical pathway (GO:0030450)",-7.582845462362813e-11,0.0
11765,sterol catabolic process (GO:0016127),-7.582845462362813e-11,0.0
11766,diterpenoid biosynthetic process (GO:0016102),-7.582845462362813e-11,0.0
11767,histone H4-K20 methylation (GO:0034770),-7.582845462362813e-11,0.0
11768,dendrite extension (GO:0097484),-7.582845462362813e-11,0.0
11769,L-fucose metabolic process (GO:0042354),-7.582845462362813e-11,0.0
11770,synaptic vesicle docking (GO:0016081),-7.582845462362813e-11,0.0
11771,negative regulation of fibroblast migration (GO:0010764),-7.582845462362813e-11,0.0
11772,regulation of intestinal cholesterol absorption (GO:0030300),-7.582845462362813e-11,0.0
11773,response to mercury ion (GO:0046689),-7.582845462362813e-11,0.0
11774,cardiac pacemaker cell differentiation (GO:0060920),-7.582845462362813e-11,0.0
11775,positive regulation of membrane depolarization (GO:1904181),-7.582845462362813e-11,0.0
11776,error-prone translesion synthesis (GO:0042276),-7.582845462362813e-11,0.0
11777,adult feeding behavior (GO:0008343),-7.582845462362813e-11,0.0
11778,regulation of cardiac muscle adaptation (GO:0010612),-7.582845462362813e-11,0.0
11779,positive regulation of triglyceride lipase activity (GO:0061365),-7.582845462362813e-11,0.0
11780,sperm DNA condensation (GO:0035093),-7.582845462362813e-11,0.0
11781,CD40 signaling pathway (GO:0023035),-7.582845462362813e-11,0.0
11782,blood vessel endothelial cell differentiation (GO:0060837),-7.582845462362813e-11,0.0
11783,growth plate cartilage chondrocyte differentiation (GO:0003418),-7.582845462362813e-11,0.0
11784,retinal rod cell development (GO:0046548),-7.582845462362813e-11,0.0
11785,mitochondrial respiratory chain complex III assembly (GO:0034551),-7.582845462362813e-11,0.0
11786,positive regulation of platelet activation (GO:0010572),-7.582845462362813e-11,0.0
11787,endothelial cell activation (GO:0042118),-7.582845462362813e-11,0.0
11788,desmosome organization (GO:0002934),-7.582845462362813e-11,0.0
11789,regulation of gap junction assembly (GO:1903596),-7.582845462362813e-11,0.0
11790,regulation of extracellular matrix constituent secretion (GO:0003330),-7.582845462362813e-11,0.0
11791,response to muscle inactivity (GO:0014870),-7.582845462362813e-11,0.0
11792,olfactory behavior (GO:0042048),-7.582845462362813e-11,0.0
11793,epithelial fluid transport (GO:0042045),-7.582845462362813e-11,0.0
11794,intercellular transport (GO:0010496),-7.582845462362813e-11,0.0
11795,urinary tract smooth muscle contraction (GO:0014848),-7.582845462362813e-11,0.0
11796,artery smooth muscle contraction (GO:0014824),-7.582845462362813e-11,0.0
11797,presynaptic membrane assembly (GO:0097105),-7.582845462362813e-11,0.0
11798,postsynaptic membrane assembly (GO:0097104),-7.582845462362813e-11,0.0
11799,regulation of rhodopsin mediated signaling pathway (GO:0022400),-7.582845462362813e-11,0.0
11800,protein localization to ciliary membrane (GO:1903441),-7.582845462362813e-11,0.0
11801,catechol-containing compound catabolic process (GO:0019614),-7.582845462362813e-11,0.0
11802,regulation of secondary heart field cardioblast proliferation (GO:0003266),-7.582845462362813e-11,0.0
11803,negative regulation of smooth muscle cell apoptotic process (GO:0034392),-7.582845462362813e-11,0.0
11804,cardiac ventricle formation (GO:0003211),-7.582845462362813e-11,0.0
11805,regulation of chromosome condensation (GO:0060623),-7.582845462362813e-11,0.0
11806,very-low-density lipoprotein particle assembly (GO:0034379),-7.582845462362813e-11,0.0
11807,triglyceride-rich lipoprotein particle remodeling (GO:0034370),-7.582845462362813e-11,0.0
11808,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-7.582845462362813e-11,0.0
11809,negative regulation of protein polyubiquitination (GO:1902915),-7.582845462362813e-11,0.0
11810,negative regulation of muscle adaptation (GO:0014745),-7.582845462362813e-11,0.0
11811,regulation of anion channel activity (GO:0010359),-7.582845462362813e-11,0.0
11812,substrate-independent telencephalic tangential interneuron migration (GO:0021843),-7.582845462362813e-11,0.0
11813,interneuron migration from the subpallium to the cortex (GO:0021830),-7.582845462362813e-11,0.0
11814,substrate-independent telencephalic tangential migration (GO:0021826),-7.582845462362813e-11,0.0
11815,mitral valve morphogenesis (GO:0003183),-7.582845462362813e-11,0.0
11816,T-helper 17 cell differentiation (GO:0072539),-7.582845462362813e-11,0.0
11817,positive regulation of response to oxidative stress (GO:1902884),-7.582845462362813e-11,0.0
11818,cellular trivalent inorganic anion homeostasis (GO:0072502),-7.582845462362813e-11,0.0
11819,cartilage morphogenesis (GO:0060536),-7.582845462362813e-11,0.0
11820,prostate glandular acinus development (GO:0060525),-7.582845462362813e-11,0.0
11821,transcription by RNA polymerase II (GO:0006366),-7.713540916811692e-11,0.8262038523274479
11822,regulation of DNA biosynthetic process (GO:2000278),-7.83322295885698e-11,0.0
11823,establishment of protein localization to extracellular region (GO:0035592),-7.83322295885698e-11,0.0
11824,mitochondrial gene expression (GO:0140053),-8.06890110250567e-11,0.0
11825,response to glucose (GO:0009749),-8.06890110250567e-11,0.0
11826,negative regulation of neuron projection development (GO:0010977),-8.06890110250567e-11,0.0
11827,endoderm development (GO:0007492),-8.165712550245125e-11,0.0
11828,organelle transport along microtubule (GO:0072384),-8.165712550245125e-11,0.0
11829,protein localization to cell junction (GO:1902414),-8.165712550245125e-11,0.0
11830,mitotic DNA damage checkpoint signaling (GO:0044773),-8.165712550245125e-11,0.0
11831,cellular response to monosaccharide stimulus (GO:0071326),-8.165712550245125e-11,0.0
11832,mitotic cytokinesis (GO:0000281),-8.165712550245125e-11,0.0
11833,ubiquitin-dependent ERAD pathway (GO:0030433),-8.165712550245125e-11,0.0
11834,negative regulation of chromosome organization (GO:2001251),-8.225176095439174e-11,0.0
11835,regulation of stem cell differentiation (GO:2000736),-8.225176095439174e-11,0.0
11836,retina homeostasis (GO:0001895),-8.225176095439174e-11,0.0
11837,polysaccharide metabolic process (GO:0005976),-8.225176095439174e-11,0.0
11838,positive regulation of organelle assembly (GO:1902117),-8.225176095439174e-11,0.0
11839,cellular response to acid chemical (GO:0071229),-8.225176095439174e-11,0.0
11840,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-8.225176095439174e-11,0.0
11841,chemokine-mediated signaling pathway (GO:0070098),-8.225176095439174e-11,0.0
11842,autophagosome organization (GO:1905037),-8.225176095439174e-11,0.0
11843,detoxification of copper ion (GO:0010273),-8.429856812242023e-11,0.0
11844,positive regulation of gluconeogenesis (GO:0045722),-8.429856812242023e-11,0.0
11845,preganglionic parasympathetic fiber development (GO:0021783),-8.429856812242023e-11,0.0
11846,negative regulation of fatty acid biosynthetic process (GO:0045717),-8.429856812242023e-11,0.0
11847,mRNA methylation (GO:0080009),-8.429856812242023e-11,0.0
11848,pyrimidine nucleoside catabolic process (GO:0046135),-8.429856812242023e-11,0.0
11849,somatic diversification of immune receptors via somatic mutation (GO:0002566),-8.429856812242023e-11,0.0
11850,production of molecular mediator involved in inflammatory response (GO:0002532),-8.429856812242023e-11,0.0
11851,positive regulation of macrophage differentiation (GO:0045651),-8.429856812242023e-11,0.0
11852,peptide antigen assembly with MHC class II protein complex (GO:0002503),-8.429856812242023e-11,0.0
11853,glycolipid catabolic process (GO:0019377),-8.429856812242023e-11,0.0
11854,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-8.429856812242023e-11,0.0
11855,regulation of response to interferon-gamma (GO:0060330),-8.429856812242023e-11,0.0
11856,CTP metabolic process (GO:0046036),-8.429856812242023e-11,0.0
11857,RNA decapping (GO:0110154),-8.429856812242023e-11,0.0
11858,cellular copper ion homeostasis (GO:0006878),-8.429856812242023e-11,0.0
11859,manganese ion transport (GO:0006828),-8.429856812242023e-11,0.0
11860,copper ion transport (GO:0006825),-8.429856812242023e-11,0.0
11861,positive regulation of B cell differentiation (GO:0045579),-8.429856812242023e-11,0.0
11862,dentate gyrus development (GO:0021542),-8.429856812242023e-11,0.0
11863,positive regulation of opsonization (GO:1903028),-8.429856812242023e-11,0.0
11864,T cell mediated cytotoxicity (GO:0001913),-8.429856812242023e-11,0.0
11865,metanephric nephron tubule development (GO:0072234),-8.429856812242023e-11,0.0
11866,negative regulation of glial cell proliferation (GO:0060253),-8.429856812242023e-11,0.0
11867,MHC class II protein complex assembly (GO:0002399),-8.429856812242023e-11,0.0
11868,ubiquinone biosynthetic process (GO:0006744),-8.429856812242023e-11,0.0
11869,NADPH regeneration (GO:0006740),-8.429856812242023e-11,0.0
11870,NADH regeneration (GO:0006735),-8.429856812242023e-11,0.0
11871,regulation of phospholipid transport (GO:2001138),-8.429856812242023e-11,0.0
11872,nonribosomal peptide biosynthetic process (GO:0019184),-8.429856812242023e-11,0.0
11873,neuron cell-cell adhesion (GO:0007158),-8.429856812242023e-11,0.0
11874,negative regulation of lipase activity (GO:0060192),-8.429856812242023e-11,0.0
11875,glycosylceramide metabolic process (GO:0006677),-8.429856812242023e-11,0.0
11876,post-translational protein targeting to endoplasmic reticulum membrane (GO:0006620),-8.429856812242023e-11,0.0
11877,neutrophil homeostasis (GO:0001780),-8.429856812242023e-11,0.0
11878,organ induction (GO:0001759),-8.429856812242023e-11,0.0
11879,"regulation of phagocytosis, engulfment (GO:0060099)",-8.429856812242023e-11,0.0
11880,formation of cytoplasmic translation initiation complex (GO:0001732),-8.429856812242023e-11,0.0
11881,cytoplasm organization (GO:0007028),-8.429856812242023e-11,0.0
11882,negative regulation of viral transcription (GO:0032897),-8.429856812242023e-11,0.0
11883,regulation of acrosome reaction (GO:0060046),-8.429856812242023e-11,0.0
11884,autophagy of nucleus (GO:0044804),-8.429856812242023e-11,0.0
11885,thyroid hormone generation (GO:0006590),-8.429856812242023e-11,0.0
11886,methionine metabolic process (GO:0006555),-8.429856812242023e-11,0.0
11887,arginine metabolic process (GO:0006525),-8.429856812242023e-11,0.0
11888,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-8.429856812242023e-11,0.0
11889,negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-8.429856812242023e-11,0.0
11890,negative regulation of receptor internalization (GO:0002091),-8.429856812242023e-11,0.0
11891,meiotic sister chromatid segregation (GO:0045144),-8.429856812242023e-11,0.0
11892,positive regulation of myoblast fusion (GO:1901741),-8.429856812242023e-11,0.0
11893,regulation of hepatocyte proliferation (GO:2000345),-8.429856812242023e-11,0.0
11894,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-8.429856812242023e-11,0.0
11895,positive regulation of T-helper 17 type immune response (GO:2000318),-8.429856812242023e-11,0.0
11896,cellular response to cholesterol (GO:0071397),-8.429856812242023e-11,0.0
11897,cellular response to estrogen stimulus (GO:0071391),-8.429856812242023e-11,0.0
11898,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-8.429856812242023e-11,0.0
11899,quinone biosynthetic process (GO:1901663),-8.429856812242023e-11,0.0
11900,positive regulation of glycogen metabolic process (GO:0070875),-8.429856812242023e-11,0.0
11901,regulation of myoblast proliferation (GO:2000291),-8.429856812242023e-11,0.0
11902,secondary metabolite biosynthetic process (GO:0044550),-8.429856812242023e-11,0.0
11903,regulation of rRNA processing (GO:2000232),-8.429856812242023e-11,0.0
11904,pyrimidine nucleobase metabolic process (GO:0006206),-8.429856812242023e-11,0.0
11905,replicative senescence (GO:0090399),-8.429856812242023e-11,0.0
11906,positive regulation of brown fat cell differentiation (GO:0090336),-8.429856812242023e-11,0.0
11907,synaptic vesicle transport along microtubule (GO:0099517),-8.429856812242023e-11,0.0
11908,synaptic vesicle cytoskeletal transport (GO:0099514),-8.429856812242023e-11,0.0
11909,keratan sulfate biosynthetic process (GO:0018146),-8.429856812242023e-11,0.0
11910,histone H4-K8 acetylation (GO:0043982),-8.429856812242023e-11,0.0
11911,histone H4-K5 acetylation (GO:0043981),-8.429856812242023e-11,0.0
11912,positive regulation of cAMP-mediated signaling (GO:0043950),-8.429856812242023e-11,0.0
11913,embryonic brain development (GO:1990403),-8.429856812242023e-11,0.0
11914,"regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",-8.429856812242023e-11,0.0
11915,neuron projection arborization (GO:0140058),-8.429856812242023e-11,0.0
11916,fucose metabolic process (GO:0006004),-8.429856812242023e-11,0.0
11917,RNA surveillance (GO:0071025),-8.429856812242023e-11,0.0
11918,negative regulation of meiotic cell cycle (GO:0051447),-8.429856812242023e-11,0.0
11919,lipid digestion (GO:0044241),-8.429856812242023e-11,0.0
11920,regulation of nucleobase-containing compound transport (GO:0032239),-8.429856812242023e-11,0.0
11921,"positive regulation of synaptic transmission, GABAergic (GO:0032230)",-8.429856812242023e-11,0.0
11922,neurotransmitter receptor transport to plasma membrane (GO:0098877),-8.429856812242023e-11,0.0
11923,post-embryonic animal morphogenesis (GO:0009886),-8.429856812242023e-11,0.0
11924,regulation of steroid hormone biosynthetic process (GO:0090030),-8.429856812242023e-11,0.0
11925,positive regulation of T cell receptor signaling pathway (GO:0050862),-8.429856812242023e-11,0.0
11926,stress response to copper ion (GO:1990169),-8.429856812242023e-11,0.0
11927,engulfment of apoptotic cell (GO:0043652),-8.429856812242023e-11,0.0
11928,regulation of trophoblast cell migration (GO:1901163),-8.429856812242023e-11,0.0
11929,anterograde synaptic vesicle transport (GO:0048490),-8.429856812242023e-11,0.0
11930,postsynaptic modulation of chemical synaptic transmission (GO:0099170),-8.429856812242023e-11,0.0
11931,tRNA 5'-end processing (GO:0099116),-8.429856812242023e-11,0.0
11932,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-8.429856812242023e-11,0.0
11933,endonucleolytic cleavage involved in rRNA processing (GO:0000478),-8.429856812242023e-11,0.0
11934,meiotic sister chromatid cohesion (GO:0051177),-8.429856812242023e-11,0.0
11935,positive regulation of actin nucleation (GO:0051127),-8.429856812242023e-11,0.0
11936,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-8.429856812242023e-11,0.0
11937,positive regulation of T cell apoptotic process (GO:0070234),-8.429856812242023e-11,0.0
11938,"protein localization to chromosome, telomeric region (GO:0070198)",-8.429856812242023e-11,0.0
11939,cytoplasmic sequestering of transcription factor (GO:0042994),-8.429856812242023e-11,0.0
11940,amyloid precursor protein catabolic process (GO:0042987),-8.429856812242023e-11,0.0
11941,clathrin coat assembly (GO:0048268),-8.429856812242023e-11,0.0
11942,behavioral response to pain (GO:0048266),-8.429856812242023e-11,0.0
11943,excitatory synapse assembly (GO:1904861),-8.429856812242023e-11,0.0
11944,regulation of long-term synaptic depression (GO:1900452),-8.429856812242023e-11,0.0
11945,polysaccharide catabolic process (GO:0000272),-8.429856812242023e-11,0.0
11946,meiotic spindle organization (GO:0000212),-8.429856812242023e-11,0.0
11947,cellular response to hepatocyte growth factor stimulus (GO:0035729),-8.429856812242023e-11,0.0
11948,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-8.429856812242023e-11,0.0
11949,positive regulation of cardiocyte differentiation (GO:1905209),-8.429856812242023e-11,0.0
11950,astrocyte activation (GO:0048143),-8.429856812242023e-11,0.0
11951,locomotory exploration behavior (GO:0035641),-8.429856812242023e-11,0.0
11952,regulation of membrane invagination (GO:1905153),-8.429856812242023e-11,0.0
11953,sulfur amino acid biosynthetic process (GO:0000097),-8.429856812242023e-11,0.0
11954,surfactant homeostasis (GO:0043129),-8.429856812242023e-11,0.0
11955,2'-deoxyribonucleotide biosynthetic process (GO:0009265),-8.429856812242023e-11,0.0
11956,deoxyribonucleotide biosynthetic process (GO:0009263),-8.429856812242023e-11,0.0
11957,regulation of telomere maintenance in response to DNA damage (GO:1904505),-8.429856812242023e-11,0.0
11958,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-8.429856812242023e-11,0.0
11959,fatty acid homeostasis (GO:0055089),-8.429856812242023e-11,0.0
11960,glucose catabolic process to pyruvate (GO:0061718),-8.429856812242023e-11,0.0
11961,phosphate ion transmembrane transport (GO:0035435),-8.429856812242023e-11,0.0
11962,nucleoside biosynthetic process (GO:0009163),-8.429856812242023e-11,0.0
11963,regulation of GTP binding (GO:1904424),-8.429856812242023e-11,0.0
11964,potassium ion export across plasma membrane (GO:0097623),-8.429856812242023e-11,0.0
11965,positive regulation of necrotic cell death (GO:0010940),-8.429856812242023e-11,0.0
11966,regulation of inositol phosphate biosynthetic process (GO:0010919),-8.429856812242023e-11,0.0
11967,histone H3-K9 modification (GO:0061647),-8.429856812242023e-11,0.0
11968,canonical glycolysis (GO:0061621),-8.429856812242023e-11,0.0
11969,aromatic amino acid family catabolic process (GO:0009074),-8.429856812242023e-11,0.0
11970,dosage compensation by inactivation of X chromosome (GO:0009048),-8.429856812242023e-11,0.0
11971,lipid phosphorylation (GO:0046834),-8.429856812242023e-11,0.0
11972,positive regulation of T cell chemotaxis (GO:0010820),-8.429856812242023e-11,0.0
11973,terpenoid biosynthetic process (GO:0016114),-8.429856812242023e-11,0.0
11974,positive regulation of fibroblast migration (GO:0010763),-8.429856812242023e-11,0.0
11975,regulation of extracellular matrix disassembly (GO:0010715),-8.429856812242023e-11,0.0
11976,negative regulation of miRNA maturation (GO:1903799),-8.429856812242023e-11,0.0
11977,positive regulation of phospholipid metabolic process (GO:1903727),-8.429856812242023e-11,0.0
11978,asymmetric cell division (GO:0008356),-8.429856812242023e-11,0.0
11979,muscle cell apoptotic process (GO:0010657),-8.429856812242023e-11,0.0
11980,regulation of cell communication by electrical coupling (GO:0010649),-8.429856812242023e-11,0.0
11981,hyaluronan catabolic process (GO:0030214),-8.429856812242023e-11,0.0
11982,heparin metabolic process (GO:0030202),-8.429856812242023e-11,0.0
11983,venous blood vessel development (GO:0060841),-8.429856812242023e-11,0.0
11984,chondrocyte differentiation involved in endochondral bone morphogenesis (GO:0003413),-8.429856812242023e-11,0.0
11985,ketone catabolic process (GO:0042182),-8.429856812242023e-11,0.0
11986,lipoprotein catabolic process (GO:0042159),-8.429856812242023e-11,0.0
11987,establishment of protein localization to postsynaptic membrane (GO:1903540),-8.429856812242023e-11,0.0
11988,cell migration involved in gastrulation (GO:0042074),-8.429856812242023e-11,0.0
11989,nucleobase-containing small molecule biosynthetic process (GO:0034404),-8.429856812242023e-11,0.0
11990,regulation of skeletal muscle contraction (GO:0014819),-8.429856812242023e-11,0.0
11991,positive regulation of immune response to tumor cell (GO:0002839),-8.429856812242023e-11,0.0
11992,positive regulation of response to tumor cell (GO:0002836),-8.429856812242023e-11,0.0
11993,deoxyribose phosphate biosynthetic process (GO:0046385),-8.429856812242023e-11,0.0
11994,high-density lipoprotein particle remodeling (GO:0034375),-8.429856812242023e-11,0.0
11995,low-density lipoprotein particle remodeling (GO:0034374),-8.429856812242023e-11,0.0
11996,regulation of dendritic cell cytokine production (GO:0002730),-8.429856812242023e-11,0.0
11997,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-8.429856812242023e-11,0.0
11998,positive regulation of meiotic nuclear division (GO:0045836),-8.429856812242023e-11,0.0
11999,regulation of cell growth involved in cardiac muscle cell development (GO:0061050),-8.429856812242023e-11,0.0
12000,parturition (GO:0007567),-8.429856812242023e-11,0.0
12001,seminiferous tubule development (GO:0072520),-8.429856812242023e-11,0.0
12002,meiosis I (GO:0007127),-8.474598800130635e-11,0.0
12003,lysosomal transport (GO:0007041),-8.474598800130635e-11,0.0
12004,cellular response to hypoxia (GO:0071456),-8.474598800130635e-11,0.0
12005,aminoglycan metabolic process (GO:0006022),-8.474598800130635e-11,0.0
12006,response to acid chemical (GO:0001101),-8.474598800130635e-11,0.0
12007,regulation of sequestering of calcium ion (GO:0051282),-8.474598800130635e-11,0.0
12008,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-8.474598800130635e-11,0.0
12009,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-8.750911106475546e-11,0.0
12010,positive regulation of cell-substrate adhesion (GO:0010811),-8.750911106475546e-11,0.0
12011,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-8.750911106475546e-11,0.0
12012,regulation of leukocyte chemotaxis (GO:0002688),-8.750911106475546e-11,0.0
12013,establishment or maintenance of transmembrane electrochemical gradient (GO:0010248),-8.946621221239151e-11,0.0
12014,regulation of dendritic cell antigen processing and presentation (GO:0002604),-8.946621221239151e-11,0.0
12015,midgut development (GO:0007494),-8.946621221239151e-11,0.0
12016,ammonium transmembrane transport (GO:0072488),-8.946621221239151e-11,0.0
12017,pigment catabolic process (GO:0046149),-8.946621221239151e-11,0.0
12018,regulation of toll-like receptor 9 signaling pathway (GO:0034163),-8.946621221239151e-11,0.0
12019,negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-8.946621221239151e-11,0.0
12020,positive regulation of tissue remodeling (GO:0034105),-8.946621221239151e-11,0.0
12021,pinocytosis (GO:0006907),-8.946621221239151e-11,0.0
12022,positive regulation of megakaryocyte differentiation (GO:0045654),-8.946621221239151e-11,0.0
12023,lipoxygenase pathway (GO:0019372),-8.946621221239151e-11,0.0
12024,positive regulation of endothelial cell differentiation (GO:0045603),-8.946621221239151e-11,0.0
12025,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-8.946621221239151e-11,0.0
12026,positive regulation of integrin activation (GO:0033625),-8.946621221239151e-11,0.0
12027,cranial nerve structural organization (GO:0021604),-8.946621221239151e-11,0.0
12028,cranial nerve formation (GO:0021603),-8.946621221239151e-11,0.0
12029,cardiac muscle cell myoblast differentiation (GO:0060379),-8.946621221239151e-11,0.0
12030,regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060368),-8.946621221239151e-11,0.0
12031,regulation of glucocorticoid secretion (GO:2000849),-8.946621221239151e-11,0.0
12032,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-8.946621221239151e-11,0.0
12033,endosomal vesicle fusion (GO:0034058),-8.946621221239151e-11,0.0
12034,purine nucleoside bisphosphate catabolic process (GO:0034034),-8.946621221239151e-11,0.0
12035,ribonucleoside bisphosphate catabolic process (GO:0034031),-8.946621221239151e-11,0.0
12036,positive regulation of podosome assembly (GO:0071803),-8.946621221239151e-11,0.0
12037,regulation of chloride transport (GO:2001225),-8.946621221239151e-11,0.0
12038,regulation of protein lipidation (GO:1903059),-8.946621221239151e-11,0.0
12039,negative regulation of extracellular matrix organization (GO:1903054),-8.946621221239151e-11,0.0
12040,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-8.946621221239151e-11,0.0
12041,regulation of osteoclast development (GO:2001204),-8.946621221239151e-11,0.0
12042,trigeminal nerve development (GO:0021559),-8.946621221239151e-11,0.0
12043,floor plate development (GO:0033504),-8.946621221239151e-11,0.0
12044,metanephric renal vesicle morphogenesis (GO:0072283),-8.946621221239151e-11,0.0
12045,metanephric glomerulus development (GO:0072224),-8.946621221239151e-11,0.0
12046,glutathione catabolic process (GO:0006751),-8.946621221239151e-11,0.0
12047,regulation of basement membrane organization (GO:0110011),-8.946621221239151e-11,0.0
12048,estrogen biosynthetic process (GO:0006703),-8.946621221239151e-11,0.0
12049,metanephric tubule morphogenesis (GO:0072173),-8.946621221239151e-11,0.0
12050,negative regulation of motor neuron apoptotic process (GO:2000672),-8.946621221239151e-11,0.0
12051,regulation of dopamine receptor signaling pathway (GO:0060159),-8.946621221239151e-11,0.0
12052,sphingomyelin biosynthetic process (GO:0006686),-8.946621221239151e-11,0.0
12053,phosphatidylglycerol biosynthetic process (GO:0006655),-8.946621221239151e-11,0.0
12054,commissural neuron axon guidance (GO:0071679),-8.946621221239151e-11,0.0
12055,xenobiotic detoxification by transmembrane export across the plasma membrane (GO:1990961),-8.946621221239151e-11,0.0
12056,receptor-mediated endocytosis of virus by host cell (GO:0019065),-8.946621221239151e-11,0.0
12057,virion attachment to host cell (GO:0019062),-8.946621221239151e-11,0.0
12058,B cell apoptotic process (GO:0001783),-8.946621221239151e-11,0.0
12059,telomere maintenance via telomere trimming (GO:0090737),-8.946621221239151e-11,0.0
12060,formation of translation preinitiation complex (GO:0001731),-8.946621221239151e-11,0.0
12061,biological phase (GO:0044848),-8.946621221239151e-11,0.0
12062,podocyte development (GO:0072015),-8.946621221239151e-11,0.0
12063,glomerular basement membrane development (GO:0032836),-8.946621221239151e-11,0.0
12064,tryptophan metabolic process (GO:0006568),-8.946621221239151e-11,0.0
12065,positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),-8.946621221239151e-11,0.0
12066,cysteine metabolic process (GO:0006534),-8.946621221239151e-11,0.0
12067,"negative regulation of synaptic transmission, glutamatergic (GO:0051967)",-8.946621221239151e-11,0.0
12068,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-8.946621221239151e-11,0.0
12069,t-circle formation (GO:0090656),-8.946621221239151e-11,0.0
12070,leptin-mediated signaling pathway (GO:0033210),-8.946621221239151e-11,0.0
12071,ribosome disassembly (GO:0032790),-8.946621221239151e-11,0.0
12072,neuron projection extension involved in neuron projection guidance (GO:1902284),-8.946621221239151e-11,0.0
12073,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237),-8.946621221239151e-11,0.0
12074,cellular response to UV-A (GO:0071492),-8.946621221239151e-11,0.0
12075,cellular hyperosmotic response (GO:0071474),-8.946621221239151e-11,0.0
12076,regulation of translational termination (GO:0006449),-8.946621221239151e-11,0.0
12077,maintenance of epithelial cell apical/basal polarity (GO:0045199),-8.946621221239151e-11,0.0
12078,cytolysis by host of symbiont cells (GO:0051838),-8.946621221239151e-11,0.0
12079,establishment of endothelial intestinal barrier (GO:0090557),-8.946621221239151e-11,0.0
12080,dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-8.946621221239151e-11,0.0
12081,CRD-mediated mRNA stabilization (GO:0070934),-8.946621221239151e-11,0.0
12082,regulation of lamellipodium morphogenesis (GO:2000392),-8.946621221239151e-11,0.0
12083,lipid export from cell (GO:0140353),-8.946621221239151e-11,0.0
12084,positive regulation of hepatocyte proliferation (GO:2000347),-8.946621221239151e-11,0.0
12085,negative regulation of T-helper 17 cell differentiation (GO:2000320),-8.946621221239151e-11,0.0
12086,protein prenylation (GO:0018342),-8.946621221239151e-11,0.0
12087,cellular response to caffeine (GO:0071313),-8.946621221239151e-11,0.0
12088,dopamine uptake (GO:0090494),-8.946621221239151e-11,0.0
12089,catecholamine uptake (GO:0090493),-8.946621221239151e-11,0.0
12090,pyrimidine nucleotide-sugar transmembrane transport (GO:0090481),-8.946621221239151e-11,0.0
12091,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901620),-8.946621221239151e-11,0.0
12092,regulation of bile acid biosynthetic process (GO:0070857),-8.946621221239151e-11,0.0
12093,phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-8.946621221239151e-11,0.0
12094,positive regulation of feeding behavior (GO:2000253),-8.946621221239151e-11,0.0
12095,UMP biosynthetic process (GO:0006222),-8.946621221239151e-11,0.0
12096,membrane disruption in another organism (GO:0051673),-8.946621221239151e-11,0.0
12097,cellular response to leucine (GO:0071233),-8.946621221239151e-11,0.0
12098,maintenance of organelle location (GO:0051657),-8.946621221239151e-11,0.0
12099,cellular response to lipoteichoic acid (GO:0071223),-8.946621221239151e-11,0.0
12100,neuron projection maintenance (GO:1990535),-8.946621221239151e-11,0.0
12101,L-aspartate transmembrane transport (GO:0070778),-8.946621221239151e-11,0.0
12102,axon extension involved in axon guidance (GO:0048846),-8.946621221239151e-11,0.0
12103,formation of extrachromosomal circular DNA (GO:0001325),-8.946621221239151e-11,0.0
12104,Rap protein signal transduction (GO:0032486),-8.946621221239151e-11,0.0
12105,IMP biosynthetic process (GO:0006188),-8.946621221239151e-11,0.0
12106,regulation of phospholipase A2 activity (GO:0032429),-8.946621221239151e-11,0.0
12107,GTP biosynthetic process (GO:0006183),-8.946621221239151e-11,0.0
12108,IRES-dependent viral translational initiation (GO:0075522),-8.946621221239151e-11,0.0
12109,positive regulation of mitochondrial calcium ion concentration (GO:0051561),-8.946621221239151e-11,0.0
12110,regulation of glucocorticoid metabolic process (GO:0031943),-8.946621221239151e-11,0.0
12111,negative regulation of synapse organization (GO:1905809),-8.946621221239151e-11,0.0
12112,chromosome localization to nuclear envelope involved in homologous chromosome segregation (GO:0090220),-8.946621221239151e-11,0.0
12113,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-8.946621221239151e-11,0.0
12114,fibroblast apoptotic process (GO:0044346),-8.946621221239151e-11,0.0
12115,regulation of stem cell division (GO:2000035),-8.946621221239151e-11,0.0
12116,N-acetylneuraminate metabolic process (GO:0006054),-8.946621221239151e-11,0.0
12117,positive regulation of phospholipid biosynthetic process (GO:0071073),-8.946621221239151e-11,0.0
12118,postsynaptic actin cytoskeleton organization (GO:0098974),-8.946621221239151e-11,0.0
12119,inositol metabolic process (GO:0006020),-8.946621221239151e-11,0.0
12120,histone mRNA catabolic process (GO:0071044),-8.946621221239151e-11,0.0
12121,vesicle fusion with vacuole (GO:0051469),-8.946621221239151e-11,0.0
12122,fructose 6-phosphate metabolic process (GO:0006002),-8.946621221239151e-11,0.0
12123,dorsal/ventral axis specification (GO:0009950),-8.946621221239151e-11,0.0
12124,positive regulation of kidney development (GO:0090184),-8.946621221239151e-11,0.0
12125,Golgi to lysosome transport (GO:0090160),-8.946621221239151e-11,0.0
12126,positive regulation of neuron projection regeneration (GO:0070572),-8.946621221239151e-11,0.0
12127,RNA polymerase I preinitiation complex assembly (GO:0001188),-8.946621221239151e-11,0.0
12128,positive regulation of collateral sprouting (GO:0048672),-8.946621221239151e-11,0.0
12129,negative regulation of collateral sprouting (GO:0048671),-8.946621221239151e-11,0.0
12130,regulation of gonadotropin secretion (GO:0032276),-8.946621221239151e-11,0.0
12131,regulation of cellular response to osmotic stress (GO:0106049),-8.946621221239151e-11,0.0
12132,synapse pruning (GO:0098883),-8.946621221239151e-11,0.0
12133,regulation of hydrogen peroxide-mediated programmed cell death (GO:1901298),-8.946621221239151e-11,0.0
12134,regulation of protein localization to chromatin (GO:1905634),-8.946621221239151e-11,0.0
12135,negative regulation of inclusion body assembly (GO:0090084),-8.946621221239151e-11,0.0
12136,leukocyte aggregation (GO:0070486),-8.946621221239151e-11,0.0
12137,rRNA base methylation (GO:0070475),-8.946621221239151e-11,0.0
12138,notochord morphogenesis (GO:0048570),-8.946621221239151e-11,0.0
12139,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-8.946621221239151e-11,0.0
12140,negative regulation of response to nutrient levels (GO:0032108),-8.946621221239151e-11,0.0
12141,negative regulation of response to extracellular stimulus (GO:0032105),-8.946621221239151e-11,0.0
12142,mitotic cell cycle phase (GO:0098763),-8.946621221239151e-11,0.0
12143,mitotic spindle midzone assembly (GO:0051256),-8.946621221239151e-11,0.0
12144,negative regulation of myelination (GO:0031642),-8.946621221239151e-11,0.0
12145,L-glutamate import across plasma membrane (GO:0098712),-8.946621221239151e-11,0.0
12146,plasminogen activation (GO:0031639),-8.946621221239151e-11,0.0
12147,response to lipoteichoic acid (GO:0070391),-8.946621221239151e-11,0.0
12148,regulation of fat cell proliferation (GO:0070344),-8.946621221239151e-11,0.0
12149,negative regulation of appetite (GO:0032099),-8.946621221239151e-11,0.0
12150,negative regulation of response to food (GO:0032096),-8.946621221239151e-11,0.0
12151,positive regulation of fatty acid beta-oxidation (GO:0032000),-8.946621221239151e-11,0.0
12152,regulation of NK T cell proliferation (GO:0051140),-8.946621221239151e-11,0.0
12153,positive regulation of NK T cell activation (GO:0051135),-8.946621221239151e-11,0.0
12154,peptidyl-serine dephosphorylation (GO:0070262),-8.946621221239151e-11,0.0
12155,thymocyte apoptotic process (GO:0070242),-8.946621221239151e-11,0.0
12156,paraxial mesoderm morphogenesis (GO:0048340),-8.946621221239151e-11,0.0
12157,regulation of establishment of protein localization to telomere (GO:0070203),-8.946621221239151e-11,0.0
12158,protein deneddylation (GO:0000338),-8.946621221239151e-11,0.0
12159,nuclear membrane disassembly (GO:0051081),-8.946621221239151e-11,0.0
12160,kynurenine metabolic process (GO:0070189),-8.946621221239151e-11,0.0
12161,regulation of Golgi to plasma membrane protein transport (GO:0042996),-8.946621221239151e-11,0.0
12162,sequestering of actin monomers (GO:0042989),-8.946621221239151e-11,0.0
12163,positive regulation of protein localization to Cajal body (GO:1904871),-8.946621221239151e-11,0.0
12164,regulation of protein localization to Cajal body (GO:1904869),-8.946621221239151e-11,0.0
12165,astral microtubule organization (GO:0030953),-8.946621221239151e-11,0.0
12166,negative regulation of cardiocyte differentiation (GO:1905208),-8.946621221239151e-11,0.0
12167,negative regulation of vascular associated smooth muscle cell migration (GO:1904753),-8.946621221239151e-11,0.0
12168,regulation of intestinal lipid absorption (GO:1904729),-8.946621221239151e-11,0.0
12169,regulation of mRNA polyadenylation (GO:1900363),-8.946621221239151e-11,0.0
12170,somatic stem cell division (GO:0048103),-8.946621221239151e-11,0.0
12171,positive regulation of guanylate cyclase activity (GO:0031284),-8.946621221239151e-11,0.0
12172,snRNA transcription by RNA polymerase II (GO:0042795),-8.946621221239151e-11,0.0
12173,positive regulation of ubiquitin protein ligase activity (GO:1904668),-8.946621221239151e-11,0.0
12174,negative regulation of long-term synaptic potentiation (GO:1900272),-8.946621221239151e-11,0.0
12175,regulation of cytoplasmic translational elongation (GO:1900247),-8.946621221239151e-11,0.0
12176,positive regulation of RIG-I signaling pathway (GO:1900246),-8.946621221239151e-11,0.0
12177,urea cycle (GO:0000050),-8.946621221239151e-11,0.0
12178,mitotic spindle elongation (GO:0000022),-8.946621221239151e-11,0.0
12179,single strand break repair (GO:0000012),-8.946621221239151e-11,0.0
12180,coenzyme A biosynthetic process (GO:0015937),-8.946621221239151e-11,0.0
12181,cellular chloride ion homeostasis (GO:0030644),-8.946621221239151e-11,0.0
12182,negative regulation of receptor binding (GO:1900121),-8.946621221239151e-11,0.0
12183,multivesicular body-lysosome fusion (GO:0061763),-8.946621221239151e-11,0.0
12184,heme transport (GO:0015886),-8.946621221239151e-11,0.0
12185,urea transport (GO:0015840),-8.946621221239151e-11,0.0
12186,aspartate transmembrane transport (GO:0015810),-8.946621221239151e-11,0.0
12187,L-alanine transport (GO:0015808),-8.946621221239151e-11,0.0
12188,branched-chain amino acid transport (GO:0015803),-8.946621221239151e-11,0.0
12189,deoxyribonucleoside metabolic process (GO:0009120),-8.946621221239151e-11,0.0
12190,G protein-coupled receptor signaling pathway involved in heart process (GO:0086103),-8.946621221239151e-11,0.0
12191,mitochondrial protein processing (GO:0034982),-8.946621221239151e-11,0.0
12192,endothelin receptor signaling pathway (GO:0086100),-8.946621221239151e-11,0.0
12193,protein folding in endoplasmic reticulum (GO:0034975),-8.946621221239151e-11,0.0
12194,regulation of dosage compensation by inactivation of X chromosome (GO:1900095),-8.946621221239151e-11,0.0
12195,negative regulation of lipoprotein particle clearance (GO:0010985),-8.946621221239151e-11,0.0
12196,regulation of microtubule nucleation (GO:0010968),-8.946621221239151e-11,0.0
12197,negative regulation of transcription by competitive promoter binding (GO:0010944),-8.946621221239151e-11,0.0
12198,ether lipid biosynthetic process (GO:0008611),-8.946621221239151e-11,0.0
12199,regulation of odontogenesis of dentin-containing tooth (GO:0042487),-8.946621221239151e-11,0.0
12200,glycoside catabolic process (GO:0016139),-8.946621221239151e-11,0.0
12201,regulation of PERK-mediated unfolded protein response (GO:1903897),-8.946621221239151e-11,0.0
12202,L-arginine transmembrane transport (GO:1903826),-8.946621221239151e-11,0.0
12203,GDP metabolic process (GO:0046710),-8.946621221239151e-11,0.0
12204,pericyte cell differentiation (GO:1904238),-8.946621221239151e-11,0.0
12205,cellular monovalent inorganic anion homeostasis (GO:0030320),-8.946621221239151e-11,0.0
12206,regulation of nitric oxide mediated signal transduction (GO:0010749),-8.946621221239151e-11,0.0
12207,negative regulation of collagen metabolic process (GO:0010713),-8.946621221239151e-11,0.0
12208,bone trabecula morphogenesis (GO:0061430),-8.946621221239151e-11,0.0
12209,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-8.946621221239151e-11,0.0
12210,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-8.946621221239151e-11,0.0
12211,cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-8.946621221239151e-11,0.0
12212,genitalia morphogenesis (GO:0035112),-8.946621221239151e-11,0.0
12213,regulation of gamma-delta T cell activation (GO:0046643),-8.946621221239151e-11,0.0
12214,cellular lipid biosynthetic process (GO:0097384),-8.946621221239151e-11,0.0
12215,embryonic camera-type eye formation (GO:0060900),-8.946621221239151e-11,0.0
12216,intestinal cholesterol absorption (GO:0030299),-8.946621221239151e-11,0.0
12217,prenylation (GO:0097354),-8.946621221239151e-11,0.0
12218,heparin biosynthetic process (GO:0030210),-8.946621221239151e-11,0.0
12219,negative regulation of sprouting angiogenesis (GO:1903671),-8.946621221239151e-11,0.0
12220,maintenance of apical/basal cell polarity (GO:0035090),-8.946621221239151e-11,0.0
12221,cornea development in camera-type eye (GO:0061303),-8.946621221239151e-11,0.0
12222,heme catabolic process (GO:0042167),-8.946621221239151e-11,0.0
12223,omega-hydroxylase P450 pathway (GO:0097267),-8.946621221239151e-11,0.0
12224,glycerol ether biosynthetic process (GO:0046504),-8.946621221239151e-11,0.0
12225,protoporphyrinogen IX metabolic process (GO:0046501),-8.946621221239151e-11,0.0
12226,mitochondrial respirasome assembly (GO:0097250),-8.946621221239151e-11,0.0
12227,monocyte activation (GO:0042117),-8.946621221239151e-11,0.0
12228,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-8.946621221239151e-11,0.0
12229,retina vasculature morphogenesis in camera-type eye (GO:0061299),-8.946621221239151e-11,0.0
12230,regulation of protein localization to cilium (GO:1903564),-8.946621221239151e-11,0.0
12231,antifungal humoral response (GO:0019732),-8.946621221239151e-11,0.0
12232,cellular response to hydroxyurea (GO:0072711),-8.946621221239151e-11,0.0
12233,epithelial cell differentiation involved in prostate gland development (GO:0060742),-8.946621221239151e-11,0.0
12234,muscle atrophy (GO:0014889),-8.946621221239151e-11,0.0
12235,microtubule anchoring at centrosome (GO:0034454),-8.946621221239151e-11,0.0
12236,"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-8.946621221239151e-11,0.0
12237,muscle filament sliding (GO:0030049),-8.946621221239151e-11,0.0
12238,tonic smooth muscle contraction (GO:0014820),-8.946621221239151e-11,0.0
12239,microvillus assembly (GO:0030033),-8.946621221239151e-11,0.0
12240,negative regulation of heart rate (GO:0010459),-8.946621221239151e-11,0.0
12241,cell cycle phase (GO:0022403),-8.946621221239151e-11,0.0
12242,rostrocaudal neural tube patterning (GO:0021903),-8.946621221239151e-11,0.0
12243,regulation of cardioblast proliferation (GO:0003264),-8.946621221239151e-11,0.0
12244,short-term memory (GO:0007614),-8.946621221239151e-11,0.0
12245,telomere localization (GO:0034397),-8.946621221239151e-11,0.0
12246,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),-8.946621221239151e-11,0.0
12247,amino sugar biosynthetic process (GO:0046349),-8.946621221239151e-11,0.0
12248,presynaptic membrane organization (GO:0097090),-8.946621221239151e-11,0.0
12249,regulation of glial cell apoptotic process (GO:0034350),-8.946621221239151e-11,0.0
12250,dendritic spine maintenance (GO:0097062),-8.946621221239151e-11,0.0
12251,immune response-inhibiting signal transduction (GO:0002765),-8.946621221239151e-11,0.0
12252,regulation of antimicrobial humoral response (GO:0002759),-8.946621221239151e-11,0.0
12253,response to granulocyte macrophage colony-stimulating factor (GO:0097012),-8.946621221239151e-11,0.0
12254,cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-8.946621221239151e-11,0.0
12255,positive regulation of dendritic cell cytokine production (GO:0002732),-8.946621221239151e-11,0.0
12256,negative regulation of T cell cytokine production (GO:0002725),-8.946621221239151e-11,0.0
12257,negative regulation of membrane potential (GO:0045837),-8.946621221239151e-11,0.0
12258,negative regulation of cell growth involved in cardiac muscle cell development (GO:0061052),-8.946621221239151e-11,0.0
12259,nucleoside bisphosphate catabolic process (GO:0033869),-8.946621221239151e-11,0.0
12260,regulation of NAD(P)H oxidase activity (GO:0033860),-8.946621221239151e-11,0.0
12261,regulation of vascular wound healing (GO:0061043),-8.946621221239151e-11,0.0
12262,olfactory bulb interneuron differentiation (GO:0021889),-8.946621221239151e-11,0.0
12263,regulation of fear response (GO:1903365),-8.946621221239151e-11,0.0
12264,oxalate transport (GO:0019532),-8.946621221239151e-11,0.0
12265,endothelial cell apoptotic process (GO:0072577),-8.946621221239151e-11,0.0
12266,mitral valve development (GO:0003174),-8.946621221239151e-11,0.0
12267,secondary heart field specification (GO:0003139),-8.946621221239151e-11,0.0
12268,regulation of osteoblast differentiation (GO:0045667),-9.078626738855185e-11,0.0
12269,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-9.078626738855185e-11,0.0
12270,mitotic cell cycle checkpoint signaling (GO:0007093),-9.078626738855185e-11,0.0
12271,regulation of protein localization to cell periphery (GO:1904375),-9.078626738855185e-11,0.0
12272,response to lead ion (GO:0010288),-9.188050320152247e-11,0.0
12273,regulation of tolerance induction (GO:0002643),-9.188050320152247e-11,0.0
12274,response to glucagon (GO:0033762),-9.188050320152247e-11,0.0
12275,melanosome assembly (GO:1903232),-9.188050320152247e-11,0.0
12276,triglyceride catabolic process (GO:0019433),-9.188050320152247e-11,0.0
12277,triglyceride biosynthetic process (GO:0019432),-9.188050320152247e-11,0.0
12278,late endosome to lysosome transport (GO:1902774),-9.188050320152247e-11,0.0
12279,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-9.188050320152247e-11,0.0
12280,tolerance induction (GO:0002507),-9.188050320152247e-11,0.0
12281,peptide antigen assembly with MHC protein complex (GO:0002501),-9.188050320152247e-11,0.0
12282,growth hormone receptor signaling pathway (GO:0060396),-9.188050320152247e-11,0.0
12283,regulation of bicellular tight junction assembly (GO:2000810),-9.188050320152247e-11,0.0
12284,Golgi to vacuole transport (GO:0006896),-9.188050320152247e-11,0.0
12285,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-9.188050320152247e-11,0.0
12286,cellular glucuronidation (GO:0052695),-9.188050320152247e-11,0.0
12287,hematopoietic stem cell differentiation (GO:0060218),-9.188050320152247e-11,0.0
12288,MHC protein complex assembly (GO:0002396),-9.188050320152247e-11,0.0
12289,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),-9.188050320152247e-11,0.0
12290,regulation of protein localization to synapse (GO:1902473),-9.188050320152247e-11,0.0
12291,positive regulation of superoxide anion generation (GO:0032930),-9.188050320152247e-11,0.0
12292,glycerol ether metabolic process (GO:0006662),-9.188050320152247e-11,0.0
12293,regulation of monocyte chemotactic protein-1 production (GO:0071637),-9.188050320152247e-11,0.0
12294,positive regulation of transforming growth factor beta production (GO:0071636),-9.188050320152247e-11,0.0
12295,regulation of MHC class II biosynthetic process (GO:0045346),-9.188050320152247e-11,0.0
12296,viral genome replication (GO:0019079),-9.188050320152247e-11,0.0
12297,regulation of skeletal muscle cell differentiation (GO:2001014),-9.188050320152247e-11,0.0
12298,positive regulation of CREB transcription factor activity (GO:0032793),-9.188050320152247e-11,0.0
12299,regulation of protein neddylation (GO:2000434),-9.188050320152247e-11,0.0
12300,N-glycan processing (GO:0006491),-9.188050320152247e-11,0.0
12301,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-9.188050320152247e-11,0.0
12302,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-9.188050320152247e-11,0.0
12303,cellular response to fluid shear stress (GO:0071498),-9.188050320152247e-11,0.0
12304,regulation of translational elongation (GO:0006448),-9.188050320152247e-11,0.0
12305,regulation of glutamate secretion (GO:0014048),-9.188050320152247e-11,0.0
12306,positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141),-9.188050320152247e-11,0.0
12307,3'-UTR-mediated mRNA stabilization (GO:0070935),-9.188050320152247e-11,0.0
12308,mRNA cleavage (GO:0006379),-9.188050320152247e-11,0.0
12309,cellular response to growth hormone stimulus (GO:0071378),-9.188050320152247e-11,0.0
12310,cellular response to gonadotropin stimulus (GO:0071371),-9.188050320152247e-11,0.0
12311,mitotic recombination (GO:0006312),-9.188050320152247e-11,0.0
12312,glycosyl compound biosynthetic process (GO:1901659),-9.188050320152247e-11,0.0
12313,cardiac muscle cell membrane repolarization (GO:0099622),-9.188050320152247e-11,0.0
12314,mitochondrial RNA processing (GO:0000963),-9.188050320152247e-11,0.0
12315,positive regulation of amyloid-beta formation (GO:1902004),-9.188050320152247e-11,0.0
12316,cellular response to arsenic-containing substance (GO:0071243),-9.188050320152247e-11,0.0
12317,response to muramyl dipeptide (GO:0032495),-9.188050320152247e-11,0.0
12318,purine nucleobase metabolic process (GO:0006144),-9.188050320152247e-11,0.0
12319,regulation of fatty acid beta-oxidation (GO:0031998),-9.188050320152247e-11,0.0
12320,positive regulation of chondrocyte differentiation (GO:0032332),-9.188050320152247e-11,0.0
12321,ethanol metabolic process (GO:0006067),-9.188050320152247e-11,0.0
12322,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-9.188050320152247e-11,0.0
12323,mitochondrion morphogenesis (GO:0070584),-9.188050320152247e-11,0.0
12324,leukocyte tethering or rolling (GO:0050901),-9.188050320152247e-11,0.0
12325,kinetochore organization (GO:0051383),-9.188050320152247e-11,0.0
12326,interleukin-1-mediated signaling pathway (GO:0070498),-9.188050320152247e-11,0.0
12327,post-embryonic animal organ development (GO:0048569),-9.188050320152247e-11,0.0
12328,negative regulation of nervous system process (GO:0031645),-9.188050320152247e-11,0.0
12329,tongue development (GO:0043586),-9.188050320152247e-11,0.0
12330,mitophagy (GO:0000423),-9.188050320152247e-11,0.0
12331,postsynaptic specialization organization (GO:0099084),-9.188050320152247e-11,0.0
12332,platelet morphogenesis (GO:0036344),-9.188050320152247e-11,0.0
12333,detection of other organism (GO:0098543),-9.188050320152247e-11,0.0
12334,regulation of defense response to bacterium (GO:1900424),-9.188050320152247e-11,0.0
12335,negative regulation of mitochondrial membrane permeability (GO:0035795),-9.188050320152247e-11,0.0
12336,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-9.188050320152247e-11,0.0
12337,amine catabolic process (GO:0009310),-9.188050320152247e-11,0.0
12338,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-9.188050320152247e-11,0.0
12339,ribosomal small subunit assembly (GO:0000028),-9.188050320152247e-11,0.0
12340,negative regulation of vascular permeability (GO:0043116),-9.188050320152247e-11,0.0
12341,peroxisomal membrane transport (GO:0015919),-9.188050320152247e-11,0.0
12342,nucleotide-sugar biosynthetic process (GO:0009226),-9.188050320152247e-11,0.0
12343,monovalent inorganic anion homeostasis (GO:0055083),-9.188050320152247e-11,0.0
12344,chloride ion homeostasis (GO:0055064),-9.188050320152247e-11,0.0
12345,phosphate ion homeostasis (GO:0055062),-9.188050320152247e-11,0.0
12346,vitamin transmembrane transport (GO:0035461),-9.188050320152247e-11,0.0
12347,DNA methylation involved in gamete generation (GO:0043046),-9.188050320152247e-11,0.0
12348,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-9.188050320152247e-11,0.0
12349,pore complex assembly (GO:0046931),-9.188050320152247e-11,0.0
12350,hippo signaling (GO:0035329),-9.188050320152247e-11,0.0
12351,serine family amino acid biosynthetic process (GO:0009070),-9.188050320152247e-11,0.0
12352,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-9.188050320152247e-11,0.0
12353,regulation of triglyceride biosynthetic process (GO:0010866),-9.188050320152247e-11,0.0
12354,cellular biogenic amine catabolic process (GO:0042402),-9.188050320152247e-11,0.0
12355,stress response to metal ion (GO:0097501),-9.188050320152247e-11,0.0
12356,transport of virus (GO:0046794),-9.188050320152247e-11,0.0
12357,regulation of viral transcription (GO:0046782),-9.188050320152247e-11,0.0
12358,rRNA catabolic process (GO:0016075),-9.188050320152247e-11,0.0
12359,negative regulation of sodium ion transport (GO:0010766),-9.188050320152247e-11,0.0
12360,negative regulation of miRNA-mediated gene silencing (GO:0060965),-9.188050320152247e-11,0.0
12361,gamma-delta T cell activation (GO:0046629),-9.188050320152247e-11,0.0
12362,maintenance of gastrointestinal epithelium (GO:0030277),-9.188050320152247e-11,0.0
12363,apoptotic nuclear changes (GO:0030262),-9.188050320152247e-11,0.0
12364,DNA strand elongation (GO:0022616),-9.188050320152247e-11,0.0
12365,histone mRNA metabolic process (GO:0008334),-9.188050320152247e-11,0.0
12366,adaptation of signaling pathway (GO:0023058),-9.188050320152247e-11,0.0
12367,protein import into mitochondrial matrix (GO:0030150),-9.188050320152247e-11,0.0
12368,regulation of calcium ion transport into cytosol (GO:0010522),-9.188050320152247e-11,0.0
12369,ether lipid metabolic process (GO:0046485),-9.188050320152247e-11,0.0
12370,labyrinthine layer blood vessel development (GO:0060716),-9.188050320152247e-11,0.0
12371,phasic smooth muscle contraction (GO:0014821),-9.188050320152247e-11,0.0
12372,maintenance of cell polarity (GO:0030011),-9.188050320152247e-11,0.0
12373,cellular anion homeostasis (GO:0030002),-9.188050320152247e-11,0.0
12374,regulation of synaptic vesicle recycling (GO:1903421),-9.188050320152247e-11,0.0
12375,retrograde axonal transport (GO:0008090),-9.188050320152247e-11,0.0
12376,Arp2/3 complex-mediated actin nucleation (GO:0034314),-9.188050320152247e-11,0.0
12377,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-9.188050320152247e-11,0.0
12378,negative regulation of natural killer cell mediated immunity (GO:0002716),-9.188050320152247e-11,0.0
12379,trivalent inorganic anion homeostasis (GO:0072506),-9.188050320152247e-11,0.0
12380,negative regulation of leukocyte chemotaxis (GO:0002689),-9.188050320152247e-11,0.0
12381,protein N-linked glycosylation (GO:0006487),-9.275247236498257e-11,0.0
12382,cellular response to amino acid stimulus (GO:0071230),-9.275247236498257e-11,0.0
12383,aminoglycan biosynthetic process (GO:0006023),-9.275247236498257e-11,0.0
12384,positive regulation of small GTPase mediated signal transduction (GO:0051057),-9.275247236498257e-11,0.0
12385,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-9.275247236498257e-11,0.0
12386,regulation of lipase activity (GO:0060191),-9.524647736726608e-11,0.0
12387,cellular response to virus (GO:0098586),-9.524647736726608e-11,0.0
12388,multicellular organism growth (GO:0035264),-9.524647736726608e-11,0.0
12389,vesicle-mediated transport to the plasma membrane (GO:0098876),-9.557732382857282e-11,0.0
12390,nuclear export (GO:0051168),-9.557732382857282e-11,0.0
12391,dicarboxylic acid transport (GO:0006835),-9.604517181110503e-11,0.0
12392,triglyceride metabolic process (GO:0006641),-9.604517181110503e-11,0.0
12393,negative regulation of protein depolymerization (GO:1901880),-9.604517181110503e-11,0.0
12394,translational initiation (GO:0006413),-9.604517181110503e-11,0.0
12395,positive regulation of reactive oxygen species metabolic process (GO:2000379),-9.604517181110503e-11,0.0
12396,peptidyl-threonine phosphorylation (GO:0018107),-9.604517181110503e-11,0.0
12397,regulation of stem cell population maintenance (GO:2000036),-9.604517181110503e-11,0.0
12398,glycosaminoglycan biosynthetic process (GO:0006024),-9.604517181110503e-11,0.0
12399,regulation of steroid biosynthetic process (GO:0050810),-9.604517181110503e-11,0.0
12400,water homeostasis (GO:0030104),-9.604517181110503e-11,0.0
12401,secondary alcohol metabolic process (GO:1902652),-9.763878594049765e-11,0.0
12402,regulation of chromosome segregation (GO:0051983),-9.763878594049765e-11,0.0
12403,positive regulation of calcium ion transport (GO:0051928),-9.763878594049765e-11,0.0
12404,mammary gland development (GO:0030879),-9.763878594049765e-11,0.0
12405,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-9.878298178956397e-11,0.0
12406,regulation of transcription initiation by RNA polymerase II (GO:0060260),-9.878298178956397e-11,0.0
12407,positive regulation of lipase activity (GO:0060193),-9.878298178956397e-11,0.0
12408,negative regulation of mRNA catabolic process (GO:1902373),-9.878298178956397e-11,0.0
12409,alpha-amino acid biosynthetic process (GO:1901607),-9.878298178956397e-11,0.0
12410,artery morphogenesis (GO:0048844),-9.878298178956397e-11,0.0
12411,energy reserve metabolic process (GO:0006112),-9.878298178956397e-11,0.0
12412,cell-cell recognition (GO:0009988),-9.878298178956397e-11,0.0
12413,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-9.878298178956397e-11,0.0
12414,killing of cells of another organism (GO:0031640),-9.878298178956397e-11,0.0
12415,animal organ regeneration (GO:0031100),-9.878298178956397e-11,0.0
12416,protein localization to extracellular region (GO:0071692),-9.939693512212084e-11,0.0
12417,internal peptidyl-lysine acetylation (GO:0018393),-9.939693512212084e-11,0.0
12418,regulation of generation of precursor metabolites and energy (GO:0043467),-9.939693512212084e-11,0.0
12419,B cell differentiation (GO:0030183),-9.939693512212084e-11,0.0
12420,regulation of leukocyte mediated cytotoxicity (GO:0001910),-9.967071611996615e-11,0.0
12421,granulocyte chemotaxis (GO:0071621),-9.967071611996615e-11,0.0
12422,cell cycle G1/S phase transition (GO:0044843),-9.967071611996615e-11,0.0
12423,proteoglycan metabolic process (GO:0006029),-9.967071611996615e-11,0.0
12424,regulation of microtubule polymerization or depolymerization (GO:0031110),-9.967071611996615e-11,0.0
12425,cellular ketone metabolic process (GO:0042180),-9.967071611996615e-11,0.0
12426,positive regulation of exocytosis (GO:0045921),-9.967071611996615e-11,0.0
12427,negative regulation of action potential (GO:0045759),-1.0088818668864801e-10,0.0
12428,maintenance of DNA methylation (GO:0010216),-1.0088818668864801e-10,0.0
12429,positive regulation of dendritic cell antigen processing and presentation (GO:0002606),-1.0088818668864801e-10,0.0
12430,positive regulation of potassium ion import across plasma membrane (GO:1903288),-1.0088818668864801e-10,0.0
12431,forebrain dorsal/ventral pattern formation (GO:0021798),-1.0088818668864801e-10,0.0
12432,cerebral cortex regionalization (GO:0021796),-1.0088818668864801e-10,0.0
12433,negative regulation of glycogen biosynthetic process (GO:0045719),-1.0088818668864801e-10,0.0
12434,negative regulation of cardiac muscle hypertrophy in response to stress (GO:1903243),-1.0088818668864801e-10,0.0
12435,regulation of endodermal cell differentiation (GO:1903224),-1.0088818668864801e-10,0.0
12436,renal water transport (GO:0003097),-1.0088818668864801e-10,0.0
12437,prevention of polyspermy (GO:0060468),-1.0088818668864801e-10,0.0
12438,negative regulation of fertilization (GO:0060467),-1.0088818668864801e-10,0.0
12439,response to DNA damage checkpoint signaling (GO:0072423),-1.0088818668864801e-10,0.0
12440,bud elongation involved in lung branching (GO:0060449),-1.0088818668864801e-10,0.0
12441,trachea formation (GO:0060440),-1.0088818668864801e-10,0.0
12442,response to DNA integrity checkpoint signaling (GO:0072402),-1.0088818668864801e-10,0.0
12443,negative regulation of vitamin metabolic process (GO:0046137),-1.0088818668864801e-10,0.0
12444,purine ribonucleoside catabolic process (GO:0046130),-1.0088818668864801e-10,0.0
12445,regulation of toll-like receptor 7 signaling pathway (GO:0034155),-1.0088818668864801e-10,0.0
12446,positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),-1.0088818668864801e-10,0.0
12447,negative regulation of toll-like receptor 2 signaling pathway (GO:0034136),-1.0088818668864801e-10,0.0
12448,inflammatory cell apoptotic process (GO:0006925),-1.0088818668864801e-10,0.0
12449,activation-induced cell death of T cells (GO:0006924),-1.0088818668864801e-10,0.0
12450,protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),-1.0088818668864801e-10,0.0
12451,determination of digestive tract left/right asymmetry (GO:0071907),-1.0088818668864801e-10,0.0
12452,negative regulation of monocyte differentiation (GO:0045656),-1.0088818668864801e-10,0.0
12453,negative regulation of macrophage differentiation (GO:0045650),-1.0088818668864801e-10,0.0
12454,positive regulation of T-helper 2 cell differentiation (GO:0045630),-1.0088818668864801e-10,0.0
12455,"fatty acid elongation, unsaturated fatty acid (GO:0019368)",-1.0088818668864801e-10,0.0
12456,"fatty acid elongation, saturated fatty acid (GO:0019367)",-1.0088818668864801e-10,0.0
12457,negative regulation of autophagy of mitochondrion (GO:1903147),-1.0088818668864801e-10,0.0
12458,vestibulocochlear nerve morphogenesis (GO:0021648),-1.0088818668864801e-10,0.0
12459,response to cell cycle checkpoint signaling (GO:0072396),-1.0088818668864801e-10,0.0
12460,plus-end-directed organelle transport along microtubule (GO:0072386),-1.0088818668864801e-10,0.0
12461,regulation of growth hormone receptor signaling pathway (GO:0060398),-1.0088818668864801e-10,0.0
12462,regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),-1.0088818668864801e-10,0.0
12463,dTMP metabolic process (GO:0046073),-1.0088818668864801e-10,0.0
12464,regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307),-1.0088818668864801e-10,0.0
12465,dAMP metabolic process (GO:0046053),-1.0088818668864801e-10,0.0
12466,CENP-A containing chromatin assembly (GO:0034080),-1.0088818668864801e-10,0.0
12467,UDP metabolic process (GO:0046048),-1.0088818668864801e-10,0.0
12468,regulation of blood vessel remodeling (GO:0060312),-1.0088818668864801e-10,0.0
12469,regulation of cell proliferation in bone marrow (GO:0071863),-1.0088818668864801e-10,0.0
12470,cobalt ion transport (GO:0006824),-1.0088818668864801e-10,0.0
12471,positive regulation of gamma-delta T cell differentiation (GO:0045588),-1.0088818668864801e-10,0.0
12472,negative regulation of B cell differentiation (GO:0045578),-1.0088818668864801e-10,0.0
12473,antigen processing and presentation of peptide antigen via MHC class Ib (GO:0002428),-1.0088818668864801e-10,0.0
12474,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),-1.0088818668864801e-10,0.0
12475,immune response to tumor cell (GO:0002418),-1.0088818668864801e-10,0.0
12476,anterior/posterior axon guidance (GO:0033564),-1.0088818668864801e-10,0.0
12477,rhombomere development (GO:0021546),-1.0088818668864801e-10,0.0
12478,intramembranous ossification (GO:0001957),-1.0088818668864801e-10,0.0
12479,ventral spinal cord interneuron specification (GO:0021521),-1.0088818668864801e-10,0.0
12480,regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000794),-1.0088818668864801e-10,0.0
12481,xenobiotic glucuronidation (GO:0052697),-1.0088818668864801e-10,0.0
12482,regulation of sarcomere organization (GO:0060297),-1.0088818668864801e-10,0.0
12483,positive regulation of transcription of Notch receptor target (GO:0007221),-1.0088818668864801e-10,0.0
12484,negative regulation of cytoplasmic translation (GO:2000766),-1.0088818668864801e-10,0.0
12485,metanephric glomerulus vasculature development (GO:0072239),-1.0088818668864801e-10,0.0
12486,metanephric distal tubule development (GO:0072235),-1.0088818668864801e-10,0.0
12487,regulation of respiratory burst involved in inflammatory response (GO:0060264),-1.0088818668864801e-10,0.0
12488,monoacylglycerol catabolic process (GO:0052651),-1.0088818668864801e-10,0.0
12489,negative regulation of serine-type peptidase activity (GO:1902572),-1.0088818668864801e-10,0.0
12490,negative regulation of cardiac muscle cell differentiation (GO:2000726),-1.0088818668864801e-10,0.0
12491,regulation of hippocampal neuron apoptotic process (GO:0110089),-1.0088818668864801e-10,0.0
12492,negative regulation of mesenchymal cell proliferation (GO:0072201),-1.0088818668864801e-10,0.0
12493,positive regulation of neutrophil activation (GO:1902565),-1.0088818668864801e-10,0.0
12494,delamination (GO:0060232),-1.0088818668864801e-10,0.0
12495,primitive hemopoiesis (GO:0060215),-1.0088818668864801e-10,0.0
12496,positive regulation of protein K63-linked ubiquitination (GO:1902523),-1.0088818668864801e-10,0.0
12497,DNA strand resection involved in replication fork processing (GO:0110025),-1.0088818668864801e-10,0.0
12498,tetrahydrobiopterin biosynthetic process (GO:0006729),-1.0088818668864801e-10,0.0
12499,glucocorticoid biosynthetic process (GO:0006704),-1.0088818668864801e-10,0.0
12500,leukotriene transport (GO:0071716),-1.0088818668864801e-10,0.0
12501,myeloid progenitor cell differentiation (GO:0002318),-1.0088818668864801e-10,0.0
12502,SMAD protein complex assembly (GO:0007183),-1.0088818668864801e-10,0.0
12503,common-partner SMAD protein phosphorylation (GO:0007182),-1.0088818668864801e-10,0.0
12504,positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698),-1.0088818668864801e-10,0.0
12505,neural fold formation (GO:0001842),-1.0088818668864801e-10,0.0
12506,positive regulation of glomerular mesangial cell proliferation (GO:0072126),-1.0088818668864801e-10,0.0
12507,regulation of SREBP signaling pathway (GO:2000638),-1.0088818668864801e-10,0.0
12508,inositol trisphosphate metabolic process (GO:0032957),-1.0088818668864801e-10,0.0
12509,embryonic process involved in female pregnancy (GO:0060136),-1.0088818668864801e-10,0.0
12510,ganglioside catabolic process (GO:0006689),-1.0088818668864801e-10,0.0
12511,positive regulation of transforming growth factor beta1 production (GO:0032914),-1.0088818668864801e-10,0.0
12512,maintenance of protein location in extracellular region (GO:0071694),-1.0088818668864801e-10,0.0
12513,TORC2 signaling (GO:0038203),-1.0088818668864801e-10,0.0
12514,CDP-choline pathway (GO:0006657),-1.0088818668864801e-10,0.0
12515,monoacylglycerol biosynthetic process (GO:0006640),-1.0088818668864801e-10,0.0
12516,positive regulation of chemokine (C-C motif) ligand 5 production (GO:0071651),-1.0088818668864801e-10,0.0
12517,wound healing involved in inflammatory response (GO:0002246),-1.0088818668864801e-10,0.0
12518,positive regulation of antimicrobial peptide production (GO:0002225),-1.0088818668864801e-10,0.0
12519,transforming growth factor beta production (GO:0071604),-1.0088818668864801e-10,0.0
12520,dense core granule transport (GO:1901950),-1.0088818668864801e-10,0.0
12521,negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-1.0088818668864801e-10,0.0
12522,S-adenosylmethionine cycle (GO:0033353),-1.0088818668864801e-10,0.0
12523,mitotic nuclear membrane disassembly (GO:0007077),-1.0088818668864801e-10,0.0
12524,S-shaped body morphogenesis (GO:0072050),-1.0088818668864801e-10,0.0
12525,relaxation of vascular associated smooth muscle (GO:0060087),-1.0088818668864801e-10,0.0
12526,cannabinoid signaling pathway (GO:0038171),-1.0088818668864801e-10,0.0
12527,oncostatin-M-mediated signaling pathway (GO:0038165),-1.0088818668864801e-10,0.0
12528,regulation of entry of bacterium into host cell (GO:2000535),-1.0088818668864801e-10,0.0
12529,mesangial cell differentiation (GO:0072007),-1.0088818668864801e-10,0.0
12530,convergent extension involved in gastrulation (GO:0060027),-1.0088818668864801e-10,0.0
12531,G-quadruplex DNA unwinding (GO:0044806),-1.0088818668864801e-10,0.0
12532,late nucleophagy (GO:0044805),-1.0088818668864801e-10,0.0
12533,"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)",-1.0088818668864801e-10,0.0
12534,"regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032829)",-1.0088818668864801e-10,0.0
12535,valine metabolic process (GO:0006573),-1.0088818668864801e-10,0.0
12536,L-serine biosynthetic process (GO:0006564),-1.0088818668864801e-10,0.0
12537,lacrimal gland development (GO:0032808),-1.0088818668864801e-10,0.0
12538,lysine catabolic process (GO:0006554),-1.0088818668864801e-10,0.0
12539,isoleucine metabolic process (GO:0006549),-1.0088818668864801e-10,0.0
12540,glycine biosynthetic process (GO:0006545),-1.0088818668864801e-10,0.0
12541,aspartate metabolic process (GO:0006531),-1.0088818668864801e-10,0.0
12542,positive regulation of transmission of nerve impulse (GO:0051971),-1.0088818668864801e-10,0.0
12543,negative regulation of synapse assembly (GO:0051964),-1.0088818668864801e-10,0.0
12544,C-terminal protein lipidation (GO:0006501),-1.0088818668864801e-10,0.0
12545,response to heparin (GO:0071503),-1.0088818668864801e-10,0.0
12546,store-operated calcium entry (GO:0002115),-1.0088818668864801e-10,0.0
12547,response to oxygen-glucose deprivation (GO:0090649),-1.0088818668864801e-10,0.0
12548,adiponectin-activated signaling pathway (GO:0033211),-1.0088818668864801e-10,0.0
12549,meiotic cytokinesis (GO:0033206),-1.0088818668864801e-10,0.0
12550,regulation of hepatic stellate cell activation (GO:2000489),-1.0088818668864801e-10,0.0
12551,DNA methylation on cytosine (GO:0032776),-1.0088818668864801e-10,0.0
12552,regulation of mast cell cytokine production (GO:0032763),-1.0088818668864801e-10,0.0
12553,positive regulation of interleukin-23 production (GO:0032747),-1.0088818668864801e-10,0.0
12554,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255),-1.0088818668864801e-10,0.0
12555,positive regulation of interleukin-1 alpha production (GO:0032730),-1.0088818668864801e-10,0.0
12556,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902231),-1.0088818668864801e-10,0.0
12557,negative regulation of interleukin-4 production (GO:0032713),-1.0088818668864801e-10,0.0
12558,paracrine signaling (GO:0038001),-1.0088818668864801e-10,0.0
12559,dorsal root ganglion development (GO:1990791),-1.0088818668864801e-10,0.0
12560,optic cup morphogenesis involved in camera-type eye development (GO:0002072),-1.0088818668864801e-10,0.0
12561,peripheral nervous system axon regeneration (GO:0014012),-1.0088818668864801e-10,0.0
12562,blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),-1.0088818668864801e-10,0.0
12563,cellular response to histamine (GO:0071420),-1.0088818668864801e-10,0.0
12564,regulation of synapse structural plasticity (GO:0051823),-1.0088818668864801e-10,0.0
12565,regulation of histone ubiquitination (GO:0033182),-1.0088818668864801e-10,0.0
12566,intermediate filament bundle assembly (GO:0045110),-1.0088818668864801e-10,0.0
12567,fatty acid alpha-oxidation (GO:0001561),-1.0088818668864801e-10,0.0
12568,podocyte cell migration (GO:0090521),-1.0088818668864801e-10,0.0
12569,luteolysis (GO:0001554),-1.0088818668864801e-10,0.0
12570,tooth eruption (GO:0044691),-1.0088818668864801e-10,0.0
12571,positive regulation of lamellipodium morphogenesis (GO:2000394),-1.0088818668864801e-10,0.0
12572,positive regulation of neutrophil extravasation (GO:2000391),-1.0088818668864801e-10,0.0
12573,aminophospholipid translocation (GO:0140331),-1.0088818668864801e-10,0.0
12574,negative regulation of interleukin-13 production (GO:0032696),-1.0088818668864801e-10,0.0
12575,histone H3-K4 dimethylation (GO:0044648),-1.0088818668864801e-10,0.0
12576,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902177),-1.0088818668864801e-10,0.0
12577,regulation of keratinocyte apoptotic process (GO:1902172),-1.0088818668864801e-10,0.0
12578,regulation of T-helper 17 cell lineage commitment (GO:2000328),-1.0088818668864801e-10,0.0
12579,regulation of glucocorticoid receptor signaling pathway (GO:2000322),-1.0088818668864801e-10,0.0
12580,positive regulation of synaptic vesicle exocytosis (GO:2000302),-1.0088818668864801e-10,0.0
12581,adenosine to inosine editing (GO:0006382),-1.0088818668864801e-10,0.0
12582,DNA methylation-dependent heterochromatin formation (GO:0006346),-1.0088818668864801e-10,0.0
12583,skeletal muscle acetylcholine-gated channel clustering (GO:0071340),-1.0088818668864801e-10,0.0
12584,cellular response to nicotine (GO:0071316),-1.0088818668864801e-10,0.0
12585,regulatory T cell differentiation (GO:0045066),-1.0088818668864801e-10,0.0
12586,nucleoside transmembrane transport (GO:1901642),-1.0088818668864801e-10,0.0
12587,inclusion body assembly (GO:0070841),-1.0088818668864801e-10,0.0
12588,postsynaptic endocytosis (GO:0140239),-1.0088818668864801e-10,0.0
12589,negative regulation of fibroblast apoptotic process (GO:2000270),-1.0088818668864801e-10,0.0
12590,protein transport within lipid bilayer (GO:0032594),-1.0088818668864801e-10,0.0
12591,guanine nucleotide transport (GO:0001408),-1.0088818668864801e-10,0.0
12592,response to vitamin K (GO:0032571),-1.0088818668864801e-10,0.0
12593,tRNA surveillance (GO:0106354),-1.0088818668864801e-10,0.0
12594,regulation of mitochondrial mRNA stability (GO:0044528),-1.0088818668864801e-10,0.0
12595,cellular response to salt (GO:1902075),-1.0088818668864801e-10,0.0
12596,positive regulation of anoikis (GO:2000210),-1.0088818668864801e-10,0.0
12597,regulation of microvillus length (GO:0032532),-1.0088818668864801e-10,0.0
12598,protein-DNA covalent cross-linking repair (GO:0106300),-1.0088818668864801e-10,0.0
12599,L-lysine transport (GO:1902022),-1.0088818668864801e-10,0.0
12600,pointed-end actin filament capping (GO:0051694),-1.0088818668864801e-10,0.0
12601,L-methionine salvage (GO:0071267),-1.0088818668864801e-10,0.0
12602,L-methionine biosynthetic process (GO:0071265),-1.0088818668864801e-10,0.0
12603,membrane raft localization (GO:0051665),-1.0088818668864801e-10,0.0
12604,'de novo' pyrimidine nucleobase biosynthetic process (GO:0006207),-1.0088818668864801e-10,0.0
12605,cellular response to peptidoglycan (GO:0071224),-1.0088818668864801e-10,0.0
12606,regulation of germ cell proliferation (GO:1905936),-1.0088818668864801e-10,0.0
12607,serotonin uptake (GO:0051610),-1.0088818668864801e-10,0.0
12608,regulation of female gonad development (GO:2000194),-1.0088818668864801e-10,0.0
12609,positive regulation of axon extension involved in axon guidance (GO:0048842),-1.0088818668864801e-10,0.0
12610,Cdc42 protein signal transduction (GO:0032488),-1.0088818668864801e-10,0.0
12611,regulation of Rab protein signal transduction (GO:0032483),-1.0088818668864801e-10,0.0
12612,negative regulation of cytokinesis (GO:0032466),-1.0088818668864801e-10,0.0
12613,positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138),-1.0088818668864801e-10,0.0
12614,dense core granule cytoskeletal transport (GO:0099519),-1.0088818668864801e-10,0.0
12615,snRNA modification (GO:0040031),-1.0088818668864801e-10,0.0
12616,mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-1.0088818668864801e-10,0.0
12617,corticosteroid receptor signaling pathway (GO:0031958),-1.0088818668864801e-10,0.0
12618,replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-1.0088818668864801e-10,0.0
12619,response to interleukin-18 (GO:0070673),-1.0088818668864801e-10,0.0
12620,response to interleukin-12 (GO:0070671),-1.0088818668864801e-10,0.0
12621,positive regulation of histone H4 acetylation (GO:0090240),-1.0088818668864801e-10,0.0
12622,response to interleukin-2 (GO:0070669),-1.0088818668864801e-10,0.0
12623,semicircular canal morphogenesis (GO:0048752),-1.0088818668864801e-10,0.0
12624,negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),-1.0088818668864801e-10,0.0
12625,regulation of cortisol biosynthetic process (GO:2000064),-1.0088818668864801e-10,0.0
12626,macropinocytosis (GO:0044351),-1.0088818668864801e-10,0.0
12627,oxygen homeostasis (GO:0032364),-1.0088818668864801e-10,0.0
12628,acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-1.0088818668864801e-10,0.0
12629,regulation of glutamate receptor clustering (GO:0106104),-1.0088818668864801e-10,0.0
12630,hyaloid vascular plexus regression (GO:1990384),-1.0088818668864801e-10,0.0
12631,polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-1.0088818668864801e-10,0.0
12632,regulation of mesodermal cell differentiation (GO:1905770),-1.0088818668864801e-10,0.0
12633,nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-1.0088818668864801e-10,0.0
12634,nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-1.0088818668864801e-10,0.0
12635,nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-1.0088818668864801e-10,0.0
12636,cellular water homeostasis (GO:0009992),-1.0088818668864801e-10,0.0
12637,nuclear ncRNA surveillance (GO:0071029),-1.0088818668864801e-10,0.0
12638,"neurotransmitter receptor transport, postsynaptic endosome to lysosome (GO:0098943)",-1.0088818668864801e-10,0.0
12639,organic heteropentacyclic compound metabolic process (GO:1901376),-1.0088818668864801e-10,0.0
12640,protection from non-homologous end joining at telomere (GO:0031848),-1.0088818668864801e-10,0.0
12641,retrograde trans-synaptic signaling (GO:0098917),-1.0088818668864801e-10,0.0
12642,regulation of SA node cell action potential (GO:0098907),-1.0088818668864801e-10,0.0
12643,regulation of membrane repolarization during action potential (GO:0098903),-1.0088818668864801e-10,0.0
12644,regulation of pancreatic juice secretion (GO:0090186),-1.0088818668864801e-10,0.0
12645,Golgi disassembly (GO:0090166),-1.0088818668864801e-10,0.0
12646,positive regulation of pigment cell differentiation (GO:0050942),-1.0088818668864801e-10,0.0
12647,cholesterol import (GO:0070508),-1.0088818668864801e-10,0.0
12648,sensory perception of umami taste (GO:0050917),-1.0088818668864801e-10,0.0
12649,sensory perception of sweet taste (GO:0050916),-1.0088818668864801e-10,0.0
12650,positive regulation of gonadotropin secretion (GO:0032278),-1.0088818668864801e-10,0.0
12651,negative regulation of gonadotropin secretion (GO:0032277),-1.0088818668864801e-10,0.0
12652,diapedesis (GO:0050904),-1.0088818668864801e-10,0.0
12653,dense core granule localization (GO:0032253),-1.0088818668864801e-10,0.0
12654,protein maturation by [4Fe-4S] cluster transfer (GO:0106035),-1.0088818668864801e-10,0.0
12655,"regulation of synaptic transmission, cholinergic (GO:0032222)",-1.0088818668864801e-10,0.0
12656,telomere maintenance via semi-conservative replication (GO:0032201),-1.0088818668864801e-10,0.0
12657,lipid droplet disassembly (GO:1905691),-1.0088818668864801e-10,0.0
12658,postsynaptic neurotransmitter receptor internalization (GO:0098884),-1.0088818668864801e-10,0.0
12659,folate transmembrane transport (GO:0098838),-1.0088818668864801e-10,0.0
12660,chromosome movement towards spindle pole (GO:0051305),-1.0088818668864801e-10,0.0
12661,voluntary musculoskeletal movement (GO:0050882),-1.0088818668864801e-10,0.0
12662,regulation of oligodendrocyte progenitor proliferation (GO:0070445),-1.0088818668864801e-10,0.0
12663,negative regulation of B cell receptor signaling pathway (GO:0050859),-1.0088818668864801e-10,0.0
12664,positive regulation of pinocytosis (GO:0048549),-1.0088818668864801e-10,0.0
12665,hydrocarbon metabolic process (GO:0120252),-1.0088818668864801e-10,0.0
12666,transposition (GO:0032196),-1.0088818668864801e-10,0.0
12667,ATF6-mediated unfolded protein response (GO:0036500),-1.0088818668864801e-10,0.0
12668,recognition of apoptotic cell (GO:0043654),-1.0088818668864801e-10,0.0
12669,positive regulation of trophoblast cell migration (GO:1901165),-1.0088818668864801e-10,0.0
12670,astrocyte cell migration (GO:0043615),-1.0088818668864801e-10,0.0
12671,response to fructose (GO:0009750),-1.0088818668864801e-10,0.0
12672,positive regulation of fever generation (GO:0031622),-1.0088818668864801e-10,0.0
12673,actin polymerization-dependent cell motility (GO:0070358),-1.0088818668864801e-10,0.0
12674,PERK-mediated unfolded protein response (GO:0036499),-1.0088818668864801e-10,0.0
12675,IRE1-mediated unfolded protein response (GO:0036498),-1.0088818668864801e-10,0.0
12676,TRAIL-activated apoptotic signaling pathway (GO:0036462),-1.0088818668864801e-10,0.0
12677,response to cGMP (GO:0070305),-1.0088818668864801e-10,0.0
12678,maintenance of lens transparency (GO:0036438),-1.0088818668864801e-10,0.0
12679,positive regulation of nuclease activity (GO:0032075),-1.0088818668864801e-10,0.0
12680,negative regulation of nuclease activity (GO:0032074),-1.0088818668864801e-10,0.0
12681,detection of muscle stretch (GO:0035995),-1.0088818668864801e-10,0.0
12682,negative regulation of insulin-like growth factor receptor signaling pathway (GO:0043569),-1.0088818668864801e-10,0.0
12683,positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),-1.0088818668864801e-10,0.0
12684,positive regulation of autophagosome maturation (GO:1901098),-1.0088818668864801e-10,0.0
12685,negative regulation of relaxation of muscle (GO:1901078),-1.0088818668864801e-10,0.0
12686,positive regulation of response to reactive oxygen species (GO:1901033),-1.0088818668864801e-10,0.0
12687,response to nematode (GO:0009624),-1.0088818668864801e-10,0.0
12688,subtelomeric heterochromatin formation (GO:0031509),-1.0088818668864801e-10,0.0
12689,regulation of cytochrome-c oxidase activity (GO:1904959),-1.0088818668864801e-10,0.0
12690,intracellular distribution of mitochondria (GO:0048312),-1.0088818668864801e-10,0.0
12691,regulation of macrophage proliferation (GO:0120040),-1.0088818668864801e-10,0.0
12692,modification of postsynaptic structure (GO:0099010),-1.0088818668864801e-10,0.0
12693,observational learning (GO:0098597),-1.0088818668864801e-10,0.0
12694,positive regulation of helicase activity (GO:0051096),-1.0088818668864801e-10,0.0
12695,lactate transmembrane transport (GO:0035873),-1.0088818668864801e-10,0.0
12696,histone H3-K27 trimethylation (GO:0098532),-1.0088818668864801e-10,0.0
12697,chiasma assembly (GO:0051026),-1.0088818668864801e-10,0.0
12698,regulation of isotype switching to IgE isotypes (GO:0048293),-1.0088818668864801e-10,0.0
12699,regulation of enamel mineralization (GO:0070173),-1.0088818668864801e-10,0.0
12700,negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-1.0088818668864801e-10,0.0
12701,regulation of adiponectin secretion (GO:0070163),-1.0088818668864801e-10,0.0
12702,D-amino acid transport (GO:0042940),-1.0088818668864801e-10,0.0
12703,RNA (guanine-N7)-methylation (GO:0036265),-1.0088818668864801e-10,0.0
12704,establishment or maintenance of cytoskeleton polarity (GO:0030952),-1.0088818668864801e-10,0.0
12705,interleukin-27-mediated signaling pathway (GO:0070106),-1.0088818668864801e-10,0.0
12706,negative regulation of chemokine-mediated signaling pathway (GO:0070100),-1.0088818668864801e-10,0.0
12707,alkanesulfonate transport (GO:0042918),-1.0088818668864801e-10,0.0
12708,positive regulation of long-term synaptic depression (GO:1900454),-1.0088818668864801e-10,0.0
12709,midbrain-hindbrain boundary development (GO:0030917),-1.0088818668864801e-10,0.0
12710,mycotoxin metabolic process (GO:0043385),-1.0088818668864801e-10,0.0
12711,"regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)",-1.0088818668864801e-10,0.0
12712,"regulation of retrograde transport, endosome to Golgi (GO:1905279)",-1.0088818668864801e-10,0.0
12713,positive regulation of prostaglandin biosynthetic process (GO:0031394),-1.0088818668864801e-10,0.0
12714,intraciliary transport involved in cilium assembly (GO:0035735),-1.0088818668864801e-10,0.0
12715,response to insecticide (GO:0017085),-1.0088818668864801e-10,0.0
12716,natural killer cell degranulation (GO:0043320),-1.0088818668864801e-10,0.0
12717,hematopoietic stem cell migration (GO:0035701),-1.0088818668864801e-10,0.0
12718,negative regulation of mast cell degranulation (GO:0043305),-1.0088818668864801e-10,0.0
12719,positive regulation of hydrogen peroxide-induced cell death (GO:1905206),-1.0088818668864801e-10,0.0
12720,methylglyoxal metabolic process (GO:0009438),-1.0088818668864801e-10,0.0
12721,regulation of core promoter binding (GO:1904796),-1.0088818668864801e-10,0.0
12722,vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072),-1.0088818668864801e-10,0.0
12723,positive regulation of protein localization to centrosome (GO:1904781),-1.0088818668864801e-10,0.0
12724,regulation of AMPA glutamate receptor clustering (GO:1904717),-1.0088818668864801e-10,0.0
12725,leukotriene catabolic process (GO:0036100),-1.0088818668864801e-10,0.0
12726,establishment of left/right asymmetry (GO:0061966),-1.0088818668864801e-10,0.0
12727,rDNA heterochromatin formation (GO:0000183),-1.0088818668864801e-10,0.0
12728,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-1.0088818668864801e-10,0.0
12729,"clathrin-coated vesicle cargo loading, AP-3-mediated (GO:0035654)",-1.0088818668864801e-10,0.0
12730,clathrin-coated vesicle cargo loading (GO:0035652),-1.0088818668864801e-10,0.0
12731,regulation of voltage-gated sodium channel activity (GO:1905150),-1.0088818668864801e-10,0.0
12732,tRNA transcription by RNA polymerase III (GO:0042797),-1.0088818668864801e-10,0.0
12733,regulation of metalloendopeptidase activity (GO:1904683),-1.0088818668864801e-10,0.0
12734,very long-chain fatty acid catabolic process (GO:0042760),-1.0088818668864801e-10,0.0
12735,cleavage furrow formation (GO:0036089),-1.0088818668864801e-10,0.0
12736,direct ossification (GO:0036072),-1.0088818668864801e-10,0.0
12737,thiamine-containing compound metabolic process (GO:0042723),-1.0088818668864801e-10,0.0
12738,"antigen processing and presentation, exogenous lipid antigen via MHC class Ib (GO:0048007)",-1.0088818668864801e-10,0.0
12739,antigen processing and presentation of lipid antigen via MHC class Ib (GO:0048003),-1.0088818668864801e-10,0.0
12740,response to erythropoietin (GO:0036017),-1.0088818668864801e-10,0.0
12741,cellular response to interleukin-3 (GO:0036016),-1.0088818668864801e-10,0.0
12742,response to interleukin-3 (GO:0036015),-1.0088818668864801e-10,0.0
12743,ribosomal small subunit export from nucleus (GO:0000056),-1.0088818668864801e-10,0.0
12744,ribosomal large subunit export from nucleus (GO:0000055),-1.0088818668864801e-10,0.0
12745,citrulline metabolic process (GO:0000052),-1.0088818668864801e-10,0.0
12746,regulation of mitotic recombination (GO:0000019),-1.0088818668864801e-10,0.0
12747,negative regulation of metallopeptidase activity (GO:1905049),-1.0088818668864801e-10,0.0
12748,protein K29-linked ubiquitination (GO:0035519),-1.0088818668864801e-10,0.0
12749,regulation of myosin-light-chain-phosphatase activity (GO:0035507),-1.0088818668864801e-10,0.0
12750,amino acid salvage (GO:0043102),-1.0088818668864801e-10,0.0
12751,purine deoxyribonucleoside triphosphate metabolic process (GO:0009215),-1.0088818668864801e-10,0.0
12752,pyrimidine deoxyribonucleoside triphosphate metabolic process (GO:0009211),-1.0088818668864801e-10,0.0
12753,regulation of oocyte maturation (GO:1900193),-1.0088818668864801e-10,0.0
12754,regulation of defense response to fungus (GO:1900150),-1.0088818668864801e-10,0.0
12755,negative regulation of histone H3-K9 trimethylation (GO:1900113),-1.0088818668864801e-10,0.0
12756,carnitine transport (GO:0015879),-1.0088818668864801e-10,0.0
12757,"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-1.0088818668864801e-10,0.0
12758,pyrimidine ribonucleoside diphosphate metabolic process (GO:0009193),-1.0088818668864801e-10,0.0
12759,nucleoside transport (GO:0015858),-1.0088818668864801e-10,0.0
12760,autocrine signaling (GO:0035425),-1.0088818668864801e-10,0.0
12761,negative regulation of histone deacetylation (GO:0031064),-1.0088818668864801e-10,0.0
12762,chromatin remodeling at centromere (GO:0031055),-1.0088818668864801e-10,0.0
12763,ornithine transport (GO:0015822),-1.0088818668864801e-10,0.0
12764,regulation of hemoglobin biosynthetic process (GO:0046984),-1.0088818668864801e-10,0.0
12765,nonassociative learning (GO:0046958),-1.0088818668864801e-10,0.0
12766,PML body organization (GO:0030578),-1.0088818668864801e-10,0.0
12767,free ubiquitin chain polymerization (GO:0010994),-1.0088818668864801e-10,0.0
12768,amylin receptor signaling pathway (GO:0097647),-1.0088818668864801e-10,0.0
12769,positive regulation of programmed necrotic cell death (GO:0062100),-1.0088818668864801e-10,0.0
12770,regulation of phosphate transport (GO:0010966),-1.0088818668864801e-10,0.0
12771,pyrimidine-containing compound salvage (GO:0008655),-1.0088818668864801e-10,0.0
12772,negative regulation of protein K63-linked ubiquitination (GO:1900045),-1.0088818668864801e-10,0.0
12773,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-1.0088818668864801e-10,0.0
12774,autophagosome membrane docking (GO:0016240),-1.0088818668864801e-10,0.0
12775,negative regulation of ruffle assembly (GO:1900028),-1.0088818668864801e-10,0.0
12776,positive regulation of protein kinase C activity (GO:1900020),-1.0088818668864801e-10,0.0
12777,regulation of protein kinase C activity (GO:1900019),-1.0088818668864801e-10,0.0
12778,spontaneous neurotransmitter secretion (GO:0061669),-1.0088818668864801e-10,0.0
12779,negative regulation of serine-type endopeptidase activity (GO:1900004),-1.0088818668864801e-10,0.0
12780,regulation of hepatocyte apoptotic process (GO:1903943),-1.0088818668864801e-10,0.0
12781,cellular triglyceride homeostasis (GO:0035356),-1.0088818668864801e-10,0.0
12782,positive regulation of receptor clustering (GO:1903911),-1.0088818668864801e-10,0.0
12783,taurine transport (GO:0015734),-1.0088818668864801e-10,0.0
12784,prostaglandin transport (GO:0015732),-1.0088818668864801e-10,0.0
12785,lactate transport (GO:0015727),-1.0088818668864801e-10,0.0
12786,cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-1.0088818668864801e-10,0.0
12787,regulation of cardiac muscle cell membrane potential (GO:0086036),-1.0088818668864801e-10,0.0
12788,AV node cell to bundle of His cell signaling (GO:0086027),-1.0088818668864801e-10,0.0
12789,SA node cell to atrial cardiac muscle cell signaling (GO:0086018),-1.0088818668864801e-10,0.0
12790,AV node cell action potential (GO:0086016),-1.0088818668864801e-10,0.0
12791,SA node cell action potential (GO:0086015),-1.0088818668864801e-10,0.0
12792,glycolipid transport (GO:0046836),-1.0088818668864801e-10,0.0
12793,sequestering of iron ion (GO:0097577),-1.0088818668864801e-10,0.0
12794,positive regulation of mitotic sister chromatid segregation (GO:0062033),-1.0088818668864801e-10,0.0
12795,receptor-mediated virion attachment to host cell (GO:0046813),-1.0088818668864801e-10,0.0
12796,axon choice point recognition (GO:0016198),-1.0088818668864801e-10,0.0
12797,synaptic vesicle uncoating (GO:0016191),-1.0088818668864801e-10,0.0
12798,positive regulation of cholesterol storage (GO:0010886),-1.0088818668864801e-10,0.0
12799,mast cell migration (GO:0097531),-1.0088818668864801e-10,0.0
12800,bradykinin catabolic process (GO:0010815),-1.0088818668864801e-10,0.0
12801,amyloid-beta clearance by transcytosis (GO:0150093),-1.0088818668864801e-10,0.0
12802,glutathione transmembrane transport (GO:0034775),-1.0088818668864801e-10,0.0
12803,regulation of iron ion transport (GO:0034756),-1.0088818668864801e-10,0.0
12804,water-soluble vitamin biosynthetic process (GO:0042364),-1.0088818668864801e-10,0.0
12805,fat-soluble vitamin biosynthetic process (GO:0042362),-1.0088818668864801e-10,0.0
12806,piecemeal microautophagy of the nucleus (GO:0034727),-1.0088818668864801e-10,0.0
12807,negative regulation of macrophage chemotaxis (GO:0010760),-1.0088818668864801e-10,0.0
12808,macrophage derived foam cell differentiation (GO:0010742),-1.0088818668864801e-10,0.0
12809,negative regulation of hydrogen peroxide metabolic process (GO:0010727),-1.0088818668864801e-10,0.0
12810,regulation of potassium ion export across plasma membrane (GO:1903764),-1.0088818668864801e-10,0.0
12811,negative regulation of p38MAPK cascade (GO:1903753),-1.0088818668864801e-10,0.0
12812,regulation of MDA-5 signaling pathway (GO:0039533),-1.0088818668864801e-10,0.0
12813,RIG-I signaling pathway (GO:0039529),-1.0088818668864801e-10,0.0
12814,negative regulation of phospholipid metabolic process (GO:1903726),-1.0088818668864801e-10,0.0
12815,regulation of centriole elongation (GO:1903722),-1.0088818668864801e-10,0.0
12816,positive regulation of I-kappaB phosphorylation (GO:1903721),-1.0088818668864801e-10,0.0
12817,cardiac vascular smooth muscle cell differentiation (GO:0060947),-1.0088818668864801e-10,0.0
12818,response to luteinizing hormone (GO:0034699),-1.0088818668864801e-10,0.0
12819,tetrahydrofolate biosynthetic process (GO:0046654),-1.0088818668864801e-10,0.0
12820,negative regulation of centriole replication (GO:0046600),-1.0088818668864801e-10,0.0
12821,positive regulation of microglial cell migration (GO:1904141),-1.0088818668864801e-10,0.0
12822,'de novo' NAD biosynthetic process (GO:0034627),-1.0088818668864801e-10,0.0
12823,"fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-1.0088818668864801e-10,0.0
12824,"fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-1.0088818668864801e-10,0.0
12825,neutrophil differentiation (GO:0030223),-1.0088818668864801e-10,0.0
12826,hyaluronan biosynthetic process (GO:0030213),-1.0088818668864801e-10,0.0
12827,heparan sulfate proteoglycan catabolic process (GO:0030200),-1.0088818668864801e-10,0.0
12828,negative regulation of cardiac muscle adaptation (GO:0010616),-1.0088818668864801e-10,0.0
12829,sperm DNA condensation (GO:0035092),-1.0088818668864801e-10,0.0
12830,BMP signaling pathway involved in heart development (GO:0061312),-1.0088818668864801e-10,0.0
12831,positive regulation of DNA catabolic process (GO:1903626),-1.0088818668864801e-10,0.0
12832,protein localization to cytoplasmic stress granule (GO:1903608),-1.0088818668864801e-10,0.0
12833,smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:0060831),-1.0088818668864801e-10,0.0
12834,development of secondary female sexual characteristics (GO:0046543),-1.0088818668864801e-10,0.0
12835,'de novo' XMP biosynthetic process (GO:0097294),-1.0088818668864801e-10,0.0
12836,XMP biosynthetic process (GO:0097293),-1.0088818668864801e-10,0.0
12837,XMP metabolic process (GO:0097292),-1.0088818668864801e-10,0.0
12838,ammonium homeostasis (GO:0097272),-1.0088818668864801e-10,0.0
12839,positive regulation of sensory perception of pain (GO:1904058),-1.0088818668864801e-10,0.0
12840,meiotic DNA double-strand break formation (GO:0042138),-1.0088818668864801e-10,0.0
12841,chromosome attachment to the nuclear envelope (GO:0097240),-1.0088818668864801e-10,0.0
12842,pancreatic juice secretion (GO:0030157),-1.0088818668864801e-10,0.0
12843,regulation of collagen fibril organization (GO:1904026),-1.0088818668864801e-10,0.0
12844,vascular endothelial growth factor production (GO:0010573),-1.0088818668864801e-10,0.0
12845,response to gonadotropin-releasing hormone (GO:0097210),-1.0088818668864801e-10,0.0
12846,lipid hydroxylation (GO:0002933),-1.0088818668864801e-10,0.0
12847,positive regulation of activation of Janus kinase activity (GO:0010536),-1.0088818668864801e-10,0.0
12848,positive regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002925),-1.0088818668864801e-10,0.0
12849,positive regulation of gap junction assembly (GO:1903598),-1.0088818668864801e-10,0.0
12850,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588),-1.0088818668864801e-10,0.0
12851,positive regulation of protein localization to cilium (GO:1903566),-1.0088818668864801e-10,0.0
12852,protein localization to photoreceptor outer segment (GO:1903546),-1.0088818668864801e-10,0.0
12853,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339),-1.0088818668864801e-10,0.0
12854,glycosylceramide catabolic process (GO:0046477),-1.0088818668864801e-10,0.0
12855,glycosylceramide biosynthetic process (GO:0046476),-1.0088818668864801e-10,0.0
12856,mammary gland branching involved in pregnancy (GO:0060745),-1.0088818668864801e-10,0.0
12857,response to sorbitol (GO:0072708),-1.0088818668864801e-10,0.0
12858,negative regulation of Wnt signaling pathway involved in heart development (GO:0003308),-1.0088818668864801e-10,0.0
12859,physiological cardiac muscle hypertrophy (GO:0003301),-1.0088818668864801e-10,0.0
12860,chorio-allantoic fusion (GO:0060710),-1.0088818668864801e-10,0.0
12861,dentinogenesis (GO:0097187),-1.0088818668864801e-10,0.0
12862,transition between fast and slow fiber (GO:0014883),-1.0088818668864801e-10,0.0
12863,protein repair (GO:0030091),-1.0088818668864801e-10,0.0
12864,insulin processing (GO:0030070),-1.0088818668864801e-10,0.0
12865,parallel actin filament bundle assembly (GO:0030046),-1.0088818668864801e-10,0.0
12866,positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),-1.0088818668864801e-10,0.0
12867,postsynaptic density assembly (GO:0097107),-1.0088818668864801e-10,0.0
12868,negative regulation of T-helper 1 type immune response (GO:0002826),-1.0088818668864801e-10,0.0
12869,fatty acid omega-oxidation (GO:0010430),-1.0088818668864801e-10,0.0
12870,positive regulation of dopamine metabolic process (GO:0045964),-1.0088818668864801e-10,0.0
12871,positive regulation of mitotic cytokinesis (GO:1903490),-1.0088818668864801e-10,0.0
12872,alkanesulfonate metabolic process (GO:0019694),-1.0088818668864801e-10,0.0
12873,pulmonary artery morphogenesis (GO:0061156),-1.0088818668864801e-10,0.0
12874,positive regulation of catecholamine metabolic process (GO:0045915),-1.0088818668864801e-10,0.0
12875,corticospinal tract morphogenesis (GO:0021957),-1.0088818668864801e-10,0.0
12876,positive regulation of cell maturation (GO:1903431),-1.0088818668864801e-10,0.0
12877,short-chain fatty acid catabolic process (GO:0019626),-1.0088818668864801e-10,0.0
12878,physiological muscle hypertrophy (GO:0003298),-1.0088818668864801e-10,0.0
12879,lamellipodium morphogenesis (GO:0072673),-1.0088818668864801e-10,0.0
12880,L-lysine transmembrane transport (GO:1903401),-1.0088818668864801e-10,0.0
12881,regulation of phospholipid catabolic process (GO:0060696),-1.0088818668864801e-10,0.0
12882,cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:0003253),-1.0088818668864801e-10,0.0
12883,mesenchymal-epithelial cell signaling (GO:0060638),-1.0088818668864801e-10,0.0
12884,high-density lipoprotein particle clearance (GO:0034384),-1.0088818668864801e-10,0.0
12885,positive regulation of tau-protein kinase activity (GO:1902949),-1.0088818668864801e-10,0.0
12886,fat pad development (GO:0060613),-1.0088818668864801e-10,0.0
12887,L-kynurenine metabolic process (GO:0097052),-1.0088818668864801e-10,0.0
12888,adherens junction maintenance (GO:0034334),-1.0088818668864801e-10,0.0
12889,negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-1.0088818668864801e-10,0.0
12890,skeletal muscle atrophy (GO:0014732),-1.0088818668864801e-10,0.0
12891,regulation of phospholipid translocation (GO:0061091),-1.0088818668864801e-10,0.0
12892,positive regulation of NAD(P)H oxidase activity (GO:0033864),-1.0088818668864801e-10,0.0
12893,cerebral cortex GABAergic interneuron development (GO:0021894),-1.0088818668864801e-10,0.0
12894,cell growth involved in cardiac muscle cell development (GO:0061049),-1.0088818668864801e-10,0.0
12895,positive regulation of fear response (GO:1903367),-1.0088818668864801e-10,0.0
12896,protein localization to basolateral plasma membrane (GO:1903361),-1.0088818668864801e-10,0.0
12897,glycerol catabolic process (GO:0019563),-1.0088818668864801e-10,0.0
12898,forebrain radial glial cell differentiation (GO:0021861),-1.0088818668864801e-10,0.0
12899,positive regulation of bicellular tight junction assembly (GO:1903348),-1.0088818668864801e-10,0.0
12900,hypothalamus cell migration (GO:0021855),-1.0088818668864801e-10,0.0
12901,negative regulation of dendritic spine morphogenesis (GO:0061002),-1.0088818668864801e-10,0.0
12902,taurine metabolic process (GO:0019530),-1.0088818668864801e-10,0.0
12903,epithelial cell proliferation involved in liver morphogenesis (GO:0072575),-1.0088818668864801e-10,0.0
12904,hepatocyte proliferation (GO:0072574),-1.0088818668864801e-10,0.0
12905,cell motility involved in cerebral cortex radial glia guided migration (GO:0021814),-1.0088818668864801e-10,0.0
12906,mammary gland formation (GO:0060592),-1.0088818668864801e-10,0.0
12907,His-Purkinje system development (GO:0003164),-1.0088818668864801e-10,0.0
12908,T-helper 17 cell lineage commitment (GO:0072540),-1.0088818668864801e-10,0.0
12909,cell fate specification involved in pattern specification (GO:0060573),-1.0088818668864801e-10,0.0
12910,pyridine-containing compound catabolic process (GO:0072526),-1.0088818668864801e-10,0.0
12911,regulation of calcidiol 1-monooxygenase activity (GO:0060558),-1.0088818668864801e-10,0.0
12912,regulation of vitamin D biosynthetic process (GO:0060556),-1.0088818668864801e-10,0.0
12913,trachea cartilage development (GO:0060534),-1.0088818668864801e-10,0.0
12914,aflatoxin metabolic process (GO:0046222),-1.0088818668864801e-10,0.0
12915,positive regulation of DNA repair (GO:0045739),-1.0177036990392577e-10,0.0
12916,positive regulation of apoptotic signaling pathway (GO:2001235),-1.0177036990392577e-10,0.0
12917,meiosis I cell cycle process (GO:0061982),-1.0177036990392577e-10,0.0
12918,regulation of protein-containing complex disassembly (GO:0043244),-1.0177036990392577e-10,0.0
12919,response to interferon-gamma (GO:0034341),-1.0177036990392577e-10,0.0
12920,regulation of protein serine/threonine kinase activity (GO:0071900),-1.0212453104874508e-10,0.752246985750822
12921,regulation of supramolecular fiber organization (GO:1902903),-1.0455880605228665e-10,0.7679597165236852
12922,proton transmembrane transport (GO:1902600),-1.0512701819623022e-10,0.0
12923,positive regulation of proteolysis involved in protein catabolic process (GO:1903052),-1.0512701819623022e-10,0.0
12924,regulation of oxidative stress-induced cell death (GO:1903201),-1.0524336956919871e-10,0.0
12925,positive regulation of interleukin-1 production (GO:0032732),-1.0524336956919871e-10,0.0
12926,regulation of membrane permeability (GO:0090559),-1.0524336956919871e-10,0.0
12927,negative regulation of reproductive process (GO:2000242),-1.0524336956919871e-10,0.0
12928,endothelial cell migration (GO:0043542),-1.0524336956919871e-10,0.0
12929,mesoderm morphogenesis (GO:0048332),-1.0524336956919871e-10,0.0
12930,regulation of ATP-dependent activity (GO:0043462),-1.0524336956919871e-10,0.0
12931,spliceosomal complex assembly (GO:0000245),-1.0524336956919871e-10,0.0
12932,proton motive force-driven ATP synthesis (GO:0015986),-1.0524336956919871e-10,0.0
12933,ribonucleoside diphosphate metabolic process (GO:0009185),-1.0524336956919871e-10,0.0
12934,glutamine family amino acid metabolic process (GO:0009064),-1.0524336956919871e-10,0.0
12935,myeloid cell development (GO:0061515),-1.0524336956919871e-10,0.0
12936,endosome to lysosome transport (GO:0008333),-1.0524336956919871e-10,0.0
12937,axo-dendritic transport (GO:0008088),-1.0524336956919871e-10,0.0
12938,regulation of cartilage development (GO:0061035),-1.0524336956919871e-10,0.0
12939,fatty acid oxidation (GO:0019395),-1.058548804110977e-10,0.0
12940,nerve development (GO:0021675),-1.058548804110977e-10,0.0
12941,ATP biosynthetic process (GO:0006754),-1.058548804110977e-10,0.0
12942,mitotic DNA integrity checkpoint signaling (GO:0044774),-1.058548804110977e-10,0.0
12943,protein lipidation (GO:0006497),-1.058548804110977e-10,0.0
12944,regulation of intracellular pH (GO:0051453),-1.058548804110977e-10,0.0
12945,G1/S transition of mitotic cell cycle (GO:0000082),-1.058548804110977e-10,0.0
12946,fatty acid catabolic process (GO:0009062),-1.058548804110977e-10,0.0
12947,response to unfolded protein (GO:0006986),-1.0677458916459939e-10,0.0
12948,regulation of cell-matrix adhesion (GO:0001952),-1.0677458916459939e-10,0.0
12949,lipoprotein metabolic process (GO:0042157),-1.0677458916459939e-10,0.0
12950,response to selenium ion (GO:0010269),-1.09655395868585e-10,0.0
12951,positive regulation of systemic arterial blood pressure (GO:0003084),-1.09655395868585e-10,0.0
12952,nuclear pore organization (GO:0006999),-1.09655395868585e-10,0.0
12953,pyrimidine ribonucleoside catabolic process (GO:0046133),-1.09655395868585e-10,0.0
12954,pyrimidine ribonucleoside metabolic process (GO:0046131),-1.09655395868585e-10,0.0
12955,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-1.09655395868585e-10,0.0
12956,negative regulation of homotypic cell-cell adhesion (GO:0034111),-1.09655395868585e-10,0.0
12957,negative regulation of epidermis development (GO:0045683),-1.09655395868585e-10,0.0
12958,negative regulation of epidermal cell differentiation (GO:0045605),-1.09655395868585e-10,0.0
12959,tricarboxylic acid metabolic process (GO:0072350),-1.09655395868585e-10,0.0
12960,negative regulation of activated T cell proliferation (GO:0046007),-1.09655395868585e-10,0.0
12961,antigen processing and presentation via MHC class Ib (GO:0002475),-1.09655395868585e-10,0.0
12962,regulation of podosome assembly (GO:0071801),-1.09655395868585e-10,0.0
12963,cardioblast differentiation (GO:0010002),-1.09655395868585e-10,0.0
12964,protein localization to condensed chromosome (GO:1903083),-1.09655395868585e-10,0.0
12965,regulation of systemic arterial blood pressure by circulatory renin-angiotensin (GO:0001991),-1.09655395868585e-10,0.0
12966,nervous system process involved in regulation of systemic arterial blood pressure (GO:0001976),-1.09655395868585e-10,0.0
12967,tyrosine phosphorylation of STAT protein (GO:0007260),-1.09655395868585e-10,0.0
12968,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-1.09655395868585e-10,0.0
12969,retinal rod cell differentiation (GO:0060221),-1.09655395868585e-10,0.0
12970,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-1.09655395868585e-10,0.0
12971,glutathione biosynthetic process (GO:0006750),-1.09655395868585e-10,0.0
12972,positive regulation of ATP biosynthetic process (GO:2001171),-1.09655395868585e-10,0.0
12973,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-1.09655395868585e-10,0.0
12974,inner cell mass cell proliferation (GO:0001833),-1.09655395868585e-10,0.0
12975,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-1.09655395868585e-10,0.0
12976,inositol phosphate biosynthetic process (GO:0032958),-1.09655395868585e-10,0.0
12977,regulation of growth hormone secretion (GO:0060123),-1.09655395868585e-10,0.0
12978,"positive regulation of phagocytosis, engulfment (GO:0060100)",-1.09655395868585e-10,0.0
12979,positive regulation of monocyte chemotactic protein-1 production (GO:0071639),-1.09655395868585e-10,0.0
12980,renal vesicle development (GO:0072087),-1.09655395868585e-10,0.0
12981,estrous cycle (GO:0044849),-1.09655395868585e-10,0.0
12982,polyamine biosynthetic process (GO:0006596),-1.09655395868585e-10,0.0
12983,radial glial cell differentiation (GO:0060019),-1.09655395868585e-10,0.0
12984,Sertoli cell development (GO:0060009),-1.09655395868585e-10,0.0
12985,positive regulation of cellular respiration (GO:1901857),-1.09655395868585e-10,0.0
12986,semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),-1.09655395868585e-10,0.0
12987,negative regulation of lymphocyte migration (GO:2000402),-1.09655395868585e-10,0.0
12988,signal peptide processing (GO:0006465),-1.09655395868585e-10,0.0
12989,cellular response to purine-containing compound (GO:0071415),-1.09655395868585e-10,0.0
12990,histone H3-K9 demethylation (GO:0033169),-1.09655395868585e-10,0.0
12991,cellular response to ethanol (GO:0071361),-1.09655395868585e-10,0.0
12992,actin crosslink formation (GO:0051764),-1.09655395868585e-10,0.0
12993,negative regulation of nitric oxide biosynthetic process (GO:0045019),-1.09655395868585e-10,0.0
12994,negative regulation of mast cell activation (GO:0033004),-1.09655395868585e-10,0.0
12995,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-1.09655395868585e-10,0.0
12996,"base-excision repair, gap-filling (GO:0006287)",-1.09655395868585e-10,0.0
12997,regulation of hematopoietic stem cell proliferation (GO:1902033),-1.09655395868585e-10,0.0
12998,CTP biosynthetic process (GO:0006241),-1.09655395868585e-10,0.0
12999,peptidyl-methionine modification (GO:0018206),-1.09655395868585e-10,0.0
13000,cellular response to antibiotic (GO:0071236),-1.09655395868585e-10,0.0
13001,Golgi localization (GO:0051645),-1.09655395868585e-10,0.0
13002,negative regulation of amyloid fibril formation (GO:1905907),-1.09655395868585e-10,0.0
13003,phagosome-lysosome fusion (GO:0090385),-1.09655395868585e-10,0.0
13004,neurotransmitter receptor internalization (GO:0099590),-1.09655395868585e-10,0.0
13005,response to peptidoglycan (GO:0032494),-1.09655395868585e-10,0.0
13006,Rab protein signal transduction (GO:0032482),-1.09655395868585e-10,0.0
13007,positive regulation of DNA-templated DNA replication (GO:2000105),-1.09655395868585e-10,0.0
13008,vesicle fusion to plasma membrane (GO:0099500),-1.09655395868585e-10,0.0
13009,GMP biosynthetic process (GO:0006177),-1.09655395868585e-10,0.0
13010,AMP biosynthetic process (GO:0006167),-1.09655395868585e-10,0.0
13011,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-1.09655395868585e-10,0.0
13012,regulation of keratinocyte migration (GO:0051547),-1.09655395868585e-10,0.0
13013,regulation of histone H4 acetylation (GO:0090239),-1.09655395868585e-10,0.0
13014,positive regulation of cholesterol metabolic process (GO:0090205),-1.09655395868585e-10,0.0
13015,type B pancreatic cell proliferation (GO:0044342),-1.09655395868585e-10,0.0
13016,acetyl-CoA biosynthetic process (GO:0006085),-1.09655395868585e-10,0.0
13017,UDP-N-acetylglucosamine metabolic process (GO:0006047),-1.09655395868585e-10,0.0
13018,telomere maintenance via recombination (GO:0000722),-1.09655395868585e-10,0.0
13019,fructose metabolic process (GO:0006000),-1.09655395868585e-10,0.0
13020,nuclear RNA surveillance (GO:0071027),-1.09655395868585e-10,0.0
13021,regulation of establishment of planar polarity involved in neural tube closure (GO:0090178),-1.09655395868585e-10,0.0
13022,endoplasmic reticulum membrane organization (GO:0090158),-1.09655395868585e-10,0.0
13023,negative regulation of axon regeneration (GO:0048681),-1.09655395868585e-10,0.0
13024,regulation of synapse maturation (GO:0090128),-1.09655395868585e-10,0.0
13025,detection of calcium ion (GO:0005513),-1.09655395868585e-10,0.0
13026,COPII-coated vesicle cargo loading (GO:0090110),-1.09655395868585e-10,0.0
13027,cellular polysaccharide catabolic process (GO:0044247),-1.09655395868585e-10,0.0
13028,regulation of pigmentation (GO:0120305),-1.09655395868585e-10,0.0
13029,regulation of protein localization to endosome (GO:1905666),-1.09655395868585e-10,0.0
13030,regulation of calcium ion import across plasma membrane (GO:1905664),-1.09655395868585e-10,0.0
13031,intestinal lipid absorption (GO:0098856),-1.09655395868585e-10,0.0
13032,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-1.09655395868585e-10,0.0
13033,mRNA cleavage involved in mRNA processing (GO:0098787),-1.09655395868585e-10,0.0
13034,cellular response to interleukin-7 (GO:0098761),-1.09655395868585e-10,0.0
13035,response to interleukin-7 (GO:0098760),-1.09655395868585e-10,0.0
13036,spindle midzone assembly (GO:0051255),-1.09655395868585e-10,0.0
13037,negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-1.09655395868585e-10,0.0
13038,macromolecule depalmitoylation (GO:0098734),-1.09655395868585e-10,0.0
13039,lens fiber cell development (GO:0070307),-1.09655395868585e-10,0.0
13040,regulation of postsynaptic specialization assembly (GO:0099150),-1.09655395868585e-10,0.0
13041,regulation of relaxation of muscle (GO:1901077),-1.09655395868585e-10,0.0
13042,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),-1.09655395868585e-10,0.0
13043,endosomal lumen acidification (GO:0048388),-1.09655395868585e-10,0.0
13044,regulation of isotype switching to IgG isotypes (GO:0048302),-1.09655395868585e-10,0.0
13045,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-1.09655395868585e-10,0.0
13046,histone exchange (GO:0043486),-1.09655395868585e-10,0.0
13047,photoreceptor cell outer segment organization (GO:0035845),-1.09655395868585e-10,0.0
13048,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-1.09655395868585e-10,0.0
13049,response to UV-A (GO:0070141),-1.09655395868585e-10,0.0
13050,macrophage chemotaxis (GO:0048246),-1.09655395868585e-10,0.0
13051,interleukin-6-mediated signaling pathway (GO:0070102),-1.09655395868585e-10,0.0
13052,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-1.09655395868585e-10,0.0
13053,positive regulation of defense response to bacterium (GO:1900426),-1.09655395868585e-10,0.0
13054,intraciliary retrograde transport (GO:0035721),-1.09655395868585e-10,0.0
13055,negative regulation of leukocyte degranulation (GO:0043301),-1.09655395868585e-10,0.0
13056,response to water (GO:0009415),-1.09655395868585e-10,0.0
13057,regulation of guanylate cyclase activity (GO:0031282),-1.09655395868585e-10,0.0
13058,positive regulation of membrane invagination (GO:1905155),-1.09655395868585e-10,0.0
13059,telomere maintenance in response to DNA damage (GO:0043247),-1.09655395868585e-10,0.0
13060,oligosaccharide catabolic process (GO:0009313),-1.09655395868585e-10,0.0
13061,snRNA transcription (GO:0009301),-1.09655395868585e-10,0.0
13062,regulation of developmental pigmentation (GO:0048070),-1.09655395868585e-10,0.0
13063,negative regulation of circadian rhythm (GO:0042754),-1.09655395868585e-10,0.0
13064,G protein-coupled purinergic nucleotide receptor signaling pathway (GO:0035589),-1.09655395868585e-10,0.0
13065,positive regulation of chromatin binding (GO:0035563),-1.09655395868585e-10,0.0
13066,regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-1.09655395868585e-10,0.0
13067,regulation of SNARE complex assembly (GO:0035542),-1.09655395868585e-10,0.0
13068,sno(s)RNA processing (GO:0043144),-1.09655395868585e-10,0.0
13069,negative regulation of microtubule polymerization (GO:0031115),-1.09655395868585e-10,0.0
13070,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-1.09655395868585e-10,0.0
13071,regulation of response to osmotic stress (GO:0047484),-1.09655395868585e-10,0.0
13072,neuroblast division (GO:0055057),-1.09655395868585e-10,0.0
13073,pre-miRNA processing (GO:0031054),-1.09655395868585e-10,0.0
13074,deoxyribonucleoside monophosphate catabolic process (GO:0009159),-1.09655395868585e-10,0.0
13075,aromatic amino acid transport (GO:0015801),-1.09655395868585e-10,0.0
13076,vitamin biosynthetic process (GO:0009110),-1.09655395868585e-10,0.0
13077,pteridine-containing compound biosynthetic process (GO:0042559),-1.09655395868585e-10,0.0
13078,negative regulation of nitric oxide metabolic process (GO:1904406),-1.09655395868585e-10,0.0
13079,regulation of cellular response to hypoxia (GO:1900037),-1.09655395868585e-10,0.0
13080,protein localization to microtubule (GO:0035372),-1.09655395868585e-10,0.0
13081,regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),-1.09655395868585e-10,0.0
13082,serine family amino acid catabolic process (GO:0009071),-1.09655395868585e-10,0.0
13083,bundle of His cell to Purkinje myocyte communication (GO:0086069),-1.09655395868585e-10,0.0
13084,atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-1.09655395868585e-10,0.0
13085,cell junction disassembly (GO:0150146),-1.09655395868585e-10,0.0
13086,atrial cardiac muscle cell action potential (GO:0086014),-1.09655395868585e-10,0.0
13087,endoplasmic reticulum mannose trimming (GO:1904380),-1.09655395868585e-10,0.0
13088,progesterone metabolic process (GO:0042448),-1.09655395868585e-10,0.0
13089,regulation of triglyceride catabolic process (GO:0010896),-1.09655395868585e-10,0.0
13090,melanin biosynthetic process (GO:0042438),-1.09655395868585e-10,0.0
13091,positive regulation of triglyceride biosynthetic process (GO:0010867),-1.09655395868585e-10,0.0
13092,positive regulation of keratinocyte proliferation (GO:0010838),-1.09655395868585e-10,0.0
13093,negative regulation of myotube differentiation (GO:0010832),-1.09655395868585e-10,0.0
13094,quaternary ammonium group transport (GO:0015697),-1.09655395868585e-10,0.0
13095,negative regulation of voltage-gated potassium channel activity (GO:1903817),-1.09655395868585e-10,0.0
13096,viral budding from plasma membrane (GO:0046761),-1.09655395868585e-10,0.0
13097,vitamin D metabolic process (GO:0042359),-1.09655395868585e-10,0.0
13098,regulation of bile acid metabolic process (GO:1904251),-1.09655395868585e-10,0.0
13099,synaptic vesicle priming (GO:0016082),-1.09655395868585e-10,0.0
13100,folic acid metabolic process (GO:0046655),-1.09655395868585e-10,0.0
13101,cardiac cell fate commitment (GO:0060911),-1.09655395868585e-10,0.0
13102,alpha-beta T cell proliferation (GO:0046633),-1.09655395868585e-10,0.0
13103,xenobiotic export from cell (GO:0046618),-1.09655395868585e-10,0.0
13104,response to laminar fluid shear stress (GO:0034616),-1.09655395868585e-10,0.0
13105,plasma membrane tubulation (GO:0097320),-1.09655395868585e-10,0.0
13106,male sex determination (GO:0030238),-1.09655395868585e-10,0.0
13107,striated muscle cell apoptotic process (GO:0010658),-1.09655395868585e-10,0.0
13108,regulation of DNA catabolic process (GO:1903624),-1.09655395868585e-10,0.0
13109,neurotransmitter biosynthetic process (GO:0042136),-1.09655395868585e-10,0.0
13110,protein localization to kinetochore (GO:0034501),-1.09655395868585e-10,0.0
13111,positive regulation of calcium ion transport into cytosol (GO:0010524),-1.09655395868585e-10,0.0
13112,negative regulation of B cell apoptotic process (GO:0002903),-1.09655395868585e-10,0.0
13113,positive regulation of cilium movement (GO:0003353),-1.09655395868585e-10,0.0
13114,glycosphingolipid catabolic process (GO:0046479),-1.09655395868585e-10,0.0
13115,monoacylglycerol metabolic process (GO:0046462),-1.09655395868585e-10,0.0
13116,positive regulation of inositol phosphate biosynthetic process (GO:0060732),-1.09655395868585e-10,0.0
13117,cardiac muscle hypertrophy in response to stress (GO:0014898),-1.09655395868585e-10,0.0
13118,cardiac muscle adaptation (GO:0014887),-1.09655395868585e-10,0.0
13119,exit from mitosis (GO:0010458),-1.09655395868585e-10,0.0
13120,positive regulation of striated muscle contraction (GO:0045989),-1.09655395868585e-10,0.0
13121,cellular potassium ion homeostasis (GO:0030007),-1.09655395868585e-10,0.0
13122,P-body assembly (GO:0033962),-1.09655395868585e-10,0.0
13123,negative regulation of complement activation (GO:0045916),-1.09655395868585e-10,0.0
13124,muscle hypertrophy in response to stress (GO:0003299),-1.09655395868585e-10,0.0
13125,mechanosensory behavior (GO:0007638),-1.09655395868585e-10,0.0
13126,ventricular trabecula myocardium morphogenesis (GO:0003222),-1.09655395868585e-10,0.0
13127,regulation of ER to Golgi vesicle-mediated transport (GO:0060628),-1.09655395868585e-10,0.0
13128,low-density lipoprotein particle clearance (GO:0034383),-1.09655395868585e-10,0.0
13129,amino sugar catabolic process (GO:0046348),-1.09655395868585e-10,0.0
13130,CDP-diacylglycerol metabolic process (GO:0046341),-1.09655395868585e-10,0.0
13131,adherens junction assembly (GO:0034333),-1.09655395868585e-10,0.0
13132,motor neuron apoptotic process (GO:0097049),-1.09655395868585e-10,0.0
13133,negative regulation of glycolytic process (GO:0045820),-1.09655395868585e-10,0.0
13134,epigenetic maintenance of chromatin in transcription-competent conformation (GO:0045815),-1.09655395868585e-10,0.0
13135,negative regulation of dendritic spine development (GO:0061000),-1.09655395868585e-10,0.0
13136,intestinal epithelial cell development (GO:0060576),-1.09655395868585e-10,0.0
13137,T-helper 17 type immune response (GO:0072538),-1.09655395868585e-10,0.0
13138,pyrimidine-containing compound transmembrane transport (GO:0072531),-1.09655395868585e-10,0.0
13139,positive regulation of keratinocyte differentiation (GO:0045618),-1.1087109008041551e-10,0.0
13140,regulation of receptor localization to synapse (GO:1902683),-1.1087109008041551e-10,0.0
13141,IMP metabolic process (GO:0046040),-1.1087109008041551e-10,0.0
13142,specification of animal organ identity (GO:0010092),-1.1087109008041551e-10,0.0
13143,dendritic cell chemotaxis (GO:0002407),-1.1087109008041551e-10,0.0
13144,regulation of opsonization (GO:1903027),-1.1087109008041551e-10,0.0
13145,positive regulation of neurotransmitter secretion (GO:0001956),-1.1087109008041551e-10,0.0
13146,activation of NF-kappaB-inducing kinase activity (GO:0007250),-1.1087109008041551e-10,0.0
13147,metanephric nephron epithelium development (GO:0072243),-1.1087109008041551e-10,0.0
13148,regulation of respiratory burst (GO:0060263),-1.1087109008041551e-10,0.0
13149,positive regulation of glial cell proliferation (GO:0060252),-1.1087109008041551e-10,0.0
13150,cell differentiation involved in metanephros development (GO:0072202),-1.1087109008041551e-10,0.0
13151,definitive hemopoiesis (GO:0060216),-1.1087109008041551e-10,0.0
13152,ubiquinone metabolic process (GO:0006743),-1.1087109008041551e-10,0.0
13153,sphingomyelin metabolic process (GO:0006684),-1.1087109008041551e-10,0.0
13154,negative regulation of amyloid-beta formation (GO:1902430),-1.1087109008041551e-10,0.0
13155,protein targeting to peroxisome (GO:0006625),-1.1087109008041551e-10,0.0
13156,mitotic sister chromatid cohesion (GO:0007064),-1.1087109008041551e-10,0.0
13157,lipoprotein localization (GO:0044872),-1.1087109008041551e-10,0.0
13158,microtubule depolymerization (GO:0007019),-1.1087109008041551e-10,0.0
13159,ERBB2 signaling pathway (GO:0038128),-1.1087109008041551e-10,0.0
13160,receptor catabolic process (GO:0032801),-1.1087109008041551e-10,0.0
13161,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-1.1087109008041551e-10,0.0
13162,regulation of mitochondrial depolarization (GO:0051900),-1.1087109008041551e-10,0.0
13163,tRNA wobble uridine modification (GO:0002098),-1.1087109008041551e-10,0.0
13164,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-1.1087109008041551e-10,0.0
13165,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-1.1087109008041551e-10,0.0
13166,V(D)J recombination (GO:0033151),-1.1087109008041551e-10,0.0
13167,pseudouridine synthesis (GO:0001522),-1.1087109008041551e-10,0.0
13168,negative regulation of interleukin-12 production (GO:0032695),-1.1087109008041551e-10,0.0
13169,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-1.1087109008041551e-10,0.0
13170,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-1.1087109008041551e-10,0.0
13171,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-1.1087109008041551e-10,0.0
13172,cellular response to ATP (GO:0071318),-1.1087109008041551e-10,0.0
13173,negative regulation of myeloid cell apoptotic process (GO:0033033),-1.1087109008041551e-10,0.0
13174,regulation of hematopoietic stem cell differentiation (GO:1902036),-1.1087109008041551e-10,0.0
13175,peptidyl-arginine methylation (GO:0018216),-1.1087109008041551e-10,0.0
13176,fatty acid derivative catabolic process (GO:1901569),-1.1087109008041551e-10,0.0
13177,chemical homeostasis within a tissue (GO:0048875),-1.1087109008041551e-10,0.0
13178,cellular response to leptin stimulus (GO:0044320),-1.1087109008041551e-10,0.0
13179,response to follicle-stimulating hormone (GO:0032354),-1.1087109008041551e-10,0.0
13180,positive regulation of protein localization to cell surface (GO:2000010),-1.1087109008041551e-10,0.0
13181,N-acetylglucosamine metabolic process (GO:0006044),-1.1087109008041551e-10,0.0
13182,"DNA catabolic process, endonucleolytic (GO:0000737)",-1.1087109008041551e-10,0.0
13183,resolution of meiotic recombination intermediates (GO:0000712),-1.1087109008041551e-10,0.0
13184,positive regulation of voltage-gated calcium channel activity (GO:1901387),-1.1087109008041551e-10,0.0
13185,epithelial cell-cell adhesion (GO:0090136),-1.1087109008041551e-10,0.0
13186,detection of temperature stimulus involved in sensory perception of pain (GO:0050965),-1.1087109008041551e-10,0.0
13187,tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-1.1087109008041551e-10,0.0
13188,detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-1.1087109008041551e-10,0.0
13189,regulation of inclusion body assembly (GO:0090083),-1.1087109008041551e-10,0.0
13190,neuromuscular process controlling posture (GO:0050884),-1.1087109008041551e-10,0.0
13191,reverse cholesterol transport (GO:0043691),-1.1087109008041551e-10,0.0
13192,positive regulation of vascular endothelial cell proliferation (GO:1905564),-1.1087109008041551e-10,0.0
13193,dicarboxylic acid catabolic process (GO:0043649),-1.1087109008041551e-10,0.0
13194,positive regulation of myelination (GO:0031643),-1.1087109008041551e-10,0.0
13195,synaptic vesicle membrane organization (GO:0048499),-1.1087109008041551e-10,0.0
13196,parasympathetic nervous system development (GO:0048486),-1.1087109008041551e-10,0.0
13197,regulation of lipoprotein metabolic process (GO:0050746),-1.1087109008041551e-10,0.0
13198,peptidyl-threonine dephosphorylation (GO:0035970),-1.1087109008041551e-10,0.0
13199,protein trimerization (GO:0070206),-1.1087109008041551e-10,0.0
13200,post-anal tail morphogenesis (GO:0036342),-1.1087109008041551e-10,0.0
13201,vascular associated smooth muscle cell differentiation (GO:0035886),-1.1087109008041551e-10,0.0
13202,response to potassium ion (GO:0035864),-1.1087109008041551e-10,0.0
13203,response to superoxide (GO:0000303),-1.1087109008041551e-10,0.0
13204,regulation of lipoprotein lipase activity (GO:0051004),-1.1087109008041551e-10,0.0
13205,regulation of telomerase RNA localization to Cajal body (GO:1904872),-1.1087109008041551e-10,0.0
13206,response to hepatocyte growth factor (GO:0035728),-1.1087109008041551e-10,0.0
13207,amyloid-beta metabolic process (GO:0050435),-1.1087109008041551e-10,0.0
13208,midbody abscission (GO:0061952),-1.1087109008041551e-10,0.0
13209,positive regulation of circadian rhythm (GO:0042753),-1.1087109008041551e-10,0.0
13210,ovulation (GO:0030728),-1.1087109008041551e-10,0.0
13211,nucleotide salvage (GO:0043173),-1.1087109008041551e-10,0.0
13212,stress fiber assembly (GO:0043149),-1.1087109008041551e-10,0.0
13213,coenzyme A metabolic process (GO:0015936),-1.1087109008041551e-10,0.0
13214,positive regulation of vascular permeability (GO:0043117),-1.1087109008041551e-10,0.0
13215,pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208),-1.1087109008041551e-10,0.0
13216,cardiac myofibril assembly (GO:0055003),-1.1087109008041551e-10,0.0
13217,negative regulation of macrophage activation (GO:0043031),-1.1087109008041551e-10,0.0
13218,basic amino acid transport (GO:0015802),-1.1087109008041551e-10,0.0
13219,female genitalia development (GO:0030540),-1.1087109008041551e-10,0.0
13220,regulation of amino acid import across plasma membrane (GO:0010958),-1.1087109008041551e-10,0.0
13221,regulation of microglial cell activation (GO:1903978),-1.1087109008041551e-10,0.0
13222,regulation of glial cell migration (GO:1903975),-1.1087109008041551e-10,0.0
13223,glycolytic process through glucose-6-phosphate (GO:0061620),-1.1087109008041551e-10,0.0
13224,glycolytic process through fructose-6-phosphate (GO:0061615),-1.1087109008041551e-10,0.0
13225,aspartate family amino acid catabolic process (GO:0009068),-1.1087109008041551e-10,0.0
13226,negative regulation of programmed necrotic cell death (GO:0062099),-1.1087109008041551e-10,0.0
13227,phosphorylated carbohydrate dephosphorylation (GO:0046838),-1.1087109008041551e-10,0.0
13228,protein localization to cell-cell junction (GO:0150105),-1.1087109008041551e-10,0.0
13229,positive regulation of protein export from nucleus (GO:0046827),-1.1087109008041551e-10,0.0
13230,negative regulation of glucose transmembrane transport (GO:0010829),-1.1087109008041551e-10,0.0
13231,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-1.1087109008041551e-10,0.0
13232,magnesium ion transmembrane transport (GO:1903830),-1.1087109008041551e-10,0.0
13233,ectopic germ cell programmed cell death (GO:0035234),-1.1087109008041551e-10,0.0
13234,keratan sulfate metabolic process (GO:0042339),-1.1087109008041551e-10,0.0
13235,regulation of plasminogen activation (GO:0010755),-1.1087109008041551e-10,0.0
13236,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-1.1087109008041551e-10,0.0
13237,protein kinase A signaling (GO:0010737),-1.1087109008041551e-10,0.0
13238,regulation of amino acid transmembrane transport (GO:1903789),-1.1087109008041551e-10,0.0
13239,regulation of plasma membrane organization (GO:1903729),-1.1087109008041551e-10,0.0
13240,coronary vasculature morphogenesis (GO:0060977),-1.1087109008041551e-10,0.0
13241,tetrahydrofolate metabolic process (GO:0046653),-1.1087109008041551e-10,0.0
13242,heart formation (GO:0060914),-1.1087109008041551e-10,0.0
13243,platelet formation (GO:0030220),-1.1087109008041551e-10,0.0
13244,chondroitin sulfate biosynthetic process (GO:0030206),-1.1087109008041551e-10,0.0
13245,negative regulation of histone acetylation (GO:0035067),-1.1087109008041551e-10,0.0
13246,growth plate cartilage development (GO:0003417),-1.1087109008041551e-10,0.0
13247,sulfate transport (GO:0008272),-1.1087109008041551e-10,0.0
13248,negative regulation of humoral immune response (GO:0002921),-1.1087109008041551e-10,0.0
13249,negative regulation of ATP metabolic process (GO:1903579),-1.1087109008041551e-10,0.0
13250,contractile actin filament bundle assembly (GO:0030038),-1.1087109008041551e-10,0.0
13251,negative adaptation of signaling pathway (GO:0022401),-1.1087109008041551e-10,0.0
13252,eosinophil migration (GO:0072677),-1.1087109008041551e-10,0.0
13253,establishment of protein localization to peroxisome (GO:0072663),-1.1087109008041551e-10,0.0
13254,protein localization to peroxisome (GO:0072662),-1.1087109008041551e-10,0.0
13255,chemosensory behavior (GO:0007635),-1.1087109008041551e-10,0.0
13256,mammary gland epithelial cell differentiation (GO:0060644),-1.1087109008041551e-10,0.0
13257,cellular response to thyroid hormone stimulus (GO:0097067),-1.1087109008041551e-10,0.0
13258,positive regulation of protein polyubiquitination (GO:1902916),-1.1087109008041551e-10,0.0
13259,mitochondrial fusion (GO:0008053),-1.1087109008041551e-10,0.0
13260,dosage compensation (GO:0007549),-1.1087109008041551e-10,0.0
13261,positive regulation of cellular extravasation (GO:0002693),-1.1087109008041551e-10,0.0
13262,negative regulation of RNA catabolic process (GO:1902369),-1.1239320584700668e-10,0.0
13263,transcription initiation at RNA polymerase II promoter (GO:0006367),-1.1239320584700668e-10,0.0
13264,cellular response to hexose stimulus (GO:0071331),-1.1239320584700668e-10,0.0
13265,peptidyl-threonine modification (GO:0018210),-1.1239320584700668e-10,0.0
13266,macromolecule deacylation (GO:0098732),-1.1239320584700668e-10,0.0
13267,nucleoside monophosphate metabolic process (GO:0009123),-1.1239320584700668e-10,0.0
13268,ribosomal small subunit biogenesis (GO:0042274),-1.1239320584700668e-10,0.0
13269,regulation of protein processing (GO:0070613),-1.1354051032052471e-10,0.0
13270,response to fungus (GO:0009620),-1.1354051032052471e-10,0.0
13271,ovulation cycle (GO:0042698),-1.1354051032052471e-10,0.0
13272,regulation of cell-substrate junction organization (GO:0150116),-1.1354051032052471e-10,0.0
13273,cardiac conduction (GO:0061337),-1.1354051032052471e-10,0.0
13274,cellular response to glucose stimulus (GO:0071333),-1.1483147765341143e-10,0.0
13275,regulation of DNA-templated transcription initiation (GO:2000142),-1.1483147765341143e-10,0.0
13276,neuron projection extension (GO:1990138),-1.1483147765341143e-10,0.0
13277,steroid hormone mediated signaling pathway (GO:0043401),-1.1483147765341143e-10,0.0
13278,chromosome organization involved in meiotic cell cycle (GO:0070192),-1.1483147765341143e-10,0.0
13279,nucleotide catabolic process (GO:0009166),-1.1483147765341143e-10,0.0
13280,histone lysine methylation (GO:0034968),-1.1483147765341143e-10,0.0
13281,protein localization to vacuole (GO:0072665),-1.1483147765341143e-10,0.0
13282,multicellular organism aging (GO:0010259),-1.1601364312989585e-10,0.0
13283,positive regulation of osteoclast differentiation (GO:0045672),-1.1601364312989585e-10,0.0
13284,innervation (GO:0060384),-1.1601364312989585e-10,0.0
13285,telencephalon glial cell migration (GO:0022030),-1.1601364312989585e-10,0.0
13286,negative regulation of protein localization to plasma membrane (GO:1903077),-1.1601364312989585e-10,0.0
13287,heme biosynthetic process (GO:0006783),-1.1601364312989585e-10,0.0
13288,folic acid-containing compound metabolic process (GO:0006760),-1.1601364312989585e-10,0.0
13289,steroid catabolic process (GO:0006706),-1.1601364312989585e-10,0.0
13290,bone resorption (GO:0045453),-1.1601364312989585e-10,0.0
13291,protein-lipid complex assembly (GO:0065005),-1.1601364312989585e-10,0.0
13292,blastocyst hatching (GO:0001835),-1.1601364312989585e-10,0.0
13293,bile acid biosynthetic process (GO:0006699),-1.1601364312989585e-10,0.0
13294,organism emergence from protective structure (GO:0071684),-1.1601364312989585e-10,0.0
13295,neurotrophin signaling pathway (GO:0038179),-1.1601364312989585e-10,0.0
13296,zinc ion transmembrane transport (GO:0071577),-1.1601364312989585e-10,0.0
13297,glutamine metabolic process (GO:0006541),-1.1601364312989585e-10,0.0
13298,positive regulation of chromosome segregation (GO:0051984),-1.1601364312989585e-10,0.0
13299,positive regulation of amino acid transport (GO:0051957),-1.1601364312989585e-10,0.0
13300,ligand-gated ion channel signaling pathway (GO:1990806),-1.1601364312989585e-10,0.0
13301,positive regulation of focal adhesion assembly (GO:0051894),-1.1601364312989585e-10,0.0
13302,regulation of AMPA receptor activity (GO:2000311),-1.1601364312989585e-10,0.0
13303,DNA-templated transcription termination (GO:0006353),-1.1601364312989585e-10,0.0
13304,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-1.1601364312989585e-10,0.0
13305,regulation of anoikis (GO:2000209),-1.1601364312989585e-10,0.0
13306,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-1.1601364312989585e-10,0.0
13307,response to cholesterol (GO:0070723),-1.1601364312989585e-10,0.0
13308,negative regulation of potassium ion transmembrane transport (GO:1901380),-1.1601364312989585e-10,0.0
13309,cochlea morphogenesis (GO:0090103),-1.1601364312989585e-10,0.0
13310,negative regulation of lyase activity (GO:0051350),-1.1601364312989585e-10,0.0
13311,embryonic camera-type eye morphogenesis (GO:0048596),-1.1601364312989585e-10,0.0
13312,negative regulation of T cell receptor signaling pathway (GO:0050860),-1.1601364312989585e-10,0.0
13313,cytoplasmic sequestering of protein (GO:0051220),-1.1601364312989585e-10,0.0
13314,presynapse organization (GO:0099172),-1.1601364312989585e-10,0.0
13315,response to muscle stretch (GO:0035994),-1.1601364312989585e-10,0.0
13316,amyloid fibril formation (GO:1990000),-1.1601364312989585e-10,0.0
13317,negative regulation of defense response to virus (GO:0050687),-1.1601364312989585e-10,0.0
13318,negative regulation of mRNA processing (GO:0050686),-1.1601364312989585e-10,0.0
13319,regulation of mitochondrial translation (GO:0070129),-1.1601364312989585e-10,0.0
13320,regulation of lysosomal lumen pH (GO:0035751),-1.1601364312989585e-10,0.0
13321,positive regulation of leukocyte degranulation (GO:0043302),-1.1601364312989585e-10,0.0
13322,defense response to protozoan (GO:0042832),-1.1601364312989585e-10,0.0
13323,regulation of ubiquitin protein ligase activity (GO:1904666),-1.1601364312989585e-10,0.0
13324,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-1.1601364312989585e-10,0.0
13325,ribosomal large subunit assembly (GO:0000027),-1.1601364312989585e-10,0.0
13326,mitochondrial genome maintenance (GO:0000002),-1.1601364312989585e-10,0.0
13327,regulation of cell fate specification (GO:0042659),-1.1601364312989585e-10,0.0
13328,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-1.1601364312989585e-10,0.0
13329,nucleoside catabolic process (GO:0009164),-1.1601364312989585e-10,0.0
13330,fatty-acyl-CoA biosynthetic process (GO:0046949),-1.1601364312989585e-10,0.0
13331,attachment of spindle microtubules to kinetochore (GO:0008608),-1.1601364312989585e-10,0.0
13332,membrane repolarization (GO:0086009),-1.1601364312989585e-10,0.0
13333,cellular response to angiotensin (GO:1904385),-1.1601364312989585e-10,0.0
13334,regulation of telomere capping (GO:1904353),-1.1601364312989585e-10,0.0
13335,secondary palate development (GO:0062009),-1.1601364312989585e-10,0.0
13336,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-1.1601364312989585e-10,0.0
13337,positive regulation of cholesterol efflux (GO:0010875),-1.1601364312989585e-10,0.0
13338,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-1.1601364312989585e-10,0.0
13339,regulation of dendrite extension (GO:1903859),-1.1601364312989585e-10,0.0
13340,ionotropic glutamate receptor signaling pathway (GO:0035235),-1.1601364312989585e-10,0.0
13341,viral budding (GO:0046755),-1.1601364312989585e-10,0.0
13342,muscle cell cellular homeostasis (GO:0046716),-1.1601364312989585e-10,0.0
13343,regulation of miRNA maturation (GO:1903798),-1.1601364312989585e-10,0.0
13344,hatching (GO:0035188),-1.1601364312989585e-10,0.0
13345,negative regulation of striated muscle cell apoptotic process (GO:0010664),-1.1601364312989585e-10,0.0
13346,positive regulation of cardiac muscle hypertrophy (GO:0010613),-1.1601364312989585e-10,0.0
13347,antigen processing and presentation of endogenous antigen (GO:0019883),-1.1601364312989585e-10,0.0
13348,xenobiotic catabolic process (GO:0042178),-1.1601364312989585e-10,0.0
13349,negative regulation of smooth muscle cell migration (GO:0014912),-1.1601364312989585e-10,0.0
13350,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-1.1601364312989585e-10,0.0
13351,rhythmic behavior (GO:0007622),-1.1601364312989585e-10,0.0
13352,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-1.1601364312989585e-10,0.0
13353,positive regulation of alcohol biosynthetic process (GO:1902932),-1.1601364312989585e-10,0.0
13354,cerebral cortex radial glia-guided migration (GO:0021801),-1.1601364312989585e-10,0.0
13355,regulation of necroptotic process (GO:0060544),-1.1601364312989585e-10,0.0
13356,receptor internalization (GO:0031623),-1.1821099653997663e-10,0.0
13357,glycolipid biosynthetic process (GO:0009247),-1.1821099653997663e-10,0.0
13358,regulation of double-strand break repair via homologous recombination (GO:0010569),-1.1821099653997663e-10,0.0
13359,peptide hormone secretion (GO:0030072),-1.1821099653997663e-10,0.0
13360,positive regulation of DNA recombination (GO:0045911),-1.1821099653997663e-10,0.0
13361,body fluid secretion (GO:0007589),-1.1821099653997663e-10,0.0
13362,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-1.1903655838098996e-10,0.0
13363,organic hydroxy compound catabolic process (GO:1901616),-1.1903655838098996e-10,0.0
13364,positive regulation of axonogenesis (GO:0050772),-1.1903655838098996e-10,0.0
13365,regulation of muscle adaptation (GO:0043502),-1.1903655838098996e-10,0.0
13366,negative regulation of protein-containing complex disassembly (GO:0043242),-1.1903655838098996e-10,0.0
13367,stress-activated protein kinase signaling cascade (GO:0031098),-1.1903655838098996e-10,0.0
13368,neutrophil chemotaxis (GO:0030593),-1.1903655838098996e-10,0.0
13369,cellular response to unfolded protein (GO:0034620),-1.1903655838098996e-10,0.0
13370,regulation of protein targeting (GO:1903533),-1.1903655838098996e-10,0.0
13371,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-1.2079315325034123e-10,0.0
13372,protein monoubiquitination (GO:0006513),-1.2079315325034123e-10,0.0
13373,fatty acid derivative metabolic process (GO:1901568),-1.2079315325034123e-10,0.0
13374,cellular polysaccharide metabolic process (GO:0044264),-1.2079315325034123e-10,0.0
13375,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-1.2079315325034123e-10,0.0
13376,negative regulation of gene expression (GO:0010629),-1.2120571212624202e-10,0.9782546721571111
13377,positive regulation of fatty acid biosynthetic process (GO:0045723),-1.2338996490462243e-10,0.0
13378,striatum development (GO:0021756),-1.2338996490462243e-10,0.0
13379,negative regulation of oxidative stress-induced neuron death (GO:1903204),-1.2338996490462243e-10,0.0
13380,axonal fasciculation (GO:0007413),-1.2338996490462243e-10,0.0
13381,regulation of antigen processing and presentation (GO:0002577),-1.2338996490462243e-10,0.0
13382,leukocyte migration involved in inflammatory response (GO:0002523),-1.2338996490462243e-10,0.0
13383,leukotriene biosynthetic process (GO:0019370),-1.2338996490462243e-10,0.0
13384,fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342),-1.2338996490462243e-10,0.0
13385,nitric oxide biosynthetic process (GO:0006809),-1.2338996490462243e-10,0.0
13386,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002433),-1.2338996490462243e-10,0.0
13387,response to manganese ion (GO:0010042),-1.2338996490462243e-10,0.0
13388,nitric oxide mediated signal transduction (GO:0007263),-1.2338996490462243e-10,0.0
13389,metanephric nephron morphogenesis (GO:0072273),-1.2338996490462243e-10,0.0
13390,negative regulation of peptidyl-lysine acetylation (GO:2000757),-1.2338996490462243e-10,0.0
13391,response to nitric oxide (GO:0071731),-1.2338996490462243e-10,0.0
13392,regulation of ATP biosynthetic process (GO:2001169),-1.2338996490462243e-10,0.0
13393,negative regulation of adenylate cyclase activity (GO:0007194),-1.2338996490462243e-10,0.0
13394,release of cytochrome c from mitochondria (GO:0001836),-1.2338996490462243e-10,0.0
13395,blastocyst growth (GO:0001832),-1.2338996490462243e-10,0.0
13396,negative regulation of transcription regulatory region DNA binding (GO:2000678),-1.2338996490462243e-10,0.0
13397,protein-DNA complex disassembly (GO:0032986),-1.2338996490462243e-10,0.0
13398,podocyte differentiation (GO:0072112),-1.2338996490462243e-10,0.0
13399,negative regulation of post-transcriptional gene silencing (GO:0060149),-1.2338996490462243e-10,0.0
13400,sphingosine metabolic process (GO:0006670),-1.2338996490462243e-10,0.0
13401,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-1.2338996490462243e-10,0.0
13402,regulation of integrin-mediated signaling pathway (GO:2001044),-1.2338996490462243e-10,0.0
13403,regulation of sister chromatid cohesion (GO:0007063),-1.2338996490462243e-10,0.0
13404,lysosomal lumen acidification (GO:0007042),-1.2338996490462243e-10,0.0
13405,telomere maintenance via telomerase (GO:0007004),-1.2338996490462243e-10,0.0
13406,glomerulus vasculature development (GO:0072012),-1.2338996490462243e-10,0.0
13407,Sertoli cell differentiation (GO:0060008),-1.2338996490462243e-10,0.0
13408,cellular response to lectin (GO:1990858),-1.2338996490462243e-10,0.0
13409,response to lectin (GO:1990840),-1.2338996490462243e-10,0.0
13410,positive regulation by host of viral process (GO:0044794),-1.2338996490462243e-10,0.0
13411,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-1.2338996490462243e-10,0.0
13412,regulation of delayed rectifier potassium channel activity (GO:1902259),-1.2338996490462243e-10,0.0
13413,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-1.2338996490462243e-10,0.0
13414,regulation of translational fidelity (GO:0006450),-1.2338996490462243e-10,0.0
13415,tRNA wobble base modification (GO:0002097),-1.2338996490462243e-10,0.0
13416,auditory receptor cell morphogenesis (GO:0002093),-1.2338996490462243e-10,0.0
13417,lens morphogenesis in camera-type eye (GO:0002089),-1.2338996490462243e-10,0.0
13418,cell migration involved in sprouting angiogenesis (GO:0002042),-1.2338996490462243e-10,0.0
13419,regulation of myoblast fusion (GO:1901739),-1.2338996490462243e-10,0.0
13420,glycogen biosynthetic process (GO:0005978),-1.2338996490462243e-10,0.0
13421,negative regulation of interleukin-10 production (GO:0032693),-1.2338996490462243e-10,0.0
13422,regulation of T-helper 17 cell differentiation (GO:2000319),-1.2338996490462243e-10,0.0
13423,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-1.2338996490462243e-10,0.0
13424,nucleotide transmembrane transport (GO:1901679),-1.2338996490462243e-10,0.0
13425,positive regulation of mast cell activation (GO:0033005),-1.2338996490462243e-10,0.0
13426,actin filament-based transport (GO:0099515),-1.2338996490462243e-10,0.0
13427,melanosome transport (GO:0032402),-1.2338996490462243e-10,0.0
13428,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-1.2338996490462243e-10,0.0
13429,regulation of spindle checkpoint (GO:0090231),-1.2338996490462243e-10,0.0
13430,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-1.2338996490462243e-10,0.0
13431,intracellular cholesterol transport (GO:0032367),-1.2338996490462243e-10,0.0
13432,glycerol metabolic process (GO:0006071),-1.2338996490462243e-10,0.0
13433,positive regulation of mitochondrial fission (GO:0090141),-1.2338996490462243e-10,0.0
13434,regulation of collateral sprouting (GO:0048670),-1.2338996490462243e-10,0.0
13435,neuron projection fasciculation (GO:0106030),-1.2338996490462243e-10,0.0
13436,negative regulation of telomere maintenance via telomerase (GO:0032211),-1.2338996490462243e-10,0.0
13437,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-1.2338996490462243e-10,0.0
13438,regulation of B cell receptor signaling pathway (GO:0050855),-1.2338996490462243e-10,0.0
13439,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-1.2338996490462243e-10,0.0
13440,linoleic acid metabolic process (GO:0043651),-1.2338996490462243e-10,0.0
13441,macrophage migration (GO:1905517),-1.2338996490462243e-10,0.0
13442,positive regulation of vacuole organization (GO:0044090),-1.2338996490462243e-10,0.0
13443,regulation of ARF protein signal transduction (GO:0032012),-1.2338996490462243e-10,0.0
13444,regulation of translation in response to stress (GO:0043555),-1.2338996490462243e-10,0.0
13445,negative regulation of purine nucleotide metabolic process (GO:1900543),-1.2338996490462243e-10,0.0
13446,cellular response to sterol (GO:0036315),-1.2338996490462243e-10,0.0
13447,RNA capping (GO:0036260),-1.2338996490462243e-10,0.0
13448,notochord development (GO:0030903),-1.2338996490462243e-10,0.0
13449,regulation of vesicle fusion (GO:0031338),-1.2338996490462243e-10,0.0
13450,negative regulation of post-transcriptional gene silencing by RNA (GO:1900369),-1.2338996490462243e-10,0.0
13451,phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-1.2338996490462243e-10,0.0
13452,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-1.2338996490462243e-10,0.0
13453,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-1.2338996490462243e-10,0.0
13454,glucan biosynthetic process (GO:0009250),-1.2338996490462243e-10,0.0
13455,response to hyperoxia (GO:0055093),-1.2338996490462243e-10,0.0
13456,myeloid dendritic cell differentiation (GO:0043011),-1.2338996490462243e-10,0.0
13457,regulation of lipoprotein particle clearance (GO:0010984),-1.2338996490462243e-10,0.0
13458,intracellular estrogen receptor signaling pathway (GO:0030520),-1.2338996490462243e-10,0.0
13459,branched-chain amino acid catabolic process (GO:0009083),-1.2338996490462243e-10,0.0
13460,aspartate family amino acid biosynthetic process (GO:0009067),-1.2338996490462243e-10,0.0
13461,ribonucleoside catabolic process (GO:0042454),-1.2338996490462243e-10,0.0
13462,negative regulation of lipid storage (GO:0010888),-1.2338996490462243e-10,0.0
13463,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-1.2338996490462243e-10,0.0
13464,sialylation (GO:0097503),-1.2338996490462243e-10,0.0
13465,gas transport (GO:0015669),-1.2338996490462243e-10,0.0
13466,regulation of ERAD pathway (GO:1904292),-1.2338996490462243e-10,0.0
13467,regulation of RIG-I signaling pathway (GO:0039535),-1.2338996490462243e-10,0.0
13468,negative regulation of gene silencing by RNA (GO:0060967),-1.2338996490462243e-10,0.0
13469,determination of adult lifespan (GO:0008340),-1.2338996490462243e-10,0.0
13470,mammary gland lobule development (GO:0061377),-1.2338996490462243e-10,0.0
13471,positive regulation of sprouting angiogenesis (GO:1903672),-1.2338996490462243e-10,0.0
13472,renal filtration cell differentiation (GO:0061318),-1.2338996490462243e-10,0.0
13473,ceramide catabolic process (GO:0046514),-1.2338996490462243e-10,0.0
13474,renal filtration (GO:0097205),-1.2338996490462243e-10,0.0
13475,regulation of B cell apoptotic process (GO:0002902),-1.2338996490462243e-10,0.0
13476,regulation of mitotic spindle checkpoint (GO:1903504),-1.2338996490462243e-10,0.0
13477,mammary gland alveolus development (GO:0060749),-1.2338996490462243e-10,0.0
13478,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-1.2338996490462243e-10,0.0
13479,regulation of immune response to tumor cell (GO:0002837),-1.2338996490462243e-10,0.0
13480,negative regulation of translational initiation (GO:0045947),-1.2338996490462243e-10,0.0
13481,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-1.2338996490462243e-10,0.0
13482,positive regulation of glycolytic process (GO:0045821),-1.2338996490462243e-10,0.0
13483,negative regulation of miRNA transcription (GO:1902894),-1.2338996490462243e-10,0.0
13484,positive regulation of oxidative stress-induced cell death (GO:1903209),-1.2707546125670656e-10,0.0
13485,cellular component disassembly involved in execution phase of apoptosis (GO:0006921),-1.2707546125670656e-10,0.0
13486,positive regulation of cell adhesion mediated by integrin (GO:0033630),-1.2707546125670656e-10,0.0
13487,glomerular epithelial cell differentiation (GO:0072311),-1.2707546125670656e-10,0.0
13488,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-1.2707546125670656e-10,0.0
13489,phosphate ion transport (GO:0006817),-1.2707546125670656e-10,0.0
13490,regulation of receptor recycling (GO:0001919),-1.2707546125670656e-10,0.0
13491,metanephric epithelium development (GO:0072207),-1.2707546125670656e-10,0.0
13492,synaptonemal complex assembly (GO:0007130),-1.2707546125670656e-10,0.0
13493,negative regulation of miRNA metabolic process (GO:2000629),-1.2707546125670656e-10,0.0
13494,mitotic cytokinetic process (GO:1902410),-1.2707546125670656e-10,0.0
13495,negative regulation of mononuclear cell migration (GO:0071676),-1.2707546125670656e-10,0.0
13496,cotranslational protein targeting to membrane (GO:0006613),-1.2707546125670656e-10,0.0
13497,modulation by host of viral genome replication (GO:0044827),-1.2707546125670656e-10,0.0
13498,pigment granule transport (GO:0051904),-1.2707546125670656e-10,0.0
13499,negative regulation of ATP-dependent activity (GO:0032780),-1.2707546125670656e-10,0.0
13500,regulation of oxidative phosphorylation (GO:0002082),-1.2707546125670656e-10,0.0
13501,protein neddylation (GO:0045116),-1.2707546125670656e-10,0.0
13502,oocyte maturation (GO:0001556),-1.2707546125670656e-10,0.0
13503,cellular response to prostaglandin stimulus (GO:0071379),-1.2707546125670656e-10,0.0
13504,regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),-1.2707546125670656e-10,0.0
13505,DNA catabolic process (GO:0006308),-1.2707546125670656e-10,0.0
13506,transcytosis (GO:0045056),-1.2707546125670656e-10,0.0
13507,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-1.2707546125670656e-10,0.0
13508,DNA unwinding involved in DNA replication (GO:0006268),-1.2707546125670656e-10,0.0
13509,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-1.2707546125670656e-10,0.0
13510,positive regulation of lymphocyte chemotaxis (GO:0140131),-1.2707546125670656e-10,0.0
13511,establishment of melanosome localization (GO:0032401),-1.2707546125670656e-10,0.0
13512,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-1.2707546125670656e-10,0.0
13513,response to leptin (GO:0044321),-1.2707546125670656e-10,0.0
13514,glucose catabolic process (GO:0006007),-1.2707546125670656e-10,0.0
13515,negative regulation of membrane permeability (GO:1905709),-1.2707546125670656e-10,0.0
13516,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-1.2707546125670656e-10,0.0
13517,regulation of flagellated sperm motility (GO:1901317),-1.2707546125670656e-10,0.0
13518,detection of light stimulus involved in sensory perception (GO:0050962),-1.2707546125670656e-10,0.0
13519,detection of temperature stimulus involved in sensory perception (GO:0050961),-1.2707546125670656e-10,0.0
13520,myelin assembly (GO:0032288),-1.2707546125670656e-10,0.0
13521,detection of light stimulus involved in visual perception (GO:0050908),-1.2707546125670656e-10,0.0
13522,meiotic chromosome separation (GO:0051307),-1.2707546125670656e-10,0.0
13523,poly(A)+ mRNA export from nucleus (GO:0016973),-1.2707546125670656e-10,0.0
13524,negative regulation of phagocytosis (GO:0050765),-1.2707546125670656e-10,0.0
13525,regulation of appetite (GO:0032098),-1.2707546125670656e-10,0.0
13526,regulation of nuclease activity (GO:0032069),-1.2707546125670656e-10,0.0
13527,peroxisomal transport (GO:0043574),-1.2707546125670656e-10,0.0
13528,chaperone-mediated protein complex assembly (GO:0051131),-1.2707546125670656e-10,0.0
13529,negative regulation of potassium ion transmembrane transporter activity (GO:1901017),-1.2707546125670656e-10,0.0
13530,presynapse assembly (GO:0099054),-1.2707546125670656e-10,0.0
13531,megakaryocyte development (GO:0035855),-1.2707546125670656e-10,0.0
13532,regulation of mRNA 3'-end processing (GO:0031440),-1.2707546125670656e-10,0.0
13533,barbed-end actin filament capping (GO:0051016),-1.2707546125670656e-10,0.0
13534,positive regulation of nitric-oxide synthase activity (GO:0051000),-1.2707546125670656e-10,0.0
13535,stem cell division (GO:0017145),-1.2707546125670656e-10,0.0
13536,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-1.2707546125670656e-10,0.0
13537,polarized epithelial cell differentiation (GO:0030859),-1.2707546125670656e-10,0.0
13538,cellular response to platelet-derived growth factor stimulus (GO:0036120),-1.2707546125670656e-10,0.0
13539,regulation of receptor binding (GO:1900120),-1.2707546125670656e-10,0.0
13540,leukocyte adhesion to vascular endothelial cell (GO:0061756),-1.2707546125670656e-10,0.0
13541,monoamine transport (GO:0015844),-1.2707546125670656e-10,0.0
13542,purine nucleoside monophosphate biosynthetic process (GO:0009127),-1.2707546125670656e-10,0.0
13543,androgen receptor signaling pathway (GO:0030521),-1.2707546125670656e-10,0.0
13544,viral budding via host ESCRT complex (GO:0039702),-1.2707546125670656e-10,0.0
13545,membrane repolarization during action potential (GO:0086011),-1.2707546125670656e-10,0.0
13546,ventricular cardiac muscle cell action potential (GO:0086005),-1.2707546125670656e-10,0.0
13547,positive regulation of steroid biosynthetic process (GO:0010893),-1.2707546125670656e-10,0.0
13548,regulation of complement activation (GO:0030449),-1.2707546125670656e-10,0.0
13549,thyroid hormone metabolic process (GO:0042403),-1.2707546125670656e-10,0.0
13550,protein mannosylation (GO:0035268),-1.2707546125670656e-10,0.0
13551,regulation of protein kinase A signaling (GO:0010738),-1.2707546125670656e-10,0.0
13552,establishment of apical/basal cell polarity (GO:0035089),-1.2707546125670656e-10,0.0
13553,tooth mineralization (GO:0034505),-1.2707546125670656e-10,0.0
13554,positive regulation of humoral immune response (GO:0002922),-1.2707546125670656e-10,0.0
13555,regulation of response to tumor cell (GO:0002834),-1.2707546125670656e-10,0.0
13556,regulation of cell maturation (GO:1903429),-1.2707546125670656e-10,0.0
13557,atrial cardiac muscle tissue development (GO:0003228),-1.2707546125670656e-10,0.0
13558,diol biosynthetic process (GO:0034312),-1.2707546125670656e-10,0.0
13559,histone H3-K4 trimethylation (GO:0080182),-1.2707546125670656e-10,0.0
13560,sex determination (GO:0007530),-1.2707546125670656e-10,0.0
13561,DNA demethylation (GO:0080111),-1.2707546125670656e-10,0.0
13562,positive regulation of osteoblast differentiation (GO:0045669),-1.294844231752292e-10,0.0
13563,positive regulation of fat cell differentiation (GO:0045600),-1.294844231752292e-10,0.0
13564,L-alpha-amino acid transmembrane transport (GO:1902475),-1.294844231752292e-10,0.0
13565,actin-mediated cell contraction (GO:0070252),-1.294844231752292e-10,0.0
13566,L-amino acid transport (GO:0015807),-1.294844231752292e-10,0.0
13567,positive regulation of protein localization to cell periphery (GO:1904377),-1.294844231752292e-10,0.0
13568,negative regulation of epithelial cell migration (GO:0010633),-1.294844231752292e-10,0.0
13569,negative regulation of leukocyte mediated immunity (GO:0002704),-1.294844231752292e-10,0.0
13570,negative regulation of acute inflammatory response (GO:0002674),-1.34958932908932e-10,0.0
13571,regulation of T cell tolerance induction (GO:0002664),-1.34958932908932e-10,0.0
13572,negative regulation of immunoglobulin production (GO:0002638),-1.34958932908932e-10,0.0
13573,ribosome localization (GO:0033750),-1.34958932908932e-10,0.0
13574,removal of superoxide radicals (GO:0019430),-1.34958932908932e-10,0.0
13575,renal sodium ion transport (GO:0003096),-1.34958932908932e-10,0.0
13576,chronic inflammatory response (GO:0002544),-1.34958932908932e-10,0.0
13577,positive regulation of osteoblast proliferation (GO:0033690),-1.34958932908932e-10,0.0
13578,phenol-containing compound catabolic process (GO:0019336),-1.34958932908932e-10,0.0
13579,microtubule anchoring at microtubule organizing center (GO:0072393),-1.34958932908932e-10,0.0
13580,negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-1.34958932908932e-10,0.0
13581,methylguanosine-cap decapping (GO:0110156),-1.34958932908932e-10,0.0
13582,xenobiotic transmembrane transport (GO:0006855),-1.34958932908932e-10,0.0
13583,complement receptor mediated signaling pathway (GO:0002430),-1.34958932908932e-10,0.0
13584,negative regulation of neuron migration (GO:2001223),-1.34958932908932e-10,0.0
13585,lymphangiogenesis (GO:0001946),-1.34958932908932e-10,0.0
13586,epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-1.34958932908932e-10,0.0
13587,facultative heterochromatin formation (GO:0140718),-1.34958932908932e-10,0.0
13588,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-1.34958932908932e-10,0.0
13589,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-1.34958932908932e-10,0.0
13590,porphyrin-containing compound catabolic process (GO:0006787),-1.34958932908932e-10,0.0
13591,defense response to tumor cell (GO:0002357),-1.34958932908932e-10,0.0
13592,locomotor rhythm (GO:0045475),-1.34958932908932e-10,0.0
13593,immature B cell differentiation (GO:0002327),-1.34958932908932e-10,0.0
13594,response to yeast (GO:0001878),-1.34958932908932e-10,0.0
13595,female meiosis I (GO:0007144),-1.34958932908932e-10,0.0
13596,regulation of dendritic cell apoptotic process (GO:2000668),-1.34958932908932e-10,0.0
13597,prepulse inhibition (GO:0060134),-1.34958932908932e-10,0.0
13598,ectodermal placode development (GO:0071696),-1.34958932908932e-10,0.0
13599,TORC1 signaling (GO:0038202),-1.34958932908932e-10,0.0
13600,neutrophil activation involved in immune response (GO:0002283),-1.34958932908932e-10,0.0
13601,negative regulation of transforming growth factor beta production (GO:0071635),-1.34958932908932e-10,0.0
13602,positive regulation of integrin-mediated signaling pathway (GO:2001046),-1.34958932908932e-10,0.0
13603,renal vesicle morphogenesis (GO:0072077),-1.34958932908932e-10,0.0
13604,"negative regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000562)",-1.34958932908932e-10,0.0
13605,endodermal cell fate commitment (GO:0001711),-1.34958932908932e-10,0.0
13606,angiotensin-activated signaling pathway (GO:0038166),-1.34958932908932e-10,0.0
13607,regulation of protein glycosylation (GO:0060049),-1.34958932908932e-10,0.0
13608,negative regulation of cardiac muscle cell proliferation (GO:0060044),-1.34958932908932e-10,0.0
13609,indolalkylamine metabolic process (GO:0006586),-1.34958932908932e-10,0.0
13610,regulation of natural killer cell differentiation (GO:0032823),-1.34958932908932e-10,0.0
13611,regulation of apoptotic process involved in morphogenesis (GO:1902337),-1.34958932908932e-10,0.0
13612,positive regulation of natural killer cell proliferation (GO:0032819),-1.34958932908932e-10,0.0
13613,L-serine metabolic process (GO:0006563),-1.34958932908932e-10,0.0
13614,negative regulation of telomerase activity (GO:0051974),-1.34958932908932e-10,0.0
13615,regulation of cellular amino acid metabolic process (GO:0006521),-1.34958932908932e-10,0.0
13616,regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901894),-1.34958932908932e-10,0.0
13617,negative regulation of muscle tissue development (GO:1901862),-1.34958932908932e-10,0.0
13618,actin-myosin filament sliding (GO:0033275),-1.34958932908932e-10,0.0
13619,regulation of high voltage-gated calcium channel activity (GO:1901841),-1.34958932908932e-10,0.0
13620,regulation of nuclear cell cycle DNA replication (GO:0033262),-1.34958932908932e-10,0.0
13621,positive regulation of protein sumoylation (GO:0033235),-1.34958932908932e-10,0.0
13622,tRNA 5'-leader removal (GO:0001682),-1.34958932908932e-10,0.0
13623,negative regulation by host of viral process (GO:0044793),-1.34958932908932e-10,0.0
13624,p38MAPK cascade (GO:0038066),-1.34958932908932e-10,0.0
13625,positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),-1.34958932908932e-10,0.0
13626,histone H3 deacetylation (GO:0070932),-1.34958932908932e-10,0.0
13627,UV-damage excision repair (GO:0070914),-1.34958932908932e-10,0.0
13628,negative regulation of interferon-beta production (GO:0032688),-1.34958932908932e-10,0.0
13629,regulation of interleukin-18 production (GO:0032661),-1.34958932908932e-10,0.0
13630,mitochondrial transcription (GO:0006390),-1.34958932908932e-10,0.0
13631,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-1.34958932908932e-10,0.0
13632,termination of RNA polymerase II transcription (GO:0006369),-1.34958932908932e-10,0.0
13633,response to redox state (GO:0051775),-1.34958932908932e-10,0.0
13634,cellular response to vitamin D (GO:0071305),-1.34958932908932e-10,0.0
13635,protein insertion into mitochondrial inner membrane (GO:0045039),-1.34958932908932e-10,0.0
13636,DNA deamination (GO:0045006),-1.34958932908932e-10,0.0
13637,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-1.34958932908932e-10,0.0
13638,protein localization to nuclear envelope (GO:0090435),-1.34958932908932e-10,0.0
13639,tetrapyrrole catabolic process (GO:0033015),-1.34958932908932e-10,0.0
13640,positive regulation of flagellated sperm motility (GO:1902093),-1.34958932908932e-10,0.0
13641,ventricular cardiac muscle cell membrane repolarization (GO:0099625),-1.34958932908932e-10,0.0
13642,regulation of cell projection size (GO:0032536),-1.34958932908932e-10,0.0
13643,regulation of microvillus organization (GO:0032530),-1.34958932908932e-10,0.0
13644,microvillus organization (GO:0032528),-1.34958932908932e-10,0.0
13645,peptidyl-histidine modification (GO:0018202),-1.34958932908932e-10,0.0
13646,cellular response to electrical stimulus (GO:0071257),-1.34958932908932e-10,0.0
13647,regulation of gonad development (GO:1905939),-1.34958932908932e-10,0.0
13648,regulation of mitophagy (GO:1901524),-1.34958932908932e-10,0.0
13649,forebrain morphogenesis (GO:0048853),-1.34958932908932e-10,0.0
13650,positive regulation of cilium-dependent cell motility (GO:2000155),-1.34958932908932e-10,0.0
13651,"trans-synaptic signaling, modulating synaptic transmission (GO:0099550)",-1.34958932908932e-10,0.0
13652,adhesion of symbiont to host (GO:0044406),-1.34958932908932e-10,0.0
13653,negative regulation of histone H3-K9 methylation (GO:0051573),-1.34958932908932e-10,0.0
13654,endocytosis involved in viral entry into host cell (GO:0075509),-1.34958932908932e-10,0.0
13655,histone H3-K9 methylation (GO:0051567),-1.34958932908932e-10,0.0
13656,negative regulation of cAMP-mediated signaling (GO:0043951),-1.34958932908932e-10,0.0
13657,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-1.34958932908932e-10,0.0
13658,regulation of metaphase plate congression (GO:0090235),-1.34958932908932e-10,0.0
13659,regulation of skeletal muscle fiber development (GO:0048742),-1.34958932908932e-10,0.0
13660,lipid droplet formation (GO:0140042),-1.34958932908932e-10,0.0
13661,negative regulation of astrocyte differentiation (GO:0048712),-1.34958932908932e-10,0.0
13662,protein polyglutamylation (GO:0018095),-1.34958932908932e-10,0.0
13663,pentose-phosphate shunt (GO:0006098),-1.34958932908932e-10,0.0
13664,myoblast migration (GO:0051451),-1.34958932908932e-10,0.0
13665,myoblast proliferation (GO:0051450),-1.34958932908932e-10,0.0
13666,dendritic transport (GO:0098935),-1.34958932908932e-10,0.0
13667,membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-1.34958932908932e-10,0.0
13668,regulation of sphingolipid biosynthetic process (GO:0090153),-1.34958932908932e-10,0.0
13669,aminoacyl-tRNA metabolism involved in translational fidelity (GO:0106074),-1.34958932908932e-10,0.0
13670,positive regulation of protein localization to endosome (GO:1905668),-1.34958932908932e-10,0.0
13671,cellular response to leucine starvation (GO:1990253),-1.34958932908932e-10,0.0
13672,protein transport along microtubule (GO:0098840),-1.34958932908932e-10,0.0
13673,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-1.34958932908932e-10,0.0
13674,flavonoid metabolic process (GO:0009812),-1.34958932908932e-10,0.0
13675,regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),-1.34958932908932e-10,0.0
13676,pre-mRNA cleavage required for polyadenylation (GO:0098789),-1.34958932908932e-10,0.0
13677,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-1.34958932908932e-10,0.0
13678,dicarboxylic acid biosynthetic process (GO:0043650),-1.34958932908932e-10,0.0
13679,spindle elongation (GO:0051231),-1.34958932908932e-10,0.0
13680,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-1.34958932908932e-10,0.0
13681,postsynaptic cytoskeleton organization (GO:0099188),-1.34958932908932e-10,0.0
13682,microtubule-based protein transport (GO:0099118),-1.34958932908932e-10,0.0
13683,positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),-1.34958932908932e-10,0.0
13684,regulation of NK T cell activation (GO:0051133),-1.34958932908932e-10,0.0
13685,UV protection (GO:0009650),-1.34958932908932e-10,0.0
13686,skeletal muscle adaptation (GO:0043501),-1.34958932908932e-10,0.0
13687,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-1.34958932908932e-10,0.0
13688,regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904923),-1.34958932908932e-10,0.0
13689,atrioventricular canal development (GO:0036302),-1.34958932908932e-10,0.0
13690,cellular response to potassium ion (GO:0035865),-1.34958932908932e-10,0.0
13691,regulation of cellular carbohydrate catabolic process (GO:0043471),-1.34958932908932e-10,0.0
13692,regulation of endosome size (GO:0051036),-1.34958932908932e-10,0.0
13693,positive regulation of urine volume (GO:0035810),-1.34958932908932e-10,0.0
13694,cellular response to increased oxygen levels (GO:0036295),-1.34958932908932e-10,0.0
13695,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-1.34958932908932e-10,0.0
13696,spliceosomal tri-snRNP complex assembly (GO:0000244),-1.34958932908932e-10,0.0
13697,regulation of aspartic-type peptidase activity (GO:1905245),-1.34958932908932e-10,0.0
13698,regulation of RNA binding (GO:1905214),-1.34958932908932e-10,0.0
13699,carnitine metabolic process (GO:0009437),-1.34958932908932e-10,0.0
13700,positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-1.34958932908932e-10,0.0
13701,regulation of apoptotic process involved in development (GO:1904748),-1.34958932908932e-10,0.0
13702,positive regulation of actin filament depolymerization (GO:0030836),-1.34958932908932e-10,0.0
13703,protein import into peroxisome matrix (GO:0016558),-1.34958932908932e-10,0.0
13704,oligopeptide transmembrane transport (GO:0035672),-1.34958932908932e-10,0.0
13705,proteasome assembly (GO:0043248),-1.34958932908932e-10,0.0
13706,positive regulation of pseudopodium assembly (GO:0031274),-1.34958932908932e-10,0.0
13707,regulation of pseudopodium assembly (GO:0031272),-1.34958932908932e-10,0.0
13708,very long-chain fatty acid biosynthetic process (GO:0042761),-1.34958932908932e-10,0.0
13709,negative regulation of ubiquitin protein ligase activity (GO:1904667),-1.34958932908932e-10,0.0
13710,positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-1.34958932908932e-10,0.0
13711,regulation of DNA-directed DNA polymerase activity (GO:1900262),-1.34958932908932e-10,0.0
13712,neurotrophin TRK receptor signaling pathway (GO:0048011),-1.34958932908932e-10,0.0
13713,regulation of synaptic vesicle endocytosis (GO:1900242),-1.34958932908932e-10,0.0
13714,ribosomal subunit export from nucleus (GO:0000054),-1.34958932908932e-10,0.0
13715,regulation of membrane lipid metabolic process (GO:1905038),-1.34958932908932e-10,0.0
13716,glucan catabolic process (GO:0009251),-1.34958932908932e-10,0.0
13717,cyclic nucleotide catabolic process (GO:0009214),-1.34958932908932e-10,0.0
13718,retinal cone cell differentiation (GO:0042670),-1.34958932908932e-10,0.0
13719,neuron remodeling (GO:0016322),-1.34958932908932e-10,0.0
13720,regulation of histone H3-K9 trimethylation (GO:1900112),-1.34958932908932e-10,0.0
13721,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-1.34958932908932e-10,0.0
13722,pyrimidine deoxyribonucleoside monophosphate metabolic process (GO:0009176),-1.34958932908932e-10,0.0
13723,primary miRNA processing (GO:0031053),-1.34958932908932e-10,0.0
13724,nucleoside triphosphate catabolic process (GO:0009143),-1.34958932908932e-10,0.0
13725,nucleoside diphosphate biosynthetic process (GO:0009133),-1.34958932908932e-10,0.0
13726,histone arginine methylation (GO:0034969),-1.34958932908932e-10,0.0
13727,regulation of intestinal absorption (GO:1904478),-1.34958932908932e-10,0.0
13728,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-1.34958932908932e-10,0.0
13729,positive regulation of anion transmembrane transport (GO:1903961),-1.34958932908932e-10,0.0
13730,negative regulation of hippo signaling (GO:0035331),-1.34958932908932e-10,0.0
13731,"wound healing, spreading of epidermal cells (GO:0035313)",-1.34958932908932e-10,0.0
13732,regulation of RNA export from nucleus (GO:0046831),-1.34958932908932e-10,0.0
13733,fatty acid elongation (GO:0030497),-1.34958932908932e-10,0.0
13734,cellular response to forskolin (GO:1904322),-1.34958932908932e-10,0.0
13735,response to forskolin (GO:1904321),-1.34958932908932e-10,0.0
13736,positive regulation of myotube differentiation (GO:0010831),-1.34958932908932e-10,0.0
13737,carbon dioxide transport (GO:0015670),-1.34958932908932e-10,0.0
13738,protein localization to non-motile cilium (GO:0097499),-1.34958932908932e-10,0.0
13739,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-1.34958932908932e-10,0.0
13740,regulation of cGMP-mediated signaling (GO:0010752),-1.34958932908932e-10,0.0
13741,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-1.34958932908932e-10,0.0
13742,positive regulation of protein kinase A signaling (GO:0010739),-1.34958932908932e-10,0.0
13743,CDP-diacylglycerol biosynthetic process (GO:0016024),-1.34958932908932e-10,0.0
13744,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-1.34958932908932e-10,0.0
13745,phosphatidylcholine catabolic process (GO:0034638),-1.34958932908932e-10,0.0
13746,cardiac muscle cell apoptotic process (GO:0010659),-1.34958932908932e-10,0.0
13747,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-1.34958932908932e-10,0.0
13748,positive regulation of cytoplasmic transport (GO:1903651),-1.34958932908932e-10,0.0
13749,hepatocyte apoptotic process (GO:0097284),-1.34958932908932e-10,0.0
13750,positive regulation of autophagy of mitochondrion (GO:1903599),-1.34958932908932e-10,0.0
13751,keratinocyte development (GO:0003334),-1.34958932908932e-10,0.0
13752,trophoblast giant cell differentiation (GO:0060707),-1.34958932908932e-10,0.0
13753,response to inactivity (GO:0014854),-1.34958932908932e-10,0.0
13754,positive regulation of inflammatory response to antigenic stimulus (GO:0002863),-1.34958932908932e-10,0.0
13755,centriole-centriole cohesion (GO:0010457),-1.34958932908932e-10,0.0
13756,endothelial tube morphogenesis (GO:0061154),-1.34958932908932e-10,0.0
13757,"phototransduction, visible light (GO:0007603)",-1.34958932908932e-10,0.0
13758,cardiac chamber formation (GO:0003207),-1.34958932908932e-10,0.0
13759,regulation of tau-protein kinase activity (GO:1902947),-1.34958932908932e-10,0.0
13760,negative regulation of alcohol biosynthetic process (GO:1902931),-1.34958932908932e-10,0.0
13761,negative regulation of glucose import (GO:0046325),-1.34958932908932e-10,0.0
13762,"blood coagulation, intrinsic pathway (GO:0007597)",-1.34958932908932e-10,0.0
13763,neurotransmitter-gated ion channel clustering (GO:0072578),-1.34958932908932e-10,0.0
13764,heart valve formation (GO:0003188),-1.34958932908932e-10,0.0
13765,adult heart development (GO:0007512),-1.34958932908932e-10,0.0
13766,morphogenesis of an endothelium (GO:0003159),-1.34958932908932e-10,0.0
13767,circadian regulation of gene expression (GO:0032922),-1.3619461113517228e-10,0.0
13768,mesoderm formation (GO:0001707),-1.3619461113517228e-10,0.0
13769,positive regulation of chemokine production (GO:0032722),-1.3619461113517228e-10,0.0
13770,regulation of mitochondrial membrane potential (GO:0051881),-1.3619461113517228e-10,0.0
13771,transcription preinitiation complex assembly (GO:0070897),-1.3619461113517228e-10,0.0
13772,exocytic process (GO:0140029),-1.3619461113517228e-10,0.0
13773,mechanoreceptor differentiation (GO:0042490),-1.3619461113517228e-10,0.0
13774,regulation of ATP metabolic process (GO:1903578),-1.3619461113517228e-10,0.0
13775,phosphatidylcholine metabolic process (GO:0046470),-1.3619461113517228e-10,0.0
13776,chaperone-mediated protein folding (GO:0061077),-1.3619461113517228e-10,0.0
13777,positive regulation of toll-like receptor signaling pathway (GO:0034123),-1.3670620190484973e-10,0.0
13778,negative regulation of biomineralization (GO:0110150),-1.3670620190484973e-10,0.0
13779,zinc ion transport (GO:0006829),-1.3670620190484973e-10,0.0
13780,mast cell activation (GO:0045576),-1.3670620190484973e-10,0.0
13781,regulation of cytoplasmic translation (GO:2000765),-1.3670620190484973e-10,0.0
13782,regulation of syncytium formation by plasma membrane fusion (GO:0060142),-1.3670620190484973e-10,0.0
13783,activin receptor signaling pathway (GO:0032924),-1.3670620190484973e-10,0.0
13784,negative regulation of microtubule depolymerization (GO:0007026),-1.3670620190484973e-10,0.0
13785,response to vitamin D (GO:0033280),-1.3670620190484973e-10,0.0
13786,Fc-gamma receptor signaling pathway (GO:0038094),-1.3670620190484973e-10,0.0
13787,protein ADP-ribosylation (GO:0006471),-1.3670620190484973e-10,0.0
13788,cellular response to gamma radiation (GO:0071480),-1.3670620190484973e-10,0.0
13789,positive regulation of receptor internalization (GO:0002092),-1.3670620190484973e-10,0.0
13790,positive regulation of signal transduction by p53 class mediator (GO:1901798),-1.3670620190484973e-10,0.0
13791,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-1.3670620190484973e-10,0.0
13792,negative regulation of RNA splicing (GO:0033119),-1.3670620190484973e-10,0.0
13793,epiboly (GO:0090504),-1.3670620190484973e-10,0.0
13794,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-1.3670620190484973e-10,0.0
13795,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-1.3670620190484973e-10,0.0
13796,DNA replication initiation (GO:0006270),-1.3670620190484973e-10,0.0
13797,establishment of mitochondrion localization (GO:0051654),-1.3670620190484973e-10,0.0
13798,nucleus localization (GO:0051647),-1.3670620190484973e-10,0.0
13799,positive regulation of protein targeting to membrane (GO:0090314),-1.3670620190484973e-10,0.0
13800,transepithelial transport (GO:0070633),-1.3670620190484973e-10,0.0
13801,acetyl-CoA metabolic process (GO:0006084),-1.3670620190484973e-10,0.0
13802,chromosome separation (GO:0051304),-1.3670620190484973e-10,0.0
13803,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-1.3670620190484973e-10,0.0
13804,regulation of heterochromatin organization (GO:0120261),-1.3670620190484973e-10,0.0
13805,protein insertion into mitochondrial membrane (GO:0051204),-1.3670620190484973e-10,0.0
13806,lens fiber cell differentiation (GO:0070306),-1.3670620190484973e-10,0.0
13807,T cell apoptotic process (GO:0070231),-1.3670620190484973e-10,0.0
13808,modulation of process of another organism (GO:0035821),-1.3670620190484973e-10,0.0
13809,regulation of heterochromatin formation (GO:0031445),-1.3670620190484973e-10,0.0
13810,response to pain (GO:0048265),-1.3670620190484973e-10,0.0
13811,sperm capacitation (GO:0048240),-1.3670620190484973e-10,0.0
13812,N-terminal protein amino acid modification (GO:0031365),-1.3670620190484973e-10,0.0
13813,histone demethylation (GO:0016577),-1.3670620190484973e-10,0.0
13814,long-chain fatty acid biosynthetic process (GO:0042759),-1.3670620190484973e-10,0.0
13815,entrainment of circadian clock by photoperiod (GO:0043153),-1.3670620190484973e-10,0.0
13816,monoubiquitinated histone H2A deubiquitination (GO:0035522),-1.3670620190484973e-10,0.0
13817,monoubiquitinated histone deubiquitination (GO:0035521),-1.3670620190484973e-10,0.0
13818,metallo-sulfur cluster assembly (GO:0031163),-1.3670620190484973e-10,0.0
13819,deoxyribonucleotide catabolic process (GO:0009264),-1.3670620190484973e-10,0.0
13820,purine nucleotide transport (GO:0015865),-1.3670620190484973e-10,0.0
13821,iron-sulfur cluster assembly (GO:0016226),-1.3670620190484973e-10,0.0
13822,regulation of anion transmembrane transport (GO:1903959),-1.3670620190484973e-10,0.0
13823,aromatic amino acid family metabolic process (GO:0009072),-1.3670620190484973e-10,0.0
13824,bicarbonate transport (GO:0015701),-1.3670620190484973e-10,0.0
13825,regulation of programmed necrotic cell death (GO:0062098),-1.3670620190484973e-10,0.0
13826,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-1.3670620190484973e-10,0.0
13827,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-1.3670620190484973e-10,0.0
13828,regulation of macrophage chemotaxis (GO:0010758),-1.3670620190484973e-10,0.0
13829,cAMP-mediated signaling (GO:0019933),-1.3670620190484973e-10,0.0
13830,dendritic spine development (GO:0060996),-1.3670620190484973e-10,0.0
13831,response to gonadotropin (GO:0034698),-1.3670620190484973e-10,0.0
13832,positive regulation of alpha-beta T cell proliferation (GO:0046641),-1.3670620190484973e-10,0.0
13833,hyaluronan metabolic process (GO:0030212),-1.3670620190484973e-10,0.0
13834,regulation of cytoplasmic transport (GO:1903649),-1.3670620190484973e-10,0.0
13835,neurotransmitter metabolic process (GO:0042133),-1.3670620190484973e-10,0.0
13836,positive regulation of vascular endothelial growth factor production (GO:0010575),-1.3670620190484973e-10,0.0
13837,neutrophil activation (GO:0042119),-1.3670620190484973e-10,0.0
13838,negative regulation of transposition (GO:0010529),-1.3670620190484973e-10,0.0
13839,regulation of transposition (GO:0010528),-1.3670620190484973e-10,0.0
13840,cell fate commitment involved in formation of primary germ layer (GO:0060795),-1.3670620190484973e-10,0.0
13841,striated muscle adaptation (GO:0014888),-1.3670620190484973e-10,0.0
13842,central nervous system projection neuron axonogenesis (GO:0021952),-1.3670620190484973e-10,0.0
13843,deoxyribose phosphate catabolic process (GO:0046386),-1.3670620190484973e-10,0.0
13844,cardiac atrium morphogenesis (GO:0003209),-1.3670620190484973e-10,0.0
13845,plasma lipoprotein particle remodeling (GO:0034369),-1.3670620190484973e-10,0.0
13846,protein-lipid complex remodeling (GO:0034368),-1.3670620190484973e-10,0.0
13847,response to thyroid hormone (GO:0097066),-1.3670620190484973e-10,0.0
13848,positive regulation of protein maturation (GO:1903319),-1.3670620190484973e-10,0.0
13849,endoderm formation (GO:0001706),-1.3947398790485803e-10,0.0
13850,glycogen metabolic process (GO:0005977),-1.3947398790485803e-10,0.0
13851,ovarian follicle development (GO:0001541),-1.3947398790485803e-10,0.0
13852,regulation of chondrocyte differentiation (GO:0032330),-1.3947398790485803e-10,0.0
13853,regulation of cytosolic calcium ion concentration (GO:0051480),-1.3947398790485803e-10,0.0
13854,regulation of telomere maintenance via telomerase (GO:0032210),-1.3947398790485803e-10,0.0
13855,positive regulation of blood vessel endothelial cell migration (GO:0043536),-1.3947398790485803e-10,0.0
13856,endoplasmic reticulum unfolded protein response (GO:0030968),-1.3947398790485803e-10,0.0
13857,negative regulation of DNA binding (GO:0043392),-1.3947398790485803e-10,0.0
13858,positive regulation of fibroblast proliferation (GO:0048146),-1.3947398790485803e-10,0.0
13859,non-canonical Wnt signaling pathway (GO:0035567),-1.3947398790485803e-10,0.0
13860,mRNA 3'-end processing (GO:0031124),-1.3947398790485803e-10,0.0
13861,hair cell differentiation (GO:0035315),-1.3947398790485803e-10,0.0
13862,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-1.3947398790485803e-10,0.0
13863,cellular carbohydrate biosynthetic process (GO:0034637),-1.3947398790485803e-10,0.0
13864,cellular response to heat (GO:0034605),-1.3947398790485803e-10,0.0
13865,regulation of cardiac muscle hypertrophy (GO:0010611),-1.3947398790485803e-10,0.0
13866,glycerolipid catabolic process (GO:0046503),-1.3947398790485803e-10,0.0
13867,regulation of plasma lipoprotein particle levels (GO:0097006),-1.3947398790485803e-10,0.0
13868,respiratory gaseous exchange by respiratory system (GO:0007585),-1.3947398790485803e-10,0.0
13869,purine-containing compound catabolic process (GO:0072523),-1.3947398790485803e-10,0.0
13870,regulation of epidermis development (GO:0045682),-1.3969692068817167e-10,0.0
13871,activation of innate immune response (GO:0002218),-1.3969692068817167e-10,0.0
13872,positive regulation of interleukin-8 production (GO:0032757),-1.3969692068817167e-10,0.0
13873,mRNA export from nucleus (GO:0006406),-1.3969692068817167e-10,0.0
13874,homologous chromosome segregation (GO:0045143),-1.3969692068817167e-10,0.0
13875,maintenance of protein location in cell (GO:0032507),-1.3969692068817167e-10,0.0
13876,vesicle cytoskeletal trafficking (GO:0099518),-1.3969692068817167e-10,0.0
13877,positive regulation of viral process (GO:0048524),-1.3969692068817167e-10,0.0
13878,RNA stabilization (GO:0043489),-1.3969692068817167e-10,0.0
13879,vesicle docking (GO:0048278),-1.3969692068817167e-10,0.0
13880,pigment metabolic process (GO:0042440),-1.3969692068817167e-10,0.0
13881,cholesterol transport (GO:0030301),-1.3969692068817167e-10,0.0
13882,regulation of membrane lipid distribution (GO:0097035),-1.3969692068817167e-10,0.0
13883,forebrain cell migration (GO:0021885),-1.3969692068817167e-10,0.0
13884,response to UV-C (GO:0010225),-1.4019030380024602e-10,0.0
13885,positive regulation of glycogen biosynthetic process (GO:0045725),-1.4019030380024602e-10,0.0
13886,aldehyde catabolic process (GO:0046185),-1.4019030380024602e-10,0.0
13887,atrial septum morphogenesis (GO:0060413),-1.4019030380024602e-10,0.0
13888,calcium ion transport into cytosol (GO:0060402),-1.4019030380024602e-10,0.0
13889,"complement activation, alternative pathway (GO:0006957)",-1.4019030380024602e-10,0.0
13890,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-1.4019030380024602e-10,0.0
13891,pathway-restricted SMAD protein phosphorylation (GO:0060389),-1.4019030380024602e-10,0.0
13892,heart trabecula formation (GO:0060347),-1.4019030380024602e-10,0.0
13893,UMP metabolic process (GO:0046049),-1.4019030380024602e-10,0.0
13894,tertiary alcohol metabolic process (GO:1902644),-1.4019030380024602e-10,0.0
13895,oligopeptide transport (GO:0006857),-1.4019030380024602e-10,0.0
13896,response to epinephrine (GO:0071871),-1.4019030380024602e-10,0.0
13897,corpus callosum development (GO:0022038),-1.4019030380024602e-10,0.0
13898,mammary gland epithelial cell proliferation (GO:0033598),-1.4019030380024602e-10,0.0
13899,regulation of store-operated calcium entry (GO:2001256),-1.4019030380024602e-10,0.0
13900,optic nerve development (GO:0021554),-1.4019030380024602e-10,0.0
13901,renal system process involved in regulation of blood volume (GO:0001977),-1.4019030380024602e-10,0.0
13902,regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-1.4019030380024602e-10,0.0
13903,negative regulation of glycoprotein metabolic process (GO:1903019),-1.4019030380024602e-10,0.0
13904,positive regulation of cytoplasmic translation (GO:2000767),-1.4019030380024602e-10,0.0
13905,regulation of cardiac muscle cell differentiation (GO:2000725),-1.4019030380024602e-10,0.0
13906,regulation of neutrophil activation (GO:1902563),-1.4019030380024602e-10,0.0
13907,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-1.4019030380024602e-10,0.0
13908,endoplasmic reticulum tubular network organization (GO:0071786),-1.4019030380024602e-10,0.0
13909,positive regulation of phospholipid transport (GO:2001140),-1.4019030380024602e-10,0.0
13910,regulation of motor neuron apoptotic process (GO:2000671),-1.4019030380024602e-10,0.0
13911,epithelial cell fate commitment (GO:0072148),-1.4019030380024602e-10,0.0
13912,positive regulation of MHC class II biosynthetic process (GO:0045348),-1.4019030380024602e-10,0.0
13913,viral translation (GO:0019081),-1.4019030380024602e-10,0.0
13914,positive regulation of endothelial cell chemotaxis (GO:2001028),-1.4019030380024602e-10,0.0
13915,mesodermal cell fate commitment (GO:0001710),-1.4019030380024602e-10,0.0
13916,nucleolus organization (GO:0007000),-1.4019030380024602e-10,0.0
13917,melanin metabolic process (GO:0006582),-1.4019030380024602e-10,0.0
13918,regulation of natural killer cell proliferation (GO:0032817),-1.4019030380024602e-10,0.0
13919,tyrosine metabolic process (GO:0006570),-1.4019030380024602e-10,0.0
13920,negative regulation of sodium ion transmembrane transport (GO:1902306),-1.4019030380024602e-10,0.0
13921,glycine metabolic process (GO:0006544),-1.4019030380024602e-10,0.0
13922,negative regulation of amino acid transport (GO:0051956),-1.4019030380024602e-10,0.0
13923,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-1.4019030380024602e-10,0.0
13924,cerebrospinal fluid circulation (GO:0090660),-1.4019030380024602e-10,0.0
13925,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-1.4019030380024602e-10,0.0
13926,negative regulation of interleukin-17 production (GO:0032700),-1.4019030380024602e-10,0.0
13927,C-terminal protein amino acid modification (GO:0018410),-1.4019030380024602e-10,0.0
13928,cellular response to superoxide (GO:0071451),-1.4019030380024602e-10,0.0
13929,cellular response to oxygen radical (GO:0071450),-1.4019030380024602e-10,0.0
13930,apical protein localization (GO:0045176),-1.4019030380024602e-10,0.0
13931,negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-1.4019030380024602e-10,0.0
13932,left/right axis specification (GO:0070986),-1.4019030380024602e-10,0.0
13933,transcription initiation at RNA polymerase I promoter (GO:0006361),-1.4019030380024602e-10,0.0
13934,positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-1.4019030380024602e-10,0.0
13935,medium-chain fatty acid metabolic process (GO:0051791),-1.4019030380024602e-10,0.0
13936,myeloid cell apoptotic process (GO:0033028),-1.4019030380024602e-10,0.0
13937,positive regulation of mast cell activation involved in immune response (GO:0033008),-1.4019030380024602e-10,0.0
13938,DNA strand elongation involved in DNA replication (GO:0006271),-1.4019030380024602e-10,0.0
13939,negative regulation of hematopoietic progenitor cell differentiation (GO:1901533),-1.4019030380024602e-10,0.0
13940,negative regulation of DNA-templated DNA replication (GO:2000104),-1.4019030380024602e-10,0.0
13941,histone H4-K16 acetylation (GO:0043984),-1.4019030380024602e-10,0.0
13942,negative regulation of neurotransmitter transport (GO:0051589),-1.4019030380024602e-10,0.0
13943,regulation of postsynaptic density organization (GO:1905874),-1.4019030380024602e-10,0.0
13944,negative regulation by host of viral transcription (GO:0043922),-1.4019030380024602e-10,0.0
13945,positive regulation of calcium ion import (GO:0090280),-1.4019030380024602e-10,0.0
13946,negative regulation of cytosolic calcium ion concentration (GO:0051481),-1.4019030380024602e-10,0.0
13947,neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-1.4019030380024602e-10,0.0
13948,negative regulation of neuron projection regeneration (GO:0070571),-1.4019030380024602e-10,0.0
13949,regulation of cellular protein metabolic process (GO:0032268),-1.4019030380024602e-10,0.0
13950,kinetochore assembly (GO:0051382),-1.4019030380024602e-10,0.0
13951,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-1.4019030380024602e-10,0.0
13952,regulation of extracellular matrix assembly (GO:1901201),-1.4019030380024602e-10,0.0
13953,positive regulation of heterochromatin organization (GO:0120263),-1.4019030380024602e-10,0.0
13954,positive regulation by symbiont of entry into host (GO:0075294),-1.4019030380024602e-10,0.0
13955,protein heterotetramerization (GO:0051290),-1.4019030380024602e-10,0.0
13956,positive regulation of sequestering of calcium ion (GO:0051284),-1.4019030380024602e-10,0.0
13957,hepatocyte differentiation (GO:0070365),-1.4019030380024602e-10,0.0
13958,regulation of respiratory system process (GO:0044065),-1.4019030380024602e-10,0.0
13959,presynaptic modulation of chemical synaptic transmission (GO:0099171),-1.4019030380024602e-10,0.0
13960,cardiolipin metabolic process (GO:0032048),-1.4019030380024602e-10,0.0
13961,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-1.4019030380024602e-10,0.0
13962,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-1.4019030380024602e-10,0.0
13963,negative regulation of JUN kinase activity (GO:0043508),-1.4019030380024602e-10,0.0
13964,sarcoplasmic reticulum calcium ion transport (GO:0070296),-1.4019030380024602e-10,0.0
13965,regulation of thymocyte apoptotic process (GO:0070243),-1.4019030380024602e-10,0.0
13966,sodium ion export across plasma membrane (GO:0036376),-1.4019030380024602e-10,0.0
13967,interneuron migration (GO:1904936),-1.4019030380024602e-10,0.0
13968,protein homotrimerization (GO:0070207),-1.4019030380024602e-10,0.0
13969,mitochondrion distribution (GO:0048311),-1.4019030380024602e-10,0.0
13970,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-1.4019030380024602e-10,0.0
13971,regulation of secondary metabolic process (GO:0043455),-1.4019030380024602e-10,0.0
13972,positive regulation of heterochromatin formation (GO:0031453),-1.4019030380024602e-10,0.0
13973,actin filament severing (GO:0051014),-1.4019030380024602e-10,0.0
13974,regulation of excitatory synapse assembly (GO:1904889),-1.4019030380024602e-10,0.0
13975,enamel mineralization (GO:0070166),-1.4019030380024602e-10,0.0
13976,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-1.4019030380024602e-10,0.0
13977,inhibitory synapse assembly (GO:1904862),-1.4019030380024602e-10,0.0
13978,"regulation of protein localization to chromosome, telomeric region (GO:1904814)",-1.4019030380024602e-10,0.0
13979,"CD4-positive, alpha-beta T cell lineage commitment (GO:0043373)",-1.4019030380024602e-10,0.0
13980,positive regulation of mast cell degranulation (GO:0043306),-1.4019030380024602e-10,0.0
13981,regulation of secondary metabolite biosynthetic process (GO:1900376),-1.4019030380024602e-10,0.0
13982,phosphatidylcholine acyl-chain remodeling (GO:0036151),-1.4019030380024602e-10,0.0
13983,sodium-independent organic anion transport (GO:0043252),-1.4019030380024602e-10,0.0
13984,erythrocyte maturation (GO:0043249),-1.4019030380024602e-10,0.0
13985,response to leucine (GO:0043201),-1.4019030380024602e-10,0.0
13986,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-1.4019030380024602e-10,0.0
13987,regulation of melanin biosynthetic process (GO:0048021),-1.4019030380024602e-10,0.0
13988,somatic hypermutation of immunoglobulin genes (GO:0016446),-1.4019030380024602e-10,0.0
13989,relaxation of cardiac muscle (GO:0055119),-1.4019030380024602e-10,0.0
13990,regulation of metallopeptidase activity (GO:1905048),-1.4019030380024602e-10,0.0
13991,purine-containing compound salvage (GO:0043101),-1.4019030380024602e-10,0.0
13992,pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209),-1.4019030380024602e-10,0.0
13993,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-1.4019030380024602e-10,0.0
13994,motor behavior (GO:0061744),-1.4019030380024602e-10,0.0
13995,dopamine transport (GO:0015872),-1.4019030380024602e-10,0.0
13996,ventricular cardiac muscle cell differentiation (GO:0055012),-1.4019030380024602e-10,0.0
13997,ribonucleoside monophosphate catabolic process (GO:0009158),-1.4019030380024602e-10,0.0
13998,response to caffeine (GO:0031000),-1.4019030380024602e-10,0.0
13999,regulation of low-density lipoprotein particle clearance (GO:0010988),-1.4019030380024602e-10,0.0
14000,regulation of protein K63-linked ubiquitination (GO:1900044),-1.4019030380024602e-10,0.0
14001,positive regulation of ruffle assembly (GO:1900029),-1.4019030380024602e-10,0.0
14002,regulation of receptor clustering (GO:1903909),-1.4019030380024602e-10,0.0
14003,atrial cardiac muscle cell to AV node cell communication (GO:0086066),-1.4019030380024602e-10,0.0
14004,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-1.4019030380024602e-10,0.0
14005,regulation of sequestering of triglyceride (GO:0010889),-1.4019030380024602e-10,0.0
14006,cristae formation (GO:0042407),-1.4019030380024602e-10,0.0
14007,T cell chemotaxis (GO:0010818),-1.4019030380024602e-10,0.0
14008,regulation of IRE1-mediated unfolded protein response (GO:1903894),-1.4019030380024602e-10,0.0
14009,miRNA-mediated gene silencing by inhibition of translation (GO:0035278),-1.4019030380024602e-10,0.0
14010,oxygen transport (GO:0015671),-1.4019030380024602e-10,0.0
14011,negative regulation of neuroinflammatory response (GO:0150079),-1.4019030380024602e-10,0.0
14012,positive regulation of neuroinflammatory response (GO:0150078),-1.4019030380024602e-10,0.0
14013,non-lytic viral release (GO:0046753),-1.4019030380024602e-10,0.0
14014,positive regulation of ERAD pathway (GO:1904294),-1.4019030380024602e-10,0.0
14015,regulation of neuron projection arborization (GO:0150011),-1.4019030380024602e-10,0.0
14016,protein maturation by iron-sulfur cluster transfer (GO:0097428),-1.4019030380024602e-10,0.0
14017,negative regulation of protein import into nucleus (GO:0042308),-1.4019030380024602e-10,0.0
14018,regulation of type B pancreatic cell proliferation (GO:0061469),-1.4019030380024602e-10,0.0
14019,positive regulation of viral entry into host cell (GO:0046598),-1.4019030380024602e-10,0.0
14020,sphingoid biosynthetic process (GO:0046520),-1.4019030380024602e-10,0.0
14021,sphingosine biosynthetic process (GO:0046512),-1.4019030380024602e-10,0.0
14022,S-adenosylmethionine metabolic process (GO:0046500),-1.4019030380024602e-10,0.0
14023,regulation of DNA-templated DNA replication initiation (GO:0030174),-1.4019030380024602e-10,0.0
14024,lysosomal membrane organization (GO:0097212),-1.4019030380024602e-10,0.0
14025,smooth muscle cell migration (GO:0014909),-1.4019030380024602e-10,0.0
14026,glucocorticoid metabolic process (GO:0008211),-1.4019030380024602e-10,0.0
14027,positive regulation of exosomal secretion (GO:1903543),-1.4019030380024602e-10,0.0
14028,short-chain fatty acid metabolic process (GO:0046459),-1.4019030380024602e-10,0.0
14029,ruffle assembly (GO:0097178),-1.4019030380024602e-10,0.0
14030,response to stimulus involved in regulation of muscle adaptation (GO:0014874),-1.4019030380024602e-10,0.0
14031,regulation of acute inflammatory response to antigenic stimulus (GO:0002864),-1.4019030380024602e-10,0.0
14032,reactive oxygen species biosynthetic process (GO:1903409),-1.4019030380024602e-10,0.0
14033,cardiac left ventricle morphogenesis (GO:0003214),-1.4019030380024602e-10,0.0
14034,negative regulation of fatty acid oxidation (GO:0046322),-1.4019030380024602e-10,0.0
14035,negative regulation of autophagosome assembly (GO:1902902),-1.4019030380024602e-10,0.0
14036,primary alcohol catabolic process (GO:0034310),-1.4019030380024602e-10,0.0
14037,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-1.4019030380024602e-10,0.0
14038,pyramidal neuron differentiation (GO:0021859),-1.4019030380024602e-10,0.0
14039,peptidyl-proline hydroxylation (GO:0019511),-1.4019030380024602e-10,0.0
14040,layer formation in cerebral cortex (GO:0021819),-1.4019030380024602e-10,0.0
14041,regulation of oxidative stress-induced neuron death (GO:1903203),-1.4115819623297808e-10,0.0
14042,positive regulation of cell cycle G2/M phase transition (GO:1902751),-1.4115819623297808e-10,0.0
14043,cranial nerve morphogenesis (GO:0021602),-1.4115819623297808e-10,0.0
14044,face morphogenesis (GO:0060325),-1.4115819623297808e-10,0.0
14045,myelination in peripheral nervous system (GO:0022011),-1.4115819623297808e-10,0.0
14046,response to iron ion (GO:0010039),-1.4115819623297808e-10,0.0
14047,ventricular system development (GO:0021591),-1.4115819623297808e-10,0.0
14048,positive regulation of T cell mediated cytotoxicity (GO:0001916),-1.4115819623297808e-10,0.0
14049,viral protein processing (GO:0019082),-1.4115819623297808e-10,0.0
14050,mitotic spindle assembly checkpoint signaling (GO:0007094),-1.4115819623297808e-10,0.0
14051,glutamate metabolic process (GO:0006536),-1.4115819623297808e-10,0.0
14052,GPI anchor biosynthetic process (GO:0006506),-1.4115819623297808e-10,0.0
14053,integrated stress response signaling (GO:0140467),-1.4115819623297808e-10,0.0
14054,positive regulation of excitatory postsynaptic potential (GO:2000463),-1.4115819623297808e-10,0.0
14055,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-1.4115819623297808e-10,0.0
14056,cellular response to lipoprotein particle stimulus (GO:0071402),-1.4115819623297808e-10,0.0
14057,regulation of interferon-alpha production (GO:0032647),-1.4115819623297808e-10,0.0
14058,regulation of T-helper 17 type immune response (GO:2000316),-1.4115819623297808e-10,0.0
14059,homeostasis of number of cells within a tissue (GO:0048873),-1.4115819623297808e-10,0.0
14060,regulation of platelet aggregation (GO:0090330),-1.4115819623297808e-10,0.0
14061,regulation of superoxide metabolic process (GO:0090322),-1.4115819623297808e-10,0.0
14062,positive regulation of protein deacetylation (GO:0090312),-1.4115819623297808e-10,0.0
14063,positive regulation of leukocyte apoptotic process (GO:2000108),-1.4115819623297808e-10,0.0
14064,mitotic spindle checkpoint signaling (GO:0071174),-1.4115819623297808e-10,0.0
14065,spindle assembly checkpoint signaling (GO:0071173),-1.4115819623297808e-10,0.0
14066,regulation of cAMP-mediated signaling (GO:0043949),-1.4115819623297808e-10,0.0
14067,skeletal muscle fiber development (GO:0048741),-1.4115819623297808e-10,0.0
14068,tricarboxylic acid cycle (GO:0006099),-1.4115819623297808e-10,0.0
14069,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-1.4115819623297808e-10,0.0
14070,regulation of neuron projection regeneration (GO:0070570),-1.4115819623297808e-10,0.0
14071,peripheral nervous system axon ensheathment (GO:0032292),-1.4115819623297808e-10,0.0
14072,regulation of monocyte chemotaxis (GO:0090025),-1.4115819623297808e-10,0.0
14073,bone cell development (GO:0098751),-1.4115819623297808e-10,0.0
14074,negative regulation of ERBB signaling pathway (GO:1901185),-1.4115819623297808e-10,0.0
14075,steroid hormone biosynthetic process (GO:0120178),-1.4115819623297808e-10,0.0
14076,response to sterol (GO:0036314),-1.4115819623297808e-10,0.0
14077,mRNA modification (GO:0016556),-1.4115819623297808e-10,0.0
14078,somatic recombination of immunoglobulin gene segments (GO:0016447),-1.4115819623297808e-10,0.0
14079,sulfur amino acid metabolic process (GO:0000096),-1.4115819623297808e-10,0.0
14080,purinergic nucleotide receptor signaling pathway (GO:0035590),-1.4115819623297808e-10,0.0
14081,neuron projection regeneration (GO:0031102),-1.4115819623297808e-10,0.0
14082,regulation of execution phase of apoptosis (GO:1900117),-1.4115819623297808e-10,0.0
14083,regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-1.4115819623297808e-10,0.0
14084,cellular metabolic compound salvage (GO:0043094),-1.4115819623297808e-10,0.0
14085,regulation of mitochondrial gene expression (GO:0062125),-1.4115819623297808e-10,0.0
14086,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-1.4115819623297808e-10,0.0
14087,regulation of ruffle assembly (GO:1900027),-1.4115819623297808e-10,0.0
14088,phosphatidylinositol dephosphorylation (GO:0046856),-1.4115819623297808e-10,0.0
14089,positive regulation of cell-substrate junction organization (GO:0150117),-1.4115819623297808e-10,0.0
14090,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-1.4115819623297808e-10,0.0
14091,regulation of macrophage derived foam cell differentiation (GO:0010743),-1.4115819623297808e-10,0.0
14092,regulation of aerobic respiration (GO:1903715),-1.4115819623297808e-10,0.0
14093,sphingolipid catabolic process (GO:0030149),-1.4115819623297808e-10,0.0
14094,glycerophospholipid catabolic process (GO:0046475),-1.4115819623297808e-10,0.0
14095,striated muscle hypertrophy (GO:0014897),-1.4115819623297808e-10,0.0
14096,positive regulation of translational initiation (GO:0045948),-1.4115819623297808e-10,0.0
14097,protein-containing complex remodeling (GO:0034367),-1.4115819623297808e-10,0.0
14098,diol metabolic process (GO:0034311),-1.4115819623297808e-10,0.0
14099,negative regulation of protein tyrosine kinase activity (GO:0061099),-1.4115819623297808e-10,0.0
14100,positive regulation of natural killer cell mediated immunity (GO:0002717),-1.4115819623297808e-10,0.0
14101,negative regulation of cartilage development (GO:0061037),-1.4115819623297808e-10,0.0
14102,negative regulation of protein maturation (GO:1903318),-1.4115819623297808e-10,0.0
14103,pyridine-containing compound biosynthetic process (GO:0072525),-1.4115819623297808e-10,0.0
14104,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002504),-1.4284950998845188e-10,0.0
14105,cell volume homeostasis (GO:0006884),-1.4284950998845188e-10,0.0
14106,regulation of membrane repolarization (GO:0060306),-1.4284950998845188e-10,0.0
14107,NADH metabolic process (GO:0006734),-1.4284950998845188e-10,0.0
14108,female meiotic nuclear division (GO:0007143),-1.4284950998845188e-10,0.0
14109,glycosphingolipid biosynthetic process (GO:0006688),-1.4284950998845188e-10,0.0
14110,positive regulation of defense response to virus by host (GO:0002230),-1.4284950998845188e-10,0.0
14111,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-1.4284950998845188e-10,0.0
14112,cytoplasmic translational initiation (GO:0002183),-1.4284950998845188e-10,0.0
14113,positive regulation of telomerase activity (GO:0051973),-1.4284950998845188e-10,0.0
14114,signal transduction in absence of ligand (GO:0038034),-1.4284950998845188e-10,0.0
14115,Schwann cell development (GO:0014044),-1.4284950998845188e-10,0.0
14116,negative regulation of signal transduction by p53 class mediator (GO:1901797),-1.4284950998845188e-10,0.0
14117,postreplication repair (GO:0006301),-1.4284950998845188e-10,0.0
14118,regulation of glycogen metabolic process (GO:0070873),-1.4284950998845188e-10,0.0
14119,regulation of mast cell activation involved in immune response (GO:0033006),-1.4284950998845188e-10,0.0
14120,mismatch repair (GO:0006298),-1.4284950998845188e-10,0.0
14121,RNA-templated DNA biosynthetic process (GO:0006278),-1.4284950998845188e-10,0.0
14122,pyrimidine nucleotide biosynthetic process (GO:0006221),-1.4284950998845188e-10,0.0
14123,protein K48-linked deubiquitination (GO:0071108),-1.4284950998845188e-10,0.0
14124,regulation of spindle assembly (GO:0090169),-1.4284950998845188e-10,0.0
14125,pigment cell differentiation (GO:0050931),-1.4284950998845188e-10,0.0
14126,positive regulation of telomere maintenance via telomerase (GO:0032212),-1.4284950998845188e-10,0.0
14127,regulation of presynapse assembly (GO:1905606),-1.4284950998845188e-10,0.0
14128,regulation of presynapse organization (GO:0099174),-1.4284950998845188e-10,0.0
14129,negative regulation of protein localization to membrane (GO:1905476),-1.4284950998845188e-10,0.0
14130,entrainment of circadian clock (GO:0009649),-1.4284950998845188e-10,0.0
14131,lymphocyte apoptotic process (GO:0070227),-1.4284950998845188e-10,0.0
14132,skeletal muscle tissue regeneration (GO:0043403),-1.4284950998845188e-10,0.0
14133,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-1.4284950998845188e-10,0.0
14134,negative regulation of fibroblast proliferation (GO:0048147),-1.4284950998845188e-10,0.0
14135,establishment of mitotic spindle orientation (GO:0000132),-1.4284950998845188e-10,0.0
14136,microtubule organizing center localization (GO:0061842),-1.4284950998845188e-10,0.0
14137,monoubiquitinated protein deubiquitination (GO:0035520),-1.4284950998845188e-10,0.0
14138,vesicle cargo loading (GO:0035459),-1.4284950998845188e-10,0.0
14139,negative regulation of protein dephosphorylation (GO:0035308),-1.4284950998845188e-10,0.0
14140,"synaptic transmission, glutamatergic (GO:0035249)",-1.4284950998845188e-10,0.0
14141,miRNA processing (GO:0035196),-1.4284950998845188e-10,0.0
14142,positive regulation of Rho protein signal transduction (GO:0035025),-1.4284950998845188e-10,0.0
14143,epithelial cell morphogenesis (GO:0003382),-1.4284950998845188e-10,0.0
14144,phosphatidylglycerol metabolic process (GO:0046471),-1.4284950998845188e-10,0.0
14145,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-1.4284950998845188e-10,0.0
14146,response to fluid shear stress (GO:0034405),-1.4284950998845188e-10,0.0
14147,positive regulation of transcription by RNA polymerase I (GO:0045943),-1.4284950998845188e-10,0.0
14148,protein localization to cell surface (GO:0034394),-1.4284950998845188e-10,0.0
14149,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-1.4284950998845188e-10,0.0
14150,negative regulation of smoothened signaling pathway (GO:0045879),-1.4284950998845188e-10,0.0
14151,negative regulation of bone resorption (GO:0045779),-1.430238150032931e-10,0.0
14152,response to UV-B (GO:0010224),-1.430238150032931e-10,0.0
14153,regulation of leukocyte tethering or rolling (GO:1903236),-1.430238150032931e-10,0.0
14154,DNA integration (GO:0015074),-1.430238150032931e-10,0.0
14155,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-1.430238150032931e-10,0.0
14156,positive regulation of homotypic cell-cell adhesion (GO:0034112),-1.430238150032931e-10,0.0
14157,regulation of establishment of endothelial barrier (GO:1903140),-1.430238150032931e-10,0.0
14158,regulation of integrin activation (GO:0033623),-1.430238150032931e-10,0.0
14159,segment specification (GO:0007379),-1.430238150032931e-10,0.0
14160,regulation of DNA strand elongation (GO:0060382),-1.430238150032931e-10,0.0
14161,regulation of corticosteroid hormone secretion (GO:2000846),-1.430238150032931e-10,0.0
14162,mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686),-1.430238150032931e-10,0.0
14163,cGMP metabolic process (GO:0046068),-1.430238150032931e-10,0.0
14164,Golgi to endosome transport (GO:0006895),-1.430238150032931e-10,0.0
14165,mitochondrial calcium ion transmembrane transport (GO:0006851),-1.430238150032931e-10,0.0
14166,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-1.430238150032931e-10,0.0
14167,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-1.430238150032931e-10,0.0
14168,regulation of vasculogenesis (GO:2001212),-1.430238150032931e-10,0.0
14169,alpha-beta T cell lineage commitment (GO:0002363),-1.430238150032931e-10,0.0
14170,cellular response to nitric oxide (GO:0071732),-1.430238150032931e-10,0.0
14171,meiosis II (GO:0007135),-1.430238150032931e-10,0.0
14172,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-1.430238150032931e-10,0.0
14173,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-1.430238150032931e-10,0.0
14174,natural killer cell differentiation (GO:0001779),-1.430238150032931e-10,0.0
14175,mitotic chromosome condensation (GO:0007076),-1.430238150032931e-10,0.0
14176,synapse maturation (GO:0060074),-1.430238150032931e-10,0.0
14177,angiogenesis involved in wound healing (GO:0060055),-1.430238150032931e-10,0.0
14178,anatomical structure regression (GO:0060033),-1.430238150032931e-10,0.0
14179,sulfate transmembrane transport (GO:1902358),-1.430238150032931e-10,0.0
14180,amino-acid betaine metabolic process (GO:0006577),-1.430238150032931e-10,0.0
14181,regulation of transmission of nerve impulse (GO:0051969),-1.430238150032931e-10,0.0
14182,catecholamine transport (GO:0051937),-1.430238150032931e-10,0.0
14183,basic amino acid transmembrane transport (GO:1990822),-1.430238150032931e-10,0.0
14184,cell-cell junction maintenance (GO:0045217),-1.430238150032931e-10,0.0
14185,suppression of viral release by host (GO:0044790),-1.430238150032931e-10,0.0
14186,collagen-activated signaling pathway (GO:0038065),-1.430238150032931e-10,0.0
14187,N-terminal protein amino acid acetylation (GO:0006474),-1.430238150032931e-10,0.0
14188,negative regulation of focal adhesion assembly (GO:0051895),-1.430238150032931e-10,0.0
14189,establishment of epithelial cell apical/basal polarity (GO:0045198),-1.430238150032931e-10,0.0
14190,response to hydroperoxide (GO:0033194),-1.430238150032931e-10,0.0
14191,ganglioside biosynthetic process (GO:0001574),-1.430238150032931e-10,0.0
14192,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-1.430238150032931e-10,0.0
14193,cellular response to prostaglandin E stimulus (GO:0071380),-1.430238150032931e-10,0.0
14194,regulation of gene expression by genomic imprinting (GO:0006349),-1.430238150032931e-10,0.0
14195,negative regulation of cell division (GO:0051782),-1.430238150032931e-10,0.0
14196,endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-1.430238150032931e-10,0.0
14197,negative regulation of cilium assembly (GO:1902018),-1.430238150032931e-10,0.0
14198,regulation of endothelial cell development (GO:1901550),-1.430238150032931e-10,0.0
14199,regulation of amyloid fibril formation (GO:1905906),-1.430238150032931e-10,0.0
14200,2-oxoglutarate metabolic process (GO:0006103),-1.430238150032931e-10,0.0
14201,positive regulation by host of viral transcription (GO:0043923),-1.430238150032931e-10,0.0
14202,lactate metabolic process (GO:0006089),-1.430238150032931e-10,0.0
14203,alanine transport (GO:0032328),-1.430238150032931e-10,0.0
14204,response to corticosterone (GO:0051412),-1.430238150032931e-10,0.0
14205,dendrite self-avoidance (GO:0070593),-1.430238150032931e-10,0.0
14206,protein kinase C signaling (GO:0070528),-1.430238150032931e-10,0.0
14207,white fat cell differentiation (GO:0050872),-1.430238150032931e-10,0.0
14208,anatomical structure arrangement (GO:0048532),-1.430238150032931e-10,0.0
14209,histone H3-K14 acetylation (GO:0044154),-1.430238150032931e-10,0.0
14210,"protein alpha-1,2-demannosylation (GO:0036508)",-1.430238150032931e-10,0.0
14211,protein demannosylation (GO:0036507),-1.430238150032931e-10,0.0
14212,regulation of response to food (GO:0032095),-1.430238150032931e-10,0.0
14213,mitochondrial DNA metabolic process (GO:0032042),-1.430238150032931e-10,0.0
14214,regulation of autophagosome maturation (GO:1901096),-1.430238150032931e-10,0.0
14215,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-1.430238150032931e-10,0.0
14216,response to light intensity (GO:0009642),-1.430238150032931e-10,0.0
14217,negative regulation of response to reactive oxygen species (GO:1901032),-1.430238150032931e-10,0.0
14218,postsynapse assembly (GO:0099068),-1.430238150032931e-10,0.0
14219,lipoprotein transport (GO:0042953),-1.430238150032931e-10,0.0
14220,positive regulation of mitochondrial translation (GO:0070131),-1.430238150032931e-10,0.0
14221,eosinophil chemotaxis (GO:0048245),-1.430238150032931e-10,0.0
14222,"retrograde protein transport, ER to cytosol (GO:0030970)",-1.430238150032931e-10,0.0
14223,mitochondrial fission (GO:0000266),-1.430238150032931e-10,0.0
14224,positive regulation of chromatin organization (GO:1905269),-1.430238150032931e-10,0.0
14225,intraciliary anterograde transport (GO:0035720),-1.430238150032931e-10,0.0
14226,toxin metabolic process (GO:0009404),-1.430238150032931e-10,0.0
14227,proton-transporting two-sector ATPase complex assembly (GO:0070071),-1.430238150032931e-10,0.0
14228,regulation of short-term neuronal synaptic plasticity (GO:0048172),-1.430238150032931e-10,0.0
14229,regulation of granulocyte differentiation (GO:0030852),-1.430238150032931e-10,0.0
14230,meiosis II cell cycle process (GO:0061983),-1.430238150032931e-10,0.0
14231,ceramide transport (GO:0035627),-1.430238150032931e-10,0.0
14232,myelin maintenance (GO:0043217),-1.430238150032931e-10,0.0
14233,fucosylation (GO:0036065),-1.430238150032931e-10,0.0
14234,insulin-like growth factor receptor signaling pathway (GO:0048009),-1.430238150032931e-10,0.0
14235,DNA replication checkpoint signaling (GO:0000076),-1.430238150032931e-10,0.0
14236,muscle cell fate commitment (GO:0042693),-1.430238150032931e-10,0.0
14237,antifungal innate immune response (GO:0061760),-1.430238150032931e-10,0.0
14238,phospholipid homeostasis (GO:0055091),-1.430238150032931e-10,0.0
14239,reticulophagy (GO:0061709),-1.430238150032931e-10,0.0
14240,ATP transport (GO:0015867),-1.430238150032931e-10,0.0
14241,pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173),-1.430238150032931e-10,0.0
14242,purine deoxyribonucleotide metabolic process (GO:0009151),-1.430238150032931e-10,0.0
14243,pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130),-1.430238150032931e-10,0.0
14244,nuclear body organization (GO:0030575),-1.430238150032931e-10,0.0
14245,regulation of cellular response to heat (GO:1900034),-1.430238150032931e-10,0.0
14246,telomere capping (GO:0016233),-1.430238150032931e-10,0.0
14247,positive regulation of dendrite development (GO:1900006),-1.430238150032931e-10,0.0
14248,regulation of striated muscle tissue development (GO:0016202),-1.430238150032931e-10,0.0
14249,glutamine family amino acid biosynthetic process (GO:0009084),-1.430238150032931e-10,0.0
14250,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-1.430238150032931e-10,0.0
14251,inositol phosphate dephosphorylation (GO:0046855),-1.430238150032931e-10,0.0
14252,negative regulation of cell-substrate junction organization (GO:0150118),-1.430238150032931e-10,0.0
14253,positive regulation of telomere capping (GO:1904355),-1.430238150032931e-10,0.0
14254,regulation of cholesterol storage (GO:0010885),-1.430238150032931e-10,0.0
14255,regulation of T cell chemotaxis (GO:0010819),-1.430238150032931e-10,0.0
14256,protein O-linked mannosylation (GO:0035269),-1.430238150032931e-10,0.0
14257,iron ion transmembrane transport (GO:0034755),-1.430238150032931e-10,0.0
14258,sno(s)RNA metabolic process (GO:0016074),-1.430238150032931e-10,0.0
14259,stabilization of membrane potential (GO:0030322),-1.430238150032931e-10,0.0
14260,detection of bacterium (GO:0016045),-1.430238150032931e-10,0.0
14261,cell migration involved in heart development (GO:0060973),-1.430238150032931e-10,0.0
14262,axonal transport of mitochondrion (GO:0019896),-1.430238150032931e-10,0.0
14263,antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-1.430238150032931e-10,0.0
14264,regulation of ketone biosynthetic process (GO:0010566),-1.430238150032931e-10,0.0
14265,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-1.430238150032931e-10,0.0
14266,regulation of exosomal secretion (GO:1903541),-1.430238150032931e-10,0.0
14267,endoplasmic reticulum to cytosol transport (GO:1903513),-1.430238150032931e-10,0.0
14268,regulation of cilium beat frequency (GO:0003356),-1.430238150032931e-10,0.0
14269,protein localization to phagophore assembly site (GO:0034497),-1.430238150032931e-10,0.0
14270,negative regulation of immunoglobulin mediated immune response (GO:0002890),-1.430238150032931e-10,0.0
14271,vascular associated smooth muscle contraction (GO:0014829),-1.430238150032931e-10,0.0
14272,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-1.430238150032931e-10,0.0
14273,adenohypophysis development (GO:0021984),-1.430238150032931e-10,0.0
14274,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-1.430238150032931e-10,0.0
14275,positive regulation of fatty acid oxidation (GO:0046321),-1.430238150032931e-10,0.0
14276,negative regulation of B cell mediated immunity (GO:0002713),-1.430238150032931e-10,0.0
14277,positive regulation of membrane potential (GO:0045838),-1.430238150032931e-10,0.0
14278,regulation of Golgi organization (GO:1903358),-1.430238150032931e-10,0.0
14279,excretion (GO:0007588),-1.430238150032931e-10,0.0
14280,regulation of fertilization (GO:0080154),-1.430238150032931e-10,0.0
14281,negative regulation of necroptotic process (GO:0060546),-1.430238150032931e-10,0.0
14282,arachidonic acid metabolic process (GO:0019369),-1.474451671759182e-10,0.0
14283,regulation of epidermal cell differentiation (GO:0045604),-1.474451671759182e-10,0.0
14284,positive regulation of cell-matrix adhesion (GO:0001954),-1.474451671759182e-10,0.0
14285,JNK cascade (GO:0007254),-1.474451671759182e-10,0.0
14286,membrane assembly (GO:0071709),-1.474451671759182e-10,0.0
14287,secretory granule organization (GO:0033363),-1.474451671759182e-10,0.0
14288,regulation of establishment of planar polarity (GO:0090175),-1.474451671759182e-10,0.0
14289,response to axon injury (GO:0048678),-1.474451671759182e-10,0.0
14290,defense response to fungus (GO:0050832),-1.474451671759182e-10,0.0
14291,negative regulation of MAP kinase activity (GO:0043407),-1.474451671759182e-10,0.0
14292,regulation of neuronal synaptic plasticity (GO:0048168),-1.474451671759182e-10,0.0
14293,selective autophagy (GO:0061912),-1.474451671759182e-10,0.0
14294,G2/M transition of mitotic cell cycle (GO:0000086),-1.474451671759182e-10,0.0
14295,cardiac muscle cell development (GO:0055013),-1.474451671759182e-10,0.0
14296,regulation of macrophage activation (GO:0043030),-1.474451671759182e-10,0.0
14297,apoptotic mitochondrial changes (GO:0008637),-1.474451671759182e-10,0.0
14298,substrate adhesion-dependent cell spreading (GO:0034446),-1.474451671759182e-10,0.0
14299,positive regulation of myeloid leukocyte differentiation (GO:0002763),-1.474451671759182e-10,0.0
14300,positive regulation of cell cycle G1/S phase transition (GO:1902808),-1.474451671759182e-10,0.0
14301,negative regulation of cell cycle G2/M phase transition (GO:1902750),-1.4811329939203888e-10,0.0
14302,protein transmembrane transport (GO:0071806),-1.4811329939203888e-10,0.0
14303,lymphocyte homeostasis (GO:0002260),-1.4811329939203888e-10,0.0
14304,somitogenesis (GO:0001756),-1.4811329939203888e-10,0.0
14305,protein deacetylation (GO:0006476),-1.4811329939203888e-10,0.0
14306,regulation of focal adhesion assembly (GO:0051893),-1.4811329939203888e-10,0.0
14307,demethylation (GO:0070988),-1.4811329939203888e-10,0.0
14308,protein K48-linked ubiquitination (GO:0070936),-1.4811329939203888e-10,0.0
14309,negative regulation of signaling receptor activity (GO:2000272),-1.4811329939203888e-10,0.0
14310,regulation of neurotransmitter receptor activity (GO:0099601),-1.4811329939203888e-10,0.0
14311,regulation of meiotic cell cycle (GO:0051445),-1.4811329939203888e-10,0.0
14312,regulation of cell-substrate junction assembly (GO:0090109),-1.4811329939203888e-10,0.0
14313,multicellular organismal water homeostasis (GO:0050891),-1.4811329939203888e-10,0.0
14314,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-1.4811329939203888e-10,0.0
14315,negative regulation of synaptic transmission (GO:0050805),-1.4811329939203888e-10,0.0
14316,oligosaccharide metabolic process (GO:0009311),-1.4811329939203888e-10,0.0
14317,proton motive force-driven mitochondrial ATP synthesis (GO:0042776),-1.4811329939203888e-10,0.0
14318,cardiac cell development (GO:0055006),-1.4811329939203888e-10,0.0
14319,positive regulation of dephosphorylation (GO:0035306),-1.4811329939203888e-10,0.0
14320,photoreceptor cell differentiation (GO:0046530),-1.4811329939203888e-10,0.0
14321,regulation of immunoglobulin mediated immune response (GO:0002889),-1.4811329939203888e-10,0.0
14322,actin polymerization or depolymerization (GO:0008154),-1.4811329939203888e-10,0.0
14323,regulation of B cell mediated immunity (GO:0002712),-1.4811329939203888e-10,0.0
14324,regulation of nitric oxide metabolic process (GO:0080164),-1.4811329939203888e-10,0.0
14325,inner ear receptor cell differentiation (GO:0060113),-1.4897638677125427e-10,0.0
14326,protein localization to endoplasmic reticulum (GO:0070972),-1.4897638677125427e-10,0.0
14327,regulation of cilium assembly (GO:1902017),-1.4897638677125427e-10,0.0
14328,regulation of dendrite morphogenesis (GO:0048814),-1.4897638677125427e-10,0.0
14329,positive regulation of DNA-templated transcription initiation (GO:2000144),-1.4897638677125427e-10,0.0
14330,positive regulation of telomere maintenance (GO:0032206),-1.4897638677125427e-10,0.0
14331,negative regulation of axonogenesis (GO:0050771),-1.4897638677125427e-10,0.0
14332,cellular response to hydrogen peroxide (GO:0070301),-1.4897638677125427e-10,0.0
14333,positive regulation of cell killing (GO:0031343),-1.4897638677125427e-10,0.0
14334,positive regulation of Ras protein signal transduction (GO:0046579),-1.4897638677125427e-10,0.0
14335,regulation of smooth muscle cell migration (GO:0014910),-1.4897638677125427e-10,0.0
14336,regulation of phospholipase activity (GO:0010517),-1.4897638677125427e-10,0.0
14337,"negative regulation of gene expression, epigenetic (GO:0045814)",-1.4897638677125427e-10,0.0
14338,renal water homeostasis (GO:0003091),-1.493543066887803e-10,0.0
14339,regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),-1.493543066887803e-10,0.0
14340,alditol metabolic process (GO:0019400),-1.493543066887803e-10,0.0
14341,branching involved in mammary gland duct morphogenesis (GO:0060444),-1.493543066887803e-10,0.0
14342,purine ribonucleoside metabolic process (GO:0046128),-1.493543066887803e-10,0.0
14343,substrate-dependent cell migration (GO:0006929),-1.493543066887803e-10,0.0
14344,regulation of macrophage differentiation (GO:0045649),-1.493543066887803e-10,0.0
14345,regulation of steroid hormone secretion (GO:2000831),-1.493543066887803e-10,0.0
14346,cAMP metabolic process (GO:0046058),-1.493543066887803e-10,0.0
14347,neuromuscular synaptic transmission (GO:0007274),-1.493543066887803e-10,0.0
14348,regulation of ncRNA transcription (GO:0140747),-1.493543066887803e-10,0.0
14349,cyclic purine nucleotide metabolic process (GO:0052652),-1.493543066887803e-10,0.0
14350,regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),-1.493543066887803e-10,0.0
14351,negative regulation of stem cell proliferation (GO:2000647),-1.493543066887803e-10,0.0
14352,regulation of superoxide anion generation (GO:0032928),-1.493543066887803e-10,0.0
14353,somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-1.493543066887803e-10,0.0
14354,centriole replication (GO:0007099),-1.493543066887803e-10,0.0
14355,nuclear migration (GO:0007097),-1.493543066887803e-10,0.0
14356,negative regulation of organic acid transport (GO:0032891),-1.493543066887803e-10,0.0
14357,"regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",-1.493543066887803e-10,0.0
14358,positive regulation of cardiac muscle cell proliferation (GO:0060045),-1.493543066887803e-10,0.0
14359,protein localization to centrosome (GO:0071539),-1.493543066887803e-10,0.0
14360,"mRNA cis splicing, via spliceosome (GO:0045292)",-1.493543066887803e-10,0.0
14361,membrane protein ectodomain proteolysis (GO:0006509),-1.493543066887803e-10,0.0
14362,establishment of pigment granule localization (GO:0051905),-1.493543066887803e-10,0.0
14363,acrosome assembly (GO:0001675),-1.493543066887803e-10,0.0
14364,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-1.493543066887803e-10,0.0
14365,epithelial cell maturation (GO:0002070),-1.493543066887803e-10,0.0
14366,isotype switching (GO:0045190),-1.493543066887803e-10,0.0
14367,regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139),-1.493543066887803e-10,0.0
14368,regulation of NMDA receptor activity (GO:2000310),-1.493543066887803e-10,0.0
14369,protein insertion into ER membrane (GO:0045048),-1.493543066887803e-10,0.0
14370,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-1.493543066887803e-10,0.0
14371,cellular response to vitamin (GO:0071295),-1.493543066887803e-10,0.0
14372,RNA 5'-end processing (GO:0000966),-1.493543066887803e-10,0.0
14373,pyrimidine nucleotide catabolic process (GO:0006244),-1.493543066887803e-10,0.0
14374,cellular response to misfolded protein (GO:0071218),-1.493543066887803e-10,0.0
14375,regulation of brown fat cell differentiation (GO:0090335),-1.493543066887803e-10,0.0
14376,synaptic membrane adhesion (GO:0099560),-1.493543066887803e-10,0.0
14377,histone H2A acetylation (GO:0043968),-1.493543066887803e-10,0.0
14378,positive regulation of triglyceride metabolic process (GO:0090208),-1.493543066887803e-10,0.0
14379,maintenance of protein location in nucleus (GO:0051457),-1.493543066887803e-10,0.0
14380,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-1.493543066887803e-10,0.0
14381,positive regulation of calcineurin-mediated signaling (GO:0106058),-1.493543066887803e-10,0.0
14382,neurotransmitter reuptake (GO:0098810),-1.493543066887803e-10,0.0
14383,positive regulation of monocyte chemotaxis (GO:0090026),-1.493543066887803e-10,0.0
14384,sequestering of metal ion (GO:0051238),-1.493543066887803e-10,0.0
14385,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-1.493543066887803e-10,0.0
14386,glucose 6-phosphate metabolic process (GO:0051156),-1.493543066887803e-10,0.0
14387,membrane raft organization (GO:0031579),-1.493543066887803e-10,0.0
14388,response to immobilization stress (GO:0035902),-1.493543066887803e-10,0.0
14389,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-1.493543066887803e-10,0.0
14390,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-1.493543066887803e-10,0.0
14391,amyloid precursor protein metabolic process (GO:0042982),-1.493543066887803e-10,0.0
14392,COPII vesicle coating (GO:0048208),-1.493543066887803e-10,0.0
14393,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-1.493543066887803e-10,0.0
14394,outer dynein arm assembly (GO:0036158),-1.493543066887803e-10,0.0
14395,positive regulation of long-term synaptic potentiation (GO:1900273),-1.493543066887803e-10,0.0
14396,calcium-mediated signaling using intracellular calcium source (GO:0035584),-1.493543066887803e-10,0.0
14397,regulation of chromatin binding (GO:0035561),-1.493543066887803e-10,0.0
14398,histone H2A monoubiquitination (GO:0035518),-1.493543066887803e-10,0.0
14399,negative regulation of execution phase of apoptosis (GO:1900118),-1.493543066887803e-10,0.0
14400,cyclic nucleotide biosynthetic process (GO:0009190),-1.493543066887803e-10,0.0
14401,filopodium assembly (GO:0046847),-1.493543066887803e-10,0.0
14402,negative regulation of nucleocytoplasmic transport (GO:0046823),-1.493543066887803e-10,0.0
14403,negative regulation of keratinocyte proliferation (GO:0010839),-1.493543066887803e-10,0.0
14404,glycoside metabolic process (GO:0016137),-1.493543066887803e-10,0.0
14405,positive regulation of dendrite extension (GO:1903861),-1.493543066887803e-10,0.0
14406,positive regulation of TORC1 signaling (GO:1904263),-1.493543066887803e-10,0.0
14407,melanocyte differentiation (GO:0030318),-1.493543066887803e-10,0.0
14408,kidney vasculature development (GO:0061440),-1.493543066887803e-10,0.0
14409,renal system vasculature development (GO:0061437),-1.493543066887803e-10,0.0
14410,negative regulation of cardiac muscle cell apoptotic process (GO:0010667),-1.493543066887803e-10,0.0
14411,programmed cell death involved in cell development (GO:0010623),-1.493543066887803e-10,0.0
14412,cytolysis (GO:0019835),-1.493543066887803e-10,0.0
14413,regulation of centriole replication (GO:0046599),-1.493543066887803e-10,0.0
14414,sphingoid metabolic process (GO:0046519),-1.493543066887803e-10,0.0
14415,amyloid-beta clearance (GO:0097242),-1.493543066887803e-10,0.0
14416,positive regulation of glycoprotein biosynthetic process (GO:0010560),-1.493543066887803e-10,0.0
14417,neuronal stem cell population maintenance (GO:0097150),-1.493543066887803e-10,0.0
14418,negative regulation of nucleotide metabolic process (GO:0045980),-1.493543066887803e-10,0.0
14419,atrial septum development (GO:0003283),-1.493543066887803e-10,0.0
14420,regulation of smooth muscle cell apoptotic process (GO:0034391),-1.493543066887803e-10,0.0
14421,plasma lipoprotein particle assembly (GO:0034377),-1.493543066887803e-10,0.0
14422,negative regulation of heart contraction (GO:0045822),-1.493543066887803e-10,0.0
14423,cell proliferation in forebrain (GO:0021846),-1.493543066887803e-10,0.0
14424,negative regulation of response to oxidative stress (GO:1902883),-1.493543066887803e-10,0.0
14425,negative regulation of necrotic cell death (GO:0060547),-1.493543066887803e-10,0.0
14426,negative regulation of Notch signaling pathway (GO:0045746),-1.494824264258029e-10,0.0
14427,positive regulation of lamellipodium organization (GO:1902745),-1.494824264258029e-10,0.0
14428,regulation of homotypic cell-cell adhesion (GO:0034110),-1.494824264258029e-10,0.0
14429,regulation of keratinocyte differentiation (GO:0045616),-1.494824264258029e-10,0.0
14430,modified amino acid transport (GO:0072337),-1.494824264258029e-10,0.0
14431,secondary alcohol biosynthetic process (GO:1902653),-1.494824264258029e-10,0.0
14432,nucleotide transport (GO:0006862),-1.494824264258029e-10,0.0
14433,inner ear receptor cell stereocilium organization (GO:0060122),-1.494824264258029e-10,0.0
14434,cholesterol biosynthetic process (GO:0006695),-1.494824264258029e-10,0.0
14435,late endosome to vacuole transport (GO:0045324),-1.494824264258029e-10,0.0
14436,negative regulation of chromosome segregation (GO:0051985),-1.494824264258029e-10,0.0
14437,signaling receptor ligand precursor processing (GO:0140448),-1.494824264258029e-10,0.0
14438,regulation of isotype switching (GO:0045191),-1.494824264258029e-10,0.0
14439,small regulatory ncRNA processing (GO:0070918),-1.494824264258029e-10,0.0
14440,quinone metabolic process (GO:1901661),-1.494824264258029e-10,0.0
14441,cellular response to cadmium ion (GO:0071276),-1.494824264258029e-10,0.0
14442,melanosome organization (GO:0032438),-1.494824264258029e-10,0.0
14443,negative regulation of chromosome separation (GO:1905819),-1.494824264258029e-10,0.0
14444,positive regulation of cholesterol transport (GO:0032376),-1.494824264258029e-10,0.0
14445,positive regulation of sterol transport (GO:0032373),-1.494824264258029e-10,0.0
14446,regulation of nitric-oxide synthase activity (GO:0050999),-1.494824264258029e-10,0.0
14447,sulfur compound catabolic process (GO:0044273),-1.494824264258029e-10,0.0
14448,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-1.494824264258029e-10,0.0
14449,RNA polyadenylation (GO:0043631),-1.494824264258029e-10,0.0
14450,positive regulation of nervous system process (GO:0031646),-1.494824264258029e-10,0.0
14451,triglyceride homeostasis (GO:0070328),-1.494824264258029e-10,0.0
14452,smooth muscle cell differentiation (GO:0051145),-1.494824264258029e-10,0.0
14453,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-1.494824264258029e-10,0.0
14454,spliceosomal snRNP assembly (GO:0000387),-1.494824264258029e-10,0.0
14455,rRNA modification (GO:0000154),-1.494824264258029e-10,0.0
14456,acylglycerol homeostasis (GO:0055090),-1.494824264258029e-10,0.0
14457,regulation of macrophage cytokine production (GO:0010935),-1.494824264258029e-10,0.0
14458,serine family amino acid metabolic process (GO:0009069),-1.494824264258029e-10,0.0
14459,cardiac muscle cell action potential involved in contraction (GO:0086002),-1.494824264258029e-10,0.0
14460,regulation of phospholipid metabolic process (GO:1903725),-1.494824264258029e-10,0.0
14461,ncRNA catabolic process (GO:0034661),-1.494824264258029e-10,0.0
14462,bile acid metabolic process (GO:0008206),-1.494824264258029e-10,0.0
14463,actin filament polymerization (GO:0030041),-1.494824264258029e-10,0.0
14464,positive regulation of fatty acid metabolic process (GO:0045923),-1.494824264258029e-10,0.0
14465,central nervous system neuron axonogenesis (GO:0021955),-1.494824264258029e-10,0.0
14466,negative regulation of JNK cascade (GO:0046329),-1.494824264258029e-10,0.0
14467,dendritic cell differentiation (GO:0097028),-1.494824264258029e-10,0.0
14468,cardiac conduction system development (GO:0003161),-1.494824264258029e-10,0.0
14469,regulation of heart growth (GO:0060420),-1.4968959404216697e-10,0.0
14470,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-1.4968959404216697e-10,0.0
14471,telencephalon cell migration (GO:0022029),-1.4968959404216697e-10,0.0
14472,cell cycle G2/M phase transition (GO:0044839),-1.4968959404216697e-10,0.0
14473,ERBB signaling pathway (GO:0038127),-1.4968959404216697e-10,0.0
14474,cellular pigmentation (GO:0033059),-1.4968959404216697e-10,0.0
14475,heterochromatin organization (GO:0070828),-1.4968959404216697e-10,0.0
14476,regulation of protein deacetylation (GO:0090311),-1.4968959404216697e-10,0.0
14477,motile cilium assembly (GO:0044458),-1.4968959404216697e-10,0.0
14478,histone H3 acetylation (GO:0043966),-1.4968959404216697e-10,0.0
14479,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-1.4968959404216697e-10,0.0
14480,detection of light stimulus (GO:0009583),-1.4968959404216697e-10,0.0
14481,antigen processing and presentation of peptide antigen (GO:0048002),-1.4968959404216697e-10,0.0
14482,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-1.4968959404216697e-10,0.0
14483,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-1.4968959404216697e-10,0.0
14484,regulation of telomere maintenance via telomere lengthening (GO:1904356),-1.4968959404216697e-10,0.0
14485,ribosome assembly (GO:0042255),-1.4968959404216697e-10,0.0
14486,tissue regeneration (GO:0042246),-1.4968959404216697e-10,0.0
14487,positive regulation of bone resorption (GO:0045780),-1.4996004437092515e-10,0.0
14488,glomerular filtration (GO:0003094),-1.4996004437092515e-10,0.0
14489,nucleobase biosynthetic process (GO:0046112),-1.4996004437092515e-10,0.0
14490,toll-like receptor 4 signaling pathway (GO:0034142),-1.4996004437092515e-10,0.0
14491,regulation of monocyte differentiation (GO:0045655),-1.4996004437092515e-10,0.0
14492,epoxygenase P450 pathway (GO:0019373),-1.4996004437092515e-10,0.0
14493,positive regulation of SMAD protein signal transduction (GO:0060391),-1.4996004437092515e-10,0.0
14494,positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-1.4996004437092515e-10,0.0
14495,negative regulation of anoikis (GO:2000811),-1.4996004437092515e-10,0.0
14496,antigen processing and presentation of endogenous peptide antigen (GO:0002483),-1.4996004437092515e-10,0.0
14497,regulation of cholesterol biosynthetic process (GO:0045540),-1.4996004437092515e-10,0.0
14498,positive regulation of neuron migration (GO:2001224),-1.4996004437092515e-10,0.0
14499,positive regulation of autophagosome assembly (GO:2000786),-1.4996004437092515e-10,0.0
14500,long-term synaptic depression (GO:0060292),-1.4996004437092515e-10,0.0
14501,"regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-1.4996004437092515e-10,0.0
14502,regulation of endocytic recycling (GO:2001135),-1.4996004437092515e-10,0.0
14503,phagolysosome assembly (GO:0001845),-1.4996004437092515e-10,0.0
14504,metanephric tubule development (GO:0072170),-1.4996004437092515e-10,0.0
14505,trophectodermal cell differentiation (GO:0001829),-1.4996004437092515e-10,0.0
14506,regulation of early endosome to late endosome transport (GO:2000641),-1.4996004437092515e-10,0.0
14507,macrophage activation involved in immune response (GO:0002281),-1.4996004437092515e-10,0.0
14508,NLS-bearing protein import into nucleus (GO:0006607),-1.4996004437092515e-10,0.0
14509,vocalization behavior (GO:0071625),-1.4996004437092515e-10,0.0
14510,positive regulation of cell cycle checkpoint (GO:1901978),-1.4996004437092515e-10,0.0
14511,positive regulation of mitotic sister chromatid separation (GO:1901970),-1.4996004437092515e-10,0.0
14512,regulation of exit from mitosis (GO:0007096),-1.4996004437092515e-10,0.0
14513,auditory receptor cell stereocilium organization (GO:0060088),-1.4996004437092515e-10,0.0
14514,pericardium development (GO:0060039),-1.4996004437092515e-10,0.0
14515,polyamine metabolic process (GO:0006595),-1.4996004437092515e-10,0.0
14516,inositol phosphate catabolic process (GO:0071545),-1.4996004437092515e-10,0.0
14517,positive regulation of protein depolymerization (GO:1901881),-1.4996004437092515e-10,0.0
14518,regulation of cAMP-dependent protein kinase activity (GO:2000479),-1.4996004437092515e-10,0.0
14519,negative regulation of interleukin-8 production (GO:0032717),-1.4996004437092515e-10,0.0
14520,response to vitamin A (GO:0033189),-1.4996004437092515e-10,0.0
14521,oxidative demethylation (GO:0070989),-1.4996004437092515e-10,0.0
14522,regulation of clathrin-dependent endocytosis (GO:2000369),-1.4996004437092515e-10,0.0
14523,positive regulation of endothelial cell apoptotic process (GO:2000353),-1.4996004437092515e-10,0.0
14524,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-1.4996004437092515e-10,0.0
14525,cellular response to reactive nitrogen species (GO:1902170),-1.4996004437092515e-10,0.0
14526,regulation of hair follicle development (GO:0051797),-1.4996004437092515e-10,0.0
14527,cellular response to exogenous dsRNA (GO:0071360),-1.4996004437092515e-10,0.0
14528,nucleosome disassembly (GO:0006337),-1.4996004437092515e-10,0.0
14529,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-1.4996004437092515e-10,0.0
14530,regulation of fibroblast apoptotic process (GO:2000269),-1.4996004437092515e-10,0.0
14531,positive regulation of actin cytoskeleton reorganization (GO:2000251),-1.4996004437092515e-10,0.0
14532,regulation of DNA methylation-dependent heterochromatin formation (GO:0090308),-1.4996004437092515e-10,0.0
14533,regulation of cell proliferation involved in heart morphogenesis (GO:2000136),-1.4996004437092515e-10,0.0
14534,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-1.4996004437092515e-10,0.0
14535,regulation of sterol biosynthetic process (GO:0106118),-1.4996004437092515e-10,0.0
14536,regulation of phospholipid biosynthetic process (GO:0071071),-1.4996004437092515e-10,0.0
14537,DNA double-strand break processing (GO:0000729),-1.4996004437092515e-10,0.0
14538,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-1.4996004437092515e-10,0.0
14539,calcium ion import (GO:0070509),-1.4996004437092515e-10,0.0
14540,regulation of tubulin deacetylation (GO:0090043),-1.4996004437092515e-10,0.0
14541,regulation of protein kinase C signaling (GO:0090036),-1.4996004437092515e-10,0.0
14542,lymph node development (GO:0048535),-1.4996004437092515e-10,0.0
14543,response to mitochondrial depolarisation (GO:0098780),-1.4996004437092515e-10,0.0
14544,small regulatory ncRNA 3'-end processing (GO:0043628),-1.4996004437092515e-10,0.0
14545,positive regulation of lymphocyte apoptotic process (GO:0070230),-1.4996004437092515e-10,0.0
14546,paraxial mesoderm development (GO:0048339),-1.4996004437092515e-10,0.0
14547,lymph vessel morphogenesis (GO:0036303),-1.4996004437092515e-10,0.0
14548,response to oxygen radical (GO:0000305),-1.4996004437092515e-10,0.0
14549,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-1.4996004437092515e-10,0.0
14550,negative regulation of B cell proliferation (GO:0030889),-1.4996004437092515e-10,0.0
14551,base conversion or substitution editing (GO:0016553),-1.4996004437092515e-10,0.0
14552,retinal ganglion cell axon guidance (GO:0031290),-1.4996004437092515e-10,0.0
14553,fibrinolysis (GO:0042730),-1.4996004437092515e-10,0.0
14554,regulation of amyloid-beta clearance (GO:1900221),-1.4996004437092515e-10,0.0
14555,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-1.4996004437092515e-10,0.0
14556,copper ion homeostasis (GO:0055070),-1.4996004437092515e-10,0.0
14557,pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148),-1.4996004437092515e-10,0.0
14558,nucleoside monophosphate catabolic process (GO:0009125),-1.4996004437092515e-10,0.0
14559,retinal metabolic process (GO:0042574),-1.4996004437092515e-10,0.0
14560,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-1.4996004437092515e-10,0.0
14561,detoxification of inorganic compound (GO:0061687),-1.4996004437092515e-10,0.0
14562,negative regulation of bone mineralization (GO:0030502),-1.4996004437092515e-10,0.0
14563,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-1.4996004437092515e-10,0.0
14564,negative regulation of bone remodeling (GO:0046851),-1.4996004437092515e-10,0.0
14565,magnesium ion transport (GO:0015693),-1.4996004437092515e-10,0.0
14566,regulation of vesicle size (GO:0097494),-1.4996004437092515e-10,0.0
14567,fibroblast migration (GO:0010761),-1.4996004437092515e-10,0.0
14568,positive regulation of macrophage chemotaxis (GO:0010759),-1.4996004437092515e-10,0.0
14569,dendritic spine morphogenesis (GO:0060997),-1.4996004437092515e-10,0.0
14570,monocyte differentiation (GO:0030224),-1.4996004437092515e-10,0.0
14571,miRNA metabolic process (GO:0010586),-1.4996004437092515e-10,0.0
14572,retina vasculature development in camera-type eye (GO:0061298),-1.4996004437092515e-10,0.0
14573,regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923),-1.4996004437092515e-10,0.0
14574,vesicle transport along actin filament (GO:0030050),-1.4996004437092515e-10,0.0
14575,postsynaptic density organization (GO:0097106),-1.4996004437092515e-10,0.0
14576,positive regulation of T-helper 1 type immune response (GO:0002827),-1.4996004437092515e-10,0.0
14577,negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-1.4996004437092515e-10,0.0
14578,positive regulation of transcription by RNA polymerase III (GO:0045945),-1.4996004437092515e-10,0.0
14579,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-1.4996004437092515e-10,0.0
14580,regulation of hydrogen peroxide metabolic process (GO:0010310),-1.4996004437092515e-10,0.0
14581,positive regulation of dendritic spine morphogenesis (GO:0061003),-1.4996004437092515e-10,0.0
14582,morphogenesis of an epithelial fold (GO:0060571),-1.4996004437092515e-10,0.0
14583,positive regulation of axon extension (GO:0045773),-1.5337620061717863e-10,0.0
14584,regulation of actin filament-based movement (GO:1903115),-1.5337620061717863e-10,0.0
14585,hexose catabolic process (GO:0019320),-1.5337620061717863e-10,0.0
14586,one-carbon metabolic process (GO:0006730),-1.5337620061717863e-10,0.0
14587,regulation of transforming growth factor beta production (GO:0071634),-1.5337620061717863e-10,0.0
14588,regulation of cardiac muscle cell proliferation (GO:0060043),-1.5337620061717863e-10,0.0
14589,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-1.5337620061717863e-10,0.0
14590,Schwann cell differentiation (GO:0014037),-1.5337620061717863e-10,0.0
14591,cell-cell fusion (GO:0140253),-1.5337620061717863e-10,0.0
14592,brain morphogenesis (GO:0048854),-1.5337620061717863e-10,0.0
14593,peptidyl-cysteine modification (GO:0018198),-1.5337620061717863e-10,0.0
14594,establishment of mitotic spindle localization (GO:0040001),-1.5337620061717863e-10,0.0
14595,pigment granule organization (GO:0048753),-1.5337620061717863e-10,0.0
14596,intracellular lipid transport (GO:0032365),-1.5337620061717863e-10,0.0
14597,syncytium formation by plasma membrane fusion (GO:0000768),-1.5337620061717863e-10,0.0
14598,DNA synthesis involved in DNA repair (GO:0000731),-1.5337620061717863e-10,0.0
14599,COPII-coated vesicle budding (GO:0090114),-1.5337620061717863e-10,0.0
14600,lipopolysaccharide-mediated signaling pathway (GO:0031663),-1.5337620061717863e-10,0.0
14601,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-1.5337620061717863e-10,0.0
14602,detection of biotic stimulus (GO:0009595),-1.5337620061717863e-10,0.0
14603,cytochrome complex assembly (GO:0017004),-1.5337620061717863e-10,0.0
14604,cortical actin cytoskeleton organization (GO:0030866),-1.5337620061717863e-10,0.0
14605,leukocyte degranulation (GO:0043299),-1.5337620061717863e-10,0.0
14606,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-1.5337620061717863e-10,0.0
14607,post-transcriptional gene silencing (GO:0016441),-1.5337620061717863e-10,0.0
14608,positive regulation of BMP signaling pathway (GO:0030513),-1.5337620061717863e-10,0.0
14609,negative regulation of phosphatase activity (GO:0010923),-1.5337620061717863e-10,0.0
14610,positive regulation of glucose metabolic process (GO:0010907),-1.5337620061717863e-10,0.0
14611,fatty-acyl-CoA metabolic process (GO:0035337),-1.5337620061717863e-10,0.0
14612,microtubule polymerization (GO:0046785),-1.5337620061717863e-10,0.0
14613,regulation of fibroblast migration (GO:0010762),-1.5337620061717863e-10,0.0
14614,estrogen metabolic process (GO:0008210),-1.5337620061717863e-10,0.0
14615,protein localization to microtubule cytoskeleton (GO:0072698),-1.5337620061717863e-10,0.0
14616,pyrimidine-containing compound catabolic process (GO:0072529),-1.5337620061717863e-10,0.0
14617,pyrimidine-containing compound biosynthetic process (GO:0072528),-1.5337620061717863e-10,0.0
14618,sulfur compound transport (GO:0072348),-1.5415513309113585e-10,0.0
14619,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-1.5415513309113585e-10,0.0
14620,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-1.5415513309113585e-10,0.0
14621,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-1.5415513309113585e-10,0.0
14622,regulation of extracellular matrix organization (GO:1903053),-1.5415513309113585e-10,0.0
14623,B cell activation involved in immune response (GO:0002312),-1.5415513309113585e-10,0.0
14624,leukocyte cell-cell adhesion (GO:0007159),-1.5415513309113585e-10,0.0
14625,reciprocal meiotic recombination (GO:0007131),-1.5415513309113585e-10,0.0
14626,reciprocal homologous recombination (GO:0140527),-1.5415513309113585e-10,0.0
14627,regulation of mitotic sister chromatid segregation (GO:0033047),-1.5415513309113585e-10,0.0
14628,DNA-templated DNA replication maintenance of fidelity (GO:0045005),-1.5415513309113585e-10,0.0
14629,nucleotide-excision repair (GO:0006289),-1.5415513309113585e-10,0.0
14630,aorta development (GO:0035904),-1.5415513309113585e-10,0.0
14631,positive regulation of receptor-mediated endocytosis (GO:0048260),-1.5415513309113585e-10,0.0
14632,mRNA stabilization (GO:0048255),-1.5415513309113585e-10,0.0
14633,response to dsRNA (GO:0043331),-1.5415513309113585e-10,0.0
14634,regulation of actin filament depolymerization (GO:0030834),-1.5415513309113585e-10,0.0
14635,intracellular steroid hormone receptor signaling pathway (GO:0030518),-1.5415513309113585e-10,0.0
14636,regulation of centrosome cycle (GO:0046605),-1.5415513309113585e-10,0.0
14637,negative regulation of lymphocyte mediated immunity (GO:0002707),-1.5415513309113585e-10,0.0
14638,nucleoside bisphosphate biosynthetic process (GO:0033866),-1.5415513309113585e-10,0.0
14639,heterotypic cell-cell adhesion (GO:0034113),-1.56382462522793e-10,0.0
14640,vesicle coating (GO:0006901),-1.56382462522793e-10,0.0
14641,regulation of endothelial cell differentiation (GO:0045601),-1.56382462522793e-10,0.0
14642,regulation of autophagy of mitochondrion (GO:1903146),-1.56382462522793e-10,0.0
14643,negative regulation of mitotic sister chromatid separation (GO:2000816),-1.56382462522793e-10,0.0
14644,intra-Golgi vesicle-mediated transport (GO:0006891),-1.56382462522793e-10,0.0
14645,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-1.56382462522793e-10,0.0
14646,negative regulation of cell-matrix adhesion (GO:0001953),-1.56382462522793e-10,0.0
14647,regulation of polysaccharide biosynthetic process (GO:0032885),-1.56382462522793e-10,0.0
14648,protein transmembrane import into intracellular organelle (GO:0044743),-1.56382462522793e-10,0.0
14649,NIK/NF-kappaB signaling (GO:0038061),-1.56382462522793e-10,0.0
14650,positive regulation of interleukin-2 production (GO:0032743),-1.56382462522793e-10,0.0
14651,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-1.56382462522793e-10,0.0
14652,mRNA polyadenylation (GO:0006378),-1.56382462522793e-10,0.0
14653,protein targeting to ER (GO:0045047),-1.56382462522793e-10,0.0
14654,negative regulation of mitotic sister chromatid segregation (GO:0033048),-1.56382462522793e-10,0.0
14655,negative regulation of sister chromatid segregation (GO:0033046),-1.56382462522793e-10,0.0
14656,regulation of amyloid-beta formation (GO:1902003),-1.56382462522793e-10,0.0
14657,peptide cross-linking (GO:0018149),-1.56382462522793e-10,0.0
14658,aminoglycan catabolic process (GO:0006026),-1.56382462522793e-10,0.0
14659,positive regulation of membrane permeability (GO:1905710),-1.56382462522793e-10,0.0
14660,protein K63-linked deubiquitination (GO:0070536),-1.56382462522793e-10,0.0
14661,sperm flagellum assembly (GO:0120316),-1.56382462522793e-10,0.0
14662,negative regulation of telomere maintenance (GO:0032205),-1.56382462522793e-10,0.0
14663,spleen development (GO:0048536),-1.56382462522793e-10,0.0
14664,positive regulation of dendrite morphogenesis (GO:0050775),-1.56382462522793e-10,0.0
14665,maturation of 5.8S rRNA (GO:0000460),-1.56382462522793e-10,0.0
14666,negative regulation of signal transduction in absence of ligand (GO:1901099),-1.56382462522793e-10,0.0
14667,epithelial cell differentiation involved in kidney development (GO:0035850),-1.56382462522793e-10,0.0
14668,fibroblast proliferation (GO:0048144),-1.56382462522793e-10,0.0
14669,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-1.56382462522793e-10,0.0
14670,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-1.56382462522793e-10,0.0
14671,glial cell activation (GO:0061900),-1.56382462522793e-10,0.0
14672,positive regulation of protein-containing complex disassembly (GO:0043243),-1.56382462522793e-10,0.0
14673,peptide hormone processing (GO:0016486),-1.56382462522793e-10,0.0
14674,platelet-derived growth factor receptor signaling pathway (GO:0048008),-1.56382462522793e-10,0.0
14675,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-1.56382462522793e-10,0.0
14676,positive regulation of phosphatase activity (GO:0010922),-1.56382462522793e-10,0.0
14677,eye photoreceptor cell development (GO:0042462),-1.56382462522793e-10,0.0
14678,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-1.56382462522793e-10,0.0
14679,positive regulation of epithelial cell apoptotic process (GO:1904037),-1.56382462522793e-10,0.0
14680,myotube cell development (GO:0014904),-1.56382462522793e-10,0.0
14681,positive regulation of ATP metabolic process (GO:1903580),-1.56382462522793e-10,0.0
14682,phosphatidic acid metabolic process (GO:0046473),-1.56382462522793e-10,0.0
14683,membrane lipid catabolic process (GO:0046466),-1.56382462522793e-10,0.0
14684,long-term memory (GO:0007616),-1.56382462522793e-10,0.0
14685,regulation of lamellipodium organization (GO:1902743),-1.5656897999090085e-10,0.0
14686,Golgi to plasma membrane transport (GO:0006893),-1.5656897999090085e-10,0.0
14687,response to zinc ion (GO:0010043),-1.5656897999090085e-10,0.0
14688,intracellular protein transmembrane transport (GO:0065002),-1.5656897999090085e-10,0.0
14689,male meiotic nuclear division (GO:0007140),-1.5656897999090085e-10,0.0
14690,homologous chromosome pairing at meiosis (GO:0007129),-1.5656897999090085e-10,0.0
14691,positive regulation of stress fiber assembly (GO:0051496),-1.5656897999090085e-10,0.0
14692,oocyte differentiation (GO:0009994),-1.5656897999090085e-10,0.0
14693,negative regulation of smooth muscle cell proliferation (GO:0048662),-1.5656897999090085e-10,0.0
14694,negative regulation of sequestering of calcium ion (GO:0051283),-1.5656897999090085e-10,0.0
14695,positive regulation of actin filament polymerization (GO:0030838),-1.5656897999090085e-10,0.0
14696,negative regulation of mitochondrion organization (GO:0010823),-1.5656897999090085e-10,0.0
14697,osteoclast differentiation (GO:0030316),-1.5656897999090085e-10,0.0
14698,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-1.5656897999090085e-10,0.0
14699,negative regulation of Ras protein signal transduction (GO:0046580),-1.5656897999090085e-10,0.0
14700,negative regulation of endothelial cell migration (GO:0010596),-1.5656897999090085e-10,0.0
14701,visual behavior (GO:0007632),-1.5656897999090085e-10,0.0
14702,alcohol catabolic process (GO:0046164),-1.589011144760606e-10,0.0
14703,somatic diversification of immune receptors (GO:0002200),-1.589011144760606e-10,0.0
14704,modulation by symbiont of entry into host (GO:0052372),-1.589011144760606e-10,0.0
14705,membrane depolarization (GO:0051899),-1.589011144760606e-10,0.0
14706,pyrimidine nucleotide metabolic process (GO:0006220),-1.589011144760606e-10,0.0
14707,negative regulation of leukocyte apoptotic process (GO:2000107),-1.589011144760606e-10,0.0
14708,cellular glucan metabolic process (GO:0006073),-1.589011144760606e-10,0.0
14709,establishment of spindle localization (GO:0051293),-1.589011144760606e-10,0.0
14710,glucan metabolic process (GO:0044042),-1.589011144760606e-10,0.0
14711,regulation of carbohydrate catabolic process (GO:0043470),-1.589011144760606e-10,0.0
14712,negative regulation of lipid biosynthetic process (GO:0051055),-1.589011144760606e-10,0.0
14713,regulation of microtubule polymerization (GO:0031113),-1.589011144760606e-10,0.0
14714,regulation of cardiac muscle tissue growth (GO:0055021),-1.589011144760606e-10,0.0
14715,protein localization to synapse (GO:0035418),-1.589011144760606e-10,0.0
14716,retinol metabolic process (GO:0042572),-1.589011144760606e-10,0.0
14717,maturation of SSU-rRNA (GO:0030490),-1.589011144760606e-10,0.0
14718,cyclic-nucleotide-mediated signaling (GO:0019935),-1.589011144760606e-10,0.0
14719,establishment or maintenance of apical/basal cell polarity (GO:0035088),-1.589011144760606e-10,0.0
14720,cellular response to glucose starvation (GO:0042149),-1.589011144760606e-10,0.0
14721,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-1.589011144760606e-10,0.0
14722,response to ischemia (GO:0002931),-1.589011144760606e-10,0.0
14723,positive regulation of phospholipase activity (GO:0010518),-1.589011144760606e-10,0.0
14724,establishment or maintenance of bipolar cell polarity (GO:0061245),-1.589011144760606e-10,0.0
14725,ventricular cardiac muscle tissue development (GO:0003229),-1.589011144760606e-10,0.0
14726,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-1.597915133416681e-10,0.0
14727,regulation of cellular senescence (GO:2000772),-1.597915133416681e-10,0.0
14728,glutamate receptor signaling pathway (GO:0007215),-1.597915133416681e-10,0.0
14729,immunoglobulin production involved in immunoglobulin-mediated immune response (GO:0002381),-1.597915133416681e-10,0.0
14730,blastocyst formation (GO:0001825),-1.597915133416681e-10,0.0
14731,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-1.597915133416681e-10,0.0
14732,histone H3-K4 methylation (GO:0051568),-1.597915133416681e-10,0.0
14733,embryonic cranial skeleton morphogenesis (GO:0048701),-1.597915133416681e-10,0.0
14734,cellular response to nerve growth factor stimulus (GO:1990090),-1.597915133416681e-10,0.0
14735,histone ubiquitination (GO:0016574),-1.597915133416681e-10,0.0
14736,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-1.597915133416681e-10,0.0
14737,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-1.597915133416681e-10,0.0
14738,amino acid activation (GO:0043038),-1.597915133416681e-10,0.0
14739,negative regulation of axon extension (GO:0030517),-1.597915133416681e-10,0.0
14740,bone remodeling (GO:0046849),-1.597915133416681e-10,0.0
14741,regulation of gene silencing by RNA (GO:0060966),-1.597915133416681e-10,0.0
14742,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-1.597915133416681e-10,0.0
14743,regulation of humoral immune response (GO:0002920),-1.597915133416681e-10,0.0
14744,NADH dehydrogenase complex assembly (GO:0010257),-1.6009882307483518e-10,0.0
14745,smooth muscle contraction (GO:0006939),-1.6009882307483518e-10,0.0
14746,homotypic cell-cell adhesion (GO:0034109),-1.6009882307483518e-10,0.0
14747,positive regulation of protein localization to plasma membrane (GO:1903078),-1.6009882307483518e-10,0.0
14748,water-soluble vitamin metabolic process (GO:0006767),-1.6009882307483518e-10,0.0
14749,mitochondrial respiratory chain complex I assembly (GO:0032981),-1.6009882307483518e-10,0.0
14750,fatty acid beta-oxidation (GO:0006635),-1.6009882307483518e-10,0.0
14751,protein targeting to mitochondrion (GO:0006626),-1.6009882307483518e-10,0.0
14752,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-1.6009882307483518e-10,0.0
14753,positive regulation of nuclear division (GO:0051785),-1.6009882307483518e-10,0.0
14754,spindle localization (GO:0051653),-1.6009882307483518e-10,0.0
14755,cellular senescence (GO:0090398),-1.6009882307483518e-10,0.0
14756,cellular component maintenance (GO:0043954),-1.6009882307483518e-10,0.0
14757,negative regulation of intracellular transport (GO:0032387),-1.6009882307483518e-10,0.0
14758,axonal transport (GO:0098930),-1.6009882307483518e-10,0.0
14759,positive regulation of oxidoreductase activity (GO:0051353),-1.6009882307483518e-10,0.0
14760,regulation of JUN kinase activity (GO:0043506),-1.6009882307483518e-10,0.0
14761,actin filament bundle assembly (GO:0051017),-1.6009882307483518e-10,0.0
14762,cortical cytoskeleton organization (GO:0030865),-1.6009882307483518e-10,0.0
14763,histone deacetylation (GO:0016575),-1.6009882307483518e-10,0.0
14764,regulation of mitochondrial membrane permeability (GO:0046902),-1.6009882307483518e-10,0.0
14765,negative regulation of cell-substrate adhesion (GO:0010812),-1.6009882307483518e-10,0.0
14766,collagen fibril organization (GO:0030199),-1.6009882307483518e-10,0.0
14767,macrophage activation (GO:0042116),-1.6009882307483518e-10,0.0
14768,positive regulation of phosphorus metabolic process (GO:0010562),-1.6124879208355715e-10,0.9685902461972714
14769,positive regulation of phosphate metabolic process (GO:0045937),-1.6124879208355715e-10,0.9685902461972714
14770,U2-type prespliceosome assembly (GO:1903241),-1.6232881704173776e-10,0.0
14771,renal system process involved in regulation of systemic arterial blood pressure (GO:0003071),-1.6232881704173776e-10,0.0
14772,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-1.6232881704173776e-10,0.0
14773,regulation of heterotypic cell-cell adhesion (GO:0034114),-1.6232881704173776e-10,0.0
14774,negative regulation of tissue remodeling (GO:0034104),-1.6232881704173776e-10,0.0
14775,acrosome reaction (GO:0007340),-1.6232881704173776e-10,0.0
14776,trabecula formation (GO:0060343),-1.6232881704173776e-10,0.0
14777,water transport (GO:0006833),-1.6232881704173776e-10,0.0
14778,positive regulation of regulatory T cell differentiation (GO:0045591),-1.6232881704173776e-10,0.0
14779,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-1.6232881704173776e-10,0.0
14780,negative regulation of cellular senescence (GO:2000773),-1.6232881704173776e-10,0.0
14781,positive regulation of stem cell differentiation (GO:2000738),-1.6232881704173776e-10,0.0
14782,response to tumor cell (GO:0002347),-1.6232881704173776e-10,0.0
14783,platelet dense granule organization (GO:0060155),-1.6232881704173776e-10,0.0
14784,positive regulation of miRNA-mediated gene silencing (GO:2000637),-1.6232881704173776e-10,0.0
14785,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-1.6232881704173776e-10,0.0
14786,phosphatidylserine metabolic process (GO:0006658),-1.6232881704173776e-10,0.0
14787,negative regulation of protein acetylation (GO:1901984),-1.6232881704173776e-10,0.0
14788,"synaptic transmission, GABAergic (GO:0051932)",-1.6232881704173776e-10,0.0
14789,sulfation (GO:0051923),-1.6232881704173776e-10,0.0
14790,nuclear DNA replication (GO:0033260),-1.6232881704173776e-10,0.0
14791,Fc-epsilon receptor signaling pathway (GO:0038095),-1.6232881704173776e-10,0.0
14792,vascular endothelial growth factor signaling pathway (GO:0038084),-1.6232881704173776e-10,0.0
14793,hematopoietic stem cell proliferation (GO:0071425),-1.6232881704173776e-10,0.0
14794,negative regulation of chemokine production (GO:0032682),-1.6232881704173776e-10,0.0
14795,cellular response to dsRNA (GO:0071359),-1.6232881704173776e-10,0.0
14796,regulation of mitotic spindle assembly (GO:1901673),-1.6232881704173776e-10,0.0
14797,neurotransmitter receptor transport (GO:0099637),-1.6232881704173776e-10,0.0
14798,protein N-linked glycosylation via asparagine (GO:0018279),-1.6232881704173776e-10,0.0
14799,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-1.6232881704173776e-10,0.0
14800,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-1.6232881704173776e-10,0.0
14801,pyrimidine nucleoside metabolic process (GO:0006213),-1.6232881704173776e-10,0.0
14802,melanosome localization (GO:0032400),-1.6232881704173776e-10,0.0
14803,peptidyl-lysine dimethylation (GO:0018027),-1.6232881704173776e-10,0.0
14804,relaxation of muscle (GO:0090075),-1.6232881704173776e-10,0.0
14805,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-1.6232881704173776e-10,0.0
14806,circadian behavior (GO:0048512),-1.6232881704173776e-10,0.0
14807,keratinocyte proliferation (GO:0043616),-1.6232881704173776e-10,0.0
14808,protein localization to microtubule organizing center (GO:1905508),-1.6232881704173776e-10,0.0
14809,regulation of respiratory gaseous exchange (GO:0043576),-1.6232881704173776e-10,0.0
14810,"alternative mRNA splicing, via spliceosome (GO:0000380)",-1.6232881704173776e-10,0.0
14811,regulation of long-term neuronal synaptic plasticity (GO:0048169),-1.6232881704173776e-10,0.0
14812,regulation of vascular associated smooth muscle cell migration (GO:1904752),-1.6232881704173776e-10,0.0
14813,granulocyte differentiation (GO:0030851),-1.6232881704173776e-10,0.0
14814,response to platelet-derived growth factor (GO:0036119),-1.6232881704173776e-10,0.0
14815,negative regulation of cyclase activity (GO:0031280),-1.6232881704173776e-10,0.0
14816,rRNA transcription (GO:0009303),-1.6232881704173776e-10,0.0
14817,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-1.6232881704173776e-10,0.0
14818,anaphase-promoting complex-dependent catabolic process (GO:0031145),-1.6232881704173776e-10,0.0
14819,pyrimidine ribonucleotide biosynthetic process (GO:0009220),-1.6232881704173776e-10,0.0
14820,cellular response to interferon-beta (GO:0035458),-1.6232881704173776e-10,0.0
14821,negative regulation of cardiac muscle tissue growth (GO:0055022),-1.6232881704173776e-10,0.0
14822,pyrimidine nucleoside monophosphate metabolic process (GO:0009129),-1.6232881704173776e-10,0.0
14823,superoxide anion generation (GO:0042554),-1.6232881704173776e-10,0.0
14824,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-1.6232881704173776e-10,0.0
14825,negative regulation of steroid biosynthetic process (GO:0010894),-1.6232881704173776e-10,0.0
14826,positive regulation of lipid storage (GO:0010884),-1.6232881704173776e-10,0.0
14827,hematopoietic stem cell homeostasis (GO:0061484),-1.6232881704173776e-10,0.0
14828,translesion synthesis (GO:0019985),-1.6232881704173776e-10,0.0
14829,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531),-1.6232881704173776e-10,0.0
14830,left/right pattern formation (GO:0060972),-1.6232881704173776e-10,0.0
14831,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-1.6232881704173776e-10,0.0
14832,negative regulation of Rho protein signal transduction (GO:0035024),-1.6232881704173776e-10,0.0
14833,regulation of Rac protein signal transduction (GO:0035020),-1.6232881704173776e-10,0.0
14834,negative regulation of viral entry into host cell (GO:0046597),-1.6232881704173776e-10,0.0
14835,piRNA metabolic process (GO:0034587),-1.6232881704173776e-10,0.0
14836,one-carbon compound transport (GO:0019755),-1.6232881704173776e-10,0.0
14837,amelogenesis (GO:0097186),-1.6232881704173776e-10,0.0
14838,establishment of monopolar cell polarity (GO:0061162),-1.6232881704173776e-10,0.0
14839,negative regulation of heart growth (GO:0061117),-1.6232881704173776e-10,0.0
14840,plasma lipoprotein particle clearance (GO:0034381),-1.6232881704173776e-10,0.0
14841,intestinal epithelial cell differentiation (GO:0060575),-1.6232881704173776e-10,0.0
14842,vesicle targeting (GO:0006903),-1.6275958357522232e-10,0.0
14843,SMAD protein signal transduction (GO:0060395),-1.6275958357522232e-10,0.0
14844,regulation of interleukin-12 production (GO:0032655),-1.6275958357522232e-10,0.0
14845,dendrite morphogenesis (GO:0048813),-1.6275958357522232e-10,0.0
14846,regulation of biological process involved in symbiotic interaction (GO:0043903),-1.6275958357522232e-10,0.0
14847,pyruvate metabolic process (GO:0006090),-1.6275958357522232e-10,0.0
14848,cellular aldehyde metabolic process (GO:0006081),-1.6275958357522232e-10,0.0
14849,response to fatty acid (GO:0070542),-1.6275958357522232e-10,0.0
14850,positive regulation of actin filament bundle assembly (GO:0032233),-1.6275958357522232e-10,0.0
14851,metaphase plate congression (GO:0051310),-1.6275958357522232e-10,0.0
14852,protein insertion into membrane (GO:0051205),-1.6275958357522232e-10,0.0
14853,membrane biogenesis (GO:0044091),-1.6275958357522232e-10,0.0
14854,regulation of lymphocyte apoptotic process (GO:0070228),-1.6275958357522232e-10,0.0
14855,homologous recombination (GO:0035825),-1.6275958357522232e-10,0.0
14856,cytoplasmic microtubule organization (GO:0031122),-1.6275958357522232e-10,0.0
14857,purine ribonucleoside diphosphate metabolic process (GO:0009179),-1.6275958357522232e-10,0.0
14858,purine nucleoside diphosphate metabolic process (GO:0009135),-1.6275958357522232e-10,0.0
14859,actin filament bundle organization (GO:0061572),-1.6275958357522232e-10,0.0
14860,snRNA metabolic process (GO:0016073),-1.6275958357522232e-10,0.0
14861,insulin receptor signaling pathway (GO:0008286),-1.6275958357522232e-10,0.0
14862,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-1.6275958357522232e-10,0.0
14863,mammary gland epithelium development (GO:0061180),-1.6275958357522232e-10,0.0
14864,positive regulation of heart growth (GO:0060421),-1.6364976039622147e-10,0.0
14865,response to growth hormone (GO:0060416),-1.6364976039622147e-10,0.0
14866,positive regulation of epidermis development (GO:0045684),-1.6364976039622147e-10,0.0
14867,regulation of SMAD protein signal transduction (GO:0060390),-1.6364976039622147e-10,0.0
14868,cartilage development involved in endochondral bone morphogenesis (GO:0060351),-1.6364976039622147e-10,0.0
14869,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-1.6364976039622147e-10,0.0
14870,regulation of water loss via skin (GO:0033561),-1.6364976039622147e-10,0.0
14871,regulation of cilium movement involved in cell motility (GO:0060295),-1.6364976039622147e-10,0.0
14872,phosphatidic acid biosynthetic process (GO:0006654),-1.6364976039622147e-10,0.0
14873,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-1.6364976039622147e-10,0.0
14874,GPI anchor metabolic process (GO:0006505),-1.6364976039622147e-10,0.0
14875,positive regulation of monooxygenase activity (GO:0032770),-1.6364976039622147e-10,0.0
14876,regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-1.6364976039622147e-10,0.0
14877,protein demethylation (GO:0006482),-1.6364976039622147e-10,0.0
14878,response to angiotensin (GO:1990776),-1.6364976039622147e-10,0.0
14879,transcription by RNA polymerase III (GO:0006383),-1.6364976039622147e-10,0.0
14880,protein palmitoylation (GO:0018345),-1.6364976039622147e-10,0.0
14881,mRNA splice site selection (GO:0006376),-1.6364976039622147e-10,0.0
14882,positive regulation of viral genome replication (GO:0045070),-1.6364976039622147e-10,0.0
14883,actin nucleation (GO:0045010),-1.6364976039622147e-10,0.0
14884,regulation of cilium-dependent cell motility (GO:1902019),-1.6364976039622147e-10,0.0
14885,negative regulation of type I interferon production (GO:0032480),-1.6364976039622147e-10,0.0
14886,regulation of meiotic nuclear division (GO:0040020),-1.6364976039622147e-10,0.0
14887,regulation of calcium ion import (GO:0090279),-1.6364976039622147e-10,0.0
14888,protein peptidyl-prolyl isomerization (GO:0000413),-1.6364976039622147e-10,0.0
14889,spindle checkpoint signaling (GO:0031577),-1.6364976039622147e-10,0.0
14890,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-1.6364976039622147e-10,0.0
14891,vesicle tethering (GO:0099022),-1.6364976039622147e-10,0.0
14892,chaperone cofactor-dependent protein refolding (GO:0051085),-1.6364976039622147e-10,0.0
14893,multivesicular body assembly (GO:0036258),-1.6364976039622147e-10,0.0
14894,positive regulation of mitochondrial membrane permeability (GO:0035794),-1.6364976039622147e-10,0.0
14895,regulation of mast cell degranulation (GO:0043304),-1.6364976039622147e-10,0.0
14896,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-1.6364976039622147e-10,0.0
14897,positive regulation of microtubule polymerization (GO:0031116),-1.6364976039622147e-10,0.0
14898,positive regulation of protein targeting to mitochondrion (GO:1903955),-1.6364976039622147e-10,0.0
14899,bile acid and bile salt transport (GO:0015721),-1.6364976039622147e-10,0.0
14900,regulation of protein export from nucleus (GO:0046825),-1.6364976039622147e-10,0.0
14901,response to arsenic-containing substance (GO:0046685),-1.6364976039622147e-10,0.0
14902,negative regulation of organ growth (GO:0046621),-1.6364976039622147e-10,0.0
14903,protein dealkylation (GO:0008214),-1.6364976039622147e-10,0.0
14904,snRNA 3'-end processing (GO:0034472),-1.6364976039622147e-10,0.0
14905,negative regulation of DNA replication (GO:0008156),-1.6364976039622147e-10,0.0
14906,positive regulation of vasoconstriction (GO:0045907),-1.6364976039622147e-10,0.0
14907,positive regulation of cartilage development (GO:0061036),-1.6364976039622147e-10,0.0
14908,clathrin-dependent endocytosis (GO:0072583),-1.6364976039622147e-10,0.0
14909,myoblast fusion (GO:0007520),-1.6364976039622147e-10,0.0
14910,negative regulation of DNA repair (GO:0045738),-1.6448065130771463e-10,0.0
14911,cerebral cortex radially oriented cell migration (GO:0021799),-1.6448065130771463e-10,0.0
14912,positive regulation of neutrophil migration (GO:1902624),-1.6448065130771463e-10,0.0
14913,regulation of regulatory T cell differentiation (GO:0045589),-1.6448065130771463e-10,0.0
14914,blood vessel remodeling (GO:0001974),-1.6448065130771463e-10,0.0
14915,maternal placenta development (GO:0001893),-1.6448065130771463e-10,0.0
14916,leukotriene metabolic process (GO:0006691),-1.6448065130771463e-10,0.0
14917,natural killer cell mediated immunity (GO:0002228),-1.6448065130771463e-10,0.0
14918,virion assembly (GO:0019068),-1.6448065130771463e-10,0.0
14919,astrocyte development (GO:0014002),-1.6448065130771463e-10,0.0
14920,cellular response to fatty acid (GO:0071398),-1.6448065130771463e-10,0.0
14921,negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100),-1.6448065130771463e-10,0.0
14922,regulation of protein targeting to membrane (GO:0090313),-1.6448065130771463e-10,0.0
14923,regulation of cholesterol metabolic process (GO:0090181),-1.6448065130771463e-10,0.0
14924,cellular carbohydrate catabolic process (GO:0044275),-1.6448065130771463e-10,0.0
14925,centrosome duplication (GO:0051298),-1.6448065130771463e-10,0.0
14926,negative regulation of striated muscle cell differentiation (GO:0051154),-1.6448065130771463e-10,0.0
14927,negative regulation of blood vessel endothelial cell migration (GO:0043537),-1.6448065130771463e-10,0.0
14928,muscle adaptation (GO:0043500),-1.6448065130771463e-10,0.0
14929,positive regulation of mRNA processing (GO:0050685),-1.6448065130771463e-10,0.0
14930,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-1.6448065130771463e-10,0.0
14931,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-1.6448065130771463e-10,0.0
14932,embryonic eye morphogenesis (GO:0048048),-1.6448065130771463e-10,0.0
14933,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-1.6448065130771463e-10,0.0
14934,very long-chain fatty acid metabolic process (GO:0000038),-1.6448065130771463e-10,0.0
14935,receptor metabolic process (GO:0043112),-1.6448065130771463e-10,0.0
14936,potassium ion homeostasis (GO:0055075),-1.6448065130771463e-10,0.0
14937,ribonucleoside monophosphate biosynthetic process (GO:0009156),-1.6448065130771463e-10,0.0
14938,nucleobase metabolic process (GO:0009112),-1.6448065130771463e-10,0.0
14939,negative regulation of macroautophagy (GO:0016242),-1.6448065130771463e-10,0.0
14940,peptidyl-tyrosine dephosphorylation (GO:0035335),-1.6448065130771463e-10,0.0
14941,mannosylation (GO:0097502),-1.6448065130771463e-10,0.0
14942,regulation of neuroinflammatory response (GO:0150077),-1.6448065130771463e-10,0.0
14943,vasoconstriction (GO:0042310),-1.6448065130771463e-10,0.0
14944,amino acid import across plasma membrane (GO:0089718),-1.6448065130771463e-10,0.0
14945,olfactory lobe development (GO:0021988),-1.6448065130771463e-10,0.0
14946,histone monoubiquitination (GO:0010390),-1.6448065130771463e-10,0.0
14947,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-1.6448065130771463e-10,0.0
14948,negative regulation of cytokine production involved in immune response (GO:0002719),-1.6448065130771463e-10,0.0
14949,cellular response to amino acid starvation (GO:0034198),-1.6484946739643436e-10,0.0
14950,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-1.6484946739643436e-10,0.0
14951,positive regulation of transcription elongation by RNA polymerase II (GO:0032968),-1.6484946739643436e-10,0.0
14952,eye photoreceptor cell differentiation (GO:0001754),-1.6484946739643436e-10,0.0
14953,morphogenesis of a polarized epithelium (GO:0001738),-1.6484946739643436e-10,0.0
14954,mitotic G2/M transition checkpoint (GO:0044818),-1.6484946739643436e-10,0.0
14955,regulation of telomerase activity (GO:0051972),-1.6484946739643436e-10,0.0
14956,peptidyl-proline modification (GO:0018208),-1.6484946739643436e-10,0.0
14957,mitochondrion localization (GO:0051646),-1.6484946739643436e-10,0.0
14958,intracellular pH reduction (GO:0051452),-1.6484946739643436e-10,0.0
14959,post-translational protein modification (GO:0043687),-1.6484946739643436e-10,0.0
14960,protein destabilization (GO:0031648),-1.6484946739643436e-10,0.0
14961,negative regulation of TOR signaling (GO:0032007),-1.6484946739643436e-10,0.0
14962,lymphocyte chemotaxis (GO:0048247),-1.6484946739643436e-10,0.0
14963,regulation of leukocyte degranulation (GO:0043300),-1.6484946739643436e-10,0.0
14964,ephrin receptor signaling pathway (GO:0048013),-1.6484946739643436e-10,0.0
14965,ribonucleotide catabolic process (GO:0009261),-1.6484946739643436e-10,0.0
14966,regulation of lipid storage (GO:0010883),-1.6484946739643436e-10,0.0
14967,protein localization to lysosome (GO:0061462),-1.6484946739643436e-10,0.0
14968,secondary metabolic process (GO:0019748),-1.6484946739643436e-10,0.0
14969,execution phase of apoptosis (GO:0097194),-1.6484946739643436e-10,0.0
14970,regulation of natural killer cell mediated immunity (GO:0002715),-1.6484946739643436e-10,0.0
14971,negative regulation of endocytosis (GO:0045806),-1.6484946739643436e-10,0.0
14972,olfactory bulb development (GO:0021772),-1.6674905899125306e-10,0.0
14973,ER-nucleus signaling pathway (GO:0006984),-1.6674905899125306e-10,0.0
14974,regulation of B cell differentiation (GO:0045577),-1.6674905899125306e-10,0.0
14975,negative regulation of double-strand break repair (GO:2000780),-1.6674905899125306e-10,0.0
14976,endothelial cell proliferation (GO:0001935),-1.6674905899125306e-10,0.0
14977,metanephric nephron development (GO:0072210),-1.6674905899125306e-10,0.0
14978,mature B cell differentiation (GO:0002335),-1.6674905899125306e-10,0.0
14979,leukocyte activation involved in inflammatory response (GO:0002269),-1.6674905899125306e-10,0.0
14980,protein export from nucleus (GO:0006611),-1.6674905899125306e-10,0.0
14981,vacuolar acidification (GO:0007035),-1.6674905899125306e-10,0.0
14982,peroxisome organization (GO:0007031),-1.6674905899125306e-10,0.0
14983,mitotic G1/S transition checkpoint signaling (GO:0044819),-1.6674905899125306e-10,0.0
14984,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-1.6674905899125306e-10,0.0
14985,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-1.6674905899125306e-10,0.0
14986,response to ATP (GO:0033198),-1.6674905899125306e-10,0.0
14987,regulation of myeloid cell apoptotic process (GO:0033032),-1.6674905899125306e-10,0.0
14988,centrosome localization (GO:0051642),-1.6674905899125306e-10,0.0
14989,regulation of axon extension involved in axon guidance (GO:0048841),-1.6674905899125306e-10,0.0
14990,positive regulation of multicellular organism growth (GO:0040018),-1.6674905899125306e-10,0.0
14991,establishment of protein localization to mitochondrial membrane (GO:0090151),-1.6674905899125306e-10,0.0
14992,regulation of neutrophil chemotaxis (GO:0090022),-1.6674905899125306e-10,0.0
14993,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-1.6674905899125306e-10,0.0
14994,synaptic vesicle transport (GO:0048489),-1.6674905899125306e-10,0.0
14995,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-1.6674905899125306e-10,0.0
14996,blood vessel endothelial cell migration (GO:0043534),-1.6674905899125306e-10,0.0
14997,photoperiodism (GO:0009648),-1.6674905899125306e-10,0.0
14998,regulation of response to reactive oxygen species (GO:1901031),-1.6674905899125306e-10,0.0
14999,multivesicular body organization (GO:0036257),-1.6674905899125306e-10,0.0
15000,granulocyte activation (GO:0036230),-1.6674905899125306e-10,0.0
15001,negative regulation of potassium ion transport (GO:0043267),-1.6674905899125306e-10,0.0
15002,peptide catabolic process (GO:0043171),-1.6674905899125306e-10,0.0
15003,regulation of microtubule depolymerization (GO:0031114),-1.6674905899125306e-10,0.0
15004,pyrimidine ribonucleotide metabolic process (GO:0009218),-1.6674905899125306e-10,0.0
15005,response to interferon-beta (GO:0035456),-1.6674905899125306e-10,0.0
15006,pteridine-containing compound metabolic process (GO:0042558),-1.6674905899125306e-10,0.0
15007,regulation of cardiac muscle cell contraction (GO:0086004),-1.6674905899125306e-10,0.0
15008,post-transcriptional gene silencing by RNA (GO:0035194),-1.6674905899125306e-10,0.0
15009,natural killer cell mediated cytotoxicity (GO:0042267),-1.6674905899125306e-10,0.0
15010,cellular modified amino acid catabolic process (GO:0042219),-1.6674905899125306e-10,0.0
15011,regulation of vascular endothelial growth factor production (GO:0010574),-1.6674905899125306e-10,0.0
15012,muscle hypertrophy (GO:0014896),-1.6674905899125306e-10,0.0
15013,fluid transport (GO:0042044),-1.6674905899125306e-10,0.0
15014,lipid droplet organization (GO:0034389),-1.6674905899125306e-10,0.0
15015,mammary gland duct morphogenesis (GO:0060603),-1.6674905899125306e-10,0.0
15016,dendritic spine organization (GO:0097061),-1.6674905899125306e-10,0.0
15017,innate immune response-activating signal transduction (GO:0002758),-1.6674905899125306e-10,0.0
15018,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-1.6674905899125306e-10,0.0
15019,establishment of endothelial barrier (GO:0061028),-1.6674905899125306e-10,0.0
15020,negative regulation of GTPase activity (GO:0034260),-1.6674905899125306e-10,0.0
15021,pyridine nucleotide biosynthetic process (GO:0019363),-1.6930501443811563e-10,0.0
15022,positive regulation of epidermal cell differentiation (GO:0045606),-1.6930501443811563e-10,0.0
15023,nicotinamide nucleotide biosynthetic process (GO:0019359),-1.6930501443811563e-10,0.0
15024,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-1.6930501443811563e-10,0.0
15025,GMP metabolic process (GO:0046037),-1.6930501443811563e-10,0.0
15026,spermatid nucleus differentiation (GO:0007289),-1.6930501443811563e-10,0.0
15027,"synaptic transmission, cholinergic (GO:0007271)",-1.6930501443811563e-10,0.0
15028,lymph vessel development (GO:0001945),-1.6930501443811563e-10,0.0
15029,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-1.6930501443811563e-10,0.0
15030,regulation of feeding behavior (GO:0060259),-1.6930501443811563e-10,0.0
15031,mature B cell differentiation involved in immune response (GO:0002313),-1.6930501443811563e-10,0.0
15032,establishment of tissue polarity (GO:0007164),-1.6930501443811563e-10,0.0
15033,positive regulation of collagen biosynthetic process (GO:0032967),-1.6930501443811563e-10,0.0
15034,auditory receptor cell development (GO:0060117),-1.6930501443811563e-10,0.0
15035,reactive nitrogen species metabolic process (GO:2001057),-1.6930501443811563e-10,0.0
15036,somatic diversification of immunoglobulins involved in immune response (GO:0002208),-1.6930501443811563e-10,0.0
15037,cholesterol efflux (GO:0033344),-1.6930501443811563e-10,0.0
15038,plasma membrane repair (GO:0001778),-1.6930501443811563e-10,0.0
15039,establishment of planar polarity (GO:0001736),-1.6930501443811563e-10,0.0
15040,glial cell proliferation (GO:0014009),-1.6930501443811563e-10,0.0
15041,ganglioside metabolic process (GO:0001573),-1.6930501443811563e-10,0.0
15042,response to protozoan (GO:0001562),-1.6930501443811563e-10,0.0
15043,regulation of production of small RNA involved in gene silencing by RNA (GO:0070920),-1.6930501443811563e-10,0.0
15044,regulation of lymphocyte chemotaxis (GO:1901623),-1.6930501443811563e-10,0.0
15045,phagosome maturation (GO:0090382),-1.6930501443811563e-10,0.0
15046,negative regulation of axon extension involved in axon guidance (GO:0048843),-1.6930501443811563e-10,0.0
15047,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-1.6930501443811563e-10,0.0
15048,protein hydroxylation (GO:0018126),-1.6930501443811563e-10,0.0
15049,positive regulation of histone H3-K4 methylation (GO:0051571),-1.6930501443811563e-10,0.0
15050,adenine nucleotide transport (GO:0051503),-1.6930501443811563e-10,0.0
15051,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-1.6930501443811563e-10,0.0
15052,regulation of DNA damage checkpoint (GO:2000001),-1.6930501443811563e-10,0.0
15053,vesicle-mediated transport between endosomal compartments (GO:0098927),-1.6930501443811563e-10,0.0
15054,protein heterooligomerization (GO:0051291),-1.6930501443811563e-10,0.0
15055,positive regulation of macrophage migration (GO:1905523),-1.6930501443811563e-10,0.0
15056,regulation of cardiocyte differentiation (GO:1905207),-1.6930501443811563e-10,0.0
15057,rRNA methylation (GO:0031167),-1.6930501443811563e-10,0.0
15058,DNA dealkylation (GO:0035510),-1.6930501443811563e-10,0.0
15059,developmental induction (GO:0031128),-1.6930501443811563e-10,0.0
15060,positive regulation of macrophage activation (GO:0043032),-1.6930501443811563e-10,0.0
15061,benzene-containing compound metabolic process (GO:0042537),-1.6930501443811563e-10,0.0
15062,positive regulation of protein processing (GO:0010954),-1.6930501443811563e-10,0.0
15063,branched-chain amino acid metabolic process (GO:0009081),-1.6930501443811563e-10,0.0
15064,C4-dicarboxylate transport (GO:0015740),-1.6930501443811563e-10,0.0
15065,cell-cell signaling involved in cardiac conduction (GO:0086019),-1.6930501443811563e-10,0.0
15066,carbohydrate phosphorylation (GO:0046835),-1.6930501443811563e-10,0.0
15067,detection of temperature stimulus (GO:0016048),-1.6930501443811563e-10,0.0
15068,miRNA-mediated gene silencing (GO:0035195),-1.6930501443811563e-10,0.0
15069,endochondral bone growth (GO:0003416),-1.6930501443811563e-10,0.0
15070,centromere complex assembly (GO:0034508),-1.6930501443811563e-10,0.0
15071,positive regulation of activated T cell proliferation (GO:0042104),-1.6930501443811563e-10,0.0
15072,C21-steroid hormone metabolic process (GO:0008207),-1.6930501443811563e-10,0.0
15073,protein localization to postsynaptic membrane (GO:1903539),-1.6930501443811563e-10,0.0
15074,acylglycerol biosynthetic process (GO:0046463),-1.6930501443811563e-10,0.0
15075,neutral lipid biosynthetic process (GO:0046460),-1.6930501443811563e-10,0.0
15076,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-1.6930501443811563e-10,0.0
15077,negative regulation of steroid metabolic process (GO:0045939),-1.6930501443811563e-10,0.0
15078,phosphatidylethanolamine metabolic process (GO:0046337),-1.6930501443811563e-10,0.0
15079,positive regulation of muscle hypertrophy (GO:0014742),-1.6930501443811563e-10,0.0
15080,negative regulation of T cell mediated immunity (GO:0002710),-1.6930501443811563e-10,0.0
15081,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-1.7070989065323745e-10,0.0
15082,protein localization to Golgi apparatus (GO:0034067),-1.7070989065323745e-10,0.0
15083,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-1.7070989065323745e-10,0.0
15084,activation of phospholipase C activity (GO:0007202),-1.7070989065323745e-10,0.0
15085,camera-type eye photoreceptor cell differentiation (GO:0060219),-1.7070989065323745e-10,0.0
15086,porphyrin-containing compound biosynthetic process (GO:0006779),-1.7070989065323745e-10,0.0
15087,basement membrane organization (GO:0071711),-1.7070989065323745e-10,0.0
15088,protein targeting to lysosome (GO:0006622),-1.7070989065323745e-10,0.0
15089,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-1.7070989065323745e-10,0.0
15090,viral release from host cell (GO:0019076),-1.7070989065323745e-10,0.0
15091,B cell homeostasis (GO:0001782),-1.7070989065323745e-10,0.0
15092,microglial cell activation (GO:0001774),-1.7070989065323745e-10,0.0
15093,glycoprotein catabolic process (GO:0006516),-1.7070989065323745e-10,0.0
15094,negative regulation of cell junction assembly (GO:1901889),-1.7070989065323745e-10,0.0
15095,protein K11-linked ubiquitination (GO:0070979),-1.7070989065323745e-10,0.0
15096,negative regulation of interleukin-1 beta production (GO:0032691),-1.7070989065323745e-10,0.0
15097,neurotransmitter uptake (GO:0001504),-1.7070989065323745e-10,0.0
15098,regulation of transcription by RNA polymerase III (GO:0006359),-1.7070989065323745e-10,0.0
15099,cellular response to interleukin-6 (GO:0071354),-1.7070989065323745e-10,0.0
15100,tetrapyrrole biosynthetic process (GO:0033014),-1.7070989065323745e-10,0.0
15101,glycosaminoglycan catabolic process (GO:0006027),-1.7070989065323745e-10,0.0
15102,regulation of cardiac muscle cell action potential (GO:0098901),-1.7070989065323745e-10,0.0
15103,regulation of mitochondrial fission (GO:0090140),-1.7070989065323745e-10,0.0
15104,bone growth (GO:0098868),-1.7070989065323745e-10,0.0
15105,regulation of response to nutrient levels (GO:0032107),-1.7070989065323745e-10,0.0
15106,regulation of response to extracellular stimulus (GO:0032104),-1.7070989065323745e-10,0.0
15107,aorta morphogenesis (GO:0035909),-1.7070989065323745e-10,0.0
15108,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-1.7070989065323745e-10,0.0
15109,exit from host cell (GO:0035891),-1.7070989065323745e-10,0.0
15110,negative regulation of receptor-mediated endocytosis (GO:0048261),-1.7070989065323745e-10,0.0
15111,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-1.7070989065323745e-10,0.0
15112,"vesicle targeting, to, from or within Golgi (GO:0048199)",-1.7070989065323745e-10,0.0
15113,Golgi to plasma membrane protein transport (GO:0043001),-1.7070989065323745e-10,0.0
15114,negative regulation of protein processing (GO:0010955),-1.7070989065323745e-10,0.0
15115,membrane depolarization during action potential (GO:0086010),-1.7070989065323745e-10,0.0
15116,respiratory chain complex IV assembly (GO:0008535),-1.7070989065323745e-10,0.0
15117,liver regeneration (GO:0097421),-1.7070989065323745e-10,0.0
15118,nucleobase-containing small molecule catabolic process (GO:0034656),-1.7070989065323745e-10,0.0
15119,epithelial structure maintenance (GO:0010669),-1.7070989065323745e-10,0.0
15120,macrophage differentiation (GO:0030225),-1.7070989065323745e-10,0.0
15121,megakaryocyte differentiation (GO:0030219),-1.7070989065323745e-10,0.0
15122,chondroitin sulfate metabolic process (GO:0030204),-1.7070989065323745e-10,0.0
15123,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-1.7070989065323745e-10,0.0
15124,ketone biosynthetic process (GO:0042181),-1.7070989065323745e-10,0.0
15125,isoprenoid biosynthetic process (GO:0008299),-1.7070989065323745e-10,0.0
15126,positive regulation of lamellipodium assembly (GO:0010592),-1.7070989065323745e-10,0.0
15127,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-1.7070989065323745e-10,0.0
15128,acylglycerol catabolic process (GO:0046464),-1.7070989065323745e-10,0.0
15129,neutral lipid catabolic process (GO:0046461),-1.7070989065323745e-10,0.0
15130,cardiac muscle hypertrophy (GO:0003300),-1.7070989065323745e-10,0.0
15131,positive regulation of steroid metabolic process (GO:0045940),-1.7070989065323745e-10,0.0
15132,regulation of protein polyubiquitination (GO:1902914),-1.7070989065323745e-10,0.0
15133,negative regulation of muscle hypertrophy (GO:0014741),-1.7070989065323745e-10,0.0
15134,motor neuron axon guidance (GO:0008045),-1.7070989065323745e-10,0.0
15135,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-1.7303181108653944e-10,0.0
15136,positive regulation of transcription initiation by RNA polymerase II (GO:0060261),-1.7303181108653944e-10,0.0
15137,regulation of nitric oxide biosynthetic process (GO:0045428),-1.7303181108653944e-10,0.0
15138,toll-like receptor signaling pathway (GO:0002224),-1.7303181108653944e-10,0.0
15139,sprouting angiogenesis (GO:0002040),-1.7303181108653944e-10,0.0
15140,tetrapyrrole metabolic process (GO:0033013),-1.7303181108653944e-10,0.0
15141,nucleoside diphosphate phosphorylation (GO:0006165),-1.7303181108653944e-10,0.0
15142,protein homotetramerization (GO:0051289),-1.7303181108653944e-10,0.0
15143,regulation of phosphoprotein phosphatase activity (GO:0043666),-1.7303181108653944e-10,0.0
15144,proteoglycan biosynthetic process (GO:0030166),-1.7303181108653944e-10,0.0
15145,regulation of microtubule-based movement (GO:0060632),-1.7303181108653944e-10,0.0
15146,cerebral cortex cell migration (GO:0021795),-1.7542589601642402e-10,0.0
15147,substantia nigra development (GO:0021762),-1.7542589601642402e-10,0.0
15148,negative regulation of oxidative stress-induced cell death (GO:1903202),-1.7542589601642402e-10,0.0
15149,regulation of neutrophil migration (GO:1902622),-1.7542589601642402e-10,0.0
15150,long-term synaptic potentiation (GO:0060291),-1.7542589601642402e-10,0.0
15151,positive regulation of stem cell population maintenance (GO:1902459),-1.7542589601642402e-10,0.0
15152,regulation of glycolytic process (GO:0006110),-1.7542589601642402e-10,0.0
15153,regulation of release of cytochrome c from mitochondria (GO:0090199),-1.7542589601642402e-10,0.0
15154,negative chemotaxis (GO:0050919),-1.7542589601642402e-10,0.0
15155,regulation of DNA-templated transcription in response to stress (GO:0043620),-1.7542589601642402e-10,0.0
15156,vitamin transport (GO:0051180),-1.7542589601642402e-10,0.0
15157,positive regulation of purine nucleotide metabolic process (GO:1900544),-1.7542589601642402e-10,0.0
15158,detection of visible light (GO:0009584),-1.7542589601642402e-10,0.0
15159,replication fork processing (GO:0031297),-1.7542589601642402e-10,0.0
15160,visual learning (GO:0008542),-1.7542589601642402e-10,0.0
15161,regulation of centrosome duplication (GO:0010824),-1.7542589601642402e-10,0.0
15162,coronary vasculature development (GO:0060976),-1.7542589601642402e-10,0.0
15163,extracellular matrix disassembly (GO:0022617),-1.7542589601642402e-10,0.0
15164,intraciliary transport (GO:0042073),-1.7542589601642402e-10,0.0
15165,positive regulation of nucleotide metabolic process (GO:0045981),-1.7542589601642402e-10,0.0
15166,adherens junction organization (GO:0034332),-1.7542589601642402e-10,0.0
15167,negative regulation of production of molecular mediator of immune response (GO:0002701),-1.7542589601642402e-10,0.0
15168,cell differentiation involved in kidney development (GO:0061005),-1.7542589601642402e-10,0.0
15169,face development (GO:0060324),-1.8538104383183691e-10,0.0
15170,inner ear receptor cell development (GO:0060119),-1.8538104383183691e-10,0.0
15171,regulation of granulocyte chemotaxis (GO:0071622),-1.8538104383183691e-10,0.0
15172,response to amino acid starvation (GO:1990928),-1.8538104383183691e-10,0.0
15173,phospholipid translocation (GO:0045332),-1.8538104383183691e-10,0.0
15174,viral gene expression (GO:0019080),-1.8538104383183691e-10,0.0
15175,Fc receptor signaling pathway (GO:0038093),-1.8538104383183691e-10,0.0
15176,release of sequestered calcium ion into cytosol (GO:0051209),-1.8538104383183691e-10,0.0
15177,heterochromatin formation (GO:0031507),-1.8538104383183691e-10,0.0
15178,intermembrane lipid transfer (GO:0120009),-1.8538104383183691e-10,0.0
15179,positive regulation of epithelial to mesenchymal transition (GO:0010718),-1.8538104383183691e-10,0.0
15180,B cell proliferation (GO:0042100),-1.8538104383183691e-10,0.0
15181,positive regulation of regulated secretory pathway (GO:1903307),-1.8538104383183691e-10,0.0
15182,pigment biosynthetic process (GO:0046148),-1.8742607464281525e-10,0.0
15183,acute-phase response (GO:0006953),-1.8742607464281525e-10,0.0
15184,monocyte chemotaxis (GO:0002548),-1.8742607464281525e-10,0.0
15185,cellular polysaccharide biosynthetic process (GO:0033692),-1.8742607464281525e-10,0.0
15186,type I interferon signaling pathway (GO:0060337),-1.8742607464281525e-10,0.0
15187,superoxide metabolic process (GO:0006801),-1.8742607464281525e-10,0.0
15188,plasma lipoprotein particle organization (GO:0071827),-1.8742607464281525e-10,0.0
15189,response to testosterone (GO:0033574),-1.8742607464281525e-10,0.0
15190,cell redox homeostasis (GO:0045454),-1.8742607464281525e-10,0.0
15191,toxin transport (GO:1901998),-1.8742607464281525e-10,0.0
15192,regulation of polysaccharide metabolic process (GO:0032881),-1.8742607464281525e-10,0.0
15193,semaphorin-plexin signaling pathway (GO:0071526),-1.8742607464281525e-10,0.0
15194,negative regulation of protein kinase B signaling (GO:0051898),-1.8742607464281525e-10,0.0
15195,tRNA aminoacylation for protein translation (GO:0006418),-1.8742607464281525e-10,0.0
15196,base-excision repair (GO:0006284),-1.8742607464281525e-10,0.0
15197,endosome transport via multivesicular body sorting pathway (GO:0032509),-1.8742607464281525e-10,0.0
15198,glycolytic process (GO:0006096),-1.8742607464281525e-10,0.0
15199,peptidyl-lysine trimethylation (GO:0018023),-1.8742607464281525e-10,0.0
15200,sensory perception of bitter taste (GO:0050913),-1.8742607464281525e-10,0.0
15201,positive regulation of calcium-mediated signaling (GO:0050850),-1.8742607464281525e-10,0.0
15202,ncRNA transcription (GO:0098781),-1.8742607464281525e-10,0.0
15203,inositol phosphate metabolic process (GO:0043647),-1.8742607464281525e-10,0.0
15204,positive regulation of JUN kinase activity (GO:0043507),-1.8742607464281525e-10,0.0
15205,polysaccharide biosynthetic process (GO:0000271),-1.8742607464281525e-10,0.0
15206,regulation of phospholipase C activity (GO:1900274),-1.8742607464281525e-10,0.0
15207,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-1.8742607464281525e-10,0.0
15208,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-1.8742607464281525e-10,0.0
15209,purine ribonucleoside monophosphate metabolic process (GO:0009167),-1.8742607464281525e-10,0.0
15210,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-1.8742607464281525e-10,0.0
15211,regulation of heart rate by cardiac conduction (GO:0086091),-1.8742607464281525e-10,0.0
15212,regulation of myotube differentiation (GO:0010830),-1.8742607464281525e-10,0.0
15213,regulation of fatty acid biosynthetic process (GO:0042304),-1.8742607464281525e-10,0.0
15214,regulation of collagen metabolic process (GO:0010712),-1.8742607464281525e-10,0.0
15215,lipid storage (GO:0019915),-1.8742607464281525e-10,0.0
15216,regulation of miRNA-mediated gene silencing (GO:0060964),-1.8742607464281525e-10,0.0
15217,response to copper ion (GO:0046688),-1.8742607464281525e-10,0.0
15218,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-1.8742607464281525e-10,0.0
15219,positive regulation of immunoglobulin mediated immune response (GO:0002891),-1.8742607464281525e-10,0.0
15220,phototransduction (GO:0007602),-1.8742607464281525e-10,0.0
15221,positive regulation of B cell mediated immunity (GO:0002714),-1.8742607464281525e-10,0.0
15222,nuclear envelope organization (GO:0006998),-1.882138889009413e-10,0.0
15223,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-1.882138889009413e-10,0.0
15224,collagen metabolic process (GO:0032963),-1.882138889009413e-10,0.0
15225,glycosphingolipid metabolic process (GO:0006687),-1.882138889009413e-10,0.0
15226,myeloid cell activation involved in immune response (GO:0002275),-1.882138889009413e-10,0.0
15227,positive regulation of interleukin-1 beta production (GO:0032731),-1.882138889009413e-10,0.0
15228,negative regulation of tumor necrosis factor production (GO:0032720),-1.882138889009413e-10,0.0
15229,histone H4 acetylation (GO:0043967),-1.882138889009413e-10,0.0
15230,negative regulation of chemotaxis (GO:0050922),-1.882138889009413e-10,0.0
15231,negative regulation of small GTPase mediated signal transduction (GO:0051058),-1.882138889009413e-10,0.0
15232,positive regulation of epithelial cell differentiation (GO:0030858),-1.882138889009413e-10,0.0
15233,negative regulation of actin filament polymerization (GO:0030837),-1.882138889009413e-10,0.0
15234,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-1.882138889009413e-10,0.0
15235,ribonucleoside monophosphate metabolic process (GO:0009161),-1.882138889009413e-10,0.0
15236,nucleotide phosphorylation (GO:0046939),-1.882138889009413e-10,0.0
15237,protein localization to cilium (GO:0061512),-1.882138889009413e-10,0.0
15238,response to cadmium ion (GO:0046686),-1.882138889009413e-10,0.0
15239,regulation of myeloid leukocyte mediated immunity (GO:0002886),-1.882138889009413e-10,0.0
15240,establishment of protein localization to vacuole (GO:0072666),-1.882138889009413e-10,0.0
15241,syncytium formation (GO:0006949),-1.8851165071608967e-10,0.0
15242,regulation of activated T cell proliferation (GO:0046006),-1.8851165071608967e-10,0.0
15243,negative regulation of endothelial cell proliferation (GO:0001937),-1.8851165071608967e-10,0.0
15244,ATP generation from ADP (GO:0006757),-1.8851165071608967e-10,0.0
15245,positive regulation of nitric oxide biosynthetic process (GO:0045429),-1.8851165071608967e-10,0.0
15246,protein targeting to vacuole (GO:0006623),-1.8851165071608967e-10,0.0
15247,positive regulation of interleukin-12 production (GO:0032735),-1.8851165071608967e-10,0.0
15248,cellular extravasation (GO:0045123),-1.8851165071608967e-10,0.0
15249,"RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",-1.8851165071608967e-10,0.0
15250,cellular response to epidermal growth factor stimulus (GO:0071364),-1.8851165071608967e-10,0.0
15251,double-strand break repair via nonhomologous end joining (GO:0006303),-1.8851165071608967e-10,0.0
15252,mitochondrial RNA metabolic process (GO:0000959),-1.8851165071608967e-10,0.0
15253,protein localization to cytoskeleton (GO:0044380),-1.8851165071608967e-10,0.0
15254,platelet aggregation (GO:0070527),-1.8851165071608967e-10,0.0
15255,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-1.8851165071608967e-10,0.0
15256,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-1.8851165071608967e-10,0.0
15257,regulation of actin nucleation (GO:0051125),-1.8851165071608967e-10,0.0
15258,regulation of T cell apoptotic process (GO:0070232),-1.8851165071608967e-10,0.0
15259,xenobiotic transport (GO:0042908),-1.8851165071608967e-10,0.0
15260,purine ribonucleotide catabolic process (GO:0009154),-1.8851165071608967e-10,0.0
15261,O-glycan processing (GO:0016266),-1.8851165071608967e-10,0.0
15262,regulation of necrotic cell death (GO:0010939),-1.8851165071608967e-10,0.0
15263,cell communication involved in cardiac conduction (GO:0086065),-1.8851165071608967e-10,0.0
15264,tRNA methylation (GO:0030488),-1.8851165071608967e-10,0.0
15265,regulation of glycoprotein biosynthetic process (GO:0010559),-1.8851165071608967e-10,0.0
15266,regulation of cilium movement (GO:0003352),-1.8851165071608967e-10,0.0
15267,receptor localization to synapse (GO:0097120),-1.8851165071608967e-10,0.0
15268,pituitary gland development (GO:0021983),-1.8851165071608967e-10,0.0
15269,regulation of reactive oxygen species biosynthetic process (GO:1903426),-1.8851165071608967e-10,0.0
15270,regulation of membrane depolarization (GO:0003254),-1.8851165071608967e-10,0.0
15271,regulation of amyloid precursor protein catabolic process (GO:1902991),-1.8851165071608967e-10,0.0
15272,monosaccharide catabolic process (GO:0046365),-1.8851165071608967e-10,0.0
15273,energy homeostasis (GO:0097009),-1.8851165071608967e-10,0.0
15274,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-1.9432078166902638e-10,0.0
15275,cellular defense response (GO:0006968),-1.9432078166902638e-10,0.0
15276,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-1.9432078166902638e-10,0.0
15277,ADP metabolic process (GO:0046031),-1.9432078166902638e-10,0.0
15278,mitotic metaphase plate congression (GO:0007080),-1.9432078166902638e-10,0.0
15279,regulation of monooxygenase activity (GO:0032768),-1.9432078166902638e-10,0.0
15280,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-1.9432078166902638e-10,0.0
15281,morphogenesis of an epithelial sheet (GO:0002011),-1.9432078166902638e-10,0.0
15282,fatty acid derivative biosynthetic process (GO:1901570),-1.9432078166902638e-10,0.0
15283,mitotic spindle assembly (GO:0090307),-1.9432078166902638e-10,0.0
15284,regulation of vacuole organization (GO:0044088),-1.9432078166902638e-10,0.0
15285,mRNA transcription (GO:0009299),-1.9432078166902638e-10,0.0
15286,photoreceptor cell development (GO:0042461),-1.9432078166902638e-10,0.0
15287,regulation of establishment of protein localization to mitochondrion (GO:1903747),-1.9432078166902638e-10,0.0
15288,respiratory burst (GO:0045730),-1.9547408134678223e-10,0.0
15289,regulation of hydrogen peroxide-induced cell death (GO:1903205),-1.9547408134678223e-10,0.0
15290,respiratory system process (GO:0003016),-1.9547408134678223e-10,0.0
15291,ether metabolic process (GO:0018904),-1.9547408134678223e-10,0.0
15292,mitochondrial cytochrome c oxidase assembly (GO:0033617),-1.9547408134678223e-10,0.0
15293,GTP metabolic process (GO:0046039),-1.9547408134678223e-10,0.0
15294,AMP metabolic process (GO:0046033),-1.9547408134678223e-10,0.0
15295,stress granule assembly (GO:0034063),-1.9547408134678223e-10,0.0
15296,positive regulation of glycoprotein metabolic process (GO:1903020),-1.9547408134678223e-10,0.0
15297,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-1.9547408134678223e-10,0.0
15298,natural killer cell activation involved in immune response (GO:0002323),-1.9547408134678223e-10,0.0
15299,positive regulation of post-transcriptional gene silencing (GO:0060148),-1.9547408134678223e-10,0.0
15300,secretion by tissue (GO:0032941),-1.9547408134678223e-10,0.0
15301,negative regulation of stem cell population maintenance (GO:1902455),-1.9547408134678223e-10,0.0
15302,phosphatidylcholine biosynthetic process (GO:0006656),-1.9547408134678223e-10,0.0
15303,mast cell activation involved in immune response (GO:0002279),-1.9547408134678223e-10,0.0
15304,myeloid dendritic cell activation (GO:0001773),-1.9547408134678223e-10,0.0
15305,glomerular epithelium development (GO:0072010),-1.9547408134678223e-10,0.0
15306,cardiac muscle cell proliferation (GO:0060038),-1.9547408134678223e-10,0.0
15307,protein deglycosylation (GO:0006517),-1.9547408134678223e-10,0.0
15308,L-glutamate import (GO:0051938),-1.9547408134678223e-10,0.0
15309,regulation of protein sumoylation (GO:0033233),-1.9547408134678223e-10,0.0
15310,cell cycle DNA replication (GO:0044786),-1.9547408134678223e-10,0.0
15311,positive regulation of interferon-alpha production (GO:0032727),-1.9547408134678223e-10,0.0
15312,pigment granule localization (GO:0051875),-1.9547408134678223e-10,0.0
15313,response to misfolded protein (GO:0051788),-1.9547408134678223e-10,0.0
15314,plasma membrane fusion (GO:0045026),-1.9547408134678223e-10,0.0
15315,early endosome to late endosome transport (GO:0045022),-1.9547408134678223e-10,0.0
15316,regulation of protein exit from endoplasmic reticulum (GO:0070861),-1.9547408134678223e-10,0.0
15317,response to salt (GO:1902074),-1.9547408134678223e-10,0.0
15318,protein exit from endoplasmic reticulum (GO:0032527),-1.9547408134678223e-10,0.0
15319,cellular response to zinc ion (GO:0071294),-1.9547408134678223e-10,0.0
15320,maintenance of synapse structure (GO:0099558),-1.9547408134678223e-10,0.0
15321,peptidyl-asparagine modification (GO:0018196),-1.9547408134678223e-10,0.0
15322,peptidyl-arginine modification (GO:0018195),-1.9547408134678223e-10,0.0
15323,mitochondrial calcium ion homeostasis (GO:0051560),-1.9547408134678223e-10,0.0
15324,intracellular sterol transport (GO:0032366),-1.9547408134678223e-10,0.0
15325,negative regulation of chondrocyte differentiation (GO:0032331),-1.9547408134678223e-10,0.0
15326,uronic acid metabolic process (GO:0006063),-1.9547408134678223e-10,0.0
15327,positive regulation of meiotic cell cycle (GO:0051446),-1.9547408134678223e-10,0.0
15328,positive regulation of neutrophil chemotaxis (GO:0090023),-1.9547408134678223e-10,0.0
15329,regulation of vascular endothelial cell proliferation (GO:1905562),-1.9547408134678223e-10,0.0
15330,calcium ion import across plasma membrane (GO:0098703),-1.9547408134678223e-10,0.0
15331,cell death in response to oxidative stress (GO:0036473),-1.9547408134678223e-10,0.0
15332,regulation of DNA methylation (GO:0044030),-1.9547408134678223e-10,0.0
15333,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-1.9547408134678223e-10,0.0
15334,glucosamine-containing compound metabolic process (GO:1901071),-1.9547408134678223e-10,0.0
15335,negative regulation of T cell apoptotic process (GO:0070233),-1.9547408134678223e-10,0.0
15336,dendritic cell migration (GO:0036336),-1.9547408134678223e-10,0.0
15337,detection of external biotic stimulus (GO:0098581),-1.9547408134678223e-10,0.0
15338,nuclear membrane reassembly (GO:0031468),-1.9547408134678223e-10,0.0
15339,synaptonemal complex organization (GO:0070193),-1.9547408134678223e-10,0.0
15340,plasma membrane phospholipid scrambling (GO:0017121),-1.9547408134678223e-10,0.0
15341,Rac protein signal transduction (GO:0016601),-1.9547408134678223e-10,0.0
15342,mast cell degranulation (GO:0043303),-1.9547408134678223e-10,0.0
15343,NAD biosynthetic process (GO:0009435),-1.9547408134678223e-10,0.0
15344,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-1.9547408134678223e-10,0.0
15345,positive regulation of post-transcriptional gene silencing by RNA (GO:1900370),-1.9547408134678223e-10,0.0
15346,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-1.9547408134678223e-10,0.0
15347,positive regulation of nucleotide biosynthetic process (GO:0030810),-1.9547408134678223e-10,0.0
15348,axon regeneration (GO:0031103),-1.9547408134678223e-10,0.0
15349,pyrimidine deoxyribonucleotide metabolic process (GO:0009219),-1.9547408134678223e-10,0.0
15350,mitochondrion transport along microtubule (GO:0047497),-1.9547408134678223e-10,0.0
15351,positive regulation of histone deacetylation (GO:0031065),-1.9547408134678223e-10,0.0
15352,negative regulation of histone methylation (GO:0031061),-1.9547408134678223e-10,0.0
15353,deoxyribonucleoside monophosphate metabolic process (GO:0009162),-1.9547408134678223e-10,0.0
15354,L-glutamate transmembrane transport (GO:0015813),-1.9547408134678223e-10,0.0
15355,pyrimidine nucleoside triphosphate metabolic process (GO:0009147),-1.9547408134678223e-10,0.0
15356,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-1.9547408134678223e-10,0.0
15357,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-1.9547408134678223e-10,0.0
15358,regulation of hippo signaling (GO:0035330),-1.9547408134678223e-10,0.0
15359,positive regulation of viral life cycle (GO:1903902),-1.9547408134678223e-10,0.0
15360,glutamine family amino acid catabolic process (GO:0009065),-1.9547408134678223e-10,0.0
15361,regulation of hormone biosynthetic process (GO:0046885),-1.9547408134678223e-10,0.0
15362,acid secretion (GO:0046717),-1.9547408134678223e-10,0.0
15363,negative regulation of TORC1 signaling (GO:1904262),-1.9547408134678223e-10,0.0
15364,negative regulation of anion transport (GO:1903792),-1.9547408134678223e-10,0.0
15365,regulation of cardiac conduction (GO:1903779),-1.9547408134678223e-10,0.0
15366,decidualization (GO:0046697),-1.9547408134678223e-10,0.0
15367,positive regulation of macrophage cytokine production (GO:0060907),-1.9547408134678223e-10,0.0
15368,"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-1.9547408134678223e-10,0.0
15369,establishment or maintenance of monopolar cell polarity (GO:0061339),-1.9547408134678223e-10,0.0
15370,negative regulation of blood circulation (GO:1903523),-1.9547408134678223e-10,0.0
15371,microtubule anchoring (GO:0034453),-1.9547408134678223e-10,0.0
15372,protein refolding (GO:0042026),-1.9547408134678223e-10,0.0
15373,diacylglycerol metabolic process (GO:0046339),-1.9547408134678223e-10,0.0
15374,glucuronate metabolic process (GO:0019585),-1.9547408134678223e-10,0.0
15375,forebrain neuron development (GO:0021884),-1.9547408134678223e-10,0.0
15376,hypothalamus development (GO:0021854),-1.9547408134678223e-10,0.0
15377,purine-containing compound transmembrane transport (GO:0072530),-1.9547408134678223e-10,0.0
15378,outflow tract septum morphogenesis (GO:0003148),-1.9547408134678223e-10,0.0
15379,nitric oxide metabolic process (GO:0046209),-1.9547408134678223e-10,0.0
15380,somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562),-1.9617307776294936e-10,0.0
15381,cell adhesion mediated by integrin (GO:0033627),-1.9617307776294936e-10,0.0
15382,regulation of T cell mediated cytotoxicity (GO:0001914),-1.9617307776294936e-10,0.0
15383,acyl-CoA biosynthetic process (GO:0071616),-1.9617307776294936e-10,0.0
15384,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-1.9617307776294936e-10,0.0
15385,'de novo' protein folding (GO:0006458),-1.9617307776294936e-10,0.0
15386,cellular response to osmotic stress (GO:0071470),-1.9617307776294936e-10,0.0
15387,regulation of interleukin-17 production (GO:0032660),-1.9617307776294936e-10,0.0
15388,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-1.9617307776294936e-10,0.0
15389,amino sugar metabolic process (GO:0006040),-1.9617307776294936e-10,0.0
15390,regulation of p38MAPK cascade (GO:1900744),-1.9617307776294936e-10,0.0
15391,establishment of spindle orientation (GO:0051294),-1.9617307776294936e-10,0.0
15392,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-1.9617307776294936e-10,0.0
15393,interstrand cross-link repair (GO:0036297),-1.9617307776294936e-10,0.0
15394,neuron cellular homeostasis (GO:0070050),-1.9617307776294936e-10,0.0
15395,negative regulation of actin filament depolymerization (GO:0030835),-1.9617307776294936e-10,0.0
15396,regulation of nucleotide biosynthetic process (GO:0030808),-1.9617307776294936e-10,0.0
15397,somatic cell DNA recombination (GO:0016444),-1.9617307776294936e-10,0.0
15398,vesicle transport along microtubule (GO:0047496),-1.9617307776294936e-10,0.0
15399,cyclic nucleotide metabolic process (GO:0009187),-1.9617307776294936e-10,0.0
15400,collagen catabolic process (GO:0030574),-1.9617307776294936e-10,0.0
15401,thioester biosynthetic process (GO:0035384),-1.9617307776294936e-10,0.0
15402,cell-substrate junction organization (GO:0150115),-1.9617307776294936e-10,0.0
15403,cellular modified amino acid biosynthetic process (GO:0042398),-1.9617307776294936e-10,0.0
15404,negative regulation of muscle cell apoptotic process (GO:0010656),-1.9617307776294936e-10,0.0
15405,heme metabolic process (GO:0042168),-1.9617307776294936e-10,0.0
15406,regulation of lamellipodium assembly (GO:0010591),-1.9617307776294936e-10,0.0
15407,negative regulation of mitotic nuclear division (GO:0045839),-1.9617307776294936e-10,0.0
15408,lactation (GO:0007595),-1.9617307776294936e-10,0.0
15409,maintenance of protein localization in organelle (GO:0072595),-1.9617307776294936e-10,0.0
15410,positive regulation of DNA replication (GO:0045740),-1.9679369243359286e-10,0.0
15411,binding of sperm to zona pellucida (GO:0007339),-1.9679369243359286e-10,0.0
15412,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-1.9679369243359286e-10,0.0
15413,cell-substrate junction assembly (GO:0007044),-1.9679369243359286e-10,0.0
15414,positive regulation of RNA splicing (GO:0033120),-1.9679369243359286e-10,0.0
15415,cellular response to estradiol stimulus (GO:0071392),-1.9679369243359286e-10,0.0
15416,negative regulation of DNA biosynthetic process (GO:2000279),-1.9679369243359286e-10,0.0
15417,regulation of triglyceride metabolic process (GO:0090207),-1.9679369243359286e-10,0.0
15418,protein depolymerization (GO:0051261),-1.9679369243359286e-10,0.0
15419,regulation of endocrine process (GO:0044060),-1.9679369243359286e-10,0.0
15420,regulation of purine nucleotide biosynthetic process (GO:1900371),-1.9679369243359286e-10,0.0
15421,hydrogen peroxide metabolic process (GO:0042743),-1.9679369243359286e-10,0.0
15422,cellular response to amyloid-beta (GO:1904646),-1.9679369243359286e-10,0.0
15423,zinc ion homeostasis (GO:0055069),-1.9679369243359286e-10,0.0
15424,T cell homeostasis (GO:0043029),-1.9679369243359286e-10,0.0
15425,positive regulation of phospholipase C activity (GO:0010863),-1.9679369243359286e-10,0.0
15426,neuroinflammatory response (GO:0150076),-1.9679369243359286e-10,0.0
15427,synaptic vesicle localization (GO:0097479),-1.9679369243359286e-10,0.0
15428,negative regulation of fatty acid metabolic process (GO:0045922),-1.9679369243359286e-10,0.0
15429,adipose tissue development (GO:0060612),-1.9679369243359286e-10,0.0
15430,establishment of protein localization to endoplasmic reticulum (GO:0072599),-1.9679369243359286e-10,0.0
15431,regulation of cellular extravasation (GO:0002691),-1.9679369243359286e-10,0.0
15432,lipid translocation (GO:0034204),-1.9960877393427445e-10,0.0
15433,cranial nerve development (GO:0021545),-1.9960877393427445e-10,0.0
15434,glutathione metabolic process (GO:0006749),-1.9960877393427445e-10,0.0
15435,vacuolar localization (GO:1990849),-1.9960877393427445e-10,0.0
15436,DNA methylation (GO:0006306),-1.9960877393427445e-10,0.0
15437,DNA alkylation (GO:0006305),-1.9960877393427445e-10,0.0
15438,cellular response to cAMP (GO:0071320),-1.9960877393427445e-10,0.0
15439,regulation of DNA-templated DNA replication (GO:0090329),-1.9960877393427445e-10,0.0
15440,export across plasma membrane (GO:0140115),-1.9960877393427445e-10,0.0
15441,lysosome localization (GO:0032418),-1.9960877393427445e-10,0.0
15442,regulation of ubiquitin-protein transferase activity (GO:0051438),-1.9960877393427445e-10,0.0
15443,non-motile cilium assembly (GO:1905515),-1.9960877393427445e-10,0.0
15444,autophagy of mitochondrion (GO:0000422),-1.9960877393427445e-10,0.0
15445,RNA polymerase II preinitiation complex assembly (GO:0051123),-1.9960877393427445e-10,0.0
15446,microtubule polymerization or depolymerization (GO:0031109),-1.9960877393427445e-10,0.0
15447,mitochondrion disassembly (GO:0061726),-1.9960877393427445e-10,0.0
15448,nucleoside metabolic process (GO:0009116),-1.9960877393427445e-10,0.0
15449,regulation of cytokine production involved in inflammatory response (GO:1900015),-1.9960877393427445e-10,0.0
15450,ceramide biosynthetic process (GO:0046513),-1.9960877393427445e-10,0.0
15451,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002823),-1.9960877393427445e-10,0.0
15452,regulation of muscle hypertrophy (GO:0014743),-1.9960877393427445e-10,0.0
15453,polyol biosynthetic process (GO:0046173),-1.9991586162282443e-10,0.0
15454,mammary gland morphogenesis (GO:0060443),-1.9991586162282443e-10,0.0
15455,negative regulation of osteoblast differentiation (GO:0045668),-1.9991586162282443e-10,0.0
15456,regulation of glycoprotein metabolic process (GO:1903018),-1.9991586162282443e-10,0.0
15457,porphyrin-containing compound metabolic process (GO:0006778),-1.9991586162282443e-10,0.0
15458,sister chromatid cohesion (GO:0007062),-1.9991586162282443e-10,0.0
15459,negative regulation of nuclear division (GO:0051784),-1.9991586162282443e-10,0.0
15460,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-1.9991586162282443e-10,0.0
15461,purine nucleotide catabolic process (GO:0006195),-1.9991586162282443e-10,0.0
15462,regulation of spindle organization (GO:0090224),-1.9991586162282443e-10,0.0
15463,positive regulation of TOR signaling (GO:0032008),-1.9991586162282443e-10,0.0
15464,response to nerve growth factor (GO:1990089),-1.9991586162282443e-10,0.0
15465,positive regulation of receptor signaling pathway via STAT (GO:1904894),-1.9991586162282443e-10,0.0
15466,phospholipid catabolic process (GO:0009395),-1.9991586162282443e-10,0.0
15467,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-1.9991586162282443e-10,0.0
15468,ovulation cycle process (GO:0022602),-1.9991586162282443e-10,0.0
15469,regulation of viral entry into host cell (GO:0046596),-1.9991586162282443e-10,0.0
15470,insulin secretion (GO:0030073),-1.9991586162282443e-10,0.0
15471,regulation of TORC1 signaling (GO:1903432),-1.9991586162282443e-10,0.0
15472,regulation of alcohol biosynthetic process (GO:1902930),-1.9991586162282443e-10,0.0
15473,neuron recognition (GO:0008038),-1.9991586162282443e-10,0.0
15474,regulation of protein targeting to mitochondrion (GO:1903214),-2.0161983192067703e-10,0.0
15475,positive regulation of myoblast differentiation (GO:0045663),-2.0161983192067703e-10,0.0
15476,extracellular transport (GO:0006858),-2.0161983192067703e-10,0.0
15477,protein-lipid complex subunit organization (GO:0071825),-2.0161983192067703e-10,0.0
15478,regulation of autophagosome assembly (GO:2000785),-2.0161983192067703e-10,0.0
15479,regulation of post-transcriptional gene silencing (GO:0060147),-2.0161983192067703e-10,0.0
15480,regulation of natural killer cell activation (GO:0032814),-2.0161983192067703e-10,0.0
15481,regulation of amino acid transport (GO:0051955),-2.0161983192067703e-10,0.0
15482,modulation by host of viral process (GO:0044788),-2.0161983192067703e-10,0.0
15483,positive regulation of ATP-dependent activity (GO:0032781),-2.0161983192067703e-10,0.0
15484,regulation of mast cell activation (GO:0033003),-2.0161983192067703e-10,0.0
15485,positive regulation of cytokinesis (GO:0032467),-2.0161983192067703e-10,0.0
15486,protein K63-linked ubiquitination (GO:0070534),-2.0161983192067703e-10,0.0
15487,positive chemotaxis (GO:0050918),-2.0161983192067703e-10,0.0
15488,regulation of T cell receptor signaling pathway (GO:0050856),-2.0161983192067703e-10,0.0
15489,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-2.0161983192067703e-10,0.0
15490,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-2.0161983192067703e-10,0.0
15491,regulation of defense response to virus by host (GO:0050691),-2.0161983192067703e-10,0.0
15492,regulation of postsynaptic membrane neurotransmitter receptor levels (GO:0099072),-2.0161983192067703e-10,0.0
15493,mRNA transcription by RNA polymerase II (GO:0042789),-2.0161983192067703e-10,0.0
15494,regulation of long-term synaptic potentiation (GO:1900271),-2.0161983192067703e-10,0.0
15495,deoxyribonucleotide metabolic process (GO:0009262),-2.0161983192067703e-10,0.0
15496,tRNA aminoacylation (GO:0043039),-2.0161983192067703e-10,0.0
15497,regulation of histone deacetylation (GO:0031063),-2.0161983192067703e-10,0.0
15498,positive regulation of nitric oxide metabolic process (GO:1904407),-2.0161983192067703e-10,0.0
15499,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-2.0161983192067703e-10,0.0
15500,inner ear auditory receptor cell differentiation (GO:0042491),-2.0161983192067703e-10,0.0
15501,hormone biosynthetic process (GO:0042446),-2.0161983192067703e-10,0.0
15502,sterol biosynthetic process (GO:0016126),-2.0161983192067703e-10,0.0
15503,autophagosome maturation (GO:0097352),-2.0161983192067703e-10,0.0
15504,glial cell migration (GO:0008347),-2.0161983192067703e-10,0.0
15505,deoxyribose phosphate metabolic process (GO:0019692),-2.0161983192067703e-10,0.0
15506,anterograde axonal transport (GO:0008089),-2.0161983192067703e-10,0.0
15507,positive regulation of mitotic nuclear division (GO:0045840),-2.0161983192067703e-10,0.0
15508,regulation of dendritic spine morphogenesis (GO:0061001),-2.0161983192067703e-10,0.0
15509,vesicle docking involved in exocytosis (GO:0006904),-2.0627188843751258e-10,0.0
15510,leukocyte apoptotic process (GO:0071887),-2.0627188843751258e-10,0.0
15511,regulation of mitotic spindle organization (GO:0060236),-2.0627188843751258e-10,0.0
15512,nuclear membrane organization (GO:0071763),-2.0627188843751258e-10,0.0
15513,photoreceptor cell maintenance (GO:0045494),-2.0627188843751258e-10,0.0
15514,response to dexamethasone (GO:0071548),-2.0627188843751258e-10,0.0
15515,regulation of chromatin organization (GO:1902275),-2.0627188843751258e-10,0.0
15516,translational elongation (GO:0006414),-2.0627188843751258e-10,0.0
15517,negative regulation of reactive oxygen species metabolic process (GO:2000378),-2.0627188843751258e-10,0.0
15518,negative regulation of organelle assembly (GO:1902116),-2.0627188843751258e-10,0.0
15519,regulation of transcription by RNA polymerase I (GO:0006356),-2.0627188843751258e-10,0.0
15520,cellular response to type I interferon (GO:0071357),-2.0627188843751258e-10,0.0
15521,potassium ion import across plasma membrane (GO:1990573),-2.0627188843751258e-10,0.0
15522,negative regulation of intracellular protein transport (GO:0090317),-2.0627188843751258e-10,0.0
15523,regulation of protein autophosphorylation (GO:0031952),-2.0627188843751258e-10,0.0
15524,membrane fission (GO:0090148),-2.0627188843751258e-10,0.0
15525,neuron projection organization (GO:0106027),-2.0627188843751258e-10,0.0
15526,modulation of excitatory postsynaptic potential (GO:0098815),-2.0627188843751258e-10,0.0
15527,regulation of macrophage migration (GO:1905521),-2.0627188843751258e-10,0.0
15528,endodermal cell differentiation (GO:0035987),-2.0627188843751258e-10,0.0
15529,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-2.0627188843751258e-10,0.0
15530,histone deubiquitination (GO:0016578),-2.0627188843751258e-10,0.0
15531,regulation of post-transcriptional gene silencing by RNA (GO:1900368),-2.0627188843751258e-10,0.0
15532,apoptotic cell clearance (GO:0043277),-2.0627188843751258e-10,0.0
15533,2'-deoxyribonucleotide metabolic process (GO:0009394),-2.0627188843751258e-10,0.0
15534,developmental pigmentation (GO:0048066),-2.0627188843751258e-10,0.0
15535,somatic diversification of immunoglobulins (GO:0016445),-2.0627188843751258e-10,0.0
15536,purine nucleoside monophosphate metabolic process (GO:0009126),-2.0627188843751258e-10,0.0
15537,nucleoside monophosphate biosynthetic process (GO:0009124),-2.0627188843751258e-10,0.0
15538,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-2.0627188843751258e-10,0.0
15539,cardiac muscle cell contraction (GO:0086003),-2.0627188843751258e-10,0.0
15540,phospholipid dephosphorylation (GO:0046839),-2.0627188843751258e-10,0.0
15541,regulation of keratinocyte proliferation (GO:0010837),-2.0627188843751258e-10,0.0
15542,regulation of peptidyl-threonine phosphorylation (GO:0010799),-2.0627188843751258e-10,0.0
15543,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-2.0627188843751258e-10,0.0
15544,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-2.0627188843751258e-10,0.0
15545,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-2.0627188843751258e-10,0.0
15546,cell junction maintenance (GO:0034331),-2.0627188843751258e-10,0.0
15547,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-2.1892221366661204e-10,0.0
15548,positive regulation of cilium assembly (GO:0045724),-2.1892221366661204e-10,0.0
15549,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-2.1892221366661204e-10,0.0
15550,polyol catabolic process (GO:0046174),-2.1892221366661204e-10,0.0
15551,regulation of osteoblast proliferation (GO:0033688),-2.1892221366661204e-10,0.0
15552,regulation of nucleotide-excision repair (GO:2000819),-2.1892221366661204e-10,0.0
15553,mast cell mediated immunity (GO:0002448),-2.1892221366661204e-10,0.0
15554,positive regulation of extracellular matrix organization (GO:1903055),-2.1892221366661204e-10,0.0
15555,sperm axoneme assembly (GO:0007288),-2.1892221366661204e-10,0.0
15556,histone H2A ubiquitination (GO:0033522),-2.1892221366661204e-10,0.0
15557,postsynaptic membrane organization (GO:0001941),-2.1892221366661204e-10,0.0
15558,negative regulation of stem cell differentiation (GO:2000737),-2.1892221366661204e-10,0.0
15559,male meiosis I (GO:0007141),-2.1892221366661204e-10,0.0
15560,cytokine production (GO:0001816),-2.1892221366661204e-10,0.0
15561,positive regulation of granulocyte chemotaxis (GO:0071624),-2.1892221366661204e-10,0.0
15562,microtubule nucleation (GO:0007020),-2.1892221366661204e-10,0.0
15563,positive regulation of natural killer cell activation (GO:0032816),-2.1892221366661204e-10,0.0
15564,cellular response to dexamethasone stimulus (GO:0071549),-2.1892221366661204e-10,0.0
15565,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-2.1892221366661204e-10,0.0
15566,positive regulation of interleukin-17 production (GO:0032740),-2.1892221366661204e-10,0.0
15567,response to isoquinoline alkaloid (GO:0014072),-2.1892221366661204e-10,0.0
15568,chondrocyte development (GO:0002063),-2.1892221366661204e-10,0.0
15569,regulation of glycogen biosynthetic process (GO:0005979),-2.1892221366661204e-10,0.0
15570,epiboly involved in wound healing (GO:0090505),-2.1892221366661204e-10,0.0
15571,transcription by RNA polymerase I (GO:0006360),-2.1892221366661204e-10,0.0
15572,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-2.1892221366661204e-10,0.0
15573,cellular response to copper ion (GO:0071280),-2.1892221366661204e-10,0.0
15574,positive regulation of protein autophosphorylation (GO:0031954),-2.1892221366661204e-10,0.0
15575,positive regulation of chromosome separation (GO:1905820),-2.1892221366661204e-10,0.0
15576,"wound healing, spreading of cells (GO:0044319)",-2.1892221366661204e-10,0.0
15577,positive regulation of lipid catabolic process (GO:0050996),-2.1892221366661204e-10,0.0
15578,regulation of axon regeneration (GO:0048679),-2.1892221366661204e-10,0.0
15579,negative regulation of oxidoreductase activity (GO:0051354),-2.1892221366661204e-10,0.0
15580,positive regulation of behavior (GO:0048520),-2.1892221366661204e-10,0.0
15581,positive regulation of p38MAPK cascade (GO:1900745),-2.1892221366661204e-10,0.0
15582,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-2.1892221366661204e-10,0.0
15583,maturation of LSU-rRNA (GO:0000470),-2.1892221366661204e-10,0.0
15584,cleavage involved in rRNA processing (GO:0000469),-2.1892221366661204e-10,0.0
15585,ruffle organization (GO:0031529),-2.1892221366661204e-10,0.0
15586,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-2.1892221366661204e-10,0.0
15587,renal absorption (GO:0070293),-2.1892221366661204e-10,0.0
15588,mesodermal cell differentiation (GO:0048333),-2.1892221366661204e-10,0.0
15589,negative regulation of biomineral tissue development (GO:0070168),-2.1892221366661204e-10,0.0
15590,response to increased oxygen levels (GO:0036296),-2.1892221366661204e-10,0.0
15591,negative regulation of cell killing (GO:0031342),-2.1892221366661204e-10,0.0
15592,histone lysine demethylation (GO:0070076),-2.1892221366661204e-10,0.0
15593,response to morphine (GO:0043278),-2.1892221366661204e-10,0.0
15594,oligosaccharide biosynthetic process (GO:0009312),-2.1892221366661204e-10,0.0
15595,hydrogen peroxide catabolic process (GO:0042744),-2.1892221366661204e-10,0.0
15596,focal adhesion assembly (GO:0048041),-2.1892221366661204e-10,0.0
15597,protein localization to postsynapse (GO:0062237),-2.1892221366661204e-10,0.0
15598,regulation of hair cycle (GO:0042634),-2.1892221366661204e-10,0.0
15599,response to lipoprotein particle (GO:0055094),-2.1892221366661204e-10,0.0
15600,positive regulation of cardiac muscle tissue growth (GO:0055023),-2.1892221366661204e-10,0.0
15601,purine ribonucleotide transport (GO:0015868),-2.1892221366661204e-10,0.0
15602,response to auditory stimulus (GO:0010996),-2.1892221366661204e-10,0.0
15603,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-2.1892221366661204e-10,0.0
15604,regulation of glucan biosynthetic process (GO:0010962),-2.1892221366661204e-10,0.0
15605,negative regulation of viral life cycle (GO:1903901),-2.1892221366661204e-10,0.0
15606,negative regulation of protein localization to cell periphery (GO:1904376),-2.1892221366661204e-10,0.0
15607,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-2.1892221366661204e-10,0.0
15608,telomere maintenance via telomere lengthening (GO:0010833),-2.1892221366661204e-10,0.0
15609,positive regulation of collagen metabolic process (GO:0010714),-2.1892221366661204e-10,0.0
15610,establishment of skin barrier (GO:0061436),-2.1892221366661204e-10,0.0
15611,cGMP-mediated signaling (GO:0019934),-2.1892221366661204e-10,0.0
15612,purine nucleoside metabolic process (GO:0042278),-2.1892221366661204e-10,0.0
15613,negative regulation of cardiac muscle hypertrophy (GO:0010614),-2.1892221366661204e-10,0.0
15614,metanephros morphogenesis (GO:0003338),-2.1892221366661204e-10,0.0
15615,muscle cell migration (GO:0014812),-2.1892221366661204e-10,0.0
15616,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-2.1892221366661204e-10,0.0
15617,positive regulation of isotype switching (GO:0045830),-2.1892221366661204e-10,0.0
15618,multivesicular body sorting pathway (GO:0071985),-2.3030399806790774e-10,0.0
15619,regulation of cell adhesion mediated by integrin (GO:0033628),-2.3030399806790774e-10,0.0
15620,regulation of neuron migration (GO:2001222),-2.3030399806790774e-10,0.0
15621,epidermal growth factor receptor signaling pathway (GO:0007173),-2.3030399806790774e-10,0.0
15622,regulation of cell cycle checkpoint (GO:1901976),-2.3030399806790774e-10,0.0
15623,negative regulation of stress-activated MAPK cascade (GO:0032873),-2.3030399806790774e-10,0.0
15624,negative regulation of interleukin-6 production (GO:0032715),-2.3030399806790774e-10,0.0
15625,axon extension (GO:0048675),-2.3030399806790774e-10,0.0
15626,oocyte development (GO:0048599),-2.3030399806790774e-10,0.0
15627,protein sumoylation (GO:0016925),-2.3030399806790774e-10,0.0
15628,negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-2.3030399806790774e-10,0.0
15629,regulation of cellular respiration (GO:0043457),-2.3030399806790774e-10,0.0
15630,lung alveolus development (GO:0048286),-2.3030399806790774e-10,0.0
15631,response to exogenous dsRNA (GO:0043330),-2.3030399806790774e-10,0.0
15632,negative regulation of epithelial cell differentiation (GO:0030857),-2.3030399806790774e-10,0.0
15633,establishment of protein localization to plasma membrane (GO:0061951),-2.3030399806790774e-10,0.0
15634,response to amyloid-beta (GO:1904645),-2.3030399806790774e-10,0.0
15635,anion homeostasis (GO:0055081),-2.3030399806790774e-10,0.0
15636,negative regulation of histone modification (GO:0031057),-2.3030399806790774e-10,0.0
15637,aspartate family amino acid metabolic process (GO:0009066),-2.3030399806790774e-10,0.0
15638,positive regulation of protein dephosphorylation (GO:0035307),-2.3030399806790774e-10,0.0
15639,negative regulation of dephosphorylation (GO:0035305),-2.3030399806790774e-10,0.0
15640,cardiac muscle cell action potential (GO:0086001),-2.3030399806790774e-10,0.0
15641,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-2.3030399806790774e-10,0.0
15642,response to antibiotic (GO:0046677),-2.3030399806790774e-10,0.0
15643,antigen processing and presentation of exogenous antigen (GO:0019884),-2.3030399806790774e-10,0.0
15644,response to nicotine (GO:0035094),-2.3030399806790774e-10,0.0
15645,sperm-egg recognition (GO:0035036),-2.3030399806790774e-10,0.0
15646,negative regulation of leukocyte migration (GO:0002686),-2.3030399806790774e-10,0.0
15647,membrane protein proteolysis (GO:0033619),-2.521909347700879e-10,0.0
15648,head morphogenesis (GO:0060323),-2.521909347700879e-10,0.0
15649,cellular zinc ion homeostasis (GO:0006882),-2.521909347700879e-10,0.0
15650,regulation of systemic arterial blood pressure by hormone (GO:0001990),-2.521909347700879e-10,0.0
15651,regulation of collagen biosynthetic process (GO:0032965),-2.521909347700879e-10,0.0
15652,inner mitochondrial membrane organization (GO:0007007),-2.521909347700879e-10,0.0
15653,detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-2.521909347700879e-10,0.0
15654,negative regulation of interleukin-1 production (GO:0032692),-2.521909347700879e-10,0.0
15655,transcription elongation by RNA polymerase II promoter (GO:0006368),-2.521909347700879e-10,0.0
15656,cellular response to alkaloid (GO:0071312),-2.521909347700879e-10,0.0
15657,glycosyl compound catabolic process (GO:1901658),-2.521909347700879e-10,0.0
15658,cytokinetic process (GO:0032506),-2.521909347700879e-10,0.0
15659,actin filament capping (GO:0051693),-2.521909347700879e-10,0.0
15660,erythrocyte development (GO:0048821),-2.521909347700879e-10,0.0
15661,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-2.521909347700879e-10,0.0
15662,positive regulation of lipid kinase activity (GO:0090218),-2.521909347700879e-10,0.0
15663,"regulation of synaptic transmission, GABAergic (GO:0032228)",-2.521909347700879e-10,0.0
15664,regulation of G0 to G1 transition (GO:0070316),-2.521909347700879e-10,0.0
15665,negative regulation of lymphocyte apoptotic process (GO:0070229),-2.521909347700879e-10,0.0
15666,'de novo' post-translational protein folding (GO:0051084),-2.521909347700879e-10,0.0
15667,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-2.521909347700879e-10,0.0
15668,nucleotide-sugar metabolic process (GO:0009225),-2.521909347700879e-10,0.0
15669,negative regulation of protein localization to nucleus (GO:1900181),-2.521909347700879e-10,0.0
15670,embryonic camera-type eye development (GO:0031076),-2.521909347700879e-10,0.0
15671,ribonucleoside metabolic process (GO:0009119),-2.521909347700879e-10,0.0
15672,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-2.521909347700879e-10,0.0
15673,snRNA processing (GO:0016180),-2.521909347700879e-10,0.0
15674,organic cation transport (GO:0015695),-2.521909347700879e-10,0.0
15675,heparan sulfate proteoglycan metabolic process (GO:0030201),-2.521909347700879e-10,0.0
15676,regulation of sprouting angiogenesis (GO:1903670),-2.521909347700879e-10,0.0
15677,positive regulation of smooth muscle cell migration (GO:0014911),-2.521909347700879e-10,0.0
15678,cardiac atrium development (GO:0003230),-2.521909347700879e-10,0.0
15679,regulation of fatty acid oxidation (GO:0046320),-2.521909347700879e-10,0.0
